data_5jyn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5jyn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.511 2.62 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -68.16 -48.25 65.82 Favored 'General case' 0 N--CA 1.528 3.468 0 CA-C-O 121.711 0.767 . . . . 0.0 110.741 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -61.54 -33.45 73.87 Favored 'General case' 0 N--CA 1.527 3.382 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.101 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.4 mm -76.23 -34.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.456 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -53.41 26.3 Favored 'General case' 1 N--CA 1.546 4.372 0 O-C-N 121.721 -0.612 . . . . 0.0 111.988 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.9 tt -55.52 -35.3 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 CA-C-O 122.479 1.133 . . . . 0.0 110.234 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -58.83 -33.68 70.68 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 112.933 -1.939 . . . . 0.0 110.478 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.0 mm -68.64 -37.93 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.072 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 24.1 mt -58.25 -39.23 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.25 -44.42 99.1 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.015 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 67.0 t -64.36 -30.35 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.943 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.83 -33.73 88.01 Favored Glycine 0 N--CA 1.514 3.883 0 C-N-CA 123.87 0.748 . . . . 0.0 112.124 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.9 m -68.16 -37.04 80.59 Favored 'General case' 0 N--CA 1.526 3.331 0 C-N-CA 123.362 0.665 . . . . 0.0 111.009 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.97 -43.23 91.34 Favored 'General case' 0 N--CA 1.537 3.921 0 C-N-CA 123.212 0.605 . . . . 0.0 111.787 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.268 0.8 OUTLIER -63.66 -48.88 84.67 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -175.718 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.43 -25.61 65.26 Favored Glycine 1 N--CA 1.526 4.694 0 O-C-N 120.704 -1.248 . . . . 0.0 112.981 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.33 -38.74 88.37 Favored 'General case' 0 N--CA 1.536 3.86 0 C-N-CA 124.116 0.967 . . . . 0.0 110.604 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -52.03 -23.74 5.66 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 18.6 tt -51.96 -36.42 19.77 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.178 0 CA-C-N 119.444 1.02 . . . . 0.0 111.333 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 11.2 p -54.64 -27.42 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 C-N-CA 124.235 1.014 . . . . 0.0 111.107 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -55.07 -28.79 55.02 Favored 'General case' 1 N--CA 1.545 4.319 0 O-C-N 121.692 -0.63 . . . . 0.0 109.879 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.19 -45.03 67.49 Favored 'General case' 0 N--CA 1.522 3.14 0 CA-C-O 122.031 0.92 . . . . 0.0 108.966 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.7 -34.31 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.816 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.233 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.6 tp -55.64 -34.81 65.27 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.965 0.906 . . . . 0.0 111.021 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 51.0 m -59.1 -45.02 91.94 Favored 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 35.7 tp -67.66 -34.8 77.65 Favored 'General case' 0 N--CA 1.538 3.95 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 66.1 t -67.86 -39.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.828 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 710' ' ' GLN . 16.1 m120 -59.21 -23.63 62.44 Favored 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.891 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 22.8 tpt85 -48.07 -41.02 24.93 Favored 'General case' 0 N--CA 1.524 3.269 0 CA-C-O 121.372 0.606 . . . . 0.0 110.84 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 52.9 t -72.6 -41.97 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-N 114.689 -1.141 . . . . 0.0 107.944 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -76.72 -11.35 59.83 Favored 'General case' 1 N--CA 1.545 4.298 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.417 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 706' ' ' ASN . 1.4 tm0? -111.87 -10.4 14.0 Favored 'General case' 0 N--CA 1.516 2.851 0 C-N-CA 125.549 1.54 . . . . 0.0 107.634 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.13 -22.83 7.04 Favored Glycine 1 N--CA 1.518 4.135 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -98.39 153.46 18.55 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 124.076 0.95 . . . . 0.0 109.472 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 66.1 m -80.51 152.17 72.55 Favored Pre-proline 0 N--CA 1.526 3.345 0 C-N-CA 126.859 2.064 . . . . 0.0 111.216 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 C--N 1.401 3.302 0 CA-C-N 121.527 1.581 . . . . 0.0 111.74 -174.719 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.518 2.929 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -63.36 -49.52 73.55 Favored 'General case' 0 N--CA 1.532 3.643 0 CA-C-N 118.367 0.531 . . . . 0.0 111.32 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -64.0 -31.53 72.75 Favored 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.88 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.02 -32.22 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.864 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.26 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -51.57 48.87 Favored 'General case' 1 N--CA 1.554 4.745 0 CA-C-N 118.713 0.688 . . . . 0.0 112.057 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.8 tt -62.1 -31.66 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-O 122.029 0.918 . . . . 0.0 110.779 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -51.94 -35.29 45.34 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.762 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.22 -41.56 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.082 0 C-N-CA 124.607 1.163 . . . . 0.0 108.788 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 47.3 mt -60.38 -37.37 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 64.0 mt -64.62 -44.79 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.43 -30.32 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 C-N-CA 123.827 0.851 . . . . 0.0 108.727 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.26 -30.58 78.1 Favored Glycine 1 N--CA 1.517 4.054 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 32.4 m -68.79 -37.59 79.4 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.431 0.692 . . . . 0.0 111.413 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.32 -41.4 75.94 Favored 'General case' 0 N--CA 1.535 3.781 0 C-N-CA 123.443 0.697 . . . . 0.0 111.932 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . 0.292 0.3 OUTLIER -60.7 -46.1 96.47 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.386 0 CA-C-N 118.956 0.798 . . . . 0.0 112.206 -176.485 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.83 -27.68 64.67 Favored Glycine 1 N--CA 1.528 4.833 0 CA-C-N 119.159 0.89 . . . . 0.0 112.307 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.4 tt -67.93 -37.38 81.58 Favored 'General case' 1 N--CA 1.548 4.431 0 C-N-CA 125.126 1.37 . . . . 0.0 109.31 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -62.89 -27.37 69.31 Favored 'General case' 1 N--CA 1.54 4.073 0 C-N-CA 123.806 0.842 . . . . 0.0 112.336 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.51 -38.78 50.73 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.593 0 CA-C-O 122.477 1.132 . . . . 0.0 109.473 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 64.3 t -57.21 -29.6 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.032 0 C-N-CA 126.962 2.105 . . . . 0.0 111.293 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -53.75 -26.92 25.7 Favored 'General case' 0 N--CA 1.534 3.774 0 C-N-CA 122.976 0.51 . . . . 0.0 111.16 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.42 -35.14 67.48 Favored 'General case' 0 N--CA 1.528 3.449 0 O-C-N 121.956 -0.465 . . . . 0.0 109.849 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.7 -32.7 53.32 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.343 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 7.9 tp -54.97 -33.67 62.62 Favored 'General case' 0 N--CA 1.539 3.999 0 C-N-CA 124.087 0.955 . . . . 0.0 110.421 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 703' ' ' SER . . . . . 0.589 ' HG ' HD21 ' C' ' 706' ' ' ASN . 84.9 p -59.01 -45.73 89.94 Favored 'General case' 0 N--CA 1.528 3.471 0 O-C-N 122.344 -0.223 . . . . 0.0 111.21 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.09 -36.56 84.0 Favored 'General case' 1 N--CA 1.548 4.427 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.74 -42.09 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.427 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -75.48 -21.41 58.09 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 123.126 0.57 . . . . 0.0 110.101 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.18 -42.63 60.98 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.52 -42.35 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.903 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -75.31 -7.54 54.23 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.225 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.99 -14.76 17.73 Favored 'General case' 1 N--CA 1.546 4.33 0 C-N-CA 124.201 1.0 . . . . 0.0 108.825 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -84.33 -18.15 63.08 Favored Glycine 1 N--CA 1.522 4.378 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -87.93 152.35 22.13 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 126.72 2.008 . . . . 0.0 108.285 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 67.0 m -93.23 148.63 36.0 Favored Pre-proline 1 N--CA 1.547 4.381 0 C-N-CA 125.914 1.686 . . . . 0.0 113.764 -176.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.404 3.46 0 CA-C-N 120.788 1.317 . . . . 0.0 109.76 -176.84 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 7.1 tt . . . . . 0 N--CA 1.516 2.86 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -61.6 -49.75 75.36 Favored 'General case' 0 N--CA 1.529 3.522 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -66.01 -33.73 76.48 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 95.5 mt -74.34 -25.33 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.807 0 C-N-CA 124.789 1.236 . . . . 0.0 110.445 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -50.69 62.52 Favored 'General case' 1 N--CA 1.555 4.82 0 CA-C-N 119.682 1.128 . . . . 0.0 110.133 -178.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.2 tt -66.25 -31.06 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 C-N-CA 123.71 0.804 . . . . 0.0 109.115 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -54.86 -28.38 49.66 Favored 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.015 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 21.4 mm -68.5 -44.13 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 C-N-CA 123.689 0.796 . . . . 0.0 109.548 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.71 -41.0 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.59 -47.35 93.36 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.91 -30.11 47.83 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.161 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.05 82.47 Favored Glycine 1 N--CA 1.516 4.029 0 C-N-CA 123.625 0.631 . . . . 0.0 112.408 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 62.4 m -67.9 -37.07 81.27 Favored 'General case' 0 N--CA 1.533 3.681 0 C-N-CA 123.463 0.705 . . . . 0.0 111.698 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.91 -40.81 77.01 Favored 'General case' 0 N--CA 1.533 3.689 0 C-N-CA 123.339 0.656 . . . . 0.0 111.868 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.62 -39.89 82.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -71.41 -25.56 75.11 Favored Glycine 1 N--CA 1.531 5.002 0 O-C-N 121.074 -1.016 . . . . 0.0 111.107 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.85 -43.38 98.96 Favored 'General case' 0 N--CA 1.535 3.806 0 C-N-CA 123.99 0.916 . . . . 0.0 109.392 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -54.2 -25.49 23.07 Favored 'General case' 0 N--CA 1.539 3.986 0 C-N-CA 125.045 1.338 . . . . 0.0 114.565 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 72.2 mt -53.84 -37.54 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.863 0 CA-C-N 118.541 0.609 . . . . 0.0 109.841 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.05 -26.18 32.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.238 0 C-N-CA 124.965 1.306 . . . . 0.0 111.971 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -53.59 -27.54 27.16 Favored 'General case' 1 N--CA 1.549 4.523 0 O-C-N 120.972 -1.08 . . . . 0.0 110.219 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.41 -46.07 91.67 Favored 'General case' 0 N--CA 1.525 3.325 0 O-C-N 121.967 -0.458 . . . . 0.0 110.881 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.1 -31.33 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.63 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.68 -34.16 57.79 Favored 'General case' 0 N--CA 1.536 3.86 0 C-N-CA 123.12 0.568 . . . . 0.0 110.742 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 86.9 p -59.67 -46.35 89.3 Favored 'General case' 0 N--CA 1.532 3.642 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 45.7 tp -65.8 -35.68 81.39 Favored 'General case' 1 N--CA 1.542 4.147 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.31 -43.45 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.38 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . 0.589 HD21 ' HG ' ' B' ' 703' ' ' SER . 5.5 m-20 -68.4 -25.43 65.04 Favored 'General case' 0 N--CA 1.515 2.8 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.25 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.09 -43.92 61.15 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 119.087 0.858 . . . . 0.0 109.233 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.25 -47.39 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.1 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -74.73 -15.72 60.77 Favored 'General case' 0 N--CA 1.535 3.792 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.895 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -114.12 -3.86 13.2 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -48.83 -27.81 6.71 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 124.399 0.999 . . . . 0.0 111.796 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -75.44 155.18 36.56 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 31.1 t -77.76 146.96 73.6 Favored Pre-proline 0 N--CA 1.536 3.865 0 C-N-CA 125.001 1.32 . . . . 0.0 112.584 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -58.51 129.95 35.02 Favored 'Trans proline' 0 C--N 1.408 3.699 0 CA-C-N 120.643 1.265 . . . . 0.0 110.234 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 60.3 tp . . . . . 0 N--CA 1.525 3.304 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.0 178.712 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 683' ' ' ARG . 18.6 mt . . . . . 0 N--CA 1.504 2.272 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -55.97 -45.38 78.92 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -73.18 -38.71 66.06 Favored 'General case' 0 N--CA 1.533 3.706 0 CA-C-O 121.555 0.693 . . . . 0.0 109.485 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.6 mm -74.89 -26.0 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 125.072 1.349 . . . . 0.0 111.276 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 679' ' ' LEU . 56.5 ttt180 -67.06 -55.7 13.21 Favored 'General case' 1 N--CA 1.542 4.146 0 C-N-CA 123.976 0.91 . . . . 0.0 110.56 -177.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.3 tt -64.4 -32.54 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.537 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -52.57 -44.02 65.62 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.946 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 66.5 mt -68.54 -37.22 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.445 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 42.9 mt -65.89 -34.69 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.697 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 48.3 mm -63.72 -42.46 96.05 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.383 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 88.0 t -64.98 -29.88 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.882 0 C-N-CA 123.664 0.786 . . . . 0.0 108.959 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -61.19 -36.84 93.01 Favored Glycine 1 N--CA 1.522 4.413 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 53.4 m -68.91 -37.34 78.89 Favored 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 124.027 0.931 . . . . 0.0 111.451 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.8 mp -58.04 -38.97 77.24 Favored 'General case' 1 N--CA 1.546 4.332 0 C-N-CA 124.175 0.99 . . . . 0.0 112.346 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.268 1.3 tp -69.23 -45.76 78.78 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.205 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -73.7 -12.21 80.66 Favored Glycine 1 N--CA 1.525 4.578 0 O-C-N 120.744 -1.222 . . . . 0.0 112.046 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.1 tt -70.48 -41.28 72.92 Favored 'General case' 0 N--CA 1.535 3.8 0 C-N-CA 124.127 0.971 . . . . 0.0 109.745 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -52.51 -28.41 20.39 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.952 0.901 . . . . 0.0 113.054 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 42.0 mm -56.39 -43.81 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.332 0 C-N-CA 124.041 0.936 . . . . 0.0 112.486 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 3.3 p -66.66 -51.91 51.32 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.623 0 CA-C-N 118.702 0.683 . . . . 0.0 112.618 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' A' ' 702' ' ' LEU 0.522 0.9 OUTLIER -54.8 -18.93 5.39 Favored 'General case' 0 C--O 1.165 -3.392 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.255 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -51.93 -29.51 20.52 Favored 'General case' 1 N--CA 1.539 4.012 0 O-C-N 120.93 -1.106 . . . . 0.0 109.009 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 12.7 m -62.75 -29.27 46.63 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.491 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 699' ' ' PHE . 7.1 tt -50.5 -34.64 25.88 Favored 'General case' 1 N--CA 1.541 4.113 0 C-N-CA 125.311 1.445 . . . . 0.0 110.955 -178.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 68.0 m -59.34 -45.32 91.7 Favored 'General case' 0 N--CA 1.534 3.772 0 CA-C-N 118.467 0.576 . . . . 0.0 110.78 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.06 -35.21 80.0 Favored 'General case' 1 N--CA 1.54 4.025 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.1 t -68.06 -39.78 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.788 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 710' ' ' GLN . 3.1 m120 -64.82 -24.6 67.6 Favored 'General case' 0 N--CA 1.512 2.674 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.61 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . 0.449 HH12 ' NH2' ' B' ' 707' ' ' ARG . 21.6 tpt180 -47.71 -30.86 4.16 Favored 'General case' 0 N--CA 1.529 3.486 0 C-N-CA 123.3 0.64 . . . . 0.0 111.446 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.1 t -75.03 -47.89 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.59 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.97 -12.19 59.96 Favored 'General case' 1 N--CA 1.549 4.496 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.707 179.254 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 706' ' ' ASN . 51.9 tt0 -112.81 -4.15 14.05 Favored 'General case' 0 N--CA 1.518 2.963 0 C-N-CA 125.591 1.556 . . . . 0.0 108.065 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.68 -27.84 50.35 Favored Glycine 0 N--CA 1.509 3.548 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -96.8 153.12 18.07 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 123.677 0.791 . . . . 0.0 109.138 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 50.8 m -80.89 149.32 66.86 Favored Pre-proline 0 N--CA 1.526 3.37 0 C-N-CA 125.965 1.706 . . . . 0.0 111.315 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo . . . . . 0 C--N 1.403 3.43 0 CA-C-N 122.019 1.757 . . . . 0.0 111.059 -177.75 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -61.61 -49.24 77.37 Favored 'General case' 0 N--CA 1.534 3.768 0 CA-C-N 118.394 0.543 . . . . 0.0 112.316 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.14 -37.82 86.65 Favored 'General case' 0 N--CA 1.525 3.325 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.43 -29.39 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.916 0 C-N-CA 125.397 1.479 . . . . 0.0 110.921 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -50.98 60.67 Favored 'General case' 1 N--CA 1.547 4.389 0 C-N-CA 123.601 0.76 . . . . 0.0 111.719 -177.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -30.84 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 124.068 0.947 . . . . 0.0 109.808 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -56.18 -34.49 66.27 Favored 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.58 1.152 . . . . 0.0 110.441 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 24.3 mm -60.43 -37.52 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.581 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.31 -40.02 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.114 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.93 -48.52 87.46 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.28 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.86 -31.37 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.761 0 C-N-CA 123.839 0.855 . . . . 0.0 109.688 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.37 -32.31 83.76 Favored Glycine 1 N--CA 1.516 4.021 0 C-N-CA 123.607 0.622 . . . . 0.0 112.439 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 62.5 m -67.98 -36.9 80.82 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 123.507 0.723 . . . . 0.0 111.971 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 9.0 mp -54.68 -41.75 70.56 Favored 'General case' 0 N--CA 1.537 3.885 0 C-N-CA 123.431 0.692 . . . . 0.0 112.737 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.37 -43.94 94.9 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.297 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -174.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -66.43 -28.49 73.75 Favored Glycine 1 N--CA 1.525 4.617 0 O-C-N 121.177 -0.952 . . . . 0.0 111.746 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -62.1 -42.13 98.91 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 124.529 1.131 . . . . 0.0 110.682 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -52.33 -25.62 10.09 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.33 -37.61 37.48 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.501 0 CA-C-N 120.538 1.517 . . . . 0.0 112.26 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.3 p -54.36 -27.66 17.49 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.128 0 C-N-CA 124.523 1.129 . . . . 0.0 112.063 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -52.08 -25.66 9.23 Favored 'General case' 0 N--CA 1.537 3.89 0 C-N-CA 123.357 0.663 . . . . 0.0 110.104 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.45 68.88 Favored 'General case' 0 N--CA 1.52 3.031 0 C-N-CA 122.72 0.408 . . . . 0.0 110.17 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -69.42 -30.39 45.42 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 8.8 tp -52.53 -35.32 53.14 Favored 'General case' 0 N--CA 1.537 3.881 0 C-N-CA 122.974 0.51 . . . . 0.0 110.71 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 1.6 t -58.74 -46.16 88.05 Favored 'General case' 1 N--CA 1.54 4.045 0 CA-C-N 118.824 0.738 . . . . 0.0 112.081 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 34.5 tp -66.38 -34.77 78.71 Favored 'General case' 1 N--CA 1.542 4.174 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.87 -38.51 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -63.58 -24.04 67.64 Favored 'General case' 0 N--CA 1.522 3.168 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.01 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . 0.449 ' NH2' HH12 ' A' ' 707' ' ' ARG . 17.2 tpt180 -49.56 -47.75 48.95 Favored 'General case' 0 N--CA 1.522 3.149 0 CA-C-O 121.8 0.809 . . . . 0.0 110.438 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 51.3 t -63.14 -37.46 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.712 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.456 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -75.31 -28.06 59.55 Favored 'General case' 0 N--CA 1.531 3.624 0 CA-C-O 121.18 0.514 . . . . 0.0 109.896 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -89.91 -4.87 57.3 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.963 1.305 . . . . 0.0 108.466 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.75 -23.42 29.49 Favored Glycine 1 N--CA 1.523 4.434 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -120.27 141.25 50.16 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 125.33 1.452 . . . . 0.0 107.59 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 68.5 m -82.97 146.61 52.38 Favored Pre-proline 0 N--CA 1.529 3.502 0 CA-C-O 117.285 -1.34 . . . . 0.0 110.157 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo . . . . . 0 C--N 1.395 3.004 0 CA-C-N 121.701 1.643 . . . . 0.0 109.192 -178.157 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.521 3.113 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -65.64 -48.75 71.1 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.813 0.445 . . . . 0.0 111.891 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -64.64 -34.46 78.33 Favored 'General case' 0 N--CA 1.529 3.495 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 93.9 mt -74.86 -24.89 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.946 0 C-N-CA 124.944 1.298 . . . . 0.0 110.662 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -66.18 -53.14 41.06 Favored 'General case' 1 N--CA 1.547 4.423 0 CA-C-N 118.999 0.818 . . . . 0.0 110.529 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.3 tt -66.34 -30.77 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.228 0 C-N-CA 123.873 0.869 . . . . 0.0 109.422 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -53.32 -31.28 43.41 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.926 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 16.5 mm -67.99 -46.93 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.015 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.4 -34.39 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.752 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 79.0 mt -68.33 -44.82 83.42 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.327 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.98 -30.67 45.99 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.44 -42.04 96.09 Favored Glycine 1 N--CA 1.523 4.47 0 C-N-CA 123.88 0.753 . . . . 0.0 112.658 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 70.2 m -67.36 -36.83 82.19 Favored 'General case' 0 N--CA 1.529 3.477 0 CA-C-O 122.232 1.015 . . . . 0.0 109.94 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.67 -41.11 80.89 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 113.306 -1.77 . . . . 0.0 113.037 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.85 -47.66 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -176.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.22 -25.87 60.68 Favored Glycine 1 N--CA 1.53 4.941 0 CA-C-N 119.62 1.1 . . . . 0.0 112.441 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.07 -42.59 99.7 Favored 'General case' 0 N--CA 1.534 3.773 0 C-N-CA 124.348 1.059 . . . . 0.0 109.237 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -53.94 -26.59 26.25 Favored 'General case' 0 N--CA 1.532 3.674 0 C-N-CA 124.927 1.291 . . . . 0.0 113.88 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 76.1 mt -54.64 -38.3 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 C-N-CA 123.413 0.685 . . . . 0.0 111.699 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.52 -28.91 23.5 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.263 0 C-N-CA 123.643 0.777 . . . . 0.0 112.55 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -52.66 -27.49 17.51 Favored 'General case' 0 N--CA 1.536 3.854 0 C-N-CA 122.978 0.511 . . . . 0.0 110.826 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.63 -33.52 66.37 Favored 'General case' 0 N--CA 1.531 3.597 0 O-C-N 121.877 -0.514 . . . . 0.0 110.259 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.8 -30.95 48.79 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.222 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 7.1 tp -52.83 -33.03 47.51 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.75 0.82 . . . . 0.0 110.441 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 83.4 p -58.08 -46.07 86.08 Favored 'General case' 0 N--CA 1.53 3.531 0 O-C-N 121.766 -0.584 . . . . 0.0 111.572 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.25 -36.09 82.52 Favored 'General case' 1 N--CA 1.544 4.246 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.9 t -68.54 -41.48 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -68.07 -22.91 64.91 Favored 'General case' 0 N--CA 1.514 2.751 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.219 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -49.85 -47.31 51.74 Favored 'General case' 0 N--CA 1.511 2.62 0 CA-C-O 121.932 0.872 . . . . 0.0 109.124 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.4 -40.06 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.416 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.93 -22.9 55.52 Favored 'General case' 0 N--CA 1.534 3.775 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -89.15 -13.52 38.21 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -53.85 -27.33 36.17 Favored Glycine 1 N--CA 1.517 4.076 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -95.34 154.67 17.08 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 124.36 1.064 . . . . 0.0 108.849 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 99.4 p -80.3 149.57 69.32 Favored Pre-proline 0 N--CA 1.529 3.508 0 C-N-CA 126.388 1.875 . . . . 0.0 111.363 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -56.45 131.29 44.85 Favored 'Trans proline' 0 C--N 1.402 3.392 0 CA-C-N 120.918 1.364 . . . . 0.0 110.289 -174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 N--CA 1.522 3.132 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.442 -179.225 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 N--CA 1.513 2.686 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -66.77 -51.42 56.0 Favored 'General case' 0 N--CA 1.532 3.64 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.95 -32.84 74.75 Favored 'General case' 0 N--CA 1.526 3.373 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 91.4 mt -74.62 -29.84 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.544 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -59.33 -52.78 64.18 Favored 'General case' 1 N--CA 1.555 4.789 0 CA-C-O 122.264 1.03 . . . . 0.0 110.942 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.8 tt -70.37 -32.28 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.715 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.079 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -50.13 -25.03 3.13 Favored 'General case' 0 N--CA 1.53 3.528 0 C-N-CA 123.85 0.86 . . . . 0.0 112.549 -174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.91 -35.17 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 17.3 pt -64.01 -39.15 84.42 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.416 0 CA-C-N 120.016 1.28 . . . . 0.0 109.62 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.1 -48.73 85.8 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.254 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 50.4 t -67.39 -41.38 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 124.513 1.125 . . . . 0.0 110.03 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.61 90.92 Favored Glycine 1 N--CA 1.522 4.402 0 C-N-CA 125.241 1.4 . . . . 0.0 112.798 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 74.2 m -67.28 -35.26 79.13 Favored 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 124.29 1.036 . . . . 0.0 108.415 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.21 -47.07 86.7 Favored 'General case' 0 N--CA 1.523 3.208 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.768 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -27.93 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.868 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.39 -29.36 70.12 Favored Glycine 1 N--CA 1.528 4.833 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.7 tt -67.01 -40.12 87.21 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 125.581 1.552 . . . . 0.0 110.36 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -52.27 -25.42 9.34 Favored 'General case' 0 N--CA 1.531 3.611 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 15.8 tt -54.13 -38.99 40.3 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.172 0 CA-C-N 119.302 0.955 . . . . 0.0 113.096 -175.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 10.3 p -57.33 -30.44 35.55 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.164 0 C-N-CA 123.412 0.685 . . . . 0.0 111.672 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -53.97 -25.25 19.85 Favored 'General case' 0 N--CA 1.537 3.886 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.05 -34.45 63.57 Favored 'General case' 0 N--CA 1.523 3.199 0 O-C-N 122.035 -0.415 . . . . 0.0 109.933 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.47 -32.02 51.43 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.209 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.2 -33.03 51.0 Favored 'General case' 0 N--CA 1.535 3.82 0 C-N-CA 123.811 0.844 . . . . 0.0 110.77 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 68.5 m -58.03 -45.64 86.62 Favored 'General case' 0 N--CA 1.531 3.612 0 O-C-N 121.652 -0.655 . . . . 0.0 110.919 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.04 -34.49 78.56 Favored 'General case' 1 N--CA 1.543 4.19 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 48.0 t -67.63 -39.66 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -67.77 -25.95 65.87 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.372 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -50.05 -41.65 48.16 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.543 0.687 . . . . 0.0 111.173 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 68.1 t -61.68 -38.97 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -76.14 -20.62 57.43 Favored 'General case' 0 N--CA 1.524 3.257 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.503 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -88.66 -12.45 42.41 Favored 'General case' 0 N--CA 1.518 2.956 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -60.2 -13.82 30.01 Favored Glycine 1 N--CA 1.517 4.076 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 177.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -108.56 154.57 21.76 Favored 'General case' 0 N--CA 1.532 3.665 0 C-N-CA 125.06 1.344 . . . . 0.0 109.77 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 48.4 t -80.47 150.13 69.79 Favored Pre-proline 0 N--CA 1.53 3.571 0 C-N-CA 126.107 1.763 . . . . 0.0 110.877 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo . . . . . 0 C--N 1.402 3.359 0 CA-C-N 122.247 1.838 . . . . 0.0 113.221 -172.744 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' B' ' 683' ' ' ARG . 63.7 mt . . . . . 0 N--CA 1.514 2.75 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -59.45 -43.44 93.16 Favored 'General case' 0 N--CA 1.532 3.661 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -72.34 -37.32 68.88 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 93.0 mt -74.82 -25.16 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 C-N-CA 125.029 1.332 . . . . 0.0 111.862 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' B' ' 679' ' ' LEU . 17.4 ttp180 -66.13 -52.24 50.39 Favored 'General case' 1 N--CA 1.549 4.481 0 C-N-CA 124.381 1.072 . . . . 0.0 110.577 -177.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.46 -32.77 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 CA-C-N 113.692 -1.595 . . . . 0.0 108.815 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -54.1 -30.79 49.91 Favored 'General case' 0 N--CA 1.52 3.028 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.276 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 17.9 mm -68.87 -41.85 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.626 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 40.3 mt -71.39 -34.86 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.016 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 50.8 mm -58.7 -40.19 78.7 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.668 0 CA-C-N 119.449 1.022 . . . . 0.0 109.738 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.41 -31.95 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.534 0 C-N-CA 123.704 0.802 . . . . 0.0 110.501 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.32 -32.34 79.37 Favored Glycine 1 N--CA 1.517 4.037 0 C-N-CA 123.404 0.526 . . . . 0.0 112.683 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 58.9 m -67.5 -36.96 82.09 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.719 0.808 . . . . 0.0 111.63 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 9.4 mp -56.55 -45.79 81.05 Favored 'General case' 0 N--CA 1.537 3.907 0 C-N-CA 123.44 0.696 . . . . 0.0 112.681 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.71 -49.04 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -175.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.9 -25.21 65.62 Favored Glycine 1 N--CA 1.525 4.601 0 CA-C-N 119.628 1.103 . . . . 0.0 113.12 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 4.4 tt -66.74 -41.86 87.18 Favored 'General case' 0 N--CA 1.535 3.797 0 C-N-CA 124.567 1.147 . . . . 0.0 110.639 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -52.13 -25.26 8.48 Favored 'General case' 0 N--CA 1.536 3.833 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.8 tt -54.14 -36.88 33.64 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 CA-C-N 119.878 1.217 . . . . 0.0 112.066 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.14 -27.97 17.21 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.012 0 C-N-CA 124.332 1.053 . . . . 0.0 111.779 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -52.15 -25.82 9.89 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 123.402 0.681 . . . . 0.0 109.756 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.73 -38.43 69.77 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 122.767 0.427 . . . . 0.0 110.017 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.24 -32.01 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.956 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.42 -36.45 61.53 Favored 'General case' 0 N--CA 1.537 3.897 0 C-N-CA 122.908 0.483 . . . . 0.0 110.809 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 26.5 m -62.11 -47.21 85.63 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.83 -35.92 79.45 Favored 'General case' 1 N--CA 1.545 4.32 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.14 -43.25 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.365 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -71.29 -20.99 62.14 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.876 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -47.73 -46.7 30.03 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 40.1 t -59.35 -41.59 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.389 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -76.69 -22.11 54.43 Favored 'General case' 0 N--CA 1.533 3.678 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.866 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -8.3 36.22 Favored 'General case' 0 N--CA 1.517 2.916 0 C-N-CA 124.925 1.29 . . . . 0.0 108.44 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.12 -32.49 35.71 Favored Glycine 1 N--CA 1.516 4.015 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -100.81 130.99 46.91 Favored 'General case' 0 N--CA 1.529 3.507 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 88.1 p -81.94 146.8 56.52 Favored Pre-proline 0 N--CA 1.527 3.422 0 C-N-CA 124.947 1.299 . . . . 0.0 110.627 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo . . . . . 0 C--N 1.399 3.195 0 CA-C-N 121.334 1.512 . . . . 0.0 109.445 -177.538 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.53 3.568 0 CA-C-O 121.244 0.545 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -69.78 -40.07 76.25 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.217 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -65.68 -37.37 86.3 Favored 'General case' 0 N--CA 1.52 3.046 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.036 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 26.9 pt -73.09 -25.7 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 CA-C-N 118.347 0.521 . . . . 0.0 110.627 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -50.07 70.86 Favored 'General case' 1 N--CA 1.546 4.361 0 C-N-CA 122.806 0.443 . . . . 0.0 110.826 -176.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.48 -31.95 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.564 0 C-N-CA 124.002 0.921 . . . . 0.0 109.7 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -53.9 -41.14 67.28 Favored 'General case' 0 N--CA 1.518 2.969 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.37 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.71 -39.12 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.92 -45.06 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 C-N-CA 123.458 0.703 . . . . 0.0 110.56 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 76.0 mt -59.9 -49.04 85.44 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.42 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.62 -29.65 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.125 0 C-N-CA 125.286 1.434 . . . . 0.0 109.688 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.27 -31.69 81.69 Favored Glycine 1 N--CA 1.519 4.21 0 C-N-CA 123.717 0.675 . . . . 0.0 112.388 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.3 m -68.28 -36.39 79.31 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.962 0.905 . . . . 0.0 111.849 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.27 -35.7 62.83 Favored 'General case' 0 N--CA 1.534 3.755 0 CA-C-O 118.295 -0.859 . . . . 0.0 113.265 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . 0.255 0.1 OUTLIER -60.53 -49.98 82.22 Favored 'Isoleucine or valine' 1 N--CA 1.561 5.121 0 CA-C-N 120.272 1.397 . . . . 0.0 112.455 -176.164 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.17 -29.22 68.02 Favored Glycine 1 N--CA 1.532 5.054 0 CA-C-N 119.452 1.024 . . . . 0.0 111.69 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.59 -42.41 98.28 Favored 'General case' 0 N--CA 1.538 3.939 0 C-N-CA 123.653 0.781 . . . . 0.0 109.836 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -53.82 -25.2 18.28 Favored 'General case' 1 N--CA 1.542 4.164 0 C-N-CA 124.673 1.189 . . . . 0.0 113.82 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 70.6 mt -54.94 -39.78 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 O-C-N 121.625 -0.672 . . . . 0.0 110.454 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.36 -30.97 50.85 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.405 0 C-N-CA 123.859 0.864 . . . . 0.0 110.875 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.56 -30.15 65.01 Favored 'General case' 1 N--CA 1.542 4.143 0 O-C-N 121.055 -1.028 . . . . 0.0 111.689 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.98 -37.59 72.73 Favored 'General case' 1 N--CA 1.54 4.025 0 CA-C-O 121.8 0.809 . . . . 0.0 109.104 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.36 -28.05 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.277 0 C-N-CA 125.066 1.346 . . . . 0.0 108.678 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.1 tp -52.25 -32.66 38.11 Favored 'General case' 0 N--CA 1.532 3.643 0 C-N-CA 123.53 0.732 . . . . 0.0 110.108 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 89.1 p -56.56 -46.13 80.87 Favored 'General case' 0 N--CA 1.53 3.553 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 46.5 tp -66.04 -35.11 79.65 Favored 'General case' 1 N--CA 1.547 4.384 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.03 -40.02 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.0 OUTLIER -71.92 -23.73 61.52 Favored 'General case' 0 N--CA 1.517 2.902 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.225 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -48.47 -32.04 7.24 Favored 'General case' 0 N--CA 1.526 3.357 0 CA-C-N 118.832 0.742 . . . . 0.0 110.499 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.74 -49.07 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -77.84 -10.26 59.47 Favored 'General case' 1 N--CA 1.54 4.06 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.701 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.6 tt0 -114.14 -9.28 12.93 Favored 'General case' 0 N--CA 1.522 3.145 0 C-N-CA 125.365 1.466 . . . . 0.0 108.759 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -57.58 -30.04 61.74 Favored Glycine 0 N--CA 1.512 3.712 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -80.76 155.13 26.84 Favored 'General case' 0 N--CA 1.524 3.269 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 97.0 p -79.49 149.15 71.39 Favored Pre-proline 0 N--CA 1.528 3.469 0 C-N-CA 126.281 1.832 . . . . 0.0 111.757 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -56.87 131.86 48.11 Favored 'Trans proline' 0 C--N 1.401 3.316 0 CA-C-N 120.669 1.274 . . . . 0.0 111.001 -174.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 N--CA 1.527 3.376 0 C-N-CA 125.616 1.566 . . . . 0.0 110.72 178.739 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -57.3 -51.1 70.72 Favored 'General case' 0 N--CA 1.533 3.689 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -64.88 -31.28 72.44 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.53 -33.59 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.966 0 C-N-CA 123.879 0.872 . . . . 0.0 108.664 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -51.79 42.42 Favored 'General case' 1 N--CA 1.554 4.748 0 CA-C-N 118.48 0.582 . . . . 0.0 112.11 -177.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.39 -38.23 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 CA-C-O 122.496 1.141 . . . . 0.0 110.184 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -52.39 -29.29 23.36 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 113.111 -1.858 . . . . 0.0 111.113 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 28.5 mm -68.46 -37.23 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 C-N-CA 124.244 1.018 . . . . 0.0 109.602 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 37.5 mt -64.9 -38.27 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.268 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.53 -41.72 93.66 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.27 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.76 -30.51 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 C-N-CA 123.965 0.906 . . . . 0.0 109.185 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.16 -34.29 89.26 Favored Glycine 1 N--CA 1.518 4.159 0 C-N-CA 123.382 0.515 . . . . 0.0 111.985 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.5 m -68.67 -37.51 79.66 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.562 0.745 . . . . 0.0 111.172 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.9 mp -57.54 -42.54 83.15 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 123.751 0.82 . . . . 0.0 112.328 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.274 0.5 OUTLIER -62.44 -48.91 86.09 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.308 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.231 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.44 -30.29 67.91 Favored Glycine 1 N--CA 1.53 4.954 0 CA-C-N 119.814 1.188 . . . . 0.0 112.899 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.94 -41.47 99.51 Favored 'General case' 1 N--CA 1.539 4.013 0 C-N-CA 124.411 1.084 . . . . 0.0 111.234 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -51.71 -24.28 5.55 Favored 'General case' 0 N--CA 1.538 3.933 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 18.5 tt -52.7 -36.03 22.22 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.26 0 CA-C-N 120.143 1.338 . . . . 0.0 111.684 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 12.6 p -54.09 -28.19 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.951 0 C-N-CA 124.304 1.042 . . . . 0.0 111.43 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -55.9 -29.08 59.44 Favored 'General case' 1 N--CA 1.544 4.256 0 O-C-N 121.489 -0.757 . . . . 0.0 109.764 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.7 -43.08 69.72 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 63.0 t -68.87 -33.34 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.112 0 C-N-CA 124.713 1.205 . . . . 0.0 109.105 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.13 -32.62 62.22 Favored 'General case' 0 N--CA 1.535 3.817 0 C-N-CA 124.175 0.99 . . . . 0.0 109.901 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.5 p -59.04 -45.14 91.48 Favored 'General case' 0 N--CA 1.528 3.426 0 O-C-N 121.353 -0.842 . . . . 0.0 111.253 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.21 -33.35 74.39 Favored 'General case' 1 N--CA 1.542 4.152 0 O-C-N 121.431 -0.793 . . . . 0.0 108.959 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.18 -39.22 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.873 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . 0.425 ' ND2' HH11 ' A' ' 709' ' ' ARG . 9.3 m120 -62.71 -22.8 66.78 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.693 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -50.38 -41.34 51.72 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-O 121.915 0.864 . . . . 0.0 110.012 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 64.1 t -62.96 -36.68 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . 0.425 HH11 ' ND2' ' A' ' 706' ' ' ASN . 50.6 mtm180 -75.7 -3.86 37.1 Favored 'General case' 0 N--CA 1.523 3.195 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.46 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -103.26 -14.9 16.15 Favored 'General case' 1 N--CA 1.552 4.662 0 C-N-CA 123.685 0.794 . . . . 0.0 108.921 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -81.94 -6.65 88.77 Favored Glycine 1 N--CA 1.528 4.82 0 N-CA-C 106.736 -2.546 . . . . 0.0 106.736 173.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -105.47 154.29 20.54 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 128.036 2.534 . . . . 0.0 106.611 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 32.1 t -98.13 147.3 32.89 Favored Pre-proline 1 N--CA 1.556 4.831 0 C-N-CA 125.422 1.489 . . . . 0.0 112.997 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 C--N 1.408 3.668 0 CA-C-N 121.212 1.468 . . . . 0.0 109.048 -176.75 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.516 2.853 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -70.98 -49.79 41.42 Favored 'General case' 0 N--CA 1.535 3.791 0 CA-C-O 121.155 0.503 . . . . 0.0 111.576 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -61.05 -31.42 71.07 Favored 'General case' 0 N--CA 1.533 3.688 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.98 -25.55 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.786 0 C-N-CA 125.913 1.685 . . . . 0.0 111.021 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.07 -52.29 50.24 Favored 'General case' 1 N--CA 1.547 4.386 0 CA-C-O 121.574 0.702 . . . . 0.0 111.409 -177.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.8 tt -68.0 -32.34 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.171 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.594 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -54.27 -30.49 50.75 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 123.827 0.851 . . . . 0.0 111.213 -177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 16.1 mm -66.21 -37.69 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.937 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 38.5 mt -62.3 -38.37 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.1 -46.53 93.41 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.361 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.4 t -62.04 -30.04 47.79 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.26 -31.73 81.82 Favored Glycine 1 N--CA 1.519 4.223 0 C-N-CA 123.562 0.601 . . . . 0.0 112.455 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 61.4 m -68.58 -36.92 79.41 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.658 0.783 . . . . 0.0 111.367 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.56 -43.19 79.73 Favored 'General case' 0 N--CA 1.536 3.868 0 C-N-CA 123.713 0.805 . . . . 0.0 112.52 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . 0.281 0.6 OUTLIER -60.42 -48.97 86.16 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.621 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.091 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.77 -26.95 71.43 Favored Glycine 1 N--CA 1.533 5.121 0 CA-C-N 120.734 1.606 . . . . 0.0 112.373 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 5.3 tt -62.95 -43.05 99.86 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.806 0.843 . . . . 0.0 110.955 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -53.14 -27.12 19.38 Favored 'General case' 1 N--CA 1.539 4.003 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 70.9 mt -54.74 -37.95 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.51 0 C-N-CA 123.954 0.902 . . . . 0.0 111.794 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.11 -31.61 42.11 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.301 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -54.23 -25.76 24.88 Favored 'General case' 0 N--CA 1.539 3.988 0 CA-C-N 118.793 0.724 . . . . 0.0 111.207 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.1 -37.78 69.85 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 121.65 -0.656 . . . . 0.0 110.248 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.22 -32.59 54.38 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 13.4 tp -54.87 -35.32 63.93 Favored 'General case' 0 N--CA 1.533 3.689 0 C-N-CA 123.154 0.581 . . . . 0.0 110.498 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 80.8 p -59.01 -48.41 81.67 Favored 'General case' 0 N--CA 1.521 3.119 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.22 -35.09 79.16 Favored 'General case' 1 N--CA 1.549 4.517 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.647 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.53 -38.78 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' B' ' 710' ' ' GLN . 2.2 p30 -62.24 -25.81 68.03 Favored 'General case' 0 N--CA 1.521 3.084 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.625 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 18.6 tpt85 -46.82 -32.56 3.78 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.617 0.767 . . . . 0.0 111.362 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 63.3 t -75.53 -48.8 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.36 -11.03 59.92 Favored 'General case' 1 N--CA 1.543 4.182 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.839 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' B' ' 706' ' ' ASN . 28.2 tt0 -113.63 -10.64 13.09 Favored 'General case' 0 N--CA 1.519 3.018 0 C-N-CA 125.929 1.692 . . . . 0.0 108.556 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.74 -24.43 32.92 Favored Glycine 0 N--CA 1.51 3.608 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -95.48 152.82 18.08 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 123.461 0.705 . . . . 0.0 109.226 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 48.7 m -81.31 150.76 68.26 Favored Pre-proline 0 N--CA 1.533 3.686 0 C-N-CA 126.264 1.826 . . . . 0.0 111.267 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 C--N 1.402 3.382 0 CA-C-N 121.984 1.744 . . . . 0.0 112.33 -175.509 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.521 3.117 0 CA-C-O 121.425 0.631 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -70.15 -45.38 66.9 Favored 'General case' 0 N--CA 1.513 2.72 0 C-N-CA 124.809 1.244 . . . . 0.0 111.204 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -61.74 -38.78 89.22 Favored 'General case' 0 N--CA 1.518 2.939 0 CA-C-N 113.978 -1.464 . . . . 0.0 111.659 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 26.5 pt -72.45 -36.6 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 C-N-CA 122.671 0.388 . . . . 0.0 111.01 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -52.86 -51.23 61.78 Favored 'General case' 0 N--CA 1.539 3.98 0 CA-C-O 121.7 0.762 . . . . 0.0 111.625 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.23 -34.48 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.828 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -55.54 -43.74 76.07 Favored 'General case' 0 N--CA 1.537 3.891 0 C-N-CA 123.618 0.767 . . . . 0.0 109.523 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.51 -37.76 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.814 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 41.5 mt -71.08 -41.99 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 49.1 mm -59.68 -48.79 86.15 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.472 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 70.8 t -60.73 -30.22 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 C-N-CA 124.136 0.975 . . . . 0.0 109.737 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.27 91.87 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 123.307 0.479 . . . . 0.0 112.488 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 66.7 m -67.5 -37.07 82.28 Favored 'General case' 0 N--CA 1.528 3.472 0 C-N-CA 123.768 0.827 . . . . 0.0 112.041 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.73 -39.9 68.73 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 123.434 0.694 . . . . 0.0 112.312 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -40.85 86.28 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.07 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -174.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -71.71 -27.38 71.04 Favored Glycine 1 N--CA 1.527 4.721 0 O-C-N 121.173 -0.954 . . . . 0.0 110.973 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.48 -42.59 99.01 Favored 'General case' 0 N--CA 1.531 3.581 0 C-N-CA 124.176 0.99 . . . . 0.0 109.651 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -53.96 -26.46 25.83 Favored 'General case' 0 N--CA 1.537 3.896 0 C-N-CA 124.471 1.109 . . . . 0.0 113.846 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 73.9 mt -54.62 -38.59 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 C-N-CA 123.578 0.751 . . . . 0.0 111.342 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 5.8 p -56.01 -27.33 22.82 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.324 0 C-N-CA 124.074 0.95 . . . . 0.0 112.281 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -51.73 -27.33 11.62 Favored 'General case' 0 N--CA 1.538 3.964 0 C-N-CA 123.311 0.645 . . . . 0.0 111.179 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.3 -34.11 66.19 Favored 'General case' 0 N--CA 1.532 3.649 0 O-C-N 121.857 -0.527 . . . . 0.0 109.952 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.1 m -69.36 -31.82 50.99 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.093 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 6.9 tp -53.5 -35.67 60.89 Favored 'General case' 0 N--CA 1.538 3.959 0 C-N-CA 123.293 0.637 . . . . 0.0 110.373 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 88.8 p -61.32 -47.8 84.28 Favored 'General case' 0 N--CA 1.516 2.867 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 45.9 tp -67.71 -35.52 78.95 Favored 'General case' 1 N--CA 1.546 4.331 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 74.7 t -69.04 -46.09 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -76.03 -23.36 55.15 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 123.515 0.51 . . . . 0.0 110.799 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -46.15 62.58 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.03 -43.23 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.891 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.682 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -75.96 -5.85 48.19 Favored 'General case' 0 N--CA 1.538 3.933 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.404 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -113.02 -12.67 13.19 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 125.619 1.568 . . . . 0.0 107.934 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.16 -33.8 31.08 Favored Glycine 0 N--CA 1.513 3.807 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -82.66 153.83 25.2 Favored 'General case' 0 N--CA 1.526 3.327 0 CA-C-N 114.201 -1.0 . . . . 0.0 108.626 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 59.8 m -80.2 149.23 69.08 Favored Pre-proline 0 N--CA 1.531 3.612 0 C-N-CA 126.201 1.8 . . . . 0.0 111.274 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -56.21 130.03 38.01 Favored 'Trans proline' 0 C--N 1.402 3.36 0 CA-C-N 121.175 1.455 . . . . 0.0 110.792 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 N--CA 1.524 3.273 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.56 -179.941 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 28.2 tp . . . . . 0 N--CA 1.514 2.752 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -64.69 -36.24 83.65 Favored 'General case' 0 N--CA 1.528 3.436 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -72.54 -36.64 68.32 Favored 'General case' 0 N--CA 1.533 3.68 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.33 -24.46 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 C-N-CA 124.725 1.21 . . . . 0.0 109.882 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -67.14 -53.44 30.62 Favored 'General case' 1 N--CA 1.554 4.75 0 CA-C-N 119.488 1.04 . . . . 0.0 112.334 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.11 -32.01 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 C-N-CA 124.234 1.014 . . . . 0.0 109.727 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -56.82 -32.28 65.57 Favored 'General case' 0 N--CA 1.508 2.474 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.234 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 24.2 mm -68.33 -46.02 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 C-N-CA 124.172 0.989 . . . . 0.0 109.344 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.64 -35.95 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.178 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.301 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.67 -48.13 90.13 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.215 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.36 -31.36 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.533 0.733 . . . . 0.0 109.83 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.27 -50.44 65.0 Favored Glycine 1 N--CA 1.52 4.261 0 C-N-CA 124.082 0.849 . . . . 0.0 112.494 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.2 m -58.66 -35.37 72.45 Favored 'General case' 0 N--CA 1.533 3.719 0 C-N-CA 124.475 1.11 . . . . 0.0 111.015 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 2.1 tp -53.81 -34.82 60.38 Favored 'General case' 0 N--CA 1.512 2.636 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.127 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -38.96 79.66 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -177.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -72.87 -29.89 64.42 Favored Glycine 1 N--CA 1.519 4.232 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.2 tt -59.75 -42.47 93.29 Favored 'General case' 1 N--CA 1.541 4.076 0 C-N-CA 124.496 1.118 . . . . 0.0 110.944 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -51.31 -24.7 4.86 Favored 'General case' 0 N--CA 1.527 3.398 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 10.1 tp -53.05 -37.61 27.2 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.671 0 CA-C-N 119.837 1.199 . . . . 0.0 112.689 -176.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.18 -28.11 17.5 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.444 0 C-N-CA 124.222 1.009 . . . . 0.0 110.981 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -56.04 -27.65 54.13 Favored 'General case' 0 N--CA 1.536 3.833 0 O-C-N 121.506 -0.747 . . . . 0.0 110.008 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -66.98 -44.55 80.15 Favored 'General case' 0 N--CA 1.526 3.336 0 CA-C-O 122.18 0.99 . . . . 0.0 108.645 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 84.2 t -68.77 -33.72 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.173 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.36 -33.93 63.84 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 123.506 0.723 . . . . 0.0 110.161 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' SER . . . . . 0.437 ' HG ' ' ND2' ' B' ' 706' ' ' ASN . 86.0 p -58.08 -46.27 85.75 Favored 'General case' 0 N--CA 1.53 3.537 0 O-C-N 121.788 -0.57 . . . . 0.0 111.985 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.54 -35.85 82.32 Favored 'General case' 1 N--CA 1.542 4.175 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.78 -39.9 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . 0.567 HD21 ' HE ' ' A' ' 709' ' ' ARG . 3.9 m120 -66.19 -24.29 66.6 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.314 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -49.55 -46.67 49.01 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 124.027 0.931 . . . . 0.0 110.48 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.65 -50.85 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.482 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . 0.567 ' HE ' HD21 ' A' ' 706' ' ' ASN . 34.1 ptt180 -80.66 -3.45 50.63 Favored 'General case' 1 N--CA 1.55 4.536 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 178.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -111.57 -13.25 13.84 Favored 'General case' 0 N--CA 1.539 3.999 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.74 -31.19 53.54 Favored Glycine 0 N--CA 1.514 3.866 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -80.24 155.09 27.5 Favored 'General case' 0 N--CA 1.521 3.079 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 67.8 m -79.4 149.68 72.5 Favored Pre-proline 0 N--CA 1.532 3.629 0 C-N-CA 126.307 1.843 . . . . 0.0 112.111 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.402 3.391 0 CA-C-N 120.614 1.255 . . . . 0.0 110.817 -174.056 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.528 3.464 0 CA-C-O 120.987 0.422 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -69.93 -36.16 75.12 Favored 'General case' 0 N--CA 1.522 3.136 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.451 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -40.73 76.76 Favored 'General case' 0 N--CA 1.531 3.586 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.893 -176.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.19 -25.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 CA-C-N 118.701 0.682 . . . . 0.0 110.905 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -52.7 38.98 Favored 'General case' 1 N--CA 1.539 4.008 0 C-N-CA 123.988 0.915 . . . . 0.0 112.34 -177.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.4 tt -70.93 -30.16 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 123.833 0.853 . . . . 0.0 110.752 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -36.36 24.77 Favored 'General case' 0 N--CA 1.524 3.227 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.239 -173.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -69.48 -37.55 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.311 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 34.4 mt -58.87 -35.04 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 35.8 mm -66.65 -46.7 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.28 -31.14 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 C-N-CA 123.85 0.86 . . . . 0.0 108.843 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.2 94.05 Favored Glycine 1 N--CA 1.523 4.436 0 C-N-CA 123.808 0.718 . . . . 0.0 111.817 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 71.1 m -69.09 -41.04 78.03 Favored 'General case' 0 N--CA 1.518 2.957 0 C-N-CA 123.563 0.745 . . . . 0.0 110.765 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.42 -45.91 88.8 Favored 'General case' 0 N--CA 1.535 3.806 0 C-N-CA 123.484 0.714 . . . . 0.0 112.614 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -34.98 73.13 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.1 -28.84 71.1 Favored Glycine 1 N--CA 1.527 4.721 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.3 tt -65.06 -43.52 91.97 Favored 'General case' 0 N--CA 1.531 3.614 0 C-N-CA 124.375 1.07 . . . . 0.0 109.808 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -54.96 -26.33 35.74 Favored 'General case' 0 N--CA 1.537 3.895 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 64.3 mt -55.18 -39.2 50.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 C-N-CA 123.236 0.614 . . . . 0.0 112.147 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.63 -28.64 23.56 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.51 0 C-N-CA 123.672 0.789 . . . . 0.0 112.468 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -51.77 -26.16 9.07 Favored 'General case' 0 N--CA 1.531 3.613 0 C-N-CA 123.2 0.6 . . . . 0.0 111.304 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.33 -32.33 62.42 Favored 'General case' 0 N--CA 1.53 3.569 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.8 m -69.26 -31.18 48.75 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.212 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 4.4 tp -53.46 -32.51 50.34 Favored 'General case' 0 N--CA 1.538 3.943 0 C-N-CA 123.671 0.789 . . . . 0.0 110.556 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 67.9 p -57.41 -45.33 84.69 Favored 'General case' 0 N--CA 1.532 3.642 0 O-C-N 121.759 -0.588 . . . . 0.0 111.019 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.11 -35.11 79.69 Favored 'General case' 1 N--CA 1.539 4.023 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.77 -40.0 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . 0.437 ' ND2' ' HG ' ' A' ' 703' ' ' SER . 23.4 m-20 -63.47 -21.8 66.52 Favored 'General case' 0 N--CA 1.519 3.025 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.631 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -47.42 -47.55 26.63 Favored 'General case' 0 N--CA 1.519 3.022 0 C-N-CA 123.335 0.654 . . . . 0.0 109.495 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 52.7 t -58.95 -42.85 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.18 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -77.21 -15.51 59.46 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.681 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.5 -14.44 23.68 Favored 'General case' 1 N--CA 1.553 4.676 0 C-N-CA 124.123 0.969 . . . . 0.0 109.865 -177.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -87.72 -26.43 29.65 Favored Glycine 1 N--CA 1.523 4.438 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -75.59 146.95 39.99 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 126.01 1.724 . . . . 0.0 108.567 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 50.9 m -88.43 149.55 44.78 Favored Pre-proline 0 N--CA 1.537 3.922 0 C-N-CA 125.637 1.575 . . . . 0.0 113.266 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 C--N 1.402 3.359 0 CA-C-N 121.513 1.576 . . . . 0.0 111.983 -178.014 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.526 3.359 0 CA-C-O 120.926 0.393 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -68.13 -39.26 82.75 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.42 0.688 . . . . 0.0 111.429 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -68.82 -38.61 80.0 Favored 'General case' 0 N--CA 1.521 3.082 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.082 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 11.5 pt -73.24 -38.96 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -45.32 62.23 Favored 'General case' 0 N--CA 1.534 3.739 0 C-N-CA 123.237 0.615 . . . . 0.0 111.276 -176.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.7 tt -74.38 -34.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.939 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -60.31 -38.59 84.15 Favored 'General case' 0 N--CA 1.536 3.837 0 C-N-CA 124.018 0.927 . . . . 0.0 109.593 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.3 -37.05 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.081 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.377 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 8.2 mm -67.15 -43.44 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 41.4 mm -59.15 -49.14 84.43 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.359 0 CA-C-O 120.581 0.229 . . . . 0.0 110.529 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.23 -31.33 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -68.66 -36.5 83.05 Favored Glycine 0 N--CA 1.51 3.605 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.462 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 65.3 m -68.15 -36.77 80.2 Favored 'General case' 0 N--CA 1.529 3.497 0 CA-C-O 121.935 0.874 . . . . 0.0 110.006 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.17 -45.88 75.75 Favored 'General case' 0 N--CA 1.521 3.114 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.683 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.15 -35.98 65.91 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.056 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -176.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -75.12 -16.42 80.6 Favored Glycine 1 N--CA 1.522 4.417 0 O-C-N 121.648 -0.658 . . . . 0.0 111.72 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.25 -41.72 85.15 Favored 'General case' 0 N--CA 1.538 3.956 0 C-N-CA 124.489 1.116 . . . . 0.0 108.491 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -52.12 -23.61 5.67 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 125.286 1.435 . . . . 0.0 114.362 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 11.0 tp -54.33 -38.51 40.38 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.431 0 CA-C-N 119.052 0.842 . . . . 0.0 112.777 -177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.89 -29.45 21.66 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.177 0 C-N-CA 124.356 1.063 . . . . 0.0 112.353 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -53.04 -25.05 11.17 Favored 'General case' 0 N--CA 1.533 3.694 0 C-N-CA 123.375 0.67 . . . . 0.0 110.086 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.15 70.53 Favored 'General case' 0 N--CA 1.523 3.195 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.35 -32.08 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.64 -34.77 59.7 Favored 'General case' 0 N--CA 1.537 3.88 0 C-N-CA 122.923 0.489 . . . . 0.0 110.314 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 58.9 m -59.28 -47.03 86.92 Favored 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 36.7 tp -66.62 -34.73 78.54 Favored 'General case' 1 N--CA 1.549 4.486 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.76 -38.39 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.371 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.95 -23.31 63.46 Favored 'General case' 0 N--CA 1.521 3.088 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.186 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -48.03 -46.06 32.68 Favored 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 121.873 0.844 . . . . 0.0 110.554 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.09 -43.45 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -77.12 -9.57 58.83 Favored 'General case' 0 N--CA 1.531 3.595 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.439 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -89.63 -15.48 32.62 Favored 'General case' 1 N--CA 1.547 4.376 0 C-N-CA 123.53 0.732 . . . . 0.0 109.782 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -71.6 -6.55 62.84 Favored Glycine 1 N--CA 1.524 4.547 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -75.97 155.14 35.31 Favored 'General case' 0 N--CA 1.512 2.632 0 C-N-CA 125.451 1.5 . . . . 0.0 109.027 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 95.9 p -100.48 146.96 32.91 Favored Pre-proline 0 N--CA 1.53 3.55 0 C-N-CA 125.357 1.463 . . . . 0.0 108.725 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -63.75 130.27 27.36 Favored 'Trans proline' 0 N--CA 1.521 3.105 0 CA-C-N 121.493 1.569 . . . . 0.0 109.061 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.525 3.307 0 C-N-CA 125.312 1.445 . . . . 0.0 109.926 -178.904 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.515 2.821 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -68.72 -50.43 50.81 Favored 'General case' 0 N--CA 1.529 3.513 0 CA-C-O 121.406 0.622 . . . . 0.0 111.989 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -61.5 -34.66 75.88 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.4 -24.95 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 C-N-CA 125.357 1.463 . . . . 0.0 110.074 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -66.79 -54.75 19.42 Favored 'General case' 1 N--CA 1.559 5.012 0 CA-C-N 119.592 1.087 . . . . 0.0 110.523 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.38 -30.78 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.945 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -55.26 -31.67 61.73 Favored 'General case' 0 N--CA 1.513 2.679 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.764 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 20.4 mm -64.11 -46.04 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.073 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 48.3 mt -56.93 -36.32 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.47 -45.3 85.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.13 -30.21 49.13 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.42 -32.79 85.37 Favored Glycine 1 N--CA 1.518 4.123 0 C-N-CA 123.596 0.617 . . . . 0.0 112.059 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 69.0 m -68.17 -36.95 80.44 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.558 0.743 . . . . 0.0 111.329 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.13 -44.16 83.09 Favored 'General case' 0 N--CA 1.538 3.962 0 C-N-CA 123.518 0.727 . . . . 0.0 112.363 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.257 0.5 OUTLIER -61.4 -49.69 83.45 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.293 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -175.587 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.34 -24.47 67.51 Favored Glycine 1 N--CA 1.527 4.741 0 CA-C-N 119.877 1.217 . . . . 0.0 112.721 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.5 tt -65.03 -43.27 92.94 Favored 'General case' 0 N--CA 1.535 3.816 0 C-N-CA 123.68 0.792 . . . . 0.0 109.715 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -53.39 -27.29 23.26 Favored 'General case' 1 N--CA 1.54 4.048 0 C-N-CA 124.199 1.0 . . . . 0.0 113.228 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.08 -38.21 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 C-N-CA 123.463 0.705 . . . . 0.0 110.36 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 2.0 p -55.71 -26.29 19.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.129 0 C-N-CA 124.566 1.146 . . . . 0.0 111.725 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -51.89 -26.02 9.28 Favored 'General case' 0 N--CA 1.539 3.995 0 C-N-CA 123.25 0.62 . . . . 0.0 110.777 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.69 -44.48 81.53 Favored 'General case' 0 N--CA 1.528 3.45 0 O-C-N 121.868 -0.52 . . . . 0.0 110.503 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 3.0 m -70.3 -33.49 54.46 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.433 0 CA-C-N 118.8 0.727 . . . . 0.0 109.969 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 4.7 tp -54.97 -33.21 62.2 Favored 'General case' 0 N--CA 1.537 3.885 0 C-N-CA 123.626 0.77 . . . . 0.0 109.857 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 96.0 p -59.36 -48.14 82.75 Favored 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 36.3 tp -63.94 -34.05 77.09 Favored 'General case' 1 N--CA 1.548 4.46 0 O-C-N 121.205 -0.935 . . . . 0.0 108.599 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.72 -38.34 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -61.47 -28.24 69.14 Favored 'General case' 0 N--CA 1.536 3.83 0 C-N-CA 122.92 0.488 . . . . 0.0 110.32 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -49.21 -47.52 46.08 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 121.714 0.769 . . . . 0.0 109.143 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.48 -36.3 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.666 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.1 -27.79 60.02 Favored 'General case' 0 N--CA 1.532 3.672 0 CA-C-O 120.925 0.393 . . . . 0.0 110.047 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -90.14 -13.47 35.63 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 124.623 1.169 . . . . 0.0 109.184 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.8 -25.64 9.69 Favored Glycine 1 N--CA 1.521 4.349 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -115.9 151.37 35.46 Favored 'General case' 0 N--CA 1.533 3.715 0 C-N-CA 124.573 1.149 . . . . 0.0 108.801 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 69.4 m -82.79 147.26 54.57 Favored Pre-proline 0 N--CA 1.528 3.442 0 C-N-CA 125.408 1.483 . . . . 0.0 109.694 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 C--N 1.396 3.067 0 CA-C-N 121.805 1.68 . . . . 0.0 110.03 -176.799 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.8 tt . . . . . 0 N--CA 1.514 2.759 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -68.32 -48.21 65.51 Favored 'General case' 0 N--CA 1.528 3.432 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -62.32 -31.96 72.65 Favored 'General case' 0 N--CA 1.536 3.872 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.05 -25.24 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.029 0 C-N-CA 125.628 1.571 . . . . 0.0 111.007 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -52.32 59.23 Favored 'General case' 1 N--CA 1.55 4.537 0 CA-C-N 118.677 0.672 . . . . 0.0 110.475 -178.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 18.5 tt -71.21 -30.29 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.664 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -51.06 -36.56 40.52 Favored 'General case' 0 N--CA 1.525 3.296 0 CA-C-O 121.64 0.733 . . . . 0.0 111.819 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.67 -36.73 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 C-N-CA 125.196 1.399 . . . . 0.0 109.677 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 18.1 mm -61.56 -41.08 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.8 -44.5 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.85 -30.7 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.799 0 C-N-CA 123.566 0.746 . . . . 0.0 109.087 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.66 -32.48 83.24 Favored Glycine 1 N--CA 1.52 4.271 0 C-N-CA 123.399 0.523 . . . . 0.0 112.114 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.6 m -68.18 -37.13 80.64 Favored 'General case' 0 N--CA 1.524 3.236 0 C-N-CA 123.597 0.759 . . . . 0.0 111.175 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.35 -44.19 84.11 Favored 'General case' 0 N--CA 1.539 3.996 0 C-N-CA 123.674 0.79 . . . . 0.0 112.391 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . 0.291 0.1 OUTLIER -67.22 -48.25 78.98 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.48 0 C-N-CA 123.036 0.534 . . . . 0.0 110.478 -176.292 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -54.89 -34.77 57.68 Favored Glycine 1 N--CA 1.53 4.945 0 O-C-N 121.379 -0.826 . . . . 0.0 112.416 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 9.5 tt -72.45 -40.41 67.06 Favored 'General case' 0 N--CA 1.534 3.768 0 C-N-CA 125.159 1.383 . . . . 0.0 109.859 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -51.64 -24.5 5.64 Favored 'General case' 0 N--CA 1.531 3.597 0 C-N-CA 126.317 1.847 . . . . 0.0 113.823 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.21 -35.63 30.35 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 C-N-CA 123.789 0.836 . . . . 0.0 112.273 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -52.97 -27.49 12.97 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 C-N-CA 124.503 1.121 . . . . 0.0 111.903 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -52.38 -25.52 10.05 Favored 'General case' 0 N--CA 1.539 3.981 0 C-N-CA 123.635 0.774 . . . . 0.0 109.909 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -57.5 -37.52 73.09 Favored 'General case' 0 N--CA 1.524 3.261 0 O-C-N 121.53 -0.731 . . . . 0.0 109.882 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.47 -33.17 55.99 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.349 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.16 -32.93 50.29 Favored 'General case' 1 N--CA 1.546 4.326 0 C-N-CA 124.303 1.041 . . . . 0.0 109.603 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 69.3 m -59.41 -45.35 91.76 Favored 'General case' 1 N--CA 1.543 4.215 0 O-C-N 120.207 -1.558 . . . . 0.0 111.088 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.71 -35.04 78.43 Favored 'General case' 1 N--CA 1.552 4.665 0 O-C-N 121.071 -1.018 . . . . 0.0 108.987 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.73 -38.5 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.469 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -55.02 -35.64 64.63 Favored 'General case' 0 N--CA 1.529 3.5 0 CA-C-O 121.258 0.552 . . . . 0.0 109.8 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -54.09 -47.44 71.73 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 122.367 1.08 . . . . 0.0 109.802 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.65 -32.05 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -77.52 -18.35 57.11 Favored 'General case' 0 N--CA 1.531 3.616 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.03 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -87.33 -14.97 39.29 Favored 'General case' 1 N--CA 1.552 4.633 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.85 -24.11 32.63 Favored Glycine 1 N--CA 1.521 4.313 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -121.53 152.95 38.63 Favored 'General case' 1 N--CA 1.542 4.135 0 C-N-CA 125.158 1.383 . . . . 0.0 110.408 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 92.4 p -82.7 148.7 58.59 Favored Pre-proline 0 N--CA 1.534 3.734 0 C-N-CA 126.344 1.857 . . . . 0.0 111.292 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.527 3.466 0 CA-C-N 121.411 1.54 . . . . 0.0 111.632 -174.669 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.687 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -72.14 -28.83 63.5 Favored 'General case' 0 N--CA 1.53 3.547 0 O-C-N 121.896 -0.503 . . . . 0.0 110.814 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -70.66 -34.12 71.68 Favored 'General case' 0 N--CA 1.526 3.341 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.077 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 23.3 pt -72.03 -26.3 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.464 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -51.44 69.53 Favored 'General case' 1 N--CA 1.541 4.084 0 C-N-CA 123.73 0.812 . . . . 0.0 112.023 -177.147 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.5 tt -73.14 -31.84 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.792 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.168 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -54.17 -29.25 44.94 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.879 0.872 . . . . 0.0 110.346 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 6.5 mm -68.68 -38.75 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.822 0 C-N-CA 123.78 0.832 . . . . 0.0 109.593 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.93 -41.75 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.257 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.46 -44.6 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.34 -30.4 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.06 -37.6 93.02 Favored Glycine 1 N--CA 1.52 4.263 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 68.1 m -68.47 -37.89 80.56 Favored 'General case' 0 N--CA 1.523 3.177 0 C-N-CA 123.581 0.752 . . . . 0.0 111.02 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.74 -45.57 93.77 Favored 'General case' 0 N--CA 1.536 3.842 0 C-N-CA 123.07 0.548 . . . . 0.0 111.576 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 1.5 tp -60.96 -49.39 84.91 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.362 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.18 -22.59 63.13 Favored Glycine 1 N--CA 1.528 4.817 0 O-C-N 120.402 -1.436 . . . . 0.0 112.566 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.55 -41.4 79.85 Favored 'General case' 0 N--CA 1.533 3.69 0 CA-C-O 121.769 0.795 . . . . 0.0 108.993 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -53.72 -24.2 14.07 Favored 'General case' 0 N--CA 1.534 3.769 0 C-N-CA 124.765 1.226 . . . . 0.0 113.409 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 75.0 mt -53.24 -35.81 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 C-N-CA 123.484 0.714 . . . . 0.0 110.549 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 5.5 m -54.27 -26.27 15.07 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.377 0 C-N-CA 123.981 0.913 . . . . 0.0 111.687 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -53.97 -31.12 49.66 Favored 'General case' 0 N--CA 1.531 3.587 0 C-N-CA 123.278 0.631 . . . . 0.0 112.144 -173.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -71.4 -45.05 63.73 Favored 'General case' 0 N--CA 1.529 3.479 0 CA-C-O 121.99 0.9 . . . . 0.0 108.833 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.64 -34.76 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.089 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.71 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.13 -34.24 71.81 Favored 'General case' 0 N--CA 1.52 3.063 0 C-N-CA 124.674 1.19 . . . . 0.0 110.027 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 54.7 m -58.97 -46.58 87.71 Favored 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.72 -36.49 84.46 Favored 'General case' 1 N--CA 1.543 4.204 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.77 -40.97 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.669 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -66.28 -23.29 66.37 Favored 'General case' 0 N--CA 1.515 2.804 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.833 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -49.35 -47.18 47.61 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 123.43 0.692 . . . . 0.0 110.153 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.94 -48.17 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.966 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.148 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -76.7 -4.81 45.2 Favored 'General case' 0 N--CA 1.534 3.752 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.881 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -114.5 -12.82 12.26 Favored 'General case' 0 N--CA 1.52 3.036 0 C-N-CA 124.769 1.228 . . . . 0.0 108.849 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -49.86 -31.89 17.62 Favored Glycine 0 N--CA 1.51 3.618 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -78.28 153.75 31.53 Favored 'General case' 0 N--CA 1.523 3.183 0 CA-C-O 121.694 0.759 . . . . 0.0 109.084 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 99.5 p -80.11 149.83 70.42 Favored Pre-proline 0 N--CA 1.53 3.546 0 C-N-CA 126.72 2.008 . . . . 0.0 112.283 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -56.18 131.08 43.69 Favored 'Trans proline' 0 C--N 1.403 3.418 0 CA-C-N 120.761 1.308 . . . . 0.0 110.341 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 57.6 tp . . . . . 0 N--CA 1.527 3.398 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.615 -179.671 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.509 2.509 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -61.88 -50.37 72.51 Favored 'General case' 0 N--CA 1.53 3.569 0 CA-C-O 121.407 0.623 . . . . 0.0 112.345 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -63.16 -35.5 80.5 Favored 'General case' 0 N--CA 1.522 3.137 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.401 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 95.6 mt -74.85 -28.08 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 C-N-CA 125.246 1.418 . . . . 0.0 110.995 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -50.97 58.28 Favored 'General case' 1 N--CA 1.559 4.984 0 CA-C-N 119.873 1.215 . . . . 0.0 110.282 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 14.3 tt -64.52 -32.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 124.199 0.999 . . . . 0.0 109.088 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -53.85 -33.04 55.13 Favored 'General case' 0 N--CA 1.518 2.936 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.906 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.24 -42.51 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.861 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.706 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.02 -34.9 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.31 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 60.8 mt -64.62 -44.64 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.95 -30.76 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 C-N-CA 123.7 0.8 . . . . 0.0 109.047 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.21 -31.88 82.25 Favored Glycine 1 N--CA 1.52 4.26 0 C-N-CA 123.427 0.537 . . . . 0.0 112.005 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.1 m -69.04 -37.26 78.47 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.476 0.71 . . . . 0.0 111.279 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.05 -44.59 91.83 Favored 'General case' 1 N--CA 1.539 4.024 0 C-N-CA 123.298 0.639 . . . . 0.0 112.574 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.268 0.1 OUTLIER -62.46 -48.76 86.77 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.742 0 CA-C-N 118.314 0.506 . . . . 0.0 111.714 -175.929 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.6 -23.78 61.13 Favored Glycine 1 N--CA 1.527 4.754 0 O-C-N 121.778 -0.576 . . . . 0.0 113.068 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.24 -42.12 72.63 Favored 'General case' 0 N--CA 1.539 3.995 0 C-N-CA 124.617 1.167 . . . . 0.0 110.705 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -52.55 -25.62 10.96 Favored 'General case' 0 N--CA 1.537 3.918 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 8.7 tp -54.5 -37.8 39.44 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.401 0 CA-C-N 119.897 1.226 . . . . 0.0 112.677 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.76 -30.47 22.66 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 C-N-CA 123.441 0.696 . . . . 0.0 111.733 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -54.46 -26.45 31.19 Favored 'General case' 0 N--CA 1.534 3.726 0 C-N-CA 122.934 0.493 . . . . 0.0 109.706 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.9 68.4 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 122.664 0.386 . . . . 0.0 110.096 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.0 -31.09 49.01 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.002 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 6.2 tp -53.31 -33.96 55.5 Favored 'General case' 0 N--CA 1.534 3.751 0 C-N-CA 123.158 0.583 . . . . 0.0 110.113 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 83.8 p -58.05 -46.03 86.05 Favored 'General case' 0 N--CA 1.531 3.579 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 39.5 tp -66.96 -35.19 79.42 Favored 'General case' 1 N--CA 1.54 4.034 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 58.8 t -69.06 -42.23 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.637 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -67.24 -23.45 65.71 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.466 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -50.76 -48.29 59.32 Favored 'General case' 0 N--CA 1.512 2.633 0 CA-C-O 121.671 0.748 . . . . 0.0 109.427 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.88 -41.04 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.583 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -76.08 -20.67 57.5 Favored 'General case' 0 N--CA 1.536 3.854 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.806 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . 0.452 HE21 ' NE2' ' B' ' 710' ' ' GLN . 33.1 tt0 -99.1 -11.91 21.0 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 125.355 1.462 . . . . 0.0 109.434 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.94 -31.12 24.18 Favored Glycine 1 N--CA 1.519 4.213 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 177.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -107.92 142.67 37.67 Favored 'General case' 0 N--CA 1.534 3.768 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 68.8 m -82.42 146.83 54.89 Favored Pre-proline 0 N--CA 1.528 3.468 0 C-N-CA 125.296 1.438 . . . . 0.0 111.201 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--N 1.402 3.382 0 CA-C-N 121.326 1.509 . . . . 0.0 109.342 -177.726 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 N--CA 1.526 3.355 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -71.46 -29.55 64.98 Favored 'General case' 0 N--CA 1.528 3.443 0 O-C-N 121.831 -0.543 . . . . 0.0 111.033 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -70.52 -36.53 73.8 Favored 'General case' 0 N--CA 1.517 2.923 0 CA-C-O 118.639 -0.695 . . . . 0.0 111.255 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 2.2 pp -71.6 -23.79 22.87 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.293 0 CA-C-N 119.544 1.065 . . . . 0.0 110.121 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.03 -53.08 61.56 Favored 'General case' 0 N--CA 1.532 3.655 0 CA-C-O 121.511 0.672 . . . . 0.0 112.309 -176.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 18.7 tt -74.76 -31.78 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.078 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -52.25 -45.79 65.5 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.376 1.07 . . . . 0.0 111.869 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.52 -36.79 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.422 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 12.0 mm -60.36 -41.58 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.44 -44.18 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.55 -31.59 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.836 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.61 -44.6 97.31 Favored Glycine 1 N--CA 1.521 4.342 0 C-N-CA 124.071 0.843 . . . . 0.0 112.316 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.4 m -68.18 -37.48 81.0 Favored 'General case' 0 N--CA 1.527 3.382 0 CA-C-O 122.121 0.962 . . . . 0.0 110.022 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 2.2 tp -58.59 -45.31 89.36 Favored 'General case' 0 N--CA 1.518 2.962 0 CA-C-N 113.339 -1.755 . . . . 0.0 113.379 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -38.75 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.857 0 C-N-CA 122.714 0.406 . . . . 0.0 111.751 -177.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.53 -28.1 67.04 Favored Glycine 1 N--CA 1.53 4.944 0 O-C-N 121.014 -1.054 . . . . 0.0 112.16 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 4.9 tt -66.46 -40.31 89.33 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 125.02 1.328 . . . . 0.0 110.213 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -51.02 -24.68 3.95 Favored 'General case' 0 N--CA 1.528 3.473 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.8 tt -53.5 -35.96 26.6 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 CA-C-N 119.329 0.968 . . . . 0.0 111.947 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 13.4 p -53.39 -30.01 17.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 C-N-CA 124.278 1.031 . . . . 0.0 111.617 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -57.34 -28.14 62.87 Favored 'General case' 0 N--CA 1.536 3.855 0 O-C-N 121.53 -0.731 . . . . 0.0 110.697 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.13 -41.76 73.5 Favored 'General case' 0 N--CA 1.529 3.508 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.59 -32.02 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.716 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 15.6 tp -54.12 -31.02 51.05 Favored 'General case' 1 N--CA 1.542 4.128 0 C-N-CA 123.516 0.726 . . . . 0.0 109.114 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 62.7 m -56.63 -45.3 81.62 Favored 'General case' 0 N--CA 1.535 3.814 0 O-C-N 121.194 -0.941 . . . . 0.0 111.762 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.14 -34.78 78.85 Favored 'General case' 1 N--CA 1.547 4.4 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.86 -39.21 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -61.28 -22.44 64.86 Favored 'General case' 0 N--CA 1.523 3.189 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -52.34 -44.75 65.33 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-O 121.96 0.886 . . . . 0.0 109.462 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 98.7 t -58.16 -37.1 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.715 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -77.64 -5.68 51.2 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.434 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . 0.452 ' NE2' HE21 ' A' ' 710' ' ' GLN . 10.5 tp-100 -89.22 -17.33 29.28 Favored 'General case' 1 N--CA 1.561 5.086 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -81.64 -24.95 55.04 Favored Glycine 1 N--CA 1.521 4.312 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -80.23 152.81 28.91 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 125.898 1.679 . . . . 0.0 108.298 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 97.8 p -102.12 146.79 32.92 Favored Pre-proline 1 N--CA 1.551 4.6 0 C-N-CA 125.222 1.409 . . . . 0.0 114.155 -176.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo . . . . . 0 C--N 1.406 3.553 0 CA-C-N 120.405 1.18 . . . . 0.0 109.939 -178.543 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 N--CA 1.53 3.555 0 CA-C-O 121.703 0.763 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -71.27 -28.6 64.26 Favored 'General case' 0 N--CA 1.524 3.233 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.537 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -72.5 -36.53 68.42 Favored 'General case' 0 N--CA 1.526 3.371 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.957 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 23.8 pt -72.91 -29.11 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 CA-C-N 118.054 0.388 . . . . 0.0 110.082 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -52.59 -54.64 30.27 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-O 121.617 0.722 . . . . 0.0 111.648 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.6 tt -69.43 -30.98 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.818 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.05 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.6 -43.33 99.07 Favored 'General case' 0 N--CA 1.528 3.446 0 CA-C-O 122.88 1.324 . . . . 0.0 109.28 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.33 -44.4 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.744 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.46 -45.62 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 CA-C-O 118.826 -0.607 . . . . 0.0 110.295 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 19.4 tt -62.55 -39.15 83.45 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.625 0 CA-C-N 119.808 1.186 . . . . 0.0 108.64 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 19.7 t -65.88 -29.91 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.763 0 C-N-CA 123.934 0.894 . . . . 0.0 108.753 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -68.75 -24.94 75.42 Favored Glycine 1 N--CA 1.526 4.694 0 CA-C-N 119.017 0.826 . . . . 0.0 113.474 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 70.5 m -67.61 -50.44 58.14 Favored 'General case' 0 N--CA 1.532 3.673 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.66 -32.62 43.19 Favored 'General case' 0 N--CA 1.519 2.986 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.99 -37.7 73.53 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 CA-C-N 119.436 1.016 . . . . 0.0 113.172 -176.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -67.99 -38.86 89.1 Favored Glycine 1 N--CA 1.523 4.479 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -37.08 86.09 Favored 'General case' 0 N--CA 1.534 3.745 0 C-N-CA 124.995 1.318 . . . . 0.0 111.946 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -50.9 -27.12 6.84 Favored 'General case' 1 N--CA 1.549 4.489 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 29.2 pt -54.07 -38.42 37.97 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.335 0 CA-C-N 120.155 1.343 . . . . 0.0 114.278 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.4 p -55.75 -35.5 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -55.89 -26.97 49.76 Favored 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.311 0.644 . . . . 0.0 110.457 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.95 69.51 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 121.939 -0.475 . . . . 0.0 110.467 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.62 -30.84 48.64 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.155 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 9.1 tp -53.4 -34.64 58.53 Favored 'General case' 0 N--CA 1.531 3.604 0 CA-C-O 118.841 -0.6 . . . . 0.0 110.786 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 62.9 m -58.7 -46.95 86.16 Favored 'General case' 0 N--CA 1.533 3.709 0 CA-C-N 119.284 0.947 . . . . 0.0 112.971 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.85 -35.3 80.28 Favored 'General case' 1 N--CA 1.549 4.523 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.879 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.94 -38.38 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' C' ' 710' ' ' GLN . 63.2 t30 -58.22 -30.1 66.22 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.642 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -47.36 -42.1 20.96 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.04 0.838 . . . . 0.0 112.168 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.65 -44.79 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -77.4 -6.61 54.01 Favored 'General case' 1 N--CA 1.539 4.004 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.75 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.4 tt0 -114.65 -11.28 12.37 Favored 'General case' 0 N--CA 1.517 2.905 0 C-N-CA 125.474 1.509 . . . . 0.0 108.745 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -53.09 -24.49 21.15 Favored Glycine 1 N--CA 1.519 4.17 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -88.15 155.95 19.51 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.942 0.897 . . . . 0.0 108.718 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 95.5 p -77.58 149.38 78.04 Favored Pre-proline 0 N--CA 1.535 3.793 0 C-N-CA 125.973 1.709 . . . . 0.0 112.551 -173.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -55.72 129.83 37.16 Favored 'Trans proline' 0 C--N 1.409 3.747 0 CA-C-N 120.374 1.169 . . . . 0.0 110.906 -173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.523 3.221 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.519 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 N--CA 1.505 2.275 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -55.13 -37.24 66.67 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -73.24 -38.26 66.07 Favored 'General case' 0 N--CA 1.532 3.645 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.46 -25.74 19.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.069 0 C-N-CA 125.624 1.57 . . . . 0.0 111.574 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -67.26 -53.7 27.58 Favored 'General case' 1 N--CA 1.544 4.248 0 C-N-CA 124.539 1.136 . . . . 0.0 112.006 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 15.2 tt -68.23 -32.89 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.195 0 CA-C-N 114.051 -1.431 . . . . 0.0 109.151 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -52.47 -34.83 50.86 Favored 'General case' 0 N--CA 1.516 2.849 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.982 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 13.0 mm -63.44 -37.62 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 CA-C-O 121.762 0.792 . . . . 0.0 109.201 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -37.24 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.183 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 62.0 mt -65.48 -43.82 94.35 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.5 t -61.99 -28.94 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.15 -31.62 78.1 Favored Glycine 0 N--CA 1.513 3.787 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.693 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 49.9 m -69.34 -37.19 77.56 Favored 'General case' 0 N--CA 1.53 3.542 0 C-N-CA 123.201 0.6 . . . . 0.0 111.077 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.6 mp -58.08 -45.05 87.8 Favored 'General case' 0 N--CA 1.538 3.944 0 C-N-CA 123.487 0.715 . . . . 0.0 112.071 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.271 0.8 OUTLIER -60.28 -48.52 87.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.135 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.771 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.5 -26.3 69.53 Favored Glycine 1 N--CA 1.531 4.997 0 CA-C-N 120.164 1.347 . . . . 0.0 112.296 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.0 tt -64.77 -42.83 94.82 Favored 'General case' 0 N--CA 1.537 3.905 0 C-N-CA 124.059 0.944 . . . . 0.0 109.985 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -54.34 -26.11 27.89 Favored 'General case' 0 N--CA 1.538 3.958 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 70.2 mt -55.11 -39.06 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 C-N-CA 123.562 0.745 . . . . 0.0 112.257 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.57 -29.1 33.27 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.522 0 C-N-CA 123.49 0.716 . . . . 0.0 112.584 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -52.06 -26.03 10.01 Favored 'General case' 0 N--CA 1.535 3.779 0 C-N-CA 123.264 0.626 . . . . 0.0 110.949 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.55 -32.42 62.97 Favored 'General case' 0 N--CA 1.532 3.642 0 O-C-N 121.936 -0.477 . . . . 0.0 109.803 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.9 m -68.65 -30.82 48.52 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.123 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.83 -34.71 55.28 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 123.42 0.688 . . . . 0.0 110.391 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 89.0 p -58.89 -46.24 88.33 Favored 'General case' 0 N--CA 1.529 3.476 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 30.2 tp -67.02 -34.79 78.49 Favored 'General case' 1 N--CA 1.543 4.21 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.16 -39.29 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -69.71 -29.08 66.4 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.246 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -50.78 -40.41 55.06 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.537 0.684 . . . . 0.0 110.376 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.22 -38.43 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.899 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.737 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -74.99 -25.72 59.04 Favored 'General case' 0 N--CA 1.538 3.937 0 CA-C-O 121.057 0.456 . . . . 0.0 109.788 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -89.36 -7.77 54.57 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.51 -20.71 7.79 Favored Glycine 1 N--CA 1.524 4.506 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -120.69 152.05 38.74 Favored 'General case' 0 N--CA 1.526 3.329 0 C-N-CA 125.265 1.426 . . . . 0.0 109.293 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 94.5 p -82.34 150.45 63.91 Favored Pre-proline 0 N--CA 1.531 3.595 0 C-N-CA 125.884 1.674 . . . . 0.0 110.244 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo . . . . . 0 C--N 1.401 3.332 0 CA-C-N 122.259 1.842 . . . . 0.0 112.503 -175.782 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.2 tt . . . . . 0 N--CA 1.524 3.262 0 CA-C-O 120.813 0.34 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -71.11 -31.06 67.31 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -69.69 -38.53 77.03 Favored 'General case' 0 N--CA 1.526 3.362 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.544 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 20.3 pt -71.56 -31.94 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.301 0 CA-C-N 117.986 0.357 . . . . 0.0 110.282 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -52.82 -54.39 34.9 Favored 'General case' 1 N--CA 1.539 4.018 0 CA-C-O 121.776 0.798 . . . . 0.0 111.007 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -31.46 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.307 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -59.55 -43.41 93.54 Favored 'General case' 1 N--CA 1.539 4.012 0 CA-C-O 121.691 0.758 . . . . 0.0 109.658 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.66 -36.33 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 C-N-CA 124.215 1.006 . . . . 0.0 108.617 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 27.8 mm -65.17 -42.72 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 47.9 mm -60.28 -41.17 86.08 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.281 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.49 -31.22 48.26 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.108 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.98 -33.19 86.57 Favored Glycine 1 N--CA 1.518 4.163 0 C-N-CA 123.924 0.773 . . . . 0.0 112.693 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.2 m -68.15 -37.26 80.86 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.52 0.728 . . . . 0.0 111.577 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.69 -43.07 80.14 Favored 'General case' 0 N--CA 1.536 3.843 0 C-N-CA 123.39 0.676 . . . . 0.0 112.559 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . 0.276 0.8 OUTLIER -60.25 -48.73 86.99 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.502 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.242 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.45 -23.29 70.17 Favored Glycine 1 N--CA 1.531 5.023 0 CA-C-N 120.423 1.465 . . . . 0.0 112.518 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.29 -43.17 92.02 Favored 'General case' 1 N--CA 1.541 4.093 0 C-N-CA 123.359 0.664 . . . . 0.0 109.655 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -52.99 -24.02 8.56 Favored 'General case' 0 N--CA 1.536 3.86 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 78.1 mt -51.72 -35.71 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 C-N-CA 123.327 0.651 . . . . 0.0 110.425 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.23 -26.08 17.88 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.235 0 C-N-CA 124.444 1.097 . . . . 0.0 111.397 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -53.66 -28.76 35.07 Favored 'General case' 1 N--CA 1.547 4.404 0 O-C-N 121.313 -0.867 . . . . 0.0 110.387 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.66 -44.11 67.78 Favored 'General case' 0 N--CA 1.525 3.282 0 CA-C-O 122.028 0.918 . . . . 0.0 108.627 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 79.0 t -68.84 -33.6 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.04 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -35.5 66.03 Favored 'General case' 0 N--CA 1.532 3.642 0 C-N-CA 123.65 0.78 . . . . 0.0 110.405 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 48.8 m -59.77 -48.01 83.4 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.54 -34.85 77.91 Favored 'General case' 1 N--CA 1.54 4.052 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.219 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.23 -44.93 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' B' ' 709' ' ' ARG . 0.1 OUTLIER -74.41 -20.52 60.02 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.568 -178.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -47.39 -35.01 7.7 Favored 'General case' 0 N--CA 1.519 3.001 0 CA-C-N 118.566 0.621 . . . . 0.0 109.921 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.37 -39.13 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.815 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' B' ' 706' ' ' ASN . 71.9 mtm180 -76.49 -30.83 57.41 Favored 'General case' 0 N--CA 1.524 3.252 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.76 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -89.23 2.33 54.41 Favored 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.6 -28.1 50.6 Favored Glycine 1 N--CA 1.517 4.086 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -108.62 127.79 54.27 Favored 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 97.9 p -82.24 147.67 57.66 Favored Pre-proline 0 N--CA 1.528 3.462 0 C-N-CA 125.278 1.431 . . . . 0.0 110.758 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 C--N 1.401 3.334 0 CA-C-N 121.473 1.562 . . . . 0.0 110.363 -176.629 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' C' ' 683' ' ' ARG . 7.8 mp . . . . . 0 N--CA 1.504 2.269 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -56.4 -38.73 71.93 Favored 'General case' 0 N--CA 1.53 3.535 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -173.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -72.93 -37.83 67.03 Favored 'General case' 0 N--CA 1.534 3.757 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 86.7 mt -73.37 -25.68 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.355 0 C-N-CA 125.365 1.466 . . . . 0.0 111.246 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' C' ' 679' ' ' LEU . 0.9 OUTLIER -67.03 -51.3 56.48 Favored 'General case' 0 N--CA 1.536 3.872 0 C-N-CA 124.449 1.099 . . . . 0.0 110.71 -177.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.3 tt -71.2 -30.31 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.928 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -52.52 -27.48 16.62 Favored 'General case' 0 N--CA 1.526 3.343 0 CA-C-O 121.512 0.673 . . . . 0.0 109.959 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 22.8 mm -68.94 -48.2 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 C-N-CA 124.635 1.174 . . . . 0.0 108.937 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 10.9 mm -57.74 -41.99 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.389 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.365 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.34 -49.19 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.702 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.97 -30.87 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.886 0 C-N-CA 123.666 0.786 . . . . 0.0 109.921 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.8 -32.54 84.56 Favored Glycine 1 N--CA 1.52 4.242 0 C-N-CA 123.367 0.508 . . . . 0.0 112.777 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 68.7 m -67.65 -35.99 79.93 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 124.056 0.942 . . . . 0.0 112.135 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.11 -41.74 68.65 Favored 'General case' 0 N--CA 1.539 3.976 0 C-N-CA 123.433 0.693 . . . . 0.0 112.606 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -41.4 86.88 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.255 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -68.46 -31.59 74.16 Favored Glycine 1 N--CA 1.524 4.553 0 O-C-N 121.093 -1.004 . . . . 0.0 111.456 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.04 -42.07 99.67 Favored 'General case' 0 N--CA 1.534 3.769 0 C-N-CA 124.594 1.158 . . . . 0.0 112.156 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -53.3 -27.36 22.57 Favored 'General case' 1 N--CA 1.542 4.146 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -176.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 10.5 tp -55.71 -39.34 54.92 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.371 0 CA-C-N 119.664 1.12 . . . . 0.0 113.848 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.82 -31.7 41.04 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.338 0 C-N-CA 123.276 0.63 . . . . 0.0 112.235 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -54.41 -25.42 24.65 Favored 'General case' 0 N--CA 1.531 3.575 0 C-N-CA 123.121 0.568 . . . . 0.0 109.95 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.46 -34.98 65.0 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 122.086 -0.384 . . . . 0.0 110.159 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.3 m -68.83 -30.73 47.99 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.045 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 11.0 tp -52.89 -36.14 58.96 Favored 'General case' 0 N--CA 1.533 3.712 0 C-N-CA 123.154 0.581 . . . . 0.0 110.474 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 703' ' ' SER . . . . . 0.448 ' HG ' ' N ' ' C' ' 704' ' ' LEU . 89.0 p -58.87 -47.0 86.47 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . 0.448 ' N ' ' HG ' ' C' ' 703' ' ' SER . 39.8 tp -67.4 -34.88 78.17 Favored 'General case' 1 N--CA 1.543 4.191 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.86 -38.95 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.546 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' C' ' 710' ' ' GLN . 64.3 t30 -66.26 -25.69 67.0 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.856 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -48.22 -33.23 8.25 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 123.643 0.777 . . . . 0.0 111.133 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.66 -47.66 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -77.93 -9.92 59.33 Favored 'General case' 1 N--CA 1.542 4.172 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.623 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' C' ' 706' ' ' ASN . 50.9 tt0 -112.56 -7.64 13.87 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 125.884 1.674 . . . . 0.0 107.869 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.5 -25.04 33.41 Favored Glycine 0 N--CA 1.511 3.665 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -99.87 152.35 20.25 Favored 'General case' 0 N--CA 1.525 3.276 0 C-N-CA 123.911 0.885 . . . . 0.0 108.782 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 53.9 m -81.71 149.26 63.67 Favored Pre-proline 0 N--CA 1.529 3.502 0 CA-C-O 116.626 -1.654 . . . . 0.0 110.601 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -54.33 130.19 38.56 Favored 'Trans proline' 0 C--N 1.401 3.308 0 CA-C-N 122.233 1.833 . . . . 0.0 112.651 -175.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 51.8 mt . . . . . 0 N--CA 1.522 3.141 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.138 179.424 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.517 2.879 0 CA-C-O 119.804 -0.141 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -61.87 -50.05 73.78 Favored 'General case' 0 N--CA 1.529 3.48 0 CA-C-O 121.474 0.655 . . . . 0.0 111.208 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -64.15 -37.47 87.57 Favored 'General case' 0 N--CA 1.518 2.944 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.072 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -25.53 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.359 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -51.38 52.39 Favored 'General case' 1 N--CA 1.562 5.162 0 CA-C-N 119.973 1.26 . . . . 0.0 110.28 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.9 tt -67.73 -30.45 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.222 0 C-N-CA 123.696 0.798 . . . . 0.0 110.292 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -52.33 -30.01 26.41 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.124 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 21.9 mm -69.18 -46.94 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.453 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 7.9 mm -55.09 -39.54 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 C-N-CA 123.522 0.729 . . . . 0.0 109.503 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 59.6 mt -59.82 -47.13 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.978 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.58 -30.61 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 123.563 0.745 . . . . 0.0 109.736 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.98 -30.88 76.62 Favored Glycine 1 N--CA 1.518 4.116 0 C-N-CA 123.49 0.566 . . . . 0.0 112.654 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 63.3 m -67.56 -36.26 80.6 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 123.664 0.786 . . . . 0.0 111.842 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.3 mp -54.44 -42.15 70.24 Favored 'General case' 0 N--CA 1.539 3.99 0 C-N-CA 123.878 0.871 . . . . 0.0 112.993 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.29 -49.8 79.41 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.08 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.59 -22.43 65.93 Favored Glycine 1 N--CA 1.528 4.827 0 CA-C-N 119.811 1.187 . . . . 0.0 112.553 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.28 -43.7 93.97 Favored 'General case' 0 N--CA 1.535 3.812 0 C-N-CA 123.835 0.854 . . . . 0.0 109.645 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -54.67 -28.66 48.98 Favored 'General case' 0 N--CA 1.537 3.898 0 C-N-CA 124.262 1.025 . . . . 0.0 113.563 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 64.1 mt -55.45 -37.69 46.02 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 C-N-CA 123.609 0.764 . . . . 0.0 109.89 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -55.18 -26.78 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 C-N-CA 124.888 1.275 . . . . 0.0 110.969 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -51.73 -27.91 13.4 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.532 0.733 . . . . 0.0 112.087 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.15 96.2 Favored 'General case' 0 N--CA 1.524 3.245 0 O-C-N 121.595 -0.691 . . . . 0.0 109.58 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.99 -33.62 56.16 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.236 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 9.9 tp -55.0 -36.09 65.08 Favored 'General case' 0 N--CA 1.535 3.804 0 C-N-CA 123.2 0.6 . . . . 0.0 110.037 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.4 p -59.16 -47.5 85.07 Favored 'General case' 0 N--CA 1.525 3.3 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 41.3 tp -64.49 -35.78 82.07 Favored 'General case' 1 N--CA 1.546 4.354 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 90.1 t -69.61 -40.27 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.625 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 710' ' ' GLN . 55.1 t30 -64.89 -25.78 68.04 Favored 'General case' 0 N--CA 1.516 2.852 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.777 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -48.57 -44.4 36.63 Favored 'General case' 0 N--CA 1.518 2.961 0 C-N-CA 124.552 1.141 . . . . 0.0 110.402 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.87 -44.16 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -77.81 -12.7 60.0 Favored 'General case' 0 N--CA 1.538 3.926 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.621 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 706' ' ' ASN . 12.1 tt0 -112.93 -12.54 13.25 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 125.615 1.566 . . . . 0.0 109.181 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.91 -29.81 20.78 Favored Glycine 0 N--CA 1.515 3.903 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -93.11 149.68 21.05 Favored 'General case' 0 N--CA 1.522 3.135 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 70.3 m -81.93 148.12 59.98 Favored Pre-proline 0 N--CA 1.532 3.638 0 C-N-CA 125.686 1.594 . . . . 0.0 110.133 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.401 3.297 0 CA-C-N 121.794 1.676 . . . . 0.0 110.6 -175.759 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 2.2 tm? . . . . . 0 N--CA 1.511 2.622 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -68.17 -43.16 78.82 Favored 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 122.449 0.3 . . . . 0.0 110.848 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -69.15 -35.33 76.22 Favored 'General case' 0 N--CA 1.53 3.545 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.56 -24.81 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 C-N-CA 124.504 1.122 . . . . 0.0 110.605 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -64.13 -53.82 43.54 Favored 'General case' 1 N--CA 1.546 4.341 0 CA-C-N 119.362 0.983 . . . . 0.0 111.496 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.2 tt -68.07 -30.33 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.146 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -51.27 -32.82 25.96 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 123.515 0.726 . . . . 0.0 112.153 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -69.23 -45.62 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.267 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 34.2 mt -56.1 -41.15 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 C-N-CA 123.271 0.628 . . . . 0.0 109.938 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 42.2 mm -62.32 -48.91 86.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.109 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.96 -29.8 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 C-N-CA 124.339 1.055 . . . . 0.0 109.967 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.73 -37.03 94.09 Favored Glycine 1 N--CA 1.524 4.553 0 C-N-CA 123.278 0.466 . . . . 0.0 112.45 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.5 m -67.36 -36.14 80.77 Favored 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 124.445 1.098 . . . . 0.0 111.873 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.1 mp -53.29 -33.91 55.15 Favored 'General case' 0 N--CA 1.533 3.711 0 CA-C-O 118.541 -0.742 . . . . 0.0 112.26 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.14 -41.33 81.36 Favored 'Isoleucine or valine' 1 N--CA 1.557 4.888 0 CA-C-N 120.246 1.384 . . . . 0.0 111.236 -177.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -55.82 -46.41 83.32 Favored Glycine 1 N--CA 1.526 4.695 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER -73.28 -32.31 64.58 Favored 'General case' 1 N--CA 1.554 4.771 0 CA-C-N 117.625 0.713 . . . . 0.0 110.82 179.298 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -50.18 -26.61 4.77 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 125.625 1.57 . . . . 0.0 113.699 -176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.44 -36.04 33.17 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.14 0 C-N-CA 124.212 1.005 . . . . 0.0 111.051 -178.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.1 p -51.91 -26.49 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 124.735 1.214 . . . . 0.0 112.037 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -51.97 -25.89 9.32 Favored 'General case' 1 N--CA 1.54 4.046 0 C-N-CA 123.321 0.648 . . . . 0.0 110.18 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.89 -42.05 79.17 Favored 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 122.992 0.517 . . . . 0.0 111.313 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.67 -32.72 56.19 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 118.405 0.548 . . . . 0.0 110.383 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -32.2 52.53 Favored 'General case' 1 N--CA 1.545 4.309 0 C-N-CA 124.159 0.984 . . . . 0.0 109.529 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 51.6 m -57.26 -44.51 84.0 Favored 'General case' 1 N--CA 1.543 4.185 0 O-C-N 120.53 -1.356 . . . . 0.0 111.936 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 45.2 tp -65.25 -34.43 78.33 Favored 'General case' 1 N--CA 1.549 4.48 0 O-C-N 121.362 -0.836 . . . . 0.0 108.88 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 26.3 t -66.76 -39.93 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -61.12 -32.9 72.59 Favored 'General case' 0 N--CA 1.522 3.157 0 CA-C-O 118.497 -0.763 . . . . 0.0 110.412 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -49.8 -47.9 51.03 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 121.277 0.561 . . . . 0.0 110.003 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.87 -40.65 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.726 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.463 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.74 -29.82 59.01 Favored 'General case' 0 N--CA 1.523 3.219 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.719 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.69 -6.5 56.04 Favored 'General case' 0 N--CA 1.519 3.01 0 C-N-CA 124.515 1.126 . . . . 0.0 109.265 -178.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -59.7 -31.98 72.82 Favored Glycine 0 N--CA 1.513 3.788 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -89.61 154.31 20.07 Favored 'General case' 0 N--CA 1.529 3.502 0 C-N-CA 124.049 0.939 . . . . 0.0 109.346 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 3.3 t -80.82 150.05 68.51 Favored Pre-proline 0 N--CA 1.534 3.758 0 C-N-CA 126.735 2.014 . . . . 0.0 111.1 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.528 3.532 0 CA-C-N 120.744 1.301 . . . . 0.0 110.468 -174.743 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.529 3.503 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -70.82 -29.7 65.93 Favored 'General case' 0 N--CA 1.528 3.447 0 CA-C-O 120.592 0.234 . . . . 0.0 110.56 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -71.72 -37.92 70.55 Favored 'General case' 0 N--CA 1.518 2.926 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.218 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 1.9 pp -72.31 -23.23 21.23 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.225 0 CA-C-N 119.365 0.984 . . . . 0.0 110.505 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -51.58 55.89 Favored 'General case' 0 N--CA 1.535 3.797 0 C-N-CA 124.026 0.931 . . . . 0.0 112.289 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -72.29 -31.77 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.867 0 C-N-CA 123.605 0.762 . . . . 0.0 110.249 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -48.75 -23.71 1.15 Allowed 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 125.546 1.538 . . . . 0.0 112.764 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.11 -37.02 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.731 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.77 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 37.7 pt -61.86 -41.54 91.16 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.679 0 CA-C-N 120.783 1.629 . . . . 0.0 110.006 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 50.2 mt -63.63 -50.14 79.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.35 -38.64 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 C-N-CA 124.202 1.001 . . . . 0.0 110.59 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.79 -49.25 50.38 Favored Glycine 1 N--CA 1.525 4.567 0 C-N-CA 125.339 1.447 . . . . 0.0 111.712 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 73.1 m -58.79 -34.97 72.07 Favored 'General case' 0 N--CA 1.52 3.072 0 CA-C-O 121.841 0.829 . . . . 0.0 108.998 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.64 -44.55 85.69 Favored 'General case' 0 N--CA 1.524 3.251 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.452 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . 0.266 0.1 OUTLIER -65.22 -47.97 85.33 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.741 0 CA-C-N 119.113 0.87 . . . . 0.0 111.595 -177.221 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.22 -21.3 46.63 Favored Glycine 1 N--CA 1.531 4.999 0 CA-C-N 118.993 0.815 . . . . 0.0 112.656 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.79 -43.08 63.23 Favored 'General case' 0 N--CA 1.537 3.891 0 C-N-CA 124.028 0.931 . . . . 0.0 109.037 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -53.5 -25.51 16.85 Favored 'General case' 0 N--CA 1.532 3.663 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 40.1 mm -53.06 -37.65 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.939 0 C-N-CA 124.33 1.052 . . . . 0.0 112.724 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.03 -30.59 23.9 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.275 0 C-N-CA 123.61 0.764 . . . . 0.0 111.737 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -63.35 -27.64 69.45 Favored 'General case' 0 N--CA 1.538 3.966 0 O-C-N 121.433 -0.792 . . . . 0.0 110.857 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.1 -39.75 75.35 Favored 'General case' 0 N--CA 1.535 3.815 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.58 -32.01 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.078 0 C-N-CA 125.095 1.358 . . . . 0.0 109.041 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 16.0 tp -55.15 -33.04 62.6 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.401 0.68 . . . . 0.0 109.537 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 67.9 m -56.81 -46.33 81.68 Favored 'General case' 0 N--CA 1.532 3.626 0 CA-C-N 118.831 0.741 . . . . 0.0 112.629 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.4 tp -65.13 -35.3 80.67 Favored 'General case' 1 N--CA 1.549 4.509 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.99 -38.93 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -64.68 -25.52 67.98 Favored 'General case' 0 N--CA 1.52 3.055 0 C-N-CA 123.793 0.837 . . . . 0.0 110.298 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . 0.417 HH11 ' NE2' ' A' ' 710' ' ' GLN . 8.7 tpp180 -48.87 -44.12 39.58 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.74 0.781 . . . . 0.0 111.048 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.01 -39.71 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.343 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -76.54 -21.45 55.67 Favored 'General case' 0 N--CA 1.53 3.562 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.707 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -88.94 -11.15 45.26 Favored 'General case' 0 N--CA 1.513 2.714 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.96 -19.11 21.12 Favored Glycine 1 N--CA 1.517 4.079 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -107.24 153.17 23.09 Favored 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 124.858 1.263 . . . . 0.0 109.11 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 83.5 p -81.6 152.21 69.43 Favored Pre-proline 0 N--CA 1.528 3.459 0 C-N-CA 126.369 1.868 . . . . 0.0 111.545 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -53.04 131.83 44.71 Favored 'Trans proline' 0 C--N 1.401 3.331 0 CA-C-N 121.625 1.616 . . . . 0.0 112.066 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 46.3 tp . . . . . 0 N--CA 1.524 3.274 0 C-N-CA 125.848 1.659 . . . . 0.0 110.795 -179.375 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.502 2.161 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -60.18 -49.72 76.51 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -65.99 -33.51 75.98 Favored 'General case' 0 N--CA 1.535 3.815 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.76 -27.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 C-N-CA 125.212 1.405 . . . . 0.0 109.853 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -63.86 -52.04 61.85 Favored 'General case' 1 N--CA 1.545 4.299 0 O-C-N 121.495 -0.753 . . . . 0.0 111.471 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.9 tt -67.42 -31.97 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 C-N-CA 123.908 0.883 . . . . 0.0 109.287 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -58.94 -41.8 88.23 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.876 0.87 . . . . 0.0 109.036 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.27 -36.04 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 C-N-CA 124.962 1.305 . . . . 0.0 108.681 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 56.5 mt -66.7 -37.41 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.75 -43.35 91.41 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.529 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.71 -29.51 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.925 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.75 -32.09 81.86 Favored Glycine 1 N--CA 1.516 4.016 0 C-N-CA 123.614 0.626 . . . . 0.0 112.309 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 68.2 m -68.31 -36.19 78.93 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 123.659 0.784 . . . . 0.0 111.764 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 8.9 mp -54.03 -39.62 66.32 Favored 'General case' 0 N--CA 1.537 3.886 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.261 0.1 OUTLIER -62.48 -49.72 82.74 Favored 'Isoleucine or valine' 1 N--CA 1.556 4.864 0 CA-C-N 119.429 1.013 . . . . 0.0 112.664 -176.12 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.15 -30.84 71.45 Favored Glycine 1 N--CA 1.527 4.719 0 CA-C-N 119.187 0.903 . . . . 0.0 112.866 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.18 -42.23 99.34 Favored 'General case' 0 N--CA 1.536 3.855 0 C-N-CA 124.568 1.147 . . . . 0.0 111.576 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -52.67 -26.02 12.58 Favored 'General case' 0 N--CA 1.537 3.916 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 16.5 tt -53.46 -38.3 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.9 p -55.25 -30.77 25.37 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 C-N-CA 123.414 0.685 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -61.45 -28.22 69.12 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.097 0.559 . . . . 0.0 110.797 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.43 -41.92 72.25 Favored 'General case' 0 N--CA 1.53 3.553 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 88.5 t -68.59 -32.85 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 125.007 1.323 . . . . 0.0 108.953 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 13.5 tp -55.33 -30.26 59.91 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 124.089 0.956 . . . . 0.0 109.371 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 78.3 p -56.04 -45.63 79.14 Favored 'General case' 0 N--CA 1.533 3.723 0 O-C-N 121.485 -0.76 . . . . 0.0 111.572 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.23 -34.81 78.46 Favored 'General case' 1 N--CA 1.545 4.319 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.38 -39.35 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -63.12 -21.05 65.93 Favored 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.407 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -49.35 -46.8 47.49 Favored 'General case' 0 N--CA 1.513 2.711 0 CA-C-O 121.748 0.785 . . . . 0.0 109.168 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.68 -41.88 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -77.25 -5.51 49.61 Favored 'General case' 0 N--CA 1.522 3.143 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.209 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.64 -17.2 23.52 Favored 'General case' 1 N--CA 1.558 4.937 0 CA-C-N 118.671 0.669 . . . . 0.0 109.947 -179.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -84.09 -28.24 34.72 Favored Glycine 1 N--CA 1.522 4.419 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -75.49 135.23 40.66 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 112.901 -1.65 . . . . 0.0 108.317 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 96.0 p -82.67 146.67 53.59 Favored Pre-proline 0 N--CA 1.534 3.725 0 CA-C-O 117.574 -1.203 . . . . 0.0 110.665 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.398 3.184 0 CA-C-N 121.42 1.543 . . . . 0.0 109.616 -176.554 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.163 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -57.84 -49.61 76.09 Favored 'General case' 0 N--CA 1.532 3.67 0 CA-C-O 121.599 0.714 . . . . 0.0 111.24 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -65.19 -33.63 76.45 Favored 'General case' 0 N--CA 1.52 3.073 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.554 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 29.2 mm -74.09 -28.45 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.152 0 C-N-CA 124.596 1.158 . . . . 0.0 110.425 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -66.13 -55.41 16.54 Favored 'General case' 1 N--CA 1.547 4.385 0 CA-C-O 122.379 1.085 . . . . 0.0 110.615 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -30.55 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.879 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.46 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.41 -44.36 65.36 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 123.647 0.779 . . . . 0.0 111.511 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 27.2 mt -62.81 -37.9 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 C-N-CA 124.869 1.268 . . . . 0.0 110.311 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 39.1 mm -57.61 -41.62 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 50.4 mm -62.98 -44.99 99.99 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.538 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 176.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.43 -31.07 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 C-N-CA 123.351 0.661 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.54 -42.84 95.45 Favored Glycine 1 N--CA 1.524 4.539 0 C-N-CA 123.539 0.59 . . . . 0.0 112.593 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 66.7 m -67.31 -36.25 81.11 Favored 'General case' 0 N--CA 1.528 3.46 0 CA-C-O 122.342 1.068 . . . . 0.0 110.212 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 2.6 tp -54.04 -35.05 61.56 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 113.191 -1.822 . . . . 0.0 112.909 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -42.32 59.47 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.624 0 CA-C-N 118.641 0.655 . . . . 0.0 110.663 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -53.58 -44.75 68.31 Favored Glycine 1 N--CA 1.523 4.472 0 N-CA-C 116.025 1.17 . . . . 0.0 116.025 -175.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . 0.321 0.0 OUTLIER -67.23 -30.85 70.87 Favored 'General case' 1 N--CA 1.557 4.893 0 CA-C-N 118.267 1.034 . . . . 0.0 112.247 -179.162 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -48.22 -25.02 1.34 Allowed 'General case' 0 N--CA 1.538 3.936 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 25.9 pt -54.27 -36.69 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.964 0 CA-C-N 118.864 0.757 . . . . 0.0 112.543 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.96 -32.57 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -55.62 -25.77 40.58 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.386 0.674 . . . . 0.0 109.67 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.18 72.6 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 122.711 0.404 . . . . 0.0 110.643 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.78 -31.38 50.52 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.3 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 11.8 tp -54.32 -33.9 59.86 Favored 'General case' 0 N--CA 1.531 3.581 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.157 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 27.0 m -57.69 -46.38 84.41 Favored 'General case' 0 N--CA 1.531 3.577 0 CA-C-N 119.246 0.93 . . . . 0.0 113.4 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 37.5 tp -65.27 -35.9 82.44 Favored 'General case' 1 N--CA 1.552 4.667 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.4 -38.58 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.354 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -62.32 -26.62 68.53 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.054 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -49.11 -47.43 45.3 Favored 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.694 0.759 . . . . 0.0 109.687 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.22 -37.97 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.853 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -75.38 -24.51 57.26 Favored 'General case' 0 N--CA 1.53 3.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.025 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -89.35 -13.38 37.99 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.1 -25.72 32.82 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -96.86 154.22 17.43 Favored 'General case' 0 N--CA 1.533 3.7 0 C-N-CA 124.559 1.144 . . . . 0.0 108.517 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 82.5 p -80.64 152.03 72.04 Favored Pre-proline 0 N--CA 1.536 3.84 0 C-N-CA 126.201 1.8 . . . . 0.0 112.973 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo . . . . . 0 C--N 1.407 3.635 0 CA-C-N 121.159 1.45 . . . . 0.0 112.022 -173.517 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.327 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -60.16 -49.4 77.8 Favored 'General case' 0 N--CA 1.533 3.692 0 C-N-CA 122.994 0.518 . . . . 0.0 110.627 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -64.18 -33.71 76.41 Favored 'General case' 0 N--CA 1.525 3.301 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 27.9 mm -73.79 -31.5 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 C-N-CA 124.451 1.101 . . . . 0.0 111.13 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -49.52 69.64 Favored 'General case' 1 N--CA 1.554 4.773 0 CA-C-O 121.617 0.722 . . . . 0.0 111.52 -176.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -29.02 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 C-N-CA 125.319 1.448 . . . . 0.0 110.27 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -51.2 -30.37 16.91 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.408 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.45 -40.69 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.981 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 45.4 mt -60.5 -34.81 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.563 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.54 -47.6 92.22 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.451 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.4 -29.12 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.231 0 C-N-CA 124.253 1.021 . . . . 0.0 109.74 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.84 92.69 Favored Glycine 1 N--CA 1.522 4.369 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 60.6 m -68.98 -37.17 78.6 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.126 0.97 . . . . 0.0 111.137 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.6 mp -55.71 -35.42 66.09 Favored 'General case' 1 N--CA 1.54 4.042 0 C-N-CA 123.573 0.749 . . . . 0.0 112.09 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . 0.269 0.4 OUTLIER -72.11 -47.22 55.35 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.704 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.52 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -53.96 -44.91 72.33 Favored Glycine 1 N--CA 1.525 4.588 0 N-CA-C 116.393 1.317 . . . . 0.0 116.393 -175.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -65.81 -31.04 71.77 Favored 'General case' 1 N--CA 1.552 4.645 0 CA-C-N 118.408 1.104 . . . . 0.0 112.697 -178.85 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -48.95 -25.26 1.84 Allowed 'General case' 1 N--CA 1.544 4.258 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 18.2 tt -53.1 -35.3 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 C-N-CA 123.256 0.622 . . . . 0.0 111.388 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -53.18 -30.65 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 C-N-CA 124.198 0.999 . . . . 0.0 111.506 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -58.89 -28.43 66.16 Favored 'General case' 0 N--CA 1.537 3.907 0 O-C-N 121.655 -0.653 . . . . 0.0 110.474 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.34 -42.38 71.98 Favored 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.49 -32.39 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.796 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 21.1 tp -54.94 -33.43 62.28 Favored 'General case' 0 N--CA 1.536 3.871 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 87.0 p -57.33 -45.37 84.36 Favored 'General case' 0 N--CA 1.529 3.485 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -37.39 85.48 Favored 'General case' 1 N--CA 1.544 4.228 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.14 -37.94 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.8 p30 -60.12 -31.91 70.5 Favored 'General case' 0 N--CA 1.518 2.953 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.143 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -48.22 -47.27 35.73 Favored 'General case' 0 N--CA 1.516 2.852 0 C-N-CA 123.517 0.727 . . . . 0.0 111.258 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 49.3 t -64.13 -47.71 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -78.76 -10.15 59.68 Favored 'General case' 0 N--CA 1.536 3.868 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' C' ' 706' ' ' ASN . 38.7 tt0 -113.7 -10.87 13.02 Favored 'General case' 0 N--CA 1.533 3.679 0 C-N-CA 124.965 1.306 . . . . 0.0 109.175 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.21 -35.33 54.83 Favored Glycine 0 N--CA 1.509 3.523 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -79.53 152.78 29.97 Favored 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 96.0 p -81.17 150.03 67.29 Favored Pre-proline 0 N--CA 1.531 3.588 0 CA-C-O 116.739 -1.601 . . . . 0.0 111.09 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.14 131.05 42.71 Favored 'Trans proline' 0 C--N 1.401 3.302 0 CA-C-N 121.9 1.714 . . . . 0.0 112.255 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 N--CA 1.53 3.566 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.246 179.616 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.369 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -62.96 -51.35 67.2 Favored 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -67.41 -31.39 71.57 Favored 'General case' 1 N--CA 1.539 4.005 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 47.6 mm -74.88 -26.68 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.489 0 C-N-CA 124.911 1.284 . . . . 0.0 110.269 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -66.35 -54.0 29.61 Favored 'General case' 1 N--CA 1.55 4.559 0 CA-C-O 121.775 0.797 . . . . 0.0 111.13 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.44 -30.82 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.353 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -56.82 -31.35 64.64 Favored 'General case' 0 N--CA 1.515 2.813 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.789 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.6 mm -68.58 -39.25 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 54.3 mt -65.42 -36.32 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.194 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 72.1 mt -67.45 -42.95 87.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.026 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.92 -30.15 47.94 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.338 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.7 97.52 Favored Glycine 1 N--CA 1.524 4.565 0 C-N-CA 124.002 0.811 . . . . 0.0 112.175 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 71.0 m -68.78 -37.83 79.6 Favored 'General case' 0 N--CA 1.522 3.16 0 CA-C-O 122.084 0.945 . . . . 0.0 109.883 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 1.9 tp -59.44 -44.78 92.86 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.02 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -32.46 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.757 0 O-C-N 121.896 -0.502 . . . . 0.0 112.092 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.18 -44.59 96.3 Favored Glycine 1 N--CA 1.52 4.246 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . 0.334 0.0 OUTLIER -68.09 -31.97 71.96 Favored 'General case' 1 N--CA 1.549 4.506 0 CA-C-N 118.279 1.039 . . . . 0.0 112.452 -178.715 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -48.6 -24.7 1.42 Allowed 'General case' 0 N--CA 1.539 3.982 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 17.4 tt -52.39 -35.07 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 123.186 0.594 . . . . 0.0 111.845 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.8 p -52.95 -30.3 15.86 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 C-N-CA 123.789 0.836 . . . . 0.0 111.309 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -61.29 -29.37 69.83 Favored 'General case' 0 N--CA 1.536 3.827 0 O-C-N 121.433 -0.792 . . . . 0.0 110.328 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.55 -37.94 74.09 Favored 'General case' 0 N--CA 1.535 3.783 0 CA-C-O 121.629 0.728 . . . . 0.0 109.059 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.47 -30.24 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.255 0 C-N-CA 124.75 1.22 . . . . 0.0 108.56 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.1 -30.58 49.06 Favored 'General case' 0 N--CA 1.534 3.74 0 C-N-CA 123.428 0.691 . . . . 0.0 109.236 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 72.6 p -56.52 -45.83 80.9 Favored 'General case' 0 N--CA 1.533 3.711 0 O-C-N 121.473 -0.767 . . . . 0.0 111.601 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 34.6 tp -62.63 -35.49 79.77 Favored 'General case' 1 N--CA 1.552 4.653 0 O-C-N 121.34 -0.85 . . . . 0.0 108.935 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.1 -38.59 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.623 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . 0.596 HD21 ' HE ' ' A' ' 709' ' ' ARG . 7.3 t-20 -60.53 -22.83 64.05 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 123.784 0.833 . . . . 0.0 109.798 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -53.5 -42.55 67.46 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.602 0.715 . . . . 0.0 109.646 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.42 -37.46 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.144 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . 0.596 ' HE ' HD21 ' A' ' 706' ' ' ASN . 54.9 mtm180 -77.67 -4.44 46.12 Favored 'General case' 0 N--CA 1.516 2.856 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.999 175.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -91.35 -17.52 25.74 Favored 'General case' 1 N--CA 1.562 5.17 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -78.6 -18.51 75.48 Favored Glycine 1 N--CA 1.523 4.498 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -98.98 144.74 27.8 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 126.654 1.982 . . . . 0.0 106.235 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 78.4 p -104.53 143.94 27.71 Favored Pre-proline 1 N--CA 1.55 4.53 0 CA-C-O 117.929 -1.034 . . . . 0.0 113.474 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo . . . . . 0 C--N 1.409 3.754 0 CA-C-N 120.988 1.389 . . . . 0.0 110.938 178.222 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -55.45 -29.44 58.66 Favored 'General case' 1 N--CA 1.541 4.08 0 CA-C-N 120.156 1.344 . . . . 0.0 111.176 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -72.66 -34.65 67.39 Favored 'General case' 0 N--CA 1.532 3.649 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.54 -25.16 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.375 0 C-N-CA 124.386 1.074 . . . . 0.0 108.78 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -65.75 -45.9 80.87 Favored 'General case' 1 N--CA 1.549 4.487 0 O-C-N 121.54 -0.725 . . . . 0.0 111.566 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 13.7 tt -66.05 -30.54 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.34 -27.3 67.02 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.842 0.857 . . . . 0.0 110.122 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.09 -43.25 81.89 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.204 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 62.6 mt -72.43 -38.41 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.091 0 C-N-CA 124.718 1.207 . . . . 0.0 111.81 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 3.3 tp -58.38 -37.53 64.25 Favored 'Isoleucine or valine' 1 N--CA 1.556 4.844 0 CA-C-N 119.161 0.891 . . . . 0.0 110.215 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.98 -27.54 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 C-N-CA 124.298 1.039 . . . . 0.0 109.98 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -80.16 -27.58 52.14 Favored Glycine 1 N--CA 1.518 4.161 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 49.9 m -69.19 -52.42 28.1 Favored 'General case' 0 N--CA 1.534 3.764 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -34.69 75.39 Favored 'General case' 0 N--CA 1.538 3.974 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 1.2 tp -58.87 -44.86 91.59 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.263 0 CA-C-N 119.54 1.064 . . . . 0.0 111.495 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.15 -31.25 80.12 Favored Glycine 1 N--CA 1.521 4.325 0 O-C-N 120.643 -1.285 . . . . 0.0 111.224 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.92 -43.18 96.7 Favored 'General case' 0 N--CA 1.535 3.824 0 C-N-CA 124.243 1.017 . . . . 0.0 111.506 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -53.03 -26.96 17.44 Favored 'General case' 1 N--CA 1.54 4.05 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.9 tt -54.82 -39.28 47.37 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.387 0 CA-C-N 120.116 1.325 . . . . 0.0 113.973 -174.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.58 -30.53 36.97 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.225 0 C-N-CA 123.332 0.653 . . . . 0.0 111.683 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -53.96 -26.48 25.86 Favored 'General case' 0 N--CA 1.533 3.709 0 C-N-CA 123.145 0.578 . . . . 0.0 109.532 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.89 -36.95 68.22 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 122.787 0.435 . . . . 0.0 110.199 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.43 -29.63 44.78 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.025 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 6.4 tp -52.37 -35.91 52.56 Favored 'General case' 0 N--CA 1.531 3.611 0 CA-C-O 118.866 -0.588 . . . . 0.0 110.721 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 68.9 m -59.28 -46.52 88.32 Favored 'General case' 0 N--CA 1.533 3.714 0 CA-C-N 118.949 0.795 . . . . 0.0 112.864 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 51.0 tp -66.23 -36.02 81.93 Favored 'General case' 1 N--CA 1.547 4.383 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.28 -38.29 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -59.54 -31.78 69.73 Favored 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.11 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -48.45 -45.29 36.35 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 124.934 1.294 . . . . 0.0 111.368 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 59.0 t -62.83 -49.95 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.25 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -79.57 -3.92 49.14 Favored 'General case' 1 N--CA 1.551 4.595 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.551 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -109.98 -13.3 14.44 Favored 'General case' 0 N--CA 1.528 3.427 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.38 -28.48 20.39 Favored Glycine 0 N--CA 1.515 3.925 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -86.23 155.14 20.83 Favored 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 123.796 0.838 . . . . 0.0 108.992 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 90.0 p -79.0 150.19 74.57 Favored Pre-proline 0 N--CA 1.534 3.74 0 C-N-CA 126.479 1.911 . . . . 0.0 112.598 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo . . . . . 0 C--N 1.408 3.679 0 CA-C-N 120.626 1.259 . . . . 0.0 111.031 -174.503 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -58.02 -50.25 74.08 Favored 'General case' 0 N--CA 1.536 3.854 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -174.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -63.21 -33.58 75.8 Favored 'General case' 0 N--CA 1.529 3.486 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.49 -29.12 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 C-N-CA 125.724 1.609 . . . . 0.0 110.514 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -51.85 52.94 Favored 'General case' 1 N--CA 1.55 4.536 0 C-N-CA 123.682 0.793 . . . . 0.0 111.479 -176.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.4 tt -63.08 -39.75 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.427 0 C-N-CA 124.099 0.96 . . . . 0.0 109.465 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -53.09 -42.61 66.07 Favored 'General case' 0 N--CA 1.517 2.88 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.82 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.88 -36.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 20.4 mt -63.5 -44.11 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.65 -43.66 95.31 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.299 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.08 -37.77 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 C-N-CA 123.853 0.861 . . . . 0.0 110.134 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -57.19 -32.96 63.97 Favored Glycine 1 N--CA 1.522 4.425 0 C-N-CA 123.727 0.68 . . . . 0.0 113.756 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 63.1 m -63.39 -34.62 78.13 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 124.355 1.062 . . . . 0.0 112.57 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 4.0 mp -52.85 -34.79 55.91 Favored 'General case' 0 N--CA 1.532 3.668 0 C-N-CA 123.618 0.767 . . . . 0.0 112.659 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.58 -43.81 88.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.445 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -69.2 -29.93 71.92 Favored Glycine 1 N--CA 1.522 4.399 0 O-C-N 121.232 -0.917 . . . . 0.0 110.917 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.85 -42.83 99.53 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 123.83 0.852 . . . . 0.0 110.506 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -56.41 -26.83 54.64 Favored 'General case' 1 N--CA 1.543 4.194 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 69.9 mt -54.85 -39.55 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 C-N-CA 122.976 0.51 . . . . 0.0 112.319 -176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.79 -32.05 54.44 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.488 0 CA-C-N 119.235 0.925 . . . . 0.0 112.241 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -53.99 -26.99 28.79 Favored 'General case' 0 N--CA 1.536 3.857 0 O-C-N 121.836 -0.54 . . . . 0.0 110.501 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.72 -32.83 65.91 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 122.039 -0.413 . . . . 0.0 110.341 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.1 m -68.81 -29.84 44.93 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.095 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.5 tp -51.77 -36.3 46.91 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-O 118.709 -0.662 . . . . 0.0 110.914 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 24.5 t -59.06 -46.24 88.77 Favored 'General case' 0 N--CA 1.534 3.747 0 CA-C-N 119.148 0.885 . . . . 0.0 112.914 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 37.9 tp -65.72 -34.53 78.39 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.31 -39.84 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' C' ' 710' ' ' GLN . 33.2 t-20 -65.81 -23.98 66.81 Favored 'General case' 0 N--CA 1.524 3.24 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.764 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -47.89 -42.83 27.88 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 123.992 0.917 . . . . 0.0 111.271 -178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 43.5 t -65.44 -47.02 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -78.1 -11.84 59.94 Favored 'General case' 0 N--CA 1.539 3.986 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.314 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' C' ' 706' ' ' ASN . 49.5 tt0 -109.91 -9.94 14.76 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 125.093 1.357 . . . . 0.0 108.654 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.78 -27.13 49.04 Favored Glycine 0 N--CA 1.514 3.899 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -99.32 152.71 19.63 Favored 'General case' 0 N--CA 1.529 3.509 0 C-N-CA 123.935 0.894 . . . . 0.0 109.327 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 88.0 p -82.28 148.96 60.86 Favored Pre-proline 0 N--CA 1.528 3.473 0 C-N-CA 125.947 1.699 . . . . 0.0 109.714 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -54.66 132.19 50.11 Favored 'Trans proline' 0 C--N 1.398 3.164 0 CA-C-N 121.612 1.611 . . . . 0.0 112.854 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.515 2.81 0 CA-C-N 112.308 -2.224 . . . . 0.0 105.917 179.169 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 N--CA 1.505 2.296 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -59.47 -49.43 77.81 Favored 'General case' 0 N--CA 1.533 3.693 0 CA-C-O 121.207 0.527 . . . . 0.0 111.348 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -66.93 -29.23 69.04 Favored 'General case' 0 N--CA 1.523 3.221 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 30.7 mm -74.96 -32.2 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.243 0 C-N-CA 124.562 1.145 . . . . 0.0 110.614 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -48.51 69.39 Favored 'General case' 1 N--CA 1.549 4.521 0 O-C-N 121.935 -0.478 . . . . 0.0 111.738 -176.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.1 tt -68.34 -31.18 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 C-N-CA 123.916 0.886 . . . . 0.0 109.826 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -48.51 -24.63 1.36 Allowed 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 124.624 1.17 . . . . 0.0 111.448 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.38 -40.14 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 117.268 -1.349 . . . . 0.0 111.094 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 40.0 pt -53.33 -36.31 26.21 Favored 'Isoleucine or valine' 1 N--CA 1.567 5.388 0 CA-C-N 121.531 1.969 . . . . 0.0 109.93 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.93 -49.14 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 23.9 t -68.17 -29.27 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 125.256 1.423 . . . . 0.0 111.295 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -82.31 -32.19 29.06 Favored Glycine 1 N--CA 1.525 4.571 0 C-N-CA 124.589 1.09 . . . . 0.0 112.317 -175.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 74.3 m -69.05 -51.37 39.63 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 123.839 0.856 . . . . 0.0 113.109 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.49 -31.77 73.02 Favored 'General case' 1 N--CA 1.541 4.096 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 1.3 tp -59.34 -42.65 88.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.431 0 CA-C-N 120.77 1.623 . . . . 0.0 111.295 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.62 -27.53 72.36 Favored Glycine 1 N--CA 1.525 4.609 0 O-C-N 121.02 -1.05 . . . . 0.0 110.968 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.7 -36.68 83.74 Favored 'General case' 1 N--CA 1.544 4.261 0 C-N-CA 123.861 0.864 . . . . 0.0 109.075 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -54.78 -29.25 53.72 Favored 'General case' 1 N--CA 1.542 4.161 0 O-C-N 121.45 -0.781 . . . . 0.0 112.025 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 46.9 mm -57.51 -38.6 64.4 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.047 0 C-N-CA 123.479 0.712 . . . . 0.0 109.839 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 92.1 t -58.17 -37.78 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 125.077 1.351 . . . . 0.0 111.265 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -55.13 -24.85 28.14 Favored 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 123.317 0.647 . . . . 0.0 110.002 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.2 64.31 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 122.163 -0.336 . . . . 0.0 110.14 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.97 -31.32 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.996 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.07 -36.7 63.4 Favored 'General case' 0 N--CA 1.534 3.765 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.651 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 61.5 m -58.75 -47.07 85.94 Favored 'General case' 0 N--CA 1.536 3.862 0 CA-C-N 119.252 0.933 . . . . 0.0 112.868 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 35.8 tp -65.76 -35.04 79.58 Favored 'General case' 1 N--CA 1.54 4.072 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 87.2 t -68.65 -38.65 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . 0.581 HD21 ' HG ' ' C' ' 703' ' ' SER . 17.6 t30 -58.34 -23.13 55.82 Favored 'General case' 0 N--CA 1.516 2.869 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.349 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -47.04 -40.01 13.95 Favored 'General case' 0 N--CA 1.527 3.395 0 C-N-CA 123.667 0.787 . . . . 0.0 111.125 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.96 -45.56 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -76.86 -11.04 59.76 Favored 'General case' 0 N--CA 1.533 3.682 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.698 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 706' ' ' ASN . 35.6 tt0 -113.55 -14.18 12.7 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 125.702 1.601 . . . . 0.0 109.466 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -74.33 -14.89 80.45 Favored Glycine 1 N--CA 1.534 5.213 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 174.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -75.76 146.52 39.97 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 128.207 2.603 . . . . 0.0 107.177 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 67.5 m -81.85 146.99 57.28 Favored Pre-proline 1 N--CA 1.54 4.051 0 C-N-CA 124.402 1.081 . . . . 0.0 112.247 -176.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--N 1.401 3.3 0 CA-C-N 120.998 1.392 . . . . 0.0 109.476 -176.54 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -55.95 -50.62 70.28 Favored 'General case' 0 N--CA 1.535 3.816 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.07 -34.54 78.26 Favored 'General case' 0 N--CA 1.529 3.514 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.5 -29.03 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.222 0 C-N-CA 125.141 1.377 . . . . 0.0 110.403 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -46.93 74.37 Favored 'General case' 1 N--CA 1.556 4.857 0 O-C-N 121.208 -0.933 . . . . 0.0 110.282 -176.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -71.22 -30.74 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 C-N-CA 124.238 1.015 . . . . 0.0 109.765 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -56.56 -45.67 81.14 Favored 'General case' 0 N--CA 1.519 2.983 0 CA-C-O 122.35 1.072 . . . . 0.0 109.351 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.22 -37.82 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.085 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 52.5 mt -65.51 -40.71 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.71 -44.17 96.64 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.335 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.82 -30.24 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 C-N-CA 123.444 0.698 . . . . 0.0 109.825 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.3 92.49 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.139 0.4 . . . . 0.0 112.969 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 66.8 m -59.48 -35.27 73.78 Favored 'General case' 0 N--CA 1.532 3.649 0 C-N-CA 124.323 1.049 . . . . 0.0 112.437 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.4 mp -53.47 -36.36 61.55 Favored 'General case' 0 N--CA 1.534 3.763 0 C-N-CA 123.747 0.819 . . . . 0.0 112.653 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.81 -46.54 96.01 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.306 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.313 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.47 -29.95 76.4 Favored Glycine 1 N--CA 1.525 4.597 0 O-C-N 121.445 -0.784 . . . . 0.0 111.747 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.97 -42.39 94.04 Favored 'General case' 0 N--CA 1.532 3.671 0 C-N-CA 124.44 1.096 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -52.68 -24.95 9.54 Favored 'General case' 0 N--CA 1.535 3.801 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 19.6 tt -53.05 -37.07 25.75 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.377 0 CA-C-N 120.28 1.4 . . . . 0.0 112.592 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 14.6 p -54.48 -29.8 20.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.348 0 C-N-CA 124.074 0.95 . . . . 0.0 111.33 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -57.08 -27.67 61.93 Favored 'General case' 0 N--CA 1.538 3.968 0 O-C-N 121.259 -0.901 . . . . 0.0 110.666 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -67.88 -42.71 80.82 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 83.9 t -68.99 -32.33 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.868 0 CA-C-N 113.835 -1.529 . . . . 0.0 109.124 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 20.2 tp -55.23 -34.23 63.78 Favored 'General case' 1 N--CA 1.54 4.032 0 C-N-CA 123.059 0.543 . . . . 0.0 109.602 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 57.0 m -57.81 -46.7 84.29 Favored 'General case' 0 N--CA 1.531 3.61 0 CA-C-N 118.79 0.723 . . . . 0.0 112.674 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.18 -36.08 83.08 Favored 'General case' 1 N--CA 1.551 4.601 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.53 -39.04 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' B' ' 710' ' ' GLN . 6.0 t-20 -66.02 -23.57 66.59 Favored 'General case' 0 N--CA 1.516 2.848 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.889 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -48.88 -45.38 41.07 Favored 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 123.993 0.917 . . . . 0.0 109.39 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 50.3 t -62.4 -48.27 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.794 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.86 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -77.92 -9.98 59.35 Favored 'General case' 0 N--CA 1.539 3.979 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.016 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . 0.46 HE22 HE22 ' A' ' 710' ' ' GLN . 26.3 tt0 -112.35 -11.55 13.67 Favored 'General case' 0 N--CA 1.527 3.394 0 C-N-CA 125.109 1.364 . . . . 0.0 109.285 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.96 -35.4 58.93 Favored Glycine 0 N--CA 1.513 3.788 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -83.85 154.46 23.46 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 114.747 -0.726 . . . . 0.0 109.157 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 67.7 m -80.18 149.65 69.85 Favored Pre-proline 0 N--CA 1.529 3.484 0 C-N-CA 126.624 1.969 . . . . 0.0 111.138 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--N 1.4 3.285 0 CA-C-N 120.981 1.386 . . . . 0.0 110.943 -174.313 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 N--CA 1.506 2.332 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -61.09 -48.86 79.72 Favored 'General case' 0 N--CA 1.535 3.813 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -35.11 79.79 Favored 'General case' 1 N--CA 1.54 4.065 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 36.2 mm -73.32 -27.23 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.908 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.667 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -66.38 -54.09 28.42 Favored 'General case' 1 N--CA 1.549 4.514 0 CA-C-O 121.86 0.838 . . . . 0.0 112.311 -176.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.17 -29.58 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.216 0 C-N-CA 125.122 1.369 . . . . 0.0 110.148 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -51.98 -33.23 37.09 Favored 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 124.327 1.051 . . . . 0.0 110.432 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.57 -47.64 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 40.2 mt -57.19 -43.82 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 C-N-CA 123.528 0.731 . . . . 0.0 110.421 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.09 -48.55 87.96 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.406 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 23.2 t -57.9 -30.73 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 C-N-CA 124.41 1.084 . . . . 0.0 109.698 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.98 -40.82 95.45 Favored Glycine 1 N--CA 1.524 4.552 0 C-N-CA 123.532 0.587 . . . . 0.0 112.887 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 71.2 m -67.66 -36.64 81.11 Favored 'General case' 0 N--CA 1.528 3.44 0 CA-C-O 122.193 0.997 . . . . 0.0 110.037 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.8 tp -55.29 -45.02 76.24 Favored 'General case' 0 N--CA 1.517 2.923 0 CA-C-N 113.438 -1.71 . . . . 0.0 114.235 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -35.82 68.66 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.212 0 CA-C-N 118.272 0.487 . . . . 0.0 112.276 -176.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.48 -26.18 70.61 Favored Glycine 1 N--CA 1.523 4.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.71 -43.25 76.4 Favored 'General case' 0 N--CA 1.535 3.819 0 C-N-CA 124.683 1.193 . . . . 0.0 110.181 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -53.24 -25.65 15.0 Favored 'General case' 0 N--CA 1.533 3.693 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 17.0 tt -54.41 -38.63 41.5 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.261 0 CA-C-N 119.513 1.051 . . . . 0.0 113.342 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.31 -31.09 26.24 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 C-N-CA 123.539 0.736 . . . . 0.0 111.814 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -54.44 -25.91 27.78 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 122.92 0.488 . . . . 0.0 109.875 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.19 -32.99 62.64 Favored 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 3.3 m -69.06 -30.82 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.919 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 5.9 tp -52.08 -34.18 42.59 Favored 'General case' 0 N--CA 1.532 3.67 0 C-N-CA 123.549 0.74 . . . . 0.0 110.68 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 703' ' ' SER . . . . . 0.581 ' HG ' HD21 ' A' ' 706' ' ' ASN . 6.4 t -58.99 -46.45 88.12 Favored 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 44.6 tp -67.05 -35.56 80.14 Favored 'General case' 1 N--CA 1.54 4.072 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.1 -39.22 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -59.81 -21.16 60.49 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.062 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -47.21 -47.97 24.17 Favored 'General case' 0 N--CA 1.525 3.28 0 CA-C-O 122.13 0.967 . . . . 0.0 110.204 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.74 -43.05 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.762 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -76.76 -9.7 58.86 Favored 'General case' 0 N--CA 1.526 3.335 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.054 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -89.62 -14.16 35.55 Favored 'General case' 1 N--CA 1.546 4.339 0 C-N-CA 123.25 0.62 . . . . 0.0 110.075 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -69.33 -7.9 58.24 Favored Glycine 1 N--CA 1.527 4.716 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -75.35 156.11 35.83 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 125.891 1.676 . . . . 0.0 109.43 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 92.6 p -114.23 146.5 35.91 Favored Pre-proline 0 N--CA 1.527 3.378 0 C-N-CA 125.714 1.606 . . . . 0.0 107.181 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -59.33 131.23 39.71 Favored 'Trans proline' 0 N--CA 1.527 3.492 0 CA-C-N 121.954 1.734 . . . . 0.0 109.961 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.532 3.627 0 C-N-CA 124.902 1.281 . . . . 0.0 110.035 -179.742 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.513 2.707 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -59.29 -48.09 82.92 Favored 'General case' 0 N--CA 1.537 3.895 0 CA-C-N 118.61 0.641 . . . . 0.0 111.735 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -70.01 -36.52 75.17 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.92 -24.42 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.832 0 C-N-CA 123.781 0.833 . . . . 0.0 109.705 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -64.92 -53.67 42.73 Favored 'General case' 1 N--CA 1.545 4.275 0 CA-C-N 118.826 0.739 . . . . 0.0 111.547 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.28 -30.43 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.994 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -51.08 -36.81 42.11 Favored 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.155 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 15.4 mt -68.9 -37.47 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 C-N-CA 124.333 1.053 . . . . 0.0 109.726 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 10.8 mm -57.81 -37.68 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.952 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.2 -42.55 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.41 -30.88 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 C-N-CA 123.584 0.754 . . . . 0.0 109.506 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.73 -41.97 98.77 Favored Glycine 1 N--CA 1.525 4.62 0 C-N-CA 123.673 0.654 . . . . 0.0 111.589 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.4 m -69.02 -37.89 78.88 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-O 122.272 1.034 . . . . 0.0 110.229 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.01 -44.6 97.18 Favored 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 113.287 -1.779 . . . . 0.0 113.458 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -35.58 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -76.69 -12.4 84.49 Favored Glycine 1 N--CA 1.535 5.24 0 O-C-N 121.012 -1.055 . . . . 0.0 110.991 178.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.92 -38.92 83.52 Favored 'General case' 0 N--CA 1.539 3.98 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -52.31 -25.23 9.02 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 125.05 1.34 . . . . 0.0 113.692 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 31.2 mm -53.28 -38.84 32.65 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.362 0 CA-C-N 118.611 0.641 . . . . 0.0 111.343 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.67 -28.63 23.68 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.305 0 C-N-CA 123.813 0.845 . . . . 0.0 112.428 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -52.46 -26.38 12.66 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 123.22 0.608 . . . . 0.0 110.901 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.87 -34.72 65.74 Favored 'General case' 0 N--CA 1.53 3.547 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.0 m -69.48 -31.79 50.54 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.107 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 10.2 tp -54.74 -36.06 64.4 Favored 'General case' 0 N--CA 1.538 3.947 0 C-N-CA 122.928 0.491 . . . . 0.0 110.252 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.0 p -59.38 -46.18 89.37 Favored 'General case' 0 N--CA 1.528 3.463 0 CA-C-N 118.383 0.538 . . . . 0.0 112.348 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 44.8 tp -65.42 -34.62 78.72 Favored 'General case' 1 N--CA 1.543 4.203 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.19 -38.89 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.597 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -62.49 -29.33 70.47 Favored 'General case' 0 N--CA 1.515 2.778 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.312 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -50.45 -48.54 56.44 Favored 'General case' 0 N--CA 1.519 3.002 0 C-N-CA 123.328 0.651 . . . . 0.0 111.954 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.34 -39.11 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -75.75 -23.38 56.0 Favored 'General case' 0 N--CA 1.527 3.421 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.369 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -92.23 -7.63 47.65 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.36 1.464 . . . . 0.0 107.429 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.83 -21.62 7.62 Favored Glycine 1 N--CA 1.524 4.532 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -119.48 135.2 54.87 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 125.336 1.454 . . . . 0.0 107.253 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 96.1 p -82.27 146.6 54.88 Favored Pre-proline 0 N--CA 1.528 3.426 0 CA-C-O 117.483 -1.246 . . . . 0.0 110.366 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 C--N 1.398 3.165 0 CA-C-N 121.414 1.541 . . . . 0.0 110.709 -177.22 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.511 2.624 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -57.77 -26.24 61.6 Favored 'General case' 1 N--CA 1.551 4.606 0 CA-C-N 121.032 1.742 . . . . 0.0 110.262 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -71.8 -40.25 69.32 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.952 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.52 -25.22 22.54 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.234 0 CA-C-N 119.582 1.083 . . . . 0.0 110.192 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -59.35 -53.55 56.87 Favored 'General case' 0 N--CA 1.538 3.953 0 CA-C-N 118.168 0.44 . . . . 0.0 111.794 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 14.6 tt -70.52 -34.36 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.164 0 C-N-CA 124.003 0.921 . . . . 0.0 110.628 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -53.74 -46.75 70.99 Favored 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 124.48 1.112 . . . . 0.0 111.367 -175.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 43.9 mt -64.46 -39.89 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.894 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 59.8 mt -64.54 -40.11 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 97.8 mt -59.67 -45.34 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.58 -38.36 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.444 0 C-N-CA 123.565 0.746 . . . . 0.0 109.723 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -53.39 -19.84 9.47 Favored Glycine 1 N--CA 1.53 4.931 0 O-C-N 121.417 -0.802 . . . . 0.0 114.136 -177.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.6 m -68.95 -51.78 36.03 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.34 -31.71 61.93 Favored 'General case' 0 N--CA 1.533 3.679 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -41.77 80.54 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.221 0 CA-C-N 120.37 1.441 . . . . 0.0 111.981 -175.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -68.81 -33.54 75.69 Favored Glycine 1 N--CA 1.525 4.574 0 O-C-N 121.08 -1.012 . . . . 0.0 110.642 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.02 -42.32 94.08 Favored 'General case' 1 N--CA 1.548 4.456 0 C-N-CA 124.116 0.967 . . . . 0.0 112.728 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -49.98 -26.19 4.02 Favored 'General case' 1 N--CA 1.542 4.139 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -38.15 35.05 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.374 0 CA-C-N 118.696 0.68 . . . . 0.0 111.51 -176.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.39 -28.2 18.27 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.182 0 C-N-CA 124.059 0.944 . . . . 0.0 112.412 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -52.93 -26.82 16.22 Favored 'General case' 1 N--CA 1.541 4.082 0 C-N-CA 123.398 0.679 . . . . 0.0 109.744 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.49 76.37 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 122.707 0.403 . . . . 0.0 110.468 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.1 m -69.08 -32.0 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.13 -35.68 59.97 Favored 'General case' 0 N--CA 1.534 3.738 0 C-N-CA 123.044 0.538 . . . . 0.0 111.379 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 8.4 t -60.8 -47.39 86.55 Favored 'General case' 0 N--CA 1.535 3.799 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.098 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 44.0 tp -65.13 -34.91 79.52 Favored 'General case' 1 N--CA 1.544 4.248 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.9 -40.71 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.69 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 710' ' ' GLN . 4.6 m120 -72.04 -24.77 61.59 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.905 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -49.57 -35.81 21.78 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 118.826 0.739 . . . . 0.0 110.284 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.52 -48.15 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -77.37 -10.77 59.65 Favored 'General case' 1 N--CA 1.543 4.177 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.509 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 706' ' ' ASN . 33.1 tt0 -112.84 -5.31 13.88 Favored 'General case' 0 N--CA 1.518 2.93 0 C-N-CA 125.523 1.529 . . . . 0.0 108.071 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.77 -29.3 33.18 Favored Glycine 0 N--CA 1.512 3.759 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -98.02 137.58 36.61 Favored 'General case' 0 N--CA 1.528 3.444 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 89.1 p -81.39 146.8 58.5 Favored Pre-proline 0 N--CA 1.528 3.444 0 C-N-CA 125.246 1.418 . . . . 0.0 111.443 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--N 1.399 3.196 0 CA-C-N 121.112 1.433 . . . . 0.0 110.262 -177.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 683' ' ' ARG . 46.8 mt . . . . . 0 N--CA 1.51 2.562 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -43.06 86.21 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -72.8 -37.48 67.52 Favored 'General case' 0 N--CA 1.538 3.927 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 49.0 mm -74.53 -25.86 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 C-N-CA 125.322 1.449 . . . . 0.0 110.917 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' C' ' 679' ' ' LEU . 64.2 ttt180 -66.13 -56.15 12.87 Favored 'General case' 1 N--CA 1.542 4.173 0 CA-C-O 121.658 0.742 . . . . 0.0 110.912 -177.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.9 -36.08 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.785 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.56 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -56.11 -45.9 79.31 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.046 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.74 -42.38 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 124.246 1.018 . . . . 0.0 109.096 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.22 -36.09 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.525 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.25 -42.12 95.27 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 74.7 t -62.67 -31.15 51.14 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.158 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.93 -29.49 74.71 Favored Glycine 1 N--CA 1.517 4.053 0 C-N-CA 123.473 0.558 . . . . 0.0 112.439 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.2 m -67.98 -36.52 80.16 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.42 0.688 . . . . 0.0 111.561 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.83 -44.29 73.76 Favored 'General case' 0 N--CA 1.537 3.883 0 C-N-CA 123.455 0.702 . . . . 0.0 112.503 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . 0.267 0.1 OUTLIER -60.21 -49.26 84.82 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.622 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.825 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.45 -27.39 60.79 Favored Glycine 1 N--CA 1.528 4.813 0 CA-C-N 119.489 1.04 . . . . 0.0 112.625 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -67.35 -42.12 84.02 Favored 'General case' 0 N--CA 1.538 3.935 0 C-N-CA 124.684 1.194 . . . . 0.0 111.118 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -52.28 -24.98 8.32 Favored 'General case' 0 N--CA 1.539 3.996 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 30.0 pt -53.75 -38.02 34.07 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.495 0 CA-C-N 120.591 1.541 . . . . 0.0 113.094 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.76 -30.1 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.638 0 C-N-CA 122.517 0.327 . . . . 0.0 111.85 -176.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.68 -26.17 31.8 Favored 'General case' 0 N--CA 1.533 3.721 0 C-N-CA 123.622 0.769 . . . . 0.0 109.436 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.61 -39.83 74.28 Favored 'General case' 0 N--CA 1.523 3.179 0 O-C-N 121.754 -0.591 . . . . 0.0 109.862 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.1 m -69.53 -32.58 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.999 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.61 -34.56 58.88 Favored 'General case' 0 N--CA 1.537 3.876 0 C-N-CA 123.5 0.72 . . . . 0.0 111.056 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 69.5 m -59.96 -46.21 90.15 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-N 118.392 0.542 . . . . 0.0 111.998 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.72 -36.1 83.2 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 94.5 t -68.02 -40.29 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' C' ' 710' ' ' GLN . 2.8 m120 -65.7 -23.56 66.79 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-O 118.711 -0.662 . . . . 0.0 109.771 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -49.27 -44.07 43.56 Favored 'General case' 0 N--CA 1.519 2.977 0 C-N-CA 123.691 0.797 . . . . 0.0 110.045 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.1 t -62.29 -48.99 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.992 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 33.7 mtp85 -78.75 -10.2 59.69 Favored 'General case' 0 N--CA 1.532 3.664 0 CA-C-N 115.084 -0.962 . . . . 0.0 113.206 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.2 tt0 -112.24 -10.62 13.82 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 124.863 1.265 . . . . 0.0 108.666 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.86 -33.73 43.77 Favored Glycine 0 N--CA 1.509 3.548 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -86.04 152.86 22.56 Favored 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 94.1 p -80.99 149.66 67.19 Favored Pre-proline 0 N--CA 1.534 3.742 0 C-N-CA 125.845 1.658 . . . . 0.0 110.063 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.45 129.96 37.52 Favored 'Trans proline' 0 C--N 1.4 3.261 0 CA-C-N 122.204 1.823 . . . . 0.0 112.992 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.527 3.391 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.379 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -57.54 -44.35 85.11 Favored 'General case' 0 N--CA 1.532 3.663 0 C-N-CA 123.769 0.828 . . . . 0.0 110.79 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -70.7 -34.65 72.18 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.706 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 25.4 mm -74.15 -26.61 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.445 0 C-N-CA 125.383 1.473 . . . . 0.0 110.879 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -66.25 -53.37 37.73 Favored 'General case' 0 N--CA 1.539 3.987 0 CA-C-O 122.271 1.034 . . . . 0.0 111.24 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.4 tt -69.5 -30.0 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.2 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -52.7 -39.42 61.99 Favored 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.35 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.47 -43.64 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.311 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 54.5 mt -56.29 -34.62 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 58.9 mt -67.02 -46.72 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.15 -30.65 39.95 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.476 0 C-N-CA 123.362 0.665 . . . . 0.0 109.295 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.07 -40.61 98.3 Favored Glycine 0 N--CA 1.516 3.97 0 C-N-CA 123.482 0.563 . . . . 0.0 112.87 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 67.0 m -58.52 -35.41 72.23 Favored 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 124.342 1.057 . . . . 0.0 112.469 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 6.6 mp -53.75 -33.58 56.22 Favored 'General case' 0 N--CA 1.532 3.666 0 C-N-CA 123.61 0.764 . . . . 0.0 111.381 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -43.97 89.95 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.274 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -174.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -67.29 -32.34 79.51 Favored Glycine 1 N--CA 1.531 4.967 0 O-C-N 121.064 -1.022 . . . . 0.0 111.215 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.24 -37.75 84.19 Favored 'General case' 1 N--CA 1.546 4.351 0 C-N-CA 124.626 1.171 . . . . 0.0 110.414 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -61.02 -29.6 69.81 Favored 'General case' 1 N--CA 1.546 4.344 0 O-C-N 121.309 -0.869 . . . . 0.0 112.45 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 39.8 mm -56.74 -37.93 55.61 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.041 0 CA-C-O 121.934 0.873 . . . . 0.0 109.803 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 39.2 t -56.54 -30.07 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.318 0 C-N-CA 125.727 1.611 . . . . 0.0 110.629 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -59.91 -30.06 68.79 Favored 'General case' 0 N--CA 1.538 3.929 0 C-N-CA 123.493 0.717 . . . . 0.0 111.469 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.98 -43.38 68.16 Favored 'General case' 0 N--CA 1.523 3.209 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.95 -33.44 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.008 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.958 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.58 -35.2 70.07 Favored 'General case' 0 N--CA 1.531 3.59 0 C-N-CA 123.494 0.717 . . . . 0.0 109.801 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.0 p -58.89 -46.62 87.43 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.92 -34.75 78.67 Favored 'General case' 1 N--CA 1.545 4.285 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.069 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.08 -39.11 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 710' ' ' GLN . 23.7 t-20 -62.19 -29.44 70.38 Favored 'General case' 0 N--CA 1.517 2.921 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.936 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -48.02 -33.72 8.38 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 123.959 0.904 . . . . 0.0 111.251 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.42 -46.75 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -77.7 -11.27 59.86 Favored 'General case' 1 N--CA 1.541 4.083 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.143 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 706' ' ' ASN . 17.7 tt0 -114.53 -11.96 12.35 Favored 'General case' 0 N--CA 1.522 3.135 0 C-N-CA 126.054 1.742 . . . . 0.0 108.545 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.73 -30.1 27.44 Favored Glycine 0 N--CA 1.51 3.598 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -85.84 152.65 22.83 Favored 'General case' 0 N--CA 1.522 3.154 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 41.7 t -81.05 149.54 66.73 Favored Pre-proline 0 N--CA 1.527 3.423 0 C-N-CA 126.055 1.742 . . . . 0.0 111.625 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo . . . . . 0 C--N 1.406 3.578 0 CA-C-N 122.215 1.827 . . . . 0.0 111.847 -176.879 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 N--CA 1.519 3.011 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -69.69 -30.4 68.05 Favored 'General case' 0 N--CA 1.527 3.42 0 O-C-N 122.183 -0.323 . . . . 0.0 111.035 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -73.05 -38.79 66.36 Favored 'General case' 0 N--CA 1.524 3.249 0 CA-C-O 118.986 -0.53 . . . . 0.0 110.275 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.8 pp -73.48 -25.42 21.06 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.01 0 CA-C-N 119.204 0.911 . . . . 0.0 109.497 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -51.81 68.27 Favored 'General case' 1 N--CA 1.539 4.007 0 C-N-CA 123.241 0.616 . . . . 0.0 111.768 -177.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.7 tt -74.19 -33.68 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.866 0.866 . . . . 0.0 110.979 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -53.96 -47.14 71.65 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 113.938 -1.483 . . . . 0.0 113.099 -173.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 16.8 mt -59.76 -36.84 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 124.074 0.95 . . . . 0.0 111.172 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.87 -37.25 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.61 -41.77 91.4 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.178 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.74 -31.62 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.931 0 C-N-CA 123.271 0.628 . . . . 0.0 109.506 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.59 -42.8 98.7 Favored Glycine 1 N--CA 1.524 4.521 0 C-N-CA 123.866 0.746 . . . . 0.0 112.474 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.3 m -67.67 -36.87 81.52 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-O 122.078 0.942 . . . . 0.0 110.218 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.23 -44.81 79.95 Favored 'General case' 0 N--CA 1.518 2.972 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.034 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -49.05 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.951 0 C-N-CA 123.334 0.654 . . . . 0.0 112.638 -176.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.9 -21.76 59.2 Favored Glycine 1 N--CA 1.524 4.53 0 CA-C-N 119.699 1.136 . . . . 0.0 112.978 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.09 -43.77 70.42 Favored 'General case' 1 N--CA 1.54 4.069 0 C-N-CA 123.621 0.769 . . . . 0.0 109.93 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -53.98 -26.02 23.8 Favored 'General case' 0 N--CA 1.536 3.852 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 38.4 mm -55.29 -38.77 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 123.904 0.882 . . . . 0.0 112.885 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.99 -31.41 45.52 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.527 0 CA-C-N 119.096 0.862 . . . . 0.0 111.95 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -54.21 -25.65 24.06 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.182 0.593 . . . . 0.0 109.94 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.45 -31.96 62.37 Favored 'General case' 0 N--CA 1.531 3.583 0 O-C-N 121.723 -0.611 . . . . 0.0 110.068 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.0 -30.04 45.35 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 9.6 tp -52.82 -35.25 56.85 Favored 'General case' 0 N--CA 1.532 3.631 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.486 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 52.1 m -58.11 -46.29 85.8 Favored 'General case' 0 N--CA 1.536 3.827 0 CA-C-N 119.233 0.924 . . . . 0.0 112.377 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 45.3 tp -64.54 -35.88 82.39 Favored 'General case' 1 N--CA 1.543 4.214 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.45 -38.42 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.554 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -58.16 -25.33 61.37 Favored 'General case' 0 N--CA 1.52 3.064 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.205 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -46.76 -47.66 20.72 Favored 'General case' 0 N--CA 1.515 2.819 0 C-N-CA 124.528 1.131 . . . . 0.0 112.569 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.56 -49.7 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.779 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -81.04 -6.91 59.36 Favored 'General case' 1 N--CA 1.545 4.29 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -110.75 -8.46 14.55 Favored 'General case' 1 N--CA 1.539 4.006 0 C-N-CA 124.569 1.148 . . . . 0.0 108.836 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -56.29 -27.08 52.16 Favored Glycine 0 N--CA 1.511 3.659 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -98.0 148.59 23.34 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.937 0.895 . . . . 0.0 108.981 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 49.5 m -82.15 149.83 63.27 Favored Pre-proline 0 N--CA 1.528 3.451 0 C-N-CA 125.808 1.643 . . . . 0.0 110.763 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo . . . . . 0 C--N 1.403 3.415 0 CA-C-N 122.138 1.799 . . . . 0.0 112.099 -176.621 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 68.6 mt . . . . . 0 N--CA 1.51 2.565 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -43.47 83.13 Favored 'General case' 0 N--CA 1.538 3.945 0 CA-C-N 119.361 0.982 . . . . 0.0 112.464 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -73.44 -36.55 65.94 Favored 'General case' 0 N--CA 1.529 3.521 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.31 -38.36 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 123.965 0.906 . . . . 0.0 110.804 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -67.96 -51.04 52.06 Favored 'General case' 0 N--CA 1.536 3.873 0 C-N-CA 124.28 1.032 . . . . 0.0 111.366 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 18.5 tt -60.84 -30.71 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 CA-C-O 122.154 0.978 . . . . 0.0 110.686 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -50.58 -27.78 7.42 Favored 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.841 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.69 -47.99 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 124.547 1.139 . . . . 0.0 109.292 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 21.4 mm -54.22 -46.0 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 C-N-CA 124.123 0.969 . . . . 0.0 111.78 -174.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 16.9 tt -68.04 -40.18 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.984 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.25 -30.36 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.767 0.827 . . . . 0.0 109.304 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -72.15 -20.71 79.22 Favored Glycine 1 N--CA 1.522 4.387 0 CA-C-N 118.914 0.779 . . . . 0.0 112.692 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.8 m -68.17 -50.33 55.15 Favored 'General case' 0 N--CA 1.529 3.485 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.73 -32.69 53.01 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -175.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.99 -33.77 59.84 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.004 0 CA-C-N 119.618 1.099 . . . . 0.0 111.364 -177.52 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -72.71 -33.28 60.61 Favored Glycine 1 N--CA 1.52 4.254 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.37 -41.93 94.75 Favored 'General case' 0 N--CA 1.535 3.796 0 C-N-CA 124.874 1.27 . . . . 0.0 111.023 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -52.08 -24.32 6.65 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 10.7 tp -52.1 -38.29 23.83 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.35 0 CA-C-N 119.434 1.016 . . . . 0.0 112.357 -176.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.3 p -56.59 -30.65 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.999 0 C-N-CA 123.543 0.737 . . . . 0.0 111.836 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -54.28 -26.95 31.97 Favored 'General case' 0 N--CA 1.536 3.86 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.84 65.58 Favored 'General case' 0 N--CA 1.521 3.116 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.54 -30.42 45.21 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.142 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 9.8 tp -53.44 -35.61 60.66 Favored 'General case' 0 N--CA 1.535 3.808 0 CA-C-O 119.067 -0.492 . . . . 0.0 110.461 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 64.8 m -59.28 -45.99 89.76 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-N 118.941 0.792 . . . . 0.0 112.789 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 40.2 tp -66.51 -34.84 78.82 Favored 'General case' 1 N--CA 1.548 4.448 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.7 -38.87 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' C' ' 710' ' ' GLN . 9.4 t-20 -58.24 -34.22 70.2 Favored 'General case' 0 C--O 1.183 -2.418 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.28 -177.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -46.63 -45.5 19.13 Favored 'General case' 0 N--CA 1.511 2.602 0 C-N-CA 124.464 1.106 . . . . 0.0 112.319 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.8 -45.81 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -77.99 -4.62 47.95 Favored 'General case' 0 N--CA 1.526 3.339 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.687 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' C' ' 706' ' ' ASN . 1.8 tt0 -111.29 -15.53 13.59 Favored 'General case' 1 N--CA 1.546 4.345 0 C-N-CA 124.307 1.043 . . . . 0.0 108.465 -178.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -77.01 -11.72 85.32 Favored Glycine 1 N--CA 1.533 5.117 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 174.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -76.03 153.67 36.28 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 128.321 2.648 . . . . 0.0 107.646 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 58.9 m -80.69 145.8 59.03 Favored Pre-proline 1 N--CA 1.545 4.317 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -69.83 131.51 21.29 Favored 'Trans proline' 0 C--N 1.4 3.272 0 CA-C-N 120.36 1.164 . . . . 0.0 110.459 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 N--CA 1.525 3.315 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.585 177.534 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.5 2.031 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -67.39 -49.35 64.24 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -66.5 -30.95 71.4 Favored 'General case' 0 N--CA 1.532 3.66 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 51.0 mm -74.65 -30.31 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.86 0 C-N-CA 125.53 1.532 . . . . 0.0 110.19 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -51.47 57.0 Favored 'General case' 1 N--CA 1.548 4.463 0 C-N-CA 123.463 0.705 . . . . 0.0 111.964 -178.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.5 tt -65.8 -35.66 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.753 0 CA-C-O 122.091 0.948 . . . . 0.0 109.611 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -60.18 -40.91 91.62 Favored 'General case' 0 N--CA 1.512 2.669 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.825 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.18 -49.19 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.793 0.837 . . . . 0.0 109.232 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 53.8 mt -56.81 -40.47 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 78.8 mt -68.26 -41.12 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.967 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.18 -30.63 49.24 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.601 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.21 -34.64 90.51 Favored Glycine 1 N--CA 1.522 4.405 0 C-N-CA 123.637 0.637 . . . . 0.0 111.991 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 62.9 m -68.39 -37.27 80.23 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.615 0.766 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.8 -44.44 86.31 Favored 'General case' 0 N--CA 1.536 3.864 0 C-N-CA 123.499 0.72 . . . . 0.0 112.627 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.259 0.3 OUTLIER -61.3 -43.83 97.3 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.215 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -173.248 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.03 -34.15 89.19 Favored Glycine 1 N--CA 1.534 5.206 0 CA-C-N 120.017 1.28 . . . . 0.0 111.822 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.0 -39.78 86.92 Favored 'General case' 1 N--CA 1.541 4.114 0 C-N-CA 124.715 1.206 . . . . 0.0 110.326 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -59.97 -28.25 67.52 Favored 'General case' 1 N--CA 1.544 4.275 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.3 -36.66 41.14 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.313 0 CA-C-O 122.09 0.948 . . . . 0.0 109.618 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 68.7 t -54.58 -28.0 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.092 0 C-N-CA 126.69 1.996 . . . . 0.0 111.216 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -53.15 -25.8 14.67 Favored 'General case' 0 N--CA 1.534 3.753 0 C-N-CA 123.559 0.744 . . . . 0.0 110.748 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.49 -39.89 74.01 Favored 'General case' 0 N--CA 1.525 3.297 0 O-C-N 121.766 -0.584 . . . . 0.0 109.668 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.8 -36.03 67.88 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.16 -35.45 64.77 Favored 'General case' 1 N--CA 1.54 4.073 0 C-N-CA 123.526 0.731 . . . . 0.0 110.806 -179.532 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 9.6 t -60.62 -46.89 88.57 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 44.8 tp -67.58 -36.82 81.65 Favored 'General case' 0 N--CA 1.536 3.865 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.88 -46.36 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 C-N-CA 123.295 0.638 . . . . 0.0 110.027 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 706' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 710' ' ' GLN . 0.2 OUTLIER -72.47 -20.09 61.45 Favored 'General case' 0 N--CA 1.513 2.68 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.142 -178.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -48.07 -44.36 31.33 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 123.682 0.793 . . . . 0.0 109.798 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.37 -43.49 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.75 -19.85 57.16 Favored 'General case' 0 N--CA 1.528 3.465 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.5 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 710' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 706' ' ' ASN . 2.6 tt0 -89.88 -14.83 33.45 Favored 'General case' 0 N--CA 1.538 3.937 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -59.15 -12.41 16.29 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -74.19 154.56 39.01 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 124.424 1.089 . . . . 0.0 108.37 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 73.0 m -94.53 147.41 33.19 Favored Pre-proline 0 N--CA 1.528 3.472 0 C-N-CA 125.123 1.369 . . . . 0.0 107.866 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 N--CA 1.527 3.496 0 CA-C-N 121.574 1.598 . . . . 0.0 109.739 -174.962 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 N--CA 1.525 3.323 0 CA-C-O 120.462 0.172 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -71.1 -30.13 66.14 Favored 'General case' 0 N--CA 1.529 3.519 0 O-C-N 122.126 -0.359 . . . . 0.0 110.607 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -68.95 -37.95 79.16 Favored 'General case' 0 N--CA 1.519 3.015 0 CA-C-O 118.902 -0.57 . . . . 0.0 111.056 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.2 -23.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.809 0 CA-C-N 118.943 0.792 . . . . 0.0 110.767 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -60.34 -54.28 47.58 Favored 'General case' 1 N--CA 1.546 4.369 0 CA-C-N 119.205 0.911 . . . . 0.0 112.736 -177.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -70.7 -31.32 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.97 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.072 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -52.56 -30.05 28.74 Favored 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 124.0 0.92 . . . . 0.0 112.873 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -68.69 -36.51 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.755 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.08 -42.45 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.321 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.84 -50.29 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.985 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.36 -29.04 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.304 0 C-N-CA 124.519 1.127 . . . . 0.0 108.879 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.13 -17.92 68.52 Favored Glycine 1 N--CA 1.524 4.516 0 C-N-CA 123.674 0.654 . . . . 0.0 113.172 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 75.1 m -68.92 -52.21 31.74 Favored 'General case' 0 N--CA 1.527 3.421 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.17 -32.78 73.44 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -38.65 79.1 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.38 0 CA-C-N 120.384 1.447 . . . . 0.0 112.148 -176.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.88 -34.62 89.12 Favored Glycine 1 N--CA 1.526 4.7 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.21 -42.44 95.14 Favored 'General case' 0 N--CA 1.538 3.933 0 C-N-CA 124.572 1.149 . . . . 0.0 111.261 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -51.85 -24.23 5.88 Favored 'General case' 0 N--CA 1.536 3.863 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 20.0 tt -52.18 -36.71 21.13 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 CA-C-N 120.959 1.709 . . . . 0.0 111.844 -176.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 13.5 p -54.84 -28.12 19.59 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.028 0 C-N-CA 123.821 0.848 . . . . 0.0 111.17 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -55.75 -28.04 53.83 Favored 'General case' 1 N--CA 1.546 4.347 0 O-C-N 121.451 -0.781 . . . . 0.0 109.828 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.54 -44.09 68.21 Favored 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 65.5 t -68.85 -32.16 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.271 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 2.9 tp -54.2 -35.52 62.46 Favored 'General case' 0 N--CA 1.536 3.858 0 C-N-CA 123.391 0.676 . . . . 0.0 110.275 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 20.7 t -60.07 -46.68 88.75 Favored 'General case' 0 N--CA 1.529 3.525 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 36.2 tp -67.4 -34.6 77.6 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.43 -43.57 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 706' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' B' ' 709' ' ' ARG . 11.5 p30 -72.4 -22.71 61.08 Favored 'General case' 0 N--CA 1.517 2.913 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.062 -178.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -48.43 -36.96 15.92 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.296 0.57 . . . . 0.0 110.306 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.42 -41.52 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 176.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 709' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' B' ' 706' ' ' ASN . 86.5 mtt180 -75.92 -17.08 59.9 Favored 'General case' 0 N--CA 1.525 3.288 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.667 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -87.96 -12.33 44.87 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.76 -19.08 6.26 Favored Glycine 1 N--CA 1.521 4.344 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -114.24 130.04 56.63 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 124.99 1.316 . . . . 0.0 107.737 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 96.4 p -82.82 147.41 54.84 Favored Pre-proline 0 N--CA 1.526 3.366 0 C-N-CA 125.182 1.393 . . . . 0.0 110.53 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--N 1.4 3.268 0 CA-C-N 121.653 1.626 . . . . 0.0 110.671 -177.365 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.527 3.41 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -68.85 -37.13 78.91 Favored 'General case' 0 N--CA 1.524 3.271 0 CA-C-O 121.597 0.713 . . . . 0.0 110.961 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -66.35 -40.37 89.76 Favored 'General case' 0 N--CA 1.518 2.935 0 CA-C-N 114.151 -1.386 . . . . 0.0 111.415 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 18.2 pt -73.01 -29.38 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -52.09 66.96 Favored 'General case' 1 N--CA 1.55 4.562 0 C-N-CA 123.106 0.563 . . . . 0.0 110.421 -176.434 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.94 -36.33 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -52.17 -27.66 15.26 Favored 'General case' 0 N--CA 1.526 3.366 0 C-N-CA 124.214 1.005 . . . . 0.0 110.816 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 9.0 mm -67.61 -48.01 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.235 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 23.8 mt -64.33 -36.06 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.749 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.891 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 44.3 mm -59.86 -42.59 89.67 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.202 0 CA-C-N 118.151 0.432 . . . . 0.0 110.192 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.62 -31.69 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 C-N-CA 123.838 0.855 . . . . 0.0 110.328 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.66 -36.3 93.08 Favored Glycine 1 N--CA 1.522 4.428 0 C-N-CA 123.259 0.457 . . . . 0.0 112.194 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 64.2 m -68.12 -37.35 81.01 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.876 0.87 . . . . 0.0 111.805 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.13 -45.01 92.05 Favored 'General case' 0 N--CA 1.536 3.866 0 C-N-CA 123.589 0.755 . . . . 0.0 112.675 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . 0.286 0.1 OUTLIER -63.38 -48.84 85.39 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.466 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.95 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -55.2 -31.99 56.8 Favored Glycine 1 N--CA 1.531 5.016 0 CA-C-N 119.214 0.915 . . . . 0.0 113.279 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.23 -38.8 88.78 Favored 'General case' 0 N--CA 1.539 3.984 0 C-N-CA 124.728 1.211 . . . . 0.0 110.357 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -60.09 -28.48 67.87 Favored 'General case' 1 N--CA 1.543 4.203 0 O-C-N 121.575 -0.703 . . . . 0.0 111.878 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.71 -36.97 44.75 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.155 0 CA-C-O 121.916 0.865 . . . . 0.0 109.512 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.59 -27.13 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.292 0 C-N-CA 126.395 1.878 . . . . 0.0 110.695 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -54.09 -27.11 30.74 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.139 0.576 . . . . 0.0 111.797 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.84 86.86 Favored 'General case' 0 N--CA 1.527 3.405 0 O-C-N 122.038 -0.414 . . . . 0.0 110.367 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 14.0 m -70.51 -31.75 47.53 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.025 0 CA-C-N 118.09 0.404 . . . . 0.0 110.085 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.66 -33.7 61.11 Favored 'General case' 0 N--CA 1.53 3.563 0 C-N-CA 123.521 0.729 . . . . 0.0 110.629 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 64.3 m -58.6 -46.95 85.9 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 21.7 tp -65.56 -34.88 79.28 Favored 'General case' 1 N--CA 1.549 4.505 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.81 -38.88 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -65.46 -23.89 67.03 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 123.251 0.62 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 11.5 tpt85 -49.73 -37.24 28.55 Favored 'General case' 0 N--CA 1.516 2.849 0 CA-C-O 121.753 0.787 . . . . 0.0 110.76 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.75 -37.33 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.015 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.83 -28.7 58.37 Favored 'General case' 1 N--CA 1.54 4.031 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -89.71 -3.05 58.39 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 124.615 1.166 . . . . 0.0 109.133 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.92 -24.34 33.96 Favored Glycine 1 N--CA 1.526 4.67 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 176.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -121.2 143.97 48.84 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 113.042 -1.579 . . . . 0.0 107.769 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 90.1 p -82.57 146.66 53.94 Favored Pre-proline 0 N--CA 1.53 3.527 0 CA-C-O 117.305 -1.331 . . . . 0.0 110.239 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.5 131.34 42.08 Favored 'Trans proline' 0 C--N 1.399 3.193 0 CA-C-N 121.614 1.612 . . . . 0.0 111.169 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 61.6 mt . . . . . 0 N--CA 1.521 3.107 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.19 179.685 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 32.9 m120 . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -64.65 -21.14 66.65 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.841 0.856 . . . . 0.0 111.106 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.91 -30.29 5.72 Favored 'General case' 0 N--CA 1.511 2.62 0 C-N-CA 125.607 1.563 . . . . 0.0 111.574 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -68.16 -48.25 65.82 Favored 'General case' 0 N--CA 1.528 3.468 0 CA-C-O 121.711 0.767 . . . . 0.0 110.741 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -61.54 -33.45 73.87 Favored 'General case' 0 N--CA 1.527 3.382 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.101 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.4 mm -76.23 -34.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.456 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -53.41 26.3 Favored 'General case' 1 N--CA 1.546 4.372 0 O-C-N 121.721 -0.612 . . . . 0.0 111.988 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.9 tt -55.52 -35.3 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 CA-C-O 122.479 1.133 . . . . 0.0 110.234 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -58.83 -33.68 70.68 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 112.933 -1.939 . . . . 0.0 110.478 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.0 mm -68.64 -37.93 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.072 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 24.1 mt -58.25 -39.23 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.25 -44.42 99.1 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.015 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 67.0 t -64.36 -30.35 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.943 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.83 -33.73 88.01 Favored Glycine 0 N--CA 1.514 3.883 0 C-N-CA 123.87 0.748 . . . . 0.0 112.124 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.9 m -68.16 -37.04 80.59 Favored 'General case' 0 N--CA 1.526 3.331 0 C-N-CA 123.362 0.665 . . . . 0.0 111.009 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.97 -43.23 91.34 Favored 'General case' 0 N--CA 1.537 3.921 0 C-N-CA 123.212 0.605 . . . . 0.0 111.787 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.268 0.8 OUTLIER -63.66 -48.88 84.67 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -175.718 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.43 -25.61 65.26 Favored Glycine 1 N--CA 1.526 4.694 0 O-C-N 120.704 -1.248 . . . . 0.0 112.981 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.33 -38.74 88.37 Favored 'General case' 0 N--CA 1.536 3.86 0 C-N-CA 124.116 0.967 . . . . 0.0 110.604 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -52.03 -23.74 5.66 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 18.6 tt -51.96 -36.42 19.77 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.178 0 CA-C-N 119.444 1.02 . . . . 0.0 111.333 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 11.2 p -54.64 -27.42 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 C-N-CA 124.235 1.014 . . . . 0.0 111.107 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -55.07 -28.79 55.02 Favored 'General case' 1 N--CA 1.545 4.319 0 O-C-N 121.692 -0.63 . . . . 0.0 109.879 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.19 -45.03 67.49 Favored 'General case' 0 N--CA 1.522 3.14 0 CA-C-O 122.031 0.92 . . . . 0.0 108.966 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.7 -34.31 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.816 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.233 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.6 tp -55.64 -34.81 65.27 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.965 0.906 . . . . 0.0 111.021 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 51.0 m -59.1 -45.02 91.94 Favored 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 35.7 tp -67.66 -34.8 77.65 Favored 'General case' 0 N--CA 1.538 3.95 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 66.1 t -67.86 -39.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.828 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 710' ' ' GLN . 16.1 m120 -59.21 -23.63 62.44 Favored 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.891 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 22.8 tpt85 -48.07 -41.02 24.93 Favored 'General case' 0 N--CA 1.524 3.269 0 CA-C-O 121.372 0.606 . . . . 0.0 110.84 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 52.9 t -72.6 -41.97 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-N 114.689 -1.141 . . . . 0.0 107.944 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -76.72 -11.35 59.83 Favored 'General case' 1 N--CA 1.545 4.298 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.417 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 706' ' ' ASN . 1.4 tm0? -111.87 -10.4 14.0 Favored 'General case' 0 N--CA 1.516 2.851 0 C-N-CA 125.549 1.54 . . . . 0.0 107.634 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.13 -22.83 7.04 Favored Glycine 1 N--CA 1.518 4.135 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -98.39 153.46 18.55 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 124.076 0.95 . . . . 0.0 109.472 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 66.1 m -80.51 152.17 72.55 Favored Pre-proline 0 N--CA 1.526 3.345 0 C-N-CA 126.859 2.064 . . . . 0.0 111.216 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.33 130.6 39.21 Favored 'Trans proline' 0 C--N 1.401 3.302 0 CA-C-N 121.527 1.581 . . . . 0.0 111.74 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 58.7 mt 60.37 42.58 14.56 Favored 'General case' 0 N--CA 1.52 3.047 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.694 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 61.5 p . . . . . 0 N--CA 1.524 3.266 0 C-N-CA 124.446 1.098 . . . . 0.0 112.1 179.609 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -71.2 174.68 6.07 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 124.119 0.968 . . . . 0.0 110.035 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -48.66 -29.24 4.16 Favored 'General case' 0 N--CA 1.518 2.929 0 C-N-CA 125.691 1.597 . . . . 0.0 112.299 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -63.36 -49.52 73.55 Favored 'General case' 0 N--CA 1.532 3.643 0 CA-C-N 118.367 0.531 . . . . 0.0 111.32 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -64.0 -31.53 72.75 Favored 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.88 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.02 -32.22 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.864 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.26 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -51.57 48.87 Favored 'General case' 1 N--CA 1.554 4.745 0 CA-C-N 118.713 0.688 . . . . 0.0 112.057 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.8 tt -62.1 -31.66 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-O 122.029 0.918 . . . . 0.0 110.779 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -51.94 -35.29 45.34 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.762 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.22 -41.56 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.082 0 C-N-CA 124.607 1.163 . . . . 0.0 108.788 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 47.3 mt -60.38 -37.37 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 64.0 mt -64.62 -44.79 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.43 -30.32 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 C-N-CA 123.827 0.851 . . . . 0.0 108.727 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.26 -30.58 78.1 Favored Glycine 1 N--CA 1.517 4.054 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 32.4 m -68.79 -37.59 79.4 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.431 0.692 . . . . 0.0 111.413 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.32 -41.4 75.94 Favored 'General case' 0 N--CA 1.535 3.781 0 C-N-CA 123.443 0.697 . . . . 0.0 111.932 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . 0.292 0.3 OUTLIER -60.7 -46.1 96.47 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.386 0 CA-C-N 118.956 0.798 . . . . 0.0 112.206 -176.485 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.83 -27.68 64.67 Favored Glycine 1 N--CA 1.528 4.833 0 CA-C-N 119.159 0.89 . . . . 0.0 112.307 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.4 tt -67.93 -37.38 81.58 Favored 'General case' 1 N--CA 1.548 4.431 0 C-N-CA 125.126 1.37 . . . . 0.0 109.31 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -62.89 -27.37 69.31 Favored 'General case' 1 N--CA 1.54 4.073 0 C-N-CA 123.806 0.842 . . . . 0.0 112.336 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.51 -38.78 50.73 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.593 0 CA-C-O 122.477 1.132 . . . . 0.0 109.473 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 64.3 t -57.21 -29.6 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.032 0 C-N-CA 126.962 2.105 . . . . 0.0 111.293 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -53.75 -26.92 25.7 Favored 'General case' 0 N--CA 1.534 3.774 0 C-N-CA 122.976 0.51 . . . . 0.0 111.16 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.42 -35.14 67.48 Favored 'General case' 0 N--CA 1.528 3.449 0 O-C-N 121.956 -0.465 . . . . 0.0 109.849 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.7 -32.7 53.32 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.343 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 7.9 tp -54.97 -33.67 62.62 Favored 'General case' 0 N--CA 1.539 3.999 0 C-N-CA 124.087 0.955 . . . . 0.0 110.421 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 703' ' ' SER . . . . . 0.589 ' HG ' HD21 ' C' ' 706' ' ' ASN . 84.9 p -59.01 -45.73 89.94 Favored 'General case' 0 N--CA 1.528 3.471 0 O-C-N 122.344 -0.223 . . . . 0.0 111.21 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.09 -36.56 84.0 Favored 'General case' 1 N--CA 1.548 4.427 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.74 -42.09 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.427 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -75.48 -21.41 58.09 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 123.126 0.57 . . . . 0.0 110.101 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.18 -42.63 60.98 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.52 -42.35 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.903 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -75.31 -7.54 54.23 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.225 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.99 -14.76 17.73 Favored 'General case' 1 N--CA 1.546 4.33 0 C-N-CA 124.201 1.0 . . . . 0.0 108.825 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -84.33 -18.15 63.08 Favored Glycine 1 N--CA 1.522 4.378 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -87.93 152.35 22.13 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 126.72 2.008 . . . . 0.0 108.285 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 67.0 m -93.23 148.63 36.0 Favored Pre-proline 1 N--CA 1.547 4.381 0 C-N-CA 125.914 1.686 . . . . 0.0 113.764 -176.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -60.46 132.75 45.07 Favored 'Trans proline' 0 C--N 1.404 3.46 0 CA-C-N 120.788 1.317 . . . . 0.0 109.76 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 28.6 mt -46.56 165.8 0.02 OUTLIER 'General case' 0 N--CA 1.535 3.787 0 C-N-CA 125.259 1.424 . . . . 0.0 111.84 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.522 3.174 0 CA-C-O 117.774 -1.108 . . . . 0.0 112.369 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 6.0 p30 . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 31.8 p90 56.55 -56.14 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 126.373 1.869 . . . . 0.0 114.016 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 7.1 tt -51.6 -44.41 62.84 Favored 'General case' 0 N--CA 1.516 2.86 0 C-N-CA 125.25 1.42 . . . . 0.0 112.293 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -61.6 -49.75 75.36 Favored 'General case' 0 N--CA 1.529 3.522 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -66.01 -33.73 76.48 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 95.5 mt -74.34 -25.33 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.807 0 C-N-CA 124.789 1.236 . . . . 0.0 110.445 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -50.69 62.52 Favored 'General case' 1 N--CA 1.555 4.82 0 CA-C-N 119.682 1.128 . . . . 0.0 110.133 -178.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.2 tt -66.25 -31.06 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 C-N-CA 123.71 0.804 . . . . 0.0 109.115 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -54.86 -28.38 49.66 Favored 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.015 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 21.4 mm -68.5 -44.13 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 C-N-CA 123.689 0.796 . . . . 0.0 109.548 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.71 -41.0 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.59 -47.35 93.36 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.91 -30.11 47.83 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.161 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.05 82.47 Favored Glycine 1 N--CA 1.516 4.029 0 C-N-CA 123.625 0.631 . . . . 0.0 112.408 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 62.4 m -67.9 -37.07 81.27 Favored 'General case' 0 N--CA 1.533 3.681 0 C-N-CA 123.463 0.705 . . . . 0.0 111.698 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.91 -40.81 77.01 Favored 'General case' 0 N--CA 1.533 3.689 0 C-N-CA 123.339 0.656 . . . . 0.0 111.868 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.62 -39.89 82.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -71.41 -25.56 75.11 Favored Glycine 1 N--CA 1.531 5.002 0 O-C-N 121.074 -1.016 . . . . 0.0 111.107 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.85 -43.38 98.96 Favored 'General case' 0 N--CA 1.535 3.806 0 C-N-CA 123.99 0.916 . . . . 0.0 109.392 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -54.2 -25.49 23.07 Favored 'General case' 0 N--CA 1.539 3.986 0 C-N-CA 125.045 1.338 . . . . 0.0 114.565 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 72.2 mt -53.84 -37.54 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.863 0 CA-C-N 118.541 0.609 . . . . 0.0 109.841 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.05 -26.18 32.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.238 0 C-N-CA 124.965 1.306 . . . . 0.0 111.971 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -53.59 -27.54 27.16 Favored 'General case' 1 N--CA 1.549 4.523 0 O-C-N 120.972 -1.08 . . . . 0.0 110.219 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.41 -46.07 91.67 Favored 'General case' 0 N--CA 1.525 3.325 0 O-C-N 121.967 -0.458 . . . . 0.0 110.881 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.1 -31.33 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.63 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.68 -34.16 57.79 Favored 'General case' 0 N--CA 1.536 3.86 0 C-N-CA 123.12 0.568 . . . . 0.0 110.742 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 86.9 p -59.67 -46.35 89.3 Favored 'General case' 0 N--CA 1.532 3.642 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 45.7 tp -65.8 -35.68 81.39 Favored 'General case' 1 N--CA 1.542 4.147 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.31 -43.45 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.38 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . 0.589 HD21 ' HG ' ' B' ' 703' ' ' SER . 5.5 m-20 -68.4 -25.43 65.04 Favored 'General case' 0 N--CA 1.515 2.8 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.25 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.09 -43.92 61.15 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 119.087 0.858 . . . . 0.0 109.233 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.25 -47.39 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.1 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -74.73 -15.72 60.77 Favored 'General case' 0 N--CA 1.535 3.792 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.895 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -114.12 -3.86 13.2 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -48.83 -27.81 6.71 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 124.399 0.999 . . . . 0.0 111.796 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -75.44 155.18 36.56 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 31.1 t -77.76 146.96 73.6 Favored Pre-proline 0 N--CA 1.536 3.865 0 C-N-CA 125.001 1.32 . . . . 0.0 112.584 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -58.51 129.95 35.02 Favored 'Trans proline' 0 C--N 1.408 3.699 0 CA-C-N 120.643 1.265 . . . . 0.0 110.234 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 60.3 tp -88.39 -43.37 11.54 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.0 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.522 3.127 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.779 179.744 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 41.9 t30 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -158.43 -173.7 4.43 Favored 'General case' 0 N--CA 1.523 3.187 0 C-N-CA 124.453 1.101 . . . . 0.0 108.535 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 683' ' ' ARG . 18.6 mt -50.34 -41.42 51.34 Favored 'General case' 0 N--CA 1.504 2.272 0 C-N-CA 125.487 1.515 . . . . 0.0 112.639 -178.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -55.97 -45.38 78.92 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -73.18 -38.71 66.06 Favored 'General case' 0 N--CA 1.533 3.706 0 CA-C-O 121.555 0.693 . . . . 0.0 109.485 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.6 mm -74.89 -26.0 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 125.072 1.349 . . . . 0.0 111.276 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 679' ' ' LEU . 56.5 ttt180 -67.06 -55.7 13.21 Favored 'General case' 1 N--CA 1.542 4.146 0 C-N-CA 123.976 0.91 . . . . 0.0 110.56 -177.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.3 tt -64.4 -32.54 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.537 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -52.57 -44.02 65.62 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.946 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 66.5 mt -68.54 -37.22 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.445 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 42.9 mt -65.89 -34.69 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.697 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 48.3 mm -63.72 -42.46 96.05 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.383 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 88.0 t -64.98 -29.88 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.882 0 C-N-CA 123.664 0.786 . . . . 0.0 108.959 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -61.19 -36.84 93.01 Favored Glycine 1 N--CA 1.522 4.413 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 53.4 m -68.91 -37.34 78.89 Favored 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 124.027 0.931 . . . . 0.0 111.451 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.8 mp -58.04 -38.97 77.24 Favored 'General case' 1 N--CA 1.546 4.332 0 C-N-CA 124.175 0.99 . . . . 0.0 112.346 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.268 1.3 tp -69.23 -45.76 78.78 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.205 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -73.7 -12.21 80.66 Favored Glycine 1 N--CA 1.525 4.578 0 O-C-N 120.744 -1.222 . . . . 0.0 112.046 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.1 tt -70.48 -41.28 72.92 Favored 'General case' 0 N--CA 1.535 3.8 0 C-N-CA 124.127 0.971 . . . . 0.0 109.745 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -52.51 -28.41 20.39 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.952 0.901 . . . . 0.0 113.054 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 42.0 mm -56.39 -43.81 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.332 0 C-N-CA 124.041 0.936 . . . . 0.0 112.486 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 3.3 p -66.66 -51.91 51.32 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.623 0 CA-C-N 118.702 0.683 . . . . 0.0 112.618 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' A' ' 702' ' ' LEU 0.522 0.9 OUTLIER -54.8 -18.93 5.39 Favored 'General case' 0 C--O 1.165 -3.392 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.255 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -51.93 -29.51 20.52 Favored 'General case' 1 N--CA 1.539 4.012 0 O-C-N 120.93 -1.106 . . . . 0.0 109.009 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 12.7 m -62.75 -29.27 46.63 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.491 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 699' ' ' PHE . 7.1 tt -50.5 -34.64 25.88 Favored 'General case' 1 N--CA 1.541 4.113 0 C-N-CA 125.311 1.445 . . . . 0.0 110.955 -178.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 68.0 m -59.34 -45.32 91.7 Favored 'General case' 0 N--CA 1.534 3.772 0 CA-C-N 118.467 0.576 . . . . 0.0 110.78 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.06 -35.21 80.0 Favored 'General case' 1 N--CA 1.54 4.025 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.1 t -68.06 -39.78 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.788 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 710' ' ' GLN . 3.1 m120 -64.82 -24.6 67.6 Favored 'General case' 0 N--CA 1.512 2.674 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.61 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . 0.449 HH12 ' NH2' ' B' ' 707' ' ' ARG . 21.6 tpt180 -47.71 -30.86 4.16 Favored 'General case' 0 N--CA 1.529 3.486 0 C-N-CA 123.3 0.64 . . . . 0.0 111.446 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.1 t -75.03 -47.89 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.59 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.97 -12.19 59.96 Favored 'General case' 1 N--CA 1.549 4.496 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.707 179.254 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 706' ' ' ASN . 51.9 tt0 -112.81 -4.15 14.05 Favored 'General case' 0 N--CA 1.518 2.963 0 C-N-CA 125.591 1.556 . . . . 0.0 108.065 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.68 -27.84 50.35 Favored Glycine 0 N--CA 1.509 3.548 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -96.8 153.12 18.07 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 123.677 0.791 . . . . 0.0 109.138 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 50.8 m -80.89 149.32 66.86 Favored Pre-proline 0 N--CA 1.526 3.37 0 C-N-CA 125.965 1.706 . . . . 0.0 111.315 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.19 130.96 43.51 Favored 'Trans proline' 0 C--N 1.403 3.43 0 CA-C-N 122.019 1.757 . . . . 0.0 111.059 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.51 -117.87 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 124.996 1.318 . . . . 0.0 110.125 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 N--CA 1.524 3.249 0 CA-C-O 118.398 -0.81 . . . . 0.0 110.816 -179.804 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -168.68 133.0 1.54 Allowed 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.3 -30.83 12.82 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.467 1.507 . . . . 0.0 112.477 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -61.61 -49.24 77.37 Favored 'General case' 0 N--CA 1.534 3.768 0 CA-C-N 118.394 0.543 . . . . 0.0 112.316 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.14 -37.82 86.65 Favored 'General case' 0 N--CA 1.525 3.325 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.43 -29.39 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.916 0 C-N-CA 125.397 1.479 . . . . 0.0 110.921 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -50.98 60.67 Favored 'General case' 1 N--CA 1.547 4.389 0 C-N-CA 123.601 0.76 . . . . 0.0 111.719 -177.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -30.84 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 124.068 0.947 . . . . 0.0 109.808 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -56.18 -34.49 66.27 Favored 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.58 1.152 . . . . 0.0 110.441 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 24.3 mm -60.43 -37.52 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.581 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.31 -40.02 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.114 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.93 -48.52 87.46 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.28 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.86 -31.37 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.761 0 C-N-CA 123.839 0.855 . . . . 0.0 109.688 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.37 -32.31 83.76 Favored Glycine 1 N--CA 1.516 4.021 0 C-N-CA 123.607 0.622 . . . . 0.0 112.439 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 62.5 m -67.98 -36.9 80.82 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 123.507 0.723 . . . . 0.0 111.971 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 9.0 mp -54.68 -41.75 70.56 Favored 'General case' 0 N--CA 1.537 3.885 0 C-N-CA 123.431 0.692 . . . . 0.0 112.737 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.37 -43.94 94.9 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.297 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -174.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -66.43 -28.49 73.75 Favored Glycine 1 N--CA 1.525 4.617 0 O-C-N 121.177 -0.952 . . . . 0.0 111.746 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -62.1 -42.13 98.91 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 124.529 1.131 . . . . 0.0 110.682 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -52.33 -25.62 10.09 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.33 -37.61 37.48 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.501 0 CA-C-N 120.538 1.517 . . . . 0.0 112.26 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.3 p -54.36 -27.66 17.49 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.128 0 C-N-CA 124.523 1.129 . . . . 0.0 112.063 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -52.08 -25.66 9.23 Favored 'General case' 0 N--CA 1.537 3.89 0 C-N-CA 123.357 0.663 . . . . 0.0 110.104 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.45 68.88 Favored 'General case' 0 N--CA 1.52 3.031 0 C-N-CA 122.72 0.408 . . . . 0.0 110.17 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -69.42 -30.39 45.42 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 8.8 tp -52.53 -35.32 53.14 Favored 'General case' 0 N--CA 1.537 3.881 0 C-N-CA 122.974 0.51 . . . . 0.0 110.71 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 1.6 t -58.74 -46.16 88.05 Favored 'General case' 1 N--CA 1.54 4.045 0 CA-C-N 118.824 0.738 . . . . 0.0 112.081 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 34.5 tp -66.38 -34.77 78.71 Favored 'General case' 1 N--CA 1.542 4.174 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.87 -38.51 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -63.58 -24.04 67.64 Favored 'General case' 0 N--CA 1.522 3.168 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.01 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . 0.449 ' NH2' HH12 ' A' ' 707' ' ' ARG . 17.2 tpt180 -49.56 -47.75 48.95 Favored 'General case' 0 N--CA 1.522 3.149 0 CA-C-O 121.8 0.809 . . . . 0.0 110.438 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 51.3 t -63.14 -37.46 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.712 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.456 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -75.31 -28.06 59.55 Favored 'General case' 0 N--CA 1.531 3.624 0 CA-C-O 121.18 0.514 . . . . 0.0 109.896 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -89.91 -4.87 57.3 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.963 1.305 . . . . 0.0 108.466 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.75 -23.42 29.49 Favored Glycine 1 N--CA 1.523 4.434 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -120.27 141.25 50.16 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 125.33 1.452 . . . . 0.0 107.59 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 68.5 m -82.97 146.61 52.38 Favored Pre-proline 0 N--CA 1.529 3.502 0 CA-C-O 117.285 -1.34 . . . . 0.0 110.157 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -65.21 130.81 26.5 Favored 'Trans proline' 0 C--N 1.395 3.004 0 CA-C-N 121.701 1.643 . . . . 0.0 109.192 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -60.18 -21.8 62.15 Favored 'General case' 0 N--CA 1.527 3.388 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.122 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.522 3.167 0 C-N-CA 124.297 1.039 . . . . 0.0 112.177 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -169.06 -40.44 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.591 0.756 . . . . 0.0 109.195 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.58 -43.21 62.37 Favored 'General case' 0 N--CA 1.521 3.113 0 C-N-CA 124.887 1.275 . . . . 0.0 111.663 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -65.64 -48.75 71.1 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.813 0.445 . . . . 0.0 111.891 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -64.64 -34.46 78.33 Favored 'General case' 0 N--CA 1.529 3.495 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 93.9 mt -74.86 -24.89 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.946 0 C-N-CA 124.944 1.298 . . . . 0.0 110.662 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -66.18 -53.14 41.06 Favored 'General case' 1 N--CA 1.547 4.423 0 CA-C-N 118.999 0.818 . . . . 0.0 110.529 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.3 tt -66.34 -30.77 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.228 0 C-N-CA 123.873 0.869 . . . . 0.0 109.422 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -53.32 -31.28 43.41 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.926 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 16.5 mm -67.99 -46.93 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.015 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.4 -34.39 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.752 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 79.0 mt -68.33 -44.82 83.42 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.327 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.98 -30.67 45.99 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.44 -42.04 96.09 Favored Glycine 1 N--CA 1.523 4.47 0 C-N-CA 123.88 0.753 . . . . 0.0 112.658 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 70.2 m -67.36 -36.83 82.19 Favored 'General case' 0 N--CA 1.529 3.477 0 CA-C-O 122.232 1.015 . . . . 0.0 109.94 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.67 -41.11 80.89 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 113.306 -1.77 . . . . 0.0 113.037 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.85 -47.66 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -176.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.22 -25.87 60.68 Favored Glycine 1 N--CA 1.53 4.941 0 CA-C-N 119.62 1.1 . . . . 0.0 112.441 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.07 -42.59 99.7 Favored 'General case' 0 N--CA 1.534 3.773 0 C-N-CA 124.348 1.059 . . . . 0.0 109.237 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -53.94 -26.59 26.25 Favored 'General case' 0 N--CA 1.532 3.674 0 C-N-CA 124.927 1.291 . . . . 0.0 113.88 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 76.1 mt -54.64 -38.3 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 C-N-CA 123.413 0.685 . . . . 0.0 111.699 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.52 -28.91 23.5 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.263 0 C-N-CA 123.643 0.777 . . . . 0.0 112.55 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -52.66 -27.49 17.51 Favored 'General case' 0 N--CA 1.536 3.854 0 C-N-CA 122.978 0.511 . . . . 0.0 110.826 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.63 -33.52 66.37 Favored 'General case' 0 N--CA 1.531 3.597 0 O-C-N 121.877 -0.514 . . . . 0.0 110.259 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.8 -30.95 48.79 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.222 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 7.1 tp -52.83 -33.03 47.51 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.75 0.82 . . . . 0.0 110.441 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 83.4 p -58.08 -46.07 86.08 Favored 'General case' 0 N--CA 1.53 3.531 0 O-C-N 121.766 -0.584 . . . . 0.0 111.572 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.25 -36.09 82.52 Favored 'General case' 1 N--CA 1.544 4.246 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.9 t -68.54 -41.48 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -68.07 -22.91 64.91 Favored 'General case' 0 N--CA 1.514 2.751 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.219 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -49.85 -47.31 51.74 Favored 'General case' 0 N--CA 1.511 2.62 0 CA-C-O 121.932 0.872 . . . . 0.0 109.124 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.4 -40.06 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.416 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.93 -22.9 55.52 Favored 'General case' 0 N--CA 1.534 3.775 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -89.15 -13.52 38.21 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -53.85 -27.33 36.17 Favored Glycine 1 N--CA 1.517 4.076 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -95.34 154.67 17.08 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 124.36 1.064 . . . . 0.0 108.849 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 99.4 p -80.3 149.57 69.32 Favored Pre-proline 0 N--CA 1.529 3.508 0 C-N-CA 126.388 1.875 . . . . 0.0 111.363 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -56.45 131.29 44.85 Favored 'Trans proline' 0 C--N 1.402 3.392 0 CA-C-N 120.918 1.364 . . . . 0.0 110.289 -174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 34.6 mt 65.28 176.81 0.2 Allowed 'General case' 0 N--CA 1.522 3.132 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.522 3.166 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.182 -179.591 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -156.65 -76.94 0.09 Allowed 'General case' 0 N--CA 1.521 3.078 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp -52.06 -27.88 15.39 Favored 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 124.212 1.005 . . . . 0.0 112.639 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -66.77 -51.42 56.0 Favored 'General case' 0 N--CA 1.532 3.64 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.95 -32.84 74.75 Favored 'General case' 0 N--CA 1.526 3.373 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 91.4 mt -74.62 -29.84 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.544 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -59.33 -52.78 64.18 Favored 'General case' 1 N--CA 1.555 4.789 0 CA-C-O 122.264 1.03 . . . . 0.0 110.942 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.8 tt -70.37 -32.28 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.715 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.079 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -50.13 -25.03 3.13 Favored 'General case' 0 N--CA 1.53 3.528 0 C-N-CA 123.85 0.86 . . . . 0.0 112.549 -174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.91 -35.17 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 17.3 pt -64.01 -39.15 84.42 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.416 0 CA-C-N 120.016 1.28 . . . . 0.0 109.62 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.1 -48.73 85.8 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.254 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 50.4 t -67.39 -41.38 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 124.513 1.125 . . . . 0.0 110.03 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.61 90.92 Favored Glycine 1 N--CA 1.522 4.402 0 C-N-CA 125.241 1.4 . . . . 0.0 112.798 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 74.2 m -67.28 -35.26 79.13 Favored 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 124.29 1.036 . . . . 0.0 108.415 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.21 -47.07 86.7 Favored 'General case' 0 N--CA 1.523 3.208 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.768 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -27.93 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.868 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.39 -29.36 70.12 Favored Glycine 1 N--CA 1.528 4.833 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.7 tt -67.01 -40.12 87.21 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 125.581 1.552 . . . . 0.0 110.36 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -52.27 -25.42 9.34 Favored 'General case' 0 N--CA 1.531 3.611 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 15.8 tt -54.13 -38.99 40.3 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.172 0 CA-C-N 119.302 0.955 . . . . 0.0 113.096 -175.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 10.3 p -57.33 -30.44 35.55 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.164 0 C-N-CA 123.412 0.685 . . . . 0.0 111.672 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -53.97 -25.25 19.85 Favored 'General case' 0 N--CA 1.537 3.886 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.05 -34.45 63.57 Favored 'General case' 0 N--CA 1.523 3.199 0 O-C-N 122.035 -0.415 . . . . 0.0 109.933 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.47 -32.02 51.43 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.209 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.2 -33.03 51.0 Favored 'General case' 0 N--CA 1.535 3.82 0 C-N-CA 123.811 0.844 . . . . 0.0 110.77 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 68.5 m -58.03 -45.64 86.62 Favored 'General case' 0 N--CA 1.531 3.612 0 O-C-N 121.652 -0.655 . . . . 0.0 110.919 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.04 -34.49 78.56 Favored 'General case' 1 N--CA 1.543 4.19 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 48.0 t -67.63 -39.66 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -67.77 -25.95 65.87 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.372 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -50.05 -41.65 48.16 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.543 0.687 . . . . 0.0 111.173 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 68.1 t -61.68 -38.97 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -76.14 -20.62 57.43 Favored 'General case' 0 N--CA 1.524 3.257 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.503 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -88.66 -12.45 42.41 Favored 'General case' 0 N--CA 1.518 2.956 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -60.2 -13.82 30.01 Favored Glycine 1 N--CA 1.517 4.076 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 177.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -108.56 154.57 21.76 Favored 'General case' 0 N--CA 1.532 3.665 0 C-N-CA 125.06 1.344 . . . . 0.0 109.77 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 48.4 t -80.47 150.13 69.79 Favored Pre-proline 0 N--CA 1.53 3.571 0 C-N-CA 126.107 1.763 . . . . 0.0 110.877 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.72 130.35 38.52 Favored 'Trans proline' 0 C--N 1.402 3.359 0 CA-C-N 122.247 1.838 . . . . 0.0 113.221 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 45.0 tp -87.73 106.97 18.41 Favored 'General case' 0 N--CA 1.523 3.191 0 CA-C-N 113.221 -1.808 . . . . 0.0 108.094 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.524 3.24 0 CA-C-O 118.106 -0.949 . . . . 0.0 111.916 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -166.15 175.16 8.61 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 124.228 1.011 . . . . 0.0 108.411 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' B' ' 683' ' ' ARG . 63.7 mt -52.36 -46.41 66.15 Favored 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 123.533 0.733 . . . . 0.0 112.656 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -59.45 -43.44 93.16 Favored 'General case' 0 N--CA 1.532 3.661 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -72.34 -37.32 68.88 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 93.0 mt -74.82 -25.16 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 C-N-CA 125.029 1.332 . . . . 0.0 111.862 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' B' ' 679' ' ' LEU . 17.4 ttp180 -66.13 -52.24 50.39 Favored 'General case' 1 N--CA 1.549 4.481 0 C-N-CA 124.381 1.072 . . . . 0.0 110.577 -177.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.46 -32.77 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 CA-C-N 113.692 -1.595 . . . . 0.0 108.815 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -54.1 -30.79 49.91 Favored 'General case' 0 N--CA 1.52 3.028 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.276 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 17.9 mm -68.87 -41.85 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.626 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 40.3 mt -71.39 -34.86 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.016 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 50.8 mm -58.7 -40.19 78.7 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.668 0 CA-C-N 119.449 1.022 . . . . 0.0 109.738 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.41 -31.95 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.534 0 C-N-CA 123.704 0.802 . . . . 0.0 110.501 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.32 -32.34 79.37 Favored Glycine 1 N--CA 1.517 4.037 0 C-N-CA 123.404 0.526 . . . . 0.0 112.683 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 58.9 m -67.5 -36.96 82.09 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.719 0.808 . . . . 0.0 111.63 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 9.4 mp -56.55 -45.79 81.05 Favored 'General case' 0 N--CA 1.537 3.907 0 C-N-CA 123.44 0.696 . . . . 0.0 112.681 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.71 -49.04 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -175.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.9 -25.21 65.62 Favored Glycine 1 N--CA 1.525 4.601 0 CA-C-N 119.628 1.103 . . . . 0.0 113.12 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 4.4 tt -66.74 -41.86 87.18 Favored 'General case' 0 N--CA 1.535 3.797 0 C-N-CA 124.567 1.147 . . . . 0.0 110.639 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -52.13 -25.26 8.48 Favored 'General case' 0 N--CA 1.536 3.833 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.8 tt -54.14 -36.88 33.64 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 CA-C-N 119.878 1.217 . . . . 0.0 112.066 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.14 -27.97 17.21 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.012 0 C-N-CA 124.332 1.053 . . . . 0.0 111.779 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -52.15 -25.82 9.89 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 123.402 0.681 . . . . 0.0 109.756 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.73 -38.43 69.77 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 122.767 0.427 . . . . 0.0 110.017 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.24 -32.01 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.956 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.42 -36.45 61.53 Favored 'General case' 0 N--CA 1.537 3.897 0 C-N-CA 122.908 0.483 . . . . 0.0 110.809 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 26.5 m -62.11 -47.21 85.63 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.83 -35.92 79.45 Favored 'General case' 1 N--CA 1.545 4.32 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.14 -43.25 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.365 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -71.29 -20.99 62.14 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.876 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -47.73 -46.7 30.03 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 40.1 t -59.35 -41.59 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.389 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -76.69 -22.11 54.43 Favored 'General case' 0 N--CA 1.533 3.678 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.866 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -8.3 36.22 Favored 'General case' 0 N--CA 1.517 2.916 0 C-N-CA 124.925 1.29 . . . . 0.0 108.44 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.12 -32.49 35.71 Favored Glycine 1 N--CA 1.516 4.015 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -100.81 130.99 46.91 Favored 'General case' 0 N--CA 1.529 3.507 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 88.1 p -81.94 146.8 56.52 Favored Pre-proline 0 N--CA 1.527 3.422 0 C-N-CA 124.947 1.299 . . . . 0.0 110.627 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -67.0 130.01 21.99 Favored 'Trans proline' 0 C--N 1.399 3.195 0 CA-C-N 121.334 1.512 . . . . 0.0 109.445 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 56.3 mt -81.83 177.2 9.01 Favored 'General case' 0 N--CA 1.52 3.064 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.401 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.521 3.124 0 CA-C-O 117.854 -1.069 . . . . 0.0 108.894 179.727 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . 0.424 ' H2 ' ' H ' ' C' ' 678' ' ' TRP . 39.7 p-10 . . . . . 0 N--CA 1.497 1.875 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . 0.424 ' H ' ' H2 ' ' C' ' 677' ' ' ASN . 8.2 p90 -170.83 -30.0 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 123.994 0.918 . . . . 0.0 109.191 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.27 -43.95 79.28 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 124.809 1.243 . . . . 0.0 111.352 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -69.78 -40.07 76.25 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.217 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -65.68 -37.37 86.3 Favored 'General case' 0 N--CA 1.52 3.046 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.036 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 26.9 pt -73.09 -25.7 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 CA-C-N 118.347 0.521 . . . . 0.0 110.627 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -50.07 70.86 Favored 'General case' 1 N--CA 1.546 4.361 0 C-N-CA 122.806 0.443 . . . . 0.0 110.826 -176.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.48 -31.95 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.564 0 C-N-CA 124.002 0.921 . . . . 0.0 109.7 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -53.9 -41.14 67.28 Favored 'General case' 0 N--CA 1.518 2.969 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.37 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.71 -39.12 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.92 -45.06 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 C-N-CA 123.458 0.703 . . . . 0.0 110.56 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 76.0 mt -59.9 -49.04 85.44 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.42 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.62 -29.65 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.125 0 C-N-CA 125.286 1.434 . . . . 0.0 109.688 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.27 -31.69 81.69 Favored Glycine 1 N--CA 1.519 4.21 0 C-N-CA 123.717 0.675 . . . . 0.0 112.388 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.3 m -68.28 -36.39 79.31 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.962 0.905 . . . . 0.0 111.849 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.27 -35.7 62.83 Favored 'General case' 0 N--CA 1.534 3.755 0 CA-C-O 118.295 -0.859 . . . . 0.0 113.265 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . 0.255 0.1 OUTLIER -60.53 -49.98 82.22 Favored 'Isoleucine or valine' 1 N--CA 1.561 5.121 0 CA-C-N 120.272 1.397 . . . . 0.0 112.455 -176.164 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.17 -29.22 68.02 Favored Glycine 1 N--CA 1.532 5.054 0 CA-C-N 119.452 1.024 . . . . 0.0 111.69 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.59 -42.41 98.28 Favored 'General case' 0 N--CA 1.538 3.939 0 C-N-CA 123.653 0.781 . . . . 0.0 109.836 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -53.82 -25.2 18.28 Favored 'General case' 1 N--CA 1.542 4.164 0 C-N-CA 124.673 1.189 . . . . 0.0 113.82 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 70.6 mt -54.94 -39.78 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 O-C-N 121.625 -0.672 . . . . 0.0 110.454 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.36 -30.97 50.85 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.405 0 C-N-CA 123.859 0.864 . . . . 0.0 110.875 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.56 -30.15 65.01 Favored 'General case' 1 N--CA 1.542 4.143 0 O-C-N 121.055 -1.028 . . . . 0.0 111.689 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.98 -37.59 72.73 Favored 'General case' 1 N--CA 1.54 4.025 0 CA-C-O 121.8 0.809 . . . . 0.0 109.104 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.36 -28.05 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.277 0 C-N-CA 125.066 1.346 . . . . 0.0 108.678 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.1 tp -52.25 -32.66 38.11 Favored 'General case' 0 N--CA 1.532 3.643 0 C-N-CA 123.53 0.732 . . . . 0.0 110.108 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 89.1 p -56.56 -46.13 80.87 Favored 'General case' 0 N--CA 1.53 3.553 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 46.5 tp -66.04 -35.11 79.65 Favored 'General case' 1 N--CA 1.547 4.384 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.03 -40.02 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.0 OUTLIER -71.92 -23.73 61.52 Favored 'General case' 0 N--CA 1.517 2.902 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.225 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -48.47 -32.04 7.24 Favored 'General case' 0 N--CA 1.526 3.357 0 CA-C-N 118.832 0.742 . . . . 0.0 110.499 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.74 -49.07 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -77.84 -10.26 59.47 Favored 'General case' 1 N--CA 1.54 4.06 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.701 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.6 tt0 -114.14 -9.28 12.93 Favored 'General case' 0 N--CA 1.522 3.145 0 C-N-CA 125.365 1.466 . . . . 0.0 108.759 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -57.58 -30.04 61.74 Favored Glycine 0 N--CA 1.512 3.712 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -80.76 155.13 26.84 Favored 'General case' 0 N--CA 1.524 3.269 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 97.0 p -79.49 149.15 71.39 Favored Pre-proline 0 N--CA 1.528 3.469 0 C-N-CA 126.281 1.832 . . . . 0.0 111.757 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -56.87 131.86 48.11 Favored 'Trans proline' 0 C--N 1.401 3.316 0 CA-C-N 120.669 1.274 . . . . 0.0 111.001 -174.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 65.56 -67.87 0.13 Allowed 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 125.616 1.566 . . . . 0.0 110.72 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 83.2 p . . . . . 0 N--CA 1.526 3.328 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.494 -179.036 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 54.87 102.74 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.19 0 C-N-CA 124.294 1.038 . . . . 0.0 112.152 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.37 -22.44 4.62 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 125.262 1.425 . . . . 0.0 112.493 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -57.3 -51.1 70.72 Favored 'General case' 0 N--CA 1.533 3.689 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -64.88 -31.28 72.44 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.53 -33.59 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.966 0 C-N-CA 123.879 0.872 . . . . 0.0 108.664 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -51.79 42.42 Favored 'General case' 1 N--CA 1.554 4.748 0 CA-C-N 118.48 0.582 . . . . 0.0 112.11 -177.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.39 -38.23 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 CA-C-O 122.496 1.141 . . . . 0.0 110.184 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -52.39 -29.29 23.36 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 113.111 -1.858 . . . . 0.0 111.113 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 28.5 mm -68.46 -37.23 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 C-N-CA 124.244 1.018 . . . . 0.0 109.602 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 37.5 mt -64.9 -38.27 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.268 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.53 -41.72 93.66 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.27 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.76 -30.51 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 C-N-CA 123.965 0.906 . . . . 0.0 109.185 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.16 -34.29 89.26 Favored Glycine 1 N--CA 1.518 4.159 0 C-N-CA 123.382 0.515 . . . . 0.0 111.985 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.5 m -68.67 -37.51 79.66 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.562 0.745 . . . . 0.0 111.172 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.9 mp -57.54 -42.54 83.15 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 123.751 0.82 . . . . 0.0 112.328 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.274 0.5 OUTLIER -62.44 -48.91 86.09 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.308 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.231 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.44 -30.29 67.91 Favored Glycine 1 N--CA 1.53 4.954 0 CA-C-N 119.814 1.188 . . . . 0.0 112.899 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.94 -41.47 99.51 Favored 'General case' 1 N--CA 1.539 4.013 0 C-N-CA 124.411 1.084 . . . . 0.0 111.234 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -51.71 -24.28 5.55 Favored 'General case' 0 N--CA 1.538 3.933 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 18.5 tt -52.7 -36.03 22.22 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.26 0 CA-C-N 120.143 1.338 . . . . 0.0 111.684 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 12.6 p -54.09 -28.19 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.951 0 C-N-CA 124.304 1.042 . . . . 0.0 111.43 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -55.9 -29.08 59.44 Favored 'General case' 1 N--CA 1.544 4.256 0 O-C-N 121.489 -0.757 . . . . 0.0 109.764 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.7 -43.08 69.72 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 63.0 t -68.87 -33.34 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.112 0 C-N-CA 124.713 1.205 . . . . 0.0 109.105 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.13 -32.62 62.22 Favored 'General case' 0 N--CA 1.535 3.817 0 C-N-CA 124.175 0.99 . . . . 0.0 109.901 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.5 p -59.04 -45.14 91.48 Favored 'General case' 0 N--CA 1.528 3.426 0 O-C-N 121.353 -0.842 . . . . 0.0 111.253 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.21 -33.35 74.39 Favored 'General case' 1 N--CA 1.542 4.152 0 O-C-N 121.431 -0.793 . . . . 0.0 108.959 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.18 -39.22 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.873 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . 0.425 ' ND2' HH11 ' A' ' 709' ' ' ARG . 9.3 m120 -62.71 -22.8 66.78 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.693 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -50.38 -41.34 51.72 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-O 121.915 0.864 . . . . 0.0 110.012 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 64.1 t -62.96 -36.68 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . 0.425 HH11 ' ND2' ' A' ' 706' ' ' ASN . 50.6 mtm180 -75.7 -3.86 37.1 Favored 'General case' 0 N--CA 1.523 3.195 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.46 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -103.26 -14.9 16.15 Favored 'General case' 1 N--CA 1.552 4.662 0 C-N-CA 123.685 0.794 . . . . 0.0 108.921 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -81.94 -6.65 88.77 Favored Glycine 1 N--CA 1.528 4.82 0 N-CA-C 106.736 -2.546 . . . . 0.0 106.736 173.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -105.47 154.29 20.54 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 128.036 2.534 . . . . 0.0 106.611 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 32.1 t -98.13 147.3 32.89 Favored Pre-proline 1 N--CA 1.556 4.831 0 C-N-CA 125.422 1.489 . . . . 0.0 112.997 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -68.76 129.82 19.4 Favored 'Trans proline' 0 C--N 1.408 3.668 0 CA-C-N 121.212 1.468 . . . . 0.0 109.048 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 41.3 mt 50.05 70.63 0.48 Allowed 'General case' 0 N--CA 1.522 3.137 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.799 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.522 3.168 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.281 -179.658 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -169.16 176.61 5.18 Favored 'General case' 0 N--CA 1.522 3.137 0 C-N-CA 124.162 0.985 . . . . 0.0 109.367 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -27.67 14.09 Favored 'General case' 0 N--CA 1.516 2.853 0 C-N-CA 124.352 1.061 . . . . 0.0 113.732 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -70.98 -49.79 41.42 Favored 'General case' 0 N--CA 1.535 3.791 0 CA-C-O 121.155 0.503 . . . . 0.0 111.576 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -61.05 -31.42 71.07 Favored 'General case' 0 N--CA 1.533 3.688 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.98 -25.55 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.786 0 C-N-CA 125.913 1.685 . . . . 0.0 111.021 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.07 -52.29 50.24 Favored 'General case' 1 N--CA 1.547 4.386 0 CA-C-O 121.574 0.702 . . . . 0.0 111.409 -177.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.8 tt -68.0 -32.34 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.171 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.594 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -54.27 -30.49 50.75 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 123.827 0.851 . . . . 0.0 111.213 -177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 16.1 mm -66.21 -37.69 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.937 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 38.5 mt -62.3 -38.37 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.1 -46.53 93.41 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.361 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.4 t -62.04 -30.04 47.79 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.26 -31.73 81.82 Favored Glycine 1 N--CA 1.519 4.223 0 C-N-CA 123.562 0.601 . . . . 0.0 112.455 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 61.4 m -68.58 -36.92 79.41 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.658 0.783 . . . . 0.0 111.367 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.56 -43.19 79.73 Favored 'General case' 0 N--CA 1.536 3.868 0 C-N-CA 123.713 0.805 . . . . 0.0 112.52 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . 0.281 0.6 OUTLIER -60.42 -48.97 86.16 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.621 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.091 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.77 -26.95 71.43 Favored Glycine 1 N--CA 1.533 5.121 0 CA-C-N 120.734 1.606 . . . . 0.0 112.373 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 5.3 tt -62.95 -43.05 99.86 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.806 0.843 . . . . 0.0 110.955 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -53.14 -27.12 19.38 Favored 'General case' 1 N--CA 1.539 4.003 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 70.9 mt -54.74 -37.95 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.51 0 C-N-CA 123.954 0.902 . . . . 0.0 111.794 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.11 -31.61 42.11 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.301 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -54.23 -25.76 24.88 Favored 'General case' 0 N--CA 1.539 3.988 0 CA-C-N 118.793 0.724 . . . . 0.0 111.207 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.1 -37.78 69.85 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 121.65 -0.656 . . . . 0.0 110.248 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.22 -32.59 54.38 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 13.4 tp -54.87 -35.32 63.93 Favored 'General case' 0 N--CA 1.533 3.689 0 C-N-CA 123.154 0.581 . . . . 0.0 110.498 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 80.8 p -59.01 -48.41 81.67 Favored 'General case' 0 N--CA 1.521 3.119 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.22 -35.09 79.16 Favored 'General case' 1 N--CA 1.549 4.517 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.647 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.53 -38.78 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' B' ' 710' ' ' GLN . 2.2 p30 -62.24 -25.81 68.03 Favored 'General case' 0 N--CA 1.521 3.084 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.625 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 18.6 tpt85 -46.82 -32.56 3.78 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.617 0.767 . . . . 0.0 111.362 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 63.3 t -75.53 -48.8 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.36 -11.03 59.92 Favored 'General case' 1 N--CA 1.543 4.182 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.839 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' B' ' 706' ' ' ASN . 28.2 tt0 -113.63 -10.64 13.09 Favored 'General case' 0 N--CA 1.519 3.018 0 C-N-CA 125.929 1.692 . . . . 0.0 108.556 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.74 -24.43 32.92 Favored Glycine 0 N--CA 1.51 3.608 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -95.48 152.82 18.08 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 123.461 0.705 . . . . 0.0 109.226 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 48.7 m -81.31 150.76 68.26 Favored Pre-proline 0 N--CA 1.533 3.686 0 C-N-CA 126.264 1.826 . . . . 0.0 111.267 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.87 130.38 38.87 Favored 'Trans proline' 0 C--N 1.402 3.382 0 CA-C-N 121.984 1.744 . . . . 0.0 112.33 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . 0.423 ' CD1' ' H ' ' B' ' 715' ' ' LEU . 0.0 OUTLIER -58.64 170.15 0.83 Allowed 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.656 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 N--CA 1.519 2.999 0 C-N-CA 124.09 0.956 . . . . 0.0 111.955 -179.458 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 12.0 m120 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 25.3 t-105 -166.31 -71.3 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.034 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -24.05 64.47 Favored 'General case' 0 N--CA 1.521 3.117 0 C-N-CA 124.574 1.15 . . . . 0.0 110.814 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -70.15 -45.38 66.9 Favored 'General case' 0 N--CA 1.513 2.72 0 C-N-CA 124.809 1.244 . . . . 0.0 111.204 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -61.74 -38.78 89.22 Favored 'General case' 0 N--CA 1.518 2.939 0 CA-C-N 113.978 -1.464 . . . . 0.0 111.659 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 26.5 pt -72.45 -36.6 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 C-N-CA 122.671 0.388 . . . . 0.0 111.01 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -52.86 -51.23 61.78 Favored 'General case' 0 N--CA 1.539 3.98 0 CA-C-O 121.7 0.762 . . . . 0.0 111.625 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.23 -34.48 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.828 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -55.54 -43.74 76.07 Favored 'General case' 0 N--CA 1.537 3.891 0 C-N-CA 123.618 0.767 . . . . 0.0 109.523 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.51 -37.76 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.814 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 41.5 mt -71.08 -41.99 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 49.1 mm -59.68 -48.79 86.15 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.472 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 70.8 t -60.73 -30.22 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 C-N-CA 124.136 0.975 . . . . 0.0 109.737 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.27 91.87 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 123.307 0.479 . . . . 0.0 112.488 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 66.7 m -67.5 -37.07 82.28 Favored 'General case' 0 N--CA 1.528 3.472 0 C-N-CA 123.768 0.827 . . . . 0.0 112.041 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.73 -39.9 68.73 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 123.434 0.694 . . . . 0.0 112.312 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -40.85 86.28 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.07 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -174.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -71.71 -27.38 71.04 Favored Glycine 1 N--CA 1.527 4.721 0 O-C-N 121.173 -0.954 . . . . 0.0 110.973 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.48 -42.59 99.01 Favored 'General case' 0 N--CA 1.531 3.581 0 C-N-CA 124.176 0.99 . . . . 0.0 109.651 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -53.96 -26.46 25.83 Favored 'General case' 0 N--CA 1.537 3.896 0 C-N-CA 124.471 1.109 . . . . 0.0 113.846 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 73.9 mt -54.62 -38.59 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 C-N-CA 123.578 0.751 . . . . 0.0 111.342 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 5.8 p -56.01 -27.33 22.82 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.324 0 C-N-CA 124.074 0.95 . . . . 0.0 112.281 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -51.73 -27.33 11.62 Favored 'General case' 0 N--CA 1.538 3.964 0 C-N-CA 123.311 0.645 . . . . 0.0 111.179 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.3 -34.11 66.19 Favored 'General case' 0 N--CA 1.532 3.649 0 O-C-N 121.857 -0.527 . . . . 0.0 109.952 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.1 m -69.36 -31.82 50.99 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.093 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 6.9 tp -53.5 -35.67 60.89 Favored 'General case' 0 N--CA 1.538 3.959 0 C-N-CA 123.293 0.637 . . . . 0.0 110.373 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 88.8 p -61.32 -47.8 84.28 Favored 'General case' 0 N--CA 1.516 2.867 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 45.9 tp -67.71 -35.52 78.95 Favored 'General case' 1 N--CA 1.546 4.331 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 74.7 t -69.04 -46.09 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -76.03 -23.36 55.15 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 123.515 0.51 . . . . 0.0 110.799 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -46.15 62.58 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.03 -43.23 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.891 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.682 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -75.96 -5.85 48.19 Favored 'General case' 0 N--CA 1.538 3.933 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.404 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -113.02 -12.67 13.19 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 125.619 1.568 . . . . 0.0 107.934 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.16 -33.8 31.08 Favored Glycine 0 N--CA 1.513 3.807 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -82.66 153.83 25.2 Favored 'General case' 0 N--CA 1.526 3.327 0 CA-C-N 114.201 -1.0 . . . . 0.0 108.626 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 59.8 m -80.2 149.23 69.08 Favored Pre-proline 0 N--CA 1.531 3.612 0 C-N-CA 126.201 1.8 . . . . 0.0 111.274 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -56.21 130.03 38.01 Favored 'Trans proline' 0 C--N 1.402 3.36 0 CA-C-N 121.175 1.455 . . . . 0.0 110.792 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -68.57 -19.77 64.49 Favored 'General case' 0 N--CA 1.524 3.273 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.56 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.52 3.061 0 C-N-CA 123.831 0.852 . . . . 0.0 109.099 -179.684 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -166.9 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 28.2 tp -51.81 -43.39 63.08 Favored 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 124.328 1.051 . . . . 0.0 111.719 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -64.69 -36.24 83.65 Favored 'General case' 0 N--CA 1.528 3.436 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -72.54 -36.64 68.32 Favored 'General case' 0 N--CA 1.533 3.68 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.33 -24.46 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 C-N-CA 124.725 1.21 . . . . 0.0 109.882 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -67.14 -53.44 30.62 Favored 'General case' 1 N--CA 1.554 4.75 0 CA-C-N 119.488 1.04 . . . . 0.0 112.334 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.11 -32.01 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 C-N-CA 124.234 1.014 . . . . 0.0 109.727 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -56.82 -32.28 65.57 Favored 'General case' 0 N--CA 1.508 2.474 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.234 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 24.2 mm -68.33 -46.02 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 C-N-CA 124.172 0.989 . . . . 0.0 109.344 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.64 -35.95 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.178 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.301 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.67 -48.13 90.13 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.215 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.36 -31.36 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.533 0.733 . . . . 0.0 109.83 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.27 -50.44 65.0 Favored Glycine 1 N--CA 1.52 4.261 0 C-N-CA 124.082 0.849 . . . . 0.0 112.494 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.2 m -58.66 -35.37 72.45 Favored 'General case' 0 N--CA 1.533 3.719 0 C-N-CA 124.475 1.11 . . . . 0.0 111.015 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 2.1 tp -53.81 -34.82 60.38 Favored 'General case' 0 N--CA 1.512 2.636 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.127 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -38.96 79.66 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -177.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -72.87 -29.89 64.42 Favored Glycine 1 N--CA 1.519 4.232 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.2 tt -59.75 -42.47 93.29 Favored 'General case' 1 N--CA 1.541 4.076 0 C-N-CA 124.496 1.118 . . . . 0.0 110.944 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -51.31 -24.7 4.86 Favored 'General case' 0 N--CA 1.527 3.398 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 10.1 tp -53.05 -37.61 27.2 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.671 0 CA-C-N 119.837 1.199 . . . . 0.0 112.689 -176.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.18 -28.11 17.5 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.444 0 C-N-CA 124.222 1.009 . . . . 0.0 110.981 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -56.04 -27.65 54.13 Favored 'General case' 0 N--CA 1.536 3.833 0 O-C-N 121.506 -0.747 . . . . 0.0 110.008 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -66.98 -44.55 80.15 Favored 'General case' 0 N--CA 1.526 3.336 0 CA-C-O 122.18 0.99 . . . . 0.0 108.645 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 84.2 t -68.77 -33.72 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.173 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.36 -33.93 63.84 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 123.506 0.723 . . . . 0.0 110.161 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' SER . . . . . 0.437 ' HG ' ' ND2' ' B' ' 706' ' ' ASN . 86.0 p -58.08 -46.27 85.75 Favored 'General case' 0 N--CA 1.53 3.537 0 O-C-N 121.788 -0.57 . . . . 0.0 111.985 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.54 -35.85 82.32 Favored 'General case' 1 N--CA 1.542 4.175 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.78 -39.9 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . 0.567 HD21 ' HE ' ' A' ' 709' ' ' ARG . 3.9 m120 -66.19 -24.29 66.6 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.314 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -49.55 -46.67 49.01 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 124.027 0.931 . . . . 0.0 110.48 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.65 -50.85 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.482 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . 0.567 ' HE ' HD21 ' A' ' 706' ' ' ASN . 34.1 ptt180 -80.66 -3.45 50.63 Favored 'General case' 1 N--CA 1.55 4.536 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 178.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -111.57 -13.25 13.84 Favored 'General case' 0 N--CA 1.539 3.999 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.74 -31.19 53.54 Favored Glycine 0 N--CA 1.514 3.866 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -80.24 155.09 27.5 Favored 'General case' 0 N--CA 1.521 3.079 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 67.8 m -79.4 149.68 72.5 Favored Pre-proline 0 N--CA 1.532 3.629 0 C-N-CA 126.307 1.843 . . . . 0.0 112.111 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -55.57 130.83 42.6 Favored 'Trans proline' 0 C--N 1.402 3.391 0 CA-C-N 120.614 1.255 . . . . 0.0 110.817 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 54.5 tp 57.95 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 125.805 1.642 . . . . 0.0 111.043 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.522 3.137 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.378 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 7.4 p90 59.07 -30.44 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 126.379 1.872 . . . . 0.0 114.863 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.35 -45.02 95.07 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 123.688 0.795 . . . . 0.0 110.882 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -69.93 -36.16 75.12 Favored 'General case' 0 N--CA 1.522 3.136 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.451 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -40.73 76.76 Favored 'General case' 0 N--CA 1.531 3.586 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.893 -176.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.19 -25.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 CA-C-N 118.701 0.682 . . . . 0.0 110.905 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -52.7 38.98 Favored 'General case' 1 N--CA 1.539 4.008 0 C-N-CA 123.988 0.915 . . . . 0.0 112.34 -177.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.4 tt -70.93 -30.16 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 123.833 0.853 . . . . 0.0 110.752 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -36.36 24.77 Favored 'General case' 0 N--CA 1.524 3.227 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.239 -173.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -69.48 -37.55 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.311 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 34.4 mt -58.87 -35.04 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 35.8 mm -66.65 -46.7 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.28 -31.14 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 C-N-CA 123.85 0.86 . . . . 0.0 108.843 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.2 94.05 Favored Glycine 1 N--CA 1.523 4.436 0 C-N-CA 123.808 0.718 . . . . 0.0 111.817 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 71.1 m -69.09 -41.04 78.03 Favored 'General case' 0 N--CA 1.518 2.957 0 C-N-CA 123.563 0.745 . . . . 0.0 110.765 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.42 -45.91 88.8 Favored 'General case' 0 N--CA 1.535 3.806 0 C-N-CA 123.484 0.714 . . . . 0.0 112.614 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -34.98 73.13 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.1 -28.84 71.1 Favored Glycine 1 N--CA 1.527 4.721 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.3 tt -65.06 -43.52 91.97 Favored 'General case' 0 N--CA 1.531 3.614 0 C-N-CA 124.375 1.07 . . . . 0.0 109.808 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -54.96 -26.33 35.74 Favored 'General case' 0 N--CA 1.537 3.895 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 64.3 mt -55.18 -39.2 50.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 C-N-CA 123.236 0.614 . . . . 0.0 112.147 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.63 -28.64 23.56 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.51 0 C-N-CA 123.672 0.789 . . . . 0.0 112.468 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -51.77 -26.16 9.07 Favored 'General case' 0 N--CA 1.531 3.613 0 C-N-CA 123.2 0.6 . . . . 0.0 111.304 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.33 -32.33 62.42 Favored 'General case' 0 N--CA 1.53 3.569 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.8 m -69.26 -31.18 48.75 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.212 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 4.4 tp -53.46 -32.51 50.34 Favored 'General case' 0 N--CA 1.538 3.943 0 C-N-CA 123.671 0.789 . . . . 0.0 110.556 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 67.9 p -57.41 -45.33 84.69 Favored 'General case' 0 N--CA 1.532 3.642 0 O-C-N 121.759 -0.588 . . . . 0.0 111.019 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.11 -35.11 79.69 Favored 'General case' 1 N--CA 1.539 4.023 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.77 -40.0 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . 0.437 ' ND2' ' HG ' ' A' ' 703' ' ' SER . 23.4 m-20 -63.47 -21.8 66.52 Favored 'General case' 0 N--CA 1.519 3.025 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.631 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -47.42 -47.55 26.63 Favored 'General case' 0 N--CA 1.519 3.022 0 C-N-CA 123.335 0.654 . . . . 0.0 109.495 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 52.7 t -58.95 -42.85 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.18 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -77.21 -15.51 59.46 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.681 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.5 -14.44 23.68 Favored 'General case' 1 N--CA 1.553 4.676 0 C-N-CA 124.123 0.969 . . . . 0.0 109.865 -177.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -87.72 -26.43 29.65 Favored Glycine 1 N--CA 1.523 4.438 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -75.59 146.95 39.99 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 126.01 1.724 . . . . 0.0 108.567 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 50.9 m -88.43 149.55 44.78 Favored Pre-proline 0 N--CA 1.537 3.922 0 C-N-CA 125.637 1.575 . . . . 0.0 113.266 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.27 132.31 51.48 Favored 'Trans proline' 0 C--N 1.402 3.359 0 CA-C-N 121.513 1.576 . . . . 0.0 111.983 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.93 -57.09 0.34 Allowed 'General case' 0 N--CA 1.537 3.914 0 C-N-CA 125.104 1.361 . . . . 0.0 107.565 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 60.4 p . . . . . 0 N--CA 1.526 3.369 0 C-N-CA 124.532 1.133 . . . . 0.0 113.054 179.067 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -165.16 176.51 8.41 Favored 'General case' 0 N--CA 1.526 3.341 0 C-N-CA 123.797 0.839 . . . . 0.0 108.988 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.45 -42.69 61.75 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 125.319 1.447 . . . . 0.0 111.907 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -68.13 -39.26 82.75 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.42 0.688 . . . . 0.0 111.429 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -68.82 -38.61 80.0 Favored 'General case' 0 N--CA 1.521 3.082 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.082 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 11.5 pt -73.24 -38.96 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -45.32 62.23 Favored 'General case' 0 N--CA 1.534 3.739 0 C-N-CA 123.237 0.615 . . . . 0.0 111.276 -176.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.7 tt -74.38 -34.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.939 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -60.31 -38.59 84.15 Favored 'General case' 0 N--CA 1.536 3.837 0 C-N-CA 124.018 0.927 . . . . 0.0 109.593 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.3 -37.05 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.081 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.377 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 8.2 mm -67.15 -43.44 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 41.4 mm -59.15 -49.14 84.43 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.359 0 CA-C-O 120.581 0.229 . . . . 0.0 110.529 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.23 -31.33 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -68.66 -36.5 83.05 Favored Glycine 0 N--CA 1.51 3.605 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.462 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 65.3 m -68.15 -36.77 80.2 Favored 'General case' 0 N--CA 1.529 3.497 0 CA-C-O 121.935 0.874 . . . . 0.0 110.006 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.17 -45.88 75.75 Favored 'General case' 0 N--CA 1.521 3.114 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.683 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.15 -35.98 65.91 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.056 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -176.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -75.12 -16.42 80.6 Favored Glycine 1 N--CA 1.522 4.417 0 O-C-N 121.648 -0.658 . . . . 0.0 111.72 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.25 -41.72 85.15 Favored 'General case' 0 N--CA 1.538 3.956 0 C-N-CA 124.489 1.116 . . . . 0.0 108.491 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -52.12 -23.61 5.67 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 125.286 1.435 . . . . 0.0 114.362 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 11.0 tp -54.33 -38.51 40.38 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.431 0 CA-C-N 119.052 0.842 . . . . 0.0 112.777 -177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.89 -29.45 21.66 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.177 0 C-N-CA 124.356 1.063 . . . . 0.0 112.353 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -53.04 -25.05 11.17 Favored 'General case' 0 N--CA 1.533 3.694 0 C-N-CA 123.375 0.67 . . . . 0.0 110.086 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.15 70.53 Favored 'General case' 0 N--CA 1.523 3.195 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.35 -32.08 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.64 -34.77 59.7 Favored 'General case' 0 N--CA 1.537 3.88 0 C-N-CA 122.923 0.489 . . . . 0.0 110.314 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 58.9 m -59.28 -47.03 86.92 Favored 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 36.7 tp -66.62 -34.73 78.54 Favored 'General case' 1 N--CA 1.549 4.486 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.76 -38.39 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.371 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.95 -23.31 63.46 Favored 'General case' 0 N--CA 1.521 3.088 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.186 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -48.03 -46.06 32.68 Favored 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 121.873 0.844 . . . . 0.0 110.554 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.09 -43.45 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -77.12 -9.57 58.83 Favored 'General case' 0 N--CA 1.531 3.595 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.439 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -89.63 -15.48 32.62 Favored 'General case' 1 N--CA 1.547 4.376 0 C-N-CA 123.53 0.732 . . . . 0.0 109.782 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -71.6 -6.55 62.84 Favored Glycine 1 N--CA 1.524 4.547 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -75.97 155.14 35.31 Favored 'General case' 0 N--CA 1.512 2.632 0 C-N-CA 125.451 1.5 . . . . 0.0 109.027 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 95.9 p -100.48 146.96 32.91 Favored Pre-proline 0 N--CA 1.53 3.55 0 C-N-CA 125.357 1.463 . . . . 0.0 108.725 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -63.75 130.27 27.36 Favored 'Trans proline' 0 N--CA 1.521 3.105 0 CA-C-N 121.493 1.569 . . . . 0.0 109.061 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 55.9 79.46 0.17 Allowed 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 125.312 1.445 . . . . 0.0 109.926 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 N--CA 1.523 3.185 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.091 -179.631 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -165.3 -77.66 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.054 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -23.68 4.28 Favored 'General case' 0 N--CA 1.515 2.821 0 C-N-CA 124.133 0.973 . . . . 0.0 112.857 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -68.72 -50.43 50.81 Favored 'General case' 0 N--CA 1.529 3.513 0 CA-C-O 121.406 0.622 . . . . 0.0 111.989 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -61.5 -34.66 75.88 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.4 -24.95 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 C-N-CA 125.357 1.463 . . . . 0.0 110.074 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -66.79 -54.75 19.42 Favored 'General case' 1 N--CA 1.559 5.012 0 CA-C-N 119.592 1.087 . . . . 0.0 110.523 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.38 -30.78 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.945 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -55.26 -31.67 61.73 Favored 'General case' 0 N--CA 1.513 2.679 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.764 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 20.4 mm -64.11 -46.04 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.073 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 48.3 mt -56.93 -36.32 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.47 -45.3 85.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.13 -30.21 49.13 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.42 -32.79 85.37 Favored Glycine 1 N--CA 1.518 4.123 0 C-N-CA 123.596 0.617 . . . . 0.0 112.059 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 69.0 m -68.17 -36.95 80.44 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.558 0.743 . . . . 0.0 111.329 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.13 -44.16 83.09 Favored 'General case' 0 N--CA 1.538 3.962 0 C-N-CA 123.518 0.727 . . . . 0.0 112.363 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.257 0.5 OUTLIER -61.4 -49.69 83.45 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.293 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -175.587 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.34 -24.47 67.51 Favored Glycine 1 N--CA 1.527 4.741 0 CA-C-N 119.877 1.217 . . . . 0.0 112.721 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.5 tt -65.03 -43.27 92.94 Favored 'General case' 0 N--CA 1.535 3.816 0 C-N-CA 123.68 0.792 . . . . 0.0 109.715 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -53.39 -27.29 23.26 Favored 'General case' 1 N--CA 1.54 4.048 0 C-N-CA 124.199 1.0 . . . . 0.0 113.228 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.08 -38.21 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 C-N-CA 123.463 0.705 . . . . 0.0 110.36 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 2.0 p -55.71 -26.29 19.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.129 0 C-N-CA 124.566 1.146 . . . . 0.0 111.725 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -51.89 -26.02 9.28 Favored 'General case' 0 N--CA 1.539 3.995 0 C-N-CA 123.25 0.62 . . . . 0.0 110.777 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.69 -44.48 81.53 Favored 'General case' 0 N--CA 1.528 3.45 0 O-C-N 121.868 -0.52 . . . . 0.0 110.503 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 3.0 m -70.3 -33.49 54.46 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.433 0 CA-C-N 118.8 0.727 . . . . 0.0 109.969 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 4.7 tp -54.97 -33.21 62.2 Favored 'General case' 0 N--CA 1.537 3.885 0 C-N-CA 123.626 0.77 . . . . 0.0 109.857 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 96.0 p -59.36 -48.14 82.75 Favored 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 36.3 tp -63.94 -34.05 77.09 Favored 'General case' 1 N--CA 1.548 4.46 0 O-C-N 121.205 -0.935 . . . . 0.0 108.599 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.72 -38.34 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -61.47 -28.24 69.14 Favored 'General case' 0 N--CA 1.536 3.83 0 C-N-CA 122.92 0.488 . . . . 0.0 110.32 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -49.21 -47.52 46.08 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 121.714 0.769 . . . . 0.0 109.143 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.48 -36.3 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.666 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.1 -27.79 60.02 Favored 'General case' 0 N--CA 1.532 3.672 0 CA-C-O 120.925 0.393 . . . . 0.0 110.047 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -90.14 -13.47 35.63 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 124.623 1.169 . . . . 0.0 109.184 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.8 -25.64 9.69 Favored Glycine 1 N--CA 1.521 4.349 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -115.9 151.37 35.46 Favored 'General case' 0 N--CA 1.533 3.715 0 C-N-CA 124.573 1.149 . . . . 0.0 108.801 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 69.4 m -82.79 147.26 54.57 Favored Pre-proline 0 N--CA 1.528 3.442 0 C-N-CA 125.408 1.483 . . . . 0.0 109.694 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -61.53 130.85 33.25 Favored 'Trans proline' 0 C--N 1.396 3.067 0 CA-C-N 121.805 1.68 . . . . 0.0 110.03 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.8 pp -66.99 148.24 52.2 Favored 'General case' 0 N--CA 1.523 3.213 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.981 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 N--CA 1.522 3.169 0 CA-C-O 117.89 -1.053 . . . . 0.0 111.898 -179.638 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -165.35 -47.31 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 123.642 0.777 . . . . 0.0 109.062 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.8 tt -54.62 -40.3 68.8 Favored 'General case' 0 N--CA 1.514 2.759 0 C-N-CA 124.701 1.2 . . . . 0.0 111.862 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -68.32 -48.21 65.51 Favored 'General case' 0 N--CA 1.528 3.432 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -62.32 -31.96 72.65 Favored 'General case' 0 N--CA 1.536 3.872 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.05 -25.24 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.029 0 C-N-CA 125.628 1.571 . . . . 0.0 111.007 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -52.32 59.23 Favored 'General case' 1 N--CA 1.55 4.537 0 CA-C-N 118.677 0.672 . . . . 0.0 110.475 -178.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 18.5 tt -71.21 -30.29 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.664 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -51.06 -36.56 40.52 Favored 'General case' 0 N--CA 1.525 3.296 0 CA-C-O 121.64 0.733 . . . . 0.0 111.819 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.67 -36.73 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 C-N-CA 125.196 1.399 . . . . 0.0 109.677 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 18.1 mm -61.56 -41.08 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.8 -44.5 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.85 -30.7 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.799 0 C-N-CA 123.566 0.746 . . . . 0.0 109.087 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.66 -32.48 83.24 Favored Glycine 1 N--CA 1.52 4.271 0 C-N-CA 123.399 0.523 . . . . 0.0 112.114 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.6 m -68.18 -37.13 80.64 Favored 'General case' 0 N--CA 1.524 3.236 0 C-N-CA 123.597 0.759 . . . . 0.0 111.175 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.35 -44.19 84.11 Favored 'General case' 0 N--CA 1.539 3.996 0 C-N-CA 123.674 0.79 . . . . 0.0 112.391 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . 0.291 0.1 OUTLIER -67.22 -48.25 78.98 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.48 0 C-N-CA 123.036 0.534 . . . . 0.0 110.478 -176.292 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -54.89 -34.77 57.68 Favored Glycine 1 N--CA 1.53 4.945 0 O-C-N 121.379 -0.826 . . . . 0.0 112.416 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 9.5 tt -72.45 -40.41 67.06 Favored 'General case' 0 N--CA 1.534 3.768 0 C-N-CA 125.159 1.383 . . . . 0.0 109.859 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -51.64 -24.5 5.64 Favored 'General case' 0 N--CA 1.531 3.597 0 C-N-CA 126.317 1.847 . . . . 0.0 113.823 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.21 -35.63 30.35 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 C-N-CA 123.789 0.836 . . . . 0.0 112.273 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -52.97 -27.49 12.97 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 C-N-CA 124.503 1.121 . . . . 0.0 111.903 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -52.38 -25.52 10.05 Favored 'General case' 0 N--CA 1.539 3.981 0 C-N-CA 123.635 0.774 . . . . 0.0 109.909 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -57.5 -37.52 73.09 Favored 'General case' 0 N--CA 1.524 3.261 0 O-C-N 121.53 -0.731 . . . . 0.0 109.882 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.47 -33.17 55.99 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.349 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.16 -32.93 50.29 Favored 'General case' 1 N--CA 1.546 4.326 0 C-N-CA 124.303 1.041 . . . . 0.0 109.603 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 69.3 m -59.41 -45.35 91.76 Favored 'General case' 1 N--CA 1.543 4.215 0 O-C-N 120.207 -1.558 . . . . 0.0 111.088 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.71 -35.04 78.43 Favored 'General case' 1 N--CA 1.552 4.665 0 O-C-N 121.071 -1.018 . . . . 0.0 108.987 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.73 -38.5 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.469 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -55.02 -35.64 64.63 Favored 'General case' 0 N--CA 1.529 3.5 0 CA-C-O 121.258 0.552 . . . . 0.0 109.8 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -54.09 -47.44 71.73 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 122.367 1.08 . . . . 0.0 109.802 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.65 -32.05 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -77.52 -18.35 57.11 Favored 'General case' 0 N--CA 1.531 3.616 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.03 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -87.33 -14.97 39.29 Favored 'General case' 1 N--CA 1.552 4.633 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.85 -24.11 32.63 Favored Glycine 1 N--CA 1.521 4.313 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -121.53 152.95 38.63 Favored 'General case' 1 N--CA 1.542 4.135 0 C-N-CA 125.158 1.383 . . . . 0.0 110.408 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 92.4 p -82.7 148.7 58.59 Favored Pre-proline 0 N--CA 1.534 3.734 0 C-N-CA 126.344 1.857 . . . . 0.0 111.292 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -57.15 131.18 43.59 Favored 'Trans proline' 0 N--CA 1.527 3.466 0 CA-C-N 121.411 1.54 . . . . 0.0 111.632 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.59 -7.21 49.05 Favored 'General case' 0 N--CA 1.535 3.806 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.327 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.523 3.191 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.863 -179.59 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 58.59 113.1 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.287 0 C-N-CA 124.251 1.02 . . . . 0.0 111.872 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.31 -23.27 5.53 Favored 'General case' 0 N--CA 1.513 2.687 0 C-N-CA 125.158 1.383 . . . . 0.0 112.514 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -72.14 -28.83 63.5 Favored 'General case' 0 N--CA 1.53 3.547 0 O-C-N 121.896 -0.503 . . . . 0.0 110.814 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -70.66 -34.12 71.68 Favored 'General case' 0 N--CA 1.526 3.341 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.077 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 23.3 pt -72.03 -26.3 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.464 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -51.44 69.53 Favored 'General case' 1 N--CA 1.541 4.084 0 C-N-CA 123.73 0.812 . . . . 0.0 112.023 -177.147 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.5 tt -73.14 -31.84 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.792 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.168 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -54.17 -29.25 44.94 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.879 0.872 . . . . 0.0 110.346 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 6.5 mm -68.68 -38.75 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.822 0 C-N-CA 123.78 0.832 . . . . 0.0 109.593 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.93 -41.75 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.257 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.46 -44.6 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.34 -30.4 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.06 -37.6 93.02 Favored Glycine 1 N--CA 1.52 4.263 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 68.1 m -68.47 -37.89 80.56 Favored 'General case' 0 N--CA 1.523 3.177 0 C-N-CA 123.581 0.752 . . . . 0.0 111.02 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.74 -45.57 93.77 Favored 'General case' 0 N--CA 1.536 3.842 0 C-N-CA 123.07 0.548 . . . . 0.0 111.576 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 1.5 tp -60.96 -49.39 84.91 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.362 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.18 -22.59 63.13 Favored Glycine 1 N--CA 1.528 4.817 0 O-C-N 120.402 -1.436 . . . . 0.0 112.566 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.55 -41.4 79.85 Favored 'General case' 0 N--CA 1.533 3.69 0 CA-C-O 121.769 0.795 . . . . 0.0 108.993 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -53.72 -24.2 14.07 Favored 'General case' 0 N--CA 1.534 3.769 0 C-N-CA 124.765 1.226 . . . . 0.0 113.409 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 75.0 mt -53.24 -35.81 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 C-N-CA 123.484 0.714 . . . . 0.0 110.549 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 5.5 m -54.27 -26.27 15.07 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.377 0 C-N-CA 123.981 0.913 . . . . 0.0 111.687 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -53.97 -31.12 49.66 Favored 'General case' 0 N--CA 1.531 3.587 0 C-N-CA 123.278 0.631 . . . . 0.0 112.144 -173.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -71.4 -45.05 63.73 Favored 'General case' 0 N--CA 1.529 3.479 0 CA-C-O 121.99 0.9 . . . . 0.0 108.833 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.64 -34.76 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.089 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.71 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.13 -34.24 71.81 Favored 'General case' 0 N--CA 1.52 3.063 0 C-N-CA 124.674 1.19 . . . . 0.0 110.027 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 54.7 m -58.97 -46.58 87.71 Favored 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.72 -36.49 84.46 Favored 'General case' 1 N--CA 1.543 4.204 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.77 -40.97 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.669 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -66.28 -23.29 66.37 Favored 'General case' 0 N--CA 1.515 2.804 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.833 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -49.35 -47.18 47.61 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 123.43 0.692 . . . . 0.0 110.153 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.94 -48.17 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.966 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.148 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -76.7 -4.81 45.2 Favored 'General case' 0 N--CA 1.534 3.752 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.881 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -114.5 -12.82 12.26 Favored 'General case' 0 N--CA 1.52 3.036 0 C-N-CA 124.769 1.228 . . . . 0.0 108.849 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -49.86 -31.89 17.62 Favored Glycine 0 N--CA 1.51 3.618 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -78.28 153.75 31.53 Favored 'General case' 0 N--CA 1.523 3.183 0 CA-C-O 121.694 0.759 . . . . 0.0 109.084 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 99.5 p -80.11 149.83 70.42 Favored Pre-proline 0 N--CA 1.53 3.546 0 C-N-CA 126.72 2.008 . . . . 0.0 112.283 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -56.18 131.08 43.69 Favored 'Trans proline' 0 C--N 1.403 3.418 0 CA-C-N 120.761 1.308 . . . . 0.0 110.341 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.94 90.89 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.398 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.615 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.52 3.065 0 CA-C-O 118.083 -0.961 . . . . 0.0 111.541 -179.882 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.538 ' HE1' HH22 ' C' ' 683' ' ' ARG . 58.3 t-105 57.58 -87.21 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 124.077 0.951 . . . . 0.0 110.867 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 5.4 tt -52.43 -35.52 52.26 Favored 'General case' 0 N--CA 1.509 2.509 0 C-N-CA 125.046 1.338 . . . . 0.0 111.859 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -61.88 -50.37 72.51 Favored 'General case' 0 N--CA 1.53 3.569 0 CA-C-O 121.407 0.623 . . . . 0.0 112.345 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -63.16 -35.5 80.5 Favored 'General case' 0 N--CA 1.522 3.137 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.401 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 95.6 mt -74.85 -28.08 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 C-N-CA 125.246 1.418 . . . . 0.0 110.995 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -50.97 58.28 Favored 'General case' 1 N--CA 1.559 4.984 0 CA-C-N 119.873 1.215 . . . . 0.0 110.282 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 14.3 tt -64.52 -32.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 124.199 0.999 . . . . 0.0 109.088 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -53.85 -33.04 55.13 Favored 'General case' 0 N--CA 1.518 2.936 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.906 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.24 -42.51 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.861 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.706 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.02 -34.9 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.31 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 60.8 mt -64.62 -44.64 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.95 -30.76 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 C-N-CA 123.7 0.8 . . . . 0.0 109.047 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.21 -31.88 82.25 Favored Glycine 1 N--CA 1.52 4.26 0 C-N-CA 123.427 0.537 . . . . 0.0 112.005 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.1 m -69.04 -37.26 78.47 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.476 0.71 . . . . 0.0 111.279 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.05 -44.59 91.83 Favored 'General case' 1 N--CA 1.539 4.024 0 C-N-CA 123.298 0.639 . . . . 0.0 112.574 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.268 0.1 OUTLIER -62.46 -48.76 86.77 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.742 0 CA-C-N 118.314 0.506 . . . . 0.0 111.714 -175.929 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.6 -23.78 61.13 Favored Glycine 1 N--CA 1.527 4.754 0 O-C-N 121.778 -0.576 . . . . 0.0 113.068 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.24 -42.12 72.63 Favored 'General case' 0 N--CA 1.539 3.995 0 C-N-CA 124.617 1.167 . . . . 0.0 110.705 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -52.55 -25.62 10.96 Favored 'General case' 0 N--CA 1.537 3.918 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 8.7 tp -54.5 -37.8 39.44 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.401 0 CA-C-N 119.897 1.226 . . . . 0.0 112.677 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.76 -30.47 22.66 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 C-N-CA 123.441 0.696 . . . . 0.0 111.733 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -54.46 -26.45 31.19 Favored 'General case' 0 N--CA 1.534 3.726 0 C-N-CA 122.934 0.493 . . . . 0.0 109.706 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.9 68.4 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 122.664 0.386 . . . . 0.0 110.096 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.0 -31.09 49.01 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.002 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 6.2 tp -53.31 -33.96 55.5 Favored 'General case' 0 N--CA 1.534 3.751 0 C-N-CA 123.158 0.583 . . . . 0.0 110.113 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 83.8 p -58.05 -46.03 86.05 Favored 'General case' 0 N--CA 1.531 3.579 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 39.5 tp -66.96 -35.19 79.42 Favored 'General case' 1 N--CA 1.54 4.034 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 58.8 t -69.06 -42.23 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.637 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -67.24 -23.45 65.71 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.466 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -50.76 -48.29 59.32 Favored 'General case' 0 N--CA 1.512 2.633 0 CA-C-O 121.671 0.748 . . . . 0.0 109.427 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.88 -41.04 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.583 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -76.08 -20.67 57.5 Favored 'General case' 0 N--CA 1.536 3.854 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.806 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . 0.452 HE21 ' NE2' ' B' ' 710' ' ' GLN . 33.1 tt0 -99.1 -11.91 21.0 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 125.355 1.462 . . . . 0.0 109.434 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.94 -31.12 24.18 Favored Glycine 1 N--CA 1.519 4.213 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 177.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -107.92 142.67 37.67 Favored 'General case' 0 N--CA 1.534 3.768 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 68.8 m -82.42 146.83 54.89 Favored Pre-proline 0 N--CA 1.528 3.468 0 C-N-CA 125.296 1.438 . . . . 0.0 111.201 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.1 131.1 33.12 Favored 'Trans proline' 0 C--N 1.402 3.382 0 CA-C-N 121.326 1.509 . . . . 0.0 109.342 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.82 153.88 13.07 Favored 'General case' 0 N--CA 1.524 3.225 0 C-N-CA 125.249 1.42 . . . . 0.0 110.293 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.521 3.091 0 C-N-CA 123.977 0.911 . . . . 0.0 111.258 -179.8 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -166.17 -74.18 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 123.616 0.767 . . . . 0.0 109.042 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.36 -46.71 89.1 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 123.77 0.828 . . . . 0.0 110.706 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -71.46 -29.55 64.98 Favored 'General case' 0 N--CA 1.528 3.443 0 O-C-N 121.831 -0.543 . . . . 0.0 111.033 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -70.52 -36.53 73.8 Favored 'General case' 0 N--CA 1.517 2.923 0 CA-C-O 118.639 -0.695 . . . . 0.0 111.255 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 2.2 pp -71.6 -23.79 22.87 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.293 0 CA-C-N 119.544 1.065 . . . . 0.0 110.121 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.03 -53.08 61.56 Favored 'General case' 0 N--CA 1.532 3.655 0 CA-C-O 121.511 0.672 . . . . 0.0 112.309 -176.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 18.7 tt -74.76 -31.78 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.078 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -52.25 -45.79 65.5 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.376 1.07 . . . . 0.0 111.869 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.52 -36.79 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.422 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 12.0 mm -60.36 -41.58 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.44 -44.18 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.55 -31.59 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.836 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.61 -44.6 97.31 Favored Glycine 1 N--CA 1.521 4.342 0 C-N-CA 124.071 0.843 . . . . 0.0 112.316 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.4 m -68.18 -37.48 81.0 Favored 'General case' 0 N--CA 1.527 3.382 0 CA-C-O 122.121 0.962 . . . . 0.0 110.022 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 2.2 tp -58.59 -45.31 89.36 Favored 'General case' 0 N--CA 1.518 2.962 0 CA-C-N 113.339 -1.755 . . . . 0.0 113.379 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -38.75 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.857 0 C-N-CA 122.714 0.406 . . . . 0.0 111.751 -177.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.53 -28.1 67.04 Favored Glycine 1 N--CA 1.53 4.944 0 O-C-N 121.014 -1.054 . . . . 0.0 112.16 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 4.9 tt -66.46 -40.31 89.33 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 125.02 1.328 . . . . 0.0 110.213 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -51.02 -24.68 3.95 Favored 'General case' 0 N--CA 1.528 3.473 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.8 tt -53.5 -35.96 26.6 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 CA-C-N 119.329 0.968 . . . . 0.0 111.947 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 13.4 p -53.39 -30.01 17.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 C-N-CA 124.278 1.031 . . . . 0.0 111.617 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -57.34 -28.14 62.87 Favored 'General case' 0 N--CA 1.536 3.855 0 O-C-N 121.53 -0.731 . . . . 0.0 110.697 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.13 -41.76 73.5 Favored 'General case' 0 N--CA 1.529 3.508 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.59 -32.02 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.716 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 15.6 tp -54.12 -31.02 51.05 Favored 'General case' 1 N--CA 1.542 4.128 0 C-N-CA 123.516 0.726 . . . . 0.0 109.114 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 62.7 m -56.63 -45.3 81.62 Favored 'General case' 0 N--CA 1.535 3.814 0 O-C-N 121.194 -0.941 . . . . 0.0 111.762 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.14 -34.78 78.85 Favored 'General case' 1 N--CA 1.547 4.4 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.86 -39.21 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -61.28 -22.44 64.86 Favored 'General case' 0 N--CA 1.523 3.189 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -52.34 -44.75 65.33 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-O 121.96 0.886 . . . . 0.0 109.462 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 98.7 t -58.16 -37.1 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.715 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -77.64 -5.68 51.2 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.434 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . 0.452 ' NE2' HE21 ' A' ' 710' ' ' GLN . 10.5 tp-100 -89.22 -17.33 29.28 Favored 'General case' 1 N--CA 1.561 5.086 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -81.64 -24.95 55.04 Favored Glycine 1 N--CA 1.521 4.312 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -80.23 152.81 28.91 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 125.898 1.679 . . . . 0.0 108.298 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 97.8 p -102.12 146.79 32.92 Favored Pre-proline 1 N--CA 1.551 4.6 0 C-N-CA 125.222 1.409 . . . . 0.0 114.155 -176.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.23 131.95 18.66 Favored 'Trans proline' 0 C--N 1.406 3.553 0 CA-C-N 120.405 1.18 . . . . 0.0 109.939 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 80.1 mt -95.65 -178.67 4.47 Favored 'General case' 0 N--CA 1.531 3.607 0 C-N-CA 125.252 1.421 . . . . 0.0 108.652 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.523 3.198 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.106 179.654 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 11.3 t30 . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 32.1 p90 -61.15 -41.31 96.52 Favored 'General case' 0 N--CA 1.526 3.358 0 C-N-CA 123.996 0.918 . . . . 0.0 111.372 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.38 -45.63 90.22 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 124.484 1.114 . . . . 0.0 109.912 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -71.27 -28.6 64.26 Favored 'General case' 0 N--CA 1.524 3.233 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.537 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -72.5 -36.53 68.42 Favored 'General case' 0 N--CA 1.526 3.371 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.957 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 23.8 pt -72.91 -29.11 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 CA-C-N 118.054 0.388 . . . . 0.0 110.082 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . 0.538 HH22 ' HE1' ' A' ' 678' ' ' TRP . 72.9 ttt180 -52.59 -54.64 30.27 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-O 121.617 0.722 . . . . 0.0 111.648 -177.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.6 tt -69.43 -30.98 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.818 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.05 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.6 -43.33 99.07 Favored 'General case' 0 N--CA 1.528 3.446 0 CA-C-O 122.88 1.324 . . . . 0.0 109.28 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.33 -44.4 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.744 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.46 -45.62 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 CA-C-O 118.826 -0.607 . . . . 0.0 110.295 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 19.4 tt -62.55 -39.15 83.45 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.625 0 CA-C-N 119.808 1.186 . . . . 0.0 108.64 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 19.7 t -65.88 -29.91 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.763 0 C-N-CA 123.934 0.894 . . . . 0.0 108.753 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -68.75 -24.94 75.42 Favored Glycine 1 N--CA 1.526 4.694 0 CA-C-N 119.017 0.826 . . . . 0.0 113.474 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 70.5 m -67.61 -50.44 58.14 Favored 'General case' 0 N--CA 1.532 3.673 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.66 -32.62 43.19 Favored 'General case' 0 N--CA 1.519 2.986 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.99 -37.7 73.53 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 CA-C-N 119.436 1.016 . . . . 0.0 113.172 -176.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -67.99 -38.86 89.1 Favored Glycine 1 N--CA 1.523 4.479 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -37.08 86.09 Favored 'General case' 0 N--CA 1.534 3.745 0 C-N-CA 124.995 1.318 . . . . 0.0 111.946 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -50.9 -27.12 6.84 Favored 'General case' 1 N--CA 1.549 4.489 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 29.2 pt -54.07 -38.42 37.97 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.335 0 CA-C-N 120.155 1.343 . . . . 0.0 114.278 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.4 p -55.75 -35.5 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -55.89 -26.97 49.76 Favored 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.311 0.644 . . . . 0.0 110.457 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.95 69.51 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 121.939 -0.475 . . . . 0.0 110.467 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.62 -30.84 48.64 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.155 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 9.1 tp -53.4 -34.64 58.53 Favored 'General case' 0 N--CA 1.531 3.604 0 CA-C-O 118.841 -0.6 . . . . 0.0 110.786 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 62.9 m -58.7 -46.95 86.16 Favored 'General case' 0 N--CA 1.533 3.709 0 CA-C-N 119.284 0.947 . . . . 0.0 112.971 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.85 -35.3 80.28 Favored 'General case' 1 N--CA 1.549 4.523 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.879 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.94 -38.38 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' C' ' 710' ' ' GLN . 63.2 t30 -58.22 -30.1 66.22 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.642 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -47.36 -42.1 20.96 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.04 0.838 . . . . 0.0 112.168 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.65 -44.79 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -77.4 -6.61 54.01 Favored 'General case' 1 N--CA 1.539 4.004 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.75 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.4 tt0 -114.65 -11.28 12.37 Favored 'General case' 0 N--CA 1.517 2.905 0 C-N-CA 125.474 1.509 . . . . 0.0 108.745 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -53.09 -24.49 21.15 Favored Glycine 1 N--CA 1.519 4.17 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -88.15 155.95 19.51 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.942 0.897 . . . . 0.0 108.718 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 95.5 p -77.58 149.38 78.04 Favored Pre-proline 0 N--CA 1.535 3.793 0 C-N-CA 125.973 1.709 . . . . 0.0 112.551 -173.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -55.72 129.83 37.16 Favored 'Trans proline' 0 C--N 1.409 3.747 0 CA-C-N 120.374 1.169 . . . . 0.0 110.906 -173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 51.92 -101.39 0.11 Allowed 'General case' 0 N--CA 1.523 3.221 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.519 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.523 3.183 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.827 179.672 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -66.41 150.47 48.86 Favored 'General case' 0 N--CA 1.522 3.167 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.426 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 6.8 mp -52.61 -43.1 65.14 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 125.267 1.427 . . . . 0.0 111.948 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -55.13 -37.24 66.67 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -73.24 -38.26 66.07 Favored 'General case' 0 N--CA 1.532 3.645 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.46 -25.74 19.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.069 0 C-N-CA 125.624 1.57 . . . . 0.0 111.574 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -67.26 -53.7 27.58 Favored 'General case' 1 N--CA 1.544 4.248 0 C-N-CA 124.539 1.136 . . . . 0.0 112.006 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 15.2 tt -68.23 -32.89 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.195 0 CA-C-N 114.051 -1.431 . . . . 0.0 109.151 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -52.47 -34.83 50.86 Favored 'General case' 0 N--CA 1.516 2.849 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.982 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 13.0 mm -63.44 -37.62 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 CA-C-O 121.762 0.792 . . . . 0.0 109.201 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -37.24 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.183 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 62.0 mt -65.48 -43.82 94.35 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.5 t -61.99 -28.94 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.15 -31.62 78.1 Favored Glycine 0 N--CA 1.513 3.787 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.693 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 49.9 m -69.34 -37.19 77.56 Favored 'General case' 0 N--CA 1.53 3.542 0 C-N-CA 123.201 0.6 . . . . 0.0 111.077 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.6 mp -58.08 -45.05 87.8 Favored 'General case' 0 N--CA 1.538 3.944 0 C-N-CA 123.487 0.715 . . . . 0.0 112.071 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.271 0.8 OUTLIER -60.28 -48.52 87.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.135 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.771 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.5 -26.3 69.53 Favored Glycine 1 N--CA 1.531 4.997 0 CA-C-N 120.164 1.347 . . . . 0.0 112.296 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.0 tt -64.77 -42.83 94.82 Favored 'General case' 0 N--CA 1.537 3.905 0 C-N-CA 124.059 0.944 . . . . 0.0 109.985 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -54.34 -26.11 27.89 Favored 'General case' 0 N--CA 1.538 3.958 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 70.2 mt -55.11 -39.06 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 C-N-CA 123.562 0.745 . . . . 0.0 112.257 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.57 -29.1 33.27 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.522 0 C-N-CA 123.49 0.716 . . . . 0.0 112.584 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -52.06 -26.03 10.01 Favored 'General case' 0 N--CA 1.535 3.779 0 C-N-CA 123.264 0.626 . . . . 0.0 110.949 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.55 -32.42 62.97 Favored 'General case' 0 N--CA 1.532 3.642 0 O-C-N 121.936 -0.477 . . . . 0.0 109.803 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.9 m -68.65 -30.82 48.52 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.123 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.83 -34.71 55.28 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 123.42 0.688 . . . . 0.0 110.391 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 89.0 p -58.89 -46.24 88.33 Favored 'General case' 0 N--CA 1.529 3.476 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 30.2 tp -67.02 -34.79 78.49 Favored 'General case' 1 N--CA 1.543 4.21 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.16 -39.29 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -69.71 -29.08 66.4 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.246 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -50.78 -40.41 55.06 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.537 0.684 . . . . 0.0 110.376 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.22 -38.43 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.899 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.737 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -74.99 -25.72 59.04 Favored 'General case' 0 N--CA 1.538 3.937 0 CA-C-O 121.057 0.456 . . . . 0.0 109.788 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -89.36 -7.77 54.57 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.51 -20.71 7.79 Favored Glycine 1 N--CA 1.524 4.506 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -120.69 152.05 38.74 Favored 'General case' 0 N--CA 1.526 3.329 0 C-N-CA 125.265 1.426 . . . . 0.0 109.293 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 94.5 p -82.34 150.45 63.91 Favored Pre-proline 0 N--CA 1.531 3.595 0 C-N-CA 125.884 1.674 . . . . 0.0 110.244 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -53.92 130.01 37.12 Favored 'Trans proline' 0 C--N 1.401 3.332 0 CA-C-N 122.259 1.842 . . . . 0.0 112.503 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 62.0 mt -97.87 42.44 1.09 Allowed 'General case' 0 N--CA 1.522 3.174 0 CA-C-N 113.589 -1.641 . . . . 0.0 108.717 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 N--CA 1.523 3.221 0 C-N-CA 124.23 1.012 . . . . 0.0 111.948 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -102.13 178.03 4.72 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 124.643 1.177 . . . . 0.0 109.84 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.2 tt -54.38 -45.68 72.88 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 125.512 1.525 . . . . 0.0 111.828 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -71.11 -31.06 67.31 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -69.69 -38.53 77.03 Favored 'General case' 0 N--CA 1.526 3.362 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.544 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 20.3 pt -71.56 -31.94 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.301 0 CA-C-N 117.986 0.357 . . . . 0.0 110.282 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -52.82 -54.39 34.9 Favored 'General case' 1 N--CA 1.539 4.018 0 CA-C-O 121.776 0.798 . . . . 0.0 111.007 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -31.46 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.307 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -59.55 -43.41 93.54 Favored 'General case' 1 N--CA 1.539 4.012 0 CA-C-O 121.691 0.758 . . . . 0.0 109.658 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.66 -36.33 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 C-N-CA 124.215 1.006 . . . . 0.0 108.617 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 27.8 mm -65.17 -42.72 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 47.9 mm -60.28 -41.17 86.08 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.281 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.49 -31.22 48.26 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.108 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.98 -33.19 86.57 Favored Glycine 1 N--CA 1.518 4.163 0 C-N-CA 123.924 0.773 . . . . 0.0 112.693 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.2 m -68.15 -37.26 80.86 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.52 0.728 . . . . 0.0 111.577 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.69 -43.07 80.14 Favored 'General case' 0 N--CA 1.536 3.843 0 C-N-CA 123.39 0.676 . . . . 0.0 112.559 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . 0.276 0.8 OUTLIER -60.25 -48.73 86.99 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.502 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.242 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.45 -23.29 70.17 Favored Glycine 1 N--CA 1.531 5.023 0 CA-C-N 120.423 1.465 . . . . 0.0 112.518 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.29 -43.17 92.02 Favored 'General case' 1 N--CA 1.541 4.093 0 C-N-CA 123.359 0.664 . . . . 0.0 109.655 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -52.99 -24.02 8.56 Favored 'General case' 0 N--CA 1.536 3.86 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 78.1 mt -51.72 -35.71 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 C-N-CA 123.327 0.651 . . . . 0.0 110.425 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.23 -26.08 17.88 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.235 0 C-N-CA 124.444 1.097 . . . . 0.0 111.397 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -53.66 -28.76 35.07 Favored 'General case' 1 N--CA 1.547 4.404 0 O-C-N 121.313 -0.867 . . . . 0.0 110.387 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.66 -44.11 67.78 Favored 'General case' 0 N--CA 1.525 3.282 0 CA-C-O 122.028 0.918 . . . . 0.0 108.627 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 79.0 t -68.84 -33.6 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.04 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -35.5 66.03 Favored 'General case' 0 N--CA 1.532 3.642 0 C-N-CA 123.65 0.78 . . . . 0.0 110.405 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 48.8 m -59.77 -48.01 83.4 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.54 -34.85 77.91 Favored 'General case' 1 N--CA 1.54 4.052 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.219 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.23 -44.93 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' B' ' 709' ' ' ARG . 0.1 OUTLIER -74.41 -20.52 60.02 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.568 -178.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -47.39 -35.01 7.7 Favored 'General case' 0 N--CA 1.519 3.001 0 CA-C-N 118.566 0.621 . . . . 0.0 109.921 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.37 -39.13 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.815 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' B' ' 706' ' ' ASN . 71.9 mtm180 -76.49 -30.83 57.41 Favored 'General case' 0 N--CA 1.524 3.252 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.76 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -89.23 2.33 54.41 Favored 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.6 -28.1 50.6 Favored Glycine 1 N--CA 1.517 4.086 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -108.62 127.79 54.27 Favored 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 97.9 p -82.24 147.67 57.66 Favored Pre-proline 0 N--CA 1.528 3.462 0 C-N-CA 125.278 1.431 . . . . 0.0 110.758 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -58.73 131.13 40.41 Favored 'Trans proline' 0 C--N 1.401 3.334 0 CA-C-N 121.473 1.562 . . . . 0.0 110.363 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 49.7 tp 60.81 143.74 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.301 0 C-N-CA 126.097 1.759 . . . . 0.0 111.042 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.52 3.068 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.548 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -66.46 177.69 1.45 Allowed 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.029 0.931 . . . . 0.0 111.636 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' C' ' 683' ' ' ARG . 7.8 mp -53.53 -43.37 68.31 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 125.619 1.568 . . . . 0.0 112.149 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -56.4 -38.73 71.93 Favored 'General case' 0 N--CA 1.53 3.535 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -173.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -72.93 -37.83 67.03 Favored 'General case' 0 N--CA 1.534 3.757 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 86.7 mt -73.37 -25.68 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.355 0 C-N-CA 125.365 1.466 . . . . 0.0 111.246 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' C' ' 679' ' ' LEU . 0.9 OUTLIER -67.03 -51.3 56.48 Favored 'General case' 0 N--CA 1.536 3.872 0 C-N-CA 124.449 1.099 . . . . 0.0 110.71 -177.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.3 tt -71.2 -30.31 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.928 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -52.52 -27.48 16.62 Favored 'General case' 0 N--CA 1.526 3.343 0 CA-C-O 121.512 0.673 . . . . 0.0 109.959 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 22.8 mm -68.94 -48.2 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 C-N-CA 124.635 1.174 . . . . 0.0 108.937 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 10.9 mm -57.74 -41.99 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.389 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.365 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.34 -49.19 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.702 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.97 -30.87 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.886 0 C-N-CA 123.666 0.786 . . . . 0.0 109.921 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.8 -32.54 84.56 Favored Glycine 1 N--CA 1.52 4.242 0 C-N-CA 123.367 0.508 . . . . 0.0 112.777 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 68.7 m -67.65 -35.99 79.93 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 124.056 0.942 . . . . 0.0 112.135 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.11 -41.74 68.65 Favored 'General case' 0 N--CA 1.539 3.976 0 C-N-CA 123.433 0.693 . . . . 0.0 112.606 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -41.4 86.88 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.255 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -68.46 -31.59 74.16 Favored Glycine 1 N--CA 1.524 4.553 0 O-C-N 121.093 -1.004 . . . . 0.0 111.456 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.04 -42.07 99.67 Favored 'General case' 0 N--CA 1.534 3.769 0 C-N-CA 124.594 1.158 . . . . 0.0 112.156 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -53.3 -27.36 22.57 Favored 'General case' 1 N--CA 1.542 4.146 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -176.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 10.5 tp -55.71 -39.34 54.92 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.371 0 CA-C-N 119.664 1.12 . . . . 0.0 113.848 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.82 -31.7 41.04 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.338 0 C-N-CA 123.276 0.63 . . . . 0.0 112.235 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -54.41 -25.42 24.65 Favored 'General case' 0 N--CA 1.531 3.575 0 C-N-CA 123.121 0.568 . . . . 0.0 109.95 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.46 -34.98 65.0 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 122.086 -0.384 . . . . 0.0 110.159 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.3 m -68.83 -30.73 47.99 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.045 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 11.0 tp -52.89 -36.14 58.96 Favored 'General case' 0 N--CA 1.533 3.712 0 C-N-CA 123.154 0.581 . . . . 0.0 110.474 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 703' ' ' SER . . . . . 0.448 ' HG ' ' N ' ' C' ' 704' ' ' LEU . 89.0 p -58.87 -47.0 86.47 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . 0.448 ' N ' ' HG ' ' C' ' 703' ' ' SER . 39.8 tp -67.4 -34.88 78.17 Favored 'General case' 1 N--CA 1.543 4.191 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.86 -38.95 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.546 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' C' ' 710' ' ' GLN . 64.3 t30 -66.26 -25.69 67.0 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.856 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -48.22 -33.23 8.25 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 123.643 0.777 . . . . 0.0 111.133 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.66 -47.66 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -77.93 -9.92 59.33 Favored 'General case' 1 N--CA 1.542 4.172 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.623 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' C' ' 706' ' ' ASN . 50.9 tt0 -112.56 -7.64 13.87 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 125.884 1.674 . . . . 0.0 107.869 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.5 -25.04 33.41 Favored Glycine 0 N--CA 1.511 3.665 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -99.87 152.35 20.25 Favored 'General case' 0 N--CA 1.525 3.276 0 C-N-CA 123.911 0.885 . . . . 0.0 108.782 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 53.9 m -81.71 149.26 63.67 Favored Pre-proline 0 N--CA 1.529 3.502 0 CA-C-O 116.626 -1.654 . . . . 0.0 110.601 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -54.33 130.19 38.56 Favored 'Trans proline' 0 C--N 1.401 3.308 0 CA-C-N 122.233 1.833 . . . . 0.0 112.651 -175.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.56 153.51 40.21 Favored 'General case' 0 N--CA 1.522 3.141 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.138 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 95.9 p . . . . . 0 N--CA 1.523 3.177 0 C-N-CA 123.634 0.774 . . . . 0.0 109.803 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -61.27 -32.4 72.22 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 124.004 0.922 . . . . 0.0 110.971 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -50.91 -43.37 59.92 Favored 'General case' 0 N--CA 1.517 2.879 0 C-N-CA 124.519 1.128 . . . . 0.0 111.185 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -61.87 -50.05 73.78 Favored 'General case' 0 N--CA 1.529 3.48 0 CA-C-O 121.474 0.655 . . . . 0.0 111.208 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -64.15 -37.47 87.57 Favored 'General case' 0 N--CA 1.518 2.944 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.072 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -25.53 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.359 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -51.38 52.39 Favored 'General case' 1 N--CA 1.562 5.162 0 CA-C-N 119.973 1.26 . . . . 0.0 110.28 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.9 tt -67.73 -30.45 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.222 0 C-N-CA 123.696 0.798 . . . . 0.0 110.292 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -52.33 -30.01 26.41 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.124 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 21.9 mm -69.18 -46.94 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.453 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 7.9 mm -55.09 -39.54 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 C-N-CA 123.522 0.729 . . . . 0.0 109.503 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 59.6 mt -59.82 -47.13 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.978 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.58 -30.61 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 123.563 0.745 . . . . 0.0 109.736 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.98 -30.88 76.62 Favored Glycine 1 N--CA 1.518 4.116 0 C-N-CA 123.49 0.566 . . . . 0.0 112.654 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 63.3 m -67.56 -36.26 80.6 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 123.664 0.786 . . . . 0.0 111.842 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.3 mp -54.44 -42.15 70.24 Favored 'General case' 0 N--CA 1.539 3.99 0 C-N-CA 123.878 0.871 . . . . 0.0 112.993 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.29 -49.8 79.41 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.08 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.59 -22.43 65.93 Favored Glycine 1 N--CA 1.528 4.827 0 CA-C-N 119.811 1.187 . . . . 0.0 112.553 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.28 -43.7 93.97 Favored 'General case' 0 N--CA 1.535 3.812 0 C-N-CA 123.835 0.854 . . . . 0.0 109.645 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -54.67 -28.66 48.98 Favored 'General case' 0 N--CA 1.537 3.898 0 C-N-CA 124.262 1.025 . . . . 0.0 113.563 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 64.1 mt -55.45 -37.69 46.02 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 C-N-CA 123.609 0.764 . . . . 0.0 109.89 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -55.18 -26.78 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 C-N-CA 124.888 1.275 . . . . 0.0 110.969 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -51.73 -27.91 13.4 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.532 0.733 . . . . 0.0 112.087 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.15 96.2 Favored 'General case' 0 N--CA 1.524 3.245 0 O-C-N 121.595 -0.691 . . . . 0.0 109.58 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.99 -33.62 56.16 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.236 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 9.9 tp -55.0 -36.09 65.08 Favored 'General case' 0 N--CA 1.535 3.804 0 C-N-CA 123.2 0.6 . . . . 0.0 110.037 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.4 p -59.16 -47.5 85.07 Favored 'General case' 0 N--CA 1.525 3.3 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 41.3 tp -64.49 -35.78 82.07 Favored 'General case' 1 N--CA 1.546 4.354 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 90.1 t -69.61 -40.27 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.625 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 710' ' ' GLN . 55.1 t30 -64.89 -25.78 68.04 Favored 'General case' 0 N--CA 1.516 2.852 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.777 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -48.57 -44.4 36.63 Favored 'General case' 0 N--CA 1.518 2.961 0 C-N-CA 124.552 1.141 . . . . 0.0 110.402 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.87 -44.16 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -77.81 -12.7 60.0 Favored 'General case' 0 N--CA 1.538 3.926 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.621 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 706' ' ' ASN . 12.1 tt0 -112.93 -12.54 13.25 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 125.615 1.566 . . . . 0.0 109.181 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.91 -29.81 20.78 Favored Glycine 0 N--CA 1.515 3.903 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -93.11 149.68 21.05 Favored 'General case' 0 N--CA 1.522 3.135 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 70.3 m -81.93 148.12 59.98 Favored Pre-proline 0 N--CA 1.532 3.638 0 C-N-CA 125.686 1.594 . . . . 0.0 110.133 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -56.72 131.22 44.3 Favored 'Trans proline' 0 C--N 1.401 3.297 0 CA-C-N 121.794 1.676 . . . . 0.0 110.6 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 52.6 tp 63.1 149.25 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 126.05 1.74 . . . . 0.0 110.33 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.523 3.202 0 C-N-CA 123.771 0.829 . . . . 0.0 110.078 -179.756 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 20.0 m120 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -166.41 135.82 3.1 Favored 'General case' 0 N--CA 1.531 3.589 0 C-N-CA 123.357 0.663 . . . . 0.0 109.545 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -50.49 -43.72 55.72 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 125.96 1.704 . . . . 0.0 111.456 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -68.17 -43.16 78.82 Favored 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 122.449 0.3 . . . . 0.0 110.848 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -69.15 -35.33 76.22 Favored 'General case' 0 N--CA 1.53 3.545 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.56 -24.81 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 C-N-CA 124.504 1.122 . . . . 0.0 110.605 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -64.13 -53.82 43.54 Favored 'General case' 1 N--CA 1.546 4.341 0 CA-C-N 119.362 0.983 . . . . 0.0 111.496 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.2 tt -68.07 -30.33 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.146 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -51.27 -32.82 25.96 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 123.515 0.726 . . . . 0.0 112.153 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -69.23 -45.62 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.267 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 34.2 mt -56.1 -41.15 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 C-N-CA 123.271 0.628 . . . . 0.0 109.938 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 42.2 mm -62.32 -48.91 86.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.109 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.96 -29.8 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 C-N-CA 124.339 1.055 . . . . 0.0 109.967 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.73 -37.03 94.09 Favored Glycine 1 N--CA 1.524 4.553 0 C-N-CA 123.278 0.466 . . . . 0.0 112.45 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.5 m -67.36 -36.14 80.77 Favored 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 124.445 1.098 . . . . 0.0 111.873 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.1 mp -53.29 -33.91 55.15 Favored 'General case' 0 N--CA 1.533 3.711 0 CA-C-O 118.541 -0.742 . . . . 0.0 112.26 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.14 -41.33 81.36 Favored 'Isoleucine or valine' 1 N--CA 1.557 4.888 0 CA-C-N 120.246 1.384 . . . . 0.0 111.236 -177.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -55.82 -46.41 83.32 Favored Glycine 1 N--CA 1.526 4.695 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER -73.28 -32.31 64.58 Favored 'General case' 1 N--CA 1.554 4.771 0 CA-C-N 117.625 0.713 . . . . 0.0 110.82 179.298 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -50.18 -26.61 4.77 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 125.625 1.57 . . . . 0.0 113.699 -176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.44 -36.04 33.17 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.14 0 C-N-CA 124.212 1.005 . . . . 0.0 111.051 -178.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.1 p -51.91 -26.49 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 124.735 1.214 . . . . 0.0 112.037 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -51.97 -25.89 9.32 Favored 'General case' 1 N--CA 1.54 4.046 0 C-N-CA 123.321 0.648 . . . . 0.0 110.18 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.89 -42.05 79.17 Favored 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 122.992 0.517 . . . . 0.0 111.313 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.67 -32.72 56.19 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 118.405 0.548 . . . . 0.0 110.383 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -32.2 52.53 Favored 'General case' 1 N--CA 1.545 4.309 0 C-N-CA 124.159 0.984 . . . . 0.0 109.529 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 51.6 m -57.26 -44.51 84.0 Favored 'General case' 1 N--CA 1.543 4.185 0 O-C-N 120.53 -1.356 . . . . 0.0 111.936 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 45.2 tp -65.25 -34.43 78.33 Favored 'General case' 1 N--CA 1.549 4.48 0 O-C-N 121.362 -0.836 . . . . 0.0 108.88 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 26.3 t -66.76 -39.93 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -61.12 -32.9 72.59 Favored 'General case' 0 N--CA 1.522 3.157 0 CA-C-O 118.497 -0.763 . . . . 0.0 110.412 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -49.8 -47.9 51.03 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 121.277 0.561 . . . . 0.0 110.003 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.87 -40.65 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.726 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.463 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.74 -29.82 59.01 Favored 'General case' 0 N--CA 1.523 3.219 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.719 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.69 -6.5 56.04 Favored 'General case' 0 N--CA 1.519 3.01 0 C-N-CA 124.515 1.126 . . . . 0.0 109.265 -178.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -59.7 -31.98 72.82 Favored Glycine 0 N--CA 1.513 3.788 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -89.61 154.31 20.07 Favored 'General case' 0 N--CA 1.529 3.502 0 C-N-CA 124.049 0.939 . . . . 0.0 109.346 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 3.3 t -80.82 150.05 68.51 Favored Pre-proline 0 N--CA 1.534 3.758 0 C-N-CA 126.735 2.014 . . . . 0.0 111.1 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -55.6 130.18 39.1 Favored 'Trans proline' 0 N--CA 1.528 3.532 0 CA-C-N 120.744 1.301 . . . . 0.0 110.468 -174.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 59.63 123.8 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.326 0 C-N-CA 126.077 1.751 . . . . 0.0 110.004 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.522 3.136 0 C-N-CA 123.847 0.859 . . . . 0.0 109.89 179.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 27.7 m120 . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -66.33 164.24 16.46 Favored 'General case' 0 N--CA 1.526 3.373 0 C-N-CA 124.135 0.974 . . . . 0.0 109.845 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.7 -29.31 17.84 Favored 'General case' 0 N--CA 1.529 3.503 0 C-N-CA 124.089 0.955 . . . . 0.0 112.671 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -70.82 -29.7 65.93 Favored 'General case' 0 N--CA 1.528 3.447 0 CA-C-O 120.592 0.234 . . . . 0.0 110.56 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -71.72 -37.92 70.55 Favored 'General case' 0 N--CA 1.518 2.926 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.218 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 1.9 pp -72.31 -23.23 21.23 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.225 0 CA-C-N 119.365 0.984 . . . . 0.0 110.505 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -51.58 55.89 Favored 'General case' 0 N--CA 1.535 3.797 0 C-N-CA 124.026 0.931 . . . . 0.0 112.289 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -72.29 -31.77 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.867 0 C-N-CA 123.605 0.762 . . . . 0.0 110.249 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -48.75 -23.71 1.15 Allowed 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 125.546 1.538 . . . . 0.0 112.764 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.11 -37.02 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.731 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.77 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 37.7 pt -61.86 -41.54 91.16 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.679 0 CA-C-N 120.783 1.629 . . . . 0.0 110.006 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 50.2 mt -63.63 -50.14 79.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.35 -38.64 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 C-N-CA 124.202 1.001 . . . . 0.0 110.59 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.79 -49.25 50.38 Favored Glycine 1 N--CA 1.525 4.567 0 C-N-CA 125.339 1.447 . . . . 0.0 111.712 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 73.1 m -58.79 -34.97 72.07 Favored 'General case' 0 N--CA 1.52 3.072 0 CA-C-O 121.841 0.829 . . . . 0.0 108.998 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.64 -44.55 85.69 Favored 'General case' 0 N--CA 1.524 3.251 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.452 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . 0.266 0.1 OUTLIER -65.22 -47.97 85.33 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.741 0 CA-C-N 119.113 0.87 . . . . 0.0 111.595 -177.221 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.22 -21.3 46.63 Favored Glycine 1 N--CA 1.531 4.999 0 CA-C-N 118.993 0.815 . . . . 0.0 112.656 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.79 -43.08 63.23 Favored 'General case' 0 N--CA 1.537 3.891 0 C-N-CA 124.028 0.931 . . . . 0.0 109.037 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -53.5 -25.51 16.85 Favored 'General case' 0 N--CA 1.532 3.663 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 40.1 mm -53.06 -37.65 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.939 0 C-N-CA 124.33 1.052 . . . . 0.0 112.724 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.03 -30.59 23.9 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.275 0 C-N-CA 123.61 0.764 . . . . 0.0 111.737 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -63.35 -27.64 69.45 Favored 'General case' 0 N--CA 1.538 3.966 0 O-C-N 121.433 -0.792 . . . . 0.0 110.857 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.1 -39.75 75.35 Favored 'General case' 0 N--CA 1.535 3.815 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.58 -32.01 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.078 0 C-N-CA 125.095 1.358 . . . . 0.0 109.041 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 16.0 tp -55.15 -33.04 62.6 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.401 0.68 . . . . 0.0 109.537 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 67.9 m -56.81 -46.33 81.68 Favored 'General case' 0 N--CA 1.532 3.626 0 CA-C-N 118.831 0.741 . . . . 0.0 112.629 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.4 tp -65.13 -35.3 80.67 Favored 'General case' 1 N--CA 1.549 4.509 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.99 -38.93 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -64.68 -25.52 67.98 Favored 'General case' 0 N--CA 1.52 3.055 0 C-N-CA 123.793 0.837 . . . . 0.0 110.298 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . 0.417 HH11 ' NE2' ' A' ' 710' ' ' GLN . 8.7 tpp180 -48.87 -44.12 39.58 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.74 0.781 . . . . 0.0 111.048 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.01 -39.71 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.343 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -76.54 -21.45 55.67 Favored 'General case' 0 N--CA 1.53 3.562 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.707 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -88.94 -11.15 45.26 Favored 'General case' 0 N--CA 1.513 2.714 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.96 -19.11 21.12 Favored Glycine 1 N--CA 1.517 4.079 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -107.24 153.17 23.09 Favored 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 124.858 1.263 . . . . 0.0 109.11 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 83.5 p -81.6 152.21 69.43 Favored Pre-proline 0 N--CA 1.528 3.459 0 C-N-CA 126.369 1.868 . . . . 0.0 111.545 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -53.04 131.83 44.71 Favored 'Trans proline' 0 C--N 1.401 3.331 0 CA-C-N 121.625 1.616 . . . . 0.0 112.066 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 46.3 tp 62.73 148.94 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 125.848 1.659 . . . . 0.0 110.795 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.52 3.067 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.464 -179.924 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -70.87 172.85 8.18 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.776 0.83 . . . . 0.0 109.975 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.6 pp -52.15 -24.62 7.33 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 125.318 1.447 . . . . 0.0 112.834 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -60.18 -49.72 76.51 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -65.99 -33.51 75.98 Favored 'General case' 0 N--CA 1.535 3.815 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.76 -27.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 C-N-CA 125.212 1.405 . . . . 0.0 109.853 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -63.86 -52.04 61.85 Favored 'General case' 1 N--CA 1.545 4.299 0 O-C-N 121.495 -0.753 . . . . 0.0 111.471 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.9 tt -67.42 -31.97 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 C-N-CA 123.908 0.883 . . . . 0.0 109.287 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -58.94 -41.8 88.23 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.876 0.87 . . . . 0.0 109.036 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.27 -36.04 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 C-N-CA 124.962 1.305 . . . . 0.0 108.681 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 56.5 mt -66.7 -37.41 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.75 -43.35 91.41 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.529 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.71 -29.51 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.925 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.75 -32.09 81.86 Favored Glycine 1 N--CA 1.516 4.016 0 C-N-CA 123.614 0.626 . . . . 0.0 112.309 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 68.2 m -68.31 -36.19 78.93 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 123.659 0.784 . . . . 0.0 111.764 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 8.9 mp -54.03 -39.62 66.32 Favored 'General case' 0 N--CA 1.537 3.886 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.261 0.1 OUTLIER -62.48 -49.72 82.74 Favored 'Isoleucine or valine' 1 N--CA 1.556 4.864 0 CA-C-N 119.429 1.013 . . . . 0.0 112.664 -176.12 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.15 -30.84 71.45 Favored Glycine 1 N--CA 1.527 4.719 0 CA-C-N 119.187 0.903 . . . . 0.0 112.866 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.18 -42.23 99.34 Favored 'General case' 0 N--CA 1.536 3.855 0 C-N-CA 124.568 1.147 . . . . 0.0 111.576 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -52.67 -26.02 12.58 Favored 'General case' 0 N--CA 1.537 3.916 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 16.5 tt -53.46 -38.3 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.9 p -55.25 -30.77 25.37 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 C-N-CA 123.414 0.685 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -61.45 -28.22 69.12 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.097 0.559 . . . . 0.0 110.797 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.43 -41.92 72.25 Favored 'General case' 0 N--CA 1.53 3.553 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 88.5 t -68.59 -32.85 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 125.007 1.323 . . . . 0.0 108.953 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 13.5 tp -55.33 -30.26 59.91 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 124.089 0.956 . . . . 0.0 109.371 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 78.3 p -56.04 -45.63 79.14 Favored 'General case' 0 N--CA 1.533 3.723 0 O-C-N 121.485 -0.76 . . . . 0.0 111.572 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.23 -34.81 78.46 Favored 'General case' 1 N--CA 1.545 4.319 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.38 -39.35 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -63.12 -21.05 65.93 Favored 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.407 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -49.35 -46.8 47.49 Favored 'General case' 0 N--CA 1.513 2.711 0 CA-C-O 121.748 0.785 . . . . 0.0 109.168 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.68 -41.88 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -77.25 -5.51 49.61 Favored 'General case' 0 N--CA 1.522 3.143 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.209 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.64 -17.2 23.52 Favored 'General case' 1 N--CA 1.558 4.937 0 CA-C-N 118.671 0.669 . . . . 0.0 109.947 -179.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -84.09 -28.24 34.72 Favored Glycine 1 N--CA 1.522 4.419 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -75.49 135.23 40.66 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 112.901 -1.65 . . . . 0.0 108.317 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 96.0 p -82.67 146.67 53.59 Favored Pre-proline 0 N--CA 1.534 3.725 0 CA-C-O 117.574 -1.203 . . . . 0.0 110.665 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -62.86 130.68 30.16 Favored 'Trans proline' 0 C--N 1.398 3.184 0 CA-C-N 121.42 1.543 . . . . 0.0 109.616 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -68.1 81.83 0.22 Allowed 'General case' 0 N--CA 1.53 3.525 0 C-N-CA 124.893 1.277 . . . . 0.0 108.947 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.52 3.029 0 C-N-CA 124.072 0.949 . . . . 0.0 111.939 -179.659 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -69.63 120.84 16.01 Favored 'General case' 0 N--CA 1.521 3.076 0 C-N-CA 123.907 0.883 . . . . 0.0 111.009 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -21.3 3.01 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 125.572 1.549 . . . . 0.0 112.847 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -57.84 -49.61 76.09 Favored 'General case' 0 N--CA 1.532 3.67 0 CA-C-O 121.599 0.714 . . . . 0.0 111.24 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -65.19 -33.63 76.45 Favored 'General case' 0 N--CA 1.52 3.073 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.554 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 29.2 mm -74.09 -28.45 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.152 0 C-N-CA 124.596 1.158 . . . . 0.0 110.425 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -66.13 -55.41 16.54 Favored 'General case' 1 N--CA 1.547 4.385 0 CA-C-O 122.379 1.085 . . . . 0.0 110.615 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -30.55 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.879 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.46 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.41 -44.36 65.36 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 123.647 0.779 . . . . 0.0 111.511 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 27.2 mt -62.81 -37.9 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 C-N-CA 124.869 1.268 . . . . 0.0 110.311 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 39.1 mm -57.61 -41.62 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 50.4 mm -62.98 -44.99 99.99 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.538 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 176.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.43 -31.07 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 C-N-CA 123.351 0.661 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.54 -42.84 95.45 Favored Glycine 1 N--CA 1.524 4.539 0 C-N-CA 123.539 0.59 . . . . 0.0 112.593 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 66.7 m -67.31 -36.25 81.11 Favored 'General case' 0 N--CA 1.528 3.46 0 CA-C-O 122.342 1.068 . . . . 0.0 110.212 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 2.6 tp -54.04 -35.05 61.56 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 113.191 -1.822 . . . . 0.0 112.909 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -42.32 59.47 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.624 0 CA-C-N 118.641 0.655 . . . . 0.0 110.663 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -53.58 -44.75 68.31 Favored Glycine 1 N--CA 1.523 4.472 0 N-CA-C 116.025 1.17 . . . . 0.0 116.025 -175.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . 0.321 0.0 OUTLIER -67.23 -30.85 70.87 Favored 'General case' 1 N--CA 1.557 4.893 0 CA-C-N 118.267 1.034 . . . . 0.0 112.247 -179.162 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -48.22 -25.02 1.34 Allowed 'General case' 0 N--CA 1.538 3.936 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 25.9 pt -54.27 -36.69 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.964 0 CA-C-N 118.864 0.757 . . . . 0.0 112.543 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.96 -32.57 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -55.62 -25.77 40.58 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.386 0.674 . . . . 0.0 109.67 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.18 72.6 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 122.711 0.404 . . . . 0.0 110.643 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.78 -31.38 50.52 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.3 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 11.8 tp -54.32 -33.9 59.86 Favored 'General case' 0 N--CA 1.531 3.581 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.157 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 27.0 m -57.69 -46.38 84.41 Favored 'General case' 0 N--CA 1.531 3.577 0 CA-C-N 119.246 0.93 . . . . 0.0 113.4 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 37.5 tp -65.27 -35.9 82.44 Favored 'General case' 1 N--CA 1.552 4.667 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.4 -38.58 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.354 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -62.32 -26.62 68.53 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.054 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -49.11 -47.43 45.3 Favored 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.694 0.759 . . . . 0.0 109.687 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.22 -37.97 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.853 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -75.38 -24.51 57.26 Favored 'General case' 0 N--CA 1.53 3.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.025 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -89.35 -13.38 37.99 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.1 -25.72 32.82 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -96.86 154.22 17.43 Favored 'General case' 0 N--CA 1.533 3.7 0 C-N-CA 124.559 1.144 . . . . 0.0 108.517 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 82.5 p -80.64 152.03 72.04 Favored Pre-proline 0 N--CA 1.536 3.84 0 C-N-CA 126.201 1.8 . . . . 0.0 112.973 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.5 130.32 39.48 Favored 'Trans proline' 0 C--N 1.407 3.635 0 CA-C-N 121.159 1.45 . . . . 0.0 112.022 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 66.4 mt -86.42 175.88 8.16 Favored 'General case' 0 N--CA 1.524 3.24 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.447 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.523 3.194 0 C-N-CA 124.123 0.969 . . . . 0.0 109.527 -179.791 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -82.96 -152.46 0.11 Allowed 'General case' 0 N--CA 1.528 3.443 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -21.77 1.66 Allowed 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 125.19 1.396 . . . . 0.0 112.843 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -60.16 -49.4 77.8 Favored 'General case' 0 N--CA 1.533 3.692 0 C-N-CA 122.994 0.518 . . . . 0.0 110.627 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -64.18 -33.71 76.41 Favored 'General case' 0 N--CA 1.525 3.301 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 27.9 mm -73.79 -31.5 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 C-N-CA 124.451 1.101 . . . . 0.0 111.13 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -49.52 69.64 Favored 'General case' 1 N--CA 1.554 4.773 0 CA-C-O 121.617 0.722 . . . . 0.0 111.52 -176.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -29.02 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 C-N-CA 125.319 1.448 . . . . 0.0 110.27 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -51.2 -30.37 16.91 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.408 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.45 -40.69 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.981 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 45.4 mt -60.5 -34.81 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.563 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.54 -47.6 92.22 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.451 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.4 -29.12 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.231 0 C-N-CA 124.253 1.021 . . . . 0.0 109.74 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.84 92.69 Favored Glycine 1 N--CA 1.522 4.369 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 60.6 m -68.98 -37.17 78.6 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.126 0.97 . . . . 0.0 111.137 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.6 mp -55.71 -35.42 66.09 Favored 'General case' 1 N--CA 1.54 4.042 0 C-N-CA 123.573 0.749 . . . . 0.0 112.09 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . 0.269 0.4 OUTLIER -72.11 -47.22 55.35 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.704 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.52 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -53.96 -44.91 72.33 Favored Glycine 1 N--CA 1.525 4.588 0 N-CA-C 116.393 1.317 . . . . 0.0 116.393 -175.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -65.81 -31.04 71.77 Favored 'General case' 1 N--CA 1.552 4.645 0 CA-C-N 118.408 1.104 . . . . 0.0 112.697 -178.85 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -48.95 -25.26 1.84 Allowed 'General case' 1 N--CA 1.544 4.258 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 18.2 tt -53.1 -35.3 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 C-N-CA 123.256 0.622 . . . . 0.0 111.388 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -53.18 -30.65 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 C-N-CA 124.198 0.999 . . . . 0.0 111.506 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -58.89 -28.43 66.16 Favored 'General case' 0 N--CA 1.537 3.907 0 O-C-N 121.655 -0.653 . . . . 0.0 110.474 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.34 -42.38 71.98 Favored 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.49 -32.39 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.796 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 21.1 tp -54.94 -33.43 62.28 Favored 'General case' 0 N--CA 1.536 3.871 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 87.0 p -57.33 -45.37 84.36 Favored 'General case' 0 N--CA 1.529 3.485 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -37.39 85.48 Favored 'General case' 1 N--CA 1.544 4.228 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.14 -37.94 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.8 p30 -60.12 -31.91 70.5 Favored 'General case' 0 N--CA 1.518 2.953 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.143 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -48.22 -47.27 35.73 Favored 'General case' 0 N--CA 1.516 2.852 0 C-N-CA 123.517 0.727 . . . . 0.0 111.258 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 49.3 t -64.13 -47.71 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -78.76 -10.15 59.68 Favored 'General case' 0 N--CA 1.536 3.868 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' C' ' 706' ' ' ASN . 38.7 tt0 -113.7 -10.87 13.02 Favored 'General case' 0 N--CA 1.533 3.679 0 C-N-CA 124.965 1.306 . . . . 0.0 109.175 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.21 -35.33 54.83 Favored Glycine 0 N--CA 1.509 3.523 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -79.53 152.78 29.97 Favored 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 96.0 p -81.17 150.03 67.29 Favored Pre-proline 0 N--CA 1.531 3.588 0 CA-C-O 116.739 -1.601 . . . . 0.0 111.09 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.14 131.05 42.71 Favored 'Trans proline' 0 C--N 1.401 3.302 0 CA-C-N 121.9 1.714 . . . . 0.0 112.255 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.97 94.64 0.05 Allowed 'General case' 0 N--CA 1.53 3.566 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.246 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.521 3.123 0 CA-C-O 117.853 -1.07 . . . . 0.0 112.444 -179.403 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -170.01 -78.02 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.099 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -23.52 5.3 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 125.328 1.451 . . . . 0.0 114.179 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -62.96 -51.35 67.2 Favored 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -67.41 -31.39 71.57 Favored 'General case' 1 N--CA 1.539 4.005 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 47.6 mm -74.88 -26.68 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.489 0 C-N-CA 124.911 1.284 . . . . 0.0 110.269 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -66.35 -54.0 29.61 Favored 'General case' 1 N--CA 1.55 4.559 0 CA-C-O 121.775 0.797 . . . . 0.0 111.13 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.44 -30.82 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.353 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -56.82 -31.35 64.64 Favored 'General case' 0 N--CA 1.515 2.813 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.789 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.6 mm -68.58 -39.25 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 54.3 mt -65.42 -36.32 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.194 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 72.1 mt -67.45 -42.95 87.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.026 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.92 -30.15 47.94 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.338 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.7 97.52 Favored Glycine 1 N--CA 1.524 4.565 0 C-N-CA 124.002 0.811 . . . . 0.0 112.175 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 71.0 m -68.78 -37.83 79.6 Favored 'General case' 0 N--CA 1.522 3.16 0 CA-C-O 122.084 0.945 . . . . 0.0 109.883 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 1.9 tp -59.44 -44.78 92.86 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.02 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -32.46 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.757 0 O-C-N 121.896 -0.502 . . . . 0.0 112.092 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.18 -44.59 96.3 Favored Glycine 1 N--CA 1.52 4.246 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . 0.334 0.0 OUTLIER -68.09 -31.97 71.96 Favored 'General case' 1 N--CA 1.549 4.506 0 CA-C-N 118.279 1.039 . . . . 0.0 112.452 -178.715 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -48.6 -24.7 1.42 Allowed 'General case' 0 N--CA 1.539 3.982 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 17.4 tt -52.39 -35.07 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 123.186 0.594 . . . . 0.0 111.845 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.8 p -52.95 -30.3 15.86 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 C-N-CA 123.789 0.836 . . . . 0.0 111.309 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -61.29 -29.37 69.83 Favored 'General case' 0 N--CA 1.536 3.827 0 O-C-N 121.433 -0.792 . . . . 0.0 110.328 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.55 -37.94 74.09 Favored 'General case' 0 N--CA 1.535 3.783 0 CA-C-O 121.629 0.728 . . . . 0.0 109.059 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.47 -30.24 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.255 0 C-N-CA 124.75 1.22 . . . . 0.0 108.56 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.1 -30.58 49.06 Favored 'General case' 0 N--CA 1.534 3.74 0 C-N-CA 123.428 0.691 . . . . 0.0 109.236 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 72.6 p -56.52 -45.83 80.9 Favored 'General case' 0 N--CA 1.533 3.711 0 O-C-N 121.473 -0.767 . . . . 0.0 111.601 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 34.6 tp -62.63 -35.49 79.77 Favored 'General case' 1 N--CA 1.552 4.653 0 O-C-N 121.34 -0.85 . . . . 0.0 108.935 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.1 -38.59 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.623 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . 0.596 HD21 ' HE ' ' A' ' 709' ' ' ARG . 7.3 t-20 -60.53 -22.83 64.05 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 123.784 0.833 . . . . 0.0 109.798 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -53.5 -42.55 67.46 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.602 0.715 . . . . 0.0 109.646 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.42 -37.46 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.144 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . 0.596 ' HE ' HD21 ' A' ' 706' ' ' ASN . 54.9 mtm180 -77.67 -4.44 46.12 Favored 'General case' 0 N--CA 1.516 2.856 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.999 175.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -91.35 -17.52 25.74 Favored 'General case' 1 N--CA 1.562 5.17 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -78.6 -18.51 75.48 Favored Glycine 1 N--CA 1.523 4.498 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -98.98 144.74 27.8 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 126.654 1.982 . . . . 0.0 106.235 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 78.4 p -104.53 143.94 27.71 Favored Pre-proline 1 N--CA 1.55 4.53 0 CA-C-O 117.929 -1.034 . . . . 0.0 113.474 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -64.06 131.42 30.58 Favored 'Trans proline' 0 C--N 1.409 3.754 0 CA-C-N 120.988 1.389 . . . . 0.0 110.938 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.97 172.31 7.07 Favored 'General case' 0 N--CA 1.535 3.779 0 C-N-CA 125.52 1.528 . . . . 0.0 108.838 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.52 3.069 0 CA-C-O 117.48 -1.247 . . . . 0.0 108.699 179.662 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 9.2 t90 60.56 56.41 3.08 Favored 'General case' 0 N--CA 1.519 2.992 0 C-N-CA 124.567 1.147 . . . . 0.0 111.399 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 1.4 pp -52.42 -17.99 1.45 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -55.45 -29.44 58.66 Favored 'General case' 1 N--CA 1.541 4.08 0 CA-C-N 120.156 1.344 . . . . 0.0 111.176 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -72.66 -34.65 67.39 Favored 'General case' 0 N--CA 1.532 3.649 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.54 -25.16 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.375 0 C-N-CA 124.386 1.074 . . . . 0.0 108.78 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -65.75 -45.9 80.87 Favored 'General case' 1 N--CA 1.549 4.487 0 O-C-N 121.54 -0.725 . . . . 0.0 111.566 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 13.7 tt -66.05 -30.54 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.34 -27.3 67.02 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.842 0.857 . . . . 0.0 110.122 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.09 -43.25 81.89 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.204 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 62.6 mt -72.43 -38.41 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.091 0 C-N-CA 124.718 1.207 . . . . 0.0 111.81 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 3.3 tp -58.38 -37.53 64.25 Favored 'Isoleucine or valine' 1 N--CA 1.556 4.844 0 CA-C-N 119.161 0.891 . . . . 0.0 110.215 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.98 -27.54 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 C-N-CA 124.298 1.039 . . . . 0.0 109.98 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -80.16 -27.58 52.14 Favored Glycine 1 N--CA 1.518 4.161 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 49.9 m -69.19 -52.42 28.1 Favored 'General case' 0 N--CA 1.534 3.764 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -34.69 75.39 Favored 'General case' 0 N--CA 1.538 3.974 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 1.2 tp -58.87 -44.86 91.59 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.263 0 CA-C-N 119.54 1.064 . . . . 0.0 111.495 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.15 -31.25 80.12 Favored Glycine 1 N--CA 1.521 4.325 0 O-C-N 120.643 -1.285 . . . . 0.0 111.224 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.92 -43.18 96.7 Favored 'General case' 0 N--CA 1.535 3.824 0 C-N-CA 124.243 1.017 . . . . 0.0 111.506 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -53.03 -26.96 17.44 Favored 'General case' 1 N--CA 1.54 4.05 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.9 tt -54.82 -39.28 47.37 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.387 0 CA-C-N 120.116 1.325 . . . . 0.0 113.973 -174.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.58 -30.53 36.97 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.225 0 C-N-CA 123.332 0.653 . . . . 0.0 111.683 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -53.96 -26.48 25.86 Favored 'General case' 0 N--CA 1.533 3.709 0 C-N-CA 123.145 0.578 . . . . 0.0 109.532 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.89 -36.95 68.22 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 122.787 0.435 . . . . 0.0 110.199 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.43 -29.63 44.78 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.025 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 6.4 tp -52.37 -35.91 52.56 Favored 'General case' 0 N--CA 1.531 3.611 0 CA-C-O 118.866 -0.588 . . . . 0.0 110.721 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 68.9 m -59.28 -46.52 88.32 Favored 'General case' 0 N--CA 1.533 3.714 0 CA-C-N 118.949 0.795 . . . . 0.0 112.864 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 51.0 tp -66.23 -36.02 81.93 Favored 'General case' 1 N--CA 1.547 4.383 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.28 -38.29 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -59.54 -31.78 69.73 Favored 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.11 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -48.45 -45.29 36.35 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 124.934 1.294 . . . . 0.0 111.368 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 59.0 t -62.83 -49.95 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.25 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -79.57 -3.92 49.14 Favored 'General case' 1 N--CA 1.551 4.595 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.551 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -109.98 -13.3 14.44 Favored 'General case' 0 N--CA 1.528 3.427 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.38 -28.48 20.39 Favored Glycine 0 N--CA 1.515 3.925 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -86.23 155.14 20.83 Favored 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 123.796 0.838 . . . . 0.0 108.992 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 90.0 p -79.0 150.19 74.57 Favored Pre-proline 0 N--CA 1.534 3.74 0 C-N-CA 126.479 1.911 . . . . 0.0 112.598 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -54.06 131.71 46.15 Favored 'Trans proline' 0 C--N 1.408 3.679 0 CA-C-N 120.626 1.259 . . . . 0.0 111.031 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 4.8 tt -144.19 -57.02 0.37 Allowed 'General case' 0 N--CA 1.527 3.417 0 CA-C-N 113.169 -1.832 . . . . 0.0 106.586 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.521 3.113 0 C-N-CA 124.908 1.283 . . . . 0.0 113.758 178.54 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 39.4 t30 . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -58.24 -57.23 13.81 Favored 'General case' 0 N--CA 1.529 3.479 0 CA-C-O 122.096 0.951 . . . . 0.0 110.172 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 pp -60.9 -28.49 68.94 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.629 1.572 . . . . 0.0 112.696 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -58.02 -50.25 74.08 Favored 'General case' 0 N--CA 1.536 3.854 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -174.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -63.21 -33.58 75.8 Favored 'General case' 0 N--CA 1.529 3.486 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.49 -29.12 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 C-N-CA 125.724 1.609 . . . . 0.0 110.514 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -51.85 52.94 Favored 'General case' 1 N--CA 1.55 4.536 0 C-N-CA 123.682 0.793 . . . . 0.0 111.479 -176.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.4 tt -63.08 -39.75 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.427 0 C-N-CA 124.099 0.96 . . . . 0.0 109.465 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -53.09 -42.61 66.07 Favored 'General case' 0 N--CA 1.517 2.88 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.82 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.88 -36.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 20.4 mt -63.5 -44.11 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.65 -43.66 95.31 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.299 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.08 -37.77 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 C-N-CA 123.853 0.861 . . . . 0.0 110.134 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -57.19 -32.96 63.97 Favored Glycine 1 N--CA 1.522 4.425 0 C-N-CA 123.727 0.68 . . . . 0.0 113.756 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 63.1 m -63.39 -34.62 78.13 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 124.355 1.062 . . . . 0.0 112.57 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 4.0 mp -52.85 -34.79 55.91 Favored 'General case' 0 N--CA 1.532 3.668 0 C-N-CA 123.618 0.767 . . . . 0.0 112.659 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.58 -43.81 88.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.445 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -69.2 -29.93 71.92 Favored Glycine 1 N--CA 1.522 4.399 0 O-C-N 121.232 -0.917 . . . . 0.0 110.917 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.85 -42.83 99.53 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 123.83 0.852 . . . . 0.0 110.506 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -56.41 -26.83 54.64 Favored 'General case' 1 N--CA 1.543 4.194 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 69.9 mt -54.85 -39.55 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 C-N-CA 122.976 0.51 . . . . 0.0 112.319 -176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.79 -32.05 54.44 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.488 0 CA-C-N 119.235 0.925 . . . . 0.0 112.241 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -53.99 -26.99 28.79 Favored 'General case' 0 N--CA 1.536 3.857 0 O-C-N 121.836 -0.54 . . . . 0.0 110.501 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.72 -32.83 65.91 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 122.039 -0.413 . . . . 0.0 110.341 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.1 m -68.81 -29.84 44.93 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.095 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.5 tp -51.77 -36.3 46.91 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-O 118.709 -0.662 . . . . 0.0 110.914 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 24.5 t -59.06 -46.24 88.77 Favored 'General case' 0 N--CA 1.534 3.747 0 CA-C-N 119.148 0.885 . . . . 0.0 112.914 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 37.9 tp -65.72 -34.53 78.39 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.31 -39.84 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' C' ' 710' ' ' GLN . 33.2 t-20 -65.81 -23.98 66.81 Favored 'General case' 0 N--CA 1.524 3.24 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.764 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -47.89 -42.83 27.88 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 123.992 0.917 . . . . 0.0 111.271 -178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 43.5 t -65.44 -47.02 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -78.1 -11.84 59.94 Favored 'General case' 0 N--CA 1.539 3.986 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.314 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' C' ' 706' ' ' ASN . 49.5 tt0 -109.91 -9.94 14.76 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 125.093 1.357 . . . . 0.0 108.654 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.78 -27.13 49.04 Favored Glycine 0 N--CA 1.514 3.899 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -99.32 152.71 19.63 Favored 'General case' 0 N--CA 1.529 3.509 0 C-N-CA 123.935 0.894 . . . . 0.0 109.327 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 88.0 p -82.28 148.96 60.86 Favored Pre-proline 0 N--CA 1.528 3.473 0 C-N-CA 125.947 1.699 . . . . 0.0 109.714 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -54.66 132.19 50.11 Favored 'Trans proline' 0 C--N 1.398 3.164 0 CA-C-N 121.612 1.611 . . . . 0.0 112.854 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -158.63 -49.93 0.06 Allowed 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 112.308 -2.224 . . . . 0.0 105.917 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 86.2 p . . . . . 0 N--CA 1.522 3.168 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.56 178.665 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.87 -13.74 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 124.002 0.921 . . . . 0.0 110.664 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp -50.12 -22.93 1.86 Allowed 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 125.306 1.443 . . . . 0.0 113.482 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -59.47 -49.43 77.81 Favored 'General case' 0 N--CA 1.533 3.693 0 CA-C-O 121.207 0.527 . . . . 0.0 111.348 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -66.93 -29.23 69.04 Favored 'General case' 0 N--CA 1.523 3.221 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 30.7 mm -74.96 -32.2 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.243 0 C-N-CA 124.562 1.145 . . . . 0.0 110.614 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -48.51 69.39 Favored 'General case' 1 N--CA 1.549 4.521 0 O-C-N 121.935 -0.478 . . . . 0.0 111.738 -176.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.1 tt -68.34 -31.18 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 C-N-CA 123.916 0.886 . . . . 0.0 109.826 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -48.51 -24.63 1.36 Allowed 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 124.624 1.17 . . . . 0.0 111.448 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.38 -40.14 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 117.268 -1.349 . . . . 0.0 111.094 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 40.0 pt -53.33 -36.31 26.21 Favored 'Isoleucine or valine' 1 N--CA 1.567 5.388 0 CA-C-N 121.531 1.969 . . . . 0.0 109.93 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.93 -49.14 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 23.9 t -68.17 -29.27 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 125.256 1.423 . . . . 0.0 111.295 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -82.31 -32.19 29.06 Favored Glycine 1 N--CA 1.525 4.571 0 C-N-CA 124.589 1.09 . . . . 0.0 112.317 -175.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 74.3 m -69.05 -51.37 39.63 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 123.839 0.856 . . . . 0.0 113.109 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.49 -31.77 73.02 Favored 'General case' 1 N--CA 1.541 4.096 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 1.3 tp -59.34 -42.65 88.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.431 0 CA-C-N 120.77 1.623 . . . . 0.0 111.295 -176.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.62 -27.53 72.36 Favored Glycine 1 N--CA 1.525 4.609 0 O-C-N 121.02 -1.05 . . . . 0.0 110.968 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.7 -36.68 83.74 Favored 'General case' 1 N--CA 1.544 4.261 0 C-N-CA 123.861 0.864 . . . . 0.0 109.075 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -54.78 -29.25 53.72 Favored 'General case' 1 N--CA 1.542 4.161 0 O-C-N 121.45 -0.781 . . . . 0.0 112.025 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 46.9 mm -57.51 -38.6 64.4 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.047 0 C-N-CA 123.479 0.712 . . . . 0.0 109.839 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 92.1 t -58.17 -37.78 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 125.077 1.351 . . . . 0.0 111.265 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -55.13 -24.85 28.14 Favored 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 123.317 0.647 . . . . 0.0 110.002 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.2 64.31 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 122.163 -0.336 . . . . 0.0 110.14 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.97 -31.32 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.996 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.07 -36.7 63.4 Favored 'General case' 0 N--CA 1.534 3.765 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.651 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 61.5 m -58.75 -47.07 85.94 Favored 'General case' 0 N--CA 1.536 3.862 0 CA-C-N 119.252 0.933 . . . . 0.0 112.868 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 35.8 tp -65.76 -35.04 79.58 Favored 'General case' 1 N--CA 1.54 4.072 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 87.2 t -68.65 -38.65 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . 0.581 HD21 ' HG ' ' C' ' 703' ' ' SER . 17.6 t30 -58.34 -23.13 55.82 Favored 'General case' 0 N--CA 1.516 2.869 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.349 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -47.04 -40.01 13.95 Favored 'General case' 0 N--CA 1.527 3.395 0 C-N-CA 123.667 0.787 . . . . 0.0 111.125 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.96 -45.56 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -76.86 -11.04 59.76 Favored 'General case' 0 N--CA 1.533 3.682 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.698 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 706' ' ' ASN . 35.6 tt0 -113.55 -14.18 12.7 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 125.702 1.601 . . . . 0.0 109.466 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -74.33 -14.89 80.45 Favored Glycine 1 N--CA 1.534 5.213 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 174.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -75.76 146.52 39.97 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 128.207 2.603 . . . . 0.0 107.177 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 67.5 m -81.85 146.99 57.28 Favored Pre-proline 1 N--CA 1.54 4.051 0 C-N-CA 124.402 1.081 . . . . 0.0 112.247 -176.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.94 130.19 31.82 Favored 'Trans proline' 0 C--N 1.401 3.3 0 CA-C-N 120.998 1.392 . . . . 0.0 109.476 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.31 169.22 18.47 Favored 'General case' 0 N--CA 1.527 3.4 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.575 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 97.8 p . . . . . 0 N--CA 1.522 3.168 0 C-N-CA 123.747 0.819 . . . . 0.0 110.423 -179.756 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 54.92 105.52 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 124.296 1.039 . . . . 0.0 111.899 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.81 -20.59 2.28 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.505 1.522 . . . . 0.0 113.432 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -55.95 -50.62 70.28 Favored 'General case' 0 N--CA 1.535 3.816 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.07 -34.54 78.26 Favored 'General case' 0 N--CA 1.529 3.514 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.5 -29.03 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.222 0 C-N-CA 125.141 1.377 . . . . 0.0 110.403 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -46.93 74.37 Favored 'General case' 1 N--CA 1.556 4.857 0 O-C-N 121.208 -0.933 . . . . 0.0 110.282 -176.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -71.22 -30.74 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 C-N-CA 124.238 1.015 . . . . 0.0 109.765 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -56.56 -45.67 81.14 Favored 'General case' 0 N--CA 1.519 2.983 0 CA-C-O 122.35 1.072 . . . . 0.0 109.351 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.22 -37.82 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.085 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 52.5 mt -65.51 -40.71 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.71 -44.17 96.64 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.335 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.82 -30.24 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 C-N-CA 123.444 0.698 . . . . 0.0 109.825 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.3 92.49 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.139 0.4 . . . . 0.0 112.969 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 66.8 m -59.48 -35.27 73.78 Favored 'General case' 0 N--CA 1.532 3.649 0 C-N-CA 124.323 1.049 . . . . 0.0 112.437 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.4 mp -53.47 -36.36 61.55 Favored 'General case' 0 N--CA 1.534 3.763 0 C-N-CA 123.747 0.819 . . . . 0.0 112.653 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.81 -46.54 96.01 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.306 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.313 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.47 -29.95 76.4 Favored Glycine 1 N--CA 1.525 4.597 0 O-C-N 121.445 -0.784 . . . . 0.0 111.747 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.97 -42.39 94.04 Favored 'General case' 0 N--CA 1.532 3.671 0 C-N-CA 124.44 1.096 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -52.68 -24.95 9.54 Favored 'General case' 0 N--CA 1.535 3.801 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 19.6 tt -53.05 -37.07 25.75 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.377 0 CA-C-N 120.28 1.4 . . . . 0.0 112.592 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 14.6 p -54.48 -29.8 20.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.348 0 C-N-CA 124.074 0.95 . . . . 0.0 111.33 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -57.08 -27.67 61.93 Favored 'General case' 0 N--CA 1.538 3.968 0 O-C-N 121.259 -0.901 . . . . 0.0 110.666 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -67.88 -42.71 80.82 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 83.9 t -68.99 -32.33 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.868 0 CA-C-N 113.835 -1.529 . . . . 0.0 109.124 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 20.2 tp -55.23 -34.23 63.78 Favored 'General case' 1 N--CA 1.54 4.032 0 C-N-CA 123.059 0.543 . . . . 0.0 109.602 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 57.0 m -57.81 -46.7 84.29 Favored 'General case' 0 N--CA 1.531 3.61 0 CA-C-N 118.79 0.723 . . . . 0.0 112.674 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.18 -36.08 83.08 Favored 'General case' 1 N--CA 1.551 4.601 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.53 -39.04 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' B' ' 710' ' ' GLN . 6.0 t-20 -66.02 -23.57 66.59 Favored 'General case' 0 N--CA 1.516 2.848 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.889 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -48.88 -45.38 41.07 Favored 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 123.993 0.917 . . . . 0.0 109.39 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 50.3 t -62.4 -48.27 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.794 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.86 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -77.92 -9.98 59.35 Favored 'General case' 0 N--CA 1.539 3.979 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.016 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . 0.46 HE22 HE22 ' A' ' 710' ' ' GLN . 26.3 tt0 -112.35 -11.55 13.67 Favored 'General case' 0 N--CA 1.527 3.394 0 C-N-CA 125.109 1.364 . . . . 0.0 109.285 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.96 -35.4 58.93 Favored Glycine 0 N--CA 1.513 3.788 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -83.85 154.46 23.46 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 114.747 -0.726 . . . . 0.0 109.157 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 67.7 m -80.18 149.65 69.85 Favored Pre-proline 0 N--CA 1.529 3.484 0 C-N-CA 126.624 1.969 . . . . 0.0 111.138 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -56.02 131.54 46.57 Favored 'Trans proline' 0 C--N 1.4 3.285 0 CA-C-N 120.981 1.386 . . . . 0.0 110.943 -174.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.34 176.35 9.06 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 114.084 -1.417 . . . . 0.0 109.699 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.522 3.169 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.039 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -3.72 1.44 Allowed 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 124.048 0.939 . . . . 0.0 112.728 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 4.5 pp -51.91 -22.77 4.12 Favored 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 124.883 1.273 . . . . 0.0 113.263 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -61.09 -48.86 79.72 Favored 'General case' 0 N--CA 1.535 3.813 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -35.11 79.79 Favored 'General case' 1 N--CA 1.54 4.065 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 36.2 mm -73.32 -27.23 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.908 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.667 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -66.38 -54.09 28.42 Favored 'General case' 1 N--CA 1.549 4.514 0 CA-C-O 121.86 0.838 . . . . 0.0 112.311 -176.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.17 -29.58 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.216 0 C-N-CA 125.122 1.369 . . . . 0.0 110.148 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -51.98 -33.23 37.09 Favored 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 124.327 1.051 . . . . 0.0 110.432 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.57 -47.64 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 40.2 mt -57.19 -43.82 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 C-N-CA 123.528 0.731 . . . . 0.0 110.421 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.09 -48.55 87.96 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.406 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 23.2 t -57.9 -30.73 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 C-N-CA 124.41 1.084 . . . . 0.0 109.698 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.98 -40.82 95.45 Favored Glycine 1 N--CA 1.524 4.552 0 C-N-CA 123.532 0.587 . . . . 0.0 112.887 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 71.2 m -67.66 -36.64 81.11 Favored 'General case' 0 N--CA 1.528 3.44 0 CA-C-O 122.193 0.997 . . . . 0.0 110.037 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.8 tp -55.29 -45.02 76.24 Favored 'General case' 0 N--CA 1.517 2.923 0 CA-C-N 113.438 -1.71 . . . . 0.0 114.235 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -35.82 68.66 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.212 0 CA-C-N 118.272 0.487 . . . . 0.0 112.276 -176.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.48 -26.18 70.61 Favored Glycine 1 N--CA 1.523 4.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.71 -43.25 76.4 Favored 'General case' 0 N--CA 1.535 3.819 0 C-N-CA 124.683 1.193 . . . . 0.0 110.181 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -53.24 -25.65 15.0 Favored 'General case' 0 N--CA 1.533 3.693 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 17.0 tt -54.41 -38.63 41.5 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.261 0 CA-C-N 119.513 1.051 . . . . 0.0 113.342 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.31 -31.09 26.24 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 C-N-CA 123.539 0.736 . . . . 0.0 111.814 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -54.44 -25.91 27.78 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 122.92 0.488 . . . . 0.0 109.875 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.19 -32.99 62.64 Favored 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 3.3 m -69.06 -30.82 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.919 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 5.9 tp -52.08 -34.18 42.59 Favored 'General case' 0 N--CA 1.532 3.67 0 C-N-CA 123.549 0.74 . . . . 0.0 110.68 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 703' ' ' SER . . . . . 0.581 ' HG ' HD21 ' A' ' 706' ' ' ASN . 6.4 t -58.99 -46.45 88.12 Favored 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 44.6 tp -67.05 -35.56 80.14 Favored 'General case' 1 N--CA 1.54 4.072 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.1 -39.22 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -59.81 -21.16 60.49 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.062 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -47.21 -47.97 24.17 Favored 'General case' 0 N--CA 1.525 3.28 0 CA-C-O 122.13 0.967 . . . . 0.0 110.204 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.74 -43.05 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.762 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -76.76 -9.7 58.86 Favored 'General case' 0 N--CA 1.526 3.335 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.054 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -89.62 -14.16 35.55 Favored 'General case' 1 N--CA 1.546 4.339 0 C-N-CA 123.25 0.62 . . . . 0.0 110.075 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -69.33 -7.9 58.24 Favored Glycine 1 N--CA 1.527 4.716 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -75.35 156.11 35.83 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 125.891 1.676 . . . . 0.0 109.43 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 92.6 p -114.23 146.5 35.91 Favored Pre-proline 0 N--CA 1.527 3.378 0 C-N-CA 125.714 1.606 . . . . 0.0 107.181 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -59.33 131.23 39.71 Favored 'Trans proline' 0 N--CA 1.527 3.492 0 CA-C-N 121.954 1.734 . . . . 0.0 109.961 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -146.23 -171.67 3.77 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 124.902 1.281 . . . . 0.0 110.035 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.519 3.01 0 C-N-CA 123.974 0.909 . . . . 0.0 109.086 179.873 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -165.58 130.52 2.43 Favored 'General case' 0 N--CA 1.522 3.165 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -50.22 -44.27 53.22 Favored 'General case' 0 N--CA 1.513 2.707 0 C-N-CA 125.225 1.41 . . . . 0.0 112.071 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -59.29 -48.09 82.92 Favored 'General case' 0 N--CA 1.537 3.895 0 CA-C-N 118.61 0.641 . . . . 0.0 111.735 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -70.01 -36.52 75.17 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.92 -24.42 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.832 0 C-N-CA 123.781 0.833 . . . . 0.0 109.705 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -64.92 -53.67 42.73 Favored 'General case' 1 N--CA 1.545 4.275 0 CA-C-N 118.826 0.739 . . . . 0.0 111.547 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.28 -30.43 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.994 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -51.08 -36.81 42.11 Favored 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.155 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 15.4 mt -68.9 -37.47 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 C-N-CA 124.333 1.053 . . . . 0.0 109.726 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 10.8 mm -57.81 -37.68 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.952 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.2 -42.55 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.41 -30.88 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 C-N-CA 123.584 0.754 . . . . 0.0 109.506 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.73 -41.97 98.77 Favored Glycine 1 N--CA 1.525 4.62 0 C-N-CA 123.673 0.654 . . . . 0.0 111.589 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.4 m -69.02 -37.89 78.88 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-O 122.272 1.034 . . . . 0.0 110.229 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.01 -44.6 97.18 Favored 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 113.287 -1.779 . . . . 0.0 113.458 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -35.58 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -76.69 -12.4 84.49 Favored Glycine 1 N--CA 1.535 5.24 0 O-C-N 121.012 -1.055 . . . . 0.0 110.991 178.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.92 -38.92 83.52 Favored 'General case' 0 N--CA 1.539 3.98 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -52.31 -25.23 9.02 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 125.05 1.34 . . . . 0.0 113.692 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 31.2 mm -53.28 -38.84 32.65 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.362 0 CA-C-N 118.611 0.641 . . . . 0.0 111.343 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.67 -28.63 23.68 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.305 0 C-N-CA 123.813 0.845 . . . . 0.0 112.428 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -52.46 -26.38 12.66 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 123.22 0.608 . . . . 0.0 110.901 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.87 -34.72 65.74 Favored 'General case' 0 N--CA 1.53 3.547 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.0 m -69.48 -31.79 50.54 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.107 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 10.2 tp -54.74 -36.06 64.4 Favored 'General case' 0 N--CA 1.538 3.947 0 C-N-CA 122.928 0.491 . . . . 0.0 110.252 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.0 p -59.38 -46.18 89.37 Favored 'General case' 0 N--CA 1.528 3.463 0 CA-C-N 118.383 0.538 . . . . 0.0 112.348 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 44.8 tp -65.42 -34.62 78.72 Favored 'General case' 1 N--CA 1.543 4.203 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.19 -38.89 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.597 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -62.49 -29.33 70.47 Favored 'General case' 0 N--CA 1.515 2.778 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.312 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -50.45 -48.54 56.44 Favored 'General case' 0 N--CA 1.519 3.002 0 C-N-CA 123.328 0.651 . . . . 0.0 111.954 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.34 -39.11 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -75.75 -23.38 56.0 Favored 'General case' 0 N--CA 1.527 3.421 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.369 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -92.23 -7.63 47.65 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.36 1.464 . . . . 0.0 107.429 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.83 -21.62 7.62 Favored Glycine 1 N--CA 1.524 4.532 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -119.48 135.2 54.87 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 125.336 1.454 . . . . 0.0 107.253 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 96.1 p -82.27 146.6 54.88 Favored Pre-proline 0 N--CA 1.528 3.426 0 CA-C-O 117.483 -1.246 . . . . 0.0 110.366 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -59.98 130.88 36.52 Favored 'Trans proline' 0 C--N 1.398 3.165 0 CA-C-N 121.414 1.541 . . . . 0.0 110.709 -177.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.3 tm? 62.19 76.88 0.35 Allowed 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 125.622 1.569 . . . . 0.0 110.133 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.522 3.151 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.167 -179.851 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 34.7 m120 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -58.32 149.22 25.09 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 123.991 0.916 . . . . 0.0 111.209 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 1.3 pp -57.87 -23.06 51.34 Favored 'General case' 0 N--CA 1.511 2.624 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -57.77 -26.24 61.6 Favored 'General case' 1 N--CA 1.551 4.606 0 CA-C-N 121.032 1.742 . . . . 0.0 110.262 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -71.8 -40.25 69.32 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.952 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.52 -25.22 22.54 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.234 0 CA-C-N 119.582 1.083 . . . . 0.0 110.192 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -59.35 -53.55 56.87 Favored 'General case' 0 N--CA 1.538 3.953 0 CA-C-N 118.168 0.44 . . . . 0.0 111.794 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 14.6 tt -70.52 -34.36 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.164 0 C-N-CA 124.003 0.921 . . . . 0.0 110.628 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -53.74 -46.75 70.99 Favored 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 124.48 1.112 . . . . 0.0 111.367 -175.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 43.9 mt -64.46 -39.89 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.894 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 59.8 mt -64.54 -40.11 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 97.8 mt -59.67 -45.34 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.58 -38.36 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.444 0 C-N-CA 123.565 0.746 . . . . 0.0 109.723 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -53.39 -19.84 9.47 Favored Glycine 1 N--CA 1.53 4.931 0 O-C-N 121.417 -0.802 . . . . 0.0 114.136 -177.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.6 m -68.95 -51.78 36.03 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.34 -31.71 61.93 Favored 'General case' 0 N--CA 1.533 3.679 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -41.77 80.54 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.221 0 CA-C-N 120.37 1.441 . . . . 0.0 111.981 -175.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -68.81 -33.54 75.69 Favored Glycine 1 N--CA 1.525 4.574 0 O-C-N 121.08 -1.012 . . . . 0.0 110.642 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.02 -42.32 94.08 Favored 'General case' 1 N--CA 1.548 4.456 0 C-N-CA 124.116 0.967 . . . . 0.0 112.728 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -49.98 -26.19 4.02 Favored 'General case' 1 N--CA 1.542 4.139 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -38.15 35.05 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.374 0 CA-C-N 118.696 0.68 . . . . 0.0 111.51 -176.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.39 -28.2 18.27 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.182 0 C-N-CA 124.059 0.944 . . . . 0.0 112.412 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -52.93 -26.82 16.22 Favored 'General case' 1 N--CA 1.541 4.082 0 C-N-CA 123.398 0.679 . . . . 0.0 109.744 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.49 76.37 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 122.707 0.403 . . . . 0.0 110.468 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.1 m -69.08 -32.0 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.13 -35.68 59.97 Favored 'General case' 0 N--CA 1.534 3.738 0 C-N-CA 123.044 0.538 . . . . 0.0 111.379 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 8.4 t -60.8 -47.39 86.55 Favored 'General case' 0 N--CA 1.535 3.799 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.098 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 44.0 tp -65.13 -34.91 79.52 Favored 'General case' 1 N--CA 1.544 4.248 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.9 -40.71 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.69 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 710' ' ' GLN . 4.6 m120 -72.04 -24.77 61.59 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.905 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -49.57 -35.81 21.78 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 118.826 0.739 . . . . 0.0 110.284 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.52 -48.15 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -77.37 -10.77 59.65 Favored 'General case' 1 N--CA 1.543 4.177 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.509 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 706' ' ' ASN . 33.1 tt0 -112.84 -5.31 13.88 Favored 'General case' 0 N--CA 1.518 2.93 0 C-N-CA 125.523 1.529 . . . . 0.0 108.071 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.77 -29.3 33.18 Favored Glycine 0 N--CA 1.512 3.759 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -98.02 137.58 36.61 Favored 'General case' 0 N--CA 1.528 3.444 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 89.1 p -81.39 146.8 58.5 Favored Pre-proline 0 N--CA 1.528 3.444 0 C-N-CA 125.246 1.418 . . . . 0.0 111.443 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -69.06 130.53 20.37 Favored 'Trans proline' 0 C--N 1.399 3.196 0 CA-C-N 121.112 1.433 . . . . 0.0 110.262 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 9.8 mp -86.73 -77.09 0.33 Allowed 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 125.41 1.484 . . . . 0.0 107.313 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.522 3.135 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.516 179.749 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -166.74 -106.2 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 123.899 0.88 . . . . 0.0 109.335 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 683' ' ' ARG . 46.8 mt -50.25 -44.32 53.51 Favored 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 124.751 1.221 . . . . 0.0 112.482 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -43.06 86.21 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -72.8 -37.48 67.52 Favored 'General case' 0 N--CA 1.538 3.927 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 49.0 mm -74.53 -25.86 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 C-N-CA 125.322 1.449 . . . . 0.0 110.917 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' C' ' 679' ' ' LEU . 64.2 ttt180 -66.13 -56.15 12.87 Favored 'General case' 1 N--CA 1.542 4.173 0 CA-C-O 121.658 0.742 . . . . 0.0 110.912 -177.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.9 -36.08 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.785 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.56 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -56.11 -45.9 79.31 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.046 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.74 -42.38 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 124.246 1.018 . . . . 0.0 109.096 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.22 -36.09 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.525 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.25 -42.12 95.27 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 74.7 t -62.67 -31.15 51.14 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.158 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.93 -29.49 74.71 Favored Glycine 1 N--CA 1.517 4.053 0 C-N-CA 123.473 0.558 . . . . 0.0 112.439 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.2 m -67.98 -36.52 80.16 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.42 0.688 . . . . 0.0 111.561 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.83 -44.29 73.76 Favored 'General case' 0 N--CA 1.537 3.883 0 C-N-CA 123.455 0.702 . . . . 0.0 112.503 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . 0.267 0.1 OUTLIER -60.21 -49.26 84.82 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.622 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.825 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.45 -27.39 60.79 Favored Glycine 1 N--CA 1.528 4.813 0 CA-C-N 119.489 1.04 . . . . 0.0 112.625 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -67.35 -42.12 84.02 Favored 'General case' 0 N--CA 1.538 3.935 0 C-N-CA 124.684 1.194 . . . . 0.0 111.118 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -52.28 -24.98 8.32 Favored 'General case' 0 N--CA 1.539 3.996 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 30.0 pt -53.75 -38.02 34.07 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.495 0 CA-C-N 120.591 1.541 . . . . 0.0 113.094 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.76 -30.1 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.638 0 C-N-CA 122.517 0.327 . . . . 0.0 111.85 -176.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.68 -26.17 31.8 Favored 'General case' 0 N--CA 1.533 3.721 0 C-N-CA 123.622 0.769 . . . . 0.0 109.436 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.61 -39.83 74.28 Favored 'General case' 0 N--CA 1.523 3.179 0 O-C-N 121.754 -0.591 . . . . 0.0 109.862 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.1 m -69.53 -32.58 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.999 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.61 -34.56 58.88 Favored 'General case' 0 N--CA 1.537 3.876 0 C-N-CA 123.5 0.72 . . . . 0.0 111.056 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 69.5 m -59.96 -46.21 90.15 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-N 118.392 0.542 . . . . 0.0 111.998 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.72 -36.1 83.2 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 94.5 t -68.02 -40.29 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' C' ' 710' ' ' GLN . 2.8 m120 -65.7 -23.56 66.79 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-O 118.711 -0.662 . . . . 0.0 109.771 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -49.27 -44.07 43.56 Favored 'General case' 0 N--CA 1.519 2.977 0 C-N-CA 123.691 0.797 . . . . 0.0 110.045 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.1 t -62.29 -48.99 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.992 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 33.7 mtp85 -78.75 -10.2 59.69 Favored 'General case' 0 N--CA 1.532 3.664 0 CA-C-N 115.084 -0.962 . . . . 0.0 113.206 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.2 tt0 -112.24 -10.62 13.82 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 124.863 1.265 . . . . 0.0 108.666 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.86 -33.73 43.77 Favored Glycine 0 N--CA 1.509 3.548 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -86.04 152.86 22.56 Favored 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 94.1 p -80.99 149.66 67.19 Favored Pre-proline 0 N--CA 1.534 3.742 0 C-N-CA 125.845 1.658 . . . . 0.0 110.063 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.45 129.96 37.52 Favored 'Trans proline' 0 C--N 1.4 3.261 0 CA-C-N 122.204 1.823 . . . . 0.0 112.992 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -177.38 5.9 Favored 'General case' 0 N--CA 1.527 3.391 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.379 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.522 3.174 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.65 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -122.58 -104.97 0.37 Allowed 'General case' 0 N--CA 1.53 3.575 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -21.43 3.04 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 124.825 1.25 . . . . 0.0 112.167 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -57.54 -44.35 85.11 Favored 'General case' 0 N--CA 1.532 3.663 0 C-N-CA 123.769 0.828 . . . . 0.0 110.79 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -70.7 -34.65 72.18 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.706 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 25.4 mm -74.15 -26.61 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.445 0 C-N-CA 125.383 1.473 . . . . 0.0 110.879 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -66.25 -53.37 37.73 Favored 'General case' 0 N--CA 1.539 3.987 0 CA-C-O 122.271 1.034 . . . . 0.0 111.24 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.4 tt -69.5 -30.0 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.2 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -52.7 -39.42 61.99 Favored 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.35 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.47 -43.64 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.311 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 54.5 mt -56.29 -34.62 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 58.9 mt -67.02 -46.72 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.15 -30.65 39.95 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.476 0 C-N-CA 123.362 0.665 . . . . 0.0 109.295 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.07 -40.61 98.3 Favored Glycine 0 N--CA 1.516 3.97 0 C-N-CA 123.482 0.563 . . . . 0.0 112.87 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 67.0 m -58.52 -35.41 72.23 Favored 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 124.342 1.057 . . . . 0.0 112.469 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 6.6 mp -53.75 -33.58 56.22 Favored 'General case' 0 N--CA 1.532 3.666 0 C-N-CA 123.61 0.764 . . . . 0.0 111.381 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -43.97 89.95 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.274 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -174.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -67.29 -32.34 79.51 Favored Glycine 1 N--CA 1.531 4.967 0 O-C-N 121.064 -1.022 . . . . 0.0 111.215 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.24 -37.75 84.19 Favored 'General case' 1 N--CA 1.546 4.351 0 C-N-CA 124.626 1.171 . . . . 0.0 110.414 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -61.02 -29.6 69.81 Favored 'General case' 1 N--CA 1.546 4.344 0 O-C-N 121.309 -0.869 . . . . 0.0 112.45 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 39.8 mm -56.74 -37.93 55.61 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.041 0 CA-C-O 121.934 0.873 . . . . 0.0 109.803 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 39.2 t -56.54 -30.07 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.318 0 C-N-CA 125.727 1.611 . . . . 0.0 110.629 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -59.91 -30.06 68.79 Favored 'General case' 0 N--CA 1.538 3.929 0 C-N-CA 123.493 0.717 . . . . 0.0 111.469 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.98 -43.38 68.16 Favored 'General case' 0 N--CA 1.523 3.209 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.95 -33.44 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.008 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.958 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.58 -35.2 70.07 Favored 'General case' 0 N--CA 1.531 3.59 0 C-N-CA 123.494 0.717 . . . . 0.0 109.801 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.0 p -58.89 -46.62 87.43 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.92 -34.75 78.67 Favored 'General case' 1 N--CA 1.545 4.285 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.069 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.08 -39.11 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 710' ' ' GLN . 23.7 t-20 -62.19 -29.44 70.38 Favored 'General case' 0 N--CA 1.517 2.921 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.936 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -48.02 -33.72 8.38 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 123.959 0.904 . . . . 0.0 111.251 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.42 -46.75 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -77.7 -11.27 59.86 Favored 'General case' 1 N--CA 1.541 4.083 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.143 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 706' ' ' ASN . 17.7 tt0 -114.53 -11.96 12.35 Favored 'General case' 0 N--CA 1.522 3.135 0 C-N-CA 126.054 1.742 . . . . 0.0 108.545 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.73 -30.1 27.44 Favored Glycine 0 N--CA 1.51 3.598 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -85.84 152.65 22.83 Favored 'General case' 0 N--CA 1.522 3.154 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 41.7 t -81.05 149.54 66.73 Favored Pre-proline 0 N--CA 1.527 3.423 0 C-N-CA 126.055 1.742 . . . . 0.0 111.625 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -54.02 130.38 39.1 Favored 'Trans proline' 0 C--N 1.406 3.578 0 CA-C-N 122.215 1.827 . . . . 0.0 111.847 -176.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 59.55 110.55 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.503 0 C-N-CA 125.203 1.401 . . . . 0.0 109.829 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.522 3.17 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.148 -179.714 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . 0.431 ' H3 ' ' H ' ' B' ' 678' ' ' TRP . 22.1 p-10 . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . 0.431 ' H ' ' H3 ' ' B' ' 677' ' ' ASN . 15.1 p90 -65.06 -33.24 75.57 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 124.121 0.968 . . . . 0.0 111.211 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp -60.54 -31.0 70.11 Favored 'General case' 0 N--CA 1.519 3.011 0 C-N-CA 124.025 0.93 . . . . 0.0 111.962 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -69.69 -30.4 68.05 Favored 'General case' 0 N--CA 1.527 3.42 0 O-C-N 122.183 -0.323 . . . . 0.0 111.035 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -73.05 -38.79 66.36 Favored 'General case' 0 N--CA 1.524 3.249 0 CA-C-O 118.986 -0.53 . . . . 0.0 110.275 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.8 pp -73.48 -25.42 21.06 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.01 0 CA-C-N 119.204 0.911 . . . . 0.0 109.497 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -51.81 68.27 Favored 'General case' 1 N--CA 1.539 4.007 0 C-N-CA 123.241 0.616 . . . . 0.0 111.768 -177.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.7 tt -74.19 -33.68 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.866 0.866 . . . . 0.0 110.979 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -53.96 -47.14 71.65 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 113.938 -1.483 . . . . 0.0 113.099 -173.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 16.8 mt -59.76 -36.84 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 124.074 0.95 . . . . 0.0 111.172 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.87 -37.25 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.61 -41.77 91.4 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.178 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.74 -31.62 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.931 0 C-N-CA 123.271 0.628 . . . . 0.0 109.506 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.59 -42.8 98.7 Favored Glycine 1 N--CA 1.524 4.521 0 C-N-CA 123.866 0.746 . . . . 0.0 112.474 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.3 m -67.67 -36.87 81.52 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-O 122.078 0.942 . . . . 0.0 110.218 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.23 -44.81 79.95 Favored 'General case' 0 N--CA 1.518 2.972 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.034 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -49.05 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.951 0 C-N-CA 123.334 0.654 . . . . 0.0 112.638 -176.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.9 -21.76 59.2 Favored Glycine 1 N--CA 1.524 4.53 0 CA-C-N 119.699 1.136 . . . . 0.0 112.978 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.09 -43.77 70.42 Favored 'General case' 1 N--CA 1.54 4.069 0 C-N-CA 123.621 0.769 . . . . 0.0 109.93 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -53.98 -26.02 23.8 Favored 'General case' 0 N--CA 1.536 3.852 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 38.4 mm -55.29 -38.77 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 123.904 0.882 . . . . 0.0 112.885 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.99 -31.41 45.52 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.527 0 CA-C-N 119.096 0.862 . . . . 0.0 111.95 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -54.21 -25.65 24.06 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.182 0.593 . . . . 0.0 109.94 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.45 -31.96 62.37 Favored 'General case' 0 N--CA 1.531 3.583 0 O-C-N 121.723 -0.611 . . . . 0.0 110.068 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.0 -30.04 45.35 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 9.6 tp -52.82 -35.25 56.85 Favored 'General case' 0 N--CA 1.532 3.631 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.486 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 52.1 m -58.11 -46.29 85.8 Favored 'General case' 0 N--CA 1.536 3.827 0 CA-C-N 119.233 0.924 . . . . 0.0 112.377 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 45.3 tp -64.54 -35.88 82.39 Favored 'General case' 1 N--CA 1.543 4.214 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.45 -38.42 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.554 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -58.16 -25.33 61.37 Favored 'General case' 0 N--CA 1.52 3.064 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.205 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -46.76 -47.66 20.72 Favored 'General case' 0 N--CA 1.515 2.819 0 C-N-CA 124.528 1.131 . . . . 0.0 112.569 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.56 -49.7 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.779 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -81.04 -6.91 59.36 Favored 'General case' 1 N--CA 1.545 4.29 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -110.75 -8.46 14.55 Favored 'General case' 1 N--CA 1.539 4.006 0 C-N-CA 124.569 1.148 . . . . 0.0 108.836 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -56.29 -27.08 52.16 Favored Glycine 0 N--CA 1.511 3.659 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -98.0 148.59 23.34 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.937 0.895 . . . . 0.0 108.981 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 49.5 m -82.15 149.83 63.27 Favored Pre-proline 0 N--CA 1.528 3.451 0 C-N-CA 125.808 1.643 . . . . 0.0 110.763 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.86 130.99 41.97 Favored 'Trans proline' 0 C--N 1.403 3.415 0 CA-C-N 122.138 1.799 . . . . 0.0 112.099 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -53.8 157.64 2.28 Favored 'General case' 0 N--CA 1.523 3.224 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.423 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.524 3.248 0 C-N-CA 124.539 1.136 . . . . 0.0 112.148 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 67.93 -59.86 0.42 Allowed 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 125.072 1.349 . . . . 0.0 110.799 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 68.6 mt -49.53 -41.45 41.23 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 124.822 1.249 . . . . 0.0 112.626 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -43.47 83.13 Favored 'General case' 0 N--CA 1.538 3.945 0 CA-C-N 119.361 0.982 . . . . 0.0 112.464 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -73.44 -36.55 65.94 Favored 'General case' 0 N--CA 1.529 3.521 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.31 -38.36 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 123.965 0.906 . . . . 0.0 110.804 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -67.96 -51.04 52.06 Favored 'General case' 0 N--CA 1.536 3.873 0 C-N-CA 124.28 1.032 . . . . 0.0 111.366 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 18.5 tt -60.84 -30.71 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 CA-C-O 122.154 0.978 . . . . 0.0 110.686 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -50.58 -27.78 7.42 Favored 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.841 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.69 -47.99 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 124.547 1.139 . . . . 0.0 109.292 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 21.4 mm -54.22 -46.0 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 C-N-CA 124.123 0.969 . . . . 0.0 111.78 -174.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 16.9 tt -68.04 -40.18 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.984 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.25 -30.36 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.767 0.827 . . . . 0.0 109.304 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -72.15 -20.71 79.22 Favored Glycine 1 N--CA 1.522 4.387 0 CA-C-N 118.914 0.779 . . . . 0.0 112.692 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.8 m -68.17 -50.33 55.15 Favored 'General case' 0 N--CA 1.529 3.485 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.73 -32.69 53.01 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -175.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.99 -33.77 59.84 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.004 0 CA-C-N 119.618 1.099 . . . . 0.0 111.364 -177.52 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -72.71 -33.28 60.61 Favored Glycine 1 N--CA 1.52 4.254 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.37 -41.93 94.75 Favored 'General case' 0 N--CA 1.535 3.796 0 C-N-CA 124.874 1.27 . . . . 0.0 111.023 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -52.08 -24.32 6.65 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 10.7 tp -52.1 -38.29 23.83 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.35 0 CA-C-N 119.434 1.016 . . . . 0.0 112.357 -176.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.3 p -56.59 -30.65 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.999 0 C-N-CA 123.543 0.737 . . . . 0.0 111.836 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -54.28 -26.95 31.97 Favored 'General case' 0 N--CA 1.536 3.86 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.84 65.58 Favored 'General case' 0 N--CA 1.521 3.116 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.54 -30.42 45.21 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.142 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 9.8 tp -53.44 -35.61 60.66 Favored 'General case' 0 N--CA 1.535 3.808 0 CA-C-O 119.067 -0.492 . . . . 0.0 110.461 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 64.8 m -59.28 -45.99 89.76 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-N 118.941 0.792 . . . . 0.0 112.789 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 40.2 tp -66.51 -34.84 78.82 Favored 'General case' 1 N--CA 1.548 4.448 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.7 -38.87 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' C' ' 710' ' ' GLN . 9.4 t-20 -58.24 -34.22 70.2 Favored 'General case' 0 C--O 1.183 -2.418 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.28 -177.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -46.63 -45.5 19.13 Favored 'General case' 0 N--CA 1.511 2.602 0 C-N-CA 124.464 1.106 . . . . 0.0 112.319 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.8 -45.81 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -77.99 -4.62 47.95 Favored 'General case' 0 N--CA 1.526 3.339 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.687 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' C' ' 706' ' ' ASN . 1.8 tt0 -111.29 -15.53 13.59 Favored 'General case' 1 N--CA 1.546 4.345 0 C-N-CA 124.307 1.043 . . . . 0.0 108.465 -178.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -77.01 -11.72 85.32 Favored Glycine 1 N--CA 1.533 5.117 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 174.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -76.03 153.67 36.28 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 128.321 2.648 . . . . 0.0 107.646 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 58.9 m -80.69 145.8 59.03 Favored Pre-proline 1 N--CA 1.545 4.317 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -69.83 131.51 21.29 Favored 'Trans proline' 0 C--N 1.4 3.272 0 CA-C-N 120.36 1.164 . . . . 0.0 110.459 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 90.3 mt -76.37 163.65 26.78 Favored 'General case' 0 N--CA 1.525 3.315 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.585 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.524 3.25 0 C-N-CA 124.395 1.078 . . . . 0.0 112.429 179.742 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 29.0 m120 . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 60.22 128.3 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.045 0 C-N-CA 124.844 1.257 . . . . 0.0 112.11 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.0 pp -51.44 -24.37 4.92 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 126.069 1.748 . . . . 0.0 113.052 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -67.39 -49.35 64.24 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -66.5 -30.95 71.4 Favored 'General case' 0 N--CA 1.532 3.66 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 51.0 mm -74.65 -30.31 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.86 0 C-N-CA 125.53 1.532 . . . . 0.0 110.19 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -51.47 57.0 Favored 'General case' 1 N--CA 1.548 4.463 0 C-N-CA 123.463 0.705 . . . . 0.0 111.964 -178.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.5 tt -65.8 -35.66 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.753 0 CA-C-O 122.091 0.948 . . . . 0.0 109.611 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -60.18 -40.91 91.62 Favored 'General case' 0 N--CA 1.512 2.669 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.825 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.2 mp -55.18 -49.19 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.793 0.837 . . . . 0.0 109.232 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 53.8 mt -56.81 -40.47 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 78.8 mt -68.26 -41.12 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.967 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.18 -30.63 49.24 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.601 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.21 -34.64 90.51 Favored Glycine 1 N--CA 1.522 4.405 0 C-N-CA 123.637 0.637 . . . . 0.0 111.991 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 62.9 m -68.39 -37.27 80.23 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.615 0.766 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.8 -44.44 86.31 Favored 'General case' 0 N--CA 1.536 3.864 0 C-N-CA 123.499 0.72 . . . . 0.0 112.627 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . 0.259 0.3 OUTLIER -61.3 -43.83 97.3 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.215 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -173.248 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.03 -34.15 89.19 Favored Glycine 1 N--CA 1.534 5.206 0 CA-C-N 120.017 1.28 . . . . 0.0 111.822 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.0 -39.78 86.92 Favored 'General case' 1 N--CA 1.541 4.114 0 C-N-CA 124.715 1.206 . . . . 0.0 110.326 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -59.97 -28.25 67.52 Favored 'General case' 1 N--CA 1.544 4.275 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.3 -36.66 41.14 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.313 0 CA-C-O 122.09 0.948 . . . . 0.0 109.618 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 68.7 t -54.58 -28.0 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.092 0 C-N-CA 126.69 1.996 . . . . 0.0 111.216 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -53.15 -25.8 14.67 Favored 'General case' 0 N--CA 1.534 3.753 0 C-N-CA 123.559 0.744 . . . . 0.0 110.748 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.49 -39.89 74.01 Favored 'General case' 0 N--CA 1.525 3.297 0 O-C-N 121.766 -0.584 . . . . 0.0 109.668 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.8 -36.03 67.88 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.16 -35.45 64.77 Favored 'General case' 1 N--CA 1.54 4.073 0 C-N-CA 123.526 0.731 . . . . 0.0 110.806 -179.532 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 9.6 t -60.62 -46.89 88.57 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 44.8 tp -67.58 -36.82 81.65 Favored 'General case' 0 N--CA 1.536 3.865 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.88 -46.36 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 C-N-CA 123.295 0.638 . . . . 0.0 110.027 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 710' ' ' GLN . 0.2 OUTLIER -72.47 -20.09 61.45 Favored 'General case' 0 N--CA 1.513 2.68 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.142 -178.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -48.07 -44.36 31.33 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 123.682 0.793 . . . . 0.0 109.798 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.37 -43.49 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.75 -19.85 57.16 Favored 'General case' 0 N--CA 1.528 3.465 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.5 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 706' ' ' ASN . 2.6 tt0 -89.88 -14.83 33.45 Favored 'General case' 0 N--CA 1.538 3.937 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -59.15 -12.41 16.29 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -74.19 154.56 39.01 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 124.424 1.089 . . . . 0.0 108.37 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 73.0 m -94.53 147.41 33.19 Favored Pre-proline 0 N--CA 1.528 3.472 0 C-N-CA 125.123 1.369 . . . . 0.0 107.866 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.07 129.99 30.81 Favored 'Trans proline' 0 N--CA 1.527 3.496 0 CA-C-N 121.574 1.598 . . . . 0.0 109.739 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -74.79 -10.83 59.89 Favored 'General case' 0 N--CA 1.525 3.318 0 CA-C-N 114.319 -1.309 . . . . 0.0 110.899 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 37.6 t . . . . . 0 N--CA 1.52 3.036 0 C-N-CA 124.122 0.969 . . . . 0.0 111.783 -179.719 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -64.15 -13.67 49.8 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 123.893 0.877 . . . . 0.0 111.41 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.69 -45.97 92.15 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.554 0.742 . . . . 0.0 110.624 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -71.1 -30.13 66.14 Favored 'General case' 0 N--CA 1.529 3.519 0 O-C-N 122.126 -0.359 . . . . 0.0 110.607 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -68.95 -37.95 79.16 Favored 'General case' 0 N--CA 1.519 3.015 0 CA-C-O 118.902 -0.57 . . . . 0.0 111.056 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.2 -23.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.809 0 CA-C-N 118.943 0.792 . . . . 0.0 110.767 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -60.34 -54.28 47.58 Favored 'General case' 1 N--CA 1.546 4.369 0 CA-C-N 119.205 0.911 . . . . 0.0 112.736 -177.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -70.7 -31.32 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.97 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.072 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -52.56 -30.05 28.74 Favored 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 124.0 0.92 . . . . 0.0 112.873 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -68.69 -36.51 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.755 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.08 -42.45 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.321 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.84 -50.29 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.985 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.36 -29.04 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.304 0 C-N-CA 124.519 1.127 . . . . 0.0 108.879 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.13 -17.92 68.52 Favored Glycine 1 N--CA 1.524 4.516 0 C-N-CA 123.674 0.654 . . . . 0.0 113.172 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 75.1 m -68.92 -52.21 31.74 Favored 'General case' 0 N--CA 1.527 3.421 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.17 -32.78 73.44 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -38.65 79.1 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.38 0 CA-C-N 120.384 1.447 . . . . 0.0 112.148 -176.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.88 -34.62 89.12 Favored Glycine 1 N--CA 1.526 4.7 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.21 -42.44 95.14 Favored 'General case' 0 N--CA 1.538 3.933 0 C-N-CA 124.572 1.149 . . . . 0.0 111.261 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -51.85 -24.23 5.88 Favored 'General case' 0 N--CA 1.536 3.863 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 20.0 tt -52.18 -36.71 21.13 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 CA-C-N 120.959 1.709 . . . . 0.0 111.844 -176.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 13.5 p -54.84 -28.12 19.59 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.028 0 C-N-CA 123.821 0.848 . . . . 0.0 111.17 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -55.75 -28.04 53.83 Favored 'General case' 1 N--CA 1.546 4.347 0 O-C-N 121.451 -0.781 . . . . 0.0 109.828 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.54 -44.09 68.21 Favored 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 65.5 t -68.85 -32.16 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.271 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 2.9 tp -54.2 -35.52 62.46 Favored 'General case' 0 N--CA 1.536 3.858 0 C-N-CA 123.391 0.676 . . . . 0.0 110.275 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 20.7 t -60.07 -46.68 88.75 Favored 'General case' 0 N--CA 1.529 3.525 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 36.2 tp -67.4 -34.6 77.6 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.43 -43.57 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 706' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' B' ' 709' ' ' ARG . 11.5 p30 -72.4 -22.71 61.08 Favored 'General case' 0 N--CA 1.517 2.913 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.062 -178.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -48.43 -36.96 15.92 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.296 0.57 . . . . 0.0 110.306 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.42 -41.52 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 176.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 709' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' B' ' 706' ' ' ASN . 86.5 mtt180 -75.92 -17.08 59.9 Favored 'General case' 0 N--CA 1.525 3.288 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.667 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -87.96 -12.33 44.87 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.76 -19.08 6.26 Favored Glycine 1 N--CA 1.521 4.344 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -114.24 130.04 56.63 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 124.99 1.316 . . . . 0.0 107.737 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 96.4 p -82.82 147.41 54.84 Favored Pre-proline 0 N--CA 1.526 3.366 0 C-N-CA 125.182 1.393 . . . . 0.0 110.53 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -57.65 131.63 45.38 Favored 'Trans proline' 0 C--N 1.4 3.268 0 CA-C-N 121.653 1.626 . . . . 0.0 110.671 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 52.5 tp -52.3 -21.9 3.96 Favored 'General case' 0 N--CA 1.528 3.435 0 CA-C-N 113.67 -1.605 . . . . 0.0 111.777 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.52 3.05 0 CA-C-O 117.588 -1.196 . . . . 0.0 109.425 179.836 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 5.1 p30 . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -66.85 144.48 56.25 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 123.848 0.859 . . . . 0.0 109.656 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.11 -44.63 64.53 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 125.288 1.435 . . . . 0.0 112.69 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -68.85 -37.13 78.91 Favored 'General case' 0 N--CA 1.524 3.271 0 CA-C-O 121.597 0.713 . . . . 0.0 110.961 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -66.35 -40.37 89.76 Favored 'General case' 0 N--CA 1.518 2.935 0 CA-C-N 114.151 -1.386 . . . . 0.0 111.415 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 18.2 pt -73.01 -29.38 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -52.09 66.96 Favored 'General case' 1 N--CA 1.55 4.562 0 C-N-CA 123.106 0.563 . . . . 0.0 110.421 -176.434 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.94 -36.33 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -52.17 -27.66 15.26 Favored 'General case' 0 N--CA 1.526 3.366 0 C-N-CA 124.214 1.005 . . . . 0.0 110.816 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 9.0 mm -67.61 -48.01 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.235 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 23.8 mt -64.33 -36.06 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.749 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.891 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 44.3 mm -59.86 -42.59 89.67 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.202 0 CA-C-N 118.151 0.432 . . . . 0.0 110.192 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.62 -31.69 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 C-N-CA 123.838 0.855 . . . . 0.0 110.328 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.66 -36.3 93.08 Favored Glycine 1 N--CA 1.522 4.428 0 C-N-CA 123.259 0.457 . . . . 0.0 112.194 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 64.2 m -68.12 -37.35 81.01 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.876 0.87 . . . . 0.0 111.805 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.13 -45.01 92.05 Favored 'General case' 0 N--CA 1.536 3.866 0 C-N-CA 123.589 0.755 . . . . 0.0 112.675 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . 0.286 0.1 OUTLIER -63.38 -48.84 85.39 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.466 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.95 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -55.2 -31.99 56.8 Favored Glycine 1 N--CA 1.531 5.016 0 CA-C-N 119.214 0.915 . . . . 0.0 113.279 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.23 -38.8 88.78 Favored 'General case' 0 N--CA 1.539 3.984 0 C-N-CA 124.728 1.211 . . . . 0.0 110.357 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -60.09 -28.48 67.87 Favored 'General case' 1 N--CA 1.543 4.203 0 O-C-N 121.575 -0.703 . . . . 0.0 111.878 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.71 -36.97 44.75 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.155 0 CA-C-O 121.916 0.865 . . . . 0.0 109.512 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.59 -27.13 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.292 0 C-N-CA 126.395 1.878 . . . . 0.0 110.695 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -54.09 -27.11 30.74 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.139 0.576 . . . . 0.0 111.797 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.84 86.86 Favored 'General case' 0 N--CA 1.527 3.405 0 O-C-N 122.038 -0.414 . . . . 0.0 110.367 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 14.0 m -70.51 -31.75 47.53 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.025 0 CA-C-N 118.09 0.404 . . . . 0.0 110.085 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.66 -33.7 61.11 Favored 'General case' 0 N--CA 1.53 3.563 0 C-N-CA 123.521 0.729 . . . . 0.0 110.629 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 64.3 m -58.6 -46.95 85.9 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 21.7 tp -65.56 -34.88 79.28 Favored 'General case' 1 N--CA 1.549 4.505 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.81 -38.88 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -65.46 -23.89 67.03 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 123.251 0.62 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 11.5 tpt85 -49.73 -37.24 28.55 Favored 'General case' 0 N--CA 1.516 2.849 0 CA-C-O 121.753 0.787 . . . . 0.0 110.76 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.75 -37.33 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.015 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.83 -28.7 58.37 Favored 'General case' 1 N--CA 1.54 4.031 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -89.71 -3.05 58.39 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 124.615 1.166 . . . . 0.0 109.133 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.92 -24.34 33.96 Favored Glycine 1 N--CA 1.526 4.67 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 176.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -121.2 143.97 48.84 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 113.042 -1.579 . . . . 0.0 107.769 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 90.1 p -82.57 146.66 53.94 Favored Pre-proline 0 N--CA 1.53 3.527 0 CA-C-O 117.305 -1.331 . . . . 0.0 110.239 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.5 131.34 42.08 Favored 'Trans proline' 0 C--N 1.399 3.193 0 CA-C-N 121.614 1.612 . . . . 0.0 111.169 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 61.6 mt -65.81 -167.14 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.19 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 N--CA 1.523 3.195 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.355 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.511 2.62 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -68.16 -48.25 65.82 Favored 'General case' 0 N--CA 1.528 3.468 0 CA-C-O 121.711 0.767 . . . . 0.0 110.741 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -61.54 -33.45 73.87 Favored 'General case' 0 N--CA 1.527 3.382 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.101 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.4 mm -76.23 -34.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.456 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -53.41 26.3 Favored 'General case' 1 N--CA 1.546 4.372 0 O-C-N 121.721 -0.612 . . . . 0.0 111.988 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.9 tt -55.52 -35.3 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 CA-C-O 122.479 1.133 . . . . 0.0 110.234 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -58.83 -33.68 70.68 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 112.933 -1.939 . . . . 0.0 110.478 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.0 mm -68.64 -37.93 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.072 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 24.1 mt -58.25 -39.23 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.25 -44.42 99.1 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.015 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 67.0 t -64.36 -30.35 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.943 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.83 -33.73 88.01 Favored Glycine 0 N--CA 1.514 3.883 0 C-N-CA 123.87 0.748 . . . . 0.0 112.124 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.9 m -68.16 -37.04 80.59 Favored 'General case' 0 N--CA 1.526 3.331 0 C-N-CA 123.362 0.665 . . . . 0.0 111.009 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.97 -43.23 91.34 Favored 'General case' 0 N--CA 1.537 3.921 0 C-N-CA 123.212 0.605 . . . . 0.0 111.787 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.7 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.268 0.8 OUTLIER -63.66 -48.88 84.67 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -175.718 . . . . . . . . 5 4 . 1 . 001 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.43 -25.61 65.26 Favored Glycine 1 N--CA 1.526 4.694 0 O-C-N 120.704 -1.248 . . . . 0.0 112.981 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.33 -38.74 88.37 Favored 'General case' 0 N--CA 1.536 3.86 0 C-N-CA 124.116 0.967 . . . . 0.0 110.604 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 696' ' ' ARG . . . . . 0.413 ' HE ' ' CD1' ' C' ' 693' ' ' ILE . 13.9 mmt180 -52.03 -23.74 5.66 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 18.6 tt -51.96 -36.42 19.77 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.178 0 CA-C-N 119.444 1.02 . . . . 0.0 111.333 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 11.2 p -54.64 -27.42 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 C-N-CA 124.235 1.014 . . . . 0.0 111.107 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -55.07 -28.79 55.02 Favored 'General case' 1 N--CA 1.545 4.319 0 O-C-N 121.692 -0.63 . . . . 0.0 109.879 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.19 -45.03 67.49 Favored 'General case' 0 N--CA 1.522 3.14 0 CA-C-O 122.031 0.92 . . . . 0.0 108.966 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.7 -34.31 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.816 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.233 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.6 tp -55.64 -34.81 65.27 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.965 0.906 . . . . 0.0 111.021 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 51.0 m -59.1 -45.02 91.94 Favored 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 35.7 tp -67.66 -34.8 77.65 Favored 'General case' 0 N--CA 1.538 3.95 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 66.1 t -67.86 -39.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.828 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 706' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 710' ' ' GLN . 16.1 m120 -59.21 -23.63 62.44 Favored 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.891 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 22.8 tpt85 -48.07 -41.02 24.93 Favored 'General case' 0 N--CA 1.524 3.269 0 CA-C-O 121.372 0.606 . . . . 0.0 110.84 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 52.9 t -72.6 -41.97 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-N 114.689 -1.141 . . . . 0.0 107.944 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -76.72 -11.35 59.83 Favored 'General case' 1 N--CA 1.545 4.298 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.417 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 710' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 706' ' ' ASN . 1.4 tm0? -111.87 -10.4 14.0 Favored 'General case' 0 N--CA 1.516 2.851 0 C-N-CA 125.549 1.54 . . . . 0.0 107.634 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.13 -22.83 7.04 Favored Glycine 1 N--CA 1.518 4.135 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -98.39 153.46 18.55 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 124.076 0.95 . . . . 0.0 109.472 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 66.1 m -80.51 152.17 72.55 Favored Pre-proline 0 N--CA 1.526 3.345 0 C-N-CA 126.859 2.064 . . . . 0.0 111.216 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 C--N 1.401 3.302 0 CA-C-N 121.527 1.581 . . . . 0.0 111.74 -174.719 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.518 2.929 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -63.36 -49.52 73.55 Favored 'General case' 0 N--CA 1.532 3.643 0 CA-C-N 118.367 0.531 . . . . 0.0 111.32 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -64.0 -31.53 72.75 Favored 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.88 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.02 -32.22 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.864 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.26 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -51.57 48.87 Favored 'General case' 1 N--CA 1.554 4.745 0 CA-C-N 118.713 0.688 . . . . 0.0 112.057 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.8 tt -62.1 -31.66 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-O 122.029 0.918 . . . . 0.0 110.779 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -51.94 -35.29 45.34 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.762 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.22 -41.56 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.082 0 C-N-CA 124.607 1.163 . . . . 0.0 108.788 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 47.3 mt -60.38 -37.37 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 64.0 mt -64.62 -44.79 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.43 -30.32 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 C-N-CA 123.827 0.851 . . . . 0.0 108.727 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.26 -30.58 78.1 Favored Glycine 1 N--CA 1.517 4.054 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 32.4 m -68.79 -37.59 79.4 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.431 0.692 . . . . 0.0 111.413 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.32 -41.4 75.94 Favored 'General case' 0 N--CA 1.535 3.781 0 C-N-CA 123.443 0.697 . . . . 0.0 111.932 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.748 HD11 ' HE ' ' C' ' 696' ' ' ARG 0.292 0.3 OUTLIER -60.7 -46.1 96.47 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.386 0 CA-C-N 118.956 0.798 . . . . 0.0 112.206 -176.485 . . . . . . . . 5 4 . 1 . 001 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.83 -27.68 64.67 Favored Glycine 1 N--CA 1.528 4.833 0 CA-C-N 119.159 0.89 . . . . 0.0 112.307 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.4 tt -67.93 -37.38 81.58 Favored 'General case' 1 N--CA 1.548 4.431 0 C-N-CA 125.126 1.37 . . . . 0.0 109.31 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 696' ' ' ARG . . . . . 0.7 ' HE ' HD11 ' A' ' 693' ' ' ILE . 25.0 mmt180 -62.89 -27.37 69.31 Favored 'General case' 1 N--CA 1.54 4.073 0 C-N-CA 123.806 0.842 . . . . 0.0 112.336 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.51 -38.78 50.73 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.593 0 CA-C-O 122.477 1.132 . . . . 0.0 109.473 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 64.3 t -57.21 -29.6 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.032 0 C-N-CA 126.962 2.105 . . . . 0.0 111.293 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -53.75 -26.92 25.7 Favored 'General case' 0 N--CA 1.534 3.774 0 C-N-CA 122.976 0.51 . . . . 0.0 111.16 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.42 -35.14 67.48 Favored 'General case' 0 N--CA 1.528 3.449 0 O-C-N 121.956 -0.465 . . . . 0.0 109.849 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.7 -32.7 53.32 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.343 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 7.9 tp -54.97 -33.67 62.62 Favored 'General case' 0 N--CA 1.539 3.999 0 C-N-CA 124.087 0.955 . . . . 0.0 110.421 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 84.9 p -59.01 -45.73 89.94 Favored 'General case' 0 N--CA 1.528 3.471 0 O-C-N 122.344 -0.223 . . . . 0.0 111.21 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.09 -36.56 84.0 Favored 'General case' 1 N--CA 1.548 4.427 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.74 -42.09 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.427 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -75.48 -21.41 58.09 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 123.126 0.57 . . . . 0.0 110.101 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.18 -42.63 60.98 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.52 -42.35 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.903 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -75.31 -7.54 54.23 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.225 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.99 -14.76 17.73 Favored 'General case' 1 N--CA 1.546 4.33 0 C-N-CA 124.201 1.0 . . . . 0.0 108.825 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -84.33 -18.15 63.08 Favored Glycine 1 N--CA 1.522 4.378 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -87.93 152.35 22.13 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 126.72 2.008 . . . . 0.0 108.285 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 67.0 m -93.23 148.63 36.0 Favored Pre-proline 1 N--CA 1.547 4.381 0 C-N-CA 125.914 1.686 . . . . 0.0 113.764 -176.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.404 3.46 0 CA-C-N 120.788 1.317 . . . . 0.0 109.76 -176.84 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 7.1 tt . . . . . 0 N--CA 1.516 2.86 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -61.6 -49.75 75.36 Favored 'General case' 0 N--CA 1.529 3.522 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -66.01 -33.73 76.48 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 95.5 mt -74.34 -25.33 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.807 0 C-N-CA 124.789 1.236 . . . . 0.0 110.445 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -50.69 62.52 Favored 'General case' 1 N--CA 1.555 4.82 0 CA-C-N 119.682 1.128 . . . . 0.0 110.133 -178.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.2 tt -66.25 -31.06 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 C-N-CA 123.71 0.804 . . . . 0.0 109.115 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -54.86 -28.38 49.66 Favored 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.015 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 21.4 mm -68.5 -44.13 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 C-N-CA 123.689 0.796 . . . . 0.0 109.548 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.71 -41.0 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.59 -47.35 93.36 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.91 -30.11 47.83 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.161 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.05 82.47 Favored Glycine 1 N--CA 1.516 4.029 0 C-N-CA 123.625 0.631 . . . . 0.0 112.408 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 62.4 m -67.9 -37.07 81.27 Favored 'General case' 0 N--CA 1.533 3.681 0 C-N-CA 123.463 0.705 . . . . 0.0 111.698 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.91 -40.81 77.01 Favored 'General case' 0 N--CA 1.533 3.689 0 C-N-CA 123.339 0.656 . . . . 0.0 111.868 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 693' ' ' ILE . . . . . 0.421 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -60.62 -39.89 82.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.181 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -71.41 -25.56 75.11 Favored Glycine 1 N--CA 1.531 5.002 0 O-C-N 121.074 -1.016 . . . . 0.0 111.107 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.85 -43.38 98.96 Favored 'General case' 0 N--CA 1.535 3.806 0 C-N-CA 123.99 0.916 . . . . 0.0 109.392 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 696' ' ' ARG . . . . . 0.748 ' HE ' HD11 ' B' ' 693' ' ' ILE . 10.1 mmt180 -54.2 -25.49 23.07 Favored 'General case' 0 N--CA 1.539 3.986 0 C-N-CA 125.045 1.338 . . . . 0.0 114.565 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 72.2 mt -53.84 -37.54 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.863 0 CA-C-N 118.541 0.609 . . . . 0.0 109.841 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.05 -26.18 32.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.238 0 C-N-CA 124.965 1.306 . . . . 0.0 111.971 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -53.59 -27.54 27.16 Favored 'General case' 1 N--CA 1.549 4.523 0 O-C-N 120.972 -1.08 . . . . 0.0 110.219 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.41 -46.07 91.67 Favored 'General case' 0 N--CA 1.525 3.325 0 O-C-N 121.967 -0.458 . . . . 0.0 110.881 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.1 -31.33 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.63 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.68 -34.16 57.79 Favored 'General case' 0 N--CA 1.536 3.86 0 C-N-CA 123.12 0.568 . . . . 0.0 110.742 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 86.9 p -59.67 -46.35 89.3 Favored 'General case' 0 N--CA 1.532 3.642 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 45.7 tp -65.8 -35.68 81.39 Favored 'General case' 1 N--CA 1.542 4.147 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.31 -43.45 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.38 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -68.4 -25.43 65.04 Favored 'General case' 0 N--CA 1.515 2.8 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.25 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.09 -43.92 61.15 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 119.087 0.858 . . . . 0.0 109.233 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.25 -47.39 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.1 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -74.73 -15.72 60.77 Favored 'General case' 0 N--CA 1.535 3.792 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.895 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -114.12 -3.86 13.2 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -48.83 -27.81 6.71 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 124.399 0.999 . . . . 0.0 111.796 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -75.44 155.18 36.56 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 31.1 t -77.76 146.96 73.6 Favored Pre-proline 0 N--CA 1.536 3.865 0 C-N-CA 125.001 1.32 . . . . 0.0 112.584 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -58.51 129.95 35.02 Favored 'Trans proline' 0 C--N 1.408 3.699 0 CA-C-N 120.643 1.265 . . . . 0.0 110.234 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 60.3 tp . . . . . 0 N--CA 1.525 3.304 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.0 178.712 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 683' ' ' ARG . 18.6 mt . . . . . 0 N--CA 1.504 2.272 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -55.97 -45.38 78.92 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -73.18 -38.71 66.06 Favored 'General case' 0 N--CA 1.533 3.706 0 CA-C-O 121.555 0.693 . . . . 0.0 109.485 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.6 mm -74.89 -26.0 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 125.072 1.349 . . . . 0.0 111.276 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 683' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 679' ' ' LEU . 56.5 ttt180 -67.06 -55.7 13.21 Favored 'General case' 1 N--CA 1.542 4.146 0 C-N-CA 123.976 0.91 . . . . 0.0 110.56 -177.276 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.3 tt -64.4 -32.54 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.537 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -52.57 -44.02 65.62 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.946 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 66.5 mt -68.54 -37.22 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.445 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 42.9 mt -65.89 -34.69 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.697 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 48.3 mm -63.72 -42.46 96.05 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.383 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 88.0 t -64.98 -29.88 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.882 0 C-N-CA 123.664 0.786 . . . . 0.0 108.959 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -61.19 -36.84 93.01 Favored Glycine 1 N--CA 1.522 4.413 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 53.4 m -68.91 -37.34 78.89 Favored 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 124.027 0.931 . . . . 0.0 111.451 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.8 mp -58.04 -38.97 77.24 Favored 'General case' 1 N--CA 1.546 4.332 0 C-N-CA 124.175 0.99 . . . . 0.0 112.346 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.806 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.268 1.3 tp -69.23 -45.76 78.78 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.205 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -73.7 -12.21 80.66 Favored Glycine 1 N--CA 1.525 4.578 0 O-C-N 120.744 -1.222 . . . . 0.0 112.046 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 695' ' ' LEU . . . . . 0.426 ' O ' HD23 ' A' ' 695' ' ' LEU . 6.1 tt -70.48 -41.28 72.92 Favored 'General case' 0 N--CA 1.535 3.8 0 C-N-CA 124.127 0.971 . . . . 0.0 109.745 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 696' ' ' ARG . . . . . 0.841 ' HE ' HD11 ' C' ' 693' ' ' ILE . 22.8 mmt180 -52.51 -28.41 20.39 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.952 0.901 . . . . 0.0 113.054 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 42.0 mm -56.39 -43.81 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.332 0 C-N-CA 124.041 0.936 . . . . 0.0 112.486 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 3.3 p -66.66 -51.91 51.32 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.623 0 CA-C-N 118.702 0.683 . . . . 0.0 112.618 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 699' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' A' ' 702' ' ' LEU 0.522 0.9 OUTLIER -54.8 -18.93 5.39 Favored 'General case' 0 C--O 1.165 -3.392 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.255 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -51.93 -29.51 20.52 Favored 'General case' 1 N--CA 1.539 4.012 0 O-C-N 120.93 -1.106 . . . . 0.0 109.009 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 12.7 m -62.75 -29.27 46.63 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.491 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 699' ' ' PHE . 7.1 tt -50.5 -34.64 25.88 Favored 'General case' 1 N--CA 1.541 4.113 0 C-N-CA 125.311 1.445 . . . . 0.0 110.955 -178.304 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 68.0 m -59.34 -45.32 91.7 Favored 'General case' 0 N--CA 1.534 3.772 0 CA-C-N 118.467 0.576 . . . . 0.0 110.78 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.06 -35.21 80.0 Favored 'General case' 1 N--CA 1.54 4.025 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.1 t -68.06 -39.78 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.788 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 706' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 710' ' ' GLN . 3.1 m120 -64.82 -24.6 67.6 Favored 'General case' 0 N--CA 1.512 2.674 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.61 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 707' ' ' ARG . . . . . 0.468 HH12 ' NH2' ' B' ' 707' ' ' ARG . 21.6 tpt180 -47.71 -30.86 4.16 Favored 'General case' 0 N--CA 1.529 3.486 0 C-N-CA 123.3 0.64 . . . . 0.0 111.446 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.1 t -75.03 -47.89 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.59 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.97 -12.19 59.96 Favored 'General case' 1 N--CA 1.549 4.496 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.707 179.254 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 710' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 706' ' ' ASN . 51.9 tt0 -112.81 -4.15 14.05 Favored 'General case' 0 N--CA 1.518 2.963 0 C-N-CA 125.591 1.556 . . . . 0.0 108.065 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.68 -27.84 50.35 Favored Glycine 0 N--CA 1.509 3.548 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -96.8 153.12 18.07 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 123.677 0.791 . . . . 0.0 109.138 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 50.8 m -80.89 149.32 66.86 Favored Pre-proline 0 N--CA 1.526 3.37 0 C-N-CA 125.965 1.706 . . . . 0.0 111.315 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo . . . . . 0 C--N 1.403 3.43 0 CA-C-N 122.019 1.757 . . . . 0.0 111.059 -177.75 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -61.61 -49.24 77.37 Favored 'General case' 0 N--CA 1.534 3.768 0 CA-C-N 118.394 0.543 . . . . 0.0 112.316 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.14 -37.82 86.65 Favored 'General case' 0 N--CA 1.525 3.325 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.43 -29.39 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.916 0 C-N-CA 125.397 1.479 . . . . 0.0 110.921 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -50.98 60.67 Favored 'General case' 1 N--CA 1.547 4.389 0 C-N-CA 123.601 0.76 . . . . 0.0 111.719 -177.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -30.84 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 124.068 0.947 . . . . 0.0 109.808 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -56.18 -34.49 66.27 Favored 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.58 1.152 . . . . 0.0 110.441 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 24.3 mm -60.43 -37.52 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.581 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.31 -40.02 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.114 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.93 -48.52 87.46 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.28 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.86 -31.37 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.761 0 C-N-CA 123.839 0.855 . . . . 0.0 109.688 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.37 -32.31 83.76 Favored Glycine 1 N--CA 1.516 4.021 0 C-N-CA 123.607 0.622 . . . . 0.0 112.439 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 62.5 m -67.98 -36.9 80.82 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 123.507 0.723 . . . . 0.0 111.971 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 9.0 mp -54.68 -41.75 70.56 Favored 'General case' 0 N--CA 1.537 3.885 0 C-N-CA 123.431 0.692 . . . . 0.0 112.737 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.422 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.2 OUTLIER -60.37 -43.94 94.9 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.297 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -174.975 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -66.43 -28.49 73.75 Favored Glycine 1 N--CA 1.525 4.617 0 O-C-N 121.177 -0.952 . . . . 0.0 111.746 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -62.1 -42.13 98.91 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 124.529 1.131 . . . . 0.0 110.682 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 696' ' ' ARG . . . . . 0.806 ' HE ' HD11 ' A' ' 693' ' ' ILE . 25.1 mmt180 -52.33 -25.62 10.09 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.33 -37.61 37.48 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.501 0 CA-C-N 120.538 1.517 . . . . 0.0 112.26 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.3 p -54.36 -27.66 17.49 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.128 0 C-N-CA 124.523 1.129 . . . . 0.0 112.063 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -52.08 -25.66 9.23 Favored 'General case' 0 N--CA 1.537 3.89 0 C-N-CA 123.357 0.663 . . . . 0.0 110.104 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.45 68.88 Favored 'General case' 0 N--CA 1.52 3.031 0 C-N-CA 122.72 0.408 . . . . 0.0 110.17 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -69.42 -30.39 45.42 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 8.8 tp -52.53 -35.32 53.14 Favored 'General case' 0 N--CA 1.537 3.881 0 C-N-CA 122.974 0.51 . . . . 0.0 110.71 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 1.6 t -58.74 -46.16 88.05 Favored 'General case' 1 N--CA 1.54 4.045 0 CA-C-N 118.824 0.738 . . . . 0.0 112.081 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 34.5 tp -66.38 -34.77 78.71 Favored 'General case' 1 N--CA 1.542 4.174 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.87 -38.51 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -63.58 -24.04 67.64 Favored 'General case' 0 N--CA 1.522 3.168 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.01 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 707' ' ' ARG . . . . . 0.468 ' NH2' HH12 ' A' ' 707' ' ' ARG . 17.2 tpt180 -49.56 -47.75 48.95 Favored 'General case' 0 N--CA 1.522 3.149 0 CA-C-O 121.8 0.809 . . . . 0.0 110.438 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 51.3 t -63.14 -37.46 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.712 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.456 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -75.31 -28.06 59.55 Favored 'General case' 0 N--CA 1.531 3.624 0 CA-C-O 121.18 0.514 . . . . 0.0 109.896 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -89.91 -4.87 57.3 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.963 1.305 . . . . 0.0 108.466 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.75 -23.42 29.49 Favored Glycine 1 N--CA 1.523 4.434 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -120.27 141.25 50.16 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 125.33 1.452 . . . . 0.0 107.59 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 68.5 m -82.97 146.61 52.38 Favored Pre-proline 0 N--CA 1.529 3.502 0 CA-C-O 117.285 -1.34 . . . . 0.0 110.157 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo . . . . . 0 C--N 1.395 3.004 0 CA-C-N 121.701 1.643 . . . . 0.0 109.192 -178.157 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.521 3.113 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -65.64 -48.75 71.1 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.813 0.445 . . . . 0.0 111.891 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -64.64 -34.46 78.33 Favored 'General case' 0 N--CA 1.529 3.495 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 93.9 mt -74.86 -24.89 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.946 0 C-N-CA 124.944 1.298 . . . . 0.0 110.662 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -66.18 -53.14 41.06 Favored 'General case' 1 N--CA 1.547 4.423 0 CA-C-N 118.999 0.818 . . . . 0.0 110.529 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.3 tt -66.34 -30.77 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.228 0 C-N-CA 123.873 0.869 . . . . 0.0 109.422 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -53.32 -31.28 43.41 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.926 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 16.5 mm -67.99 -46.93 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.015 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.4 -34.39 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.752 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 79.0 mt -68.33 -44.82 83.42 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.327 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.98 -30.67 45.99 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.44 -42.04 96.09 Favored Glycine 1 N--CA 1.523 4.47 0 C-N-CA 123.88 0.753 . . . . 0.0 112.658 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 70.2 m -67.36 -36.83 82.19 Favored 'General case' 0 N--CA 1.529 3.477 0 CA-C-O 122.232 1.015 . . . . 0.0 109.94 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.67 -41.11 80.89 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 113.306 -1.77 . . . . 0.0 113.037 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 693' ' ' ILE . . . . . 0.841 HD11 ' HE ' ' A' ' 696' ' ' ARG . 0.6 OUTLIER -68.85 -47.66 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -176.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.22 -25.87 60.68 Favored Glycine 1 N--CA 1.53 4.941 0 CA-C-N 119.62 1.1 . . . . 0.0 112.441 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.07 -42.59 99.7 Favored 'General case' 0 N--CA 1.534 3.773 0 C-N-CA 124.348 1.059 . . . . 0.0 109.237 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -53.94 -26.59 26.25 Favored 'General case' 0 N--CA 1.532 3.674 0 C-N-CA 124.927 1.291 . . . . 0.0 113.88 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 76.1 mt -54.64 -38.3 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 C-N-CA 123.413 0.685 . . . . 0.0 111.699 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.52 -28.91 23.5 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.263 0 C-N-CA 123.643 0.777 . . . . 0.0 112.55 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -52.66 -27.49 17.51 Favored 'General case' 0 N--CA 1.536 3.854 0 C-N-CA 122.978 0.511 . . . . 0.0 110.826 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.63 -33.52 66.37 Favored 'General case' 0 N--CA 1.531 3.597 0 O-C-N 121.877 -0.514 . . . . 0.0 110.259 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.8 -30.95 48.79 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.222 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 7.1 tp -52.83 -33.03 47.51 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.75 0.82 . . . . 0.0 110.441 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 83.4 p -58.08 -46.07 86.08 Favored 'General case' 0 N--CA 1.53 3.531 0 O-C-N 121.766 -0.584 . . . . 0.0 111.572 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.25 -36.09 82.52 Favored 'General case' 1 N--CA 1.544 4.246 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.9 t -68.54 -41.48 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -68.07 -22.91 64.91 Favored 'General case' 0 N--CA 1.514 2.751 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.219 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -49.85 -47.31 51.74 Favored 'General case' 0 N--CA 1.511 2.62 0 CA-C-O 121.932 0.872 . . . . 0.0 109.124 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.4 -40.06 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.416 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.93 -22.9 55.52 Favored 'General case' 0 N--CA 1.534 3.775 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -89.15 -13.52 38.21 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -53.85 -27.33 36.17 Favored Glycine 1 N--CA 1.517 4.076 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -95.34 154.67 17.08 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 124.36 1.064 . . . . 0.0 108.849 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 99.4 p -80.3 149.57 69.32 Favored Pre-proline 0 N--CA 1.529 3.508 0 C-N-CA 126.388 1.875 . . . . 0.0 111.363 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -56.45 131.29 44.85 Favored 'Trans proline' 0 C--N 1.402 3.392 0 CA-C-N 120.918 1.364 . . . . 0.0 110.289 -174.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 N--CA 1.522 3.132 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.442 -179.225 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 N--CA 1.513 2.686 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -66.77 -51.42 56.0 Favored 'General case' 0 N--CA 1.532 3.64 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.95 -32.84 74.75 Favored 'General case' 0 N--CA 1.526 3.373 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 91.4 mt -74.62 -29.84 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.544 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -59.33 -52.78 64.18 Favored 'General case' 1 N--CA 1.555 4.789 0 CA-C-O 122.264 1.03 . . . . 0.0 110.942 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.8 tt -70.37 -32.28 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.715 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.079 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -50.13 -25.03 3.13 Favored 'General case' 0 N--CA 1.53 3.528 0 C-N-CA 123.85 0.86 . . . . 0.0 112.549 -174.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.91 -35.17 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 17.3 pt -64.01 -39.15 84.42 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.416 0 CA-C-N 120.016 1.28 . . . . 0.0 109.62 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.1 -48.73 85.8 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.254 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 50.4 t -67.39 -41.38 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 124.513 1.125 . . . . 0.0 110.03 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.61 90.92 Favored Glycine 1 N--CA 1.522 4.402 0 C-N-CA 125.241 1.4 . . . . 0.0 112.798 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 74.2 m -67.28 -35.26 79.13 Favored 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 124.29 1.036 . . . . 0.0 108.415 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.21 -47.07 86.7 Favored 'General case' 0 N--CA 1.523 3.208 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.768 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.516 HD11 ' HE ' ' B' ' 696' ' ' ARG . 0.0 OUTLIER -70.82 -27.93 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.868 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.39 -29.36 70.12 Favored Glycine 1 N--CA 1.528 4.833 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.7 tt -67.01 -40.12 87.21 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 125.581 1.552 . . . . 0.0 110.36 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 696' ' ' ARG . . . . . 0.475 ' HE ' HD11 ' C' ' 693' ' ' ILE . 38.4 mmt180 -52.27 -25.42 9.34 Favored 'General case' 0 N--CA 1.531 3.611 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 15.8 tt -54.13 -38.99 40.3 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.172 0 CA-C-N 119.302 0.955 . . . . 0.0 113.096 -175.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 10.3 p -57.33 -30.44 35.55 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.164 0 C-N-CA 123.412 0.685 . . . . 0.0 111.672 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -53.97 -25.25 19.85 Favored 'General case' 0 N--CA 1.537 3.886 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.05 -34.45 63.57 Favored 'General case' 0 N--CA 1.523 3.199 0 O-C-N 122.035 -0.415 . . . . 0.0 109.933 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.47 -32.02 51.43 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.209 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.2 -33.03 51.0 Favored 'General case' 0 N--CA 1.535 3.82 0 C-N-CA 123.811 0.844 . . . . 0.0 110.77 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 68.5 m -58.03 -45.64 86.62 Favored 'General case' 0 N--CA 1.531 3.612 0 O-C-N 121.652 -0.655 . . . . 0.0 110.919 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.04 -34.49 78.56 Favored 'General case' 1 N--CA 1.543 4.19 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 48.0 t -67.63 -39.66 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -67.77 -25.95 65.87 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.372 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -50.05 -41.65 48.16 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.543 0.687 . . . . 0.0 111.173 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 68.1 t -61.68 -38.97 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -76.14 -20.62 57.43 Favored 'General case' 0 N--CA 1.524 3.257 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.503 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -88.66 -12.45 42.41 Favored 'General case' 0 N--CA 1.518 2.956 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -60.2 -13.82 30.01 Favored Glycine 1 N--CA 1.517 4.076 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 177.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -108.56 154.57 21.76 Favored 'General case' 0 N--CA 1.532 3.665 0 C-N-CA 125.06 1.344 . . . . 0.0 109.77 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 48.4 t -80.47 150.13 69.79 Favored Pre-proline 0 N--CA 1.53 3.571 0 C-N-CA 126.107 1.763 . . . . 0.0 110.877 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo . . . . . 0 C--N 1.402 3.359 0 CA-C-N 122.247 1.838 . . . . 0.0 113.221 -172.744 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 679' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' B' ' 683' ' ' ARG . 63.7 mt . . . . . 0 N--CA 1.514 2.75 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -59.45 -43.44 93.16 Favored 'General case' 0 N--CA 1.532 3.661 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -72.34 -37.32 68.88 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 93.0 mt -74.82 -25.16 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 C-N-CA 125.029 1.332 . . . . 0.0 111.862 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 683' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' B' ' 679' ' ' LEU . 17.4 ttp180 -66.13 -52.24 50.39 Favored 'General case' 1 N--CA 1.549 4.481 0 C-N-CA 124.381 1.072 . . . . 0.0 110.577 -177.116 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.46 -32.77 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 CA-C-N 113.692 -1.595 . . . . 0.0 108.815 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -54.1 -30.79 49.91 Favored 'General case' 0 N--CA 1.52 3.028 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.276 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 17.9 mm -68.87 -41.85 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.626 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 40.3 mt -71.39 -34.86 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.016 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 50.8 mm -58.7 -40.19 78.7 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.668 0 CA-C-N 119.449 1.022 . . . . 0.0 109.738 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.41 -31.95 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.534 0 C-N-CA 123.704 0.802 . . . . 0.0 110.501 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.32 -32.34 79.37 Favored Glycine 1 N--CA 1.517 4.037 0 C-N-CA 123.404 0.526 . . . . 0.0 112.683 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 58.9 m -67.5 -36.96 82.09 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.719 0.808 . . . . 0.0 111.63 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 9.4 mp -56.55 -45.79 81.05 Favored 'General case' 0 N--CA 1.537 3.907 0 C-N-CA 123.44 0.696 . . . . 0.0 112.681 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.738 HD11 ' HE ' ' C' ' 696' ' ' ARG . 1.0 OUTLIER -62.71 -49.04 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -175.475 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.9 -25.21 65.62 Favored Glycine 1 N--CA 1.525 4.601 0 CA-C-N 119.628 1.103 . . . . 0.0 113.12 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 4.4 tt -66.74 -41.86 87.18 Favored 'General case' 0 N--CA 1.535 3.797 0 C-N-CA 124.567 1.147 . . . . 0.0 110.639 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 696' ' ' ARG . . . . . 0.516 ' HE ' HD11 ' A' ' 693' ' ' ILE . 26.7 mmt180 -52.13 -25.26 8.48 Favored 'General case' 0 N--CA 1.536 3.833 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.8 tt -54.14 -36.88 33.64 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 CA-C-N 119.878 1.217 . . . . 0.0 112.066 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.14 -27.97 17.21 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.012 0 C-N-CA 124.332 1.053 . . . . 0.0 111.779 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -52.15 -25.82 9.89 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 123.402 0.681 . . . . 0.0 109.756 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.73 -38.43 69.77 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 122.767 0.427 . . . . 0.0 110.017 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.24 -32.01 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.956 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.42 -36.45 61.53 Favored 'General case' 0 N--CA 1.537 3.897 0 C-N-CA 122.908 0.483 . . . . 0.0 110.809 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 26.5 m -62.11 -47.21 85.63 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.83 -35.92 79.45 Favored 'General case' 1 N--CA 1.545 4.32 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.14 -43.25 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.365 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -71.29 -20.99 62.14 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.876 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -47.73 -46.7 30.03 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 40.1 t -59.35 -41.59 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.389 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -76.69 -22.11 54.43 Favored 'General case' 0 N--CA 1.533 3.678 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.866 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -8.3 36.22 Favored 'General case' 0 N--CA 1.517 2.916 0 C-N-CA 124.925 1.29 . . . . 0.0 108.44 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.12 -32.49 35.71 Favored Glycine 1 N--CA 1.516 4.015 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -100.81 130.99 46.91 Favored 'General case' 0 N--CA 1.529 3.507 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 88.1 p -81.94 146.8 56.52 Favored Pre-proline 0 N--CA 1.527 3.422 0 C-N-CA 124.947 1.299 . . . . 0.0 110.627 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo . . . . . 0 C--N 1.399 3.195 0 CA-C-N 121.334 1.512 . . . . 0.0 109.445 -177.538 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.53 3.568 0 CA-C-O 121.244 0.545 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -69.78 -40.07 76.25 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.217 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -65.68 -37.37 86.3 Favored 'General case' 0 N--CA 1.52 3.046 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.036 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 26.9 pt -73.09 -25.7 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 CA-C-N 118.347 0.521 . . . . 0.0 110.627 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -50.07 70.86 Favored 'General case' 1 N--CA 1.546 4.361 0 C-N-CA 122.806 0.443 . . . . 0.0 110.826 -176.241 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.48 -31.95 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.564 0 C-N-CA 124.002 0.921 . . . . 0.0 109.7 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -53.9 -41.14 67.28 Favored 'General case' 0 N--CA 1.518 2.969 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.37 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.71 -39.12 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.92 -45.06 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 C-N-CA 123.458 0.703 . . . . 0.0 110.56 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 76.0 mt -59.9 -49.04 85.44 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.42 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.62 -29.65 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.125 0 C-N-CA 125.286 1.434 . . . . 0.0 109.688 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.27 -31.69 81.69 Favored Glycine 1 N--CA 1.519 4.21 0 C-N-CA 123.717 0.675 . . . . 0.0 112.388 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.3 m -68.28 -36.39 79.31 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.962 0.905 . . . . 0.0 111.849 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.27 -35.7 62.83 Favored 'General case' 0 N--CA 1.534 3.755 0 CA-C-O 118.295 -0.859 . . . . 0.0 113.265 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 693' ' ' ILE . . . . . 0.497 ' O ' HD12 ' C' ' 693' ' ' ILE 0.255 0.1 OUTLIER -60.53 -49.98 82.22 Favored 'Isoleucine or valine' 1 N--CA 1.561 5.121 0 CA-C-N 120.272 1.397 . . . . 0.0 112.455 -176.164 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.17 -29.22 68.02 Favored Glycine 1 N--CA 1.532 5.054 0 CA-C-N 119.452 1.024 . . . . 0.0 111.69 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.59 -42.41 98.28 Favored 'General case' 0 N--CA 1.538 3.939 0 C-N-CA 123.653 0.781 . . . . 0.0 109.836 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 696' ' ' ARG . . . . . 0.738 ' HE ' HD11 ' B' ' 693' ' ' ILE . 24.4 mmt180 -53.82 -25.2 18.28 Favored 'General case' 1 N--CA 1.542 4.164 0 C-N-CA 124.673 1.189 . . . . 0.0 113.82 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 70.6 mt -54.94 -39.78 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 O-C-N 121.625 -0.672 . . . . 0.0 110.454 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.36 -30.97 50.85 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.405 0 C-N-CA 123.859 0.864 . . . . 0.0 110.875 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.56 -30.15 65.01 Favored 'General case' 1 N--CA 1.542 4.143 0 O-C-N 121.055 -1.028 . . . . 0.0 111.689 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.98 -37.59 72.73 Favored 'General case' 1 N--CA 1.54 4.025 0 CA-C-O 121.8 0.809 . . . . 0.0 109.104 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.36 -28.05 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.277 0 C-N-CA 125.066 1.346 . . . . 0.0 108.678 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.1 tp -52.25 -32.66 38.11 Favored 'General case' 0 N--CA 1.532 3.643 0 C-N-CA 123.53 0.732 . . . . 0.0 110.108 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 89.1 p -56.56 -46.13 80.87 Favored 'General case' 0 N--CA 1.53 3.553 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 46.5 tp -66.04 -35.11 79.65 Favored 'General case' 1 N--CA 1.547 4.384 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.03 -40.02 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 706' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.0 OUTLIER -71.92 -23.73 61.52 Favored 'General case' 0 N--CA 1.517 2.902 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.225 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -48.47 -32.04 7.24 Favored 'General case' 0 N--CA 1.526 3.357 0 CA-C-N 118.832 0.742 . . . . 0.0 110.499 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.74 -49.07 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -77.84 -10.26 59.47 Favored 'General case' 1 N--CA 1.54 4.06 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.701 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 710' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.6 tt0 -114.14 -9.28 12.93 Favored 'General case' 0 N--CA 1.522 3.145 0 C-N-CA 125.365 1.466 . . . . 0.0 108.759 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -57.58 -30.04 61.74 Favored Glycine 0 N--CA 1.512 3.712 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -80.76 155.13 26.84 Favored 'General case' 0 N--CA 1.524 3.269 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 97.0 p -79.49 149.15 71.39 Favored Pre-proline 0 N--CA 1.528 3.469 0 C-N-CA 126.281 1.832 . . . . 0.0 111.757 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -56.87 131.86 48.11 Favored 'Trans proline' 0 C--N 1.401 3.316 0 CA-C-N 120.669 1.274 . . . . 0.0 111.001 -174.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 N--CA 1.527 3.376 0 C-N-CA 125.616 1.566 . . . . 0.0 110.72 178.739 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 680' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 680' ' ' TRP . . . . . 0.406 ' N ' HD12 ' A' ' 679' ' ' LEU . 95.1 m95 -57.3 -51.1 70.72 Favored 'General case' 0 N--CA 1.533 3.689 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -64.88 -31.28 72.44 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.53 -33.59 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.966 0 C-N-CA 123.879 0.872 . . . . 0.0 108.664 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -51.79 42.42 Favored 'General case' 1 N--CA 1.554 4.748 0 CA-C-N 118.48 0.582 . . . . 0.0 112.11 -177.585 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.39 -38.23 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 CA-C-O 122.496 1.141 . . . . 0.0 110.184 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -52.39 -29.29 23.36 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 113.111 -1.858 . . . . 0.0 111.113 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 28.5 mm -68.46 -37.23 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 C-N-CA 124.244 1.018 . . . . 0.0 109.602 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 37.5 mt -64.9 -38.27 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.268 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.53 -41.72 93.66 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.27 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.76 -30.51 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 C-N-CA 123.965 0.906 . . . . 0.0 109.185 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.16 -34.29 89.26 Favored Glycine 1 N--CA 1.518 4.159 0 C-N-CA 123.382 0.515 . . . . 0.0 111.985 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.5 m -68.67 -37.51 79.66 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.562 0.745 . . . . 0.0 111.172 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.9 mp -57.54 -42.54 83.15 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 123.751 0.82 . . . . 0.0 112.328 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.77 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.274 0.5 OUTLIER -62.44 -48.91 86.09 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.308 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.231 . . . . . . . . 5 4 . 1 . 004 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.44 -30.29 67.91 Favored Glycine 1 N--CA 1.53 4.954 0 CA-C-N 119.814 1.188 . . . . 0.0 112.899 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.94 -41.47 99.51 Favored 'General case' 1 N--CA 1.539 4.013 0 C-N-CA 124.411 1.084 . . . . 0.0 111.234 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -51.71 -24.28 5.55 Favored 'General case' 0 N--CA 1.538 3.933 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 18.5 tt -52.7 -36.03 22.22 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.26 0 CA-C-N 120.143 1.338 . . . . 0.0 111.684 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 12.6 p -54.09 -28.19 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.951 0 C-N-CA 124.304 1.042 . . . . 0.0 111.43 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -55.9 -29.08 59.44 Favored 'General case' 1 N--CA 1.544 4.256 0 O-C-N 121.489 -0.757 . . . . 0.0 109.764 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.7 -43.08 69.72 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 63.0 t -68.87 -33.34 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.112 0 C-N-CA 124.713 1.205 . . . . 0.0 109.105 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.13 -32.62 62.22 Favored 'General case' 0 N--CA 1.535 3.817 0 C-N-CA 124.175 0.99 . . . . 0.0 109.901 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.5 p -59.04 -45.14 91.48 Favored 'General case' 0 N--CA 1.528 3.426 0 O-C-N 121.353 -0.842 . . . . 0.0 111.253 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.21 -33.35 74.39 Favored 'General case' 1 N--CA 1.542 4.152 0 O-C-N 121.431 -0.793 . . . . 0.0 108.959 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.18 -39.22 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.873 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 706' ' ' ASN . . . . . 0.438 ' ND2' HH11 ' A' ' 709' ' ' ARG . 9.3 m120 -62.71 -22.8 66.78 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.693 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -50.38 -41.34 51.72 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-O 121.915 0.864 . . . . 0.0 110.012 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 64.1 t -62.96 -36.68 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 709' ' ' ARG . . . . . 0.438 HH11 ' ND2' ' A' ' 706' ' ' ASN . 50.6 mtm180 -75.7 -3.86 37.1 Favored 'General case' 0 N--CA 1.523 3.195 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.46 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -103.26 -14.9 16.15 Favored 'General case' 1 N--CA 1.552 4.662 0 C-N-CA 123.685 0.794 . . . . 0.0 108.921 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -81.94 -6.65 88.77 Favored Glycine 1 N--CA 1.528 4.82 0 N-CA-C 106.736 -2.546 . . . . 0.0 106.736 173.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -105.47 154.29 20.54 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 128.036 2.534 . . . . 0.0 106.611 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 32.1 t -98.13 147.3 32.89 Favored Pre-proline 1 N--CA 1.556 4.831 0 C-N-CA 125.422 1.489 . . . . 0.0 112.997 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 C--N 1.408 3.668 0 CA-C-N 121.212 1.468 . . . . 0.0 109.048 -176.75 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.516 2.853 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -70.98 -49.79 41.42 Favored 'General case' 0 N--CA 1.535 3.791 0 CA-C-O 121.155 0.503 . . . . 0.0 111.576 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -61.05 -31.42 71.07 Favored 'General case' 0 N--CA 1.533 3.688 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.98 -25.55 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.786 0 C-N-CA 125.913 1.685 . . . . 0.0 111.021 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 683' ' ' ARG . . . . . 0.404 HH11 HD12 ' B' ' 687' ' ' ILE . 0.6 OUTLIER -66.07 -52.29 50.24 Favored 'General case' 1 N--CA 1.547 4.386 0 CA-C-O 121.574 0.702 . . . . 0.0 111.409 -177.964 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.8 tt -68.0 -32.34 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.171 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.594 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -54.27 -30.49 50.75 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 123.827 0.851 . . . . 0.0 111.213 -177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 16.1 mm -66.21 -37.69 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.937 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 687' ' ' ILE . . . . . 0.404 HD12 HH11 ' B' ' 683' ' ' ARG . 38.5 mt -62.3 -38.37 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.1 -46.53 93.41 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.361 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.4 t -62.04 -30.04 47.79 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.26 -31.73 81.82 Favored Glycine 1 N--CA 1.519 4.223 0 C-N-CA 123.562 0.601 . . . . 0.0 112.455 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 61.4 m -68.58 -36.92 79.41 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.658 0.783 . . . . 0.0 111.367 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.56 -43.19 79.73 Favored 'General case' 0 N--CA 1.536 3.868 0 C-N-CA 123.713 0.805 . . . . 0.0 112.52 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.801 HD11 ' HE ' ' C' ' 696' ' ' ARG 0.281 0.6 OUTLIER -60.42 -48.97 86.16 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.621 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.091 . . . . . . . . 5 4 . 1 . 004 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.77 -26.95 71.43 Favored Glycine 1 N--CA 1.533 5.121 0 CA-C-N 120.734 1.606 . . . . 0.0 112.373 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 5.3 tt -62.95 -43.05 99.86 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.806 0.843 . . . . 0.0 110.955 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 696' ' ' ARG . . . . . 0.77 ' HE ' HD11 ' A' ' 693' ' ' ILE . 26.0 mmt180 -53.14 -27.12 19.38 Favored 'General case' 1 N--CA 1.539 4.003 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 70.9 mt -54.74 -37.95 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.51 0 C-N-CA 123.954 0.902 . . . . 0.0 111.794 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.11 -31.61 42.11 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.301 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -54.23 -25.76 24.88 Favored 'General case' 0 N--CA 1.539 3.988 0 CA-C-N 118.793 0.724 . . . . 0.0 111.207 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.1 -37.78 69.85 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 121.65 -0.656 . . . . 0.0 110.248 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.22 -32.59 54.38 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 13.4 tp -54.87 -35.32 63.93 Favored 'General case' 0 N--CA 1.533 3.689 0 C-N-CA 123.154 0.581 . . . . 0.0 110.498 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 80.8 p -59.01 -48.41 81.67 Favored 'General case' 0 N--CA 1.521 3.119 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.22 -35.09 79.16 Favored 'General case' 1 N--CA 1.549 4.517 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.647 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.53 -38.78 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 706' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' B' ' 710' ' ' GLN . 2.2 p30 -62.24 -25.81 68.03 Favored 'General case' 0 N--CA 1.521 3.084 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.625 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 18.6 tpt85 -46.82 -32.56 3.78 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.617 0.767 . . . . 0.0 111.362 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 63.3 t -75.53 -48.8 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.36 -11.03 59.92 Favored 'General case' 1 N--CA 1.543 4.182 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.839 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 710' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' B' ' 706' ' ' ASN . 28.2 tt0 -113.63 -10.64 13.09 Favored 'General case' 0 N--CA 1.519 3.018 0 C-N-CA 125.929 1.692 . . . . 0.0 108.556 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.74 -24.43 32.92 Favored Glycine 0 N--CA 1.51 3.608 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -95.48 152.82 18.08 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 123.461 0.705 . . . . 0.0 109.226 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 48.7 m -81.31 150.76 68.26 Favored Pre-proline 0 N--CA 1.533 3.686 0 C-N-CA 126.264 1.826 . . . . 0.0 111.267 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 C--N 1.402 3.382 0 CA-C-N 121.984 1.744 . . . . 0.0 112.33 -175.509 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.521 3.117 0 CA-C-O 121.425 0.631 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -70.15 -45.38 66.9 Favored 'General case' 0 N--CA 1.513 2.72 0 C-N-CA 124.809 1.244 . . . . 0.0 111.204 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -61.74 -38.78 89.22 Favored 'General case' 0 N--CA 1.518 2.939 0 CA-C-N 113.978 -1.464 . . . . 0.0 111.659 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 26.5 pt -72.45 -36.6 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 C-N-CA 122.671 0.388 . . . . 0.0 111.01 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -52.86 -51.23 61.78 Favored 'General case' 0 N--CA 1.539 3.98 0 CA-C-O 121.7 0.762 . . . . 0.0 111.625 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.23 -34.48 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.828 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -55.54 -43.74 76.07 Favored 'General case' 0 N--CA 1.537 3.891 0 C-N-CA 123.618 0.767 . . . . 0.0 109.523 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.51 -37.76 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.814 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 41.5 mt -71.08 -41.99 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 49.1 mm -59.68 -48.79 86.15 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.472 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 70.8 t -60.73 -30.22 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 C-N-CA 124.136 0.975 . . . . 0.0 109.737 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.27 91.87 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 123.307 0.479 . . . . 0.0 112.488 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 66.7 m -67.5 -37.07 82.28 Favored 'General case' 0 N--CA 1.528 3.472 0 C-N-CA 123.768 0.827 . . . . 0.0 112.041 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.73 -39.9 68.73 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 123.434 0.694 . . . . 0.0 112.312 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -40.85 86.28 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.07 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -174.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -71.71 -27.38 71.04 Favored Glycine 1 N--CA 1.527 4.721 0 O-C-N 121.173 -0.954 . . . . 0.0 110.973 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.48 -42.59 99.01 Favored 'General case' 0 N--CA 1.531 3.581 0 C-N-CA 124.176 0.99 . . . . 0.0 109.651 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 696' ' ' ARG . . . . . 0.801 ' HE ' HD11 ' B' ' 693' ' ' ILE . 25.5 mmt180 -53.96 -26.46 25.83 Favored 'General case' 0 N--CA 1.537 3.896 0 C-N-CA 124.471 1.109 . . . . 0.0 113.846 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 73.9 mt -54.62 -38.59 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 C-N-CA 123.578 0.751 . . . . 0.0 111.342 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 5.8 p -56.01 -27.33 22.82 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.324 0 C-N-CA 124.074 0.95 . . . . 0.0 112.281 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -51.73 -27.33 11.62 Favored 'General case' 0 N--CA 1.538 3.964 0 C-N-CA 123.311 0.645 . . . . 0.0 111.179 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.3 -34.11 66.19 Favored 'General case' 0 N--CA 1.532 3.649 0 O-C-N 121.857 -0.527 . . . . 0.0 109.952 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.1 m -69.36 -31.82 50.99 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.093 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 6.9 tp -53.5 -35.67 60.89 Favored 'General case' 0 N--CA 1.538 3.959 0 C-N-CA 123.293 0.637 . . . . 0.0 110.373 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 88.8 p -61.32 -47.8 84.28 Favored 'General case' 0 N--CA 1.516 2.867 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 45.9 tp -67.71 -35.52 78.95 Favored 'General case' 1 N--CA 1.546 4.331 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 74.7 t -69.04 -46.09 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -76.03 -23.36 55.15 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 123.515 0.51 . . . . 0.0 110.799 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -46.15 62.58 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.03 -43.23 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.891 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.682 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -75.96 -5.85 48.19 Favored 'General case' 0 N--CA 1.538 3.933 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.404 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -113.02 -12.67 13.19 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 125.619 1.568 . . . . 0.0 107.934 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.16 -33.8 31.08 Favored Glycine 0 N--CA 1.513 3.807 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -82.66 153.83 25.2 Favored 'General case' 0 N--CA 1.526 3.327 0 CA-C-N 114.201 -1.0 . . . . 0.0 108.626 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 59.8 m -80.2 149.23 69.08 Favored Pre-proline 0 N--CA 1.531 3.612 0 C-N-CA 126.201 1.8 . . . . 0.0 111.274 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -56.21 130.03 38.01 Favored 'Trans proline' 0 C--N 1.402 3.36 0 CA-C-N 121.175 1.455 . . . . 0.0 110.792 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 N--CA 1.524 3.273 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.56 -179.941 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 28.2 tp . . . . . 0 N--CA 1.514 2.752 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -64.69 -36.24 83.65 Favored 'General case' 0 N--CA 1.528 3.436 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -72.54 -36.64 68.32 Favored 'General case' 0 N--CA 1.533 3.68 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.33 -24.46 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 C-N-CA 124.725 1.21 . . . . 0.0 109.882 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -67.14 -53.44 30.62 Favored 'General case' 1 N--CA 1.554 4.75 0 CA-C-N 119.488 1.04 . . . . 0.0 112.334 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.11 -32.01 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 C-N-CA 124.234 1.014 . . . . 0.0 109.727 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -56.82 -32.28 65.57 Favored 'General case' 0 N--CA 1.508 2.474 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.234 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 24.2 mm -68.33 -46.02 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 C-N-CA 124.172 0.989 . . . . 0.0 109.344 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.64 -35.95 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.178 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.301 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.67 -48.13 90.13 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.215 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.36 -31.36 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.533 0.733 . . . . 0.0 109.83 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.27 -50.44 65.0 Favored Glycine 1 N--CA 1.52 4.261 0 C-N-CA 124.082 0.849 . . . . 0.0 112.494 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.2 m -58.66 -35.37 72.45 Favored 'General case' 0 N--CA 1.533 3.719 0 C-N-CA 124.475 1.11 . . . . 0.0 111.015 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 2.1 tp -53.81 -34.82 60.38 Favored 'General case' 0 N--CA 1.512 2.636 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.127 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.408 ' O ' HD13 ' A' ' 693' ' ' ILE . 0.3 OUTLIER -60.45 -38.96 79.66 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -177.088 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -72.87 -29.89 64.42 Favored Glycine 1 N--CA 1.519 4.232 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.2 tt -59.75 -42.47 93.29 Favored 'General case' 1 N--CA 1.541 4.076 0 C-N-CA 124.496 1.118 . . . . 0.0 110.944 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -51.31 -24.7 4.86 Favored 'General case' 0 N--CA 1.527 3.398 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 10.1 tp -53.05 -37.61 27.2 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.671 0 CA-C-N 119.837 1.199 . . . . 0.0 112.689 -176.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.18 -28.11 17.5 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.444 0 C-N-CA 124.222 1.009 . . . . 0.0 110.981 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -56.04 -27.65 54.13 Favored 'General case' 0 N--CA 1.536 3.833 0 O-C-N 121.506 -0.747 . . . . 0.0 110.008 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -66.98 -44.55 80.15 Favored 'General case' 0 N--CA 1.526 3.336 0 CA-C-O 122.18 0.99 . . . . 0.0 108.645 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 84.2 t -68.77 -33.72 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.173 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.36 -33.93 63.84 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 123.506 0.723 . . . . 0.0 110.161 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 86.0 p -58.08 -46.27 85.75 Favored 'General case' 0 N--CA 1.53 3.537 0 O-C-N 121.788 -0.57 . . . . 0.0 111.985 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.54 -35.85 82.32 Favored 'General case' 1 N--CA 1.542 4.175 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.78 -39.9 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -66.19 -24.29 66.6 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.314 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -49.55 -46.67 49.01 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 124.027 0.931 . . . . 0.0 110.48 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.65 -50.85 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.482 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -80.66 -3.45 50.63 Favored 'General case' 1 N--CA 1.55 4.536 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -111.57 -13.25 13.84 Favored 'General case' 0 N--CA 1.539 3.999 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.74 -31.19 53.54 Favored Glycine 0 N--CA 1.514 3.866 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -80.24 155.09 27.5 Favored 'General case' 0 N--CA 1.521 3.079 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 67.8 m -79.4 149.68 72.5 Favored Pre-proline 0 N--CA 1.532 3.629 0 C-N-CA 126.307 1.843 . . . . 0.0 112.111 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.402 3.391 0 CA-C-N 120.614 1.255 . . . . 0.0 110.817 -174.056 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.528 3.464 0 CA-C-O 120.987 0.422 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -69.93 -36.16 75.12 Favored 'General case' 0 N--CA 1.522 3.136 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.451 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -40.73 76.76 Favored 'General case' 0 N--CA 1.531 3.586 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.893 -176.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 682' ' ' ILE . . . . . 0.534 HD12 ' N ' ' B' ' 683' ' ' ARG . 2.0 pp -72.19 -25.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 CA-C-N 118.701 0.682 . . . . 0.0 110.905 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 683' ' ' ARG . . . . . 0.534 ' N ' HD12 ' B' ' 682' ' ' ILE . 0.0 OUTLIER -67.05 -52.7 38.98 Favored 'General case' 1 N--CA 1.539 4.008 0 C-N-CA 123.988 0.915 . . . . 0.0 112.34 -177.739 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.4 tt -70.93 -30.16 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 123.833 0.853 . . . . 0.0 110.752 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -36.36 24.77 Favored 'General case' 0 N--CA 1.524 3.227 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.239 -173.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 686' ' ' ILE . . . . . 0.462 ' N ' HD12 ' B' ' 686' ' ' ILE . 1.5 mp -69.48 -37.55 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.311 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 34.4 mt -58.87 -35.04 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 35.8 mm -66.65 -46.7 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.28 -31.14 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 C-N-CA 123.85 0.86 . . . . 0.0 108.843 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.2 94.05 Favored Glycine 1 N--CA 1.523 4.436 0 C-N-CA 123.808 0.718 . . . . 0.0 111.817 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 71.1 m -69.09 -41.04 78.03 Favored 'General case' 0 N--CA 1.518 2.957 0 C-N-CA 123.563 0.745 . . . . 0.0 110.765 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.42 -45.91 88.8 Favored 'General case' 0 N--CA 1.535 3.806 0 C-N-CA 123.484 0.714 . . . . 0.0 112.614 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.683 HD11 ' HE ' ' C' ' 696' ' ' ARG . 0.0 OUTLIER -64.5 -34.98 73.13 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.719 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.1 -28.84 71.1 Favored Glycine 1 N--CA 1.527 4.721 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.3 tt -65.06 -43.52 91.97 Favored 'General case' 0 N--CA 1.531 3.614 0 C-N-CA 124.375 1.07 . . . . 0.0 109.808 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -54.96 -26.33 35.74 Favored 'General case' 0 N--CA 1.537 3.895 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 64.3 mt -55.18 -39.2 50.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 C-N-CA 123.236 0.614 . . . . 0.0 112.147 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.63 -28.64 23.56 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.51 0 C-N-CA 123.672 0.789 . . . . 0.0 112.468 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -51.77 -26.16 9.07 Favored 'General case' 0 N--CA 1.531 3.613 0 C-N-CA 123.2 0.6 . . . . 0.0 111.304 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.33 -32.33 62.42 Favored 'General case' 0 N--CA 1.53 3.569 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.8 m -69.26 -31.18 48.75 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.212 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 4.4 tp -53.46 -32.51 50.34 Favored 'General case' 0 N--CA 1.538 3.943 0 C-N-CA 123.671 0.789 . . . . 0.0 110.556 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 67.9 p -57.41 -45.33 84.69 Favored 'General case' 0 N--CA 1.532 3.642 0 O-C-N 121.759 -0.588 . . . . 0.0 111.019 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.11 -35.11 79.69 Favored 'General case' 1 N--CA 1.539 4.023 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.77 -40.0 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -63.47 -21.8 66.52 Favored 'General case' 0 N--CA 1.519 3.025 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.631 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -47.42 -47.55 26.63 Favored 'General case' 0 N--CA 1.519 3.022 0 C-N-CA 123.335 0.654 . . . . 0.0 109.495 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 52.7 t -58.95 -42.85 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.18 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -77.21 -15.51 59.46 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.681 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -95.5 -14.44 23.68 Favored 'General case' 1 N--CA 1.553 4.676 0 C-N-CA 124.123 0.969 . . . . 0.0 109.865 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -87.72 -26.43 29.65 Favored Glycine 1 N--CA 1.523 4.438 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -75.59 146.95 39.99 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 126.01 1.724 . . . . 0.0 108.567 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 50.9 m -88.43 149.55 44.78 Favored Pre-proline 0 N--CA 1.537 3.922 0 C-N-CA 125.637 1.575 . . . . 0.0 113.266 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 C--N 1.402 3.359 0 CA-C-N 121.513 1.576 . . . . 0.0 111.983 -178.014 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.526 3.359 0 CA-C-O 120.926 0.393 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -68.13 -39.26 82.75 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.42 0.688 . . . . 0.0 111.429 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -68.82 -38.61 80.0 Favored 'General case' 0 N--CA 1.521 3.082 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.082 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 11.5 pt -73.24 -38.96 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -45.32 62.23 Favored 'General case' 0 N--CA 1.534 3.739 0 C-N-CA 123.237 0.615 . . . . 0.0 111.276 -176.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.7 tt -74.38 -34.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.939 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -60.31 -38.59 84.15 Favored 'General case' 0 N--CA 1.536 3.837 0 C-N-CA 124.018 0.927 . . . . 0.0 109.593 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.3 -37.05 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.081 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.377 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 8.2 mm -67.15 -43.44 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 41.4 mm -59.15 -49.14 84.43 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.359 0 CA-C-O 120.581 0.229 . . . . 0.0 110.529 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.23 -31.33 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -68.66 -36.5 83.05 Favored Glycine 0 N--CA 1.51 3.605 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.462 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 65.3 m -68.15 -36.77 80.2 Favored 'General case' 0 N--CA 1.529 3.497 0 CA-C-O 121.935 0.874 . . . . 0.0 110.006 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.17 -45.88 75.75 Favored 'General case' 0 N--CA 1.521 3.114 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.683 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 693' ' ' ILE . . . . . 0.54 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.1 OUTLIER -70.15 -35.98 65.91 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.056 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -176.676 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -75.12 -16.42 80.6 Favored Glycine 1 N--CA 1.522 4.417 0 O-C-N 121.648 -0.658 . . . . 0.0 111.72 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.25 -41.72 85.15 Favored 'General case' 0 N--CA 1.538 3.956 0 C-N-CA 124.489 1.116 . . . . 0.0 108.491 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 696' ' ' ARG . . . . . 0.683 ' HE ' HD11 ' B' ' 693' ' ' ILE . 32.0 mmt180 -52.12 -23.61 5.67 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 125.286 1.435 . . . . 0.0 114.362 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 11.0 tp -54.33 -38.51 40.38 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.431 0 CA-C-N 119.052 0.842 . . . . 0.0 112.777 -177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.89 -29.45 21.66 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.177 0 C-N-CA 124.356 1.063 . . . . 0.0 112.353 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -53.04 -25.05 11.17 Favored 'General case' 0 N--CA 1.533 3.694 0 C-N-CA 123.375 0.67 . . . . 0.0 110.086 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.15 70.53 Favored 'General case' 0 N--CA 1.523 3.195 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.35 -32.08 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.64 -34.77 59.7 Favored 'General case' 0 N--CA 1.537 3.88 0 C-N-CA 122.923 0.489 . . . . 0.0 110.314 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 58.9 m -59.28 -47.03 86.92 Favored 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 36.7 tp -66.62 -34.73 78.54 Favored 'General case' 1 N--CA 1.549 4.486 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.76 -38.39 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.371 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.95 -23.31 63.46 Favored 'General case' 0 N--CA 1.521 3.088 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.186 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -48.03 -46.06 32.68 Favored 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 121.873 0.844 . . . . 0.0 110.554 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.09 -43.45 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -77.12 -9.57 58.83 Favored 'General case' 0 N--CA 1.531 3.595 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.439 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -89.63 -15.48 32.62 Favored 'General case' 1 N--CA 1.547 4.376 0 C-N-CA 123.53 0.732 . . . . 0.0 109.782 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -71.6 -6.55 62.84 Favored Glycine 1 N--CA 1.524 4.547 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -75.97 155.14 35.31 Favored 'General case' 0 N--CA 1.512 2.632 0 C-N-CA 125.451 1.5 . . . . 0.0 109.027 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 95.9 p -100.48 146.96 32.91 Favored Pre-proline 0 N--CA 1.53 3.55 0 C-N-CA 125.357 1.463 . . . . 0.0 108.725 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -63.75 130.27 27.36 Favored 'Trans proline' 0 N--CA 1.521 3.105 0 CA-C-N 121.493 1.569 . . . . 0.0 109.061 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.525 3.307 0 C-N-CA 125.312 1.445 . . . . 0.0 109.926 -178.904 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.515 2.821 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -68.72 -50.43 50.81 Favored 'General case' 0 N--CA 1.529 3.513 0 CA-C-O 121.406 0.622 . . . . 0.0 111.989 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -61.5 -34.66 75.88 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.4 -24.95 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 C-N-CA 125.357 1.463 . . . . 0.0 110.074 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -66.79 -54.75 19.42 Favored 'General case' 1 N--CA 1.559 5.012 0 CA-C-N 119.592 1.087 . . . . 0.0 110.523 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.38 -30.78 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.945 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -55.26 -31.67 61.73 Favored 'General case' 0 N--CA 1.513 2.679 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.764 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 20.4 mm -64.11 -46.04 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.073 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 48.3 mt -56.93 -36.32 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.47 -45.3 85.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.13 -30.21 49.13 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.42 -32.79 85.37 Favored Glycine 1 N--CA 1.518 4.123 0 C-N-CA 123.596 0.617 . . . . 0.0 112.059 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 69.0 m -68.17 -36.95 80.44 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.558 0.743 . . . . 0.0 111.329 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.13 -44.16 83.09 Favored 'General case' 0 N--CA 1.538 3.962 0 C-N-CA 123.518 0.727 . . . . 0.0 112.363 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.533 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.257 0.5 OUTLIER -61.4 -49.69 83.45 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.293 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -175.587 . . . . . . . . 5 4 . 1 . 006 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.34 -24.47 67.51 Favored Glycine 1 N--CA 1.527 4.741 0 CA-C-N 119.877 1.217 . . . . 0.0 112.721 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.5 tt -65.03 -43.27 92.94 Favored 'General case' 0 N--CA 1.535 3.816 0 C-N-CA 123.68 0.792 . . . . 0.0 109.715 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -53.39 -27.29 23.26 Favored 'General case' 1 N--CA 1.54 4.048 0 C-N-CA 124.199 1.0 . . . . 0.0 113.228 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.08 -38.21 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 C-N-CA 123.463 0.705 . . . . 0.0 110.36 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 2.0 p -55.71 -26.29 19.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.129 0 C-N-CA 124.566 1.146 . . . . 0.0 111.725 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -51.89 -26.02 9.28 Favored 'General case' 0 N--CA 1.539 3.995 0 C-N-CA 123.25 0.62 . . . . 0.0 110.777 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.69 -44.48 81.53 Favored 'General case' 0 N--CA 1.528 3.45 0 O-C-N 121.868 -0.52 . . . . 0.0 110.503 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 3.0 m -70.3 -33.49 54.46 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.433 0 CA-C-N 118.8 0.727 . . . . 0.0 109.969 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 4.7 tp -54.97 -33.21 62.2 Favored 'General case' 0 N--CA 1.537 3.885 0 C-N-CA 123.626 0.77 . . . . 0.0 109.857 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 96.0 p -59.36 -48.14 82.75 Favored 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 36.3 tp -63.94 -34.05 77.09 Favored 'General case' 1 N--CA 1.548 4.46 0 O-C-N 121.205 -0.935 . . . . 0.0 108.599 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.72 -38.34 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -61.47 -28.24 69.14 Favored 'General case' 0 N--CA 1.536 3.83 0 C-N-CA 122.92 0.488 . . . . 0.0 110.32 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -49.21 -47.52 46.08 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 121.714 0.769 . . . . 0.0 109.143 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.48 -36.3 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.666 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.1 -27.79 60.02 Favored 'General case' 0 N--CA 1.532 3.672 0 CA-C-O 120.925 0.393 . . . . 0.0 110.047 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -90.14 -13.47 35.63 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 124.623 1.169 . . . . 0.0 109.184 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.8 -25.64 9.69 Favored Glycine 1 N--CA 1.521 4.349 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -115.9 151.37 35.46 Favored 'General case' 0 N--CA 1.533 3.715 0 C-N-CA 124.573 1.149 . . . . 0.0 108.801 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 69.4 m -82.79 147.26 54.57 Favored Pre-proline 0 N--CA 1.528 3.442 0 C-N-CA 125.408 1.483 . . . . 0.0 109.694 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 C--N 1.396 3.067 0 CA-C-N 121.805 1.68 . . . . 0.0 110.03 -176.799 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.8 tt . . . . . 0 N--CA 1.514 2.759 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -68.32 -48.21 65.51 Favored 'General case' 0 N--CA 1.528 3.432 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -62.32 -31.96 72.65 Favored 'General case' 0 N--CA 1.536 3.872 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.05 -25.24 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.029 0 C-N-CA 125.628 1.571 . . . . 0.0 111.007 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -52.32 59.23 Favored 'General case' 1 N--CA 1.55 4.537 0 CA-C-N 118.677 0.672 . . . . 0.0 110.475 -178.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 18.5 tt -71.21 -30.29 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.664 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -51.06 -36.56 40.52 Favored 'General case' 0 N--CA 1.525 3.296 0 CA-C-O 121.64 0.733 . . . . 0.0 111.819 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.67 -36.73 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 C-N-CA 125.196 1.399 . . . . 0.0 109.677 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 18.1 mm -61.56 -41.08 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.8 -44.5 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.85 -30.7 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.799 0 C-N-CA 123.566 0.746 . . . . 0.0 109.087 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.66 -32.48 83.24 Favored Glycine 1 N--CA 1.52 4.271 0 C-N-CA 123.399 0.523 . . . . 0.0 112.114 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.6 m -68.18 -37.13 80.64 Favored 'General case' 0 N--CA 1.524 3.236 0 C-N-CA 123.597 0.759 . . . . 0.0 111.175 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.35 -44.19 84.11 Favored 'General case' 0 N--CA 1.539 3.996 0 C-N-CA 123.674 0.79 . . . . 0.0 112.391 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.451 ' CD1' ' HE ' ' C' ' 696' ' ' ARG 0.291 0.1 OUTLIER -67.22 -48.25 78.98 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.48 0 C-N-CA 123.036 0.534 . . . . 0.0 110.478 -176.292 . . . . . . . . 5 4 . 1 . 006 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -54.89 -34.77 57.68 Favored Glycine 1 N--CA 1.53 4.945 0 O-C-N 121.379 -0.826 . . . . 0.0 112.416 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 9.5 tt -72.45 -40.41 67.06 Favored 'General case' 0 N--CA 1.534 3.768 0 C-N-CA 125.159 1.383 . . . . 0.0 109.859 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 696' ' ' ARG . . . . . 0.533 ' HE ' HD11 ' A' ' 693' ' ' ILE . 11.7 tpp180 -51.64 -24.5 5.64 Favored 'General case' 0 N--CA 1.531 3.597 0 C-N-CA 126.317 1.847 . . . . 0.0 113.823 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.21 -35.63 30.35 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 C-N-CA 123.789 0.836 . . . . 0.0 112.273 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -52.97 -27.49 12.97 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 C-N-CA 124.503 1.121 . . . . 0.0 111.903 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -52.38 -25.52 10.05 Favored 'General case' 0 N--CA 1.539 3.981 0 C-N-CA 123.635 0.774 . . . . 0.0 109.909 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -57.5 -37.52 73.09 Favored 'General case' 0 N--CA 1.524 3.261 0 O-C-N 121.53 -0.731 . . . . 0.0 109.882 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.47 -33.17 55.99 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.349 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.16 -32.93 50.29 Favored 'General case' 1 N--CA 1.546 4.326 0 C-N-CA 124.303 1.041 . . . . 0.0 109.603 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 69.3 m -59.41 -45.35 91.76 Favored 'General case' 1 N--CA 1.543 4.215 0 O-C-N 120.207 -1.558 . . . . 0.0 111.088 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.71 -35.04 78.43 Favored 'General case' 1 N--CA 1.552 4.665 0 O-C-N 121.071 -1.018 . . . . 0.0 108.987 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.73 -38.5 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.469 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -55.02 -35.64 64.63 Favored 'General case' 0 N--CA 1.529 3.5 0 CA-C-O 121.258 0.552 . . . . 0.0 109.8 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -54.09 -47.44 71.73 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 122.367 1.08 . . . . 0.0 109.802 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.65 -32.05 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -77.52 -18.35 57.11 Favored 'General case' 0 N--CA 1.531 3.616 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.03 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -87.33 -14.97 39.29 Favored 'General case' 1 N--CA 1.552 4.633 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.85 -24.11 32.63 Favored Glycine 1 N--CA 1.521 4.313 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -121.53 152.95 38.63 Favored 'General case' 1 N--CA 1.542 4.135 0 C-N-CA 125.158 1.383 . . . . 0.0 110.408 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 92.4 p -82.7 148.7 58.59 Favored Pre-proline 0 N--CA 1.534 3.734 0 C-N-CA 126.344 1.857 . . . . 0.0 111.292 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.527 3.466 0 CA-C-N 121.411 1.54 . . . . 0.0 111.632 -174.669 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.687 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -72.14 -28.83 63.5 Favored 'General case' 0 N--CA 1.53 3.547 0 O-C-N 121.896 -0.503 . . . . 0.0 110.814 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -70.66 -34.12 71.68 Favored 'General case' 0 N--CA 1.526 3.341 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.077 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 23.3 pt -72.03 -26.3 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.464 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -51.44 69.53 Favored 'General case' 1 N--CA 1.541 4.084 0 C-N-CA 123.73 0.812 . . . . 0.0 112.023 -177.147 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.5 tt -73.14 -31.84 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.792 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.168 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -54.17 -29.25 44.94 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.879 0.872 . . . . 0.0 110.346 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 6.5 mm -68.68 -38.75 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.822 0 C-N-CA 123.78 0.832 . . . . 0.0 109.593 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.93 -41.75 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.257 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.46 -44.6 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.34 -30.4 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.06 -37.6 93.02 Favored Glycine 1 N--CA 1.52 4.263 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 68.1 m -68.47 -37.89 80.56 Favored 'General case' 0 N--CA 1.523 3.177 0 C-N-CA 123.581 0.752 . . . . 0.0 111.02 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.74 -45.57 93.77 Favored 'General case' 0 N--CA 1.536 3.842 0 C-N-CA 123.07 0.548 . . . . 0.0 111.576 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 1.5 tp -60.96 -49.39 84.91 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.362 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.18 -22.59 63.13 Favored Glycine 1 N--CA 1.528 4.817 0 O-C-N 120.402 -1.436 . . . . 0.0 112.566 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.55 -41.4 79.85 Favored 'General case' 0 N--CA 1.533 3.69 0 CA-C-O 121.769 0.795 . . . . 0.0 108.993 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 696' ' ' ARG . . . . . 0.451 ' HE ' ' CD1' ' B' ' 693' ' ' ILE . 25.4 mmt180 -53.72 -24.2 14.07 Favored 'General case' 0 N--CA 1.534 3.769 0 C-N-CA 124.765 1.226 . . . . 0.0 113.409 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 75.0 mt -53.24 -35.81 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 C-N-CA 123.484 0.714 . . . . 0.0 110.549 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 5.5 m -54.27 -26.27 15.07 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.377 0 C-N-CA 123.981 0.913 . . . . 0.0 111.687 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -53.97 -31.12 49.66 Favored 'General case' 0 N--CA 1.531 3.587 0 C-N-CA 123.278 0.631 . . . . 0.0 112.144 -173.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -71.4 -45.05 63.73 Favored 'General case' 0 N--CA 1.529 3.479 0 CA-C-O 121.99 0.9 . . . . 0.0 108.833 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.64 -34.76 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.089 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.71 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.13 -34.24 71.81 Favored 'General case' 0 N--CA 1.52 3.063 0 C-N-CA 124.674 1.19 . . . . 0.0 110.027 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 54.7 m -58.97 -46.58 87.71 Favored 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.72 -36.49 84.46 Favored 'General case' 1 N--CA 1.543 4.204 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.77 -40.97 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.669 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -66.28 -23.29 66.37 Favored 'General case' 0 N--CA 1.515 2.804 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.833 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -49.35 -47.18 47.61 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 123.43 0.692 . . . . 0.0 110.153 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.94 -48.17 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.966 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.148 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -76.7 -4.81 45.2 Favored 'General case' 0 N--CA 1.534 3.752 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.881 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -114.5 -12.82 12.26 Favored 'General case' 0 N--CA 1.52 3.036 0 C-N-CA 124.769 1.228 . . . . 0.0 108.849 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -49.86 -31.89 17.62 Favored Glycine 0 N--CA 1.51 3.618 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -78.28 153.75 31.53 Favored 'General case' 0 N--CA 1.523 3.183 0 CA-C-O 121.694 0.759 . . . . 0.0 109.084 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 99.5 p -80.11 149.83 70.42 Favored Pre-proline 0 N--CA 1.53 3.546 0 C-N-CA 126.72 2.008 . . . . 0.0 112.283 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -56.18 131.08 43.69 Favored 'Trans proline' 0 C--N 1.403 3.418 0 CA-C-N 120.761 1.308 . . . . 0.0 110.341 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 57.6 tp . . . . . 0 N--CA 1.527 3.398 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.615 -179.671 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.509 2.509 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -61.88 -50.37 72.51 Favored 'General case' 0 N--CA 1.53 3.569 0 CA-C-O 121.407 0.623 . . . . 0.0 112.345 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -63.16 -35.5 80.5 Favored 'General case' 0 N--CA 1.522 3.137 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.401 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 95.6 mt -74.85 -28.08 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 C-N-CA 125.246 1.418 . . . . 0.0 110.995 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -50.97 58.28 Favored 'General case' 1 N--CA 1.559 4.984 0 CA-C-N 119.873 1.215 . . . . 0.0 110.282 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 14.3 tt -64.52 -32.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 124.199 0.999 . . . . 0.0 109.088 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -53.85 -33.04 55.13 Favored 'General case' 0 N--CA 1.518 2.936 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.906 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.24 -42.51 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.861 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.706 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.02 -34.9 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.31 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 60.8 mt -64.62 -44.64 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.95 -30.76 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 C-N-CA 123.7 0.8 . . . . 0.0 109.047 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.21 -31.88 82.25 Favored Glycine 1 N--CA 1.52 4.26 0 C-N-CA 123.427 0.537 . . . . 0.0 112.005 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.1 m -69.04 -37.26 78.47 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.476 0.71 . . . . 0.0 111.279 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.05 -44.59 91.83 Favored 'General case' 1 N--CA 1.539 4.024 0 C-N-CA 123.298 0.639 . . . . 0.0 112.574 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 693' ' ' ILE 0.268 0.1 OUTLIER -62.46 -48.76 86.77 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.742 0 CA-C-N 118.314 0.506 . . . . 0.0 111.714 -175.929 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.6 -23.78 61.13 Favored Glycine 1 N--CA 1.527 4.754 0 O-C-N 121.778 -0.576 . . . . 0.0 113.068 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.24 -42.12 72.63 Favored 'General case' 0 N--CA 1.539 3.995 0 C-N-CA 124.617 1.167 . . . . 0.0 110.705 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -52.55 -25.62 10.96 Favored 'General case' 0 N--CA 1.537 3.918 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 8.7 tp -54.5 -37.8 39.44 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.401 0 CA-C-N 119.897 1.226 . . . . 0.0 112.677 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.76 -30.47 22.66 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 C-N-CA 123.441 0.696 . . . . 0.0 111.733 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -54.46 -26.45 31.19 Favored 'General case' 0 N--CA 1.534 3.726 0 C-N-CA 122.934 0.493 . . . . 0.0 109.706 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.9 68.4 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 122.664 0.386 . . . . 0.0 110.096 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.0 -31.09 49.01 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.002 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 6.2 tp -53.31 -33.96 55.5 Favored 'General case' 0 N--CA 1.534 3.751 0 C-N-CA 123.158 0.583 . . . . 0.0 110.113 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 83.8 p -58.05 -46.03 86.05 Favored 'General case' 0 N--CA 1.531 3.579 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 39.5 tp -66.96 -35.19 79.42 Favored 'General case' 1 N--CA 1.54 4.034 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 58.8 t -69.06 -42.23 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.637 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -67.24 -23.45 65.71 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.466 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -50.76 -48.29 59.32 Favored 'General case' 0 N--CA 1.512 2.633 0 CA-C-O 121.671 0.748 . . . . 0.0 109.427 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.88 -41.04 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.583 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -76.08 -20.67 57.5 Favored 'General case' 0 N--CA 1.536 3.854 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.806 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -99.1 -11.91 21.0 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 125.355 1.462 . . . . 0.0 109.434 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.94 -31.12 24.18 Favored Glycine 1 N--CA 1.519 4.213 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 177.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -107.92 142.67 37.67 Favored 'General case' 0 N--CA 1.534 3.768 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 68.8 m -82.42 146.83 54.89 Favored Pre-proline 0 N--CA 1.528 3.468 0 C-N-CA 125.296 1.438 . . . . 0.0 111.201 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--N 1.402 3.382 0 CA-C-N 121.326 1.509 . . . . 0.0 109.342 -177.726 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 N--CA 1.526 3.355 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -71.46 -29.55 64.98 Favored 'General case' 0 N--CA 1.528 3.443 0 O-C-N 121.831 -0.543 . . . . 0.0 111.033 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -70.52 -36.53 73.8 Favored 'General case' 0 N--CA 1.517 2.923 0 CA-C-O 118.639 -0.695 . . . . 0.0 111.255 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 682' ' ' ILE . . . . . 0.555 HD12 ' N ' ' B' ' 683' ' ' ARG . 2.2 pp -71.6 -23.79 22.87 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.293 0 CA-C-N 119.544 1.065 . . . . 0.0 110.121 179.199 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 683' ' ' ARG . . . . . 0.555 ' N ' HD12 ' B' ' 682' ' ' ILE . 0.2 OUTLIER -61.03 -53.08 61.56 Favored 'General case' 0 N--CA 1.532 3.655 0 CA-C-O 121.511 0.672 . . . . 0.0 112.309 -176.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 18.7 tt -74.76 -31.78 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.078 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -52.25 -45.79 65.5 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.376 1.07 . . . . 0.0 111.869 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.52 -36.79 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.422 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 12.0 mm -60.36 -41.58 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.44 -44.18 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.55 -31.59 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.836 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.61 -44.6 97.31 Favored Glycine 1 N--CA 1.521 4.342 0 C-N-CA 124.071 0.843 . . . . 0.0 112.316 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.4 m -68.18 -37.48 81.0 Favored 'General case' 0 N--CA 1.527 3.382 0 CA-C-O 122.121 0.962 . . . . 0.0 110.022 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 2.2 tp -58.59 -45.31 89.36 Favored 'General case' 0 N--CA 1.518 2.962 0 CA-C-N 113.339 -1.755 . . . . 0.0 113.379 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.491 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.1 OUTLIER -70.52 -38.75 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.857 0 C-N-CA 122.714 0.406 . . . . 0.0 111.751 -177.433 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.53 -28.1 67.04 Favored Glycine 1 N--CA 1.53 4.944 0 O-C-N 121.014 -1.054 . . . . 0.0 112.16 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 4.9 tt -66.46 -40.31 89.33 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 125.02 1.328 . . . . 0.0 110.213 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 696' ' ' ARG . . . . . 0.478 ' HE ' HD11 ' A' ' 693' ' ' ILE . 36.1 mmt180 -51.02 -24.68 3.95 Favored 'General case' 0 N--CA 1.528 3.473 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.8 tt -53.5 -35.96 26.6 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 CA-C-N 119.329 0.968 . . . . 0.0 111.947 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 13.4 p -53.39 -30.01 17.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 C-N-CA 124.278 1.031 . . . . 0.0 111.617 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -57.34 -28.14 62.87 Favored 'General case' 0 N--CA 1.536 3.855 0 O-C-N 121.53 -0.731 . . . . 0.0 110.697 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.13 -41.76 73.5 Favored 'General case' 0 N--CA 1.529 3.508 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.59 -32.02 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.716 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 15.6 tp -54.12 -31.02 51.05 Favored 'General case' 1 N--CA 1.542 4.128 0 C-N-CA 123.516 0.726 . . . . 0.0 109.114 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 62.7 m -56.63 -45.3 81.62 Favored 'General case' 0 N--CA 1.535 3.814 0 O-C-N 121.194 -0.941 . . . . 0.0 111.762 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.14 -34.78 78.85 Favored 'General case' 1 N--CA 1.547 4.4 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.86 -39.21 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -61.28 -22.44 64.86 Favored 'General case' 0 N--CA 1.523 3.189 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -52.34 -44.75 65.33 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-O 121.96 0.886 . . . . 0.0 109.462 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 98.7 t -58.16 -37.1 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.715 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -77.64 -5.68 51.2 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.434 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -89.22 -17.33 29.28 Favored 'General case' 1 N--CA 1.561 5.086 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -81.64 -24.95 55.04 Favored Glycine 1 N--CA 1.521 4.312 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -80.23 152.81 28.91 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 125.898 1.679 . . . . 0.0 108.298 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 97.8 p -102.12 146.79 32.92 Favored Pre-proline 1 N--CA 1.551 4.6 0 C-N-CA 125.222 1.409 . . . . 0.0 114.155 -176.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo . . . . . 0 C--N 1.406 3.553 0 CA-C-N 120.405 1.18 . . . . 0.0 109.939 -178.543 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 N--CA 1.53 3.555 0 CA-C-O 121.703 0.763 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -71.27 -28.6 64.26 Favored 'General case' 0 N--CA 1.524 3.233 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.537 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -72.5 -36.53 68.42 Favored 'General case' 0 N--CA 1.526 3.371 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.957 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 23.8 pt -72.91 -29.11 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 CA-C-N 118.054 0.388 . . . . 0.0 110.082 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -52.59 -54.64 30.27 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-O 121.617 0.722 . . . . 0.0 111.648 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.6 tt -69.43 -30.98 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.818 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.05 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.6 -43.33 99.07 Favored 'General case' 0 N--CA 1.528 3.446 0 CA-C-O 122.88 1.324 . . . . 0.0 109.28 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.33 -44.4 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.744 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.46 -45.62 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 CA-C-O 118.826 -0.607 . . . . 0.0 110.295 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 19.4 tt -62.55 -39.15 83.45 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.625 0 CA-C-N 119.808 1.186 . . . . 0.0 108.64 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 19.7 t -65.88 -29.91 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.763 0 C-N-CA 123.934 0.894 . . . . 0.0 108.753 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -68.75 -24.94 75.42 Favored Glycine 1 N--CA 1.526 4.694 0 CA-C-N 119.017 0.826 . . . . 0.0 113.474 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 70.5 m -67.61 -50.44 58.14 Favored 'General case' 0 N--CA 1.532 3.673 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 692' ' ' LEU . . . . . 0.478 HD12 ' H ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -52.66 -32.62 43.19 Favored 'General case' 0 N--CA 1.519 2.986 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.486 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 693' ' ' ILE . . . . . 0.5 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.2 OUTLIER -59.99 -37.7 73.53 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 CA-C-N 119.436 1.016 . . . . 0.0 113.172 -176.004 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -67.99 -38.86 89.1 Favored Glycine 1 N--CA 1.523 4.479 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 695' ' ' LEU . . . . . 0.592 HD22 ' O ' ' C' ' 695' ' ' LEU . 0.0 OUTLIER -63.9 -37.08 86.09 Favored 'General case' 0 N--CA 1.534 3.745 0 C-N-CA 124.995 1.318 . . . . 0.0 111.946 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -50.9 -27.12 6.84 Favored 'General case' 1 N--CA 1.549 4.489 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 29.2 pt -54.07 -38.42 37.97 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.335 0 CA-C-N 120.155 1.343 . . . . 0.0 114.278 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.4 p -55.75 -35.5 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -55.89 -26.97 49.76 Favored 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.311 0.644 . . . . 0.0 110.457 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.95 69.51 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 121.939 -0.475 . . . . 0.0 110.467 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.62 -30.84 48.64 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.155 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 9.1 tp -53.4 -34.64 58.53 Favored 'General case' 0 N--CA 1.531 3.604 0 CA-C-O 118.841 -0.6 . . . . 0.0 110.786 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 62.9 m -58.7 -46.95 86.16 Favored 'General case' 0 N--CA 1.533 3.709 0 CA-C-N 119.284 0.947 . . . . 0.0 112.971 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.85 -35.3 80.28 Favored 'General case' 1 N--CA 1.549 4.523 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.879 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.94 -38.38 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 706' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.8 t-20 -58.22 -30.1 66.22 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.642 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -47.36 -42.1 20.96 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.04 0.838 . . . . 0.0 112.168 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.65 -44.79 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -77.4 -6.61 54.01 Favored 'General case' 1 N--CA 1.539 4.004 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.75 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 710' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' C' ' 706' ' ' ASN . 13.0 tt0 -114.65 -11.28 12.37 Favored 'General case' 0 N--CA 1.517 2.905 0 C-N-CA 125.474 1.509 . . . . 0.0 108.745 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -53.09 -24.49 21.15 Favored Glycine 1 N--CA 1.519 4.17 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -88.15 155.95 19.51 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.942 0.897 . . . . 0.0 108.718 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 95.5 p -77.58 149.38 78.04 Favored Pre-proline 0 N--CA 1.535 3.793 0 C-N-CA 125.973 1.709 . . . . 0.0 112.551 -173.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -55.72 129.83 37.16 Favored 'Trans proline' 0 C--N 1.409 3.747 0 CA-C-N 120.374 1.169 . . . . 0.0 110.906 -173.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.523 3.221 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.519 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 N--CA 1.505 2.275 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -55.13 -37.24 66.67 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -73.24 -38.26 66.07 Favored 'General case' 0 N--CA 1.532 3.645 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.46 -25.74 19.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.069 0 C-N-CA 125.624 1.57 . . . . 0.0 111.574 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -67.26 -53.7 27.58 Favored 'General case' 1 N--CA 1.544 4.248 0 C-N-CA 124.539 1.136 . . . . 0.0 112.006 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 15.2 tt -68.23 -32.89 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.195 0 CA-C-N 114.051 -1.431 . . . . 0.0 109.151 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -52.47 -34.83 50.86 Favored 'General case' 0 N--CA 1.516 2.849 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.982 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 13.0 mm -63.44 -37.62 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 CA-C-O 121.762 0.792 . . . . 0.0 109.201 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -37.24 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.183 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 62.0 mt -65.48 -43.82 94.35 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.5 t -61.99 -28.94 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.15 -31.62 78.1 Favored Glycine 0 N--CA 1.513 3.787 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.693 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 49.9 m -69.34 -37.19 77.56 Favored 'General case' 0 N--CA 1.53 3.542 0 C-N-CA 123.201 0.6 . . . . 0.0 111.077 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.6 mp -58.08 -45.05 87.8 Favored 'General case' 0 N--CA 1.538 3.944 0 C-N-CA 123.487 0.715 . . . . 0.0 112.071 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.875 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.271 0.8 OUTLIER -60.28 -48.52 87.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.135 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.771 . . . . . . . . 5 4 . 1 . 008 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.5 -26.3 69.53 Favored Glycine 1 N--CA 1.531 4.997 0 CA-C-N 120.164 1.347 . . . . 0.0 112.296 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.0 tt -64.77 -42.83 94.82 Favored 'General case' 0 N--CA 1.537 3.905 0 C-N-CA 124.059 0.944 . . . . 0.0 109.985 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -54.34 -26.11 27.89 Favored 'General case' 0 N--CA 1.538 3.958 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 70.2 mt -55.11 -39.06 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 C-N-CA 123.562 0.745 . . . . 0.0 112.257 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.57 -29.1 33.27 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.522 0 C-N-CA 123.49 0.716 . . . . 0.0 112.584 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -52.06 -26.03 10.01 Favored 'General case' 0 N--CA 1.535 3.779 0 C-N-CA 123.264 0.626 . . . . 0.0 110.949 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.55 -32.42 62.97 Favored 'General case' 0 N--CA 1.532 3.642 0 O-C-N 121.936 -0.477 . . . . 0.0 109.803 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.9 m -68.65 -30.82 48.52 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.123 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.83 -34.71 55.28 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 123.42 0.688 . . . . 0.0 110.391 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 89.0 p -58.89 -46.24 88.33 Favored 'General case' 0 N--CA 1.529 3.476 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 30.2 tp -67.02 -34.79 78.49 Favored 'General case' 1 N--CA 1.543 4.21 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.16 -39.29 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 706' ' ' ASN . . . . . 0.424 HD21 ' HE ' ' A' ' 709' ' ' ARG . 2.8 t-20 -69.71 -29.08 66.4 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.246 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -50.78 -40.41 55.06 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.537 0.684 . . . . 0.0 110.376 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.22 -38.43 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.899 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.737 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 709' ' ' ARG . . . . . 0.424 ' HE ' HD21 ' A' ' 706' ' ' ASN . 78.8 mtm180 -74.99 -25.72 59.04 Favored 'General case' 0 N--CA 1.538 3.937 0 CA-C-O 121.057 0.456 . . . . 0.0 109.788 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -89.36 -7.77 54.57 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.51 -20.71 7.79 Favored Glycine 1 N--CA 1.524 4.506 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -120.69 152.05 38.74 Favored 'General case' 0 N--CA 1.526 3.329 0 C-N-CA 125.265 1.426 . . . . 0.0 109.293 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 94.5 p -82.34 150.45 63.91 Favored Pre-proline 0 N--CA 1.531 3.595 0 C-N-CA 125.884 1.674 . . . . 0.0 110.244 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo . . . . . 0 C--N 1.401 3.332 0 CA-C-N 122.259 1.842 . . . . 0.0 112.503 -175.782 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.2 tt . . . . . 0 N--CA 1.524 3.262 0 CA-C-O 120.813 0.34 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -71.11 -31.06 67.31 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -69.69 -38.53 77.03 Favored 'General case' 0 N--CA 1.526 3.362 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.544 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 20.3 pt -71.56 -31.94 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.301 0 CA-C-N 117.986 0.357 . . . . 0.0 110.282 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -52.82 -54.39 34.9 Favored 'General case' 1 N--CA 1.539 4.018 0 CA-C-O 121.776 0.798 . . . . 0.0 111.007 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -31.46 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.307 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -59.55 -43.41 93.54 Favored 'General case' 1 N--CA 1.539 4.012 0 CA-C-O 121.691 0.758 . . . . 0.0 109.658 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.66 -36.33 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 C-N-CA 124.215 1.006 . . . . 0.0 108.617 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 27.8 mm -65.17 -42.72 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 47.9 mm -60.28 -41.17 86.08 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.281 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.49 -31.22 48.26 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.108 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.98 -33.19 86.57 Favored Glycine 1 N--CA 1.518 4.163 0 C-N-CA 123.924 0.773 . . . . 0.0 112.693 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.2 m -68.15 -37.26 80.86 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.52 0.728 . . . . 0.0 111.577 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.69 -43.07 80.14 Favored 'General case' 0 N--CA 1.536 3.843 0 C-N-CA 123.39 0.676 . . . . 0.0 112.559 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.798 HD11 ' HE ' ' C' ' 696' ' ' ARG 0.276 0.8 OUTLIER -60.25 -48.73 86.99 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.502 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.242 . . . . . . . . 5 4 . 1 . 008 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.45 -23.29 70.17 Favored Glycine 1 N--CA 1.531 5.023 0 CA-C-N 120.423 1.465 . . . . 0.0 112.518 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.29 -43.17 92.02 Favored 'General case' 1 N--CA 1.541 4.093 0 C-N-CA 123.359 0.664 . . . . 0.0 109.655 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 696' ' ' ARG . . . . . 0.875 ' HE ' HD11 ' A' ' 693' ' ' ILE . 23.5 mmt180 -52.99 -24.02 8.56 Favored 'General case' 0 N--CA 1.536 3.86 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 78.1 mt -51.72 -35.71 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 C-N-CA 123.327 0.651 . . . . 0.0 110.425 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.23 -26.08 17.88 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.235 0 C-N-CA 124.444 1.097 . . . . 0.0 111.397 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -53.66 -28.76 35.07 Favored 'General case' 1 N--CA 1.547 4.404 0 O-C-N 121.313 -0.867 . . . . 0.0 110.387 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.66 -44.11 67.78 Favored 'General case' 0 N--CA 1.525 3.282 0 CA-C-O 122.028 0.918 . . . . 0.0 108.627 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 79.0 t -68.84 -33.6 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.04 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -35.5 66.03 Favored 'General case' 0 N--CA 1.532 3.642 0 C-N-CA 123.65 0.78 . . . . 0.0 110.405 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 48.8 m -59.77 -48.01 83.4 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.54 -34.85 77.91 Favored 'General case' 1 N--CA 1.54 4.052 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.219 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.23 -44.93 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 706' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' B' ' 709' ' ' ARG . 23.3 p30 -74.41 -20.52 60.02 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.568 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -47.39 -35.01 7.7 Favored 'General case' 0 N--CA 1.519 3.001 0 CA-C-N 118.566 0.621 . . . . 0.0 109.921 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.37 -39.13 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.815 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 709' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' B' ' 706' ' ' ASN . 71.9 mtm180 -76.49 -30.83 57.41 Favored 'General case' 0 N--CA 1.524 3.252 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.76 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -89.23 2.33 54.41 Favored 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.6 -28.1 50.6 Favored Glycine 1 N--CA 1.517 4.086 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -108.62 127.79 54.27 Favored 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 97.9 p -82.24 147.67 57.66 Favored Pre-proline 0 N--CA 1.528 3.462 0 C-N-CA 125.278 1.431 . . . . 0.0 110.758 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 C--N 1.401 3.334 0 CA-C-N 121.473 1.562 . . . . 0.0 110.363 -176.629 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 679' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' C' ' 683' ' ' ARG . 7.8 mp . . . . . 0 N--CA 1.504 2.269 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -56.4 -38.73 71.93 Favored 'General case' 0 N--CA 1.53 3.535 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -173.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -72.93 -37.83 67.03 Favored 'General case' 0 N--CA 1.534 3.757 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 86.7 mt -73.37 -25.68 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.355 0 C-N-CA 125.365 1.466 . . . . 0.0 111.246 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 683' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' C' ' 679' ' ' LEU . 0.9 OUTLIER -67.03 -51.3 56.48 Favored 'General case' 0 N--CA 1.536 3.872 0 C-N-CA 124.449 1.099 . . . . 0.0 110.71 -177.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.3 tt -71.2 -30.31 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.928 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -52.52 -27.48 16.62 Favored 'General case' 0 N--CA 1.526 3.343 0 CA-C-O 121.512 0.673 . . . . 0.0 109.959 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 22.8 mm -68.94 -48.2 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 C-N-CA 124.635 1.174 . . . . 0.0 108.937 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 10.9 mm -57.74 -41.99 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.389 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.365 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.34 -49.19 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.702 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.97 -30.87 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.886 0 C-N-CA 123.666 0.786 . . . . 0.0 109.921 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.8 -32.54 84.56 Favored Glycine 1 N--CA 1.52 4.242 0 C-N-CA 123.367 0.508 . . . . 0.0 112.777 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 68.7 m -67.65 -35.99 79.93 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 124.056 0.942 . . . . 0.0 112.135 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.11 -41.74 68.65 Favored 'General case' 0 N--CA 1.539 3.976 0 C-N-CA 123.433 0.693 . . . . 0.0 112.606 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 693' ' ' ILE . . . . . 0.432 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -60.27 -41.4 86.88 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.255 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.166 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -68.46 -31.59 74.16 Favored Glycine 1 N--CA 1.524 4.553 0 O-C-N 121.093 -1.004 . . . . 0.0 111.456 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.04 -42.07 99.67 Favored 'General case' 0 N--CA 1.534 3.769 0 C-N-CA 124.594 1.158 . . . . 0.0 112.156 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 696' ' ' ARG . . . . . 0.798 ' HE ' HD11 ' B' ' 693' ' ' ILE . 25.6 mmt180 -53.3 -27.36 22.57 Favored 'General case' 1 N--CA 1.542 4.146 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -176.125 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 10.5 tp -55.71 -39.34 54.92 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.371 0 CA-C-N 119.664 1.12 . . . . 0.0 113.848 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.82 -31.7 41.04 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.338 0 C-N-CA 123.276 0.63 . . . . 0.0 112.235 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -54.41 -25.42 24.65 Favored 'General case' 0 N--CA 1.531 3.575 0 C-N-CA 123.121 0.568 . . . . 0.0 109.95 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.46 -34.98 65.0 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 122.086 -0.384 . . . . 0.0 110.159 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.3 m -68.83 -30.73 47.99 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.045 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 11.0 tp -52.89 -36.14 58.96 Favored 'General case' 0 N--CA 1.533 3.712 0 C-N-CA 123.154 0.581 . . . . 0.0 110.474 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 89.0 p -58.87 -47.0 86.47 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 39.8 tp -67.4 -34.88 78.17 Favored 'General case' 1 N--CA 1.543 4.191 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.86 -38.95 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.546 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 706' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' C' ' 710' ' ' GLN . 64.3 t30 -66.26 -25.69 67.0 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.856 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -48.22 -33.23 8.25 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 123.643 0.777 . . . . 0.0 111.133 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.66 -47.66 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -77.93 -9.92 59.33 Favored 'General case' 1 N--CA 1.542 4.172 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.623 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 710' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' C' ' 706' ' ' ASN . 20.3 tt0 -112.56 -7.64 13.87 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 125.884 1.674 . . . . 0.0 107.869 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.5 -25.04 33.41 Favored Glycine 0 N--CA 1.511 3.665 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -99.87 152.35 20.25 Favored 'General case' 0 N--CA 1.525 3.276 0 C-N-CA 123.911 0.885 . . . . 0.0 108.782 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 53.9 m -81.71 149.26 63.67 Favored Pre-proline 0 N--CA 1.529 3.502 0 CA-C-O 116.626 -1.654 . . . . 0.0 110.601 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -54.33 130.19 38.56 Favored 'Trans proline' 0 C--N 1.401 3.308 0 CA-C-N 122.233 1.833 . . . . 0.0 112.651 -175.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 51.8 mt . . . . . 0 N--CA 1.522 3.141 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.138 179.424 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.517 2.879 0 CA-C-O 119.804 -0.141 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -61.87 -50.05 73.78 Favored 'General case' 0 N--CA 1.529 3.48 0 CA-C-O 121.474 0.655 . . . . 0.0 111.208 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -64.15 -37.47 87.57 Favored 'General case' 0 N--CA 1.518 2.944 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.072 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -25.53 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.359 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -51.38 52.39 Favored 'General case' 1 N--CA 1.562 5.162 0 CA-C-N 119.973 1.26 . . . . 0.0 110.28 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.9 tt -67.73 -30.45 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.222 0 C-N-CA 123.696 0.798 . . . . 0.0 110.292 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -52.33 -30.01 26.41 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.124 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 21.9 mm -69.18 -46.94 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.453 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 7.9 mm -55.09 -39.54 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 C-N-CA 123.522 0.729 . . . . 0.0 109.503 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 59.6 mt -59.82 -47.13 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.978 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.58 -30.61 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 123.563 0.745 . . . . 0.0 109.736 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.98 -30.88 76.62 Favored Glycine 1 N--CA 1.518 4.116 0 C-N-CA 123.49 0.566 . . . . 0.0 112.654 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 63.3 m -67.56 -36.26 80.6 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 123.664 0.786 . . . . 0.0 111.842 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.3 mp -54.44 -42.15 70.24 Favored 'General case' 0 N--CA 1.539 3.99 0 C-N-CA 123.878 0.871 . . . . 0.0 112.993 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.522 HD11 ' HE ' ' B' ' 696' ' ' ARG . 0.4 OUTLIER -64.29 -49.8 79.41 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.08 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.494 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.59 -22.43 65.93 Favored Glycine 1 N--CA 1.528 4.827 0 CA-C-N 119.811 1.187 . . . . 0.0 112.553 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.28 -43.7 93.97 Favored 'General case' 0 N--CA 1.535 3.812 0 C-N-CA 123.835 0.854 . . . . 0.0 109.645 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 696' ' ' ARG . . . . . 0.718 ' HE ' HD11 ' C' ' 693' ' ' ILE . 17.6 mmt180 -54.67 -28.66 48.98 Favored 'General case' 0 N--CA 1.537 3.898 0 C-N-CA 124.262 1.025 . . . . 0.0 113.563 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 64.1 mt -55.45 -37.69 46.02 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 C-N-CA 123.609 0.764 . . . . 0.0 109.89 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -55.18 -26.78 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 C-N-CA 124.888 1.275 . . . . 0.0 110.969 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -51.73 -27.91 13.4 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.532 0.733 . . . . 0.0 112.087 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.15 96.2 Favored 'General case' 0 N--CA 1.524 3.245 0 O-C-N 121.595 -0.691 . . . . 0.0 109.58 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.99 -33.62 56.16 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.236 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.289 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 9.9 tp -55.0 -36.09 65.08 Favored 'General case' 0 N--CA 1.535 3.804 0 C-N-CA 123.2 0.6 . . . . 0.0 110.037 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.4 p -59.16 -47.5 85.07 Favored 'General case' 0 N--CA 1.525 3.3 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 41.3 tp -64.49 -35.78 82.07 Favored 'General case' 1 N--CA 1.546 4.354 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 90.1 t -69.61 -40.27 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.625 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 706' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 710' ' ' GLN . 55.1 t30 -64.89 -25.78 68.04 Favored 'General case' 0 N--CA 1.516 2.852 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.777 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -48.57 -44.4 36.63 Favored 'General case' 0 N--CA 1.518 2.961 0 C-N-CA 124.552 1.141 . . . . 0.0 110.402 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.87 -44.16 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -77.81 -12.7 60.0 Favored 'General case' 0 N--CA 1.538 3.926 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.621 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 710' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 706' ' ' ASN . 12.1 tt0 -112.93 -12.54 13.25 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 125.615 1.566 . . . . 0.0 109.181 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.91 -29.81 20.78 Favored Glycine 0 N--CA 1.515 3.903 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -93.11 149.68 21.05 Favored 'General case' 0 N--CA 1.522 3.135 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 70.3 m -81.93 148.12 59.98 Favored Pre-proline 0 N--CA 1.532 3.638 0 C-N-CA 125.686 1.594 . . . . 0.0 110.133 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.401 3.297 0 CA-C-N 121.794 1.676 . . . . 0.0 110.6 -175.759 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 2.2 tm? . . . . . 0 N--CA 1.511 2.622 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -68.17 -43.16 78.82 Favored 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 122.449 0.3 . . . . 0.0 110.848 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -69.15 -35.33 76.22 Favored 'General case' 0 N--CA 1.53 3.545 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.56 -24.81 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 C-N-CA 124.504 1.122 . . . . 0.0 110.605 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -64.13 -53.82 43.54 Favored 'General case' 1 N--CA 1.546 4.341 0 CA-C-N 119.362 0.983 . . . . 0.0 111.496 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.2 tt -68.07 -30.33 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.146 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -51.27 -32.82 25.96 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 123.515 0.726 . . . . 0.0 112.153 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 686' ' ' ILE . . . . . 0.452 ' N ' HD12 ' B' ' 686' ' ' ILE . 1.5 mp -69.23 -45.62 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.267 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 34.2 mt -56.1 -41.15 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 C-N-CA 123.271 0.628 . . . . 0.0 109.938 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 42.2 mm -62.32 -48.91 86.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.109 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.96 -29.8 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 C-N-CA 124.339 1.055 . . . . 0.0 109.967 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.73 -37.03 94.09 Favored Glycine 1 N--CA 1.524 4.553 0 C-N-CA 123.278 0.466 . . . . 0.0 112.45 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.5 m -67.36 -36.14 80.77 Favored 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 124.445 1.098 . . . . 0.0 111.873 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.1 mp -53.29 -33.91 55.15 Favored 'General case' 0 N--CA 1.533 3.711 0 CA-C-O 118.541 -0.742 . . . . 0.0 112.26 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.14 -41.33 81.36 Favored 'Isoleucine or valine' 1 N--CA 1.557 4.888 0 CA-C-N 120.246 1.384 . . . . 0.0 111.236 -177.712 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -55.82 -46.41 83.32 Favored Glycine 1 N--CA 1.526 4.695 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER -73.28 -32.31 64.58 Favored 'General case' 1 N--CA 1.554 4.771 0 CA-C-N 117.625 0.713 . . . . 0.0 110.82 179.298 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' B' B ' 696' ' ' ARG . . . . . 0.522 ' HE ' HD11 ' A' ' 693' ' ' ILE . 14.1 tpp180 -50.18 -26.61 4.77 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 125.625 1.57 . . . . 0.0 113.699 -176.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 697' ' ' ILE . . . . . 0.494 HD13 ' O ' ' B' ' 697' ' ' ILE . 0.0 OUTLIER -54.44 -36.04 33.17 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.14 0 C-N-CA 124.212 1.005 . . . . 0.0 111.051 -178.874 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.1 p -51.91 -26.49 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 124.735 1.214 . . . . 0.0 112.037 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -51.97 -25.89 9.32 Favored 'General case' 1 N--CA 1.54 4.046 0 C-N-CA 123.321 0.648 . . . . 0.0 110.18 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.89 -42.05 79.17 Favored 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 122.992 0.517 . . . . 0.0 111.313 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.67 -32.72 56.19 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 118.405 0.548 . . . . 0.0 110.383 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -32.2 52.53 Favored 'General case' 1 N--CA 1.545 4.309 0 C-N-CA 124.159 0.984 . . . . 0.0 109.529 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 51.6 m -57.26 -44.51 84.0 Favored 'General case' 1 N--CA 1.543 4.185 0 O-C-N 120.53 -1.356 . . . . 0.0 111.936 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 45.2 tp -65.25 -34.43 78.33 Favored 'General case' 1 N--CA 1.549 4.48 0 O-C-N 121.362 -0.836 . . . . 0.0 108.88 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 26.3 t -66.76 -39.93 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -61.12 -32.9 72.59 Favored 'General case' 0 N--CA 1.522 3.157 0 CA-C-O 118.497 -0.763 . . . . 0.0 110.412 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -49.8 -47.9 51.03 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 121.277 0.561 . . . . 0.0 110.003 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.87 -40.65 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.726 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.463 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.74 -29.82 59.01 Favored 'General case' 0 N--CA 1.523 3.219 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.719 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.69 -6.5 56.04 Favored 'General case' 0 N--CA 1.519 3.01 0 C-N-CA 124.515 1.126 . . . . 0.0 109.265 -178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -59.7 -31.98 72.82 Favored Glycine 0 N--CA 1.513 3.788 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -89.61 154.31 20.07 Favored 'General case' 0 N--CA 1.529 3.502 0 C-N-CA 124.049 0.939 . . . . 0.0 109.346 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 3.3 t -80.82 150.05 68.51 Favored Pre-proline 0 N--CA 1.534 3.758 0 C-N-CA 126.735 2.014 . . . . 0.0 111.1 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.528 3.532 0 CA-C-N 120.744 1.301 . . . . 0.0 110.468 -174.743 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.529 3.503 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -70.82 -29.7 65.93 Favored 'General case' 0 N--CA 1.528 3.447 0 CA-C-O 120.592 0.234 . . . . 0.0 110.56 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -71.72 -37.92 70.55 Favored 'General case' 0 N--CA 1.518 2.926 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.218 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 682' ' ' ILE . . . . . 0.502 HD12 ' N ' ' C' ' 683' ' ' ARG . 1.9 pp -72.31 -23.23 21.23 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.225 0 CA-C-N 119.365 0.984 . . . . 0.0 110.505 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 683' ' ' ARG . . . . . 0.502 ' N ' HD12 ' C' ' 682' ' ' ILE . 0.0 OUTLIER -66.32 -51.58 55.89 Favored 'General case' 0 N--CA 1.535 3.797 0 C-N-CA 124.026 0.931 . . . . 0.0 112.289 -176.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -72.29 -31.77 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.867 0 C-N-CA 123.605 0.762 . . . . 0.0 110.249 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -48.75 -23.71 1.15 Allowed 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 125.546 1.538 . . . . 0.0 112.764 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.11 -37.02 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.731 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.77 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 37.7 pt -61.86 -41.54 91.16 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.679 0 CA-C-N 120.783 1.629 . . . . 0.0 110.006 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 50.2 mt -63.63 -50.14 79.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.35 -38.64 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 C-N-CA 124.202 1.001 . . . . 0.0 110.59 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.79 -49.25 50.38 Favored Glycine 1 N--CA 1.525 4.567 0 C-N-CA 125.339 1.447 . . . . 0.0 111.712 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 73.1 m -58.79 -34.97 72.07 Favored 'General case' 0 N--CA 1.52 3.072 0 CA-C-O 121.841 0.829 . . . . 0.0 108.998 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.64 -44.55 85.69 Favored 'General case' 0 N--CA 1.524 3.251 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.452 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 693' ' ' ILE . . . . . 0.718 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.266 0.1 OUTLIER -65.22 -47.97 85.33 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.741 0 CA-C-N 119.113 0.87 . . . . 0.0 111.595 -177.221 . . . . . . . . 5 4 . 1 . 009 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.22 -21.3 46.63 Favored Glycine 1 N--CA 1.531 4.999 0 CA-C-N 118.993 0.815 . . . . 0.0 112.656 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.79 -43.08 63.23 Favored 'General case' 0 N--CA 1.537 3.891 0 C-N-CA 124.028 0.931 . . . . 0.0 109.037 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -53.5 -25.51 16.85 Favored 'General case' 0 N--CA 1.532 3.663 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 40.1 mm -53.06 -37.65 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.939 0 C-N-CA 124.33 1.052 . . . . 0.0 112.724 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.03 -30.59 23.9 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.275 0 C-N-CA 123.61 0.764 . . . . 0.0 111.737 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -63.35 -27.64 69.45 Favored 'General case' 0 N--CA 1.538 3.966 0 O-C-N 121.433 -0.792 . . . . 0.0 110.857 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.1 -39.75 75.35 Favored 'General case' 0 N--CA 1.535 3.815 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.58 -32.01 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.078 0 C-N-CA 125.095 1.358 . . . . 0.0 109.041 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 16.0 tp -55.15 -33.04 62.6 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.401 0.68 . . . . 0.0 109.537 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 67.9 m -56.81 -46.33 81.68 Favored 'General case' 0 N--CA 1.532 3.626 0 CA-C-N 118.831 0.741 . . . . 0.0 112.629 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.4 tp -65.13 -35.3 80.67 Favored 'General case' 1 N--CA 1.549 4.509 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.99 -38.93 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -64.68 -25.52 67.98 Favored 'General case' 0 N--CA 1.52 3.055 0 C-N-CA 123.793 0.837 . . . . 0.0 110.298 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 707' ' ' ARG . . . . . 0.428 HH11 ' NE2' ' A' ' 710' ' ' GLN . 8.7 tpp180 -48.87 -44.12 39.58 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.74 0.781 . . . . 0.0 111.048 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.01 -39.71 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.343 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -76.54 -21.45 55.67 Favored 'General case' 0 N--CA 1.53 3.562 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.707 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -88.94 -11.15 45.26 Favored 'General case' 0 N--CA 1.513 2.714 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.96 -19.11 21.12 Favored Glycine 1 N--CA 1.517 4.079 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -107.24 153.17 23.09 Favored 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 124.858 1.263 . . . . 0.0 109.11 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 83.5 p -81.6 152.21 69.43 Favored Pre-proline 0 N--CA 1.528 3.459 0 C-N-CA 126.369 1.868 . . . . 0.0 111.545 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -53.04 131.83 44.71 Favored 'Trans proline' 0 C--N 1.401 3.331 0 CA-C-N 121.625 1.616 . . . . 0.0 112.066 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 46.3 tp . . . . . 0 N--CA 1.524 3.274 0 C-N-CA 125.848 1.659 . . . . 0.0 110.795 -179.375 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.502 2.161 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -60.18 -49.72 76.51 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -65.99 -33.51 75.98 Favored 'General case' 0 N--CA 1.535 3.815 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.76 -27.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 C-N-CA 125.212 1.405 . . . . 0.0 109.853 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -63.86 -52.04 61.85 Favored 'General case' 1 N--CA 1.545 4.299 0 O-C-N 121.495 -0.753 . . . . 0.0 111.471 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.9 tt -67.42 -31.97 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 C-N-CA 123.908 0.883 . . . . 0.0 109.287 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -58.94 -41.8 88.23 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.876 0.87 . . . . 0.0 109.036 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.27 -36.04 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 C-N-CA 124.962 1.305 . . . . 0.0 108.681 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 56.5 mt -66.7 -37.41 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.75 -43.35 91.41 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.529 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.71 -29.51 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.925 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.75 -32.09 81.86 Favored Glycine 1 N--CA 1.516 4.016 0 C-N-CA 123.614 0.626 . . . . 0.0 112.309 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 68.2 m -68.31 -36.19 78.93 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 123.659 0.784 . . . . 0.0 111.764 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 8.9 mp -54.03 -39.62 66.32 Favored 'General case' 0 N--CA 1.537 3.886 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.53 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.261 0.1 OUTLIER -62.48 -49.72 82.74 Favored 'Isoleucine or valine' 1 N--CA 1.556 4.864 0 CA-C-N 119.429 1.013 . . . . 0.0 112.664 -176.12 . . . . . . . . 5 4 . 1 . 010 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.15 -30.84 71.45 Favored Glycine 1 N--CA 1.527 4.719 0 CA-C-N 119.187 0.903 . . . . 0.0 112.866 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.18 -42.23 99.34 Favored 'General case' 0 N--CA 1.536 3.855 0 C-N-CA 124.568 1.147 . . . . 0.0 111.576 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 696' ' ' ARG . . . . . 0.783 ' HE ' HD11 ' C' ' 693' ' ' ILE . 26.5 mmt180 -52.67 -26.02 12.58 Favored 'General case' 0 N--CA 1.537 3.916 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 16.5 tt -53.46 -38.3 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.9 p -55.25 -30.77 25.37 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 C-N-CA 123.414 0.685 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -61.45 -28.22 69.12 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.097 0.559 . . . . 0.0 110.797 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.43 -41.92 72.25 Favored 'General case' 0 N--CA 1.53 3.553 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 88.5 t -68.59 -32.85 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 125.007 1.323 . . . . 0.0 108.953 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 13.5 tp -55.33 -30.26 59.91 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 124.089 0.956 . . . . 0.0 109.371 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 78.3 p -56.04 -45.63 79.14 Favored 'General case' 0 N--CA 1.533 3.723 0 O-C-N 121.485 -0.76 . . . . 0.0 111.572 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.23 -34.81 78.46 Favored 'General case' 1 N--CA 1.545 4.319 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.38 -39.35 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -63.12 -21.05 65.93 Favored 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.407 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -49.35 -46.8 47.49 Favored 'General case' 0 N--CA 1.513 2.711 0 CA-C-O 121.748 0.785 . . . . 0.0 109.168 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.68 -41.88 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -77.25 -5.51 49.61 Favored 'General case' 0 N--CA 1.522 3.143 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.209 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.64 -17.2 23.52 Favored 'General case' 1 N--CA 1.558 4.937 0 CA-C-N 118.671 0.669 . . . . 0.0 109.947 -179.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -84.09 -28.24 34.72 Favored Glycine 1 N--CA 1.522 4.419 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -75.49 135.23 40.66 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 112.901 -1.65 . . . . 0.0 108.317 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 96.0 p -82.67 146.67 53.59 Favored Pre-proline 0 N--CA 1.534 3.725 0 CA-C-O 117.574 -1.203 . . . . 0.0 110.665 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.398 3.184 0 CA-C-N 121.42 1.543 . . . . 0.0 109.616 -176.554 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.163 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -57.84 -49.61 76.09 Favored 'General case' 0 N--CA 1.532 3.67 0 CA-C-O 121.599 0.714 . . . . 0.0 111.24 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -65.19 -33.63 76.45 Favored 'General case' 0 N--CA 1.52 3.073 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.554 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 29.2 mm -74.09 -28.45 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.152 0 C-N-CA 124.596 1.158 . . . . 0.0 110.425 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -66.13 -55.41 16.54 Favored 'General case' 1 N--CA 1.547 4.385 0 CA-C-O 122.379 1.085 . . . . 0.0 110.615 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 684' ' ' ILE . . . . . 0.55 ' O ' HD13 ' B' ' 684' ' ' ILE . 0.0 OUTLIER -64.75 -30.55 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.879 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.46 -178.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.41 -44.36 65.36 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 123.647 0.779 . . . . 0.0 111.511 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 27.2 mt -62.81 -37.9 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 C-N-CA 124.869 1.268 . . . . 0.0 110.311 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 39.1 mm -57.61 -41.62 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 50.4 mm -62.98 -44.99 99.99 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.538 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 176.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.43 -31.07 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 C-N-CA 123.351 0.661 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.54 -42.84 95.45 Favored Glycine 1 N--CA 1.524 4.539 0 C-N-CA 123.539 0.59 . . . . 0.0 112.593 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 66.7 m -67.31 -36.25 81.11 Favored 'General case' 0 N--CA 1.528 3.46 0 CA-C-O 122.342 1.068 . . . . 0.0 110.212 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 2.6 tp -54.04 -35.05 61.56 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 113.191 -1.822 . . . . 0.0 112.909 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -42.32 59.47 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.624 0 CA-C-N 118.641 0.655 . . . . 0.0 110.663 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -53.58 -44.75 68.31 Favored Glycine 1 N--CA 1.523 4.472 0 N-CA-C 116.025 1.17 . . . . 0.0 116.025 -175.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . 0.321 0.0 OUTLIER -67.23 -30.85 70.87 Favored 'General case' 1 N--CA 1.557 4.893 0 CA-C-N 118.267 1.034 . . . . 0.0 112.247 -179.162 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' B' B ' 696' ' ' ARG . . . . . 0.53 ' HE ' HD11 ' A' ' 693' ' ' ILE . 34.1 mmt180 -48.22 -25.02 1.34 Allowed 'General case' 0 N--CA 1.538 3.936 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 25.9 pt -54.27 -36.69 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.964 0 CA-C-N 118.864 0.757 . . . . 0.0 112.543 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.96 -32.57 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -55.62 -25.77 40.58 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.386 0.674 . . . . 0.0 109.67 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.18 72.6 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 122.711 0.404 . . . . 0.0 110.643 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.78 -31.38 50.52 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.3 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 11.8 tp -54.32 -33.9 59.86 Favored 'General case' 0 N--CA 1.531 3.581 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.157 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 27.0 m -57.69 -46.38 84.41 Favored 'General case' 0 N--CA 1.531 3.577 0 CA-C-N 119.246 0.93 . . . . 0.0 113.4 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 37.5 tp -65.27 -35.9 82.44 Favored 'General case' 1 N--CA 1.552 4.667 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.4 -38.58 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.354 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -62.32 -26.62 68.53 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.054 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -49.11 -47.43 45.3 Favored 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.694 0.759 . . . . 0.0 109.687 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.22 -37.97 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.853 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -75.38 -24.51 57.26 Favored 'General case' 0 N--CA 1.53 3.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.025 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -89.35 -13.38 37.99 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.1 -25.72 32.82 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -96.86 154.22 17.43 Favored 'General case' 0 N--CA 1.533 3.7 0 C-N-CA 124.559 1.144 . . . . 0.0 108.517 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 82.5 p -80.64 152.03 72.04 Favored Pre-proline 0 N--CA 1.536 3.84 0 C-N-CA 126.201 1.8 . . . . 0.0 112.973 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo . . . . . 0 C--N 1.407 3.635 0 CA-C-N 121.159 1.45 . . . . 0.0 112.022 -173.517 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.327 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -60.16 -49.4 77.8 Favored 'General case' 0 N--CA 1.533 3.692 0 C-N-CA 122.994 0.518 . . . . 0.0 110.627 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -64.18 -33.71 76.41 Favored 'General case' 0 N--CA 1.525 3.301 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 27.9 mm -73.79 -31.5 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 C-N-CA 124.451 1.101 . . . . 0.0 111.13 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -49.52 69.64 Favored 'General case' 1 N--CA 1.554 4.773 0 CA-C-O 121.617 0.722 . . . . 0.0 111.52 -176.72 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -29.02 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 C-N-CA 125.319 1.448 . . . . 0.0 110.27 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -51.2 -30.37 16.91 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.408 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 686' ' ' ILE . . . . . 0.414 ' N ' HD12 ' C' ' 686' ' ' ILE . 1.5 mp -68.45 -40.69 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.981 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 45.4 mt -60.5 -34.81 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.563 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.54 -47.6 92.22 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.451 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.4 -29.12 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.231 0 C-N-CA 124.253 1.021 . . . . 0.0 109.74 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.84 92.69 Favored Glycine 1 N--CA 1.522 4.369 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 60.6 m -68.98 -37.17 78.6 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.126 0.97 . . . . 0.0 111.137 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.6 mp -55.71 -35.42 66.09 Favored 'General case' 1 N--CA 1.54 4.042 0 C-N-CA 123.573 0.749 . . . . 0.0 112.09 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 693' ' ' ILE . . . . . 0.783 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.269 0.4 OUTLIER -72.11 -47.22 55.35 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.704 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.52 . . . . . . . . 5 4 . 1 . 010 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -53.96 -44.91 72.33 Favored Glycine 1 N--CA 1.525 4.588 0 N-CA-C 116.393 1.317 . . . . 0.0 116.393 -175.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -65.81 -31.04 71.77 Favored 'General case' 1 N--CA 1.552 4.645 0 CA-C-N 118.408 1.104 . . . . 0.0 112.697 -178.85 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -48.95 -25.26 1.84 Allowed 'General case' 1 N--CA 1.544 4.258 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 18.2 tt -53.1 -35.3 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 C-N-CA 123.256 0.622 . . . . 0.0 111.388 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -53.18 -30.65 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 C-N-CA 124.198 0.999 . . . . 0.0 111.506 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -58.89 -28.43 66.16 Favored 'General case' 0 N--CA 1.537 3.907 0 O-C-N 121.655 -0.653 . . . . 0.0 110.474 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.34 -42.38 71.98 Favored 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.49 -32.39 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.796 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 21.1 tp -54.94 -33.43 62.28 Favored 'General case' 0 N--CA 1.536 3.871 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 87.0 p -57.33 -45.37 84.36 Favored 'General case' 0 N--CA 1.529 3.485 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -37.39 85.48 Favored 'General case' 1 N--CA 1.544 4.228 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.14 -37.94 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 706' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.8 p30 -60.12 -31.91 70.5 Favored 'General case' 0 N--CA 1.518 2.953 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.143 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -48.22 -47.27 35.73 Favored 'General case' 0 N--CA 1.516 2.852 0 C-N-CA 123.517 0.727 . . . . 0.0 111.258 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 49.3 t -64.13 -47.71 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -78.76 -10.15 59.68 Favored 'General case' 0 N--CA 1.536 3.868 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 710' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' C' ' 706' ' ' ASN . 38.7 tt0 -113.7 -10.87 13.02 Favored 'General case' 0 N--CA 1.533 3.679 0 C-N-CA 124.965 1.306 . . . . 0.0 109.175 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.21 -35.33 54.83 Favored Glycine 0 N--CA 1.509 3.523 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -79.53 152.78 29.97 Favored 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 96.0 p -81.17 150.03 67.29 Favored Pre-proline 0 N--CA 1.531 3.588 0 CA-C-O 116.739 -1.601 . . . . 0.0 111.09 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.14 131.05 42.71 Favored 'Trans proline' 0 C--N 1.401 3.302 0 CA-C-N 121.9 1.714 . . . . 0.0 112.255 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 N--CA 1.53 3.566 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.246 179.616 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.369 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -62.96 -51.35 67.2 Favored 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -67.41 -31.39 71.57 Favored 'General case' 1 N--CA 1.539 4.005 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 47.6 mm -74.88 -26.68 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.489 0 C-N-CA 124.911 1.284 . . . . 0.0 110.269 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -66.35 -54.0 29.61 Favored 'General case' 1 N--CA 1.55 4.559 0 CA-C-O 121.775 0.797 . . . . 0.0 111.13 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.44 -30.82 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.353 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -56.82 -31.35 64.64 Favored 'General case' 0 N--CA 1.515 2.813 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.789 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.6 mm -68.58 -39.25 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 54.3 mt -65.42 -36.32 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.194 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 72.1 mt -67.45 -42.95 87.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.026 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.92 -30.15 47.94 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.338 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.7 97.52 Favored Glycine 1 N--CA 1.524 4.565 0 C-N-CA 124.002 0.811 . . . . 0.0 112.175 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 71.0 m -68.78 -37.83 79.6 Favored 'General case' 0 N--CA 1.522 3.16 0 CA-C-O 122.084 0.945 . . . . 0.0 109.883 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 1.9 tp -59.44 -44.78 92.86 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.02 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.535 ' O ' HD13 ' A' ' 693' ' ' ILE . 0.0 OUTLIER -72.13 -32.46 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.757 0 O-C-N 121.896 -0.502 . . . . 0.0 112.092 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.18 -44.59 96.3 Favored Glycine 1 N--CA 1.52 4.246 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . 0.334 0.0 OUTLIER -68.09 -31.97 71.96 Favored 'General case' 1 N--CA 1.549 4.506 0 CA-C-N 118.279 1.039 . . . . 0.0 112.452 -178.715 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -48.6 -24.7 1.42 Allowed 'General case' 0 N--CA 1.539 3.982 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 17.4 tt -52.39 -35.07 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 123.186 0.594 . . . . 0.0 111.845 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.8 p -52.95 -30.3 15.86 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 C-N-CA 123.789 0.836 . . . . 0.0 111.309 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -61.29 -29.37 69.83 Favored 'General case' 0 N--CA 1.536 3.827 0 O-C-N 121.433 -0.792 . . . . 0.0 110.328 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.55 -37.94 74.09 Favored 'General case' 0 N--CA 1.535 3.783 0 CA-C-O 121.629 0.728 . . . . 0.0 109.059 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.47 -30.24 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.255 0 C-N-CA 124.75 1.22 . . . . 0.0 108.56 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.1 -30.58 49.06 Favored 'General case' 0 N--CA 1.534 3.74 0 C-N-CA 123.428 0.691 . . . . 0.0 109.236 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 72.6 p -56.52 -45.83 80.9 Favored 'General case' 0 N--CA 1.533 3.711 0 O-C-N 121.473 -0.767 . . . . 0.0 111.601 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 34.6 tp -62.63 -35.49 79.77 Favored 'General case' 1 N--CA 1.552 4.653 0 O-C-N 121.34 -0.85 . . . . 0.0 108.935 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.1 -38.59 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.623 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 706' ' ' ASN . . . . . 0.588 ' ND2' HH11 ' C' ' 707' ' ' ARG . 21.5 t30 -60.53 -22.83 64.05 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 123.784 0.833 . . . . 0.0 109.798 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -53.5 -42.55 67.46 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.602 0.715 . . . . 0.0 109.646 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.42 -37.46 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.144 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -77.67 -4.44 46.12 Favored 'General case' 0 N--CA 1.516 2.856 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.999 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.35 -17.52 25.74 Favored 'General case' 1 N--CA 1.562 5.17 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -78.6 -18.51 75.48 Favored Glycine 1 N--CA 1.523 4.498 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -98.98 144.74 27.8 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 126.654 1.982 . . . . 0.0 106.235 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 78.4 p -104.53 143.94 27.71 Favored Pre-proline 1 N--CA 1.55 4.53 0 CA-C-O 117.929 -1.034 . . . . 0.0 113.474 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo . . . . . 0 C--N 1.409 3.754 0 CA-C-N 120.988 1.389 . . . . 0.0 110.938 178.222 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -55.45 -29.44 58.66 Favored 'General case' 1 N--CA 1.541 4.08 0 CA-C-N 120.156 1.344 . . . . 0.0 111.176 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -72.66 -34.65 67.39 Favored 'General case' 0 N--CA 1.532 3.649 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.54 -25.16 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.375 0 C-N-CA 124.386 1.074 . . . . 0.0 108.78 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -65.75 -45.9 80.87 Favored 'General case' 1 N--CA 1.549 4.487 0 O-C-N 121.54 -0.725 . . . . 0.0 111.566 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 13.7 tt -66.05 -30.54 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.34 -27.3 67.02 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.842 0.857 . . . . 0.0 110.122 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.09 -43.25 81.89 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.204 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 62.6 mt -72.43 -38.41 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.091 0 C-N-CA 124.718 1.207 . . . . 0.0 111.81 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 3.3 tp -58.38 -37.53 64.25 Favored 'Isoleucine or valine' 1 N--CA 1.556 4.844 0 CA-C-N 119.161 0.891 . . . . 0.0 110.215 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.98 -27.54 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 C-N-CA 124.298 1.039 . . . . 0.0 109.98 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -80.16 -27.58 52.14 Favored Glycine 1 N--CA 1.518 4.161 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 49.9 m -69.19 -52.42 28.1 Favored 'General case' 0 N--CA 1.534 3.764 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -34.69 75.39 Favored 'General case' 0 N--CA 1.538 3.974 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.452 HD11 ' HE ' ' C' ' 696' ' ' ARG . 1.2 tp -58.87 -44.86 91.59 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.263 0 CA-C-N 119.54 1.064 . . . . 0.0 111.495 -177.208 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.15 -31.25 80.12 Favored Glycine 1 N--CA 1.521 4.325 0 O-C-N 120.643 -1.285 . . . . 0.0 111.224 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.92 -43.18 96.7 Favored 'General case' 0 N--CA 1.535 3.824 0 C-N-CA 124.243 1.017 . . . . 0.0 111.506 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -53.03 -26.96 17.44 Favored 'General case' 1 N--CA 1.54 4.05 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.9 tt -54.82 -39.28 47.37 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.387 0 CA-C-N 120.116 1.325 . . . . 0.0 113.973 -174.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.58 -30.53 36.97 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.225 0 C-N-CA 123.332 0.653 . . . . 0.0 111.683 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -53.96 -26.48 25.86 Favored 'General case' 0 N--CA 1.533 3.709 0 C-N-CA 123.145 0.578 . . . . 0.0 109.532 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.89 -36.95 68.22 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 122.787 0.435 . . . . 0.0 110.199 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.43 -29.63 44.78 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.025 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 6.4 tp -52.37 -35.91 52.56 Favored 'General case' 0 N--CA 1.531 3.611 0 CA-C-O 118.866 -0.588 . . . . 0.0 110.721 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 68.9 m -59.28 -46.52 88.32 Favored 'General case' 0 N--CA 1.533 3.714 0 CA-C-N 118.949 0.795 . . . . 0.0 112.864 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 51.0 tp -66.23 -36.02 81.93 Favored 'General case' 1 N--CA 1.547 4.383 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.28 -38.29 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.54 -31.78 69.73 Favored 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.11 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -48.45 -45.29 36.35 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 124.934 1.294 . . . . 0.0 111.368 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 59.0 t -62.83 -49.95 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.25 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -79.57 -3.92 49.14 Favored 'General case' 1 N--CA 1.551 4.595 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.551 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -109.98 -13.3 14.44 Favored 'General case' 0 N--CA 1.528 3.427 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.38 -28.48 20.39 Favored Glycine 0 N--CA 1.515 3.925 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -86.23 155.14 20.83 Favored 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 123.796 0.838 . . . . 0.0 108.992 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 90.0 p -79.0 150.19 74.57 Favored Pre-proline 0 N--CA 1.534 3.74 0 C-N-CA 126.479 1.911 . . . . 0.0 112.598 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo . . . . . 0 C--N 1.408 3.679 0 CA-C-N 120.626 1.259 . . . . 0.0 111.031 -174.503 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -58.02 -50.25 74.08 Favored 'General case' 0 N--CA 1.536 3.854 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -174.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -63.21 -33.58 75.8 Favored 'General case' 0 N--CA 1.529 3.486 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.49 -29.12 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 C-N-CA 125.724 1.609 . . . . 0.0 110.514 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -51.85 52.94 Favored 'General case' 1 N--CA 1.55 4.536 0 C-N-CA 123.682 0.793 . . . . 0.0 111.479 -176.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.4 tt -63.08 -39.75 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.427 0 C-N-CA 124.099 0.96 . . . . 0.0 109.465 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -53.09 -42.61 66.07 Favored 'General case' 0 N--CA 1.517 2.88 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.82 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.88 -36.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 20.4 mt -63.5 -44.11 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.65 -43.66 95.31 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.299 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.08 -37.77 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 C-N-CA 123.853 0.861 . . . . 0.0 110.134 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -57.19 -32.96 63.97 Favored Glycine 1 N--CA 1.522 4.425 0 C-N-CA 123.727 0.68 . . . . 0.0 113.756 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 63.1 m -63.39 -34.62 78.13 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 124.355 1.062 . . . . 0.0 112.57 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 4.0 mp -52.85 -34.79 55.91 Favored 'General case' 0 N--CA 1.532 3.668 0 C-N-CA 123.618 0.767 . . . . 0.0 112.659 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 693' ' ' ILE . . . . . 0.44 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.2 OUTLIER -58.58 -43.81 88.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.445 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.643 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -69.2 -29.93 71.92 Favored Glycine 1 N--CA 1.522 4.399 0 O-C-N 121.232 -0.917 . . . . 0.0 110.917 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.85 -42.83 99.53 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 123.83 0.852 . . . . 0.0 110.506 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 696' ' ' ARG . . . . . 0.452 ' HE ' HD11 ' B' ' 693' ' ' ILE . 26.2 mmt180 -56.41 -26.83 54.64 Favored 'General case' 1 N--CA 1.543 4.194 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 69.9 mt -54.85 -39.55 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 C-N-CA 122.976 0.51 . . . . 0.0 112.319 -176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.79 -32.05 54.44 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.488 0 CA-C-N 119.235 0.925 . . . . 0.0 112.241 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -53.99 -26.99 28.79 Favored 'General case' 0 N--CA 1.536 3.857 0 O-C-N 121.836 -0.54 . . . . 0.0 110.501 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.72 -32.83 65.91 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 122.039 -0.413 . . . . 0.0 110.341 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.1 m -68.81 -29.84 44.93 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.095 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.5 tp -51.77 -36.3 46.91 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-O 118.709 -0.662 . . . . 0.0 110.914 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 24.5 t -59.06 -46.24 88.77 Favored 'General case' 0 N--CA 1.534 3.747 0 CA-C-N 119.148 0.885 . . . . 0.0 112.914 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 37.9 tp -65.72 -34.53 78.39 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.31 -39.84 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 706' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' C' ' 710' ' ' GLN . 33.2 t-20 -65.81 -23.98 66.81 Favored 'General case' 0 N--CA 1.524 3.24 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.764 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 707' ' ' ARG . . . . . 0.588 HH11 ' ND2' ' A' ' 706' ' ' ASN . 6.2 tpp180 -47.89 -42.83 27.88 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 123.992 0.917 . . . . 0.0 111.271 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 43.5 t -65.44 -47.02 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -78.1 -11.84 59.94 Favored 'General case' 0 N--CA 1.539 3.986 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.314 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 710' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' C' ' 706' ' ' ASN . 12.5 tt0 -109.91 -9.94 14.76 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 125.093 1.357 . . . . 0.0 108.654 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.78 -27.13 49.04 Favored Glycine 0 N--CA 1.514 3.899 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -99.32 152.71 19.63 Favored 'General case' 0 N--CA 1.529 3.509 0 C-N-CA 123.935 0.894 . . . . 0.0 109.327 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 88.0 p -82.28 148.96 60.86 Favored Pre-proline 0 N--CA 1.528 3.473 0 C-N-CA 125.947 1.699 . . . . 0.0 109.714 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -54.66 132.19 50.11 Favored 'Trans proline' 0 C--N 1.398 3.164 0 CA-C-N 121.612 1.611 . . . . 0.0 112.854 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.515 2.81 0 CA-C-N 112.308 -2.224 . . . . 0.0 105.917 179.169 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 N--CA 1.505 2.296 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -59.47 -49.43 77.81 Favored 'General case' 0 N--CA 1.533 3.693 0 CA-C-O 121.207 0.527 . . . . 0.0 111.348 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -66.93 -29.23 69.04 Favored 'General case' 0 N--CA 1.523 3.221 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 30.7 mm -74.96 -32.2 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.243 0 C-N-CA 124.562 1.145 . . . . 0.0 110.614 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -48.51 69.39 Favored 'General case' 1 N--CA 1.549 4.521 0 O-C-N 121.935 -0.478 . . . . 0.0 111.738 -176.208 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.1 tt -68.34 -31.18 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 C-N-CA 123.916 0.886 . . . . 0.0 109.826 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -48.51 -24.63 1.36 Allowed 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 124.624 1.17 . . . . 0.0 111.448 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.38 -40.14 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 117.268 -1.349 . . . . 0.0 111.094 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 40.0 pt -53.33 -36.31 26.21 Favored 'Isoleucine or valine' 1 N--CA 1.567 5.388 0 CA-C-N 121.531 1.969 . . . . 0.0 109.93 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.93 -49.14 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 23.9 t -68.17 -29.27 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 125.256 1.423 . . . . 0.0 111.295 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -82.31 -32.19 29.06 Favored Glycine 1 N--CA 1.525 4.571 0 C-N-CA 124.589 1.09 . . . . 0.0 112.317 -175.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 74.3 m -69.05 -51.37 39.63 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 123.839 0.856 . . . . 0.0 113.109 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.49 -31.77 73.02 Favored 'General case' 1 N--CA 1.541 4.096 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.806 HD11 ' HE ' ' B' ' 696' ' ' ARG . 1.3 tp -59.34 -42.65 88.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.431 0 CA-C-N 120.77 1.623 . . . . 0.0 111.295 -176.371 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.62 -27.53 72.36 Favored Glycine 1 N--CA 1.525 4.609 0 O-C-N 121.02 -1.05 . . . . 0.0 110.968 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.7 -36.68 83.74 Favored 'General case' 1 N--CA 1.544 4.261 0 C-N-CA 123.861 0.864 . . . . 0.0 109.075 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -54.78 -29.25 53.72 Favored 'General case' 1 N--CA 1.542 4.161 0 O-C-N 121.45 -0.781 . . . . 0.0 112.025 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 46.9 mm -57.51 -38.6 64.4 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.047 0 C-N-CA 123.479 0.712 . . . . 0.0 109.839 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 92.1 t -58.17 -37.78 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 125.077 1.351 . . . . 0.0 111.265 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -55.13 -24.85 28.14 Favored 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 123.317 0.647 . . . . 0.0 110.002 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.2 64.31 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 122.163 -0.336 . . . . 0.0 110.14 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.97 -31.32 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.996 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.07 -36.7 63.4 Favored 'General case' 0 N--CA 1.534 3.765 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.651 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 61.5 m -58.75 -47.07 85.94 Favored 'General case' 0 N--CA 1.536 3.862 0 CA-C-N 119.252 0.933 . . . . 0.0 112.868 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 35.8 tp -65.76 -35.04 79.58 Favored 'General case' 1 N--CA 1.54 4.072 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 87.2 t -68.65 -38.65 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 706' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 710' ' ' GLN . 17.6 t30 -58.34 -23.13 55.82 Favored 'General case' 0 N--CA 1.516 2.869 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.349 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -47.04 -40.01 13.95 Favored 'General case' 0 N--CA 1.527 3.395 0 C-N-CA 123.667 0.787 . . . . 0.0 111.125 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.96 -45.56 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -76.86 -11.04 59.76 Favored 'General case' 0 N--CA 1.533 3.682 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.698 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 710' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 706' ' ' ASN . 35.6 tt0 -113.55 -14.18 12.7 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 125.702 1.601 . . . . 0.0 109.466 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -74.33 -14.89 80.45 Favored Glycine 1 N--CA 1.534 5.213 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 174.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -75.76 146.52 39.97 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 128.207 2.603 . . . . 0.0 107.177 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 67.5 m -81.85 146.99 57.28 Favored Pre-proline 1 N--CA 1.54 4.051 0 C-N-CA 124.402 1.081 . . . . 0.0 112.247 -176.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--N 1.401 3.3 0 CA-C-N 120.998 1.392 . . . . 0.0 109.476 -176.54 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -55.95 -50.62 70.28 Favored 'General case' 0 N--CA 1.535 3.816 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.07 -34.54 78.26 Favored 'General case' 0 N--CA 1.529 3.514 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.5 -29.03 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.222 0 C-N-CA 125.141 1.377 . . . . 0.0 110.403 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -46.93 74.37 Favored 'General case' 1 N--CA 1.556 4.857 0 O-C-N 121.208 -0.933 . . . . 0.0 110.282 -176.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -71.22 -30.74 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 C-N-CA 124.238 1.015 . . . . 0.0 109.765 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -56.56 -45.67 81.14 Favored 'General case' 0 N--CA 1.519 2.983 0 CA-C-O 122.35 1.072 . . . . 0.0 109.351 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.22 -37.82 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.085 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 52.5 mt -65.51 -40.71 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.71 -44.17 96.64 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.335 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.82 -30.24 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 C-N-CA 123.444 0.698 . . . . 0.0 109.825 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.3 92.49 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.139 0.4 . . . . 0.0 112.969 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 66.8 m -59.48 -35.27 73.78 Favored 'General case' 0 N--CA 1.532 3.649 0 C-N-CA 124.323 1.049 . . . . 0.0 112.437 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.4 mp -53.47 -36.36 61.55 Favored 'General case' 0 N--CA 1.534 3.763 0 C-N-CA 123.747 0.819 . . . . 0.0 112.653 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.412 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.3 OUTLIER -60.81 -46.54 96.01 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.306 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.313 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.47 -29.95 76.4 Favored Glycine 1 N--CA 1.525 4.597 0 O-C-N 121.445 -0.784 . . . . 0.0 111.747 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.97 -42.39 94.04 Favored 'General case' 0 N--CA 1.532 3.671 0 C-N-CA 124.44 1.096 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 696' ' ' ARG . . . . . 0.806 ' HE ' HD11 ' A' ' 693' ' ' ILE . 20.9 mmt180 -52.68 -24.95 9.54 Favored 'General case' 0 N--CA 1.535 3.801 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 19.6 tt -53.05 -37.07 25.75 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.377 0 CA-C-N 120.28 1.4 . . . . 0.0 112.592 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 14.6 p -54.48 -29.8 20.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.348 0 C-N-CA 124.074 0.95 . . . . 0.0 111.33 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -57.08 -27.67 61.93 Favored 'General case' 0 N--CA 1.538 3.968 0 O-C-N 121.259 -0.901 . . . . 0.0 110.666 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -67.88 -42.71 80.82 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 83.9 t -68.99 -32.33 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.868 0 CA-C-N 113.835 -1.529 . . . . 0.0 109.124 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 20.2 tp -55.23 -34.23 63.78 Favored 'General case' 1 N--CA 1.54 4.032 0 C-N-CA 123.059 0.543 . . . . 0.0 109.602 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 57.0 m -57.81 -46.7 84.29 Favored 'General case' 0 N--CA 1.531 3.61 0 CA-C-N 118.79 0.723 . . . . 0.0 112.674 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.18 -36.08 83.08 Favored 'General case' 1 N--CA 1.551 4.601 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.53 -39.04 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 706' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' B' ' 710' ' ' GLN . 6.0 t-20 -66.02 -23.57 66.59 Favored 'General case' 0 N--CA 1.516 2.848 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.889 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -48.88 -45.38 41.07 Favored 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 123.993 0.917 . . . . 0.0 109.39 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 50.3 t -62.4 -48.27 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.794 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.86 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -77.92 -9.98 59.35 Favored 'General case' 0 N--CA 1.539 3.979 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.016 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 710' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' B' ' 706' ' ' ASN . 41.6 tt0 -112.35 -11.55 13.67 Favored 'General case' 0 N--CA 1.527 3.394 0 C-N-CA 125.109 1.364 . . . . 0.0 109.285 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.96 -35.4 58.93 Favored Glycine 0 N--CA 1.513 3.788 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -83.85 154.46 23.46 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 114.747 -0.726 . . . . 0.0 109.157 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 67.7 m -80.18 149.65 69.85 Favored Pre-proline 0 N--CA 1.529 3.484 0 C-N-CA 126.624 1.969 . . . . 0.0 111.138 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--N 1.4 3.285 0 CA-C-N 120.981 1.386 . . . . 0.0 110.943 -174.313 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 N--CA 1.506 2.332 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -61.09 -48.86 79.72 Favored 'General case' 0 N--CA 1.535 3.813 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -35.11 79.79 Favored 'General case' 1 N--CA 1.54 4.065 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 36.2 mm -73.32 -27.23 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.908 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.667 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -66.38 -54.09 28.42 Favored 'General case' 1 N--CA 1.549 4.514 0 CA-C-O 121.86 0.838 . . . . 0.0 112.311 -176.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.17 -29.58 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.216 0 C-N-CA 125.122 1.369 . . . . 0.0 110.148 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -51.98 -33.23 37.09 Favored 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 124.327 1.051 . . . . 0.0 110.432 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 686' ' ' ILE . . . . . 0.417 ' N ' HD12 ' C' ' 686' ' ' ILE . 1.5 mp -68.57 -47.64 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 40.2 mt -57.19 -43.82 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 C-N-CA 123.528 0.731 . . . . 0.0 110.421 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.09 -48.55 87.96 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.406 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 23.2 t -57.9 -30.73 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 C-N-CA 124.41 1.084 . . . . 0.0 109.698 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.98 -40.82 95.45 Favored Glycine 1 N--CA 1.524 4.552 0 C-N-CA 123.532 0.587 . . . . 0.0 112.887 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 71.2 m -67.66 -36.64 81.11 Favored 'General case' 0 N--CA 1.528 3.44 0 CA-C-O 122.193 0.997 . . . . 0.0 110.037 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.8 tp -55.29 -45.02 76.24 Favored 'General case' 0 N--CA 1.517 2.923 0 CA-C-N 113.438 -1.71 . . . . 0.0 114.235 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 693' ' ' ILE . . . . . 0.545 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.0 OUTLIER -69.45 -35.82 68.66 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.212 0 CA-C-N 118.272 0.487 . . . . 0.0 112.276 -176.414 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.48 -26.18 70.61 Favored Glycine 1 N--CA 1.523 4.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.71 -43.25 76.4 Favored 'General case' 0 N--CA 1.535 3.819 0 C-N-CA 124.683 1.193 . . . . 0.0 110.181 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -53.24 -25.65 15.0 Favored 'General case' 0 N--CA 1.533 3.693 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 17.0 tt -54.41 -38.63 41.5 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.261 0 CA-C-N 119.513 1.051 . . . . 0.0 113.342 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 698' ' ' VAL . . . . . 0.461 ' O ' HG22 ' C' ' 701' ' ' VAL . 10.0 p -55.31 -31.09 26.24 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 C-N-CA 123.539 0.736 . . . . 0.0 111.814 -178.459 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -54.44 -25.91 27.78 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 122.92 0.488 . . . . 0.0 109.875 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.19 -32.99 62.64 Favored 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 701' ' ' VAL . . . . . 0.461 HG22 ' O ' ' C' ' 698' ' ' VAL . 3.3 m -69.06 -30.82 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.919 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 5.9 tp -52.08 -34.18 42.59 Favored 'General case' 0 N--CA 1.532 3.67 0 C-N-CA 123.549 0.74 . . . . 0.0 110.68 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 6.4 t -58.99 -46.45 88.12 Favored 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 44.6 tp -67.05 -35.56 80.14 Favored 'General case' 1 N--CA 1.54 4.072 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.1 -39.22 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -59.81 -21.16 60.49 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.062 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -47.21 -47.97 24.17 Favored 'General case' 0 N--CA 1.525 3.28 0 CA-C-O 122.13 0.967 . . . . 0.0 110.204 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.74 -43.05 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.762 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -76.76 -9.7 58.86 Favored 'General case' 0 N--CA 1.526 3.335 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.054 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -89.62 -14.16 35.55 Favored 'General case' 1 N--CA 1.546 4.339 0 C-N-CA 123.25 0.62 . . . . 0.0 110.075 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -69.33 -7.9 58.24 Favored Glycine 1 N--CA 1.527 4.716 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -75.35 156.11 35.83 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 125.891 1.676 . . . . 0.0 109.43 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 92.6 p -114.23 146.5 35.91 Favored Pre-proline 0 N--CA 1.527 3.378 0 C-N-CA 125.714 1.606 . . . . 0.0 107.181 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -59.33 131.23 39.71 Favored 'Trans proline' 0 N--CA 1.527 3.492 0 CA-C-N 121.954 1.734 . . . . 0.0 109.961 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.532 3.627 0 C-N-CA 124.902 1.281 . . . . 0.0 110.035 -179.742 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.513 2.707 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -59.29 -48.09 82.92 Favored 'General case' 0 N--CA 1.537 3.895 0 CA-C-N 118.61 0.641 . . . . 0.0 111.735 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -70.01 -36.52 75.17 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.92 -24.42 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.832 0 C-N-CA 123.781 0.833 . . . . 0.0 109.705 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -64.92 -53.67 42.73 Favored 'General case' 1 N--CA 1.545 4.275 0 CA-C-N 118.826 0.739 . . . . 0.0 111.547 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.28 -30.43 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.994 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -51.08 -36.81 42.11 Favored 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.155 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 15.4 mt -68.9 -37.47 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 C-N-CA 124.333 1.053 . . . . 0.0 109.726 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 10.8 mm -57.81 -37.68 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.952 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.2 -42.55 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.41 -30.88 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 C-N-CA 123.584 0.754 . . . . 0.0 109.506 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.73 -41.97 98.77 Favored Glycine 1 N--CA 1.525 4.62 0 C-N-CA 123.673 0.654 . . . . 0.0 111.589 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.4 m -69.02 -37.89 78.88 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-O 122.272 1.034 . . . . 0.0 110.229 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.01 -44.6 97.18 Favored 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 113.287 -1.779 . . . . 0.0 113.458 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.517 ' O ' HD13 ' A' ' 693' ' ' ILE . 0.1 OUTLIER -70.13 -35.58 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.152 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -76.69 -12.4 84.49 Favored Glycine 1 N--CA 1.535 5.24 0 O-C-N 121.012 -1.055 . . . . 0.0 110.991 178.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.92 -38.92 83.52 Favored 'General case' 0 N--CA 1.539 3.98 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 696' ' ' ARG . . . . . 0.657 ' HE ' HD11 ' C' ' 693' ' ' ILE . 32.4 mmt180 -52.31 -25.23 9.02 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 125.05 1.34 . . . . 0.0 113.692 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 31.2 mm -53.28 -38.84 32.65 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.362 0 CA-C-N 118.611 0.641 . . . . 0.0 111.343 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.67 -28.63 23.68 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.305 0 C-N-CA 123.813 0.845 . . . . 0.0 112.428 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -52.46 -26.38 12.66 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 123.22 0.608 . . . . 0.0 110.901 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.87 -34.72 65.74 Favored 'General case' 0 N--CA 1.53 3.547 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.0 m -69.48 -31.79 50.54 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.107 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 10.2 tp -54.74 -36.06 64.4 Favored 'General case' 0 N--CA 1.538 3.947 0 C-N-CA 122.928 0.491 . . . . 0.0 110.252 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.0 p -59.38 -46.18 89.37 Favored 'General case' 0 N--CA 1.528 3.463 0 CA-C-N 118.383 0.538 . . . . 0.0 112.348 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 44.8 tp -65.42 -34.62 78.72 Favored 'General case' 1 N--CA 1.543 4.203 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.19 -38.89 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.597 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -62.49 -29.33 70.47 Favored 'General case' 0 N--CA 1.515 2.778 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.312 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -50.45 -48.54 56.44 Favored 'General case' 0 N--CA 1.519 3.002 0 C-N-CA 123.328 0.651 . . . . 0.0 111.954 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.34 -39.11 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -75.75 -23.38 56.0 Favored 'General case' 0 N--CA 1.527 3.421 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.369 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -92.23 -7.63 47.65 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.36 1.464 . . . . 0.0 107.429 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.83 -21.62 7.62 Favored Glycine 1 N--CA 1.524 4.532 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -119.48 135.2 54.87 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 125.336 1.454 . . . . 0.0 107.253 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 96.1 p -82.27 146.6 54.88 Favored Pre-proline 0 N--CA 1.528 3.426 0 CA-C-O 117.483 -1.246 . . . . 0.0 110.366 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 C--N 1.398 3.165 0 CA-C-N 121.414 1.541 . . . . 0.0 110.709 -177.22 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 679' ' ' LEU . . . . . 0.493 HD12 ' N ' ' B' ' 680' ' ' TRP . 1.3 pp . . . . . 0 N--CA 1.511 2.624 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 680' ' ' TRP . . . . . 0.493 ' N ' HD12 ' B' ' 679' ' ' LEU . 16.6 t-105 -57.77 -26.24 61.6 Favored 'General case' 1 N--CA 1.551 4.606 0 CA-C-N 121.032 1.742 . . . . 0.0 110.262 -179.188 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -71.8 -40.25 69.32 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.952 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 682' ' ' ILE . . . . . 0.467 HD12 ' N ' ' B' ' 683' ' ' ARG . 1.3 pp -72.52 -25.22 22.54 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.234 0 CA-C-N 119.582 1.083 . . . . 0.0 110.192 178.698 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 683' ' ' ARG . . . . . 0.467 ' N ' HD12 ' B' ' 682' ' ' ILE . 3.3 tmt_? -59.35 -53.55 56.87 Favored 'General case' 0 N--CA 1.538 3.953 0 CA-C-N 118.168 0.44 . . . . 0.0 111.794 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 14.6 tt -70.52 -34.36 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.164 0 C-N-CA 124.003 0.921 . . . . 0.0 110.628 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -53.74 -46.75 70.99 Favored 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 124.48 1.112 . . . . 0.0 111.367 -175.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 43.9 mt -64.46 -39.89 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.894 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 59.8 mt -64.54 -40.11 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 97.8 mt -59.67 -45.34 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.58 -38.36 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.444 0 C-N-CA 123.565 0.746 . . . . 0.0 109.723 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -53.39 -19.84 9.47 Favored Glycine 1 N--CA 1.53 4.931 0 O-C-N 121.417 -0.802 . . . . 0.0 114.136 -177.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.6 m -68.95 -51.78 36.03 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.34 -31.71 61.93 Favored 'General case' 0 N--CA 1.533 3.679 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.667 HD11 ' HE ' ' C' ' 696' ' ' ARG . 0.1 OUTLIER -57.82 -41.77 80.54 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.221 0 CA-C-N 120.37 1.441 . . . . 0.0 111.981 -175.182 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -68.81 -33.54 75.69 Favored Glycine 1 N--CA 1.525 4.574 0 O-C-N 121.08 -1.012 . . . . 0.0 110.642 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.02 -42.32 94.08 Favored 'General case' 1 N--CA 1.548 4.456 0 C-N-CA 124.116 0.967 . . . . 0.0 112.728 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -49.98 -26.19 4.02 Favored 'General case' 1 N--CA 1.542 4.139 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 697' ' ' ILE . . . . . 0.45 HD13 ' O ' ' B' ' 697' ' ' ILE . 0.1 OUTLIER -53.82 -38.15 35.05 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.374 0 CA-C-N 118.696 0.68 . . . . 0.0 111.51 -176.809 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.39 -28.2 18.27 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.182 0 C-N-CA 124.059 0.944 . . . . 0.0 112.412 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -52.93 -26.82 16.22 Favored 'General case' 1 N--CA 1.541 4.082 0 C-N-CA 123.398 0.679 . . . . 0.0 109.744 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.49 76.37 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 122.707 0.403 . . . . 0.0 110.468 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.1 m -69.08 -32.0 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.13 -35.68 59.97 Favored 'General case' 0 N--CA 1.534 3.738 0 C-N-CA 123.044 0.538 . . . . 0.0 111.379 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 8.4 t -60.8 -47.39 86.55 Favored 'General case' 0 N--CA 1.535 3.799 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.098 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 44.0 tp -65.13 -34.91 79.52 Favored 'General case' 1 N--CA 1.544 4.248 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.9 -40.71 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.69 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 706' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 710' ' ' GLN . 4.6 m120 -72.04 -24.77 61.59 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.905 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -49.57 -35.81 21.78 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 118.826 0.739 . . . . 0.0 110.284 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.52 -48.15 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -77.37 -10.77 59.65 Favored 'General case' 1 N--CA 1.543 4.177 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.509 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 710' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 706' ' ' ASN . 33.1 tt0 -112.84 -5.31 13.88 Favored 'General case' 0 N--CA 1.518 2.93 0 C-N-CA 125.523 1.529 . . . . 0.0 108.071 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.77 -29.3 33.18 Favored Glycine 0 N--CA 1.512 3.759 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -98.02 137.58 36.61 Favored 'General case' 0 N--CA 1.528 3.444 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 89.1 p -81.39 146.8 58.5 Favored Pre-proline 0 N--CA 1.528 3.444 0 C-N-CA 125.246 1.418 . . . . 0.0 111.443 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--N 1.399 3.196 0 CA-C-N 121.112 1.433 . . . . 0.0 110.262 -177.965 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 679' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 683' ' ' ARG . 46.8 mt . . . . . 0 N--CA 1.51 2.562 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -43.06 86.21 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -72.8 -37.48 67.52 Favored 'General case' 0 N--CA 1.538 3.927 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 49.0 mm -74.53 -25.86 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 C-N-CA 125.322 1.449 . . . . 0.0 110.917 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 683' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' C' ' 679' ' ' LEU . 64.2 ttt180 -66.13 -56.15 12.87 Favored 'General case' 1 N--CA 1.542 4.173 0 CA-C-O 121.658 0.742 . . . . 0.0 110.912 -177.301 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.9 -36.08 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.785 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.56 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -56.11 -45.9 79.31 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.046 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.74 -42.38 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 124.246 1.018 . . . . 0.0 109.096 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.22 -36.09 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.525 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.25 -42.12 95.27 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 74.7 t -62.67 -31.15 51.14 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.158 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.93 -29.49 74.71 Favored Glycine 1 N--CA 1.517 4.053 0 C-N-CA 123.473 0.558 . . . . 0.0 112.439 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.2 m -67.98 -36.52 80.16 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.42 0.688 . . . . 0.0 111.561 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.83 -44.29 73.76 Favored 'General case' 0 N--CA 1.537 3.883 0 C-N-CA 123.455 0.702 . . . . 0.0 112.503 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 693' ' ' ILE . . . . . 0.657 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.267 0.1 OUTLIER -60.21 -49.26 84.82 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.622 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.825 . . . . . . . . 5 4 . 1 . 013 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.45 -27.39 60.79 Favored Glycine 1 N--CA 1.528 4.813 0 CA-C-N 119.489 1.04 . . . . 0.0 112.625 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -67.35 -42.12 84.02 Favored 'General case' 0 N--CA 1.538 3.935 0 C-N-CA 124.684 1.194 . . . . 0.0 111.118 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 696' ' ' ARG . . . . . 0.667 ' HE ' HD11 ' B' ' 693' ' ' ILE . 29.5 mmt180 -52.28 -24.98 8.32 Favored 'General case' 0 N--CA 1.539 3.996 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 30.0 pt -53.75 -38.02 34.07 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.495 0 CA-C-N 120.591 1.541 . . . . 0.0 113.094 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.76 -30.1 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.638 0 C-N-CA 122.517 0.327 . . . . 0.0 111.85 -176.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.68 -26.17 31.8 Favored 'General case' 0 N--CA 1.533 3.721 0 C-N-CA 123.622 0.769 . . . . 0.0 109.436 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.61 -39.83 74.28 Favored 'General case' 0 N--CA 1.523 3.179 0 O-C-N 121.754 -0.591 . . . . 0.0 109.862 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.1 m -69.53 -32.58 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.999 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.61 -34.56 58.88 Favored 'General case' 0 N--CA 1.537 3.876 0 C-N-CA 123.5 0.72 . . . . 0.0 111.056 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 69.5 m -59.96 -46.21 90.15 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-N 118.392 0.542 . . . . 0.0 111.998 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.72 -36.1 83.2 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 94.5 t -68.02 -40.29 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 706' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' C' ' 710' ' ' GLN . 2.8 m120 -65.7 -23.56 66.79 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-O 118.711 -0.662 . . . . 0.0 109.771 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -49.27 -44.07 43.56 Favored 'General case' 0 N--CA 1.519 2.977 0 C-N-CA 123.691 0.797 . . . . 0.0 110.045 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.1 t -62.29 -48.99 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.992 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 33.7 mtp85 -78.75 -10.2 59.69 Favored 'General case' 0 N--CA 1.532 3.664 0 CA-C-N 115.084 -0.962 . . . . 0.0 113.206 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 710' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.2 tt0 -112.24 -10.62 13.82 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 124.863 1.265 . . . . 0.0 108.666 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.86 -33.73 43.77 Favored Glycine 0 N--CA 1.509 3.548 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -86.04 152.86 22.56 Favored 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 94.1 p -80.99 149.66 67.19 Favored Pre-proline 0 N--CA 1.534 3.742 0 C-N-CA 125.845 1.658 . . . . 0.0 110.063 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.45 129.96 37.52 Favored 'Trans proline' 0 C--N 1.4 3.261 0 CA-C-N 122.204 1.823 . . . . 0.0 112.992 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 715' ' ' LEU . . . . . 0.518 ' CD1' ' H ' ' C' ' 715' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.527 3.391 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.379 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -57.54 -44.35 85.11 Favored 'General case' 0 N--CA 1.532 3.663 0 C-N-CA 123.769 0.828 . . . . 0.0 110.79 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -70.7 -34.65 72.18 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.706 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 25.4 mm -74.15 -26.61 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.445 0 C-N-CA 125.383 1.473 . . . . 0.0 110.879 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -66.25 -53.37 37.73 Favored 'General case' 0 N--CA 1.539 3.987 0 CA-C-O 122.271 1.034 . . . . 0.0 111.24 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.4 tt -69.5 -30.0 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.2 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -52.7 -39.42 61.99 Favored 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.35 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.47 -43.64 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.311 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 54.5 mt -56.29 -34.62 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 58.9 mt -67.02 -46.72 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.15 -30.65 39.95 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.476 0 C-N-CA 123.362 0.665 . . . . 0.0 109.295 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.07 -40.61 98.3 Favored Glycine 0 N--CA 1.516 3.97 0 C-N-CA 123.482 0.563 . . . . 0.0 112.87 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 67.0 m -58.52 -35.41 72.23 Favored 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 124.342 1.057 . . . . 0.0 112.469 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 6.6 mp -53.75 -33.58 56.22 Favored 'General case' 0 N--CA 1.532 3.666 0 C-N-CA 123.61 0.764 . . . . 0.0 111.381 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -43.97 89.95 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.274 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -174.331 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -67.29 -32.34 79.51 Favored Glycine 1 N--CA 1.531 4.967 0 O-C-N 121.064 -1.022 . . . . 0.0 111.215 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.24 -37.75 84.19 Favored 'General case' 1 N--CA 1.546 4.351 0 C-N-CA 124.626 1.171 . . . . 0.0 110.414 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 696' ' ' ARG . . . . . 0.41 ' HE ' ' CD1' ' C' ' 693' ' ' ILE . 24.7 mmt180 -61.02 -29.6 69.81 Favored 'General case' 1 N--CA 1.546 4.344 0 O-C-N 121.309 -0.869 . . . . 0.0 112.45 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 39.8 mm -56.74 -37.93 55.61 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.041 0 CA-C-O 121.934 0.873 . . . . 0.0 109.803 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 39.2 t -56.54 -30.07 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.318 0 C-N-CA 125.727 1.611 . . . . 0.0 110.629 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -59.91 -30.06 68.79 Favored 'General case' 0 N--CA 1.538 3.929 0 C-N-CA 123.493 0.717 . . . . 0.0 111.469 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.98 -43.38 68.16 Favored 'General case' 0 N--CA 1.523 3.209 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.95 -33.44 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.008 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.958 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.58 -35.2 70.07 Favored 'General case' 0 N--CA 1.531 3.59 0 C-N-CA 123.494 0.717 . . . . 0.0 109.801 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.0 p -58.89 -46.62 87.43 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.92 -34.75 78.67 Favored 'General case' 1 N--CA 1.545 4.285 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.069 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.08 -39.11 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 706' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 710' ' ' GLN . 23.7 t-20 -62.19 -29.44 70.38 Favored 'General case' 0 N--CA 1.517 2.921 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.936 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -48.02 -33.72 8.38 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 123.959 0.904 . . . . 0.0 111.251 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.42 -46.75 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -77.7 -11.27 59.86 Favored 'General case' 1 N--CA 1.541 4.083 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.143 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 710' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 706' ' ' ASN . 17.7 tt0 -114.53 -11.96 12.35 Favored 'General case' 0 N--CA 1.522 3.135 0 C-N-CA 126.054 1.742 . . . . 0.0 108.545 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.73 -30.1 27.44 Favored Glycine 0 N--CA 1.51 3.598 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -85.84 152.65 22.83 Favored 'General case' 0 N--CA 1.522 3.154 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 41.7 t -81.05 149.54 66.73 Favored Pre-proline 0 N--CA 1.527 3.423 0 C-N-CA 126.055 1.742 . . . . 0.0 111.625 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo . . . . . 0 C--N 1.406 3.578 0 CA-C-N 122.215 1.827 . . . . 0.0 111.847 -176.879 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 N--CA 1.519 3.011 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -69.69 -30.4 68.05 Favored 'General case' 0 N--CA 1.527 3.42 0 O-C-N 122.183 -0.323 . . . . 0.0 111.035 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -73.05 -38.79 66.36 Favored 'General case' 0 N--CA 1.524 3.249 0 CA-C-O 118.986 -0.53 . . . . 0.0 110.275 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 682' ' ' ILE . . . . . 0.489 HD12 ' N ' ' B' ' 683' ' ' ARG . 1.8 pp -73.48 -25.42 21.06 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.01 0 CA-C-N 119.204 0.911 . . . . 0.0 109.497 177.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 683' ' ' ARG . . . . . 0.489 ' N ' HD12 ' B' ' 682' ' ' ILE . 0.0 OUTLIER -58.43 -51.81 68.27 Favored 'General case' 1 N--CA 1.539 4.007 0 C-N-CA 123.241 0.616 . . . . 0.0 111.768 -177.495 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.7 tt -74.19 -33.68 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.866 0.866 . . . . 0.0 110.979 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -53.96 -47.14 71.65 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 113.938 -1.483 . . . . 0.0 113.099 -173.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 16.8 mt -59.76 -36.84 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 124.074 0.95 . . . . 0.0 111.172 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 687' ' ' ILE . . . . . 0.474 ' N ' HD12 ' B' ' 687' ' ' ILE . 1.4 mp -59.87 -37.25 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.61 -41.77 91.4 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.178 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.74 -31.62 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.931 0 C-N-CA 123.271 0.628 . . . . 0.0 109.506 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.59 -42.8 98.7 Favored Glycine 1 N--CA 1.524 4.521 0 C-N-CA 123.866 0.746 . . . . 0.0 112.474 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.3 m -67.67 -36.87 81.52 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-O 122.078 0.942 . . . . 0.0 110.218 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.23 -44.81 79.95 Favored 'General case' 0 N--CA 1.518 2.972 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.034 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -49.05 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.951 0 C-N-CA 123.334 0.654 . . . . 0.0 112.638 -176.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.9 -21.76 59.2 Favored Glycine 1 N--CA 1.524 4.53 0 CA-C-N 119.699 1.136 . . . . 0.0 112.978 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.09 -43.77 70.42 Favored 'General case' 1 N--CA 1.54 4.069 0 C-N-CA 123.621 0.769 . . . . 0.0 109.93 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -53.98 -26.02 23.8 Favored 'General case' 0 N--CA 1.536 3.852 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 38.4 mm -55.29 -38.77 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 123.904 0.882 . . . . 0.0 112.885 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.99 -31.41 45.52 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.527 0 CA-C-N 119.096 0.862 . . . . 0.0 111.95 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -54.21 -25.65 24.06 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.182 0.593 . . . . 0.0 109.94 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.45 -31.96 62.37 Favored 'General case' 0 N--CA 1.531 3.583 0 O-C-N 121.723 -0.611 . . . . 0.0 110.068 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.0 -30.04 45.35 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 9.6 tp -52.82 -35.25 56.85 Favored 'General case' 0 N--CA 1.532 3.631 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.486 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 52.1 m -58.11 -46.29 85.8 Favored 'General case' 0 N--CA 1.536 3.827 0 CA-C-N 119.233 0.924 . . . . 0.0 112.377 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 45.3 tp -64.54 -35.88 82.39 Favored 'General case' 1 N--CA 1.543 4.214 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.45 -38.42 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.554 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -58.16 -25.33 61.37 Favored 'General case' 0 N--CA 1.52 3.064 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.205 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -46.76 -47.66 20.72 Favored 'General case' 0 N--CA 1.515 2.819 0 C-N-CA 124.528 1.131 . . . . 0.0 112.569 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.56 -49.7 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.779 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -81.04 -6.91 59.36 Favored 'General case' 1 N--CA 1.545 4.29 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -110.75 -8.46 14.55 Favored 'General case' 1 N--CA 1.539 4.006 0 C-N-CA 124.569 1.148 . . . . 0.0 108.836 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -56.29 -27.08 52.16 Favored Glycine 0 N--CA 1.511 3.659 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -98.0 148.59 23.34 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.937 0.895 . . . . 0.0 108.981 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 49.5 m -82.15 149.83 63.27 Favored Pre-proline 0 N--CA 1.528 3.451 0 C-N-CA 125.808 1.643 . . . . 0.0 110.763 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo . . . . . 0 C--N 1.403 3.415 0 CA-C-N 122.138 1.799 . . . . 0.0 112.099 -176.621 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 68.6 mt . . . . . 0 N--CA 1.51 2.565 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -43.47 83.13 Favored 'General case' 0 N--CA 1.538 3.945 0 CA-C-N 119.361 0.982 . . . . 0.0 112.464 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -73.44 -36.55 65.94 Favored 'General case' 0 N--CA 1.529 3.521 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.31 -38.36 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 123.965 0.906 . . . . 0.0 110.804 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -67.96 -51.04 52.06 Favored 'General case' 0 N--CA 1.536 3.873 0 C-N-CA 124.28 1.032 . . . . 0.0 111.366 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 18.5 tt -60.84 -30.71 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 CA-C-O 122.154 0.978 . . . . 0.0 110.686 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -50.58 -27.78 7.42 Favored 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.841 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.69 -47.99 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 124.547 1.139 . . . . 0.0 109.292 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 21.4 mm -54.22 -46.0 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 C-N-CA 124.123 0.969 . . . . 0.0 111.78 -174.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 16.9 tt -68.04 -40.18 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.984 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.25 -30.36 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.767 0.827 . . . . 0.0 109.304 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -72.15 -20.71 79.22 Favored Glycine 1 N--CA 1.522 4.387 0 CA-C-N 118.914 0.779 . . . . 0.0 112.692 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.8 m -68.17 -50.33 55.15 Favored 'General case' 0 N--CA 1.529 3.485 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 692' ' ' LEU . . . . . 0.479 HD12 ' H ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -53.73 -32.69 53.01 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -175.526 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 693' ' ' ILE . . . . . 0.479 ' H ' HD12 ' C' ' 692' ' ' LEU . 0.3 OUTLIER -61.99 -33.77 59.84 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.004 0 CA-C-N 119.618 1.099 . . . . 0.0 111.364 -177.52 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -72.71 -33.28 60.61 Favored Glycine 1 N--CA 1.52 4.254 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.37 -41.93 94.75 Favored 'General case' 0 N--CA 1.535 3.796 0 C-N-CA 124.874 1.27 . . . . 0.0 111.023 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -52.08 -24.32 6.65 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 10.7 tp -52.1 -38.29 23.83 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.35 0 CA-C-N 119.434 1.016 . . . . 0.0 112.357 -176.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.3 p -56.59 -30.65 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.999 0 C-N-CA 123.543 0.737 . . . . 0.0 111.836 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -54.28 -26.95 31.97 Favored 'General case' 0 N--CA 1.536 3.86 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.84 65.58 Favored 'General case' 0 N--CA 1.521 3.116 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.54 -30.42 45.21 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.142 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 9.8 tp -53.44 -35.61 60.66 Favored 'General case' 0 N--CA 1.535 3.808 0 CA-C-O 119.067 -0.492 . . . . 0.0 110.461 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 64.8 m -59.28 -45.99 89.76 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-N 118.941 0.792 . . . . 0.0 112.789 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 40.2 tp -66.51 -34.84 78.82 Favored 'General case' 1 N--CA 1.548 4.448 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.7 -38.87 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 706' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' C' ' 710' ' ' GLN . 38.2 t30 -58.24 -34.22 70.2 Favored 'General case' 0 C--O 1.183 -2.418 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.28 -177.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -46.63 -45.5 19.13 Favored 'General case' 0 N--CA 1.511 2.602 0 C-N-CA 124.464 1.106 . . . . 0.0 112.319 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.8 -45.81 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -77.99 -4.62 47.95 Favored 'General case' 0 N--CA 1.526 3.339 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.687 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 710' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' C' ' 706' ' ' ASN . 1.8 tt0 -111.29 -15.53 13.59 Favored 'General case' 1 N--CA 1.546 4.345 0 C-N-CA 124.307 1.043 . . . . 0.0 108.465 -178.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -77.01 -11.72 85.32 Favored Glycine 1 N--CA 1.533 5.117 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 174.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -76.03 153.67 36.28 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 128.321 2.648 . . . . 0.0 107.646 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 58.9 m -80.69 145.8 59.03 Favored Pre-proline 1 N--CA 1.545 4.317 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -69.83 131.51 21.29 Favored 'Trans proline' 0 C--N 1.4 3.272 0 CA-C-N 120.36 1.164 . . . . 0.0 110.459 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 N--CA 1.525 3.315 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.585 177.534 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.5 2.031 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -67.39 -49.35 64.24 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -66.5 -30.95 71.4 Favored 'General case' 0 N--CA 1.532 3.66 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 682' ' ' ILE . . . . . 0.45 ' O ' HD13 ' A' ' 686' ' ' ILE . 51.0 mm -74.65 -30.31 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.86 0 C-N-CA 125.53 1.532 . . . . 0.0 110.19 177.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -51.47 57.0 Favored 'General case' 1 N--CA 1.548 4.463 0 C-N-CA 123.463 0.705 . . . . 0.0 111.964 -178.15 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.5 tt -65.8 -35.66 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.753 0 CA-C-O 122.091 0.948 . . . . 0.0 109.611 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -60.18 -40.91 91.62 Favored 'General case' 0 N--CA 1.512 2.669 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.825 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 686' ' ' ILE . . . . . 0.45 HD13 ' O ' ' A' ' 682' ' ' ILE . 1.2 mp -55.18 -49.19 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.793 0.837 . . . . 0.0 109.232 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 53.8 mt -56.81 -40.47 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 78.8 mt -68.26 -41.12 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.967 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.18 -30.63 49.24 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.601 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.21 -34.64 90.51 Favored Glycine 1 N--CA 1.522 4.405 0 C-N-CA 123.637 0.637 . . . . 0.0 111.991 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 62.9 m -68.39 -37.27 80.23 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.615 0.766 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.8 -44.44 86.31 Favored 'General case' 0 N--CA 1.536 3.864 0 C-N-CA 123.499 0.72 . . . . 0.0 112.627 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 693' ' ' ILE . . . . . 0.43 ' O ' HD13 ' A' ' 693' ' ' ILE 0.259 0.3 OUTLIER -61.3 -43.83 97.3 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.215 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -173.248 . . . . . . . . 5 4 . 1 . 015 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.03 -34.15 89.19 Favored Glycine 1 N--CA 1.534 5.206 0 CA-C-N 120.017 1.28 . . . . 0.0 111.822 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.0 -39.78 86.92 Favored 'General case' 1 N--CA 1.541 4.114 0 C-N-CA 124.715 1.206 . . . . 0.0 110.326 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 696' ' ' ARG . . . . . 0.651 ' HE ' HD11 ' C' ' 693' ' ' ILE . 23.0 mmt180 -59.97 -28.25 67.52 Favored 'General case' 1 N--CA 1.544 4.275 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.3 -36.66 41.14 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.313 0 CA-C-O 122.09 0.948 . . . . 0.0 109.618 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 68.7 t -54.58 -28.0 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.092 0 C-N-CA 126.69 1.996 . . . . 0.0 111.216 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -53.15 -25.8 14.67 Favored 'General case' 0 N--CA 1.534 3.753 0 C-N-CA 123.559 0.744 . . . . 0.0 110.748 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.49 -39.89 74.01 Favored 'General case' 0 N--CA 1.525 3.297 0 O-C-N 121.766 -0.584 . . . . 0.0 109.668 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.8 -36.03 67.88 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.16 -35.45 64.77 Favored 'General case' 1 N--CA 1.54 4.073 0 C-N-CA 123.526 0.731 . . . . 0.0 110.806 -179.532 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 9.6 t -60.62 -46.89 88.57 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 44.8 tp -67.58 -36.82 81.65 Favored 'General case' 0 N--CA 1.536 3.865 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.88 -46.36 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 C-N-CA 123.295 0.638 . . . . 0.0 110.027 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 706' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 710' ' ' GLN . 23.7 p30 -72.47 -20.09 61.45 Favored 'General case' 0 N--CA 1.513 2.68 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.142 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -48.07 -44.36 31.33 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 123.682 0.793 . . . . 0.0 109.798 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.37 -43.49 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.75 -19.85 57.16 Favored 'General case' 0 N--CA 1.528 3.465 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.5 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 710' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 706' ' ' ASN . 2.6 tt0 -89.88 -14.83 33.45 Favored 'General case' 0 N--CA 1.538 3.937 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -59.15 -12.41 16.29 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -74.19 154.56 39.01 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 124.424 1.089 . . . . 0.0 108.37 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 73.0 m -94.53 147.41 33.19 Favored Pre-proline 0 N--CA 1.528 3.472 0 C-N-CA 125.123 1.369 . . . . 0.0 107.866 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 N--CA 1.527 3.496 0 CA-C-N 121.574 1.598 . . . . 0.0 109.739 -174.962 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 N--CA 1.525 3.323 0 CA-C-O 120.462 0.172 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -71.1 -30.13 66.14 Favored 'General case' 0 N--CA 1.529 3.519 0 O-C-N 122.126 -0.359 . . . . 0.0 110.607 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -68.95 -37.95 79.16 Favored 'General case' 0 N--CA 1.519 3.015 0 CA-C-O 118.902 -0.57 . . . . 0.0 111.056 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 682' ' ' ILE . . . . . 0.473 HD12 ' N ' ' B' ' 683' ' ' ARG . 2.1 pp -72.2 -23.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.809 0 CA-C-N 118.943 0.792 . . . . 0.0 110.767 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 683' ' ' ARG . . . . . 0.473 ' N ' HD12 ' B' ' 682' ' ' ILE . 1.3 ttp180 -60.34 -54.28 47.58 Favored 'General case' 1 N--CA 1.546 4.369 0 CA-C-N 119.205 0.911 . . . . 0.0 112.736 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -70.7 -31.32 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.97 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.072 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -52.56 -30.05 28.74 Favored 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 124.0 0.92 . . . . 0.0 112.873 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 686' ' ' ILE . . . . . 0.475 ' N ' HD12 ' B' ' 686' ' ' ILE . 1.4 mp -68.69 -36.51 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.755 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.08 -42.45 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.321 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.84 -50.29 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.985 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.36 -29.04 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.304 0 C-N-CA 124.519 1.127 . . . . 0.0 108.879 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.13 -17.92 68.52 Favored Glycine 1 N--CA 1.524 4.516 0 C-N-CA 123.674 0.654 . . . . 0.0 113.172 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 75.1 m -68.92 -52.21 31.74 Favored 'General case' 0 N--CA 1.527 3.421 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.17 -32.78 73.44 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.469 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.2 OUTLIER -60.64 -38.65 79.1 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.38 0 CA-C-N 120.384 1.447 . . . . 0.0 112.148 -176.425 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.88 -34.62 89.12 Favored Glycine 1 N--CA 1.526 4.7 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.21 -42.44 95.14 Favored 'General case' 0 N--CA 1.538 3.933 0 C-N-CA 124.572 1.149 . . . . 0.0 111.261 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -51.85 -24.23 5.88 Favored 'General case' 0 N--CA 1.536 3.863 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 20.0 tt -52.18 -36.71 21.13 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 CA-C-N 120.959 1.709 . . . . 0.0 111.844 -176.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 13.5 p -54.84 -28.12 19.59 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.028 0 C-N-CA 123.821 0.848 . . . . 0.0 111.17 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -55.75 -28.04 53.83 Favored 'General case' 1 N--CA 1.546 4.347 0 O-C-N 121.451 -0.781 . . . . 0.0 109.828 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.54 -44.09 68.21 Favored 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 65.5 t -68.85 -32.16 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.271 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 2.9 tp -54.2 -35.52 62.46 Favored 'General case' 0 N--CA 1.536 3.858 0 C-N-CA 123.391 0.676 . . . . 0.0 110.275 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 20.7 t -60.07 -46.68 88.75 Favored 'General case' 0 N--CA 1.529 3.525 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 36.2 tp -67.4 -34.6 77.6 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.43 -43.57 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 706' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' B' ' 709' ' ' ARG . 11.5 p30 -72.4 -22.71 61.08 Favored 'General case' 0 N--CA 1.517 2.913 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.062 -178.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -48.43 -36.96 15.92 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.296 0.57 . . . . 0.0 110.306 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.42 -41.52 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 176.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 709' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' B' ' 706' ' ' ASN . 86.5 mtt180 -75.92 -17.08 59.9 Favored 'General case' 0 N--CA 1.525 3.288 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.667 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -87.96 -12.33 44.87 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.76 -19.08 6.26 Favored Glycine 1 N--CA 1.521 4.344 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -114.24 130.04 56.63 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 124.99 1.316 . . . . 0.0 107.737 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 96.4 p -82.82 147.41 54.84 Favored Pre-proline 0 N--CA 1.526 3.366 0 C-N-CA 125.182 1.393 . . . . 0.0 110.53 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--N 1.4 3.268 0 CA-C-N 121.653 1.626 . . . . 0.0 110.671 -177.365 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.527 3.41 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -68.85 -37.13 78.91 Favored 'General case' 0 N--CA 1.524 3.271 0 CA-C-O 121.597 0.713 . . . . 0.0 110.961 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -66.35 -40.37 89.76 Favored 'General case' 0 N--CA 1.518 2.935 0 CA-C-N 114.151 -1.386 . . . . 0.0 111.415 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 18.2 pt -73.01 -29.38 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -52.09 66.96 Favored 'General case' 1 N--CA 1.55 4.562 0 C-N-CA 123.106 0.563 . . . . 0.0 110.421 -176.434 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.94 -36.33 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -52.17 -27.66 15.26 Favored 'General case' 0 N--CA 1.526 3.366 0 C-N-CA 124.214 1.005 . . . . 0.0 110.816 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 9.0 mm -67.61 -48.01 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.235 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 23.8 mt -64.33 -36.06 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.749 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.891 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 44.3 mm -59.86 -42.59 89.67 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.202 0 CA-C-N 118.151 0.432 . . . . 0.0 110.192 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.62 -31.69 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 C-N-CA 123.838 0.855 . . . . 0.0 110.328 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.66 -36.3 93.08 Favored Glycine 1 N--CA 1.522 4.428 0 C-N-CA 123.259 0.457 . . . . 0.0 112.194 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 64.2 m -68.12 -37.35 81.01 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.876 0.87 . . . . 0.0 111.805 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.13 -45.01 92.05 Favored 'General case' 0 N--CA 1.536 3.866 0 C-N-CA 123.589 0.755 . . . . 0.0 112.675 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 693' ' ' ILE . . . . . 0.651 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.286 0.1 OUTLIER -63.38 -48.84 85.39 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.466 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.95 . . . . . . . . 5 4 . 1 . 015 nuclear build core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -55.2 -31.99 56.8 Favored Glycine 1 N--CA 1.531 5.016 0 CA-C-N 119.214 0.915 . . . . 0.0 113.279 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.23 -38.8 88.78 Favored 'General case' 0 N--CA 1.539 3.984 0 C-N-CA 124.728 1.211 . . . . 0.0 110.357 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -60.09 -28.48 67.87 Favored 'General case' 1 N--CA 1.543 4.203 0 O-C-N 121.575 -0.703 . . . . 0.0 111.878 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.71 -36.97 44.75 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.155 0 CA-C-O 121.916 0.865 . . . . 0.0 109.512 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.59 -27.13 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.292 0 C-N-CA 126.395 1.878 . . . . 0.0 110.695 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -54.09 -27.11 30.74 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.139 0.576 . . . . 0.0 111.797 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.84 86.86 Favored 'General case' 0 N--CA 1.527 3.405 0 O-C-N 122.038 -0.414 . . . . 0.0 110.367 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 14.0 m -70.51 -31.75 47.53 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.025 0 CA-C-N 118.09 0.404 . . . . 0.0 110.085 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.66 -33.7 61.11 Favored 'General case' 0 N--CA 1.53 3.563 0 C-N-CA 123.521 0.729 . . . . 0.0 110.629 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 64.3 m -58.6 -46.95 85.9 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 21.7 tp -65.56 -34.88 79.28 Favored 'General case' 1 N--CA 1.549 4.505 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.81 -38.88 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -65.46 -23.89 67.03 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 123.251 0.62 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 11.5 tpt85 -49.73 -37.24 28.55 Favored 'General case' 0 N--CA 1.516 2.849 0 CA-C-O 121.753 0.787 . . . . 0.0 110.76 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.75 -37.33 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.015 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.83 -28.7 58.37 Favored 'General case' 1 N--CA 1.54 4.031 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -89.71 -3.05 58.39 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 124.615 1.166 . . . . 0.0 109.133 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.92 -24.34 33.96 Favored Glycine 1 N--CA 1.526 4.67 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 176.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -121.2 143.97 48.84 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 113.042 -1.579 . . . . 0.0 107.769 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 90.1 p -82.57 146.66 53.94 Favored Pre-proline 0 N--CA 1.53 3.527 0 CA-C-O 117.305 -1.331 . . . . 0.0 110.239 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.5 131.34 42.08 Favored 'Trans proline' 0 C--N 1.399 3.193 0 CA-C-N 121.614 1.612 . . . . 0.0 111.169 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 61.6 mt . . . . . 0 N--CA 1.521 3.107 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.19 179.685 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 32.9 m120 . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -64.65 -21.14 66.65 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.841 0.856 . . . . 0.0 111.106 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.91 -30.29 5.72 Favored 'General case' 0 N--CA 1.511 2.62 0 C-N-CA 125.607 1.563 . . . . 0.0 111.574 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -68.16 -48.25 65.82 Favored 'General case' 0 N--CA 1.528 3.468 0 CA-C-O 121.711 0.767 . . . . 0.0 110.741 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -61.54 -33.45 73.87 Favored 'General case' 0 N--CA 1.527 3.382 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.101 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.4 mm -76.23 -34.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.456 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -53.41 26.3 Favored 'General case' 1 N--CA 1.546 4.372 0 O-C-N 121.721 -0.612 . . . . 0.0 111.988 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.9 tt -55.52 -35.3 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 CA-C-O 122.479 1.133 . . . . 0.0 110.234 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -58.83 -33.68 70.68 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 112.933 -1.939 . . . . 0.0 110.478 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.0 mm -68.64 -37.93 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.072 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 24.1 mt -58.25 -39.23 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.25 -44.42 99.1 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.015 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 67.0 t -64.36 -30.35 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.943 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.83 -33.73 88.01 Favored Glycine 0 N--CA 1.514 3.883 0 C-N-CA 123.87 0.748 . . . . 0.0 112.124 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.9 m -68.16 -37.04 80.59 Favored 'General case' 0 N--CA 1.526 3.331 0 C-N-CA 123.362 0.665 . . . . 0.0 111.009 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.97 -43.23 91.34 Favored 'General case' 0 N--CA 1.537 3.921 0 C-N-CA 123.212 0.605 . . . . 0.0 111.787 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.7 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.268 0.8 OUTLIER -63.66 -48.88 84.67 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -175.718 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.43 -25.61 65.26 Favored Glycine 1 N--CA 1.526 4.694 0 O-C-N 120.704 -1.248 . . . . 0.0 112.981 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.33 -38.74 88.37 Favored 'General case' 0 N--CA 1.536 3.86 0 C-N-CA 124.116 0.967 . . . . 0.0 110.604 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 696' ' ' ARG . . . . . 0.413 ' HE ' ' CD1' ' C' ' 693' ' ' ILE . 13.9 mmt180 -52.03 -23.74 5.66 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 18.6 tt -51.96 -36.42 19.77 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.178 0 CA-C-N 119.444 1.02 . . . . 0.0 111.333 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 11.2 p -54.64 -27.42 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 C-N-CA 124.235 1.014 . . . . 0.0 111.107 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -55.07 -28.79 55.02 Favored 'General case' 1 N--CA 1.545 4.319 0 O-C-N 121.692 -0.63 . . . . 0.0 109.879 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.19 -45.03 67.49 Favored 'General case' 0 N--CA 1.522 3.14 0 CA-C-O 122.031 0.92 . . . . 0.0 108.966 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.7 -34.31 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.816 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.233 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.6 tp -55.64 -34.81 65.27 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.965 0.906 . . . . 0.0 111.021 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 51.0 m -59.1 -45.02 91.94 Favored 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 35.7 tp -67.66 -34.8 77.65 Favored 'General case' 0 N--CA 1.538 3.95 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 66.1 t -67.86 -39.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.828 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 706' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 710' ' ' GLN . 16.1 m120 -59.21 -23.63 62.44 Favored 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.891 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 22.8 tpt85 -48.07 -41.02 24.93 Favored 'General case' 0 N--CA 1.524 3.269 0 CA-C-O 121.372 0.606 . . . . 0.0 110.84 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 52.9 t -72.6 -41.97 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-N 114.689 -1.141 . . . . 0.0 107.944 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -76.72 -11.35 59.83 Favored 'General case' 1 N--CA 1.545 4.298 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.417 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 710' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 706' ' ' ASN . 1.4 tm0? -111.87 -10.4 14.0 Favored 'General case' 0 N--CA 1.516 2.851 0 C-N-CA 125.549 1.54 . . . . 0.0 107.634 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.13 -22.83 7.04 Favored Glycine 1 N--CA 1.518 4.135 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -98.39 153.46 18.55 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 124.076 0.95 . . . . 0.0 109.472 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 66.1 m -80.51 152.17 72.55 Favored Pre-proline 0 N--CA 1.526 3.345 0 C-N-CA 126.859 2.064 . . . . 0.0 111.216 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.33 130.6 39.21 Favored 'Trans proline' 0 C--N 1.401 3.302 0 CA-C-N 121.527 1.581 . . . . 0.0 111.74 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 58.7 mt 60.37 42.58 14.56 Favored 'General case' 0 N--CA 1.52 3.047 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.694 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 61.5 p . . . . . 0 N--CA 1.524 3.266 0 C-N-CA 124.446 1.098 . . . . 0.0 112.1 179.609 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -71.2 174.68 6.07 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 124.119 0.968 . . . . 0.0 110.035 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -48.66 -29.24 4.16 Favored 'General case' 0 N--CA 1.518 2.929 0 C-N-CA 125.691 1.597 . . . . 0.0 112.299 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -63.36 -49.52 73.55 Favored 'General case' 0 N--CA 1.532 3.643 0 CA-C-N 118.367 0.531 . . . . 0.0 111.32 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -64.0 -31.53 72.75 Favored 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.88 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.02 -32.22 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.864 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.26 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -51.57 48.87 Favored 'General case' 1 N--CA 1.554 4.745 0 CA-C-N 118.713 0.688 . . . . 0.0 112.057 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.8 tt -62.1 -31.66 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-O 122.029 0.918 . . . . 0.0 110.779 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -51.94 -35.29 45.34 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.762 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.22 -41.56 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.082 0 C-N-CA 124.607 1.163 . . . . 0.0 108.788 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 47.3 mt -60.38 -37.37 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 64.0 mt -64.62 -44.79 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.43 -30.32 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 C-N-CA 123.827 0.851 . . . . 0.0 108.727 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.26 -30.58 78.1 Favored Glycine 1 N--CA 1.517 4.054 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 32.4 m -68.79 -37.59 79.4 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.431 0.692 . . . . 0.0 111.413 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.32 -41.4 75.94 Favored 'General case' 0 N--CA 1.535 3.781 0 C-N-CA 123.443 0.697 . . . . 0.0 111.932 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.748 HD11 ' HE ' ' C' ' 696' ' ' ARG 0.292 0.3 OUTLIER -60.7 -46.1 96.47 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.386 0 CA-C-N 118.956 0.798 . . . . 0.0 112.206 -176.485 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.83 -27.68 64.67 Favored Glycine 1 N--CA 1.528 4.833 0 CA-C-N 119.159 0.89 . . . . 0.0 112.307 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.4 tt -67.93 -37.38 81.58 Favored 'General case' 1 N--CA 1.548 4.431 0 C-N-CA 125.126 1.37 . . . . 0.0 109.31 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 696' ' ' ARG . . . . . 0.7 ' HE ' HD11 ' A' ' 693' ' ' ILE . 25.0 mmt180 -62.89 -27.37 69.31 Favored 'General case' 1 N--CA 1.54 4.073 0 C-N-CA 123.806 0.842 . . . . 0.0 112.336 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.51 -38.78 50.73 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.593 0 CA-C-O 122.477 1.132 . . . . 0.0 109.473 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 64.3 t -57.21 -29.6 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.032 0 C-N-CA 126.962 2.105 . . . . 0.0 111.293 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -53.75 -26.92 25.7 Favored 'General case' 0 N--CA 1.534 3.774 0 C-N-CA 122.976 0.51 . . . . 0.0 111.16 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.42 -35.14 67.48 Favored 'General case' 0 N--CA 1.528 3.449 0 O-C-N 121.956 -0.465 . . . . 0.0 109.849 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.7 -32.7 53.32 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.343 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 7.9 tp -54.97 -33.67 62.62 Favored 'General case' 0 N--CA 1.539 3.999 0 C-N-CA 124.087 0.955 . . . . 0.0 110.421 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 84.9 p -59.01 -45.73 89.94 Favored 'General case' 0 N--CA 1.528 3.471 0 O-C-N 122.344 -0.223 . . . . 0.0 111.21 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.09 -36.56 84.0 Favored 'General case' 1 N--CA 1.548 4.427 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.74 -42.09 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.427 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -75.48 -21.41 58.09 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 123.126 0.57 . . . . 0.0 110.101 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.18 -42.63 60.98 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.52 -42.35 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.903 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -75.31 -7.54 54.23 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.225 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.99 -14.76 17.73 Favored 'General case' 1 N--CA 1.546 4.33 0 C-N-CA 124.201 1.0 . . . . 0.0 108.825 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -84.33 -18.15 63.08 Favored Glycine 1 N--CA 1.522 4.378 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -87.93 152.35 22.13 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 126.72 2.008 . . . . 0.0 108.285 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 67.0 m -93.23 148.63 36.0 Favored Pre-proline 1 N--CA 1.547 4.381 0 C-N-CA 125.914 1.686 . . . . 0.0 113.764 -176.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -60.46 132.75 45.07 Favored 'Trans proline' 0 C--N 1.404 3.46 0 CA-C-N 120.788 1.317 . . . . 0.0 109.76 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 28.6 mt -46.56 165.8 0.02 OUTLIER 'General case' 0 N--CA 1.535 3.787 0 C-N-CA 125.259 1.424 . . . . 0.0 111.84 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.522 3.174 0 CA-C-O 117.774 -1.108 . . . . 0.0 112.369 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 6.0 p30 . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 31.8 p90 56.55 -56.14 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 126.373 1.869 . . . . 0.0 114.016 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 7.1 tt -51.6 -44.41 62.84 Favored 'General case' 0 N--CA 1.516 2.86 0 C-N-CA 125.25 1.42 . . . . 0.0 112.293 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -61.6 -49.75 75.36 Favored 'General case' 0 N--CA 1.529 3.522 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -66.01 -33.73 76.48 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 95.5 mt -74.34 -25.33 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.807 0 C-N-CA 124.789 1.236 . . . . 0.0 110.445 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -50.69 62.52 Favored 'General case' 1 N--CA 1.555 4.82 0 CA-C-N 119.682 1.128 . . . . 0.0 110.133 -178.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.2 tt -66.25 -31.06 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 C-N-CA 123.71 0.804 . . . . 0.0 109.115 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -54.86 -28.38 49.66 Favored 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.015 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 21.4 mm -68.5 -44.13 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 C-N-CA 123.689 0.796 . . . . 0.0 109.548 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.71 -41.0 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.59 -47.35 93.36 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.91 -30.11 47.83 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.161 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.05 82.47 Favored Glycine 1 N--CA 1.516 4.029 0 C-N-CA 123.625 0.631 . . . . 0.0 112.408 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 62.4 m -67.9 -37.07 81.27 Favored 'General case' 0 N--CA 1.533 3.681 0 C-N-CA 123.463 0.705 . . . . 0.0 111.698 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.91 -40.81 77.01 Favored 'General case' 0 N--CA 1.533 3.689 0 C-N-CA 123.339 0.656 . . . . 0.0 111.868 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 693' ' ' ILE . . . . . 0.421 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -60.62 -39.89 82.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.181 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -71.41 -25.56 75.11 Favored Glycine 1 N--CA 1.531 5.002 0 O-C-N 121.074 -1.016 . . . . 0.0 111.107 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.85 -43.38 98.96 Favored 'General case' 0 N--CA 1.535 3.806 0 C-N-CA 123.99 0.916 . . . . 0.0 109.392 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 696' ' ' ARG . . . . . 0.748 ' HE ' HD11 ' B' ' 693' ' ' ILE . 10.1 mmt180 -54.2 -25.49 23.07 Favored 'General case' 0 N--CA 1.539 3.986 0 C-N-CA 125.045 1.338 . . . . 0.0 114.565 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 72.2 mt -53.84 -37.54 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.863 0 CA-C-N 118.541 0.609 . . . . 0.0 109.841 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.05 -26.18 32.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.238 0 C-N-CA 124.965 1.306 . . . . 0.0 111.971 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -53.59 -27.54 27.16 Favored 'General case' 1 N--CA 1.549 4.523 0 O-C-N 120.972 -1.08 . . . . 0.0 110.219 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.41 -46.07 91.67 Favored 'General case' 0 N--CA 1.525 3.325 0 O-C-N 121.967 -0.458 . . . . 0.0 110.881 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.1 -31.33 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.63 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.68 -34.16 57.79 Favored 'General case' 0 N--CA 1.536 3.86 0 C-N-CA 123.12 0.568 . . . . 0.0 110.742 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 86.9 p -59.67 -46.35 89.3 Favored 'General case' 0 N--CA 1.532 3.642 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 45.7 tp -65.8 -35.68 81.39 Favored 'General case' 1 N--CA 1.542 4.147 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.31 -43.45 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.38 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -68.4 -25.43 65.04 Favored 'General case' 0 N--CA 1.515 2.8 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.25 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.09 -43.92 61.15 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 119.087 0.858 . . . . 0.0 109.233 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.25 -47.39 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.1 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -74.73 -15.72 60.77 Favored 'General case' 0 N--CA 1.535 3.792 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.895 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -114.12 -3.86 13.2 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -48.83 -27.81 6.71 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 124.399 0.999 . . . . 0.0 111.796 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -75.44 155.18 36.56 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 31.1 t -77.76 146.96 73.6 Favored Pre-proline 0 N--CA 1.536 3.865 0 C-N-CA 125.001 1.32 . . . . 0.0 112.584 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -58.51 129.95 35.02 Favored 'Trans proline' 0 C--N 1.408 3.699 0 CA-C-N 120.643 1.265 . . . . 0.0 110.234 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 60.3 tp -88.39 -43.37 11.54 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.0 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.522 3.127 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.779 179.744 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 41.9 t30 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -158.43 -173.7 4.43 Favored 'General case' 0 N--CA 1.523 3.187 0 C-N-CA 124.453 1.101 . . . . 0.0 108.535 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 683' ' ' ARG . 18.6 mt -50.34 -41.42 51.34 Favored 'General case' 0 N--CA 1.504 2.272 0 C-N-CA 125.487 1.515 . . . . 0.0 112.639 -178.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -55.97 -45.38 78.92 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -73.18 -38.71 66.06 Favored 'General case' 0 N--CA 1.533 3.706 0 CA-C-O 121.555 0.693 . . . . 0.0 109.485 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.6 mm -74.89 -26.0 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 125.072 1.349 . . . . 0.0 111.276 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 683' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 679' ' ' LEU . 56.5 ttt180 -67.06 -55.7 13.21 Favored 'General case' 1 N--CA 1.542 4.146 0 C-N-CA 123.976 0.91 . . . . 0.0 110.56 -177.276 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.3 tt -64.4 -32.54 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.537 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -52.57 -44.02 65.62 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.946 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 66.5 mt -68.54 -37.22 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.445 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 42.9 mt -65.89 -34.69 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.697 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 48.3 mm -63.72 -42.46 96.05 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.383 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 88.0 t -64.98 -29.88 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.882 0 C-N-CA 123.664 0.786 . . . . 0.0 108.959 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -61.19 -36.84 93.01 Favored Glycine 1 N--CA 1.522 4.413 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 53.4 m -68.91 -37.34 78.89 Favored 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 124.027 0.931 . . . . 0.0 111.451 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.8 mp -58.04 -38.97 77.24 Favored 'General case' 1 N--CA 1.546 4.332 0 C-N-CA 124.175 0.99 . . . . 0.0 112.346 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.806 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.268 1.3 tp -69.23 -45.76 78.78 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.205 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -73.7 -12.21 80.66 Favored Glycine 1 N--CA 1.525 4.578 0 O-C-N 120.744 -1.222 . . . . 0.0 112.046 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 695' ' ' LEU . . . . . 0.426 ' O ' HD23 ' A' ' 695' ' ' LEU . 6.1 tt -70.48 -41.28 72.92 Favored 'General case' 0 N--CA 1.535 3.8 0 C-N-CA 124.127 0.971 . . . . 0.0 109.745 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 696' ' ' ARG . . . . . 0.841 ' HE ' HD11 ' C' ' 693' ' ' ILE . 22.8 mmt180 -52.51 -28.41 20.39 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.952 0.901 . . . . 0.0 113.054 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 42.0 mm -56.39 -43.81 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.332 0 C-N-CA 124.041 0.936 . . . . 0.0 112.486 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 3.3 p -66.66 -51.91 51.32 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.623 0 CA-C-N 118.702 0.683 . . . . 0.0 112.618 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 699' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' A' ' 702' ' ' LEU 0.522 0.9 OUTLIER -54.8 -18.93 5.39 Favored 'General case' 0 C--O 1.165 -3.392 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.255 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -51.93 -29.51 20.52 Favored 'General case' 1 N--CA 1.539 4.012 0 O-C-N 120.93 -1.106 . . . . 0.0 109.009 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 12.7 m -62.75 -29.27 46.63 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.491 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 699' ' ' PHE . 7.1 tt -50.5 -34.64 25.88 Favored 'General case' 1 N--CA 1.541 4.113 0 C-N-CA 125.311 1.445 . . . . 0.0 110.955 -178.304 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 68.0 m -59.34 -45.32 91.7 Favored 'General case' 0 N--CA 1.534 3.772 0 CA-C-N 118.467 0.576 . . . . 0.0 110.78 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.06 -35.21 80.0 Favored 'General case' 1 N--CA 1.54 4.025 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.1 t -68.06 -39.78 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.788 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 706' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 710' ' ' GLN . 3.1 m120 -64.82 -24.6 67.6 Favored 'General case' 0 N--CA 1.512 2.674 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.61 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 707' ' ' ARG . . . . . 0.468 HH12 ' NH2' ' B' ' 707' ' ' ARG . 21.6 tpt180 -47.71 -30.86 4.16 Favored 'General case' 0 N--CA 1.529 3.486 0 C-N-CA 123.3 0.64 . . . . 0.0 111.446 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.1 t -75.03 -47.89 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.59 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.97 -12.19 59.96 Favored 'General case' 1 N--CA 1.549 4.496 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.707 179.254 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 710' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 706' ' ' ASN . 51.9 tt0 -112.81 -4.15 14.05 Favored 'General case' 0 N--CA 1.518 2.963 0 C-N-CA 125.591 1.556 . . . . 0.0 108.065 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.68 -27.84 50.35 Favored Glycine 0 N--CA 1.509 3.548 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -96.8 153.12 18.07 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 123.677 0.791 . . . . 0.0 109.138 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 50.8 m -80.89 149.32 66.86 Favored Pre-proline 0 N--CA 1.526 3.37 0 C-N-CA 125.965 1.706 . . . . 0.0 111.315 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.19 130.96 43.51 Favored 'Trans proline' 0 C--N 1.403 3.43 0 CA-C-N 122.019 1.757 . . . . 0.0 111.059 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 715' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 715' ' ' LEU . 1.7 mm? -61.51 -117.87 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 124.996 1.318 . . . . 0.0 110.125 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 N--CA 1.524 3.249 0 CA-C-O 118.398 -0.81 . . . . 0.0 110.816 -179.804 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -168.68 133.0 1.54 Allowed 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.3 -30.83 12.82 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.467 1.507 . . . . 0.0 112.477 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -61.61 -49.24 77.37 Favored 'General case' 0 N--CA 1.534 3.768 0 CA-C-N 118.394 0.543 . . . . 0.0 112.316 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.14 -37.82 86.65 Favored 'General case' 0 N--CA 1.525 3.325 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.43 -29.39 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.916 0 C-N-CA 125.397 1.479 . . . . 0.0 110.921 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -50.98 60.67 Favored 'General case' 1 N--CA 1.547 4.389 0 C-N-CA 123.601 0.76 . . . . 0.0 111.719 -177.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -30.84 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 124.068 0.947 . . . . 0.0 109.808 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -56.18 -34.49 66.27 Favored 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.58 1.152 . . . . 0.0 110.441 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 24.3 mm -60.43 -37.52 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.581 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.31 -40.02 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.114 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.93 -48.52 87.46 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.28 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.86 -31.37 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.761 0 C-N-CA 123.839 0.855 . . . . 0.0 109.688 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.37 -32.31 83.76 Favored Glycine 1 N--CA 1.516 4.021 0 C-N-CA 123.607 0.622 . . . . 0.0 112.439 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 62.5 m -67.98 -36.9 80.82 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 123.507 0.723 . . . . 0.0 111.971 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 9.0 mp -54.68 -41.75 70.56 Favored 'General case' 0 N--CA 1.537 3.885 0 C-N-CA 123.431 0.692 . . . . 0.0 112.737 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.422 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.2 OUTLIER -60.37 -43.94 94.9 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.297 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -174.975 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -66.43 -28.49 73.75 Favored Glycine 1 N--CA 1.525 4.617 0 O-C-N 121.177 -0.952 . . . . 0.0 111.746 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -62.1 -42.13 98.91 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 124.529 1.131 . . . . 0.0 110.682 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 696' ' ' ARG . . . . . 0.806 ' HE ' HD11 ' A' ' 693' ' ' ILE . 25.1 mmt180 -52.33 -25.62 10.09 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.33 -37.61 37.48 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.501 0 CA-C-N 120.538 1.517 . . . . 0.0 112.26 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.3 p -54.36 -27.66 17.49 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.128 0 C-N-CA 124.523 1.129 . . . . 0.0 112.063 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -52.08 -25.66 9.23 Favored 'General case' 0 N--CA 1.537 3.89 0 C-N-CA 123.357 0.663 . . . . 0.0 110.104 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.45 68.88 Favored 'General case' 0 N--CA 1.52 3.031 0 C-N-CA 122.72 0.408 . . . . 0.0 110.17 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -69.42 -30.39 45.42 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 8.8 tp -52.53 -35.32 53.14 Favored 'General case' 0 N--CA 1.537 3.881 0 C-N-CA 122.974 0.51 . . . . 0.0 110.71 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 1.6 t -58.74 -46.16 88.05 Favored 'General case' 1 N--CA 1.54 4.045 0 CA-C-N 118.824 0.738 . . . . 0.0 112.081 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 34.5 tp -66.38 -34.77 78.71 Favored 'General case' 1 N--CA 1.542 4.174 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.87 -38.51 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -63.58 -24.04 67.64 Favored 'General case' 0 N--CA 1.522 3.168 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.01 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 707' ' ' ARG . . . . . 0.468 ' NH2' HH12 ' A' ' 707' ' ' ARG . 17.2 tpt180 -49.56 -47.75 48.95 Favored 'General case' 0 N--CA 1.522 3.149 0 CA-C-O 121.8 0.809 . . . . 0.0 110.438 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 51.3 t -63.14 -37.46 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.712 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.456 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -75.31 -28.06 59.55 Favored 'General case' 0 N--CA 1.531 3.624 0 CA-C-O 121.18 0.514 . . . . 0.0 109.896 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -89.91 -4.87 57.3 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.963 1.305 . . . . 0.0 108.466 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.75 -23.42 29.49 Favored Glycine 1 N--CA 1.523 4.434 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -120.27 141.25 50.16 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 125.33 1.452 . . . . 0.0 107.59 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 68.5 m -82.97 146.61 52.38 Favored Pre-proline 0 N--CA 1.529 3.502 0 CA-C-O 117.285 -1.34 . . . . 0.0 110.157 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -65.21 130.81 26.5 Favored 'Trans proline' 0 C--N 1.395 3.004 0 CA-C-N 121.701 1.643 . . . . 0.0 109.192 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -60.18 -21.8 62.15 Favored 'General case' 0 N--CA 1.527 3.388 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.122 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.522 3.167 0 C-N-CA 124.297 1.039 . . . . 0.0 112.177 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -169.06 -40.44 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.591 0.756 . . . . 0.0 109.195 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.58 -43.21 62.37 Favored 'General case' 0 N--CA 1.521 3.113 0 C-N-CA 124.887 1.275 . . . . 0.0 111.663 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -65.64 -48.75 71.1 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.813 0.445 . . . . 0.0 111.891 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -64.64 -34.46 78.33 Favored 'General case' 0 N--CA 1.529 3.495 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 93.9 mt -74.86 -24.89 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.946 0 C-N-CA 124.944 1.298 . . . . 0.0 110.662 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -66.18 -53.14 41.06 Favored 'General case' 1 N--CA 1.547 4.423 0 CA-C-N 118.999 0.818 . . . . 0.0 110.529 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.3 tt -66.34 -30.77 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.228 0 C-N-CA 123.873 0.869 . . . . 0.0 109.422 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -53.32 -31.28 43.41 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.926 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 16.5 mm -67.99 -46.93 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.015 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.4 -34.39 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.752 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 79.0 mt -68.33 -44.82 83.42 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.327 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.98 -30.67 45.99 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.44 -42.04 96.09 Favored Glycine 1 N--CA 1.523 4.47 0 C-N-CA 123.88 0.753 . . . . 0.0 112.658 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 70.2 m -67.36 -36.83 82.19 Favored 'General case' 0 N--CA 1.529 3.477 0 CA-C-O 122.232 1.015 . . . . 0.0 109.94 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.67 -41.11 80.89 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 113.306 -1.77 . . . . 0.0 113.037 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 693' ' ' ILE . . . . . 0.841 HD11 ' HE ' ' A' ' 696' ' ' ARG . 0.6 OUTLIER -68.85 -47.66 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -176.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.22 -25.87 60.68 Favored Glycine 1 N--CA 1.53 4.941 0 CA-C-N 119.62 1.1 . . . . 0.0 112.441 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.07 -42.59 99.7 Favored 'General case' 0 N--CA 1.534 3.773 0 C-N-CA 124.348 1.059 . . . . 0.0 109.237 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -53.94 -26.59 26.25 Favored 'General case' 0 N--CA 1.532 3.674 0 C-N-CA 124.927 1.291 . . . . 0.0 113.88 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 76.1 mt -54.64 -38.3 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 C-N-CA 123.413 0.685 . . . . 0.0 111.699 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.52 -28.91 23.5 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.263 0 C-N-CA 123.643 0.777 . . . . 0.0 112.55 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -52.66 -27.49 17.51 Favored 'General case' 0 N--CA 1.536 3.854 0 C-N-CA 122.978 0.511 . . . . 0.0 110.826 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.63 -33.52 66.37 Favored 'General case' 0 N--CA 1.531 3.597 0 O-C-N 121.877 -0.514 . . . . 0.0 110.259 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.8 -30.95 48.79 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.222 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 7.1 tp -52.83 -33.03 47.51 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.75 0.82 . . . . 0.0 110.441 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 83.4 p -58.08 -46.07 86.08 Favored 'General case' 0 N--CA 1.53 3.531 0 O-C-N 121.766 -0.584 . . . . 0.0 111.572 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.25 -36.09 82.52 Favored 'General case' 1 N--CA 1.544 4.246 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.9 t -68.54 -41.48 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -68.07 -22.91 64.91 Favored 'General case' 0 N--CA 1.514 2.751 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.219 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -49.85 -47.31 51.74 Favored 'General case' 0 N--CA 1.511 2.62 0 CA-C-O 121.932 0.872 . . . . 0.0 109.124 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.4 -40.06 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.416 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.93 -22.9 55.52 Favored 'General case' 0 N--CA 1.534 3.775 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -89.15 -13.52 38.21 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -53.85 -27.33 36.17 Favored Glycine 1 N--CA 1.517 4.076 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -95.34 154.67 17.08 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 124.36 1.064 . . . . 0.0 108.849 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 99.4 p -80.3 149.57 69.32 Favored Pre-proline 0 N--CA 1.529 3.508 0 C-N-CA 126.388 1.875 . . . . 0.0 111.363 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -56.45 131.29 44.85 Favored 'Trans proline' 0 C--N 1.402 3.392 0 CA-C-N 120.918 1.364 . . . . 0.0 110.289 -174.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 34.6 mt 65.28 176.81 0.2 Allowed 'General case' 0 N--CA 1.522 3.132 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.522 3.166 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.182 -179.591 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -156.65 -76.94 0.09 Allowed 'General case' 0 N--CA 1.521 3.078 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp -52.06 -27.88 15.39 Favored 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 124.212 1.005 . . . . 0.0 112.639 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -66.77 -51.42 56.0 Favored 'General case' 0 N--CA 1.532 3.64 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.95 -32.84 74.75 Favored 'General case' 0 N--CA 1.526 3.373 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 91.4 mt -74.62 -29.84 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.544 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -59.33 -52.78 64.18 Favored 'General case' 1 N--CA 1.555 4.789 0 CA-C-O 122.264 1.03 . . . . 0.0 110.942 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.8 tt -70.37 -32.28 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.715 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.079 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -50.13 -25.03 3.13 Favored 'General case' 0 N--CA 1.53 3.528 0 C-N-CA 123.85 0.86 . . . . 0.0 112.549 -174.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.91 -35.17 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 17.3 pt -64.01 -39.15 84.42 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.416 0 CA-C-N 120.016 1.28 . . . . 0.0 109.62 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.1 -48.73 85.8 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.254 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 50.4 t -67.39 -41.38 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 124.513 1.125 . . . . 0.0 110.03 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.61 90.92 Favored Glycine 1 N--CA 1.522 4.402 0 C-N-CA 125.241 1.4 . . . . 0.0 112.798 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 74.2 m -67.28 -35.26 79.13 Favored 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 124.29 1.036 . . . . 0.0 108.415 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.21 -47.07 86.7 Favored 'General case' 0 N--CA 1.523 3.208 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.768 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.516 HD11 ' HE ' ' B' ' 696' ' ' ARG . 0.0 OUTLIER -70.82 -27.93 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.868 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.39 -29.36 70.12 Favored Glycine 1 N--CA 1.528 4.833 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.7 tt -67.01 -40.12 87.21 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 125.581 1.552 . . . . 0.0 110.36 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 696' ' ' ARG . . . . . 0.475 ' HE ' HD11 ' C' ' 693' ' ' ILE . 38.4 mmt180 -52.27 -25.42 9.34 Favored 'General case' 0 N--CA 1.531 3.611 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 15.8 tt -54.13 -38.99 40.3 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.172 0 CA-C-N 119.302 0.955 . . . . 0.0 113.096 -175.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 10.3 p -57.33 -30.44 35.55 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.164 0 C-N-CA 123.412 0.685 . . . . 0.0 111.672 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -53.97 -25.25 19.85 Favored 'General case' 0 N--CA 1.537 3.886 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.05 -34.45 63.57 Favored 'General case' 0 N--CA 1.523 3.199 0 O-C-N 122.035 -0.415 . . . . 0.0 109.933 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.47 -32.02 51.43 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.209 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.2 -33.03 51.0 Favored 'General case' 0 N--CA 1.535 3.82 0 C-N-CA 123.811 0.844 . . . . 0.0 110.77 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 68.5 m -58.03 -45.64 86.62 Favored 'General case' 0 N--CA 1.531 3.612 0 O-C-N 121.652 -0.655 . . . . 0.0 110.919 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.04 -34.49 78.56 Favored 'General case' 1 N--CA 1.543 4.19 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 48.0 t -67.63 -39.66 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -67.77 -25.95 65.87 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.372 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -50.05 -41.65 48.16 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.543 0.687 . . . . 0.0 111.173 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 68.1 t -61.68 -38.97 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -76.14 -20.62 57.43 Favored 'General case' 0 N--CA 1.524 3.257 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.503 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -88.66 -12.45 42.41 Favored 'General case' 0 N--CA 1.518 2.956 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -60.2 -13.82 30.01 Favored Glycine 1 N--CA 1.517 4.076 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 177.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -108.56 154.57 21.76 Favored 'General case' 0 N--CA 1.532 3.665 0 C-N-CA 125.06 1.344 . . . . 0.0 109.77 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 48.4 t -80.47 150.13 69.79 Favored Pre-proline 0 N--CA 1.53 3.571 0 C-N-CA 126.107 1.763 . . . . 0.0 110.877 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.72 130.35 38.52 Favored 'Trans proline' 0 C--N 1.402 3.359 0 CA-C-N 122.247 1.838 . . . . 0.0 113.221 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 45.0 tp -87.73 106.97 18.41 Favored 'General case' 0 N--CA 1.523 3.191 0 CA-C-N 113.221 -1.808 . . . . 0.0 108.094 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.524 3.24 0 CA-C-O 118.106 -0.949 . . . . 0.0 111.916 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 677' ' ' ASN . . . . . 0.644 ' N ' HD21 ' B' ' 677' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -166.15 175.16 8.61 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 124.228 1.011 . . . . 0.0 108.411 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 679' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' B' ' 683' ' ' ARG . 63.7 mt -52.36 -46.41 66.15 Favored 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 123.533 0.733 . . . . 0.0 112.656 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -59.45 -43.44 93.16 Favored 'General case' 0 N--CA 1.532 3.661 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -72.34 -37.32 68.88 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 93.0 mt -74.82 -25.16 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 C-N-CA 125.029 1.332 . . . . 0.0 111.862 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 683' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' B' ' 679' ' ' LEU . 17.4 ttp180 -66.13 -52.24 50.39 Favored 'General case' 1 N--CA 1.549 4.481 0 C-N-CA 124.381 1.072 . . . . 0.0 110.577 -177.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.46 -32.77 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 CA-C-N 113.692 -1.595 . . . . 0.0 108.815 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -54.1 -30.79 49.91 Favored 'General case' 0 N--CA 1.52 3.028 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.276 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 17.9 mm -68.87 -41.85 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.626 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 40.3 mt -71.39 -34.86 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.016 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 50.8 mm -58.7 -40.19 78.7 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.668 0 CA-C-N 119.449 1.022 . . . . 0.0 109.738 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.41 -31.95 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.534 0 C-N-CA 123.704 0.802 . . . . 0.0 110.501 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.32 -32.34 79.37 Favored Glycine 1 N--CA 1.517 4.037 0 C-N-CA 123.404 0.526 . . . . 0.0 112.683 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 58.9 m -67.5 -36.96 82.09 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.719 0.808 . . . . 0.0 111.63 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 9.4 mp -56.55 -45.79 81.05 Favored 'General case' 0 N--CA 1.537 3.907 0 C-N-CA 123.44 0.696 . . . . 0.0 112.681 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.738 HD11 ' HE ' ' C' ' 696' ' ' ARG . 1.0 OUTLIER -62.71 -49.04 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -175.475 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.9 -25.21 65.62 Favored Glycine 1 N--CA 1.525 4.601 0 CA-C-N 119.628 1.103 . . . . 0.0 113.12 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 4.4 tt -66.74 -41.86 87.18 Favored 'General case' 0 N--CA 1.535 3.797 0 C-N-CA 124.567 1.147 . . . . 0.0 110.639 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 696' ' ' ARG . . . . . 0.516 ' HE ' HD11 ' A' ' 693' ' ' ILE . 26.7 mmt180 -52.13 -25.26 8.48 Favored 'General case' 0 N--CA 1.536 3.833 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.8 tt -54.14 -36.88 33.64 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 CA-C-N 119.878 1.217 . . . . 0.0 112.066 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.14 -27.97 17.21 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.012 0 C-N-CA 124.332 1.053 . . . . 0.0 111.779 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -52.15 -25.82 9.89 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 123.402 0.681 . . . . 0.0 109.756 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.73 -38.43 69.77 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 122.767 0.427 . . . . 0.0 110.017 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.24 -32.01 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.956 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.42 -36.45 61.53 Favored 'General case' 0 N--CA 1.537 3.897 0 C-N-CA 122.908 0.483 . . . . 0.0 110.809 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 26.5 m -62.11 -47.21 85.63 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.83 -35.92 79.45 Favored 'General case' 1 N--CA 1.545 4.32 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.14 -43.25 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.365 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -71.29 -20.99 62.14 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.876 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -47.73 -46.7 30.03 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 40.1 t -59.35 -41.59 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.389 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -76.69 -22.11 54.43 Favored 'General case' 0 N--CA 1.533 3.678 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.866 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -8.3 36.22 Favored 'General case' 0 N--CA 1.517 2.916 0 C-N-CA 124.925 1.29 . . . . 0.0 108.44 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.12 -32.49 35.71 Favored Glycine 1 N--CA 1.516 4.015 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -100.81 130.99 46.91 Favored 'General case' 0 N--CA 1.529 3.507 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 88.1 p -81.94 146.8 56.52 Favored Pre-proline 0 N--CA 1.527 3.422 0 C-N-CA 124.947 1.299 . . . . 0.0 110.627 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -67.0 130.01 21.99 Favored 'Trans proline' 0 C--N 1.399 3.195 0 CA-C-N 121.334 1.512 . . . . 0.0 109.445 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 56.3 mt -81.83 177.2 9.01 Favored 'General case' 0 N--CA 1.52 3.064 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.401 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.521 3.124 0 CA-C-O 117.854 -1.069 . . . . 0.0 108.894 179.727 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 . . . . . 0 N--CA 1.497 1.875 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -170.83 -30.0 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 123.994 0.918 . . . . 0.0 109.191 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.27 -43.95 79.28 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 124.809 1.243 . . . . 0.0 111.352 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -69.78 -40.07 76.25 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.217 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -65.68 -37.37 86.3 Favored 'General case' 0 N--CA 1.52 3.046 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.036 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 26.9 pt -73.09 -25.7 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 CA-C-N 118.347 0.521 . . . . 0.0 110.627 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -50.07 70.86 Favored 'General case' 1 N--CA 1.546 4.361 0 C-N-CA 122.806 0.443 . . . . 0.0 110.826 -176.241 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.48 -31.95 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.564 0 C-N-CA 124.002 0.921 . . . . 0.0 109.7 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -53.9 -41.14 67.28 Favored 'General case' 0 N--CA 1.518 2.969 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.37 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.71 -39.12 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.92 -45.06 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 C-N-CA 123.458 0.703 . . . . 0.0 110.56 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 76.0 mt -59.9 -49.04 85.44 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.42 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.62 -29.65 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.125 0 C-N-CA 125.286 1.434 . . . . 0.0 109.688 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.27 -31.69 81.69 Favored Glycine 1 N--CA 1.519 4.21 0 C-N-CA 123.717 0.675 . . . . 0.0 112.388 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.3 m -68.28 -36.39 79.31 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.962 0.905 . . . . 0.0 111.849 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.27 -35.7 62.83 Favored 'General case' 0 N--CA 1.534 3.755 0 CA-C-O 118.295 -0.859 . . . . 0.0 113.265 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 693' ' ' ILE . . . . . 0.497 ' O ' HD12 ' C' ' 693' ' ' ILE 0.255 0.1 OUTLIER -60.53 -49.98 82.22 Favored 'Isoleucine or valine' 1 N--CA 1.561 5.121 0 CA-C-N 120.272 1.397 . . . . 0.0 112.455 -176.164 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.17 -29.22 68.02 Favored Glycine 1 N--CA 1.532 5.054 0 CA-C-N 119.452 1.024 . . . . 0.0 111.69 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.59 -42.41 98.28 Favored 'General case' 0 N--CA 1.538 3.939 0 C-N-CA 123.653 0.781 . . . . 0.0 109.836 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 696' ' ' ARG . . . . . 0.738 ' HE ' HD11 ' B' ' 693' ' ' ILE . 24.4 mmt180 -53.82 -25.2 18.28 Favored 'General case' 1 N--CA 1.542 4.164 0 C-N-CA 124.673 1.189 . . . . 0.0 113.82 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 70.6 mt -54.94 -39.78 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 O-C-N 121.625 -0.672 . . . . 0.0 110.454 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.36 -30.97 50.85 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.405 0 C-N-CA 123.859 0.864 . . . . 0.0 110.875 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.56 -30.15 65.01 Favored 'General case' 1 N--CA 1.542 4.143 0 O-C-N 121.055 -1.028 . . . . 0.0 111.689 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.98 -37.59 72.73 Favored 'General case' 1 N--CA 1.54 4.025 0 CA-C-O 121.8 0.809 . . . . 0.0 109.104 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.36 -28.05 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.277 0 C-N-CA 125.066 1.346 . . . . 0.0 108.678 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.1 tp -52.25 -32.66 38.11 Favored 'General case' 0 N--CA 1.532 3.643 0 C-N-CA 123.53 0.732 . . . . 0.0 110.108 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 89.1 p -56.56 -46.13 80.87 Favored 'General case' 0 N--CA 1.53 3.553 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 46.5 tp -66.04 -35.11 79.65 Favored 'General case' 1 N--CA 1.547 4.384 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.03 -40.02 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 706' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.0 OUTLIER -71.92 -23.73 61.52 Favored 'General case' 0 N--CA 1.517 2.902 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.225 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -48.47 -32.04 7.24 Favored 'General case' 0 N--CA 1.526 3.357 0 CA-C-N 118.832 0.742 . . . . 0.0 110.499 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.74 -49.07 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -77.84 -10.26 59.47 Favored 'General case' 1 N--CA 1.54 4.06 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.701 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 710' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.6 tt0 -114.14 -9.28 12.93 Favored 'General case' 0 N--CA 1.522 3.145 0 C-N-CA 125.365 1.466 . . . . 0.0 108.759 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -57.58 -30.04 61.74 Favored Glycine 0 N--CA 1.512 3.712 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -80.76 155.13 26.84 Favored 'General case' 0 N--CA 1.524 3.269 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 97.0 p -79.49 149.15 71.39 Favored Pre-proline 0 N--CA 1.528 3.469 0 C-N-CA 126.281 1.832 . . . . 0.0 111.757 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -56.87 131.86 48.11 Favored 'Trans proline' 0 C--N 1.401 3.316 0 CA-C-N 120.669 1.274 . . . . 0.0 111.001 -174.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 65.56 -67.87 0.13 Allowed 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 125.616 1.566 . . . . 0.0 110.72 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 83.2 p . . . . . 0 N--CA 1.526 3.328 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.494 -179.036 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 54.87 102.74 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.19 0 C-N-CA 124.294 1.038 . . . . 0.0 112.152 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 680' ' ' TRP . 0.3 OUTLIER -52.37 -22.44 4.62 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 125.262 1.425 . . . . 0.0 112.493 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 680' ' ' TRP . . . . . 0.406 ' N ' HD12 ' A' ' 679' ' ' LEU . 95.1 m95 -57.3 -51.1 70.72 Favored 'General case' 0 N--CA 1.533 3.689 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -64.88 -31.28 72.44 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.53 -33.59 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.966 0 C-N-CA 123.879 0.872 . . . . 0.0 108.664 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -51.79 42.42 Favored 'General case' 1 N--CA 1.554 4.748 0 CA-C-N 118.48 0.582 . . . . 0.0 112.11 -177.585 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.39 -38.23 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 CA-C-O 122.496 1.141 . . . . 0.0 110.184 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -52.39 -29.29 23.36 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 113.111 -1.858 . . . . 0.0 111.113 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 28.5 mm -68.46 -37.23 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 C-N-CA 124.244 1.018 . . . . 0.0 109.602 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 37.5 mt -64.9 -38.27 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.268 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.53 -41.72 93.66 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.27 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.76 -30.51 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 C-N-CA 123.965 0.906 . . . . 0.0 109.185 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.16 -34.29 89.26 Favored Glycine 1 N--CA 1.518 4.159 0 C-N-CA 123.382 0.515 . . . . 0.0 111.985 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.5 m -68.67 -37.51 79.66 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.562 0.745 . . . . 0.0 111.172 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.9 mp -57.54 -42.54 83.15 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 123.751 0.82 . . . . 0.0 112.328 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.77 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.274 0.5 OUTLIER -62.44 -48.91 86.09 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.308 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.231 . . . . . . . . 5 4 . 1 . 004 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.44 -30.29 67.91 Favored Glycine 1 N--CA 1.53 4.954 0 CA-C-N 119.814 1.188 . . . . 0.0 112.899 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.94 -41.47 99.51 Favored 'General case' 1 N--CA 1.539 4.013 0 C-N-CA 124.411 1.084 . . . . 0.0 111.234 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -51.71 -24.28 5.55 Favored 'General case' 0 N--CA 1.538 3.933 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 18.5 tt -52.7 -36.03 22.22 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.26 0 CA-C-N 120.143 1.338 . . . . 0.0 111.684 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 12.6 p -54.09 -28.19 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.951 0 C-N-CA 124.304 1.042 . . . . 0.0 111.43 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -55.9 -29.08 59.44 Favored 'General case' 1 N--CA 1.544 4.256 0 O-C-N 121.489 -0.757 . . . . 0.0 109.764 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.7 -43.08 69.72 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 63.0 t -68.87 -33.34 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.112 0 C-N-CA 124.713 1.205 . . . . 0.0 109.105 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.13 -32.62 62.22 Favored 'General case' 0 N--CA 1.535 3.817 0 C-N-CA 124.175 0.99 . . . . 0.0 109.901 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.5 p -59.04 -45.14 91.48 Favored 'General case' 0 N--CA 1.528 3.426 0 O-C-N 121.353 -0.842 . . . . 0.0 111.253 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.21 -33.35 74.39 Favored 'General case' 1 N--CA 1.542 4.152 0 O-C-N 121.431 -0.793 . . . . 0.0 108.959 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.18 -39.22 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.873 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 706' ' ' ASN . . . . . 0.438 ' ND2' HH11 ' A' ' 709' ' ' ARG . 9.3 m120 -62.71 -22.8 66.78 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.693 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -50.38 -41.34 51.72 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-O 121.915 0.864 . . . . 0.0 110.012 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 64.1 t -62.96 -36.68 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 709' ' ' ARG . . . . . 0.438 HH11 ' ND2' ' A' ' 706' ' ' ASN . 50.6 mtm180 -75.7 -3.86 37.1 Favored 'General case' 0 N--CA 1.523 3.195 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.46 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -103.26 -14.9 16.15 Favored 'General case' 1 N--CA 1.552 4.662 0 C-N-CA 123.685 0.794 . . . . 0.0 108.921 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -81.94 -6.65 88.77 Favored Glycine 1 N--CA 1.528 4.82 0 N-CA-C 106.736 -2.546 . . . . 0.0 106.736 173.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -105.47 154.29 20.54 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 128.036 2.534 . . . . 0.0 106.611 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 32.1 t -98.13 147.3 32.89 Favored Pre-proline 1 N--CA 1.556 4.831 0 C-N-CA 125.422 1.489 . . . . 0.0 112.997 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -68.76 129.82 19.4 Favored 'Trans proline' 0 C--N 1.408 3.668 0 CA-C-N 121.212 1.468 . . . . 0.0 109.048 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 41.3 mt 50.05 70.63 0.48 Allowed 'General case' 0 N--CA 1.522 3.137 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.799 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.522 3.168 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.281 -179.658 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -169.16 176.61 5.18 Favored 'General case' 0 N--CA 1.522 3.137 0 C-N-CA 124.162 0.985 . . . . 0.0 109.367 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -27.67 14.09 Favored 'General case' 0 N--CA 1.516 2.853 0 C-N-CA 124.352 1.061 . . . . 0.0 113.732 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -70.98 -49.79 41.42 Favored 'General case' 0 N--CA 1.535 3.791 0 CA-C-O 121.155 0.503 . . . . 0.0 111.576 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -61.05 -31.42 71.07 Favored 'General case' 0 N--CA 1.533 3.688 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.98 -25.55 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.786 0 C-N-CA 125.913 1.685 . . . . 0.0 111.021 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 683' ' ' ARG . . . . . 0.404 HH11 HD12 ' B' ' 687' ' ' ILE . 0.6 OUTLIER -66.07 -52.29 50.24 Favored 'General case' 1 N--CA 1.547 4.386 0 CA-C-O 121.574 0.702 . . . . 0.0 111.409 -177.964 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.8 tt -68.0 -32.34 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.171 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.594 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -54.27 -30.49 50.75 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 123.827 0.851 . . . . 0.0 111.213 -177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 16.1 mm -66.21 -37.69 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.937 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 687' ' ' ILE . . . . . 0.404 HD12 HH11 ' B' ' 683' ' ' ARG . 38.5 mt -62.3 -38.37 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.1 -46.53 93.41 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.361 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.4 t -62.04 -30.04 47.79 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.26 -31.73 81.82 Favored Glycine 1 N--CA 1.519 4.223 0 C-N-CA 123.562 0.601 . . . . 0.0 112.455 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 61.4 m -68.58 -36.92 79.41 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.658 0.783 . . . . 0.0 111.367 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.56 -43.19 79.73 Favored 'General case' 0 N--CA 1.536 3.868 0 C-N-CA 123.713 0.805 . . . . 0.0 112.52 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.801 HD11 ' HE ' ' C' ' 696' ' ' ARG 0.281 0.6 OUTLIER -60.42 -48.97 86.16 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.621 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.091 . . . . . . . . 5 4 . 1 . 004 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.77 -26.95 71.43 Favored Glycine 1 N--CA 1.533 5.121 0 CA-C-N 120.734 1.606 . . . . 0.0 112.373 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 5.3 tt -62.95 -43.05 99.86 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.806 0.843 . . . . 0.0 110.955 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 696' ' ' ARG . . . . . 0.77 ' HE ' HD11 ' A' ' 693' ' ' ILE . 26.0 mmt180 -53.14 -27.12 19.38 Favored 'General case' 1 N--CA 1.539 4.003 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 70.9 mt -54.74 -37.95 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.51 0 C-N-CA 123.954 0.902 . . . . 0.0 111.794 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.11 -31.61 42.11 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.301 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -54.23 -25.76 24.88 Favored 'General case' 0 N--CA 1.539 3.988 0 CA-C-N 118.793 0.724 . . . . 0.0 111.207 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.1 -37.78 69.85 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 121.65 -0.656 . . . . 0.0 110.248 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.22 -32.59 54.38 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 13.4 tp -54.87 -35.32 63.93 Favored 'General case' 0 N--CA 1.533 3.689 0 C-N-CA 123.154 0.581 . . . . 0.0 110.498 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 80.8 p -59.01 -48.41 81.67 Favored 'General case' 0 N--CA 1.521 3.119 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.22 -35.09 79.16 Favored 'General case' 1 N--CA 1.549 4.517 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.647 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.53 -38.78 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 706' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' B' ' 710' ' ' GLN . 2.2 p30 -62.24 -25.81 68.03 Favored 'General case' 0 N--CA 1.521 3.084 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.625 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 18.6 tpt85 -46.82 -32.56 3.78 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.617 0.767 . . . . 0.0 111.362 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 63.3 t -75.53 -48.8 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.36 -11.03 59.92 Favored 'General case' 1 N--CA 1.543 4.182 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.839 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 710' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' B' ' 706' ' ' ASN . 28.2 tt0 -113.63 -10.64 13.09 Favored 'General case' 0 N--CA 1.519 3.018 0 C-N-CA 125.929 1.692 . . . . 0.0 108.556 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.74 -24.43 32.92 Favored Glycine 0 N--CA 1.51 3.608 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -95.48 152.82 18.08 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 123.461 0.705 . . . . 0.0 109.226 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 48.7 m -81.31 150.76 68.26 Favored Pre-proline 0 N--CA 1.533 3.686 0 C-N-CA 126.264 1.826 . . . . 0.0 111.267 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.87 130.38 38.87 Favored 'Trans proline' 0 C--N 1.402 3.382 0 CA-C-N 121.984 1.744 . . . . 0.0 112.33 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 715' ' ' LEU . . . . . 0.754 ' H ' HD13 ' B' ' 715' ' ' LEU . 0.0 OUTLIER -58.64 170.15 0.83 Allowed 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.656 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 N--CA 1.519 2.999 0 C-N-CA 124.09 0.956 . . . . 0.0 111.955 -179.458 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 12.0 m120 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 25.3 t-105 -166.31 -71.3 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.034 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -24.05 64.47 Favored 'General case' 0 N--CA 1.521 3.117 0 C-N-CA 124.574 1.15 . . . . 0.0 110.814 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -70.15 -45.38 66.9 Favored 'General case' 0 N--CA 1.513 2.72 0 C-N-CA 124.809 1.244 . . . . 0.0 111.204 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -61.74 -38.78 89.22 Favored 'General case' 0 N--CA 1.518 2.939 0 CA-C-N 113.978 -1.464 . . . . 0.0 111.659 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 26.5 pt -72.45 -36.6 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 C-N-CA 122.671 0.388 . . . . 0.0 111.01 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -52.86 -51.23 61.78 Favored 'General case' 0 N--CA 1.539 3.98 0 CA-C-O 121.7 0.762 . . . . 0.0 111.625 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.23 -34.48 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.828 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -55.54 -43.74 76.07 Favored 'General case' 0 N--CA 1.537 3.891 0 C-N-CA 123.618 0.767 . . . . 0.0 109.523 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.51 -37.76 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.814 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 41.5 mt -71.08 -41.99 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 49.1 mm -59.68 -48.79 86.15 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.472 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 70.8 t -60.73 -30.22 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 C-N-CA 124.136 0.975 . . . . 0.0 109.737 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.27 91.87 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 123.307 0.479 . . . . 0.0 112.488 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 66.7 m -67.5 -37.07 82.28 Favored 'General case' 0 N--CA 1.528 3.472 0 C-N-CA 123.768 0.827 . . . . 0.0 112.041 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.73 -39.9 68.73 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 123.434 0.694 . . . . 0.0 112.312 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -40.85 86.28 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.07 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -174.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -71.71 -27.38 71.04 Favored Glycine 1 N--CA 1.527 4.721 0 O-C-N 121.173 -0.954 . . . . 0.0 110.973 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.48 -42.59 99.01 Favored 'General case' 0 N--CA 1.531 3.581 0 C-N-CA 124.176 0.99 . . . . 0.0 109.651 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 696' ' ' ARG . . . . . 0.801 ' HE ' HD11 ' B' ' 693' ' ' ILE . 25.5 mmt180 -53.96 -26.46 25.83 Favored 'General case' 0 N--CA 1.537 3.896 0 C-N-CA 124.471 1.109 . . . . 0.0 113.846 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 73.9 mt -54.62 -38.59 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 C-N-CA 123.578 0.751 . . . . 0.0 111.342 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 5.8 p -56.01 -27.33 22.82 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.324 0 C-N-CA 124.074 0.95 . . . . 0.0 112.281 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -51.73 -27.33 11.62 Favored 'General case' 0 N--CA 1.538 3.964 0 C-N-CA 123.311 0.645 . . . . 0.0 111.179 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.3 -34.11 66.19 Favored 'General case' 0 N--CA 1.532 3.649 0 O-C-N 121.857 -0.527 . . . . 0.0 109.952 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.1 m -69.36 -31.82 50.99 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.093 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 6.9 tp -53.5 -35.67 60.89 Favored 'General case' 0 N--CA 1.538 3.959 0 C-N-CA 123.293 0.637 . . . . 0.0 110.373 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 88.8 p -61.32 -47.8 84.28 Favored 'General case' 0 N--CA 1.516 2.867 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 45.9 tp -67.71 -35.52 78.95 Favored 'General case' 1 N--CA 1.546 4.331 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 74.7 t -69.04 -46.09 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -76.03 -23.36 55.15 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 123.515 0.51 . . . . 0.0 110.799 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -46.15 62.58 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.03 -43.23 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.891 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.682 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -75.96 -5.85 48.19 Favored 'General case' 0 N--CA 1.538 3.933 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.404 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -113.02 -12.67 13.19 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 125.619 1.568 . . . . 0.0 107.934 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.16 -33.8 31.08 Favored Glycine 0 N--CA 1.513 3.807 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -82.66 153.83 25.2 Favored 'General case' 0 N--CA 1.526 3.327 0 CA-C-N 114.201 -1.0 . . . . 0.0 108.626 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 59.8 m -80.2 149.23 69.08 Favored Pre-proline 0 N--CA 1.531 3.612 0 C-N-CA 126.201 1.8 . . . . 0.0 111.274 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -56.21 130.03 38.01 Favored 'Trans proline' 0 C--N 1.402 3.36 0 CA-C-N 121.175 1.455 . . . . 0.0 110.792 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -68.57 -19.77 64.49 Favored 'General case' 0 N--CA 1.524 3.273 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.56 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.52 3.061 0 C-N-CA 123.831 0.852 . . . . 0.0 109.099 -179.684 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -166.9 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 28.2 tp -51.81 -43.39 63.08 Favored 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 124.328 1.051 . . . . 0.0 111.719 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -64.69 -36.24 83.65 Favored 'General case' 0 N--CA 1.528 3.436 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -72.54 -36.64 68.32 Favored 'General case' 0 N--CA 1.533 3.68 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.33 -24.46 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 C-N-CA 124.725 1.21 . . . . 0.0 109.882 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -67.14 -53.44 30.62 Favored 'General case' 1 N--CA 1.554 4.75 0 CA-C-N 119.488 1.04 . . . . 0.0 112.334 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.11 -32.01 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 C-N-CA 124.234 1.014 . . . . 0.0 109.727 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -56.82 -32.28 65.57 Favored 'General case' 0 N--CA 1.508 2.474 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.234 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 24.2 mm -68.33 -46.02 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 C-N-CA 124.172 0.989 . . . . 0.0 109.344 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.64 -35.95 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.178 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.301 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.67 -48.13 90.13 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.215 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.36 -31.36 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.533 0.733 . . . . 0.0 109.83 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.27 -50.44 65.0 Favored Glycine 1 N--CA 1.52 4.261 0 C-N-CA 124.082 0.849 . . . . 0.0 112.494 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.2 m -58.66 -35.37 72.45 Favored 'General case' 0 N--CA 1.533 3.719 0 C-N-CA 124.475 1.11 . . . . 0.0 111.015 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 2.1 tp -53.81 -34.82 60.38 Favored 'General case' 0 N--CA 1.512 2.636 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.127 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.408 ' O ' HD13 ' A' ' 693' ' ' ILE . 0.3 OUTLIER -60.45 -38.96 79.66 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -177.088 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -72.87 -29.89 64.42 Favored Glycine 1 N--CA 1.519 4.232 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.2 tt -59.75 -42.47 93.29 Favored 'General case' 1 N--CA 1.541 4.076 0 C-N-CA 124.496 1.118 . . . . 0.0 110.944 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -51.31 -24.7 4.86 Favored 'General case' 0 N--CA 1.527 3.398 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 10.1 tp -53.05 -37.61 27.2 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.671 0 CA-C-N 119.837 1.199 . . . . 0.0 112.689 -176.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.18 -28.11 17.5 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.444 0 C-N-CA 124.222 1.009 . . . . 0.0 110.981 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -56.04 -27.65 54.13 Favored 'General case' 0 N--CA 1.536 3.833 0 O-C-N 121.506 -0.747 . . . . 0.0 110.008 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -66.98 -44.55 80.15 Favored 'General case' 0 N--CA 1.526 3.336 0 CA-C-O 122.18 0.99 . . . . 0.0 108.645 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 84.2 t -68.77 -33.72 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.173 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.36 -33.93 63.84 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 123.506 0.723 . . . . 0.0 110.161 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 86.0 p -58.08 -46.27 85.75 Favored 'General case' 0 N--CA 1.53 3.537 0 O-C-N 121.788 -0.57 . . . . 0.0 111.985 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.54 -35.85 82.32 Favored 'General case' 1 N--CA 1.542 4.175 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.78 -39.9 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -66.19 -24.29 66.6 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.314 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -49.55 -46.67 49.01 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 124.027 0.931 . . . . 0.0 110.48 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.65 -50.85 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.482 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -80.66 -3.45 50.63 Favored 'General case' 1 N--CA 1.55 4.536 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -111.57 -13.25 13.84 Favored 'General case' 0 N--CA 1.539 3.999 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.74 -31.19 53.54 Favored Glycine 0 N--CA 1.514 3.866 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -80.24 155.09 27.5 Favored 'General case' 0 N--CA 1.521 3.079 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 67.8 m -79.4 149.68 72.5 Favored Pre-proline 0 N--CA 1.532 3.629 0 C-N-CA 126.307 1.843 . . . . 0.0 112.111 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -55.57 130.83 42.6 Favored 'Trans proline' 0 C--N 1.402 3.391 0 CA-C-N 120.614 1.255 . . . . 0.0 110.817 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 54.5 tp 57.95 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 125.805 1.642 . . . . 0.0 111.043 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.522 3.137 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.378 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 677' ' ' ASN . . . . . 0.597 ' N ' HD21 ' B' ' 677' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 7.4 p90 59.07 -30.44 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 126.379 1.872 . . . . 0.0 114.863 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.35 -45.02 95.07 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 123.688 0.795 . . . . 0.0 110.882 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -69.93 -36.16 75.12 Favored 'General case' 0 N--CA 1.522 3.136 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.451 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -40.73 76.76 Favored 'General case' 0 N--CA 1.531 3.586 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.893 -176.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 682' ' ' ILE . . . . . 0.534 HD12 ' N ' ' B' ' 683' ' ' ARG . 2.0 pp -72.19 -25.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 CA-C-N 118.701 0.682 . . . . 0.0 110.905 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 683' ' ' ARG . . . . . 0.534 ' N ' HD12 ' B' ' 682' ' ' ILE . 0.0 OUTLIER -67.05 -52.7 38.98 Favored 'General case' 1 N--CA 1.539 4.008 0 C-N-CA 123.988 0.915 . . . . 0.0 112.34 -177.739 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.4 tt -70.93 -30.16 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 123.833 0.853 . . . . 0.0 110.752 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -36.36 24.77 Favored 'General case' 0 N--CA 1.524 3.227 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.239 -173.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 686' ' ' ILE . . . . . 0.462 ' N ' HD12 ' B' ' 686' ' ' ILE . 1.5 mp -69.48 -37.55 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.311 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 34.4 mt -58.87 -35.04 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 35.8 mm -66.65 -46.7 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.28 -31.14 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 C-N-CA 123.85 0.86 . . . . 0.0 108.843 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.2 94.05 Favored Glycine 1 N--CA 1.523 4.436 0 C-N-CA 123.808 0.718 . . . . 0.0 111.817 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 71.1 m -69.09 -41.04 78.03 Favored 'General case' 0 N--CA 1.518 2.957 0 C-N-CA 123.563 0.745 . . . . 0.0 110.765 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.42 -45.91 88.8 Favored 'General case' 0 N--CA 1.535 3.806 0 C-N-CA 123.484 0.714 . . . . 0.0 112.614 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.683 HD11 ' HE ' ' C' ' 696' ' ' ARG . 0.0 OUTLIER -64.5 -34.98 73.13 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.719 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.1 -28.84 71.1 Favored Glycine 1 N--CA 1.527 4.721 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.3 tt -65.06 -43.52 91.97 Favored 'General case' 0 N--CA 1.531 3.614 0 C-N-CA 124.375 1.07 . . . . 0.0 109.808 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -54.96 -26.33 35.74 Favored 'General case' 0 N--CA 1.537 3.895 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 64.3 mt -55.18 -39.2 50.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 C-N-CA 123.236 0.614 . . . . 0.0 112.147 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.63 -28.64 23.56 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.51 0 C-N-CA 123.672 0.789 . . . . 0.0 112.468 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -51.77 -26.16 9.07 Favored 'General case' 0 N--CA 1.531 3.613 0 C-N-CA 123.2 0.6 . . . . 0.0 111.304 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.33 -32.33 62.42 Favored 'General case' 0 N--CA 1.53 3.569 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.8 m -69.26 -31.18 48.75 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.212 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 4.4 tp -53.46 -32.51 50.34 Favored 'General case' 0 N--CA 1.538 3.943 0 C-N-CA 123.671 0.789 . . . . 0.0 110.556 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 67.9 p -57.41 -45.33 84.69 Favored 'General case' 0 N--CA 1.532 3.642 0 O-C-N 121.759 -0.588 . . . . 0.0 111.019 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.11 -35.11 79.69 Favored 'General case' 1 N--CA 1.539 4.023 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.77 -40.0 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -63.47 -21.8 66.52 Favored 'General case' 0 N--CA 1.519 3.025 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.631 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -47.42 -47.55 26.63 Favored 'General case' 0 N--CA 1.519 3.022 0 C-N-CA 123.335 0.654 . . . . 0.0 109.495 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 52.7 t -58.95 -42.85 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.18 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -77.21 -15.51 59.46 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.681 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -95.5 -14.44 23.68 Favored 'General case' 1 N--CA 1.553 4.676 0 C-N-CA 124.123 0.969 . . . . 0.0 109.865 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -87.72 -26.43 29.65 Favored Glycine 1 N--CA 1.523 4.438 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -75.59 146.95 39.99 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 126.01 1.724 . . . . 0.0 108.567 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 50.9 m -88.43 149.55 44.78 Favored Pre-proline 0 N--CA 1.537 3.922 0 C-N-CA 125.637 1.575 . . . . 0.0 113.266 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.27 132.31 51.48 Favored 'Trans proline' 0 C--N 1.402 3.359 0 CA-C-N 121.513 1.576 . . . . 0.0 111.983 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.93 -57.09 0.34 Allowed 'General case' 0 N--CA 1.537 3.914 0 C-N-CA 125.104 1.361 . . . . 0.0 107.565 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 60.4 p . . . . . 0 N--CA 1.526 3.369 0 C-N-CA 124.532 1.133 . . . . 0.0 113.054 179.067 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -165.16 176.51 8.41 Favored 'General case' 0 N--CA 1.526 3.341 0 C-N-CA 123.797 0.839 . . . . 0.0 108.988 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.45 -42.69 61.75 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 125.319 1.447 . . . . 0.0 111.907 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -68.13 -39.26 82.75 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.42 0.688 . . . . 0.0 111.429 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -68.82 -38.61 80.0 Favored 'General case' 0 N--CA 1.521 3.082 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.082 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 11.5 pt -73.24 -38.96 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -45.32 62.23 Favored 'General case' 0 N--CA 1.534 3.739 0 C-N-CA 123.237 0.615 . . . . 0.0 111.276 -176.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.7 tt -74.38 -34.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.939 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -60.31 -38.59 84.15 Favored 'General case' 0 N--CA 1.536 3.837 0 C-N-CA 124.018 0.927 . . . . 0.0 109.593 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.3 -37.05 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.081 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.377 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 8.2 mm -67.15 -43.44 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 41.4 mm -59.15 -49.14 84.43 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.359 0 CA-C-O 120.581 0.229 . . . . 0.0 110.529 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.23 -31.33 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -68.66 -36.5 83.05 Favored Glycine 0 N--CA 1.51 3.605 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.462 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 65.3 m -68.15 -36.77 80.2 Favored 'General case' 0 N--CA 1.529 3.497 0 CA-C-O 121.935 0.874 . . . . 0.0 110.006 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.17 -45.88 75.75 Favored 'General case' 0 N--CA 1.521 3.114 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.683 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 693' ' ' ILE . . . . . 0.54 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.1 OUTLIER -70.15 -35.98 65.91 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.056 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -176.676 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -75.12 -16.42 80.6 Favored Glycine 1 N--CA 1.522 4.417 0 O-C-N 121.648 -0.658 . . . . 0.0 111.72 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.25 -41.72 85.15 Favored 'General case' 0 N--CA 1.538 3.956 0 C-N-CA 124.489 1.116 . . . . 0.0 108.491 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 696' ' ' ARG . . . . . 0.683 ' HE ' HD11 ' B' ' 693' ' ' ILE . 32.0 mmt180 -52.12 -23.61 5.67 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 125.286 1.435 . . . . 0.0 114.362 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 11.0 tp -54.33 -38.51 40.38 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.431 0 CA-C-N 119.052 0.842 . . . . 0.0 112.777 -177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.89 -29.45 21.66 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.177 0 C-N-CA 124.356 1.063 . . . . 0.0 112.353 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -53.04 -25.05 11.17 Favored 'General case' 0 N--CA 1.533 3.694 0 C-N-CA 123.375 0.67 . . . . 0.0 110.086 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.15 70.53 Favored 'General case' 0 N--CA 1.523 3.195 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.35 -32.08 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.64 -34.77 59.7 Favored 'General case' 0 N--CA 1.537 3.88 0 C-N-CA 122.923 0.489 . . . . 0.0 110.314 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 58.9 m -59.28 -47.03 86.92 Favored 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 36.7 tp -66.62 -34.73 78.54 Favored 'General case' 1 N--CA 1.549 4.486 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.76 -38.39 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.371 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.95 -23.31 63.46 Favored 'General case' 0 N--CA 1.521 3.088 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.186 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -48.03 -46.06 32.68 Favored 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 121.873 0.844 . . . . 0.0 110.554 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.09 -43.45 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -77.12 -9.57 58.83 Favored 'General case' 0 N--CA 1.531 3.595 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.439 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -89.63 -15.48 32.62 Favored 'General case' 1 N--CA 1.547 4.376 0 C-N-CA 123.53 0.732 . . . . 0.0 109.782 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -71.6 -6.55 62.84 Favored Glycine 1 N--CA 1.524 4.547 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -75.97 155.14 35.31 Favored 'General case' 0 N--CA 1.512 2.632 0 C-N-CA 125.451 1.5 . . . . 0.0 109.027 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 95.9 p -100.48 146.96 32.91 Favored Pre-proline 0 N--CA 1.53 3.55 0 C-N-CA 125.357 1.463 . . . . 0.0 108.725 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -63.75 130.27 27.36 Favored 'Trans proline' 0 N--CA 1.521 3.105 0 CA-C-N 121.493 1.569 . . . . 0.0 109.061 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 55.9 79.46 0.17 Allowed 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 125.312 1.445 . . . . 0.0 109.926 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 N--CA 1.523 3.185 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.091 -179.631 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -165.3 -77.66 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.054 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -23.68 4.28 Favored 'General case' 0 N--CA 1.515 2.821 0 C-N-CA 124.133 0.973 . . . . 0.0 112.857 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -68.72 -50.43 50.81 Favored 'General case' 0 N--CA 1.529 3.513 0 CA-C-O 121.406 0.622 . . . . 0.0 111.989 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -61.5 -34.66 75.88 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.4 -24.95 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 C-N-CA 125.357 1.463 . . . . 0.0 110.074 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -66.79 -54.75 19.42 Favored 'General case' 1 N--CA 1.559 5.012 0 CA-C-N 119.592 1.087 . . . . 0.0 110.523 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.38 -30.78 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.945 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -55.26 -31.67 61.73 Favored 'General case' 0 N--CA 1.513 2.679 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.764 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 20.4 mm -64.11 -46.04 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.073 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 48.3 mt -56.93 -36.32 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.47 -45.3 85.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.13 -30.21 49.13 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.42 -32.79 85.37 Favored Glycine 1 N--CA 1.518 4.123 0 C-N-CA 123.596 0.617 . . . . 0.0 112.059 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 69.0 m -68.17 -36.95 80.44 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.558 0.743 . . . . 0.0 111.329 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.13 -44.16 83.09 Favored 'General case' 0 N--CA 1.538 3.962 0 C-N-CA 123.518 0.727 . . . . 0.0 112.363 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.533 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.257 0.5 OUTLIER -61.4 -49.69 83.45 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.293 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -175.587 . . . . . . . . 5 4 . 1 . 006 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.34 -24.47 67.51 Favored Glycine 1 N--CA 1.527 4.741 0 CA-C-N 119.877 1.217 . . . . 0.0 112.721 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.5 tt -65.03 -43.27 92.94 Favored 'General case' 0 N--CA 1.535 3.816 0 C-N-CA 123.68 0.792 . . . . 0.0 109.715 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -53.39 -27.29 23.26 Favored 'General case' 1 N--CA 1.54 4.048 0 C-N-CA 124.199 1.0 . . . . 0.0 113.228 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.08 -38.21 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 C-N-CA 123.463 0.705 . . . . 0.0 110.36 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 2.0 p -55.71 -26.29 19.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.129 0 C-N-CA 124.566 1.146 . . . . 0.0 111.725 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -51.89 -26.02 9.28 Favored 'General case' 0 N--CA 1.539 3.995 0 C-N-CA 123.25 0.62 . . . . 0.0 110.777 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.69 -44.48 81.53 Favored 'General case' 0 N--CA 1.528 3.45 0 O-C-N 121.868 -0.52 . . . . 0.0 110.503 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 3.0 m -70.3 -33.49 54.46 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.433 0 CA-C-N 118.8 0.727 . . . . 0.0 109.969 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 4.7 tp -54.97 -33.21 62.2 Favored 'General case' 0 N--CA 1.537 3.885 0 C-N-CA 123.626 0.77 . . . . 0.0 109.857 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 96.0 p -59.36 -48.14 82.75 Favored 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 36.3 tp -63.94 -34.05 77.09 Favored 'General case' 1 N--CA 1.548 4.46 0 O-C-N 121.205 -0.935 . . . . 0.0 108.599 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.72 -38.34 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -61.47 -28.24 69.14 Favored 'General case' 0 N--CA 1.536 3.83 0 C-N-CA 122.92 0.488 . . . . 0.0 110.32 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -49.21 -47.52 46.08 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 121.714 0.769 . . . . 0.0 109.143 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.48 -36.3 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.666 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.1 -27.79 60.02 Favored 'General case' 0 N--CA 1.532 3.672 0 CA-C-O 120.925 0.393 . . . . 0.0 110.047 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -90.14 -13.47 35.63 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 124.623 1.169 . . . . 0.0 109.184 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.8 -25.64 9.69 Favored Glycine 1 N--CA 1.521 4.349 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -115.9 151.37 35.46 Favored 'General case' 0 N--CA 1.533 3.715 0 C-N-CA 124.573 1.149 . . . . 0.0 108.801 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 69.4 m -82.79 147.26 54.57 Favored Pre-proline 0 N--CA 1.528 3.442 0 C-N-CA 125.408 1.483 . . . . 0.0 109.694 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -61.53 130.85 33.25 Favored 'Trans proline' 0 C--N 1.396 3.067 0 CA-C-N 121.805 1.68 . . . . 0.0 110.03 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.8 pp -66.99 148.24 52.2 Favored 'General case' 0 N--CA 1.523 3.213 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.981 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 N--CA 1.522 3.169 0 CA-C-O 117.89 -1.053 . . . . 0.0 111.898 -179.638 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -165.35 -47.31 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 123.642 0.777 . . . . 0.0 109.062 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.8 tt -54.62 -40.3 68.8 Favored 'General case' 0 N--CA 1.514 2.759 0 C-N-CA 124.701 1.2 . . . . 0.0 111.862 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -68.32 -48.21 65.51 Favored 'General case' 0 N--CA 1.528 3.432 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -62.32 -31.96 72.65 Favored 'General case' 0 N--CA 1.536 3.872 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.05 -25.24 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.029 0 C-N-CA 125.628 1.571 . . . . 0.0 111.007 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -52.32 59.23 Favored 'General case' 1 N--CA 1.55 4.537 0 CA-C-N 118.677 0.672 . . . . 0.0 110.475 -178.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 18.5 tt -71.21 -30.29 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.664 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -51.06 -36.56 40.52 Favored 'General case' 0 N--CA 1.525 3.296 0 CA-C-O 121.64 0.733 . . . . 0.0 111.819 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.67 -36.73 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 C-N-CA 125.196 1.399 . . . . 0.0 109.677 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 18.1 mm -61.56 -41.08 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.8 -44.5 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.85 -30.7 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.799 0 C-N-CA 123.566 0.746 . . . . 0.0 109.087 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.66 -32.48 83.24 Favored Glycine 1 N--CA 1.52 4.271 0 C-N-CA 123.399 0.523 . . . . 0.0 112.114 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.6 m -68.18 -37.13 80.64 Favored 'General case' 0 N--CA 1.524 3.236 0 C-N-CA 123.597 0.759 . . . . 0.0 111.175 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.35 -44.19 84.11 Favored 'General case' 0 N--CA 1.539 3.996 0 C-N-CA 123.674 0.79 . . . . 0.0 112.391 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.451 ' CD1' ' HE ' ' C' ' 696' ' ' ARG 0.291 0.1 OUTLIER -67.22 -48.25 78.98 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.48 0 C-N-CA 123.036 0.534 . . . . 0.0 110.478 -176.292 . . . . . . . . 5 4 . 1 . 006 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -54.89 -34.77 57.68 Favored Glycine 1 N--CA 1.53 4.945 0 O-C-N 121.379 -0.826 . . . . 0.0 112.416 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 9.5 tt -72.45 -40.41 67.06 Favored 'General case' 0 N--CA 1.534 3.768 0 C-N-CA 125.159 1.383 . . . . 0.0 109.859 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 696' ' ' ARG . . . . . 0.533 ' HE ' HD11 ' A' ' 693' ' ' ILE . 11.7 tpp180 -51.64 -24.5 5.64 Favored 'General case' 0 N--CA 1.531 3.597 0 C-N-CA 126.317 1.847 . . . . 0.0 113.823 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.21 -35.63 30.35 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 C-N-CA 123.789 0.836 . . . . 0.0 112.273 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -52.97 -27.49 12.97 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 C-N-CA 124.503 1.121 . . . . 0.0 111.903 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -52.38 -25.52 10.05 Favored 'General case' 0 N--CA 1.539 3.981 0 C-N-CA 123.635 0.774 . . . . 0.0 109.909 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -57.5 -37.52 73.09 Favored 'General case' 0 N--CA 1.524 3.261 0 O-C-N 121.53 -0.731 . . . . 0.0 109.882 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.47 -33.17 55.99 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.349 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.16 -32.93 50.29 Favored 'General case' 1 N--CA 1.546 4.326 0 C-N-CA 124.303 1.041 . . . . 0.0 109.603 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 69.3 m -59.41 -45.35 91.76 Favored 'General case' 1 N--CA 1.543 4.215 0 O-C-N 120.207 -1.558 . . . . 0.0 111.088 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.71 -35.04 78.43 Favored 'General case' 1 N--CA 1.552 4.665 0 O-C-N 121.071 -1.018 . . . . 0.0 108.987 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.73 -38.5 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.469 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -55.02 -35.64 64.63 Favored 'General case' 0 N--CA 1.529 3.5 0 CA-C-O 121.258 0.552 . . . . 0.0 109.8 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -54.09 -47.44 71.73 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 122.367 1.08 . . . . 0.0 109.802 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.65 -32.05 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -77.52 -18.35 57.11 Favored 'General case' 0 N--CA 1.531 3.616 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.03 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -87.33 -14.97 39.29 Favored 'General case' 1 N--CA 1.552 4.633 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.85 -24.11 32.63 Favored Glycine 1 N--CA 1.521 4.313 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -121.53 152.95 38.63 Favored 'General case' 1 N--CA 1.542 4.135 0 C-N-CA 125.158 1.383 . . . . 0.0 110.408 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 92.4 p -82.7 148.7 58.59 Favored Pre-proline 0 N--CA 1.534 3.734 0 C-N-CA 126.344 1.857 . . . . 0.0 111.292 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -57.15 131.18 43.59 Favored 'Trans proline' 0 N--CA 1.527 3.466 0 CA-C-N 121.411 1.54 . . . . 0.0 111.632 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.59 -7.21 49.05 Favored 'General case' 0 N--CA 1.535 3.806 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.327 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.523 3.191 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.863 -179.59 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 58.59 113.1 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.287 0 C-N-CA 124.251 1.02 . . . . 0.0 111.872 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.31 -23.27 5.53 Favored 'General case' 0 N--CA 1.513 2.687 0 C-N-CA 125.158 1.383 . . . . 0.0 112.514 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -72.14 -28.83 63.5 Favored 'General case' 0 N--CA 1.53 3.547 0 O-C-N 121.896 -0.503 . . . . 0.0 110.814 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -70.66 -34.12 71.68 Favored 'General case' 0 N--CA 1.526 3.341 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.077 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 23.3 pt -72.03 -26.3 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.464 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -51.44 69.53 Favored 'General case' 1 N--CA 1.541 4.084 0 C-N-CA 123.73 0.812 . . . . 0.0 112.023 -177.147 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.5 tt -73.14 -31.84 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.792 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.168 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -54.17 -29.25 44.94 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.879 0.872 . . . . 0.0 110.346 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 6.5 mm -68.68 -38.75 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.822 0 C-N-CA 123.78 0.832 . . . . 0.0 109.593 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.93 -41.75 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.257 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.46 -44.6 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.34 -30.4 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.06 -37.6 93.02 Favored Glycine 1 N--CA 1.52 4.263 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 68.1 m -68.47 -37.89 80.56 Favored 'General case' 0 N--CA 1.523 3.177 0 C-N-CA 123.581 0.752 . . . . 0.0 111.02 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.74 -45.57 93.77 Favored 'General case' 0 N--CA 1.536 3.842 0 C-N-CA 123.07 0.548 . . . . 0.0 111.576 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 1.5 tp -60.96 -49.39 84.91 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.362 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.18 -22.59 63.13 Favored Glycine 1 N--CA 1.528 4.817 0 O-C-N 120.402 -1.436 . . . . 0.0 112.566 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.55 -41.4 79.85 Favored 'General case' 0 N--CA 1.533 3.69 0 CA-C-O 121.769 0.795 . . . . 0.0 108.993 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 696' ' ' ARG . . . . . 0.451 ' HE ' ' CD1' ' B' ' 693' ' ' ILE . 25.4 mmt180 -53.72 -24.2 14.07 Favored 'General case' 0 N--CA 1.534 3.769 0 C-N-CA 124.765 1.226 . . . . 0.0 113.409 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 75.0 mt -53.24 -35.81 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 C-N-CA 123.484 0.714 . . . . 0.0 110.549 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 5.5 m -54.27 -26.27 15.07 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.377 0 C-N-CA 123.981 0.913 . . . . 0.0 111.687 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -53.97 -31.12 49.66 Favored 'General case' 0 N--CA 1.531 3.587 0 C-N-CA 123.278 0.631 . . . . 0.0 112.144 -173.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -71.4 -45.05 63.73 Favored 'General case' 0 N--CA 1.529 3.479 0 CA-C-O 121.99 0.9 . . . . 0.0 108.833 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.64 -34.76 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.089 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.71 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.13 -34.24 71.81 Favored 'General case' 0 N--CA 1.52 3.063 0 C-N-CA 124.674 1.19 . . . . 0.0 110.027 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 54.7 m -58.97 -46.58 87.71 Favored 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.72 -36.49 84.46 Favored 'General case' 1 N--CA 1.543 4.204 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.77 -40.97 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.669 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -66.28 -23.29 66.37 Favored 'General case' 0 N--CA 1.515 2.804 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.833 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -49.35 -47.18 47.61 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 123.43 0.692 . . . . 0.0 110.153 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.94 -48.17 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.966 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.148 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -76.7 -4.81 45.2 Favored 'General case' 0 N--CA 1.534 3.752 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.881 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -114.5 -12.82 12.26 Favored 'General case' 0 N--CA 1.52 3.036 0 C-N-CA 124.769 1.228 . . . . 0.0 108.849 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -49.86 -31.89 17.62 Favored Glycine 0 N--CA 1.51 3.618 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -78.28 153.75 31.53 Favored 'General case' 0 N--CA 1.523 3.183 0 CA-C-O 121.694 0.759 . . . . 0.0 109.084 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 99.5 p -80.11 149.83 70.42 Favored Pre-proline 0 N--CA 1.53 3.546 0 C-N-CA 126.72 2.008 . . . . 0.0 112.283 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -56.18 131.08 43.69 Favored 'Trans proline' 0 C--N 1.403 3.418 0 CA-C-N 120.761 1.308 . . . . 0.0 110.341 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.94 90.89 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.398 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.615 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.52 3.065 0 CA-C-O 118.083 -0.961 . . . . 0.0 111.541 -179.882 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.589 ' HE1' HH22 ' C' ' 683' ' ' ARG . 58.3 t-105 57.58 -87.21 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 124.077 0.951 . . . . 0.0 110.867 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 5.4 tt -52.43 -35.52 52.26 Favored 'General case' 0 N--CA 1.509 2.509 0 C-N-CA 125.046 1.338 . . . . 0.0 111.859 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -61.88 -50.37 72.51 Favored 'General case' 0 N--CA 1.53 3.569 0 CA-C-O 121.407 0.623 . . . . 0.0 112.345 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -63.16 -35.5 80.5 Favored 'General case' 0 N--CA 1.522 3.137 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.401 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 95.6 mt -74.85 -28.08 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 C-N-CA 125.246 1.418 . . . . 0.0 110.995 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -50.97 58.28 Favored 'General case' 1 N--CA 1.559 4.984 0 CA-C-N 119.873 1.215 . . . . 0.0 110.282 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 14.3 tt -64.52 -32.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 124.199 0.999 . . . . 0.0 109.088 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -53.85 -33.04 55.13 Favored 'General case' 0 N--CA 1.518 2.936 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.906 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.24 -42.51 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.861 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.706 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.02 -34.9 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.31 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 60.8 mt -64.62 -44.64 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.95 -30.76 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 C-N-CA 123.7 0.8 . . . . 0.0 109.047 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.21 -31.88 82.25 Favored Glycine 1 N--CA 1.52 4.26 0 C-N-CA 123.427 0.537 . . . . 0.0 112.005 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.1 m -69.04 -37.26 78.47 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.476 0.71 . . . . 0.0 111.279 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.05 -44.59 91.83 Favored 'General case' 1 N--CA 1.539 4.024 0 C-N-CA 123.298 0.639 . . . . 0.0 112.574 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 693' ' ' ILE 0.268 0.1 OUTLIER -62.46 -48.76 86.77 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.742 0 CA-C-N 118.314 0.506 . . . . 0.0 111.714 -175.929 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.6 -23.78 61.13 Favored Glycine 1 N--CA 1.527 4.754 0 O-C-N 121.778 -0.576 . . . . 0.0 113.068 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.24 -42.12 72.63 Favored 'General case' 0 N--CA 1.539 3.995 0 C-N-CA 124.617 1.167 . . . . 0.0 110.705 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -52.55 -25.62 10.96 Favored 'General case' 0 N--CA 1.537 3.918 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 8.7 tp -54.5 -37.8 39.44 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.401 0 CA-C-N 119.897 1.226 . . . . 0.0 112.677 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.76 -30.47 22.66 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 C-N-CA 123.441 0.696 . . . . 0.0 111.733 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -54.46 -26.45 31.19 Favored 'General case' 0 N--CA 1.534 3.726 0 C-N-CA 122.934 0.493 . . . . 0.0 109.706 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.9 68.4 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 122.664 0.386 . . . . 0.0 110.096 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.0 -31.09 49.01 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.002 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 6.2 tp -53.31 -33.96 55.5 Favored 'General case' 0 N--CA 1.534 3.751 0 C-N-CA 123.158 0.583 . . . . 0.0 110.113 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 83.8 p -58.05 -46.03 86.05 Favored 'General case' 0 N--CA 1.531 3.579 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 39.5 tp -66.96 -35.19 79.42 Favored 'General case' 1 N--CA 1.54 4.034 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 58.8 t -69.06 -42.23 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.637 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -67.24 -23.45 65.71 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.466 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -50.76 -48.29 59.32 Favored 'General case' 0 N--CA 1.512 2.633 0 CA-C-O 121.671 0.748 . . . . 0.0 109.427 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.88 -41.04 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.583 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -76.08 -20.67 57.5 Favored 'General case' 0 N--CA 1.536 3.854 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.806 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -99.1 -11.91 21.0 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 125.355 1.462 . . . . 0.0 109.434 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.94 -31.12 24.18 Favored Glycine 1 N--CA 1.519 4.213 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 177.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -107.92 142.67 37.67 Favored 'General case' 0 N--CA 1.534 3.768 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 68.8 m -82.42 146.83 54.89 Favored Pre-proline 0 N--CA 1.528 3.468 0 C-N-CA 125.296 1.438 . . . . 0.0 111.201 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.1 131.1 33.12 Favored 'Trans proline' 0 C--N 1.402 3.382 0 CA-C-N 121.326 1.509 . . . . 0.0 109.342 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.82 153.88 13.07 Favored 'General case' 0 N--CA 1.524 3.225 0 C-N-CA 125.249 1.42 . . . . 0.0 110.293 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.521 3.091 0 C-N-CA 123.977 0.911 . . . . 0.0 111.258 -179.8 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -166.17 -74.18 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 123.616 0.767 . . . . 0.0 109.042 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.36 -46.71 89.1 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 123.77 0.828 . . . . 0.0 110.706 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -71.46 -29.55 64.98 Favored 'General case' 0 N--CA 1.528 3.443 0 O-C-N 121.831 -0.543 . . . . 0.0 111.033 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -70.52 -36.53 73.8 Favored 'General case' 0 N--CA 1.517 2.923 0 CA-C-O 118.639 -0.695 . . . . 0.0 111.255 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 682' ' ' ILE . . . . . 0.555 HD12 ' N ' ' B' ' 683' ' ' ARG . 2.2 pp -71.6 -23.79 22.87 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.293 0 CA-C-N 119.544 1.065 . . . . 0.0 110.121 179.199 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 683' ' ' ARG . . . . . 0.555 ' N ' HD12 ' B' ' 682' ' ' ILE . 0.2 OUTLIER -61.03 -53.08 61.56 Favored 'General case' 0 N--CA 1.532 3.655 0 CA-C-O 121.511 0.672 . . . . 0.0 112.309 -176.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 18.7 tt -74.76 -31.78 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.078 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -52.25 -45.79 65.5 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.376 1.07 . . . . 0.0 111.869 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.52 -36.79 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.422 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 12.0 mm -60.36 -41.58 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.44 -44.18 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.55 -31.59 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.836 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.61 -44.6 97.31 Favored Glycine 1 N--CA 1.521 4.342 0 C-N-CA 124.071 0.843 . . . . 0.0 112.316 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.4 m -68.18 -37.48 81.0 Favored 'General case' 0 N--CA 1.527 3.382 0 CA-C-O 122.121 0.962 . . . . 0.0 110.022 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 2.2 tp -58.59 -45.31 89.36 Favored 'General case' 0 N--CA 1.518 2.962 0 CA-C-N 113.339 -1.755 . . . . 0.0 113.379 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.491 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.1 OUTLIER -70.52 -38.75 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.857 0 C-N-CA 122.714 0.406 . . . . 0.0 111.751 -177.433 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.53 -28.1 67.04 Favored Glycine 1 N--CA 1.53 4.944 0 O-C-N 121.014 -1.054 . . . . 0.0 112.16 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 4.9 tt -66.46 -40.31 89.33 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 125.02 1.328 . . . . 0.0 110.213 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 696' ' ' ARG . . . . . 0.478 ' HE ' HD11 ' A' ' 693' ' ' ILE . 36.1 mmt180 -51.02 -24.68 3.95 Favored 'General case' 0 N--CA 1.528 3.473 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.8 tt -53.5 -35.96 26.6 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 CA-C-N 119.329 0.968 . . . . 0.0 111.947 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 13.4 p -53.39 -30.01 17.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 C-N-CA 124.278 1.031 . . . . 0.0 111.617 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -57.34 -28.14 62.87 Favored 'General case' 0 N--CA 1.536 3.855 0 O-C-N 121.53 -0.731 . . . . 0.0 110.697 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.13 -41.76 73.5 Favored 'General case' 0 N--CA 1.529 3.508 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.59 -32.02 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.716 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 15.6 tp -54.12 -31.02 51.05 Favored 'General case' 1 N--CA 1.542 4.128 0 C-N-CA 123.516 0.726 . . . . 0.0 109.114 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 62.7 m -56.63 -45.3 81.62 Favored 'General case' 0 N--CA 1.535 3.814 0 O-C-N 121.194 -0.941 . . . . 0.0 111.762 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.14 -34.78 78.85 Favored 'General case' 1 N--CA 1.547 4.4 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.86 -39.21 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -61.28 -22.44 64.86 Favored 'General case' 0 N--CA 1.523 3.189 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -52.34 -44.75 65.33 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-O 121.96 0.886 . . . . 0.0 109.462 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 98.7 t -58.16 -37.1 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.715 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -77.64 -5.68 51.2 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.434 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -89.22 -17.33 29.28 Favored 'General case' 1 N--CA 1.561 5.086 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -81.64 -24.95 55.04 Favored Glycine 1 N--CA 1.521 4.312 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -80.23 152.81 28.91 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 125.898 1.679 . . . . 0.0 108.298 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 97.8 p -102.12 146.79 32.92 Favored Pre-proline 1 N--CA 1.551 4.6 0 C-N-CA 125.222 1.409 . . . . 0.0 114.155 -176.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.23 131.95 18.66 Favored 'Trans proline' 0 C--N 1.406 3.553 0 CA-C-N 120.405 1.18 . . . . 0.0 109.939 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 80.1 mt -95.65 -178.67 4.47 Favored 'General case' 0 N--CA 1.531 3.607 0 C-N-CA 125.252 1.421 . . . . 0.0 108.652 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.523 3.198 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.106 179.654 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 11.3 t30 . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 32.1 p90 -61.15 -41.31 96.52 Favored 'General case' 0 N--CA 1.526 3.358 0 C-N-CA 123.996 0.918 . . . . 0.0 111.372 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.38 -45.63 90.22 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 124.484 1.114 . . . . 0.0 109.912 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -71.27 -28.6 64.26 Favored 'General case' 0 N--CA 1.524 3.233 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.537 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -72.5 -36.53 68.42 Favored 'General case' 0 N--CA 1.526 3.371 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.957 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 23.8 pt -72.91 -29.11 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 CA-C-N 118.054 0.388 . . . . 0.0 110.082 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 683' ' ' ARG . . . . . 0.589 HH22 ' HE1' ' A' ' 678' ' ' TRP . 72.9 ttt180 -52.59 -54.64 30.27 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-O 121.617 0.722 . . . . 0.0 111.648 -177.033 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.6 tt -69.43 -30.98 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.818 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.05 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.6 -43.33 99.07 Favored 'General case' 0 N--CA 1.528 3.446 0 CA-C-O 122.88 1.324 . . . . 0.0 109.28 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.33 -44.4 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.744 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.46 -45.62 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 CA-C-O 118.826 -0.607 . . . . 0.0 110.295 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 19.4 tt -62.55 -39.15 83.45 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.625 0 CA-C-N 119.808 1.186 . . . . 0.0 108.64 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 19.7 t -65.88 -29.91 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.763 0 C-N-CA 123.934 0.894 . . . . 0.0 108.753 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -68.75 -24.94 75.42 Favored Glycine 1 N--CA 1.526 4.694 0 CA-C-N 119.017 0.826 . . . . 0.0 113.474 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 70.5 m -67.61 -50.44 58.14 Favored 'General case' 0 N--CA 1.532 3.673 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 692' ' ' LEU . . . . . 0.478 HD12 ' H ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -52.66 -32.62 43.19 Favored 'General case' 0 N--CA 1.519 2.986 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 693' ' ' ILE . . . . . 0.5 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.2 OUTLIER -59.99 -37.7 73.53 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 CA-C-N 119.436 1.016 . . . . 0.0 113.172 -176.004 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -67.99 -38.86 89.1 Favored Glycine 1 N--CA 1.523 4.479 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 695' ' ' LEU . . . . . 0.592 HD22 ' O ' ' C' ' 695' ' ' LEU . 0.0 OUTLIER -63.9 -37.08 86.09 Favored 'General case' 0 N--CA 1.534 3.745 0 C-N-CA 124.995 1.318 . . . . 0.0 111.946 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -50.9 -27.12 6.84 Favored 'General case' 1 N--CA 1.549 4.489 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 29.2 pt -54.07 -38.42 37.97 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.335 0 CA-C-N 120.155 1.343 . . . . 0.0 114.278 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.4 p -55.75 -35.5 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -55.89 -26.97 49.76 Favored 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.311 0.644 . . . . 0.0 110.457 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.95 69.51 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 121.939 -0.475 . . . . 0.0 110.467 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.62 -30.84 48.64 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.155 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 9.1 tp -53.4 -34.64 58.53 Favored 'General case' 0 N--CA 1.531 3.604 0 CA-C-O 118.841 -0.6 . . . . 0.0 110.786 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 62.9 m -58.7 -46.95 86.16 Favored 'General case' 0 N--CA 1.533 3.709 0 CA-C-N 119.284 0.947 . . . . 0.0 112.971 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.85 -35.3 80.28 Favored 'General case' 1 N--CA 1.549 4.523 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.879 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.94 -38.38 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 706' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.8 t-20 -58.22 -30.1 66.22 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.642 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -47.36 -42.1 20.96 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.04 0.838 . . . . 0.0 112.168 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.65 -44.79 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -77.4 -6.61 54.01 Favored 'General case' 1 N--CA 1.539 4.004 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.75 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 710' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' C' ' 706' ' ' ASN . 13.0 tt0 -114.65 -11.28 12.37 Favored 'General case' 0 N--CA 1.517 2.905 0 C-N-CA 125.474 1.509 . . . . 0.0 108.745 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -53.09 -24.49 21.15 Favored Glycine 1 N--CA 1.519 4.17 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -88.15 155.95 19.51 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.942 0.897 . . . . 0.0 108.718 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 95.5 p -77.58 149.38 78.04 Favored Pre-proline 0 N--CA 1.535 3.793 0 C-N-CA 125.973 1.709 . . . . 0.0 112.551 -173.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -55.72 129.83 37.16 Favored 'Trans proline' 0 C--N 1.409 3.747 0 CA-C-N 120.374 1.169 . . . . 0.0 110.906 -173.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 51.92 -101.39 0.11 Allowed 'General case' 0 N--CA 1.523 3.221 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.519 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.523 3.183 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.827 179.672 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -66.41 150.47 48.86 Favored 'General case' 0 N--CA 1.522 3.167 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.426 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 6.8 mp -52.61 -43.1 65.14 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 125.267 1.427 . . . . 0.0 111.948 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -55.13 -37.24 66.67 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -73.24 -38.26 66.07 Favored 'General case' 0 N--CA 1.532 3.645 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.46 -25.74 19.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.069 0 C-N-CA 125.624 1.57 . . . . 0.0 111.574 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -67.26 -53.7 27.58 Favored 'General case' 1 N--CA 1.544 4.248 0 C-N-CA 124.539 1.136 . . . . 0.0 112.006 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 15.2 tt -68.23 -32.89 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.195 0 CA-C-N 114.051 -1.431 . . . . 0.0 109.151 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -52.47 -34.83 50.86 Favored 'General case' 0 N--CA 1.516 2.849 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.982 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 13.0 mm -63.44 -37.62 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 CA-C-O 121.762 0.792 . . . . 0.0 109.201 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -37.24 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.183 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 62.0 mt -65.48 -43.82 94.35 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.5 t -61.99 -28.94 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.15 -31.62 78.1 Favored Glycine 0 N--CA 1.513 3.787 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.693 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 49.9 m -69.34 -37.19 77.56 Favored 'General case' 0 N--CA 1.53 3.542 0 C-N-CA 123.201 0.6 . . . . 0.0 111.077 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.6 mp -58.08 -45.05 87.8 Favored 'General case' 0 N--CA 1.538 3.944 0 C-N-CA 123.487 0.715 . . . . 0.0 112.071 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.875 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.271 0.8 OUTLIER -60.28 -48.52 87.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.135 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.771 . . . . . . . . 5 4 . 1 . 008 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.5 -26.3 69.53 Favored Glycine 1 N--CA 1.531 4.997 0 CA-C-N 120.164 1.347 . . . . 0.0 112.296 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.0 tt -64.77 -42.83 94.82 Favored 'General case' 0 N--CA 1.537 3.905 0 C-N-CA 124.059 0.944 . . . . 0.0 109.985 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -54.34 -26.11 27.89 Favored 'General case' 0 N--CA 1.538 3.958 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 70.2 mt -55.11 -39.06 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 C-N-CA 123.562 0.745 . . . . 0.0 112.257 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.57 -29.1 33.27 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.522 0 C-N-CA 123.49 0.716 . . . . 0.0 112.584 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -52.06 -26.03 10.01 Favored 'General case' 0 N--CA 1.535 3.779 0 C-N-CA 123.264 0.626 . . . . 0.0 110.949 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.55 -32.42 62.97 Favored 'General case' 0 N--CA 1.532 3.642 0 O-C-N 121.936 -0.477 . . . . 0.0 109.803 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.9 m -68.65 -30.82 48.52 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.123 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.83 -34.71 55.28 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 123.42 0.688 . . . . 0.0 110.391 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 89.0 p -58.89 -46.24 88.33 Favored 'General case' 0 N--CA 1.529 3.476 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 30.2 tp -67.02 -34.79 78.49 Favored 'General case' 1 N--CA 1.543 4.21 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.16 -39.29 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 706' ' ' ASN . . . . . 0.424 HD21 ' HE ' ' A' ' 709' ' ' ARG . 2.8 t-20 -69.71 -29.08 66.4 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.246 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -50.78 -40.41 55.06 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.537 0.684 . . . . 0.0 110.376 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.22 -38.43 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.899 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.737 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 709' ' ' ARG . . . . . 0.424 ' HE ' HD21 ' A' ' 706' ' ' ASN . 78.8 mtm180 -74.99 -25.72 59.04 Favored 'General case' 0 N--CA 1.538 3.937 0 CA-C-O 121.057 0.456 . . . . 0.0 109.788 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -89.36 -7.77 54.57 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.51 -20.71 7.79 Favored Glycine 1 N--CA 1.524 4.506 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -120.69 152.05 38.74 Favored 'General case' 0 N--CA 1.526 3.329 0 C-N-CA 125.265 1.426 . . . . 0.0 109.293 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 94.5 p -82.34 150.45 63.91 Favored Pre-proline 0 N--CA 1.531 3.595 0 C-N-CA 125.884 1.674 . . . . 0.0 110.244 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -53.92 130.01 37.12 Favored 'Trans proline' 0 C--N 1.401 3.332 0 CA-C-N 122.259 1.842 . . . . 0.0 112.503 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 62.0 mt -97.87 42.44 1.09 Allowed 'General case' 0 N--CA 1.522 3.174 0 CA-C-N 113.589 -1.641 . . . . 0.0 108.717 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 N--CA 1.523 3.221 0 C-N-CA 124.23 1.012 . . . . 0.0 111.948 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -102.13 178.03 4.72 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 124.643 1.177 . . . . 0.0 109.84 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.2 tt -54.38 -45.68 72.88 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 125.512 1.525 . . . . 0.0 111.828 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -71.11 -31.06 67.31 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -69.69 -38.53 77.03 Favored 'General case' 0 N--CA 1.526 3.362 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.544 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 20.3 pt -71.56 -31.94 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.301 0 CA-C-N 117.986 0.357 . . . . 0.0 110.282 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -52.82 -54.39 34.9 Favored 'General case' 1 N--CA 1.539 4.018 0 CA-C-O 121.776 0.798 . . . . 0.0 111.007 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -31.46 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.307 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -59.55 -43.41 93.54 Favored 'General case' 1 N--CA 1.539 4.012 0 CA-C-O 121.691 0.758 . . . . 0.0 109.658 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.66 -36.33 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 C-N-CA 124.215 1.006 . . . . 0.0 108.617 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 27.8 mm -65.17 -42.72 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 47.9 mm -60.28 -41.17 86.08 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.281 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.49 -31.22 48.26 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.108 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.98 -33.19 86.57 Favored Glycine 1 N--CA 1.518 4.163 0 C-N-CA 123.924 0.773 . . . . 0.0 112.693 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.2 m -68.15 -37.26 80.86 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.52 0.728 . . . . 0.0 111.577 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.69 -43.07 80.14 Favored 'General case' 0 N--CA 1.536 3.843 0 C-N-CA 123.39 0.676 . . . . 0.0 112.559 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.798 HD11 ' HE ' ' C' ' 696' ' ' ARG 0.276 0.8 OUTLIER -60.25 -48.73 86.99 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.502 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.242 . . . . . . . . 5 4 . 1 . 008 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.45 -23.29 70.17 Favored Glycine 1 N--CA 1.531 5.023 0 CA-C-N 120.423 1.465 . . . . 0.0 112.518 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.29 -43.17 92.02 Favored 'General case' 1 N--CA 1.541 4.093 0 C-N-CA 123.359 0.664 . . . . 0.0 109.655 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 696' ' ' ARG . . . . . 0.875 ' HE ' HD11 ' A' ' 693' ' ' ILE . 23.5 mmt180 -52.99 -24.02 8.56 Favored 'General case' 0 N--CA 1.536 3.86 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 78.1 mt -51.72 -35.71 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 C-N-CA 123.327 0.651 . . . . 0.0 110.425 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.23 -26.08 17.88 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.235 0 C-N-CA 124.444 1.097 . . . . 0.0 111.397 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -53.66 -28.76 35.07 Favored 'General case' 1 N--CA 1.547 4.404 0 O-C-N 121.313 -0.867 . . . . 0.0 110.387 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.66 -44.11 67.78 Favored 'General case' 0 N--CA 1.525 3.282 0 CA-C-O 122.028 0.918 . . . . 0.0 108.627 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 79.0 t -68.84 -33.6 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.04 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -35.5 66.03 Favored 'General case' 0 N--CA 1.532 3.642 0 C-N-CA 123.65 0.78 . . . . 0.0 110.405 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 48.8 m -59.77 -48.01 83.4 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.54 -34.85 77.91 Favored 'General case' 1 N--CA 1.54 4.052 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.219 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.23 -44.93 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 706' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' B' ' 709' ' ' ARG . 23.3 p30 -74.41 -20.52 60.02 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.568 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -47.39 -35.01 7.7 Favored 'General case' 0 N--CA 1.519 3.001 0 CA-C-N 118.566 0.621 . . . . 0.0 109.921 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.37 -39.13 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.815 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 709' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' B' ' 706' ' ' ASN . 71.9 mtm180 -76.49 -30.83 57.41 Favored 'General case' 0 N--CA 1.524 3.252 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.76 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -89.23 2.33 54.41 Favored 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.6 -28.1 50.6 Favored Glycine 1 N--CA 1.517 4.086 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -108.62 127.79 54.27 Favored 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 97.9 p -82.24 147.67 57.66 Favored Pre-proline 0 N--CA 1.528 3.462 0 C-N-CA 125.278 1.431 . . . . 0.0 110.758 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -58.73 131.13 40.41 Favored 'Trans proline' 0 C--N 1.401 3.334 0 CA-C-N 121.473 1.562 . . . . 0.0 110.363 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 49.7 tp 60.81 143.74 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.301 0 C-N-CA 126.097 1.759 . . . . 0.0 111.042 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.52 3.068 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.548 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -66.46 177.69 1.45 Allowed 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.029 0.931 . . . . 0.0 111.636 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 679' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' C' ' 683' ' ' ARG . 7.8 mp -53.53 -43.37 68.31 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 125.619 1.568 . . . . 0.0 112.149 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -56.4 -38.73 71.93 Favored 'General case' 0 N--CA 1.53 3.535 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -173.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -72.93 -37.83 67.03 Favored 'General case' 0 N--CA 1.534 3.757 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 86.7 mt -73.37 -25.68 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.355 0 C-N-CA 125.365 1.466 . . . . 0.0 111.246 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 683' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' C' ' 679' ' ' LEU . 0.9 OUTLIER -67.03 -51.3 56.48 Favored 'General case' 0 N--CA 1.536 3.872 0 C-N-CA 124.449 1.099 . . . . 0.0 110.71 -177.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.3 tt -71.2 -30.31 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.928 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -52.52 -27.48 16.62 Favored 'General case' 0 N--CA 1.526 3.343 0 CA-C-O 121.512 0.673 . . . . 0.0 109.959 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 22.8 mm -68.94 -48.2 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 C-N-CA 124.635 1.174 . . . . 0.0 108.937 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 10.9 mm -57.74 -41.99 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.389 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.365 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.34 -49.19 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.702 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.97 -30.87 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.886 0 C-N-CA 123.666 0.786 . . . . 0.0 109.921 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.8 -32.54 84.56 Favored Glycine 1 N--CA 1.52 4.242 0 C-N-CA 123.367 0.508 . . . . 0.0 112.777 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 68.7 m -67.65 -35.99 79.93 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 124.056 0.942 . . . . 0.0 112.135 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.11 -41.74 68.65 Favored 'General case' 0 N--CA 1.539 3.976 0 C-N-CA 123.433 0.693 . . . . 0.0 112.606 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 693' ' ' ILE . . . . . 0.432 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -60.27 -41.4 86.88 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.255 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.166 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -68.46 -31.59 74.16 Favored Glycine 1 N--CA 1.524 4.553 0 O-C-N 121.093 -1.004 . . . . 0.0 111.456 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.04 -42.07 99.67 Favored 'General case' 0 N--CA 1.534 3.769 0 C-N-CA 124.594 1.158 . . . . 0.0 112.156 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 696' ' ' ARG . . . . . 0.798 ' HE ' HD11 ' B' ' 693' ' ' ILE . 25.6 mmt180 -53.3 -27.36 22.57 Favored 'General case' 1 N--CA 1.542 4.146 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -176.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 10.5 tp -55.71 -39.34 54.92 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.371 0 CA-C-N 119.664 1.12 . . . . 0.0 113.848 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.82 -31.7 41.04 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.338 0 C-N-CA 123.276 0.63 . . . . 0.0 112.235 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -54.41 -25.42 24.65 Favored 'General case' 0 N--CA 1.531 3.575 0 C-N-CA 123.121 0.568 . . . . 0.0 109.95 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.46 -34.98 65.0 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 122.086 -0.384 . . . . 0.0 110.159 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.3 m -68.83 -30.73 47.99 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.045 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 11.0 tp -52.89 -36.14 58.96 Favored 'General case' 0 N--CA 1.533 3.712 0 C-N-CA 123.154 0.581 . . . . 0.0 110.474 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 89.0 p -58.87 -47.0 86.47 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 39.8 tp -67.4 -34.88 78.17 Favored 'General case' 1 N--CA 1.543 4.191 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.86 -38.95 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.546 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 706' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' C' ' 710' ' ' GLN . 64.3 t30 -66.26 -25.69 67.0 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.856 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -48.22 -33.23 8.25 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 123.643 0.777 . . . . 0.0 111.133 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.66 -47.66 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -77.93 -9.92 59.33 Favored 'General case' 1 N--CA 1.542 4.172 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.623 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 710' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' C' ' 706' ' ' ASN . 20.3 tt0 -112.56 -7.64 13.87 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 125.884 1.674 . . . . 0.0 107.869 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.5 -25.04 33.41 Favored Glycine 0 N--CA 1.511 3.665 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -99.87 152.35 20.25 Favored 'General case' 0 N--CA 1.525 3.276 0 C-N-CA 123.911 0.885 . . . . 0.0 108.782 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 53.9 m -81.71 149.26 63.67 Favored Pre-proline 0 N--CA 1.529 3.502 0 CA-C-O 116.626 -1.654 . . . . 0.0 110.601 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -54.33 130.19 38.56 Favored 'Trans proline' 0 C--N 1.401 3.308 0 CA-C-N 122.233 1.833 . . . . 0.0 112.651 -175.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.56 153.51 40.21 Favored 'General case' 0 N--CA 1.522 3.141 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.138 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 95.9 p . . . . . 0 N--CA 1.523 3.177 0 C-N-CA 123.634 0.774 . . . . 0.0 109.803 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -61.27 -32.4 72.22 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 124.004 0.922 . . . . 0.0 110.971 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -50.91 -43.37 59.92 Favored 'General case' 0 N--CA 1.517 2.879 0 C-N-CA 124.519 1.128 . . . . 0.0 111.185 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -61.87 -50.05 73.78 Favored 'General case' 0 N--CA 1.529 3.48 0 CA-C-O 121.474 0.655 . . . . 0.0 111.208 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -64.15 -37.47 87.57 Favored 'General case' 0 N--CA 1.518 2.944 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.072 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -25.53 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.359 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -51.38 52.39 Favored 'General case' 1 N--CA 1.562 5.162 0 CA-C-N 119.973 1.26 . . . . 0.0 110.28 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.9 tt -67.73 -30.45 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.222 0 C-N-CA 123.696 0.798 . . . . 0.0 110.292 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -52.33 -30.01 26.41 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.124 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 21.9 mm -69.18 -46.94 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.453 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 7.9 mm -55.09 -39.54 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 C-N-CA 123.522 0.729 . . . . 0.0 109.503 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 59.6 mt -59.82 -47.13 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.978 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.58 -30.61 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 123.563 0.745 . . . . 0.0 109.736 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.98 -30.88 76.62 Favored Glycine 1 N--CA 1.518 4.116 0 C-N-CA 123.49 0.566 . . . . 0.0 112.654 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 63.3 m -67.56 -36.26 80.6 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 123.664 0.786 . . . . 0.0 111.842 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.3 mp -54.44 -42.15 70.24 Favored 'General case' 0 N--CA 1.539 3.99 0 C-N-CA 123.878 0.871 . . . . 0.0 112.993 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.522 HD11 ' HE ' ' B' ' 696' ' ' ARG . 0.4 OUTLIER -64.29 -49.8 79.41 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.08 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.494 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.59 -22.43 65.93 Favored Glycine 1 N--CA 1.528 4.827 0 CA-C-N 119.811 1.187 . . . . 0.0 112.553 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.28 -43.7 93.97 Favored 'General case' 0 N--CA 1.535 3.812 0 C-N-CA 123.835 0.854 . . . . 0.0 109.645 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 696' ' ' ARG . . . . . 0.718 ' HE ' HD11 ' C' ' 693' ' ' ILE . 17.6 mmt180 -54.67 -28.66 48.98 Favored 'General case' 0 N--CA 1.537 3.898 0 C-N-CA 124.262 1.025 . . . . 0.0 113.563 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 64.1 mt -55.45 -37.69 46.02 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 C-N-CA 123.609 0.764 . . . . 0.0 109.89 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -55.18 -26.78 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 C-N-CA 124.888 1.275 . . . . 0.0 110.969 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -51.73 -27.91 13.4 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.532 0.733 . . . . 0.0 112.087 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.15 96.2 Favored 'General case' 0 N--CA 1.524 3.245 0 O-C-N 121.595 -0.691 . . . . 0.0 109.58 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.99 -33.62 56.16 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.236 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.289 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 9.9 tp -55.0 -36.09 65.08 Favored 'General case' 0 N--CA 1.535 3.804 0 C-N-CA 123.2 0.6 . . . . 0.0 110.037 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.4 p -59.16 -47.5 85.07 Favored 'General case' 0 N--CA 1.525 3.3 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 41.3 tp -64.49 -35.78 82.07 Favored 'General case' 1 N--CA 1.546 4.354 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 90.1 t -69.61 -40.27 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.625 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 706' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 710' ' ' GLN . 55.1 t30 -64.89 -25.78 68.04 Favored 'General case' 0 N--CA 1.516 2.852 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.777 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -48.57 -44.4 36.63 Favored 'General case' 0 N--CA 1.518 2.961 0 C-N-CA 124.552 1.141 . . . . 0.0 110.402 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.87 -44.16 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -77.81 -12.7 60.0 Favored 'General case' 0 N--CA 1.538 3.926 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.621 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 710' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 706' ' ' ASN . 12.1 tt0 -112.93 -12.54 13.25 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 125.615 1.566 . . . . 0.0 109.181 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.91 -29.81 20.78 Favored Glycine 0 N--CA 1.515 3.903 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -93.11 149.68 21.05 Favored 'General case' 0 N--CA 1.522 3.135 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 70.3 m -81.93 148.12 59.98 Favored Pre-proline 0 N--CA 1.532 3.638 0 C-N-CA 125.686 1.594 . . . . 0.0 110.133 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -56.72 131.22 44.3 Favored 'Trans proline' 0 C--N 1.401 3.297 0 CA-C-N 121.794 1.676 . . . . 0.0 110.6 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 52.6 tp 63.1 149.25 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 126.05 1.74 . . . . 0.0 110.33 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.523 3.202 0 C-N-CA 123.771 0.829 . . . . 0.0 110.078 -179.756 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 20.0 m120 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -166.41 135.82 3.1 Favored 'General case' 0 N--CA 1.531 3.589 0 C-N-CA 123.357 0.663 . . . . 0.0 109.545 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -50.49 -43.72 55.72 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 125.96 1.704 . . . . 0.0 111.456 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -68.17 -43.16 78.82 Favored 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 122.449 0.3 . . . . 0.0 110.848 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -69.15 -35.33 76.22 Favored 'General case' 0 N--CA 1.53 3.545 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.56 -24.81 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 C-N-CA 124.504 1.122 . . . . 0.0 110.605 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -64.13 -53.82 43.54 Favored 'General case' 1 N--CA 1.546 4.341 0 CA-C-N 119.362 0.983 . . . . 0.0 111.496 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.2 tt -68.07 -30.33 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.146 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -51.27 -32.82 25.96 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 123.515 0.726 . . . . 0.0 112.153 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 686' ' ' ILE . . . . . 0.452 ' N ' HD12 ' B' ' 686' ' ' ILE . 1.5 mp -69.23 -45.62 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.267 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 34.2 mt -56.1 -41.15 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 C-N-CA 123.271 0.628 . . . . 0.0 109.938 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 42.2 mm -62.32 -48.91 86.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.109 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.96 -29.8 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 C-N-CA 124.339 1.055 . . . . 0.0 109.967 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.73 -37.03 94.09 Favored Glycine 1 N--CA 1.524 4.553 0 C-N-CA 123.278 0.466 . . . . 0.0 112.45 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.5 m -67.36 -36.14 80.77 Favored 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 124.445 1.098 . . . . 0.0 111.873 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.1 mp -53.29 -33.91 55.15 Favored 'General case' 0 N--CA 1.533 3.711 0 CA-C-O 118.541 -0.742 . . . . 0.0 112.26 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.14 -41.33 81.36 Favored 'Isoleucine or valine' 1 N--CA 1.557 4.888 0 CA-C-N 120.246 1.384 . . . . 0.0 111.236 -177.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -55.82 -46.41 83.32 Favored Glycine 1 N--CA 1.526 4.695 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER -73.28 -32.31 64.58 Favored 'General case' 1 N--CA 1.554 4.771 0 CA-C-N 117.625 0.713 . . . . 0.0 110.82 179.298 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' B' B ' 696' ' ' ARG . . . . . 0.522 ' HE ' HD11 ' A' ' 693' ' ' ILE . 14.1 tpp180 -50.18 -26.61 4.77 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 125.625 1.57 . . . . 0.0 113.699 -176.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 697' ' ' ILE . . . . . 0.494 HD13 ' O ' ' B' ' 697' ' ' ILE . 0.0 OUTLIER -54.44 -36.04 33.17 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.14 0 C-N-CA 124.212 1.005 . . . . 0.0 111.051 -178.874 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.1 p -51.91 -26.49 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 124.735 1.214 . . . . 0.0 112.037 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -51.97 -25.89 9.32 Favored 'General case' 1 N--CA 1.54 4.046 0 C-N-CA 123.321 0.648 . . . . 0.0 110.18 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.89 -42.05 79.17 Favored 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 122.992 0.517 . . . . 0.0 111.313 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.67 -32.72 56.19 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 118.405 0.548 . . . . 0.0 110.383 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -32.2 52.53 Favored 'General case' 1 N--CA 1.545 4.309 0 C-N-CA 124.159 0.984 . . . . 0.0 109.529 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 51.6 m -57.26 -44.51 84.0 Favored 'General case' 1 N--CA 1.543 4.185 0 O-C-N 120.53 -1.356 . . . . 0.0 111.936 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 45.2 tp -65.25 -34.43 78.33 Favored 'General case' 1 N--CA 1.549 4.48 0 O-C-N 121.362 -0.836 . . . . 0.0 108.88 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 26.3 t -66.76 -39.93 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -61.12 -32.9 72.59 Favored 'General case' 0 N--CA 1.522 3.157 0 CA-C-O 118.497 -0.763 . . . . 0.0 110.412 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -49.8 -47.9 51.03 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 121.277 0.561 . . . . 0.0 110.003 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.87 -40.65 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.726 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.463 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.74 -29.82 59.01 Favored 'General case' 0 N--CA 1.523 3.219 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.719 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.69 -6.5 56.04 Favored 'General case' 0 N--CA 1.519 3.01 0 C-N-CA 124.515 1.126 . . . . 0.0 109.265 -178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -59.7 -31.98 72.82 Favored Glycine 0 N--CA 1.513 3.788 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -89.61 154.31 20.07 Favored 'General case' 0 N--CA 1.529 3.502 0 C-N-CA 124.049 0.939 . . . . 0.0 109.346 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 3.3 t -80.82 150.05 68.51 Favored Pre-proline 0 N--CA 1.534 3.758 0 C-N-CA 126.735 2.014 . . . . 0.0 111.1 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -55.6 130.18 39.1 Favored 'Trans proline' 0 N--CA 1.528 3.532 0 CA-C-N 120.744 1.301 . . . . 0.0 110.468 -174.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 59.63 123.8 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.326 0 C-N-CA 126.077 1.751 . . . . 0.0 110.004 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.522 3.136 0 C-N-CA 123.847 0.859 . . . . 0.0 109.89 179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 27.7 m120 . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -66.33 164.24 16.46 Favored 'General case' 0 N--CA 1.526 3.373 0 C-N-CA 124.135 0.974 . . . . 0.0 109.845 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.7 -29.31 17.84 Favored 'General case' 0 N--CA 1.529 3.503 0 C-N-CA 124.089 0.955 . . . . 0.0 112.671 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -70.82 -29.7 65.93 Favored 'General case' 0 N--CA 1.528 3.447 0 CA-C-O 120.592 0.234 . . . . 0.0 110.56 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -71.72 -37.92 70.55 Favored 'General case' 0 N--CA 1.518 2.926 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.218 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 682' ' ' ILE . . . . . 0.502 HD12 ' N ' ' C' ' 683' ' ' ARG . 1.9 pp -72.31 -23.23 21.23 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.225 0 CA-C-N 119.365 0.984 . . . . 0.0 110.505 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 683' ' ' ARG . . . . . 0.502 ' N ' HD12 ' C' ' 682' ' ' ILE . 0.0 OUTLIER -66.32 -51.58 55.89 Favored 'General case' 0 N--CA 1.535 3.797 0 C-N-CA 124.026 0.931 . . . . 0.0 112.289 -176.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -72.29 -31.77 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.867 0 C-N-CA 123.605 0.762 . . . . 0.0 110.249 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -48.75 -23.71 1.15 Allowed 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 125.546 1.538 . . . . 0.0 112.764 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.11 -37.02 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.731 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.77 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 37.7 pt -61.86 -41.54 91.16 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.679 0 CA-C-N 120.783 1.629 . . . . 0.0 110.006 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 50.2 mt -63.63 -50.14 79.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.35 -38.64 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 C-N-CA 124.202 1.001 . . . . 0.0 110.59 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.79 -49.25 50.38 Favored Glycine 1 N--CA 1.525 4.567 0 C-N-CA 125.339 1.447 . . . . 0.0 111.712 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 73.1 m -58.79 -34.97 72.07 Favored 'General case' 0 N--CA 1.52 3.072 0 CA-C-O 121.841 0.829 . . . . 0.0 108.998 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.64 -44.55 85.69 Favored 'General case' 0 N--CA 1.524 3.251 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.452 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 693' ' ' ILE . . . . . 0.718 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.266 0.1 OUTLIER -65.22 -47.97 85.33 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.741 0 CA-C-N 119.113 0.87 . . . . 0.0 111.595 -177.221 . . . . . . . . 5 4 . 1 . 009 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.22 -21.3 46.63 Favored Glycine 1 N--CA 1.531 4.999 0 CA-C-N 118.993 0.815 . . . . 0.0 112.656 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.79 -43.08 63.23 Favored 'General case' 0 N--CA 1.537 3.891 0 C-N-CA 124.028 0.931 . . . . 0.0 109.037 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -53.5 -25.51 16.85 Favored 'General case' 0 N--CA 1.532 3.663 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 40.1 mm -53.06 -37.65 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.939 0 C-N-CA 124.33 1.052 . . . . 0.0 112.724 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.03 -30.59 23.9 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.275 0 C-N-CA 123.61 0.764 . . . . 0.0 111.737 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -63.35 -27.64 69.45 Favored 'General case' 0 N--CA 1.538 3.966 0 O-C-N 121.433 -0.792 . . . . 0.0 110.857 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.1 -39.75 75.35 Favored 'General case' 0 N--CA 1.535 3.815 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.58 -32.01 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.078 0 C-N-CA 125.095 1.358 . . . . 0.0 109.041 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 16.0 tp -55.15 -33.04 62.6 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.401 0.68 . . . . 0.0 109.537 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 67.9 m -56.81 -46.33 81.68 Favored 'General case' 0 N--CA 1.532 3.626 0 CA-C-N 118.831 0.741 . . . . 0.0 112.629 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.4 tp -65.13 -35.3 80.67 Favored 'General case' 1 N--CA 1.549 4.509 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.99 -38.93 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -64.68 -25.52 67.98 Favored 'General case' 0 N--CA 1.52 3.055 0 C-N-CA 123.793 0.837 . . . . 0.0 110.298 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 707' ' ' ARG . . . . . 0.428 HH11 ' NE2' ' A' ' 710' ' ' GLN . 8.7 tpp180 -48.87 -44.12 39.58 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.74 0.781 . . . . 0.0 111.048 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.01 -39.71 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.343 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -76.54 -21.45 55.67 Favored 'General case' 0 N--CA 1.53 3.562 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.707 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -88.94 -11.15 45.26 Favored 'General case' 0 N--CA 1.513 2.714 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.96 -19.11 21.12 Favored Glycine 1 N--CA 1.517 4.079 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -107.24 153.17 23.09 Favored 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 124.858 1.263 . . . . 0.0 109.11 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 83.5 p -81.6 152.21 69.43 Favored Pre-proline 0 N--CA 1.528 3.459 0 C-N-CA 126.369 1.868 . . . . 0.0 111.545 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -53.04 131.83 44.71 Favored 'Trans proline' 0 C--N 1.401 3.331 0 CA-C-N 121.625 1.616 . . . . 0.0 112.066 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 46.3 tp 62.73 148.94 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 125.848 1.659 . . . . 0.0 110.795 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.52 3.067 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.464 -179.924 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -70.87 172.85 8.18 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.776 0.83 . . . . 0.0 109.975 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.6 pp -52.15 -24.62 7.33 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 125.318 1.447 . . . . 0.0 112.834 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -60.18 -49.72 76.51 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -65.99 -33.51 75.98 Favored 'General case' 0 N--CA 1.535 3.815 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.76 -27.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 C-N-CA 125.212 1.405 . . . . 0.0 109.853 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -63.86 -52.04 61.85 Favored 'General case' 1 N--CA 1.545 4.299 0 O-C-N 121.495 -0.753 . . . . 0.0 111.471 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.9 tt -67.42 -31.97 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 C-N-CA 123.908 0.883 . . . . 0.0 109.287 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -58.94 -41.8 88.23 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.876 0.87 . . . . 0.0 109.036 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.27 -36.04 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 C-N-CA 124.962 1.305 . . . . 0.0 108.681 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 56.5 mt -66.7 -37.41 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.75 -43.35 91.41 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.529 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.71 -29.51 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.925 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.75 -32.09 81.86 Favored Glycine 1 N--CA 1.516 4.016 0 C-N-CA 123.614 0.626 . . . . 0.0 112.309 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 68.2 m -68.31 -36.19 78.93 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 123.659 0.784 . . . . 0.0 111.764 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 8.9 mp -54.03 -39.62 66.32 Favored 'General case' 0 N--CA 1.537 3.886 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.53 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.261 0.1 OUTLIER -62.48 -49.72 82.74 Favored 'Isoleucine or valine' 1 N--CA 1.556 4.864 0 CA-C-N 119.429 1.013 . . . . 0.0 112.664 -176.12 . . . . . . . . 5 4 . 1 . 010 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.15 -30.84 71.45 Favored Glycine 1 N--CA 1.527 4.719 0 CA-C-N 119.187 0.903 . . . . 0.0 112.866 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.18 -42.23 99.34 Favored 'General case' 0 N--CA 1.536 3.855 0 C-N-CA 124.568 1.147 . . . . 0.0 111.576 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 696' ' ' ARG . . . . . 0.783 ' HE ' HD11 ' C' ' 693' ' ' ILE . 26.5 mmt180 -52.67 -26.02 12.58 Favored 'General case' 0 N--CA 1.537 3.916 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 16.5 tt -53.46 -38.3 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.9 p -55.25 -30.77 25.37 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 C-N-CA 123.414 0.685 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -61.45 -28.22 69.12 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.097 0.559 . . . . 0.0 110.797 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.43 -41.92 72.25 Favored 'General case' 0 N--CA 1.53 3.553 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 88.5 t -68.59 -32.85 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 125.007 1.323 . . . . 0.0 108.953 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 13.5 tp -55.33 -30.26 59.91 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 124.089 0.956 . . . . 0.0 109.371 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 78.3 p -56.04 -45.63 79.14 Favored 'General case' 0 N--CA 1.533 3.723 0 O-C-N 121.485 -0.76 . . . . 0.0 111.572 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.23 -34.81 78.46 Favored 'General case' 1 N--CA 1.545 4.319 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.38 -39.35 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -63.12 -21.05 65.93 Favored 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.407 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -49.35 -46.8 47.49 Favored 'General case' 0 N--CA 1.513 2.711 0 CA-C-O 121.748 0.785 . . . . 0.0 109.168 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.68 -41.88 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -77.25 -5.51 49.61 Favored 'General case' 0 N--CA 1.522 3.143 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.209 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.64 -17.2 23.52 Favored 'General case' 1 N--CA 1.558 4.937 0 CA-C-N 118.671 0.669 . . . . 0.0 109.947 -179.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -84.09 -28.24 34.72 Favored Glycine 1 N--CA 1.522 4.419 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -75.49 135.23 40.66 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 112.901 -1.65 . . . . 0.0 108.317 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 96.0 p -82.67 146.67 53.59 Favored Pre-proline 0 N--CA 1.534 3.725 0 CA-C-O 117.574 -1.203 . . . . 0.0 110.665 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -62.86 130.68 30.16 Favored 'Trans proline' 0 C--N 1.398 3.184 0 CA-C-N 121.42 1.543 . . . . 0.0 109.616 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -68.1 81.83 0.22 Allowed 'General case' 0 N--CA 1.53 3.525 0 C-N-CA 124.893 1.277 . . . . 0.0 108.947 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.52 3.029 0 C-N-CA 124.072 0.949 . . . . 0.0 111.939 -179.659 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -69.63 120.84 16.01 Favored 'General case' 0 N--CA 1.521 3.076 0 C-N-CA 123.907 0.883 . . . . 0.0 111.009 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -21.3 3.01 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 125.572 1.549 . . . . 0.0 112.847 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -57.84 -49.61 76.09 Favored 'General case' 0 N--CA 1.532 3.67 0 CA-C-O 121.599 0.714 . . . . 0.0 111.24 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -65.19 -33.63 76.45 Favored 'General case' 0 N--CA 1.52 3.073 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.554 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 29.2 mm -74.09 -28.45 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.152 0 C-N-CA 124.596 1.158 . . . . 0.0 110.425 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -66.13 -55.41 16.54 Favored 'General case' 1 N--CA 1.547 4.385 0 CA-C-O 122.379 1.085 . . . . 0.0 110.615 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 684' ' ' ILE . . . . . 0.55 ' O ' HD13 ' B' ' 684' ' ' ILE . 0.0 OUTLIER -64.75 -30.55 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.879 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.46 -178.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.41 -44.36 65.36 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 123.647 0.779 . . . . 0.0 111.511 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 27.2 mt -62.81 -37.9 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 C-N-CA 124.869 1.268 . . . . 0.0 110.311 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 39.1 mm -57.61 -41.62 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 50.4 mm -62.98 -44.99 99.99 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.538 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 176.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.43 -31.07 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 C-N-CA 123.351 0.661 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.54 -42.84 95.45 Favored Glycine 1 N--CA 1.524 4.539 0 C-N-CA 123.539 0.59 . . . . 0.0 112.593 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 66.7 m -67.31 -36.25 81.11 Favored 'General case' 0 N--CA 1.528 3.46 0 CA-C-O 122.342 1.068 . . . . 0.0 110.212 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 2.6 tp -54.04 -35.05 61.56 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 113.191 -1.822 . . . . 0.0 112.909 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -42.32 59.47 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.624 0 CA-C-N 118.641 0.655 . . . . 0.0 110.663 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -53.58 -44.75 68.31 Favored Glycine 1 N--CA 1.523 4.472 0 N-CA-C 116.025 1.17 . . . . 0.0 116.025 -175.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . 0.321 0.0 OUTLIER -67.23 -30.85 70.87 Favored 'General case' 1 N--CA 1.557 4.893 0 CA-C-N 118.267 1.034 . . . . 0.0 112.247 -179.162 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' B' B ' 696' ' ' ARG . . . . . 0.53 ' HE ' HD11 ' A' ' 693' ' ' ILE . 34.1 mmt180 -48.22 -25.02 1.34 Allowed 'General case' 0 N--CA 1.538 3.936 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 25.9 pt -54.27 -36.69 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.964 0 CA-C-N 118.864 0.757 . . . . 0.0 112.543 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.96 -32.57 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -55.62 -25.77 40.58 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.386 0.674 . . . . 0.0 109.67 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.18 72.6 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 122.711 0.404 . . . . 0.0 110.643 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.78 -31.38 50.52 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.3 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 11.8 tp -54.32 -33.9 59.86 Favored 'General case' 0 N--CA 1.531 3.581 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.157 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 27.0 m -57.69 -46.38 84.41 Favored 'General case' 0 N--CA 1.531 3.577 0 CA-C-N 119.246 0.93 . . . . 0.0 113.4 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 37.5 tp -65.27 -35.9 82.44 Favored 'General case' 1 N--CA 1.552 4.667 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.4 -38.58 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.354 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -62.32 -26.62 68.53 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.054 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -49.11 -47.43 45.3 Favored 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.694 0.759 . . . . 0.0 109.687 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.22 -37.97 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.853 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -75.38 -24.51 57.26 Favored 'General case' 0 N--CA 1.53 3.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.025 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -89.35 -13.38 37.99 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.1 -25.72 32.82 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -96.86 154.22 17.43 Favored 'General case' 0 N--CA 1.533 3.7 0 C-N-CA 124.559 1.144 . . . . 0.0 108.517 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 82.5 p -80.64 152.03 72.04 Favored Pre-proline 0 N--CA 1.536 3.84 0 C-N-CA 126.201 1.8 . . . . 0.0 112.973 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.5 130.32 39.48 Favored 'Trans proline' 0 C--N 1.407 3.635 0 CA-C-N 121.159 1.45 . . . . 0.0 112.022 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 66.4 mt -86.42 175.88 8.16 Favored 'General case' 0 N--CA 1.524 3.24 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.447 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.523 3.194 0 C-N-CA 124.123 0.969 . . . . 0.0 109.527 -179.791 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -82.96 -152.46 0.11 Allowed 'General case' 0 N--CA 1.528 3.443 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -21.77 1.66 Allowed 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 125.19 1.396 . . . . 0.0 112.843 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -60.16 -49.4 77.8 Favored 'General case' 0 N--CA 1.533 3.692 0 C-N-CA 122.994 0.518 . . . . 0.0 110.627 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -64.18 -33.71 76.41 Favored 'General case' 0 N--CA 1.525 3.301 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 27.9 mm -73.79 -31.5 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 C-N-CA 124.451 1.101 . . . . 0.0 111.13 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -49.52 69.64 Favored 'General case' 1 N--CA 1.554 4.773 0 CA-C-O 121.617 0.722 . . . . 0.0 111.52 -176.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -29.02 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 C-N-CA 125.319 1.448 . . . . 0.0 110.27 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -51.2 -30.37 16.91 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.408 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 686' ' ' ILE . . . . . 0.414 ' N ' HD12 ' C' ' 686' ' ' ILE . 1.5 mp -68.45 -40.69 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.981 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 45.4 mt -60.5 -34.81 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.563 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.54 -47.6 92.22 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.451 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.4 -29.12 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.231 0 C-N-CA 124.253 1.021 . . . . 0.0 109.74 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.84 92.69 Favored Glycine 1 N--CA 1.522 4.369 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 60.6 m -68.98 -37.17 78.6 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.126 0.97 . . . . 0.0 111.137 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.6 mp -55.71 -35.42 66.09 Favored 'General case' 1 N--CA 1.54 4.042 0 C-N-CA 123.573 0.749 . . . . 0.0 112.09 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 693' ' ' ILE . . . . . 0.783 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.269 0.4 OUTLIER -72.11 -47.22 55.35 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.704 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.52 . . . . . . . . 5 4 . 1 . 010 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -53.96 -44.91 72.33 Favored Glycine 1 N--CA 1.525 4.588 0 N-CA-C 116.393 1.317 . . . . 0.0 116.393 -175.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -65.81 -31.04 71.77 Favored 'General case' 1 N--CA 1.552 4.645 0 CA-C-N 118.408 1.104 . . . . 0.0 112.697 -178.85 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -48.95 -25.26 1.84 Allowed 'General case' 1 N--CA 1.544 4.258 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 18.2 tt -53.1 -35.3 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 C-N-CA 123.256 0.622 . . . . 0.0 111.388 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -53.18 -30.65 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 C-N-CA 124.198 0.999 . . . . 0.0 111.506 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -58.89 -28.43 66.16 Favored 'General case' 0 N--CA 1.537 3.907 0 O-C-N 121.655 -0.653 . . . . 0.0 110.474 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.34 -42.38 71.98 Favored 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.49 -32.39 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.796 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 21.1 tp -54.94 -33.43 62.28 Favored 'General case' 0 N--CA 1.536 3.871 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 87.0 p -57.33 -45.37 84.36 Favored 'General case' 0 N--CA 1.529 3.485 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -37.39 85.48 Favored 'General case' 1 N--CA 1.544 4.228 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.14 -37.94 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 706' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.8 p30 -60.12 -31.91 70.5 Favored 'General case' 0 N--CA 1.518 2.953 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.143 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -48.22 -47.27 35.73 Favored 'General case' 0 N--CA 1.516 2.852 0 C-N-CA 123.517 0.727 . . . . 0.0 111.258 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 49.3 t -64.13 -47.71 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -78.76 -10.15 59.68 Favored 'General case' 0 N--CA 1.536 3.868 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 710' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' C' ' 706' ' ' ASN . 38.7 tt0 -113.7 -10.87 13.02 Favored 'General case' 0 N--CA 1.533 3.679 0 C-N-CA 124.965 1.306 . . . . 0.0 109.175 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.21 -35.33 54.83 Favored Glycine 0 N--CA 1.509 3.523 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -79.53 152.78 29.97 Favored 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 96.0 p -81.17 150.03 67.29 Favored Pre-proline 0 N--CA 1.531 3.588 0 CA-C-O 116.739 -1.601 . . . . 0.0 111.09 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.14 131.05 42.71 Favored 'Trans proline' 0 C--N 1.401 3.302 0 CA-C-N 121.9 1.714 . . . . 0.0 112.255 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.97 94.64 0.05 Allowed 'General case' 0 N--CA 1.53 3.566 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.246 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.521 3.123 0 CA-C-O 117.853 -1.07 . . . . 0.0 112.444 -179.403 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -170.01 -78.02 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.099 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -23.52 5.3 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 125.328 1.451 . . . . 0.0 114.179 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -62.96 -51.35 67.2 Favored 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -67.41 -31.39 71.57 Favored 'General case' 1 N--CA 1.539 4.005 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 47.6 mm -74.88 -26.68 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.489 0 C-N-CA 124.911 1.284 . . . . 0.0 110.269 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -66.35 -54.0 29.61 Favored 'General case' 1 N--CA 1.55 4.559 0 CA-C-O 121.775 0.797 . . . . 0.0 111.13 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.44 -30.82 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.353 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -56.82 -31.35 64.64 Favored 'General case' 0 N--CA 1.515 2.813 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.789 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.6 mm -68.58 -39.25 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 54.3 mt -65.42 -36.32 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.194 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 72.1 mt -67.45 -42.95 87.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.026 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.92 -30.15 47.94 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.338 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.7 97.52 Favored Glycine 1 N--CA 1.524 4.565 0 C-N-CA 124.002 0.811 . . . . 0.0 112.175 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 71.0 m -68.78 -37.83 79.6 Favored 'General case' 0 N--CA 1.522 3.16 0 CA-C-O 122.084 0.945 . . . . 0.0 109.883 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 1.9 tp -59.44 -44.78 92.86 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.02 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.535 ' O ' HD13 ' A' ' 693' ' ' ILE . 0.0 OUTLIER -72.13 -32.46 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.757 0 O-C-N 121.896 -0.502 . . . . 0.0 112.092 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.18 -44.59 96.3 Favored Glycine 1 N--CA 1.52 4.246 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . 0.334 0.0 OUTLIER -68.09 -31.97 71.96 Favored 'General case' 1 N--CA 1.549 4.506 0 CA-C-N 118.279 1.039 . . . . 0.0 112.452 -178.715 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -48.6 -24.7 1.42 Allowed 'General case' 0 N--CA 1.539 3.982 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 17.4 tt -52.39 -35.07 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 123.186 0.594 . . . . 0.0 111.845 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.8 p -52.95 -30.3 15.86 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 C-N-CA 123.789 0.836 . . . . 0.0 111.309 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -61.29 -29.37 69.83 Favored 'General case' 0 N--CA 1.536 3.827 0 O-C-N 121.433 -0.792 . . . . 0.0 110.328 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.55 -37.94 74.09 Favored 'General case' 0 N--CA 1.535 3.783 0 CA-C-O 121.629 0.728 . . . . 0.0 109.059 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.47 -30.24 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.255 0 C-N-CA 124.75 1.22 . . . . 0.0 108.56 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.1 -30.58 49.06 Favored 'General case' 0 N--CA 1.534 3.74 0 C-N-CA 123.428 0.691 . . . . 0.0 109.236 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 72.6 p -56.52 -45.83 80.9 Favored 'General case' 0 N--CA 1.533 3.711 0 O-C-N 121.473 -0.767 . . . . 0.0 111.601 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 34.6 tp -62.63 -35.49 79.77 Favored 'General case' 1 N--CA 1.552 4.653 0 O-C-N 121.34 -0.85 . . . . 0.0 108.935 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.1 -38.59 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.623 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 706' ' ' ASN . . . . . 0.588 ' ND2' HH11 ' C' ' 707' ' ' ARG . 21.5 t30 -60.53 -22.83 64.05 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 123.784 0.833 . . . . 0.0 109.798 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -53.5 -42.55 67.46 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.602 0.715 . . . . 0.0 109.646 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.42 -37.46 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.144 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -77.67 -4.44 46.12 Favored 'General case' 0 N--CA 1.516 2.856 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.999 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.35 -17.52 25.74 Favored 'General case' 1 N--CA 1.562 5.17 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -78.6 -18.51 75.48 Favored Glycine 1 N--CA 1.523 4.498 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -98.98 144.74 27.8 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 126.654 1.982 . . . . 0.0 106.235 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 78.4 p -104.53 143.94 27.71 Favored Pre-proline 1 N--CA 1.55 4.53 0 CA-C-O 117.929 -1.034 . . . . 0.0 113.474 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -64.06 131.42 30.58 Favored 'Trans proline' 0 C--N 1.409 3.754 0 CA-C-N 120.988 1.389 . . . . 0.0 110.938 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.97 172.31 7.07 Favored 'General case' 0 N--CA 1.535 3.779 0 C-N-CA 125.52 1.528 . . . . 0.0 108.838 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.52 3.069 0 CA-C-O 117.48 -1.247 . . . . 0.0 108.699 179.662 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 9.2 t90 60.56 56.41 3.08 Favored 'General case' 0 N--CA 1.519 2.992 0 C-N-CA 124.567 1.147 . . . . 0.0 111.399 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 1.4 pp -52.42 -17.99 1.45 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -55.45 -29.44 58.66 Favored 'General case' 1 N--CA 1.541 4.08 0 CA-C-N 120.156 1.344 . . . . 0.0 111.176 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -72.66 -34.65 67.39 Favored 'General case' 0 N--CA 1.532 3.649 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.54 -25.16 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.375 0 C-N-CA 124.386 1.074 . . . . 0.0 108.78 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -65.75 -45.9 80.87 Favored 'General case' 1 N--CA 1.549 4.487 0 O-C-N 121.54 -0.725 . . . . 0.0 111.566 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 13.7 tt -66.05 -30.54 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.34 -27.3 67.02 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.842 0.857 . . . . 0.0 110.122 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.09 -43.25 81.89 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.204 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 62.6 mt -72.43 -38.41 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.091 0 C-N-CA 124.718 1.207 . . . . 0.0 111.81 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 3.3 tp -58.38 -37.53 64.25 Favored 'Isoleucine or valine' 1 N--CA 1.556 4.844 0 CA-C-N 119.161 0.891 . . . . 0.0 110.215 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.98 -27.54 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 C-N-CA 124.298 1.039 . . . . 0.0 109.98 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -80.16 -27.58 52.14 Favored Glycine 1 N--CA 1.518 4.161 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 49.9 m -69.19 -52.42 28.1 Favored 'General case' 0 N--CA 1.534 3.764 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -34.69 75.39 Favored 'General case' 0 N--CA 1.538 3.974 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.452 HD11 ' HE ' ' C' ' 696' ' ' ARG . 1.2 tp -58.87 -44.86 91.59 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.263 0 CA-C-N 119.54 1.064 . . . . 0.0 111.495 -177.208 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.15 -31.25 80.12 Favored Glycine 1 N--CA 1.521 4.325 0 O-C-N 120.643 -1.285 . . . . 0.0 111.224 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.92 -43.18 96.7 Favored 'General case' 0 N--CA 1.535 3.824 0 C-N-CA 124.243 1.017 . . . . 0.0 111.506 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -53.03 -26.96 17.44 Favored 'General case' 1 N--CA 1.54 4.05 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.9 tt -54.82 -39.28 47.37 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.387 0 CA-C-N 120.116 1.325 . . . . 0.0 113.973 -174.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.58 -30.53 36.97 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.225 0 C-N-CA 123.332 0.653 . . . . 0.0 111.683 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -53.96 -26.48 25.86 Favored 'General case' 0 N--CA 1.533 3.709 0 C-N-CA 123.145 0.578 . . . . 0.0 109.532 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.89 -36.95 68.22 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 122.787 0.435 . . . . 0.0 110.199 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.43 -29.63 44.78 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.025 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 6.4 tp -52.37 -35.91 52.56 Favored 'General case' 0 N--CA 1.531 3.611 0 CA-C-O 118.866 -0.588 . . . . 0.0 110.721 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 68.9 m -59.28 -46.52 88.32 Favored 'General case' 0 N--CA 1.533 3.714 0 CA-C-N 118.949 0.795 . . . . 0.0 112.864 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 51.0 tp -66.23 -36.02 81.93 Favored 'General case' 1 N--CA 1.547 4.383 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.28 -38.29 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.54 -31.78 69.73 Favored 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.11 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -48.45 -45.29 36.35 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 124.934 1.294 . . . . 0.0 111.368 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 59.0 t -62.83 -49.95 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.25 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -79.57 -3.92 49.14 Favored 'General case' 1 N--CA 1.551 4.595 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.551 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -109.98 -13.3 14.44 Favored 'General case' 0 N--CA 1.528 3.427 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.38 -28.48 20.39 Favored Glycine 0 N--CA 1.515 3.925 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -86.23 155.14 20.83 Favored 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 123.796 0.838 . . . . 0.0 108.992 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 90.0 p -79.0 150.19 74.57 Favored Pre-proline 0 N--CA 1.534 3.74 0 C-N-CA 126.479 1.911 . . . . 0.0 112.598 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -54.06 131.71 46.15 Favored 'Trans proline' 0 C--N 1.408 3.679 0 CA-C-N 120.626 1.259 . . . . 0.0 111.031 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 4.8 tt -144.19 -57.02 0.37 Allowed 'General case' 0 N--CA 1.527 3.417 0 CA-C-N 113.169 -1.832 . . . . 0.0 106.586 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.521 3.113 0 C-N-CA 124.908 1.283 . . . . 0.0 113.758 178.54 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 39.4 t30 . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -58.24 -57.23 13.81 Favored 'General case' 0 N--CA 1.529 3.479 0 CA-C-O 122.096 0.951 . . . . 0.0 110.172 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 pp -60.9 -28.49 68.94 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.629 1.572 . . . . 0.0 112.696 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -58.02 -50.25 74.08 Favored 'General case' 0 N--CA 1.536 3.854 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -174.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -63.21 -33.58 75.8 Favored 'General case' 0 N--CA 1.529 3.486 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.49 -29.12 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 C-N-CA 125.724 1.609 . . . . 0.0 110.514 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -51.85 52.94 Favored 'General case' 1 N--CA 1.55 4.536 0 C-N-CA 123.682 0.793 . . . . 0.0 111.479 -176.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.4 tt -63.08 -39.75 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.427 0 C-N-CA 124.099 0.96 . . . . 0.0 109.465 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -53.09 -42.61 66.07 Favored 'General case' 0 N--CA 1.517 2.88 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.82 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.88 -36.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 20.4 mt -63.5 -44.11 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.65 -43.66 95.31 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.299 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.08 -37.77 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 C-N-CA 123.853 0.861 . . . . 0.0 110.134 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -57.19 -32.96 63.97 Favored Glycine 1 N--CA 1.522 4.425 0 C-N-CA 123.727 0.68 . . . . 0.0 113.756 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 63.1 m -63.39 -34.62 78.13 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 124.355 1.062 . . . . 0.0 112.57 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 4.0 mp -52.85 -34.79 55.91 Favored 'General case' 0 N--CA 1.532 3.668 0 C-N-CA 123.618 0.767 . . . . 0.0 112.659 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 693' ' ' ILE . . . . . 0.44 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.2 OUTLIER -58.58 -43.81 88.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.445 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.643 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -69.2 -29.93 71.92 Favored Glycine 1 N--CA 1.522 4.399 0 O-C-N 121.232 -0.917 . . . . 0.0 110.917 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.85 -42.83 99.53 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 123.83 0.852 . . . . 0.0 110.506 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 696' ' ' ARG . . . . . 0.452 ' HE ' HD11 ' B' ' 693' ' ' ILE . 26.2 mmt180 -56.41 -26.83 54.64 Favored 'General case' 1 N--CA 1.543 4.194 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 69.9 mt -54.85 -39.55 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 C-N-CA 122.976 0.51 . . . . 0.0 112.319 -176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.79 -32.05 54.44 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.488 0 CA-C-N 119.235 0.925 . . . . 0.0 112.241 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -53.99 -26.99 28.79 Favored 'General case' 0 N--CA 1.536 3.857 0 O-C-N 121.836 -0.54 . . . . 0.0 110.501 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.72 -32.83 65.91 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 122.039 -0.413 . . . . 0.0 110.341 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.1 m -68.81 -29.84 44.93 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.095 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.5 tp -51.77 -36.3 46.91 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-O 118.709 -0.662 . . . . 0.0 110.914 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 24.5 t -59.06 -46.24 88.77 Favored 'General case' 0 N--CA 1.534 3.747 0 CA-C-N 119.148 0.885 . . . . 0.0 112.914 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 37.9 tp -65.72 -34.53 78.39 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.31 -39.84 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 706' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' C' ' 710' ' ' GLN . 33.2 t-20 -65.81 -23.98 66.81 Favored 'General case' 0 N--CA 1.524 3.24 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.764 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 707' ' ' ARG . . . . . 0.588 HH11 ' ND2' ' A' ' 706' ' ' ASN . 6.2 tpp180 -47.89 -42.83 27.88 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 123.992 0.917 . . . . 0.0 111.271 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 43.5 t -65.44 -47.02 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -78.1 -11.84 59.94 Favored 'General case' 0 N--CA 1.539 3.986 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.314 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 710' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' C' ' 706' ' ' ASN . 12.5 tt0 -109.91 -9.94 14.76 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 125.093 1.357 . . . . 0.0 108.654 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.78 -27.13 49.04 Favored Glycine 0 N--CA 1.514 3.899 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -99.32 152.71 19.63 Favored 'General case' 0 N--CA 1.529 3.509 0 C-N-CA 123.935 0.894 . . . . 0.0 109.327 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 88.0 p -82.28 148.96 60.86 Favored Pre-proline 0 N--CA 1.528 3.473 0 C-N-CA 125.947 1.699 . . . . 0.0 109.714 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -54.66 132.19 50.11 Favored 'Trans proline' 0 C--N 1.398 3.164 0 CA-C-N 121.612 1.611 . . . . 0.0 112.854 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -158.63 -49.93 0.06 Allowed 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 112.308 -2.224 . . . . 0.0 105.917 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 86.2 p . . . . . 0 N--CA 1.522 3.168 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.56 178.665 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.87 -13.74 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 124.002 0.921 . . . . 0.0 110.664 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp -50.12 -22.93 1.86 Allowed 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 125.306 1.443 . . . . 0.0 113.482 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -59.47 -49.43 77.81 Favored 'General case' 0 N--CA 1.533 3.693 0 CA-C-O 121.207 0.527 . . . . 0.0 111.348 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -66.93 -29.23 69.04 Favored 'General case' 0 N--CA 1.523 3.221 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 30.7 mm -74.96 -32.2 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.243 0 C-N-CA 124.562 1.145 . . . . 0.0 110.614 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -48.51 69.39 Favored 'General case' 1 N--CA 1.549 4.521 0 O-C-N 121.935 -0.478 . . . . 0.0 111.738 -176.208 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.1 tt -68.34 -31.18 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 C-N-CA 123.916 0.886 . . . . 0.0 109.826 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -48.51 -24.63 1.36 Allowed 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 124.624 1.17 . . . . 0.0 111.448 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.38 -40.14 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 117.268 -1.349 . . . . 0.0 111.094 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 40.0 pt -53.33 -36.31 26.21 Favored 'Isoleucine or valine' 1 N--CA 1.567 5.388 0 CA-C-N 121.531 1.969 . . . . 0.0 109.93 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.93 -49.14 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 23.9 t -68.17 -29.27 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 125.256 1.423 . . . . 0.0 111.295 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -82.31 -32.19 29.06 Favored Glycine 1 N--CA 1.525 4.571 0 C-N-CA 124.589 1.09 . . . . 0.0 112.317 -175.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 74.3 m -69.05 -51.37 39.63 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 123.839 0.856 . . . . 0.0 113.109 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.49 -31.77 73.02 Favored 'General case' 1 N--CA 1.541 4.096 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.806 HD11 ' HE ' ' B' ' 696' ' ' ARG . 1.3 tp -59.34 -42.65 88.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.431 0 CA-C-N 120.77 1.623 . . . . 0.0 111.295 -176.371 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.62 -27.53 72.36 Favored Glycine 1 N--CA 1.525 4.609 0 O-C-N 121.02 -1.05 . . . . 0.0 110.968 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.7 -36.68 83.74 Favored 'General case' 1 N--CA 1.544 4.261 0 C-N-CA 123.861 0.864 . . . . 0.0 109.075 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -54.78 -29.25 53.72 Favored 'General case' 1 N--CA 1.542 4.161 0 O-C-N 121.45 -0.781 . . . . 0.0 112.025 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 46.9 mm -57.51 -38.6 64.4 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.047 0 C-N-CA 123.479 0.712 . . . . 0.0 109.839 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 92.1 t -58.17 -37.78 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 125.077 1.351 . . . . 0.0 111.265 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -55.13 -24.85 28.14 Favored 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 123.317 0.647 . . . . 0.0 110.002 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.2 64.31 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 122.163 -0.336 . . . . 0.0 110.14 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.97 -31.32 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.996 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.07 -36.7 63.4 Favored 'General case' 0 N--CA 1.534 3.765 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.651 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 61.5 m -58.75 -47.07 85.94 Favored 'General case' 0 N--CA 1.536 3.862 0 CA-C-N 119.252 0.933 . . . . 0.0 112.868 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 35.8 tp -65.76 -35.04 79.58 Favored 'General case' 1 N--CA 1.54 4.072 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 87.2 t -68.65 -38.65 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 706' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 710' ' ' GLN . 17.6 t30 -58.34 -23.13 55.82 Favored 'General case' 0 N--CA 1.516 2.869 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.349 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -47.04 -40.01 13.95 Favored 'General case' 0 N--CA 1.527 3.395 0 C-N-CA 123.667 0.787 . . . . 0.0 111.125 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.96 -45.56 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -76.86 -11.04 59.76 Favored 'General case' 0 N--CA 1.533 3.682 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.698 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 710' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 706' ' ' ASN . 35.6 tt0 -113.55 -14.18 12.7 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 125.702 1.601 . . . . 0.0 109.466 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -74.33 -14.89 80.45 Favored Glycine 1 N--CA 1.534 5.213 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 174.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -75.76 146.52 39.97 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 128.207 2.603 . . . . 0.0 107.177 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 67.5 m -81.85 146.99 57.28 Favored Pre-proline 1 N--CA 1.54 4.051 0 C-N-CA 124.402 1.081 . . . . 0.0 112.247 -176.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.94 130.19 31.82 Favored 'Trans proline' 0 C--N 1.401 3.3 0 CA-C-N 120.998 1.392 . . . . 0.0 109.476 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.31 169.22 18.47 Favored 'General case' 0 N--CA 1.527 3.4 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.575 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 97.8 p . . . . . 0 N--CA 1.522 3.168 0 C-N-CA 123.747 0.819 . . . . 0.0 110.423 -179.756 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 54.92 105.52 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 124.296 1.039 . . . . 0.0 111.899 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.81 -20.59 2.28 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.505 1.522 . . . . 0.0 113.432 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -55.95 -50.62 70.28 Favored 'General case' 0 N--CA 1.535 3.816 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.07 -34.54 78.26 Favored 'General case' 0 N--CA 1.529 3.514 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.5 -29.03 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.222 0 C-N-CA 125.141 1.377 . . . . 0.0 110.403 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -46.93 74.37 Favored 'General case' 1 N--CA 1.556 4.857 0 O-C-N 121.208 -0.933 . . . . 0.0 110.282 -176.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -71.22 -30.74 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 C-N-CA 124.238 1.015 . . . . 0.0 109.765 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -56.56 -45.67 81.14 Favored 'General case' 0 N--CA 1.519 2.983 0 CA-C-O 122.35 1.072 . . . . 0.0 109.351 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.22 -37.82 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.085 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 52.5 mt -65.51 -40.71 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.71 -44.17 96.64 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.335 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.82 -30.24 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 C-N-CA 123.444 0.698 . . . . 0.0 109.825 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.3 92.49 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.139 0.4 . . . . 0.0 112.969 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 66.8 m -59.48 -35.27 73.78 Favored 'General case' 0 N--CA 1.532 3.649 0 C-N-CA 124.323 1.049 . . . . 0.0 112.437 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.4 mp -53.47 -36.36 61.55 Favored 'General case' 0 N--CA 1.534 3.763 0 C-N-CA 123.747 0.819 . . . . 0.0 112.653 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.412 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.3 OUTLIER -60.81 -46.54 96.01 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.306 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.313 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.47 -29.95 76.4 Favored Glycine 1 N--CA 1.525 4.597 0 O-C-N 121.445 -0.784 . . . . 0.0 111.747 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.97 -42.39 94.04 Favored 'General case' 0 N--CA 1.532 3.671 0 C-N-CA 124.44 1.096 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 696' ' ' ARG . . . . . 0.806 ' HE ' HD11 ' A' ' 693' ' ' ILE . 20.9 mmt180 -52.68 -24.95 9.54 Favored 'General case' 0 N--CA 1.535 3.801 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 19.6 tt -53.05 -37.07 25.75 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.377 0 CA-C-N 120.28 1.4 . . . . 0.0 112.592 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 14.6 p -54.48 -29.8 20.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.348 0 C-N-CA 124.074 0.95 . . . . 0.0 111.33 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -57.08 -27.67 61.93 Favored 'General case' 0 N--CA 1.538 3.968 0 O-C-N 121.259 -0.901 . . . . 0.0 110.666 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -67.88 -42.71 80.82 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 83.9 t -68.99 -32.33 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.868 0 CA-C-N 113.835 -1.529 . . . . 0.0 109.124 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 20.2 tp -55.23 -34.23 63.78 Favored 'General case' 1 N--CA 1.54 4.032 0 C-N-CA 123.059 0.543 . . . . 0.0 109.602 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 57.0 m -57.81 -46.7 84.29 Favored 'General case' 0 N--CA 1.531 3.61 0 CA-C-N 118.79 0.723 . . . . 0.0 112.674 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.18 -36.08 83.08 Favored 'General case' 1 N--CA 1.551 4.601 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.53 -39.04 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 706' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' B' ' 710' ' ' GLN . 6.0 t-20 -66.02 -23.57 66.59 Favored 'General case' 0 N--CA 1.516 2.848 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.889 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -48.88 -45.38 41.07 Favored 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 123.993 0.917 . . . . 0.0 109.39 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 50.3 t -62.4 -48.27 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.794 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.86 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -77.92 -9.98 59.35 Favored 'General case' 0 N--CA 1.539 3.979 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.016 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 710' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' B' ' 706' ' ' ASN . 41.6 tt0 -112.35 -11.55 13.67 Favored 'General case' 0 N--CA 1.527 3.394 0 C-N-CA 125.109 1.364 . . . . 0.0 109.285 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.96 -35.4 58.93 Favored Glycine 0 N--CA 1.513 3.788 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -83.85 154.46 23.46 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 114.747 -0.726 . . . . 0.0 109.157 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 67.7 m -80.18 149.65 69.85 Favored Pre-proline 0 N--CA 1.529 3.484 0 C-N-CA 126.624 1.969 . . . . 0.0 111.138 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -56.02 131.54 46.57 Favored 'Trans proline' 0 C--N 1.4 3.285 0 CA-C-N 120.981 1.386 . . . . 0.0 110.943 -174.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.34 176.35 9.06 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 114.084 -1.417 . . . . 0.0 109.699 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.522 3.169 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.039 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -3.72 1.44 Allowed 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 124.048 0.939 . . . . 0.0 112.728 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 4.5 pp -51.91 -22.77 4.12 Favored 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 124.883 1.273 . . . . 0.0 113.263 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -61.09 -48.86 79.72 Favored 'General case' 0 N--CA 1.535 3.813 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -35.11 79.79 Favored 'General case' 1 N--CA 1.54 4.065 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 36.2 mm -73.32 -27.23 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.908 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.667 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -66.38 -54.09 28.42 Favored 'General case' 1 N--CA 1.549 4.514 0 CA-C-O 121.86 0.838 . . . . 0.0 112.311 -176.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.17 -29.58 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.216 0 C-N-CA 125.122 1.369 . . . . 0.0 110.148 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -51.98 -33.23 37.09 Favored 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 124.327 1.051 . . . . 0.0 110.432 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 686' ' ' ILE . . . . . 0.417 ' N ' HD12 ' C' ' 686' ' ' ILE . 1.5 mp -68.57 -47.64 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 40.2 mt -57.19 -43.82 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 C-N-CA 123.528 0.731 . . . . 0.0 110.421 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.09 -48.55 87.96 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.406 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 23.2 t -57.9 -30.73 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 C-N-CA 124.41 1.084 . . . . 0.0 109.698 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.98 -40.82 95.45 Favored Glycine 1 N--CA 1.524 4.552 0 C-N-CA 123.532 0.587 . . . . 0.0 112.887 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 71.2 m -67.66 -36.64 81.11 Favored 'General case' 0 N--CA 1.528 3.44 0 CA-C-O 122.193 0.997 . . . . 0.0 110.037 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.8 tp -55.29 -45.02 76.24 Favored 'General case' 0 N--CA 1.517 2.923 0 CA-C-N 113.438 -1.71 . . . . 0.0 114.235 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 693' ' ' ILE . . . . . 0.545 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.0 OUTLIER -69.45 -35.82 68.66 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.212 0 CA-C-N 118.272 0.487 . . . . 0.0 112.276 -176.414 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.48 -26.18 70.61 Favored Glycine 1 N--CA 1.523 4.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.71 -43.25 76.4 Favored 'General case' 0 N--CA 1.535 3.819 0 C-N-CA 124.683 1.193 . . . . 0.0 110.181 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -53.24 -25.65 15.0 Favored 'General case' 0 N--CA 1.533 3.693 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 17.0 tt -54.41 -38.63 41.5 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.261 0 CA-C-N 119.513 1.051 . . . . 0.0 113.342 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 698' ' ' VAL . . . . . 0.461 ' O ' HG22 ' C' ' 701' ' ' VAL . 10.0 p -55.31 -31.09 26.24 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 C-N-CA 123.539 0.736 . . . . 0.0 111.814 -178.459 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -54.44 -25.91 27.78 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 122.92 0.488 . . . . 0.0 109.875 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.19 -32.99 62.64 Favored 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 701' ' ' VAL . . . . . 0.461 HG22 ' O ' ' C' ' 698' ' ' VAL . 3.3 m -69.06 -30.82 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.919 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 5.9 tp -52.08 -34.18 42.59 Favored 'General case' 0 N--CA 1.532 3.67 0 C-N-CA 123.549 0.74 . . . . 0.0 110.68 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 6.4 t -58.99 -46.45 88.12 Favored 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 44.6 tp -67.05 -35.56 80.14 Favored 'General case' 1 N--CA 1.54 4.072 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.1 -39.22 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -59.81 -21.16 60.49 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.062 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -47.21 -47.97 24.17 Favored 'General case' 0 N--CA 1.525 3.28 0 CA-C-O 122.13 0.967 . . . . 0.0 110.204 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.74 -43.05 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.762 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -76.76 -9.7 58.86 Favored 'General case' 0 N--CA 1.526 3.335 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.054 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -89.62 -14.16 35.55 Favored 'General case' 1 N--CA 1.546 4.339 0 C-N-CA 123.25 0.62 . . . . 0.0 110.075 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -69.33 -7.9 58.24 Favored Glycine 1 N--CA 1.527 4.716 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -75.35 156.11 35.83 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 125.891 1.676 . . . . 0.0 109.43 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 92.6 p -114.23 146.5 35.91 Favored Pre-proline 0 N--CA 1.527 3.378 0 C-N-CA 125.714 1.606 . . . . 0.0 107.181 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -59.33 131.23 39.71 Favored 'Trans proline' 0 N--CA 1.527 3.492 0 CA-C-N 121.954 1.734 . . . . 0.0 109.961 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -146.23 -171.67 3.77 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 124.902 1.281 . . . . 0.0 110.035 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.519 3.01 0 C-N-CA 123.974 0.909 . . . . 0.0 109.086 179.873 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -165.58 130.52 2.43 Favored 'General case' 0 N--CA 1.522 3.165 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -50.22 -44.27 53.22 Favored 'General case' 0 N--CA 1.513 2.707 0 C-N-CA 125.225 1.41 . . . . 0.0 112.071 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -59.29 -48.09 82.92 Favored 'General case' 0 N--CA 1.537 3.895 0 CA-C-N 118.61 0.641 . . . . 0.0 111.735 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -70.01 -36.52 75.17 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.92 -24.42 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.832 0 C-N-CA 123.781 0.833 . . . . 0.0 109.705 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -64.92 -53.67 42.73 Favored 'General case' 1 N--CA 1.545 4.275 0 CA-C-N 118.826 0.739 . . . . 0.0 111.547 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.28 -30.43 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.994 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -51.08 -36.81 42.11 Favored 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.155 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 15.4 mt -68.9 -37.47 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 C-N-CA 124.333 1.053 . . . . 0.0 109.726 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 10.8 mm -57.81 -37.68 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.952 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.2 -42.55 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.41 -30.88 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 C-N-CA 123.584 0.754 . . . . 0.0 109.506 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.73 -41.97 98.77 Favored Glycine 1 N--CA 1.525 4.62 0 C-N-CA 123.673 0.654 . . . . 0.0 111.589 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.4 m -69.02 -37.89 78.88 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-O 122.272 1.034 . . . . 0.0 110.229 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.01 -44.6 97.18 Favored 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 113.287 -1.779 . . . . 0.0 113.458 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.517 ' O ' HD13 ' A' ' 693' ' ' ILE . 0.1 OUTLIER -70.13 -35.58 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.152 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -76.69 -12.4 84.49 Favored Glycine 1 N--CA 1.535 5.24 0 O-C-N 121.012 -1.055 . . . . 0.0 110.991 178.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.92 -38.92 83.52 Favored 'General case' 0 N--CA 1.539 3.98 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 696' ' ' ARG . . . . . 0.657 ' HE ' HD11 ' C' ' 693' ' ' ILE . 32.4 mmt180 -52.31 -25.23 9.02 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 125.05 1.34 . . . . 0.0 113.692 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 31.2 mm -53.28 -38.84 32.65 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.362 0 CA-C-N 118.611 0.641 . . . . 0.0 111.343 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.67 -28.63 23.68 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.305 0 C-N-CA 123.813 0.845 . . . . 0.0 112.428 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -52.46 -26.38 12.66 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 123.22 0.608 . . . . 0.0 110.901 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.87 -34.72 65.74 Favored 'General case' 0 N--CA 1.53 3.547 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.0 m -69.48 -31.79 50.54 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.107 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 10.2 tp -54.74 -36.06 64.4 Favored 'General case' 0 N--CA 1.538 3.947 0 C-N-CA 122.928 0.491 . . . . 0.0 110.252 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.0 p -59.38 -46.18 89.37 Favored 'General case' 0 N--CA 1.528 3.463 0 CA-C-N 118.383 0.538 . . . . 0.0 112.348 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 44.8 tp -65.42 -34.62 78.72 Favored 'General case' 1 N--CA 1.543 4.203 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.19 -38.89 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.597 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -62.49 -29.33 70.47 Favored 'General case' 0 N--CA 1.515 2.778 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.312 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -50.45 -48.54 56.44 Favored 'General case' 0 N--CA 1.519 3.002 0 C-N-CA 123.328 0.651 . . . . 0.0 111.954 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.34 -39.11 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -75.75 -23.38 56.0 Favored 'General case' 0 N--CA 1.527 3.421 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.369 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -92.23 -7.63 47.65 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.36 1.464 . . . . 0.0 107.429 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.83 -21.62 7.62 Favored Glycine 1 N--CA 1.524 4.532 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -119.48 135.2 54.87 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 125.336 1.454 . . . . 0.0 107.253 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 96.1 p -82.27 146.6 54.88 Favored Pre-proline 0 N--CA 1.528 3.426 0 CA-C-O 117.483 -1.246 . . . . 0.0 110.366 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -59.98 130.88 36.52 Favored 'Trans proline' 0 C--N 1.398 3.165 0 CA-C-N 121.414 1.541 . . . . 0.0 110.709 -177.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.3 tm? 62.19 76.88 0.35 Allowed 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 125.622 1.569 . . . . 0.0 110.133 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.522 3.151 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.167 -179.851 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 34.7 m120 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -58.32 149.22 25.09 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 123.991 0.916 . . . . 0.0 111.209 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 679' ' ' LEU . . . . . 0.493 HD12 ' N ' ' B' ' 680' ' ' TRP . 1.3 pp -57.87 -23.06 51.34 Favored 'General case' 0 N--CA 1.511 2.624 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 680' ' ' TRP . . . . . 0.493 ' N ' HD12 ' B' ' 679' ' ' LEU . 16.6 t-105 -57.77 -26.24 61.6 Favored 'General case' 1 N--CA 1.551 4.606 0 CA-C-N 121.032 1.742 . . . . 0.0 110.262 -179.188 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -71.8 -40.25 69.32 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.952 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 682' ' ' ILE . . . . . 0.467 HD12 ' N ' ' B' ' 683' ' ' ARG . 1.3 pp -72.52 -25.22 22.54 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.234 0 CA-C-N 119.582 1.083 . . . . 0.0 110.192 178.698 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 683' ' ' ARG . . . . . 0.467 ' N ' HD12 ' B' ' 682' ' ' ILE . 3.3 tmt_? -59.35 -53.55 56.87 Favored 'General case' 0 N--CA 1.538 3.953 0 CA-C-N 118.168 0.44 . . . . 0.0 111.794 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 14.6 tt -70.52 -34.36 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.164 0 C-N-CA 124.003 0.921 . . . . 0.0 110.628 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -53.74 -46.75 70.99 Favored 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 124.48 1.112 . . . . 0.0 111.367 -175.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 43.9 mt -64.46 -39.89 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.894 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 59.8 mt -64.54 -40.11 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 97.8 mt -59.67 -45.34 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.58 -38.36 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.444 0 C-N-CA 123.565 0.746 . . . . 0.0 109.723 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -53.39 -19.84 9.47 Favored Glycine 1 N--CA 1.53 4.931 0 O-C-N 121.417 -0.802 . . . . 0.0 114.136 -177.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.6 m -68.95 -51.78 36.03 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.34 -31.71 61.93 Favored 'General case' 0 N--CA 1.533 3.679 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.667 HD11 ' HE ' ' C' ' 696' ' ' ARG . 0.1 OUTLIER -57.82 -41.77 80.54 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.221 0 CA-C-N 120.37 1.441 . . . . 0.0 111.981 -175.182 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -68.81 -33.54 75.69 Favored Glycine 1 N--CA 1.525 4.574 0 O-C-N 121.08 -1.012 . . . . 0.0 110.642 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.02 -42.32 94.08 Favored 'General case' 1 N--CA 1.548 4.456 0 C-N-CA 124.116 0.967 . . . . 0.0 112.728 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -49.98 -26.19 4.02 Favored 'General case' 1 N--CA 1.542 4.139 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 697' ' ' ILE . . . . . 0.45 HD13 ' O ' ' B' ' 697' ' ' ILE . 0.1 OUTLIER -53.82 -38.15 35.05 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.374 0 CA-C-N 118.696 0.68 . . . . 0.0 111.51 -176.809 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.39 -28.2 18.27 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.182 0 C-N-CA 124.059 0.944 . . . . 0.0 112.412 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -52.93 -26.82 16.22 Favored 'General case' 1 N--CA 1.541 4.082 0 C-N-CA 123.398 0.679 . . . . 0.0 109.744 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.49 76.37 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 122.707 0.403 . . . . 0.0 110.468 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.1 m -69.08 -32.0 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.13 -35.68 59.97 Favored 'General case' 0 N--CA 1.534 3.738 0 C-N-CA 123.044 0.538 . . . . 0.0 111.379 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 8.4 t -60.8 -47.39 86.55 Favored 'General case' 0 N--CA 1.535 3.799 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.098 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 44.0 tp -65.13 -34.91 79.52 Favored 'General case' 1 N--CA 1.544 4.248 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.9 -40.71 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.69 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 706' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 710' ' ' GLN . 4.6 m120 -72.04 -24.77 61.59 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.905 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -49.57 -35.81 21.78 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 118.826 0.739 . . . . 0.0 110.284 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.52 -48.15 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -77.37 -10.77 59.65 Favored 'General case' 1 N--CA 1.543 4.177 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.509 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 710' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 706' ' ' ASN . 33.1 tt0 -112.84 -5.31 13.88 Favored 'General case' 0 N--CA 1.518 2.93 0 C-N-CA 125.523 1.529 . . . . 0.0 108.071 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.77 -29.3 33.18 Favored Glycine 0 N--CA 1.512 3.759 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -98.02 137.58 36.61 Favored 'General case' 0 N--CA 1.528 3.444 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 89.1 p -81.39 146.8 58.5 Favored Pre-proline 0 N--CA 1.528 3.444 0 C-N-CA 125.246 1.418 . . . . 0.0 111.443 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -69.06 130.53 20.37 Favored 'Trans proline' 0 C--N 1.399 3.196 0 CA-C-N 121.112 1.433 . . . . 0.0 110.262 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 9.8 mp -86.73 -77.09 0.33 Allowed 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 125.41 1.484 . . . . 0.0 107.313 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.522 3.135 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.516 179.749 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -166.74 -106.2 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 123.899 0.88 . . . . 0.0 109.335 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 679' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 683' ' ' ARG . 46.8 mt -50.25 -44.32 53.51 Favored 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 124.751 1.221 . . . . 0.0 112.482 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -43.06 86.21 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -72.8 -37.48 67.52 Favored 'General case' 0 N--CA 1.538 3.927 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 49.0 mm -74.53 -25.86 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 C-N-CA 125.322 1.449 . . . . 0.0 110.917 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 683' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' C' ' 679' ' ' LEU . 64.2 ttt180 -66.13 -56.15 12.87 Favored 'General case' 1 N--CA 1.542 4.173 0 CA-C-O 121.658 0.742 . . . . 0.0 110.912 -177.301 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.9 -36.08 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.785 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.56 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -56.11 -45.9 79.31 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.046 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.74 -42.38 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 124.246 1.018 . . . . 0.0 109.096 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.22 -36.09 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.525 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.25 -42.12 95.27 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 74.7 t -62.67 -31.15 51.14 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.158 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.93 -29.49 74.71 Favored Glycine 1 N--CA 1.517 4.053 0 C-N-CA 123.473 0.558 . . . . 0.0 112.439 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.2 m -67.98 -36.52 80.16 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.42 0.688 . . . . 0.0 111.561 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.83 -44.29 73.76 Favored 'General case' 0 N--CA 1.537 3.883 0 C-N-CA 123.455 0.702 . . . . 0.0 112.503 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 693' ' ' ILE . . . . . 0.657 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.267 0.1 OUTLIER -60.21 -49.26 84.82 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.622 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.825 . . . . . . . . 5 4 . 1 . 013 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.45 -27.39 60.79 Favored Glycine 1 N--CA 1.528 4.813 0 CA-C-N 119.489 1.04 . . . . 0.0 112.625 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -67.35 -42.12 84.02 Favored 'General case' 0 N--CA 1.538 3.935 0 C-N-CA 124.684 1.194 . . . . 0.0 111.118 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 696' ' ' ARG . . . . . 0.667 ' HE ' HD11 ' B' ' 693' ' ' ILE . 29.5 mmt180 -52.28 -24.98 8.32 Favored 'General case' 0 N--CA 1.539 3.996 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 30.0 pt -53.75 -38.02 34.07 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.495 0 CA-C-N 120.591 1.541 . . . . 0.0 113.094 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.76 -30.1 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.638 0 C-N-CA 122.517 0.327 . . . . 0.0 111.85 -176.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.68 -26.17 31.8 Favored 'General case' 0 N--CA 1.533 3.721 0 C-N-CA 123.622 0.769 . . . . 0.0 109.436 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.61 -39.83 74.28 Favored 'General case' 0 N--CA 1.523 3.179 0 O-C-N 121.754 -0.591 . . . . 0.0 109.862 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.1 m -69.53 -32.58 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.999 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.61 -34.56 58.88 Favored 'General case' 0 N--CA 1.537 3.876 0 C-N-CA 123.5 0.72 . . . . 0.0 111.056 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 69.5 m -59.96 -46.21 90.15 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-N 118.392 0.542 . . . . 0.0 111.998 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.72 -36.1 83.2 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 94.5 t -68.02 -40.29 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 706' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' C' ' 710' ' ' GLN . 2.8 m120 -65.7 -23.56 66.79 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-O 118.711 -0.662 . . . . 0.0 109.771 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -49.27 -44.07 43.56 Favored 'General case' 0 N--CA 1.519 2.977 0 C-N-CA 123.691 0.797 . . . . 0.0 110.045 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.1 t -62.29 -48.99 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.992 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 33.7 mtp85 -78.75 -10.2 59.69 Favored 'General case' 0 N--CA 1.532 3.664 0 CA-C-N 115.084 -0.962 . . . . 0.0 113.206 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 710' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.2 tt0 -112.24 -10.62 13.82 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 124.863 1.265 . . . . 0.0 108.666 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.86 -33.73 43.77 Favored Glycine 0 N--CA 1.509 3.548 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -86.04 152.86 22.56 Favored 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 94.1 p -80.99 149.66 67.19 Favored Pre-proline 0 N--CA 1.534 3.742 0 C-N-CA 125.845 1.658 . . . . 0.0 110.063 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.45 129.96 37.52 Favored 'Trans proline' 0 C--N 1.4 3.261 0 CA-C-N 122.204 1.823 . . . . 0.0 112.992 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 715' ' ' LEU . . . . . 0.518 ' CD1' ' H ' ' C' ' 715' ' ' LEU . 0.0 OUTLIER -87.46 -177.38 5.9 Favored 'General case' 0 N--CA 1.527 3.391 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.379 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.522 3.174 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.65 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 677' ' ' ASN . . . . . 0.606 HD21 ' N ' ' A' ' 677' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -122.58 -104.97 0.37 Allowed 'General case' 0 N--CA 1.53 3.575 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -21.43 3.04 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 124.825 1.25 . . . . 0.0 112.167 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -57.54 -44.35 85.11 Favored 'General case' 0 N--CA 1.532 3.663 0 C-N-CA 123.769 0.828 . . . . 0.0 110.79 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -70.7 -34.65 72.18 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.706 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 25.4 mm -74.15 -26.61 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.445 0 C-N-CA 125.383 1.473 . . . . 0.0 110.879 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -66.25 -53.37 37.73 Favored 'General case' 0 N--CA 1.539 3.987 0 CA-C-O 122.271 1.034 . . . . 0.0 111.24 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.4 tt -69.5 -30.0 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.2 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -52.7 -39.42 61.99 Favored 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.35 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.47 -43.64 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.311 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 54.5 mt -56.29 -34.62 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 58.9 mt -67.02 -46.72 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.15 -30.65 39.95 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.476 0 C-N-CA 123.362 0.665 . . . . 0.0 109.295 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.07 -40.61 98.3 Favored Glycine 0 N--CA 1.516 3.97 0 C-N-CA 123.482 0.563 . . . . 0.0 112.87 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 67.0 m -58.52 -35.41 72.23 Favored 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 124.342 1.057 . . . . 0.0 112.469 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 6.6 mp -53.75 -33.58 56.22 Favored 'General case' 0 N--CA 1.532 3.666 0 C-N-CA 123.61 0.764 . . . . 0.0 111.381 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -43.97 89.95 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.274 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -174.331 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -67.29 -32.34 79.51 Favored Glycine 1 N--CA 1.531 4.967 0 O-C-N 121.064 -1.022 . . . . 0.0 111.215 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.24 -37.75 84.19 Favored 'General case' 1 N--CA 1.546 4.351 0 C-N-CA 124.626 1.171 . . . . 0.0 110.414 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 696' ' ' ARG . . . . . 0.41 ' HE ' ' CD1' ' C' ' 693' ' ' ILE . 24.7 mmt180 -61.02 -29.6 69.81 Favored 'General case' 1 N--CA 1.546 4.344 0 O-C-N 121.309 -0.869 . . . . 0.0 112.45 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 39.8 mm -56.74 -37.93 55.61 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.041 0 CA-C-O 121.934 0.873 . . . . 0.0 109.803 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 39.2 t -56.54 -30.07 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.318 0 C-N-CA 125.727 1.611 . . . . 0.0 110.629 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -59.91 -30.06 68.79 Favored 'General case' 0 N--CA 1.538 3.929 0 C-N-CA 123.493 0.717 . . . . 0.0 111.469 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.98 -43.38 68.16 Favored 'General case' 0 N--CA 1.523 3.209 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.95 -33.44 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.008 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.958 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.58 -35.2 70.07 Favored 'General case' 0 N--CA 1.531 3.59 0 C-N-CA 123.494 0.717 . . . . 0.0 109.801 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.0 p -58.89 -46.62 87.43 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.92 -34.75 78.67 Favored 'General case' 1 N--CA 1.545 4.285 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.069 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.08 -39.11 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 706' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 710' ' ' GLN . 23.7 t-20 -62.19 -29.44 70.38 Favored 'General case' 0 N--CA 1.517 2.921 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.936 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -48.02 -33.72 8.38 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 123.959 0.904 . . . . 0.0 111.251 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.42 -46.75 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -77.7 -11.27 59.86 Favored 'General case' 1 N--CA 1.541 4.083 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.143 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 710' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 706' ' ' ASN . 17.7 tt0 -114.53 -11.96 12.35 Favored 'General case' 0 N--CA 1.522 3.135 0 C-N-CA 126.054 1.742 . . . . 0.0 108.545 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.73 -30.1 27.44 Favored Glycine 0 N--CA 1.51 3.598 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -85.84 152.65 22.83 Favored 'General case' 0 N--CA 1.522 3.154 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 41.7 t -81.05 149.54 66.73 Favored Pre-proline 0 N--CA 1.527 3.423 0 C-N-CA 126.055 1.742 . . . . 0.0 111.625 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -54.02 130.38 39.1 Favored 'Trans proline' 0 C--N 1.406 3.578 0 CA-C-N 122.215 1.827 . . . . 0.0 111.847 -176.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 59.55 110.55 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.503 0 C-N-CA 125.203 1.401 . . . . 0.0 109.829 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.522 3.17 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.148 -179.714 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 677' ' ' ASN . . . . . 0.647 ' N ' HD21 ' B' ' 677' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -65.06 -33.24 75.57 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 124.121 0.968 . . . . 0.0 111.211 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp -60.54 -31.0 70.11 Favored 'General case' 0 N--CA 1.519 3.011 0 C-N-CA 124.025 0.93 . . . . 0.0 111.962 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -69.69 -30.4 68.05 Favored 'General case' 0 N--CA 1.527 3.42 0 O-C-N 122.183 -0.323 . . . . 0.0 111.035 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -73.05 -38.79 66.36 Favored 'General case' 0 N--CA 1.524 3.249 0 CA-C-O 118.986 -0.53 . . . . 0.0 110.275 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 682' ' ' ILE . . . . . 0.489 HD12 ' N ' ' B' ' 683' ' ' ARG . 1.8 pp -73.48 -25.42 21.06 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.01 0 CA-C-N 119.204 0.911 . . . . 0.0 109.497 177.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 683' ' ' ARG . . . . . 0.489 ' N ' HD12 ' B' ' 682' ' ' ILE . 0.0 OUTLIER -58.43 -51.81 68.27 Favored 'General case' 1 N--CA 1.539 4.007 0 C-N-CA 123.241 0.616 . . . . 0.0 111.768 -177.495 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.7 tt -74.19 -33.68 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.866 0.866 . . . . 0.0 110.979 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -53.96 -47.14 71.65 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 113.938 -1.483 . . . . 0.0 113.099 -173.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 16.8 mt -59.76 -36.84 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 124.074 0.95 . . . . 0.0 111.172 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 687' ' ' ILE . . . . . 0.474 ' N ' HD12 ' B' ' 687' ' ' ILE . 1.4 mp -59.87 -37.25 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.61 -41.77 91.4 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.178 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.74 -31.62 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.931 0 C-N-CA 123.271 0.628 . . . . 0.0 109.506 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.59 -42.8 98.7 Favored Glycine 1 N--CA 1.524 4.521 0 C-N-CA 123.866 0.746 . . . . 0.0 112.474 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.3 m -67.67 -36.87 81.52 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-O 122.078 0.942 . . . . 0.0 110.218 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.23 -44.81 79.95 Favored 'General case' 0 N--CA 1.518 2.972 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.034 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -49.05 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.951 0 C-N-CA 123.334 0.654 . . . . 0.0 112.638 -176.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.9 -21.76 59.2 Favored Glycine 1 N--CA 1.524 4.53 0 CA-C-N 119.699 1.136 . . . . 0.0 112.978 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.09 -43.77 70.42 Favored 'General case' 1 N--CA 1.54 4.069 0 C-N-CA 123.621 0.769 . . . . 0.0 109.93 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -53.98 -26.02 23.8 Favored 'General case' 0 N--CA 1.536 3.852 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 38.4 mm -55.29 -38.77 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 123.904 0.882 . . . . 0.0 112.885 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.99 -31.41 45.52 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.527 0 CA-C-N 119.096 0.862 . . . . 0.0 111.95 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -54.21 -25.65 24.06 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.182 0.593 . . . . 0.0 109.94 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.45 -31.96 62.37 Favored 'General case' 0 N--CA 1.531 3.583 0 O-C-N 121.723 -0.611 . . . . 0.0 110.068 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.0 -30.04 45.35 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 9.6 tp -52.82 -35.25 56.85 Favored 'General case' 0 N--CA 1.532 3.631 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.486 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 52.1 m -58.11 -46.29 85.8 Favored 'General case' 0 N--CA 1.536 3.827 0 CA-C-N 119.233 0.924 . . . . 0.0 112.377 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 45.3 tp -64.54 -35.88 82.39 Favored 'General case' 1 N--CA 1.543 4.214 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.45 -38.42 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.554 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -58.16 -25.33 61.37 Favored 'General case' 0 N--CA 1.52 3.064 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.205 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -46.76 -47.66 20.72 Favored 'General case' 0 N--CA 1.515 2.819 0 C-N-CA 124.528 1.131 . . . . 0.0 112.569 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.56 -49.7 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.779 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -81.04 -6.91 59.36 Favored 'General case' 1 N--CA 1.545 4.29 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -110.75 -8.46 14.55 Favored 'General case' 1 N--CA 1.539 4.006 0 C-N-CA 124.569 1.148 . . . . 0.0 108.836 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -56.29 -27.08 52.16 Favored Glycine 0 N--CA 1.511 3.659 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -98.0 148.59 23.34 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.937 0.895 . . . . 0.0 108.981 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 49.5 m -82.15 149.83 63.27 Favored Pre-proline 0 N--CA 1.528 3.451 0 C-N-CA 125.808 1.643 . . . . 0.0 110.763 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.86 130.99 41.97 Favored 'Trans proline' 0 C--N 1.403 3.415 0 CA-C-N 122.138 1.799 . . . . 0.0 112.099 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -53.8 157.64 2.28 Favored 'General case' 0 N--CA 1.523 3.224 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.423 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.524 3.248 0 C-N-CA 124.539 1.136 . . . . 0.0 112.148 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 677' ' ' ASN . . . . . 0.627 ' N ' HD21 ' C' ' 677' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 67.93 -59.86 0.42 Allowed 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 125.072 1.349 . . . . 0.0 110.799 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 68.6 mt -49.53 -41.45 41.23 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 124.822 1.249 . . . . 0.0 112.626 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -43.47 83.13 Favored 'General case' 0 N--CA 1.538 3.945 0 CA-C-N 119.361 0.982 . . . . 0.0 112.464 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -73.44 -36.55 65.94 Favored 'General case' 0 N--CA 1.529 3.521 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.31 -38.36 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 123.965 0.906 . . . . 0.0 110.804 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -67.96 -51.04 52.06 Favored 'General case' 0 N--CA 1.536 3.873 0 C-N-CA 124.28 1.032 . . . . 0.0 111.366 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 18.5 tt -60.84 -30.71 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 CA-C-O 122.154 0.978 . . . . 0.0 110.686 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -50.58 -27.78 7.42 Favored 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.841 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.69 -47.99 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 124.547 1.139 . . . . 0.0 109.292 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 21.4 mm -54.22 -46.0 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 C-N-CA 124.123 0.969 . . . . 0.0 111.78 -174.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 16.9 tt -68.04 -40.18 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.984 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.25 -30.36 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.767 0.827 . . . . 0.0 109.304 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -72.15 -20.71 79.22 Favored Glycine 1 N--CA 1.522 4.387 0 CA-C-N 118.914 0.779 . . . . 0.0 112.692 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.8 m -68.17 -50.33 55.15 Favored 'General case' 0 N--CA 1.529 3.485 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 692' ' ' LEU . . . . . 0.479 HD12 ' H ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -53.73 -32.69 53.01 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -175.526 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 693' ' ' ILE . . . . . 0.479 ' H ' HD12 ' C' ' 692' ' ' LEU . 0.3 OUTLIER -61.99 -33.77 59.84 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.004 0 CA-C-N 119.618 1.099 . . . . 0.0 111.364 -177.52 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -72.71 -33.28 60.61 Favored Glycine 1 N--CA 1.52 4.254 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.37 -41.93 94.75 Favored 'General case' 0 N--CA 1.535 3.796 0 C-N-CA 124.874 1.27 . . . . 0.0 111.023 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -52.08 -24.32 6.65 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 10.7 tp -52.1 -38.29 23.83 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.35 0 CA-C-N 119.434 1.016 . . . . 0.0 112.357 -176.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.3 p -56.59 -30.65 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.999 0 C-N-CA 123.543 0.737 . . . . 0.0 111.836 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -54.28 -26.95 31.97 Favored 'General case' 0 N--CA 1.536 3.86 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.84 65.58 Favored 'General case' 0 N--CA 1.521 3.116 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.54 -30.42 45.21 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.142 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 9.8 tp -53.44 -35.61 60.66 Favored 'General case' 0 N--CA 1.535 3.808 0 CA-C-O 119.067 -0.492 . . . . 0.0 110.461 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 64.8 m -59.28 -45.99 89.76 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-N 118.941 0.792 . . . . 0.0 112.789 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 40.2 tp -66.51 -34.84 78.82 Favored 'General case' 1 N--CA 1.548 4.448 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.7 -38.87 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 706' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' C' ' 710' ' ' GLN . 38.2 t30 -58.24 -34.22 70.2 Favored 'General case' 0 C--O 1.183 -2.418 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.28 -177.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -46.63 -45.5 19.13 Favored 'General case' 0 N--CA 1.511 2.602 0 C-N-CA 124.464 1.106 . . . . 0.0 112.319 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.8 -45.81 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -77.99 -4.62 47.95 Favored 'General case' 0 N--CA 1.526 3.339 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.687 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 710' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' C' ' 706' ' ' ASN . 1.8 tt0 -111.29 -15.53 13.59 Favored 'General case' 1 N--CA 1.546 4.345 0 C-N-CA 124.307 1.043 . . . . 0.0 108.465 -178.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -77.01 -11.72 85.32 Favored Glycine 1 N--CA 1.533 5.117 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 174.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -76.03 153.67 36.28 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 128.321 2.648 . . . . 0.0 107.646 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 58.9 m -80.69 145.8 59.03 Favored Pre-proline 1 N--CA 1.545 4.317 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -69.83 131.51 21.29 Favored 'Trans proline' 0 C--N 1.4 3.272 0 CA-C-N 120.36 1.164 . . . . 0.0 110.459 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 90.3 mt -76.37 163.65 26.78 Favored 'General case' 0 N--CA 1.525 3.315 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.585 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.524 3.25 0 C-N-CA 124.395 1.078 . . . . 0.0 112.429 179.742 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 29.0 m120 . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 60.22 128.3 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.045 0 C-N-CA 124.844 1.257 . . . . 0.0 112.11 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.0 pp -51.44 -24.37 4.92 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 126.069 1.748 . . . . 0.0 113.052 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -67.39 -49.35 64.24 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -66.5 -30.95 71.4 Favored 'General case' 0 N--CA 1.532 3.66 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 682' ' ' ILE . . . . . 0.45 ' O ' HD13 ' A' ' 686' ' ' ILE . 51.0 mm -74.65 -30.31 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.86 0 C-N-CA 125.53 1.532 . . . . 0.0 110.19 177.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -51.47 57.0 Favored 'General case' 1 N--CA 1.548 4.463 0 C-N-CA 123.463 0.705 . . . . 0.0 111.964 -178.15 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.5 tt -65.8 -35.66 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.753 0 CA-C-O 122.091 0.948 . . . . 0.0 109.611 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -60.18 -40.91 91.62 Favored 'General case' 0 N--CA 1.512 2.669 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.825 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 686' ' ' ILE . . . . . 0.45 HD13 ' O ' ' A' ' 682' ' ' ILE . 1.2 mp -55.18 -49.19 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.793 0.837 . . . . 0.0 109.232 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 53.8 mt -56.81 -40.47 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 78.8 mt -68.26 -41.12 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.967 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.18 -30.63 49.24 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.601 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.21 -34.64 90.51 Favored Glycine 1 N--CA 1.522 4.405 0 C-N-CA 123.637 0.637 . . . . 0.0 111.991 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 62.9 m -68.39 -37.27 80.23 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.615 0.766 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.8 -44.44 86.31 Favored 'General case' 0 N--CA 1.536 3.864 0 C-N-CA 123.499 0.72 . . . . 0.0 112.627 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 693' ' ' ILE . . . . . 0.43 ' O ' HD13 ' A' ' 693' ' ' ILE 0.259 0.3 OUTLIER -61.3 -43.83 97.3 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.215 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -173.248 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.03 -34.15 89.19 Favored Glycine 1 N--CA 1.534 5.206 0 CA-C-N 120.017 1.28 . . . . 0.0 111.822 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.0 -39.78 86.92 Favored 'General case' 1 N--CA 1.541 4.114 0 C-N-CA 124.715 1.206 . . . . 0.0 110.326 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 696' ' ' ARG . . . . . 0.651 ' HE ' HD11 ' C' ' 693' ' ' ILE . 23.0 mmt180 -59.97 -28.25 67.52 Favored 'General case' 1 N--CA 1.544 4.275 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.3 -36.66 41.14 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.313 0 CA-C-O 122.09 0.948 . . . . 0.0 109.618 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 68.7 t -54.58 -28.0 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.092 0 C-N-CA 126.69 1.996 . . . . 0.0 111.216 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -53.15 -25.8 14.67 Favored 'General case' 0 N--CA 1.534 3.753 0 C-N-CA 123.559 0.744 . . . . 0.0 110.748 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.49 -39.89 74.01 Favored 'General case' 0 N--CA 1.525 3.297 0 O-C-N 121.766 -0.584 . . . . 0.0 109.668 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.8 -36.03 67.88 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.16 -35.45 64.77 Favored 'General case' 1 N--CA 1.54 4.073 0 C-N-CA 123.526 0.731 . . . . 0.0 110.806 -179.532 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 9.6 t -60.62 -46.89 88.57 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 44.8 tp -67.58 -36.82 81.65 Favored 'General case' 0 N--CA 1.536 3.865 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.88 -46.36 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 C-N-CA 123.295 0.638 . . . . 0.0 110.027 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 706' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 710' ' ' GLN . 23.7 p30 -72.47 -20.09 61.45 Favored 'General case' 0 N--CA 1.513 2.68 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.142 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -48.07 -44.36 31.33 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 123.682 0.793 . . . . 0.0 109.798 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.37 -43.49 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.75 -19.85 57.16 Favored 'General case' 0 N--CA 1.528 3.465 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.5 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 710' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 706' ' ' ASN . 2.6 tt0 -89.88 -14.83 33.45 Favored 'General case' 0 N--CA 1.538 3.937 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -59.15 -12.41 16.29 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -74.19 154.56 39.01 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 124.424 1.089 . . . . 0.0 108.37 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 73.0 m -94.53 147.41 33.19 Favored Pre-proline 0 N--CA 1.528 3.472 0 C-N-CA 125.123 1.369 . . . . 0.0 107.866 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.07 129.99 30.81 Favored 'Trans proline' 0 N--CA 1.527 3.496 0 CA-C-N 121.574 1.598 . . . . 0.0 109.739 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 715' ' ' LEU . . . . . 0.434 ' H ' ' CD2' ' A' ' 715' ' ' LEU . 1.5 pt? -74.79 -10.83 59.89 Favored 'General case' 0 N--CA 1.525 3.318 0 CA-C-N 114.319 -1.309 . . . . 0.0 110.899 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 37.6 t . . . . . 0 N--CA 1.52 3.036 0 C-N-CA 124.122 0.969 . . . . 0.0 111.783 -179.719 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -64.15 -13.67 49.8 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 123.893 0.877 . . . . 0.0 111.41 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.69 -45.97 92.15 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.554 0.742 . . . . 0.0 110.624 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -71.1 -30.13 66.14 Favored 'General case' 0 N--CA 1.529 3.519 0 O-C-N 122.126 -0.359 . . . . 0.0 110.607 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -68.95 -37.95 79.16 Favored 'General case' 0 N--CA 1.519 3.015 0 CA-C-O 118.902 -0.57 . . . . 0.0 111.056 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 682' ' ' ILE . . . . . 0.473 HD12 ' N ' ' B' ' 683' ' ' ARG . 2.1 pp -72.2 -23.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.809 0 CA-C-N 118.943 0.792 . . . . 0.0 110.767 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 683' ' ' ARG . . . . . 0.473 ' N ' HD12 ' B' ' 682' ' ' ILE . 1.3 ttp180 -60.34 -54.28 47.58 Favored 'General case' 1 N--CA 1.546 4.369 0 CA-C-N 119.205 0.911 . . . . 0.0 112.736 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -70.7 -31.32 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.97 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.072 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -52.56 -30.05 28.74 Favored 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 124.0 0.92 . . . . 0.0 112.873 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 686' ' ' ILE . . . . . 0.475 ' N ' HD12 ' B' ' 686' ' ' ILE . 1.4 mp -68.69 -36.51 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.755 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.08 -42.45 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.321 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.84 -50.29 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.985 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.36 -29.04 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.304 0 C-N-CA 124.519 1.127 . . . . 0.0 108.879 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.13 -17.92 68.52 Favored Glycine 1 N--CA 1.524 4.516 0 C-N-CA 123.674 0.654 . . . . 0.0 113.172 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 75.1 m -68.92 -52.21 31.74 Favored 'General case' 0 N--CA 1.527 3.421 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.17 -32.78 73.44 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.469 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.2 OUTLIER -60.64 -38.65 79.1 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.38 0 CA-C-N 120.384 1.447 . . . . 0.0 112.148 -176.425 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.88 -34.62 89.12 Favored Glycine 1 N--CA 1.526 4.7 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.21 -42.44 95.14 Favored 'General case' 0 N--CA 1.538 3.933 0 C-N-CA 124.572 1.149 . . . . 0.0 111.261 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -51.85 -24.23 5.88 Favored 'General case' 0 N--CA 1.536 3.863 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 20.0 tt -52.18 -36.71 21.13 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 CA-C-N 120.959 1.709 . . . . 0.0 111.844 -176.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 13.5 p -54.84 -28.12 19.59 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.028 0 C-N-CA 123.821 0.848 . . . . 0.0 111.17 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -55.75 -28.04 53.83 Favored 'General case' 1 N--CA 1.546 4.347 0 O-C-N 121.451 -0.781 . . . . 0.0 109.828 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.54 -44.09 68.21 Favored 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 65.5 t -68.85 -32.16 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.271 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 2.9 tp -54.2 -35.52 62.46 Favored 'General case' 0 N--CA 1.536 3.858 0 C-N-CA 123.391 0.676 . . . . 0.0 110.275 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 20.7 t -60.07 -46.68 88.75 Favored 'General case' 0 N--CA 1.529 3.525 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 36.2 tp -67.4 -34.6 77.6 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.43 -43.57 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 706' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' B' ' 709' ' ' ARG . 11.5 p30 -72.4 -22.71 61.08 Favored 'General case' 0 N--CA 1.517 2.913 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.062 -178.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -48.43 -36.96 15.92 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.296 0.57 . . . . 0.0 110.306 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.42 -41.52 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 176.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 709' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' B' ' 706' ' ' ASN . 86.5 mtt180 -75.92 -17.08 59.9 Favored 'General case' 0 N--CA 1.525 3.288 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.667 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -87.96 -12.33 44.87 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.76 -19.08 6.26 Favored Glycine 1 N--CA 1.521 4.344 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -114.24 130.04 56.63 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 124.99 1.316 . . . . 0.0 107.737 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 96.4 p -82.82 147.41 54.84 Favored Pre-proline 0 N--CA 1.526 3.366 0 C-N-CA 125.182 1.393 . . . . 0.0 110.53 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -57.65 131.63 45.38 Favored 'Trans proline' 0 C--N 1.4 3.268 0 CA-C-N 121.653 1.626 . . . . 0.0 110.671 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 52.5 tp -52.3 -21.9 3.96 Favored 'General case' 0 N--CA 1.528 3.435 0 CA-C-N 113.67 -1.605 . . . . 0.0 111.777 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.52 3.05 0 CA-C-O 117.588 -1.196 . . . . 0.0 109.425 179.836 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 5.1 p30 . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -66.85 144.48 56.25 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 123.848 0.859 . . . . 0.0 109.656 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.11 -44.63 64.53 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 125.288 1.435 . . . . 0.0 112.69 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -68.85 -37.13 78.91 Favored 'General case' 0 N--CA 1.524 3.271 0 CA-C-O 121.597 0.713 . . . . 0.0 110.961 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -66.35 -40.37 89.76 Favored 'General case' 0 N--CA 1.518 2.935 0 CA-C-N 114.151 -1.386 . . . . 0.0 111.415 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 18.2 pt -73.01 -29.38 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -52.09 66.96 Favored 'General case' 1 N--CA 1.55 4.562 0 C-N-CA 123.106 0.563 . . . . 0.0 110.421 -176.434 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.94 -36.33 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -52.17 -27.66 15.26 Favored 'General case' 0 N--CA 1.526 3.366 0 C-N-CA 124.214 1.005 . . . . 0.0 110.816 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 9.0 mm -67.61 -48.01 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.235 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 23.8 mt -64.33 -36.06 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.749 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.891 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 44.3 mm -59.86 -42.59 89.67 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.202 0 CA-C-N 118.151 0.432 . . . . 0.0 110.192 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.62 -31.69 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 C-N-CA 123.838 0.855 . . . . 0.0 110.328 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.66 -36.3 93.08 Favored Glycine 1 N--CA 1.522 4.428 0 C-N-CA 123.259 0.457 . . . . 0.0 112.194 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 64.2 m -68.12 -37.35 81.01 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.876 0.87 . . . . 0.0 111.805 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.13 -45.01 92.05 Favored 'General case' 0 N--CA 1.536 3.866 0 C-N-CA 123.589 0.755 . . . . 0.0 112.675 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 693' ' ' ILE . . . . . 0.651 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.286 0.1 OUTLIER -63.38 -48.84 85.39 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.466 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.95 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -55.2 -31.99 56.8 Favored Glycine 1 N--CA 1.531 5.016 0 CA-C-N 119.214 0.915 . . . . 0.0 113.279 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.23 -38.8 88.78 Favored 'General case' 0 N--CA 1.539 3.984 0 C-N-CA 124.728 1.211 . . . . 0.0 110.357 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -60.09 -28.48 67.87 Favored 'General case' 1 N--CA 1.543 4.203 0 O-C-N 121.575 -0.703 . . . . 0.0 111.878 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.71 -36.97 44.75 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.155 0 CA-C-O 121.916 0.865 . . . . 0.0 109.512 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.59 -27.13 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.292 0 C-N-CA 126.395 1.878 . . . . 0.0 110.695 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -54.09 -27.11 30.74 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.139 0.576 . . . . 0.0 111.797 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.84 86.86 Favored 'General case' 0 N--CA 1.527 3.405 0 O-C-N 122.038 -0.414 . . . . 0.0 110.367 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 14.0 m -70.51 -31.75 47.53 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.025 0 CA-C-N 118.09 0.404 . . . . 0.0 110.085 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.66 -33.7 61.11 Favored 'General case' 0 N--CA 1.53 3.563 0 C-N-CA 123.521 0.729 . . . . 0.0 110.629 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 64.3 m -58.6 -46.95 85.9 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 21.7 tp -65.56 -34.88 79.28 Favored 'General case' 1 N--CA 1.549 4.505 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.81 -38.88 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -65.46 -23.89 67.03 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 123.251 0.62 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 11.5 tpt85 -49.73 -37.24 28.55 Favored 'General case' 0 N--CA 1.516 2.849 0 CA-C-O 121.753 0.787 . . . . 0.0 110.76 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.75 -37.33 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.015 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.83 -28.7 58.37 Favored 'General case' 1 N--CA 1.54 4.031 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -89.71 -3.05 58.39 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 124.615 1.166 . . . . 0.0 109.133 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.92 -24.34 33.96 Favored Glycine 1 N--CA 1.526 4.67 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 176.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -121.2 143.97 48.84 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 113.042 -1.579 . . . . 0.0 107.769 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 90.1 p -82.57 146.66 53.94 Favored Pre-proline 0 N--CA 1.53 3.527 0 CA-C-O 117.305 -1.331 . . . . 0.0 110.239 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.5 131.34 42.08 Favored 'Trans proline' 0 C--N 1.399 3.193 0 CA-C-N 121.614 1.612 . . . . 0.0 111.169 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 61.6 mt -65.81 -167.14 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.19 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 N--CA 1.523 3.195 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.355 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.511 2.62 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -68.16 -48.25 65.82 Favored 'General case' 0 N--CA 1.528 3.468 0 CA-C-O 121.711 0.767 . . . . 0.0 110.741 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -61.54 -33.45 73.87 Favored 'General case' 0 N--CA 1.527 3.382 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.101 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.4 mm -76.23 -34.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.456 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -53.41 26.3 Favored 'General case' 1 N--CA 1.546 4.372 0 O-C-N 121.721 -0.612 . . . . 0.0 111.988 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.9 tt -55.52 -35.3 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 CA-C-O 122.479 1.133 . . . . 0.0 110.234 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -58.83 -33.68 70.68 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 112.933 -1.939 . . . . 0.0 110.478 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.0 mm -68.64 -37.93 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.072 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 24.1 mt -58.25 -39.23 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.25 -44.42 99.1 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.015 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 67.0 t -64.36 -30.35 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.943 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.83 -33.73 88.01 Favored Glycine 0 N--CA 1.514 3.883 0 C-N-CA 123.87 0.748 . . . . 0.0 112.124 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.9 m -68.16 -37.04 80.59 Favored 'General case' 0 N--CA 1.526 3.331 0 C-N-CA 123.362 0.665 . . . . 0.0 111.009 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.97 -43.23 91.34 Favored 'General case' 0 N--CA 1.537 3.921 0 C-N-CA 123.212 0.605 . . . . 0.0 111.787 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.7 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.268 0.8 OUTLIER -63.66 -48.88 84.67 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -175.718 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.43 -25.61 65.26 Favored Glycine 1 N--CA 1.526 4.694 0 O-C-N 120.704 -1.248 . . . . 0.0 112.981 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.33 -38.74 88.37 Favored 'General case' 0 N--CA 1.536 3.86 0 C-N-CA 124.116 0.967 . . . . 0.0 110.604 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . 0.413 ' HE ' ' CD1' ' C' ' 693' ' ' ILE . 13.9 mmt180 -52.03 -23.74 5.66 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 18.6 tt -51.96 -36.42 19.77 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.178 0 CA-C-N 119.444 1.02 . . . . 0.0 111.333 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 11.2 p -54.64 -27.42 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 C-N-CA 124.235 1.014 . . . . 0.0 111.107 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -55.07 -28.79 55.02 Favored 'General case' 1 N--CA 1.545 4.319 0 O-C-N 121.692 -0.63 . . . . 0.0 109.879 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.19 -45.03 67.49 Favored 'General case' 0 N--CA 1.522 3.14 0 CA-C-O 122.031 0.92 . . . . 0.0 108.966 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.7 -34.31 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.816 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.233 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.6 tp -55.64 -34.81 65.27 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.965 0.906 . . . . 0.0 111.021 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 51.0 m -59.1 -45.02 91.94 Favored 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 35.7 tp -67.66 -34.8 77.65 Favored 'General case' 0 N--CA 1.538 3.95 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 66.1 t -67.86 -39.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.828 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 710' ' ' GLN . 16.1 m120 -59.21 -23.63 62.44 Favored 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.891 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 22.8 tpt85 -48.07 -41.02 24.93 Favored 'General case' 0 N--CA 1.524 3.269 0 CA-C-O 121.372 0.606 . . . . 0.0 110.84 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 52.9 t -72.6 -41.97 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-N 114.689 -1.141 . . . . 0.0 107.944 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -76.72 -11.35 59.83 Favored 'General case' 1 N--CA 1.545 4.298 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.417 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 706' ' ' ASN . 1.4 tm0? -111.87 -10.4 14.0 Favored 'General case' 0 N--CA 1.516 2.851 0 C-N-CA 125.549 1.54 . . . . 0.0 107.634 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.13 -22.83 7.04 Favored Glycine 1 N--CA 1.518 4.135 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -98.39 153.46 18.55 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 124.076 0.95 . . . . 0.0 109.472 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 66.1 m -80.51 152.17 72.55 Favored Pre-proline 0 N--CA 1.526 3.345 0 C-N-CA 126.859 2.064 . . . . 0.0 111.216 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 C--N 1.401 3.302 0 CA-C-N 121.527 1.581 . . . . 0.0 111.74 -174.719 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.518 2.929 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -63.36 -49.52 73.55 Favored 'General case' 0 N--CA 1.532 3.643 0 CA-C-N 118.367 0.531 . . . . 0.0 111.32 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -64.0 -31.53 72.75 Favored 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.88 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.02 -32.22 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.864 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.26 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -51.57 48.87 Favored 'General case' 1 N--CA 1.554 4.745 0 CA-C-N 118.713 0.688 . . . . 0.0 112.057 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.8 tt -62.1 -31.66 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-O 122.029 0.918 . . . . 0.0 110.779 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -51.94 -35.29 45.34 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.762 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.22 -41.56 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.082 0 C-N-CA 124.607 1.163 . . . . 0.0 108.788 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 47.3 mt -60.38 -37.37 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 64.0 mt -64.62 -44.79 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.43 -30.32 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 C-N-CA 123.827 0.851 . . . . 0.0 108.727 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.26 -30.58 78.1 Favored Glycine 1 N--CA 1.517 4.054 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 32.4 m -68.79 -37.59 79.4 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.431 0.692 . . . . 0.0 111.413 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.32 -41.4 75.94 Favored 'General case' 0 N--CA 1.535 3.781 0 C-N-CA 123.443 0.697 . . . . 0.0 111.932 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.748 HD11 ' HE ' ' C' ' 696' ' ' ARG 0.292 0.3 OUTLIER -60.7 -46.1 96.47 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.386 0 CA-C-N 118.956 0.798 . . . . 0.0 112.206 -176.485 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.83 -27.68 64.67 Favored Glycine 1 N--CA 1.528 4.833 0 CA-C-N 119.159 0.89 . . . . 0.0 112.307 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.4 tt -67.93 -37.38 81.58 Favored 'General case' 1 N--CA 1.548 4.431 0 C-N-CA 125.126 1.37 . . . . 0.0 109.31 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . 0.7 ' HE ' HD11 ' A' ' 693' ' ' ILE . 25.0 mmt180 -62.89 -27.37 69.31 Favored 'General case' 1 N--CA 1.54 4.073 0 C-N-CA 123.806 0.842 . . . . 0.0 112.336 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.51 -38.78 50.73 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.593 0 CA-C-O 122.477 1.132 . . . . 0.0 109.473 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 64.3 t -57.21 -29.6 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.032 0 C-N-CA 126.962 2.105 . . . . 0.0 111.293 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -53.75 -26.92 25.7 Favored 'General case' 0 N--CA 1.534 3.774 0 C-N-CA 122.976 0.51 . . . . 0.0 111.16 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.42 -35.14 67.48 Favored 'General case' 0 N--CA 1.528 3.449 0 O-C-N 121.956 -0.465 . . . . 0.0 109.849 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.7 -32.7 53.32 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.343 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 7.9 tp -54.97 -33.67 62.62 Favored 'General case' 0 N--CA 1.539 3.999 0 C-N-CA 124.087 0.955 . . . . 0.0 110.421 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 84.9 p -59.01 -45.73 89.94 Favored 'General case' 0 N--CA 1.528 3.471 0 O-C-N 122.344 -0.223 . . . . 0.0 111.21 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . 0.404 HD13 HE21 ' C' ' 710' ' ' GLN . 23.3 tp -63.09 -36.56 84.0 Favored 'General case' 1 N--CA 1.548 4.427 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.74 -42.09 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.427 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -75.48 -21.41 58.09 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 123.126 0.57 . . . . 0.0 110.101 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.18 -42.63 60.98 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.52 -42.35 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.903 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -75.31 -7.54 54.23 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.225 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.99 -14.76 17.73 Favored 'General case' 1 N--CA 1.546 4.33 0 C-N-CA 124.201 1.0 . . . . 0.0 108.825 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -84.33 -18.15 63.08 Favored Glycine 1 N--CA 1.522 4.378 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -87.93 152.35 22.13 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 126.72 2.008 . . . . 0.0 108.285 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 67.0 m -93.23 148.63 36.0 Favored Pre-proline 1 N--CA 1.547 4.381 0 C-N-CA 125.914 1.686 . . . . 0.0 113.764 -176.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.404 3.46 0 CA-C-N 120.788 1.317 . . . . 0.0 109.76 -176.84 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 7.1 tt . . . . . 0 N--CA 1.516 2.86 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -61.6 -49.75 75.36 Favored 'General case' 0 N--CA 1.529 3.522 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -66.01 -33.73 76.48 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 95.5 mt -74.34 -25.33 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.807 0 C-N-CA 124.789 1.236 . . . . 0.0 110.445 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -50.69 62.52 Favored 'General case' 1 N--CA 1.555 4.82 0 CA-C-N 119.682 1.128 . . . . 0.0 110.133 -178.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.2 tt -66.25 -31.06 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 C-N-CA 123.71 0.804 . . . . 0.0 109.115 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -54.86 -28.38 49.66 Favored 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.015 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 21.4 mm -68.5 -44.13 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 C-N-CA 123.689 0.796 . . . . 0.0 109.548 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.71 -41.0 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.59 -47.35 93.36 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.91 -30.11 47.83 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.161 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.05 82.47 Favored Glycine 1 N--CA 1.516 4.029 0 C-N-CA 123.625 0.631 . . . . 0.0 112.408 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 62.4 m -67.9 -37.07 81.27 Favored 'General case' 0 N--CA 1.533 3.681 0 C-N-CA 123.463 0.705 . . . . 0.0 111.698 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.91 -40.81 77.01 Favored 'General case' 0 N--CA 1.533 3.689 0 C-N-CA 123.339 0.656 . . . . 0.0 111.868 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . 0.421 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -60.62 -39.89 82.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.181 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -71.41 -25.56 75.11 Favored Glycine 1 N--CA 1.531 5.002 0 O-C-N 121.074 -1.016 . . . . 0.0 111.107 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.85 -43.38 98.96 Favored 'General case' 0 N--CA 1.535 3.806 0 C-N-CA 123.99 0.916 . . . . 0.0 109.392 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . 0.748 ' HE ' HD11 ' B' ' 693' ' ' ILE . 10.1 mmt180 -54.2 -25.49 23.07 Favored 'General case' 0 N--CA 1.539 3.986 0 C-N-CA 125.045 1.338 . . . . 0.0 114.565 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 72.2 mt -53.84 -37.54 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.863 0 CA-C-N 118.541 0.609 . . . . 0.0 109.841 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.05 -26.18 32.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.238 0 C-N-CA 124.965 1.306 . . . . 0.0 111.971 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -53.59 -27.54 27.16 Favored 'General case' 1 N--CA 1.549 4.523 0 O-C-N 120.972 -1.08 . . . . 0.0 110.219 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.41 -46.07 91.67 Favored 'General case' 0 N--CA 1.525 3.325 0 O-C-N 121.967 -0.458 . . . . 0.0 110.881 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.1 -31.33 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.63 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.68 -34.16 57.79 Favored 'General case' 0 N--CA 1.536 3.86 0 C-N-CA 123.12 0.568 . . . . 0.0 110.742 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 86.9 p -59.67 -46.35 89.3 Favored 'General case' 0 N--CA 1.532 3.642 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 45.7 tp -65.8 -35.68 81.39 Favored 'General case' 1 N--CA 1.542 4.147 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.31 -43.45 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.38 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -68.4 -25.43 65.04 Favored 'General case' 0 N--CA 1.515 2.8 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.25 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.09 -43.92 61.15 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 119.087 0.858 . . . . 0.0 109.233 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.25 -47.39 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.1 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -74.73 -15.72 60.77 Favored 'General case' 0 N--CA 1.535 3.792 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.895 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . 0.404 HE21 HD13 ' B' ' 704' ' ' LEU . 4.7 mm100 -114.12 -3.86 13.2 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -48.83 -27.81 6.71 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 124.399 0.999 . . . . 0.0 111.796 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -75.44 155.18 36.56 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 31.1 t -77.76 146.96 73.6 Favored Pre-proline 0 N--CA 1.536 3.865 0 C-N-CA 125.001 1.32 . . . . 0.0 112.584 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -58.51 129.95 35.02 Favored 'Trans proline' 0 C--N 1.408 3.699 0 CA-C-N 120.643 1.265 . . . . 0.0 110.234 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 60.3 tp . . . . . 0 N--CA 1.525 3.304 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.0 178.712 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 683' ' ' ARG . 18.6 mt . . . . . 0 N--CA 1.504 2.272 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -55.97 -45.38 78.92 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -73.18 -38.71 66.06 Favored 'General case' 0 N--CA 1.533 3.706 0 CA-C-O 121.555 0.693 . . . . 0.0 109.485 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.6 mm -74.89 -26.0 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 125.072 1.349 . . . . 0.0 111.276 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 679' ' ' LEU . 56.5 ttt180 -67.06 -55.7 13.21 Favored 'General case' 1 N--CA 1.542 4.146 0 C-N-CA 123.976 0.91 . . . . 0.0 110.56 -177.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.3 tt -64.4 -32.54 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.537 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -52.57 -44.02 65.62 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.946 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 66.5 mt -68.54 -37.22 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.445 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 42.9 mt -65.89 -34.69 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.697 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 48.3 mm -63.72 -42.46 96.05 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.383 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 88.0 t -64.98 -29.88 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.882 0 C-N-CA 123.664 0.786 . . . . 0.0 108.959 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -61.19 -36.84 93.01 Favored Glycine 1 N--CA 1.522 4.413 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 53.4 m -68.91 -37.34 78.89 Favored 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 124.027 0.931 . . . . 0.0 111.451 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.8 mp -58.04 -38.97 77.24 Favored 'General case' 1 N--CA 1.546 4.332 0 C-N-CA 124.175 0.99 . . . . 0.0 112.346 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.806 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.268 1.3 tp -69.23 -45.76 78.78 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.205 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -73.7 -12.21 80.66 Favored Glycine 1 N--CA 1.525 4.578 0 O-C-N 120.744 -1.222 . . . . 0.0 112.046 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . 0.426 ' O ' HD23 ' A' ' 695' ' ' LEU . 6.1 tt -70.48 -41.28 72.92 Favored 'General case' 0 N--CA 1.535 3.8 0 C-N-CA 124.127 0.971 . . . . 0.0 109.745 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . 0.841 ' HE ' HD11 ' C' ' 693' ' ' ILE . 22.8 mmt180 -52.51 -28.41 20.39 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.952 0.901 . . . . 0.0 113.054 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 42.0 mm -56.39 -43.81 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.332 0 C-N-CA 124.041 0.936 . . . . 0.0 112.486 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 3.3 p -66.66 -51.91 51.32 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.623 0 CA-C-N 118.702 0.683 . . . . 0.0 112.618 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' A' ' 702' ' ' LEU 0.522 0.9 OUTLIER -54.8 -18.93 5.39 Favored 'General case' 0 C--O 1.165 -3.392 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.255 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -51.93 -29.51 20.52 Favored 'General case' 1 N--CA 1.539 4.012 0 O-C-N 120.93 -1.106 . . . . 0.0 109.009 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 12.7 m -62.75 -29.27 46.63 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.491 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 699' ' ' PHE . 7.1 tt -50.5 -34.64 25.88 Favored 'General case' 1 N--CA 1.541 4.113 0 C-N-CA 125.311 1.445 . . . . 0.0 110.955 -178.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 68.0 m -59.34 -45.32 91.7 Favored 'General case' 0 N--CA 1.534 3.772 0 CA-C-N 118.467 0.576 . . . . 0.0 110.78 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.06 -35.21 80.0 Favored 'General case' 1 N--CA 1.54 4.025 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.1 t -68.06 -39.78 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.788 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 710' ' ' GLN . 3.1 m120 -64.82 -24.6 67.6 Favored 'General case' 0 N--CA 1.512 2.674 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.61 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . 0.468 HH12 ' NH2' ' B' ' 707' ' ' ARG . 21.6 tpt180 -47.71 -30.86 4.16 Favored 'General case' 0 N--CA 1.529 3.486 0 C-N-CA 123.3 0.64 . . . . 0.0 111.446 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.1 t -75.03 -47.89 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.59 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.97 -12.19 59.96 Favored 'General case' 1 N--CA 1.549 4.496 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.707 179.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 706' ' ' ASN . 51.9 tt0 -112.81 -4.15 14.05 Favored 'General case' 0 N--CA 1.518 2.963 0 C-N-CA 125.591 1.556 . . . . 0.0 108.065 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.68 -27.84 50.35 Favored Glycine 0 N--CA 1.509 3.548 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -96.8 153.12 18.07 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 123.677 0.791 . . . . 0.0 109.138 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 50.8 m -80.89 149.32 66.86 Favored Pre-proline 0 N--CA 1.526 3.37 0 C-N-CA 125.965 1.706 . . . . 0.0 111.315 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo . . . . . 0 C--N 1.403 3.43 0 CA-C-N 122.019 1.757 . . . . 0.0 111.059 -177.75 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -61.61 -49.24 77.37 Favored 'General case' 0 N--CA 1.534 3.768 0 CA-C-N 118.394 0.543 . . . . 0.0 112.316 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.14 -37.82 86.65 Favored 'General case' 0 N--CA 1.525 3.325 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.43 -29.39 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.916 0 C-N-CA 125.397 1.479 . . . . 0.0 110.921 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -50.98 60.67 Favored 'General case' 1 N--CA 1.547 4.389 0 C-N-CA 123.601 0.76 . . . . 0.0 111.719 -177.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -30.84 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 124.068 0.947 . . . . 0.0 109.808 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -56.18 -34.49 66.27 Favored 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.58 1.152 . . . . 0.0 110.441 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 24.3 mm -60.43 -37.52 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.581 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.31 -40.02 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.114 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.93 -48.52 87.46 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.28 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.86 -31.37 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.761 0 C-N-CA 123.839 0.855 . . . . 0.0 109.688 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.37 -32.31 83.76 Favored Glycine 1 N--CA 1.516 4.021 0 C-N-CA 123.607 0.622 . . . . 0.0 112.439 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 62.5 m -67.98 -36.9 80.82 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 123.507 0.723 . . . . 0.0 111.971 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 9.0 mp -54.68 -41.75 70.56 Favored 'General case' 0 N--CA 1.537 3.885 0 C-N-CA 123.431 0.692 . . . . 0.0 112.737 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.422 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.2 OUTLIER -60.37 -43.94 94.9 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.297 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -174.975 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -66.43 -28.49 73.75 Favored Glycine 1 N--CA 1.525 4.617 0 O-C-N 121.177 -0.952 . . . . 0.0 111.746 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -62.1 -42.13 98.91 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 124.529 1.131 . . . . 0.0 110.682 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . 0.806 ' HE ' HD11 ' A' ' 693' ' ' ILE . 25.1 mmt180 -52.33 -25.62 10.09 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.33 -37.61 37.48 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.501 0 CA-C-N 120.538 1.517 . . . . 0.0 112.26 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.3 p -54.36 -27.66 17.49 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.128 0 C-N-CA 124.523 1.129 . . . . 0.0 112.063 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -52.08 -25.66 9.23 Favored 'General case' 0 N--CA 1.537 3.89 0 C-N-CA 123.357 0.663 . . . . 0.0 110.104 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.45 68.88 Favored 'General case' 0 N--CA 1.52 3.031 0 C-N-CA 122.72 0.408 . . . . 0.0 110.17 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -69.42 -30.39 45.42 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 8.8 tp -52.53 -35.32 53.14 Favored 'General case' 0 N--CA 1.537 3.881 0 C-N-CA 122.974 0.51 . . . . 0.0 110.71 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 1.6 t -58.74 -46.16 88.05 Favored 'General case' 1 N--CA 1.54 4.045 0 CA-C-N 118.824 0.738 . . . . 0.0 112.081 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 34.5 tp -66.38 -34.77 78.71 Favored 'General case' 1 N--CA 1.542 4.174 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.87 -38.51 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -63.58 -24.04 67.64 Favored 'General case' 0 N--CA 1.522 3.168 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.01 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . 0.468 ' NH2' HH12 ' A' ' 707' ' ' ARG . 17.2 tpt180 -49.56 -47.75 48.95 Favored 'General case' 0 N--CA 1.522 3.149 0 CA-C-O 121.8 0.809 . . . . 0.0 110.438 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 51.3 t -63.14 -37.46 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.712 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.456 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -75.31 -28.06 59.55 Favored 'General case' 0 N--CA 1.531 3.624 0 CA-C-O 121.18 0.514 . . . . 0.0 109.896 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -89.91 -4.87 57.3 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.963 1.305 . . . . 0.0 108.466 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.75 -23.42 29.49 Favored Glycine 1 N--CA 1.523 4.434 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -120.27 141.25 50.16 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 125.33 1.452 . . . . 0.0 107.59 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 68.5 m -82.97 146.61 52.38 Favored Pre-proline 0 N--CA 1.529 3.502 0 CA-C-O 117.285 -1.34 . . . . 0.0 110.157 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo . . . . . 0 C--N 1.395 3.004 0 CA-C-N 121.701 1.643 . . . . 0.0 109.192 -178.157 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.521 3.113 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -65.64 -48.75 71.1 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.813 0.445 . . . . 0.0 111.891 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -64.64 -34.46 78.33 Favored 'General case' 0 N--CA 1.529 3.495 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 93.9 mt -74.86 -24.89 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.946 0 C-N-CA 124.944 1.298 . . . . 0.0 110.662 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -66.18 -53.14 41.06 Favored 'General case' 1 N--CA 1.547 4.423 0 CA-C-N 118.999 0.818 . . . . 0.0 110.529 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.3 tt -66.34 -30.77 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.228 0 C-N-CA 123.873 0.869 . . . . 0.0 109.422 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -53.32 -31.28 43.41 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.926 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 16.5 mm -67.99 -46.93 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.015 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.4 -34.39 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.752 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 79.0 mt -68.33 -44.82 83.42 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.327 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.98 -30.67 45.99 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.44 -42.04 96.09 Favored Glycine 1 N--CA 1.523 4.47 0 C-N-CA 123.88 0.753 . . . . 0.0 112.658 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 70.2 m -67.36 -36.83 82.19 Favored 'General case' 0 N--CA 1.529 3.477 0 CA-C-O 122.232 1.015 . . . . 0.0 109.94 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.67 -41.11 80.89 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 113.306 -1.77 . . . . 0.0 113.037 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . 0.841 HD11 ' HE ' ' A' ' 696' ' ' ARG . 0.6 OUTLIER -68.85 -47.66 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -176.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.22 -25.87 60.68 Favored Glycine 1 N--CA 1.53 4.941 0 CA-C-N 119.62 1.1 . . . . 0.0 112.441 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.07 -42.59 99.7 Favored 'General case' 0 N--CA 1.534 3.773 0 C-N-CA 124.348 1.059 . . . . 0.0 109.237 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -53.94 -26.59 26.25 Favored 'General case' 0 N--CA 1.532 3.674 0 C-N-CA 124.927 1.291 . . . . 0.0 113.88 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 76.1 mt -54.64 -38.3 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 C-N-CA 123.413 0.685 . . . . 0.0 111.699 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.52 -28.91 23.5 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.263 0 C-N-CA 123.643 0.777 . . . . 0.0 112.55 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -52.66 -27.49 17.51 Favored 'General case' 0 N--CA 1.536 3.854 0 C-N-CA 122.978 0.511 . . . . 0.0 110.826 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.63 -33.52 66.37 Favored 'General case' 0 N--CA 1.531 3.597 0 O-C-N 121.877 -0.514 . . . . 0.0 110.259 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.8 -30.95 48.79 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.222 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 7.1 tp -52.83 -33.03 47.51 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.75 0.82 . . . . 0.0 110.441 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 83.4 p -58.08 -46.07 86.08 Favored 'General case' 0 N--CA 1.53 3.531 0 O-C-N 121.766 -0.584 . . . . 0.0 111.572 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.25 -36.09 82.52 Favored 'General case' 1 N--CA 1.544 4.246 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.9 t -68.54 -41.48 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -68.07 -22.91 64.91 Favored 'General case' 0 N--CA 1.514 2.751 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.219 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -49.85 -47.31 51.74 Favored 'General case' 0 N--CA 1.511 2.62 0 CA-C-O 121.932 0.872 . . . . 0.0 109.124 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.4 -40.06 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.416 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.93 -22.9 55.52 Favored 'General case' 0 N--CA 1.534 3.775 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -89.15 -13.52 38.21 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -53.85 -27.33 36.17 Favored Glycine 1 N--CA 1.517 4.076 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -95.34 154.67 17.08 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 124.36 1.064 . . . . 0.0 108.849 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 99.4 p -80.3 149.57 69.32 Favored Pre-proline 0 N--CA 1.529 3.508 0 C-N-CA 126.388 1.875 . . . . 0.0 111.363 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -56.45 131.29 44.85 Favored 'Trans proline' 0 C--N 1.402 3.392 0 CA-C-N 120.918 1.364 . . . . 0.0 110.289 -174.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 N--CA 1.522 3.132 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.442 -179.225 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 N--CA 1.513 2.686 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -66.77 -51.42 56.0 Favored 'General case' 0 N--CA 1.532 3.64 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.95 -32.84 74.75 Favored 'General case' 0 N--CA 1.526 3.373 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 91.4 mt -74.62 -29.84 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.544 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -59.33 -52.78 64.18 Favored 'General case' 1 N--CA 1.555 4.789 0 CA-C-O 122.264 1.03 . . . . 0.0 110.942 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.8 tt -70.37 -32.28 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.715 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.079 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -50.13 -25.03 3.13 Favored 'General case' 0 N--CA 1.53 3.528 0 C-N-CA 123.85 0.86 . . . . 0.0 112.549 -174.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.91 -35.17 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 17.3 pt -64.01 -39.15 84.42 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.416 0 CA-C-N 120.016 1.28 . . . . 0.0 109.62 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.1 -48.73 85.8 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.254 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 50.4 t -67.39 -41.38 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 124.513 1.125 . . . . 0.0 110.03 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.61 90.92 Favored Glycine 1 N--CA 1.522 4.402 0 C-N-CA 125.241 1.4 . . . . 0.0 112.798 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 74.2 m -67.28 -35.26 79.13 Favored 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 124.29 1.036 . . . . 0.0 108.415 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.21 -47.07 86.7 Favored 'General case' 0 N--CA 1.523 3.208 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.768 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.516 HD11 ' HE ' ' B' ' 696' ' ' ARG . 0.0 OUTLIER -70.82 -27.93 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.868 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.39 -29.36 70.12 Favored Glycine 1 N--CA 1.528 4.833 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.7 tt -67.01 -40.12 87.21 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 125.581 1.552 . . . . 0.0 110.36 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . 0.475 ' HE ' HD11 ' C' ' 693' ' ' ILE . 38.4 mmt180 -52.27 -25.42 9.34 Favored 'General case' 0 N--CA 1.531 3.611 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 15.8 tt -54.13 -38.99 40.3 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.172 0 CA-C-N 119.302 0.955 . . . . 0.0 113.096 -175.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 10.3 p -57.33 -30.44 35.55 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.164 0 C-N-CA 123.412 0.685 . . . . 0.0 111.672 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -53.97 -25.25 19.85 Favored 'General case' 0 N--CA 1.537 3.886 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.05 -34.45 63.57 Favored 'General case' 0 N--CA 1.523 3.199 0 O-C-N 122.035 -0.415 . . . . 0.0 109.933 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.47 -32.02 51.43 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.209 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.2 -33.03 51.0 Favored 'General case' 0 N--CA 1.535 3.82 0 C-N-CA 123.811 0.844 . . . . 0.0 110.77 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 68.5 m -58.03 -45.64 86.62 Favored 'General case' 0 N--CA 1.531 3.612 0 O-C-N 121.652 -0.655 . . . . 0.0 110.919 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.04 -34.49 78.56 Favored 'General case' 1 N--CA 1.543 4.19 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 48.0 t -67.63 -39.66 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -67.77 -25.95 65.87 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.372 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -50.05 -41.65 48.16 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.543 0.687 . . . . 0.0 111.173 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 68.1 t -61.68 -38.97 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -76.14 -20.62 57.43 Favored 'General case' 0 N--CA 1.524 3.257 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.503 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -88.66 -12.45 42.41 Favored 'General case' 0 N--CA 1.518 2.956 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -60.2 -13.82 30.01 Favored Glycine 1 N--CA 1.517 4.076 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 177.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -108.56 154.57 21.76 Favored 'General case' 0 N--CA 1.532 3.665 0 C-N-CA 125.06 1.344 . . . . 0.0 109.77 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 48.4 t -80.47 150.13 69.79 Favored Pre-proline 0 N--CA 1.53 3.571 0 C-N-CA 126.107 1.763 . . . . 0.0 110.877 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo . . . . . 0 C--N 1.402 3.359 0 CA-C-N 122.247 1.838 . . . . 0.0 113.221 -172.744 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' B' ' 683' ' ' ARG . 63.7 mt . . . . . 0 N--CA 1.514 2.75 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -59.45 -43.44 93.16 Favored 'General case' 0 N--CA 1.532 3.661 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -72.34 -37.32 68.88 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 93.0 mt -74.82 -25.16 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 C-N-CA 125.029 1.332 . . . . 0.0 111.862 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' B' ' 679' ' ' LEU . 17.4 ttp180 -66.13 -52.24 50.39 Favored 'General case' 1 N--CA 1.549 4.481 0 C-N-CA 124.381 1.072 . . . . 0.0 110.577 -177.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.46 -32.77 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 CA-C-N 113.692 -1.595 . . . . 0.0 108.815 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -54.1 -30.79 49.91 Favored 'General case' 0 N--CA 1.52 3.028 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.276 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 17.9 mm -68.87 -41.85 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.626 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 40.3 mt -71.39 -34.86 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.016 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 50.8 mm -58.7 -40.19 78.7 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.668 0 CA-C-N 119.449 1.022 . . . . 0.0 109.738 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.41 -31.95 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.534 0 C-N-CA 123.704 0.802 . . . . 0.0 110.501 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.32 -32.34 79.37 Favored Glycine 1 N--CA 1.517 4.037 0 C-N-CA 123.404 0.526 . . . . 0.0 112.683 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 58.9 m -67.5 -36.96 82.09 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.719 0.808 . . . . 0.0 111.63 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 9.4 mp -56.55 -45.79 81.05 Favored 'General case' 0 N--CA 1.537 3.907 0 C-N-CA 123.44 0.696 . . . . 0.0 112.681 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.738 HD11 ' HE ' ' C' ' 696' ' ' ARG . 1.0 OUTLIER -62.71 -49.04 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -175.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.9 -25.21 65.62 Favored Glycine 1 N--CA 1.525 4.601 0 CA-C-N 119.628 1.103 . . . . 0.0 113.12 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 4.4 tt -66.74 -41.86 87.18 Favored 'General case' 0 N--CA 1.535 3.797 0 C-N-CA 124.567 1.147 . . . . 0.0 110.639 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . 0.516 ' HE ' HD11 ' A' ' 693' ' ' ILE . 26.7 mmt180 -52.13 -25.26 8.48 Favored 'General case' 0 N--CA 1.536 3.833 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.8 tt -54.14 -36.88 33.64 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 CA-C-N 119.878 1.217 . . . . 0.0 112.066 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.14 -27.97 17.21 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.012 0 C-N-CA 124.332 1.053 . . . . 0.0 111.779 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -52.15 -25.82 9.89 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 123.402 0.681 . . . . 0.0 109.756 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.73 -38.43 69.77 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 122.767 0.427 . . . . 0.0 110.017 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.24 -32.01 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.956 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.42 -36.45 61.53 Favored 'General case' 0 N--CA 1.537 3.897 0 C-N-CA 122.908 0.483 . . . . 0.0 110.809 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 26.5 m -62.11 -47.21 85.63 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.83 -35.92 79.45 Favored 'General case' 1 N--CA 1.545 4.32 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.14 -43.25 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.365 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -71.29 -20.99 62.14 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.876 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -47.73 -46.7 30.03 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 40.1 t -59.35 -41.59 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.389 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -76.69 -22.11 54.43 Favored 'General case' 0 N--CA 1.533 3.678 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.866 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -8.3 36.22 Favored 'General case' 0 N--CA 1.517 2.916 0 C-N-CA 124.925 1.29 . . . . 0.0 108.44 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.12 -32.49 35.71 Favored Glycine 1 N--CA 1.516 4.015 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -100.81 130.99 46.91 Favored 'General case' 0 N--CA 1.529 3.507 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 88.1 p -81.94 146.8 56.52 Favored Pre-proline 0 N--CA 1.527 3.422 0 C-N-CA 124.947 1.299 . . . . 0.0 110.627 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo . . . . . 0 C--N 1.399 3.195 0 CA-C-N 121.334 1.512 . . . . 0.0 109.445 -177.538 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.53 3.568 0 CA-C-O 121.244 0.545 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -69.78 -40.07 76.25 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.217 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -65.68 -37.37 86.3 Favored 'General case' 0 N--CA 1.52 3.046 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.036 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 26.9 pt -73.09 -25.7 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 CA-C-N 118.347 0.521 . . . . 0.0 110.627 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -50.07 70.86 Favored 'General case' 1 N--CA 1.546 4.361 0 C-N-CA 122.806 0.443 . . . . 0.0 110.826 -176.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.48 -31.95 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.564 0 C-N-CA 124.002 0.921 . . . . 0.0 109.7 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -53.9 -41.14 67.28 Favored 'General case' 0 N--CA 1.518 2.969 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.37 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.71 -39.12 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.92 -45.06 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 C-N-CA 123.458 0.703 . . . . 0.0 110.56 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 76.0 mt -59.9 -49.04 85.44 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.42 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.62 -29.65 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.125 0 C-N-CA 125.286 1.434 . . . . 0.0 109.688 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.27 -31.69 81.69 Favored Glycine 1 N--CA 1.519 4.21 0 C-N-CA 123.717 0.675 . . . . 0.0 112.388 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.3 m -68.28 -36.39 79.31 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.962 0.905 . . . . 0.0 111.849 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.27 -35.7 62.83 Favored 'General case' 0 N--CA 1.534 3.755 0 CA-C-O 118.295 -0.859 . . . . 0.0 113.265 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . 0.497 ' O ' HD12 ' C' ' 693' ' ' ILE 0.255 0.1 OUTLIER -60.53 -49.98 82.22 Favored 'Isoleucine or valine' 1 N--CA 1.561 5.121 0 CA-C-N 120.272 1.397 . . . . 0.0 112.455 -176.164 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.17 -29.22 68.02 Favored Glycine 1 N--CA 1.532 5.054 0 CA-C-N 119.452 1.024 . . . . 0.0 111.69 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.59 -42.41 98.28 Favored 'General case' 0 N--CA 1.538 3.939 0 C-N-CA 123.653 0.781 . . . . 0.0 109.836 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . 0.738 ' HE ' HD11 ' B' ' 693' ' ' ILE . 24.4 mmt180 -53.82 -25.2 18.28 Favored 'General case' 1 N--CA 1.542 4.164 0 C-N-CA 124.673 1.189 . . . . 0.0 113.82 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 70.6 mt -54.94 -39.78 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 O-C-N 121.625 -0.672 . . . . 0.0 110.454 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.36 -30.97 50.85 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.405 0 C-N-CA 123.859 0.864 . . . . 0.0 110.875 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.56 -30.15 65.01 Favored 'General case' 1 N--CA 1.542 4.143 0 O-C-N 121.055 -1.028 . . . . 0.0 111.689 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.98 -37.59 72.73 Favored 'General case' 1 N--CA 1.54 4.025 0 CA-C-O 121.8 0.809 . . . . 0.0 109.104 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.36 -28.05 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.277 0 C-N-CA 125.066 1.346 . . . . 0.0 108.678 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.1 tp -52.25 -32.66 38.11 Favored 'General case' 0 N--CA 1.532 3.643 0 C-N-CA 123.53 0.732 . . . . 0.0 110.108 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 89.1 p -56.56 -46.13 80.87 Favored 'General case' 0 N--CA 1.53 3.553 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 46.5 tp -66.04 -35.11 79.65 Favored 'General case' 1 N--CA 1.547 4.384 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.03 -40.02 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.0 OUTLIER -71.92 -23.73 61.52 Favored 'General case' 0 N--CA 1.517 2.902 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.225 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -48.47 -32.04 7.24 Favored 'General case' 0 N--CA 1.526 3.357 0 CA-C-N 118.832 0.742 . . . . 0.0 110.499 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.74 -49.07 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -77.84 -10.26 59.47 Favored 'General case' 1 N--CA 1.54 4.06 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.701 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.6 tt0 -114.14 -9.28 12.93 Favored 'General case' 0 N--CA 1.522 3.145 0 C-N-CA 125.365 1.466 . . . . 0.0 108.759 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -57.58 -30.04 61.74 Favored Glycine 0 N--CA 1.512 3.712 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -80.76 155.13 26.84 Favored 'General case' 0 N--CA 1.524 3.269 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 97.0 p -79.49 149.15 71.39 Favored Pre-proline 0 N--CA 1.528 3.469 0 C-N-CA 126.281 1.832 . . . . 0.0 111.757 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -56.87 131.86 48.11 Favored 'Trans proline' 0 C--N 1.401 3.316 0 CA-C-N 120.669 1.274 . . . . 0.0 111.001 -174.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 N--CA 1.527 3.376 0 C-N-CA 125.616 1.566 . . . . 0.0 110.72 178.739 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 680' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . 0.406 ' N ' HD12 ' A' ' 679' ' ' LEU . 95.1 m95 -57.3 -51.1 70.72 Favored 'General case' 0 N--CA 1.533 3.689 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -64.88 -31.28 72.44 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.53 -33.59 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.966 0 C-N-CA 123.879 0.872 . . . . 0.0 108.664 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -51.79 42.42 Favored 'General case' 1 N--CA 1.554 4.748 0 CA-C-N 118.48 0.582 . . . . 0.0 112.11 -177.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.39 -38.23 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 CA-C-O 122.496 1.141 . . . . 0.0 110.184 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -52.39 -29.29 23.36 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 113.111 -1.858 . . . . 0.0 111.113 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 28.5 mm -68.46 -37.23 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 C-N-CA 124.244 1.018 . . . . 0.0 109.602 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 37.5 mt -64.9 -38.27 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.268 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.53 -41.72 93.66 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.27 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.76 -30.51 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 C-N-CA 123.965 0.906 . . . . 0.0 109.185 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.16 -34.29 89.26 Favored Glycine 1 N--CA 1.518 4.159 0 C-N-CA 123.382 0.515 . . . . 0.0 111.985 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.5 m -68.67 -37.51 79.66 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.562 0.745 . . . . 0.0 111.172 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.9 mp -57.54 -42.54 83.15 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 123.751 0.82 . . . . 0.0 112.328 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.77 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.274 0.5 OUTLIER -62.44 -48.91 86.09 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.308 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.231 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.44 -30.29 67.91 Favored Glycine 1 N--CA 1.53 4.954 0 CA-C-N 119.814 1.188 . . . . 0.0 112.899 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.94 -41.47 99.51 Favored 'General case' 1 N--CA 1.539 4.013 0 C-N-CA 124.411 1.084 . . . . 0.0 111.234 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -51.71 -24.28 5.55 Favored 'General case' 0 N--CA 1.538 3.933 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 18.5 tt -52.7 -36.03 22.22 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.26 0 CA-C-N 120.143 1.338 . . . . 0.0 111.684 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 12.6 p -54.09 -28.19 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.951 0 C-N-CA 124.304 1.042 . . . . 0.0 111.43 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -55.9 -29.08 59.44 Favored 'General case' 1 N--CA 1.544 4.256 0 O-C-N 121.489 -0.757 . . . . 0.0 109.764 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.7 -43.08 69.72 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 63.0 t -68.87 -33.34 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.112 0 C-N-CA 124.713 1.205 . . . . 0.0 109.105 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.13 -32.62 62.22 Favored 'General case' 0 N--CA 1.535 3.817 0 C-N-CA 124.175 0.99 . . . . 0.0 109.901 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.5 p -59.04 -45.14 91.48 Favored 'General case' 0 N--CA 1.528 3.426 0 O-C-N 121.353 -0.842 . . . . 0.0 111.253 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.21 -33.35 74.39 Favored 'General case' 1 N--CA 1.542 4.152 0 O-C-N 121.431 -0.793 . . . . 0.0 108.959 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.18 -39.22 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.873 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . 0.438 ' ND2' HH11 ' A' ' 709' ' ' ARG . 9.3 m120 -62.71 -22.8 66.78 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.693 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -50.38 -41.34 51.72 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-O 121.915 0.864 . . . . 0.0 110.012 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 64.1 t -62.96 -36.68 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . 0.438 HH11 ' ND2' ' A' ' 706' ' ' ASN . 50.6 mtm180 -75.7 -3.86 37.1 Favored 'General case' 0 N--CA 1.523 3.195 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.46 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -103.26 -14.9 16.15 Favored 'General case' 1 N--CA 1.552 4.662 0 C-N-CA 123.685 0.794 . . . . 0.0 108.921 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -81.94 -6.65 88.77 Favored Glycine 1 N--CA 1.528 4.82 0 N-CA-C 106.736 -2.546 . . . . 0.0 106.736 173.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -105.47 154.29 20.54 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 128.036 2.534 . . . . 0.0 106.611 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 32.1 t -98.13 147.3 32.89 Favored Pre-proline 1 N--CA 1.556 4.831 0 C-N-CA 125.422 1.489 . . . . 0.0 112.997 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 C--N 1.408 3.668 0 CA-C-N 121.212 1.468 . . . . 0.0 109.048 -176.75 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.516 2.853 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -70.98 -49.79 41.42 Favored 'General case' 0 N--CA 1.535 3.791 0 CA-C-O 121.155 0.503 . . . . 0.0 111.576 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -61.05 -31.42 71.07 Favored 'General case' 0 N--CA 1.533 3.688 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.98 -25.55 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.786 0 C-N-CA 125.913 1.685 . . . . 0.0 111.021 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . 0.404 HH11 HD12 ' B' ' 687' ' ' ILE . 0.6 OUTLIER -66.07 -52.29 50.24 Favored 'General case' 1 N--CA 1.547 4.386 0 CA-C-O 121.574 0.702 . . . . 0.0 111.409 -177.964 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.8 tt -68.0 -32.34 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.171 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.594 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -54.27 -30.49 50.75 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 123.827 0.851 . . . . 0.0 111.213 -177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 16.1 mm -66.21 -37.69 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.937 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . 0.404 HD12 HH11 ' B' ' 683' ' ' ARG . 38.5 mt -62.3 -38.37 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.1 -46.53 93.41 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.361 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.4 t -62.04 -30.04 47.79 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.26 -31.73 81.82 Favored Glycine 1 N--CA 1.519 4.223 0 C-N-CA 123.562 0.601 . . . . 0.0 112.455 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 61.4 m -68.58 -36.92 79.41 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.658 0.783 . . . . 0.0 111.367 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.56 -43.19 79.73 Favored 'General case' 0 N--CA 1.536 3.868 0 C-N-CA 123.713 0.805 . . . . 0.0 112.52 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.801 HD11 ' HE ' ' C' ' 696' ' ' ARG 0.281 0.6 OUTLIER -60.42 -48.97 86.16 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.621 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.091 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.77 -26.95 71.43 Favored Glycine 1 N--CA 1.533 5.121 0 CA-C-N 120.734 1.606 . . . . 0.0 112.373 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 5.3 tt -62.95 -43.05 99.86 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.806 0.843 . . . . 0.0 110.955 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . 0.77 ' HE ' HD11 ' A' ' 693' ' ' ILE . 26.0 mmt180 -53.14 -27.12 19.38 Favored 'General case' 1 N--CA 1.539 4.003 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 70.9 mt -54.74 -37.95 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.51 0 C-N-CA 123.954 0.902 . . . . 0.0 111.794 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.11 -31.61 42.11 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.301 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -54.23 -25.76 24.88 Favored 'General case' 0 N--CA 1.539 3.988 0 CA-C-N 118.793 0.724 . . . . 0.0 111.207 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.1 -37.78 69.85 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 121.65 -0.656 . . . . 0.0 110.248 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.22 -32.59 54.38 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 13.4 tp -54.87 -35.32 63.93 Favored 'General case' 0 N--CA 1.533 3.689 0 C-N-CA 123.154 0.581 . . . . 0.0 110.498 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 80.8 p -59.01 -48.41 81.67 Favored 'General case' 0 N--CA 1.521 3.119 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.22 -35.09 79.16 Favored 'General case' 1 N--CA 1.549 4.517 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.647 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.53 -38.78 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' B' ' 710' ' ' GLN . 2.2 p30 -62.24 -25.81 68.03 Favored 'General case' 0 N--CA 1.521 3.084 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.625 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 18.6 tpt85 -46.82 -32.56 3.78 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.617 0.767 . . . . 0.0 111.362 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 63.3 t -75.53 -48.8 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.36 -11.03 59.92 Favored 'General case' 1 N--CA 1.543 4.182 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.839 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' B' ' 706' ' ' ASN . 28.2 tt0 -113.63 -10.64 13.09 Favored 'General case' 0 N--CA 1.519 3.018 0 C-N-CA 125.929 1.692 . . . . 0.0 108.556 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.74 -24.43 32.92 Favored Glycine 0 N--CA 1.51 3.608 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -95.48 152.82 18.08 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 123.461 0.705 . . . . 0.0 109.226 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 48.7 m -81.31 150.76 68.26 Favored Pre-proline 0 N--CA 1.533 3.686 0 C-N-CA 126.264 1.826 . . . . 0.0 111.267 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 C--N 1.402 3.382 0 CA-C-N 121.984 1.744 . . . . 0.0 112.33 -175.509 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.521 3.117 0 CA-C-O 121.425 0.631 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -70.15 -45.38 66.9 Favored 'General case' 0 N--CA 1.513 2.72 0 C-N-CA 124.809 1.244 . . . . 0.0 111.204 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -61.74 -38.78 89.22 Favored 'General case' 0 N--CA 1.518 2.939 0 CA-C-N 113.978 -1.464 . . . . 0.0 111.659 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 26.5 pt -72.45 -36.6 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 C-N-CA 122.671 0.388 . . . . 0.0 111.01 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -52.86 -51.23 61.78 Favored 'General case' 0 N--CA 1.539 3.98 0 CA-C-O 121.7 0.762 . . . . 0.0 111.625 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.23 -34.48 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.828 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -55.54 -43.74 76.07 Favored 'General case' 0 N--CA 1.537 3.891 0 C-N-CA 123.618 0.767 . . . . 0.0 109.523 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.51 -37.76 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.814 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 41.5 mt -71.08 -41.99 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 49.1 mm -59.68 -48.79 86.15 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.472 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 70.8 t -60.73 -30.22 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 C-N-CA 124.136 0.975 . . . . 0.0 109.737 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.27 91.87 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 123.307 0.479 . . . . 0.0 112.488 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 66.7 m -67.5 -37.07 82.28 Favored 'General case' 0 N--CA 1.528 3.472 0 C-N-CA 123.768 0.827 . . . . 0.0 112.041 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.73 -39.9 68.73 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 123.434 0.694 . . . . 0.0 112.312 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -40.85 86.28 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.07 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -174.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -71.71 -27.38 71.04 Favored Glycine 1 N--CA 1.527 4.721 0 O-C-N 121.173 -0.954 . . . . 0.0 110.973 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.48 -42.59 99.01 Favored 'General case' 0 N--CA 1.531 3.581 0 C-N-CA 124.176 0.99 . . . . 0.0 109.651 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . 0.801 ' HE ' HD11 ' B' ' 693' ' ' ILE . 25.5 mmt180 -53.96 -26.46 25.83 Favored 'General case' 0 N--CA 1.537 3.896 0 C-N-CA 124.471 1.109 . . . . 0.0 113.846 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 73.9 mt -54.62 -38.59 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 C-N-CA 123.578 0.751 . . . . 0.0 111.342 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 5.8 p -56.01 -27.33 22.82 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.324 0 C-N-CA 124.074 0.95 . . . . 0.0 112.281 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -51.73 -27.33 11.62 Favored 'General case' 0 N--CA 1.538 3.964 0 C-N-CA 123.311 0.645 . . . . 0.0 111.179 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.3 -34.11 66.19 Favored 'General case' 0 N--CA 1.532 3.649 0 O-C-N 121.857 -0.527 . . . . 0.0 109.952 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.1 m -69.36 -31.82 50.99 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.093 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 6.9 tp -53.5 -35.67 60.89 Favored 'General case' 0 N--CA 1.538 3.959 0 C-N-CA 123.293 0.637 . . . . 0.0 110.373 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 88.8 p -61.32 -47.8 84.28 Favored 'General case' 0 N--CA 1.516 2.867 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 45.9 tp -67.71 -35.52 78.95 Favored 'General case' 1 N--CA 1.546 4.331 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 74.7 t -69.04 -46.09 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -76.03 -23.36 55.15 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 123.515 0.51 . . . . 0.0 110.799 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -46.15 62.58 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.03 -43.23 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.891 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.682 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -75.96 -5.85 48.19 Favored 'General case' 0 N--CA 1.538 3.933 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.404 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -113.02 -12.67 13.19 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 125.619 1.568 . . . . 0.0 107.934 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.16 -33.8 31.08 Favored Glycine 0 N--CA 1.513 3.807 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -82.66 153.83 25.2 Favored 'General case' 0 N--CA 1.526 3.327 0 CA-C-N 114.201 -1.0 . . . . 0.0 108.626 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 59.8 m -80.2 149.23 69.08 Favored Pre-proline 0 N--CA 1.531 3.612 0 C-N-CA 126.201 1.8 . . . . 0.0 111.274 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -56.21 130.03 38.01 Favored 'Trans proline' 0 C--N 1.402 3.36 0 CA-C-N 121.175 1.455 . . . . 0.0 110.792 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 N--CA 1.524 3.273 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.56 -179.941 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 28.2 tp . . . . . 0 N--CA 1.514 2.752 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -64.69 -36.24 83.65 Favored 'General case' 0 N--CA 1.528 3.436 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -72.54 -36.64 68.32 Favored 'General case' 0 N--CA 1.533 3.68 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.33 -24.46 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 C-N-CA 124.725 1.21 . . . . 0.0 109.882 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -67.14 -53.44 30.62 Favored 'General case' 1 N--CA 1.554 4.75 0 CA-C-N 119.488 1.04 . . . . 0.0 112.334 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.11 -32.01 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 C-N-CA 124.234 1.014 . . . . 0.0 109.727 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -56.82 -32.28 65.57 Favored 'General case' 0 N--CA 1.508 2.474 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.234 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 24.2 mm -68.33 -46.02 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 C-N-CA 124.172 0.989 . . . . 0.0 109.344 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.64 -35.95 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.178 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.301 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.67 -48.13 90.13 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.215 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.36 -31.36 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.533 0.733 . . . . 0.0 109.83 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.27 -50.44 65.0 Favored Glycine 1 N--CA 1.52 4.261 0 C-N-CA 124.082 0.849 . . . . 0.0 112.494 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.2 m -58.66 -35.37 72.45 Favored 'General case' 0 N--CA 1.533 3.719 0 C-N-CA 124.475 1.11 . . . . 0.0 111.015 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 2.1 tp -53.81 -34.82 60.38 Favored 'General case' 0 N--CA 1.512 2.636 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.127 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.408 ' O ' HD13 ' A' ' 693' ' ' ILE . 0.3 OUTLIER -60.45 -38.96 79.66 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -177.088 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -72.87 -29.89 64.42 Favored Glycine 1 N--CA 1.519 4.232 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.2 tt -59.75 -42.47 93.29 Favored 'General case' 1 N--CA 1.541 4.076 0 C-N-CA 124.496 1.118 . . . . 0.0 110.944 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -51.31 -24.7 4.86 Favored 'General case' 0 N--CA 1.527 3.398 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 10.1 tp -53.05 -37.61 27.2 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.671 0 CA-C-N 119.837 1.199 . . . . 0.0 112.689 -176.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.18 -28.11 17.5 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.444 0 C-N-CA 124.222 1.009 . . . . 0.0 110.981 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -56.04 -27.65 54.13 Favored 'General case' 0 N--CA 1.536 3.833 0 O-C-N 121.506 -0.747 . . . . 0.0 110.008 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -66.98 -44.55 80.15 Favored 'General case' 0 N--CA 1.526 3.336 0 CA-C-O 122.18 0.99 . . . . 0.0 108.645 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 84.2 t -68.77 -33.72 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.173 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.36 -33.93 63.84 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 123.506 0.723 . . . . 0.0 110.161 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 86.0 p -58.08 -46.27 85.75 Favored 'General case' 0 N--CA 1.53 3.537 0 O-C-N 121.788 -0.57 . . . . 0.0 111.985 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.54 -35.85 82.32 Favored 'General case' 1 N--CA 1.542 4.175 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.78 -39.9 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . 0.633 HD22 ' HE ' ' A' ' 709' ' ' ARG . 3.9 m120 -66.19 -24.29 66.6 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.314 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -49.55 -46.67 49.01 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 124.027 0.931 . . . . 0.0 110.48 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.65 -50.85 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.482 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . 0.633 ' HE ' HD22 ' A' ' 706' ' ' ASN . 34.1 ptt180 -80.66 -3.45 50.63 Favored 'General case' 1 N--CA 1.55 4.536 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 178.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -111.57 -13.25 13.84 Favored 'General case' 0 N--CA 1.539 3.999 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.74 -31.19 53.54 Favored Glycine 0 N--CA 1.514 3.866 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -80.24 155.09 27.5 Favored 'General case' 0 N--CA 1.521 3.079 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 67.8 m -79.4 149.68 72.5 Favored Pre-proline 0 N--CA 1.532 3.629 0 C-N-CA 126.307 1.843 . . . . 0.0 112.111 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.402 3.391 0 CA-C-N 120.614 1.255 . . . . 0.0 110.817 -174.056 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.528 3.464 0 CA-C-O 120.987 0.422 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -69.93 -36.16 75.12 Favored 'General case' 0 N--CA 1.522 3.136 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.451 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -40.73 76.76 Favored 'General case' 0 N--CA 1.531 3.586 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.893 -176.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . 0.534 HD12 ' N ' ' B' ' 683' ' ' ARG . 2.0 pp -72.19 -25.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 CA-C-N 118.701 0.682 . . . . 0.0 110.905 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . 0.534 ' N ' HD12 ' B' ' 682' ' ' ILE . 0.0 OUTLIER -67.05 -52.7 38.98 Favored 'General case' 1 N--CA 1.539 4.008 0 C-N-CA 123.988 0.915 . . . . 0.0 112.34 -177.739 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.4 tt -70.93 -30.16 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 123.833 0.853 . . . . 0.0 110.752 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -36.36 24.77 Favored 'General case' 0 N--CA 1.524 3.227 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.239 -173.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . 0.462 ' N ' HD12 ' B' ' 686' ' ' ILE . 1.5 mp -69.48 -37.55 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.311 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 34.4 mt -58.87 -35.04 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 35.8 mm -66.65 -46.7 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.28 -31.14 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 C-N-CA 123.85 0.86 . . . . 0.0 108.843 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.2 94.05 Favored Glycine 1 N--CA 1.523 4.436 0 C-N-CA 123.808 0.718 . . . . 0.0 111.817 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 71.1 m -69.09 -41.04 78.03 Favored 'General case' 0 N--CA 1.518 2.957 0 C-N-CA 123.563 0.745 . . . . 0.0 110.765 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.42 -45.91 88.8 Favored 'General case' 0 N--CA 1.535 3.806 0 C-N-CA 123.484 0.714 . . . . 0.0 112.614 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.683 HD11 ' HE ' ' C' ' 696' ' ' ARG . 0.0 OUTLIER -64.5 -34.98 73.13 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.719 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.1 -28.84 71.1 Favored Glycine 1 N--CA 1.527 4.721 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.3 tt -65.06 -43.52 91.97 Favored 'General case' 0 N--CA 1.531 3.614 0 C-N-CA 124.375 1.07 . . . . 0.0 109.808 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -54.96 -26.33 35.74 Favored 'General case' 0 N--CA 1.537 3.895 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 64.3 mt -55.18 -39.2 50.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 C-N-CA 123.236 0.614 . . . . 0.0 112.147 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.63 -28.64 23.56 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.51 0 C-N-CA 123.672 0.789 . . . . 0.0 112.468 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -51.77 -26.16 9.07 Favored 'General case' 0 N--CA 1.531 3.613 0 C-N-CA 123.2 0.6 . . . . 0.0 111.304 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.33 -32.33 62.42 Favored 'General case' 0 N--CA 1.53 3.569 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.8 m -69.26 -31.18 48.75 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.212 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 4.4 tp -53.46 -32.51 50.34 Favored 'General case' 0 N--CA 1.538 3.943 0 C-N-CA 123.671 0.789 . . . . 0.0 110.556 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 67.9 p -57.41 -45.33 84.69 Favored 'General case' 0 N--CA 1.532 3.642 0 O-C-N 121.759 -0.588 . . . . 0.0 111.019 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.11 -35.11 79.69 Favored 'General case' 1 N--CA 1.539 4.023 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.77 -40.0 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -63.47 -21.8 66.52 Favored 'General case' 0 N--CA 1.519 3.025 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.631 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -47.42 -47.55 26.63 Favored 'General case' 0 N--CA 1.519 3.022 0 C-N-CA 123.335 0.654 . . . . 0.0 109.495 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 52.7 t -58.95 -42.85 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.18 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -77.21 -15.51 59.46 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.681 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.5 -14.44 23.68 Favored 'General case' 1 N--CA 1.553 4.676 0 C-N-CA 124.123 0.969 . . . . 0.0 109.865 -177.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -87.72 -26.43 29.65 Favored Glycine 1 N--CA 1.523 4.438 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -75.59 146.95 39.99 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 126.01 1.724 . . . . 0.0 108.567 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 50.9 m -88.43 149.55 44.78 Favored Pre-proline 0 N--CA 1.537 3.922 0 C-N-CA 125.637 1.575 . . . . 0.0 113.266 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 C--N 1.402 3.359 0 CA-C-N 121.513 1.576 . . . . 0.0 111.983 -178.014 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.526 3.359 0 CA-C-O 120.926 0.393 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -68.13 -39.26 82.75 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.42 0.688 . . . . 0.0 111.429 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -68.82 -38.61 80.0 Favored 'General case' 0 N--CA 1.521 3.082 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.082 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 11.5 pt -73.24 -38.96 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -45.32 62.23 Favored 'General case' 0 N--CA 1.534 3.739 0 C-N-CA 123.237 0.615 . . . . 0.0 111.276 -176.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.7 tt -74.38 -34.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.939 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -60.31 -38.59 84.15 Favored 'General case' 0 N--CA 1.536 3.837 0 C-N-CA 124.018 0.927 . . . . 0.0 109.593 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.3 -37.05 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.081 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.377 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 8.2 mm -67.15 -43.44 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 41.4 mm -59.15 -49.14 84.43 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.359 0 CA-C-O 120.581 0.229 . . . . 0.0 110.529 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.23 -31.33 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -68.66 -36.5 83.05 Favored Glycine 0 N--CA 1.51 3.605 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.462 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 65.3 m -68.15 -36.77 80.2 Favored 'General case' 0 N--CA 1.529 3.497 0 CA-C-O 121.935 0.874 . . . . 0.0 110.006 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.17 -45.88 75.75 Favored 'General case' 0 N--CA 1.521 3.114 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.683 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . 0.54 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.1 OUTLIER -70.15 -35.98 65.91 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.056 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -176.676 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -75.12 -16.42 80.6 Favored Glycine 1 N--CA 1.522 4.417 0 O-C-N 121.648 -0.658 . . . . 0.0 111.72 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.25 -41.72 85.15 Favored 'General case' 0 N--CA 1.538 3.956 0 C-N-CA 124.489 1.116 . . . . 0.0 108.491 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . 0.683 ' HE ' HD11 ' B' ' 693' ' ' ILE . 32.0 mmt180 -52.12 -23.61 5.67 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 125.286 1.435 . . . . 0.0 114.362 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 11.0 tp -54.33 -38.51 40.38 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.431 0 CA-C-N 119.052 0.842 . . . . 0.0 112.777 -177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.89 -29.45 21.66 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.177 0 C-N-CA 124.356 1.063 . . . . 0.0 112.353 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -53.04 -25.05 11.17 Favored 'General case' 0 N--CA 1.533 3.694 0 C-N-CA 123.375 0.67 . . . . 0.0 110.086 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.15 70.53 Favored 'General case' 0 N--CA 1.523 3.195 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.35 -32.08 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.64 -34.77 59.7 Favored 'General case' 0 N--CA 1.537 3.88 0 C-N-CA 122.923 0.489 . . . . 0.0 110.314 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 58.9 m -59.28 -47.03 86.92 Favored 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 36.7 tp -66.62 -34.73 78.54 Favored 'General case' 1 N--CA 1.549 4.486 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.76 -38.39 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.371 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.95 -23.31 63.46 Favored 'General case' 0 N--CA 1.521 3.088 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.186 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -48.03 -46.06 32.68 Favored 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 121.873 0.844 . . . . 0.0 110.554 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.09 -43.45 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -77.12 -9.57 58.83 Favored 'General case' 0 N--CA 1.531 3.595 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.439 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -89.63 -15.48 32.62 Favored 'General case' 1 N--CA 1.547 4.376 0 C-N-CA 123.53 0.732 . . . . 0.0 109.782 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -71.6 -6.55 62.84 Favored Glycine 1 N--CA 1.524 4.547 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -75.97 155.14 35.31 Favored 'General case' 0 N--CA 1.512 2.632 0 C-N-CA 125.451 1.5 . . . . 0.0 109.027 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 95.9 p -100.48 146.96 32.91 Favored Pre-proline 0 N--CA 1.53 3.55 0 C-N-CA 125.357 1.463 . . . . 0.0 108.725 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -63.75 130.27 27.36 Favored 'Trans proline' 0 N--CA 1.521 3.105 0 CA-C-N 121.493 1.569 . . . . 0.0 109.061 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.525 3.307 0 C-N-CA 125.312 1.445 . . . . 0.0 109.926 -178.904 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.515 2.821 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -68.72 -50.43 50.81 Favored 'General case' 0 N--CA 1.529 3.513 0 CA-C-O 121.406 0.622 . . . . 0.0 111.989 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -61.5 -34.66 75.88 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.4 -24.95 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 C-N-CA 125.357 1.463 . . . . 0.0 110.074 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -66.79 -54.75 19.42 Favored 'General case' 1 N--CA 1.559 5.012 0 CA-C-N 119.592 1.087 . . . . 0.0 110.523 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.38 -30.78 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.945 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -55.26 -31.67 61.73 Favored 'General case' 0 N--CA 1.513 2.679 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.764 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 20.4 mm -64.11 -46.04 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.073 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 48.3 mt -56.93 -36.32 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.47 -45.3 85.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.13 -30.21 49.13 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.42 -32.79 85.37 Favored Glycine 1 N--CA 1.518 4.123 0 C-N-CA 123.596 0.617 . . . . 0.0 112.059 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 69.0 m -68.17 -36.95 80.44 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.558 0.743 . . . . 0.0 111.329 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.13 -44.16 83.09 Favored 'General case' 0 N--CA 1.538 3.962 0 C-N-CA 123.518 0.727 . . . . 0.0 112.363 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.533 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.257 0.5 OUTLIER -61.4 -49.69 83.45 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.293 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -175.587 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.34 -24.47 67.51 Favored Glycine 1 N--CA 1.527 4.741 0 CA-C-N 119.877 1.217 . . . . 0.0 112.721 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.5 tt -65.03 -43.27 92.94 Favored 'General case' 0 N--CA 1.535 3.816 0 C-N-CA 123.68 0.792 . . . . 0.0 109.715 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -53.39 -27.29 23.26 Favored 'General case' 1 N--CA 1.54 4.048 0 C-N-CA 124.199 1.0 . . . . 0.0 113.228 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.08 -38.21 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 C-N-CA 123.463 0.705 . . . . 0.0 110.36 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 2.0 p -55.71 -26.29 19.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.129 0 C-N-CA 124.566 1.146 . . . . 0.0 111.725 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -51.89 -26.02 9.28 Favored 'General case' 0 N--CA 1.539 3.995 0 C-N-CA 123.25 0.62 . . . . 0.0 110.777 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.69 -44.48 81.53 Favored 'General case' 0 N--CA 1.528 3.45 0 O-C-N 121.868 -0.52 . . . . 0.0 110.503 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 3.0 m -70.3 -33.49 54.46 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.433 0 CA-C-N 118.8 0.727 . . . . 0.0 109.969 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 4.7 tp -54.97 -33.21 62.2 Favored 'General case' 0 N--CA 1.537 3.885 0 C-N-CA 123.626 0.77 . . . . 0.0 109.857 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 96.0 p -59.36 -48.14 82.75 Favored 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 36.3 tp -63.94 -34.05 77.09 Favored 'General case' 1 N--CA 1.548 4.46 0 O-C-N 121.205 -0.935 . . . . 0.0 108.599 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.72 -38.34 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -61.47 -28.24 69.14 Favored 'General case' 0 N--CA 1.536 3.83 0 C-N-CA 122.92 0.488 . . . . 0.0 110.32 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -49.21 -47.52 46.08 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 121.714 0.769 . . . . 0.0 109.143 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.48 -36.3 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.666 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.1 -27.79 60.02 Favored 'General case' 0 N--CA 1.532 3.672 0 CA-C-O 120.925 0.393 . . . . 0.0 110.047 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -90.14 -13.47 35.63 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 124.623 1.169 . . . . 0.0 109.184 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.8 -25.64 9.69 Favored Glycine 1 N--CA 1.521 4.349 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -115.9 151.37 35.46 Favored 'General case' 0 N--CA 1.533 3.715 0 C-N-CA 124.573 1.149 . . . . 0.0 108.801 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 69.4 m -82.79 147.26 54.57 Favored Pre-proline 0 N--CA 1.528 3.442 0 C-N-CA 125.408 1.483 . . . . 0.0 109.694 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 C--N 1.396 3.067 0 CA-C-N 121.805 1.68 . . . . 0.0 110.03 -176.799 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.8 tt . . . . . 0 N--CA 1.514 2.759 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -68.32 -48.21 65.51 Favored 'General case' 0 N--CA 1.528 3.432 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -62.32 -31.96 72.65 Favored 'General case' 0 N--CA 1.536 3.872 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.05 -25.24 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.029 0 C-N-CA 125.628 1.571 . . . . 0.0 111.007 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -52.32 59.23 Favored 'General case' 1 N--CA 1.55 4.537 0 CA-C-N 118.677 0.672 . . . . 0.0 110.475 -178.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 18.5 tt -71.21 -30.29 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.664 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -51.06 -36.56 40.52 Favored 'General case' 0 N--CA 1.525 3.296 0 CA-C-O 121.64 0.733 . . . . 0.0 111.819 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.67 -36.73 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 C-N-CA 125.196 1.399 . . . . 0.0 109.677 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 18.1 mm -61.56 -41.08 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.8 -44.5 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.85 -30.7 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.799 0 C-N-CA 123.566 0.746 . . . . 0.0 109.087 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.66 -32.48 83.24 Favored Glycine 1 N--CA 1.52 4.271 0 C-N-CA 123.399 0.523 . . . . 0.0 112.114 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.6 m -68.18 -37.13 80.64 Favored 'General case' 0 N--CA 1.524 3.236 0 C-N-CA 123.597 0.759 . . . . 0.0 111.175 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.35 -44.19 84.11 Favored 'General case' 0 N--CA 1.539 3.996 0 C-N-CA 123.674 0.79 . . . . 0.0 112.391 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.451 ' CD1' ' HE ' ' C' ' 696' ' ' ARG 0.291 0.1 OUTLIER -67.22 -48.25 78.98 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.48 0 C-N-CA 123.036 0.534 . . . . 0.0 110.478 -176.292 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -54.89 -34.77 57.68 Favored Glycine 1 N--CA 1.53 4.945 0 O-C-N 121.379 -0.826 . . . . 0.0 112.416 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 9.5 tt -72.45 -40.41 67.06 Favored 'General case' 0 N--CA 1.534 3.768 0 C-N-CA 125.159 1.383 . . . . 0.0 109.859 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . 0.533 ' HE ' HD11 ' A' ' 693' ' ' ILE . 11.7 tpp180 -51.64 -24.5 5.64 Favored 'General case' 0 N--CA 1.531 3.597 0 C-N-CA 126.317 1.847 . . . . 0.0 113.823 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.21 -35.63 30.35 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 C-N-CA 123.789 0.836 . . . . 0.0 112.273 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -52.97 -27.49 12.97 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 C-N-CA 124.503 1.121 . . . . 0.0 111.903 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -52.38 -25.52 10.05 Favored 'General case' 0 N--CA 1.539 3.981 0 C-N-CA 123.635 0.774 . . . . 0.0 109.909 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -57.5 -37.52 73.09 Favored 'General case' 0 N--CA 1.524 3.261 0 O-C-N 121.53 -0.731 . . . . 0.0 109.882 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.47 -33.17 55.99 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.349 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.16 -32.93 50.29 Favored 'General case' 1 N--CA 1.546 4.326 0 C-N-CA 124.303 1.041 . . . . 0.0 109.603 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 69.3 m -59.41 -45.35 91.76 Favored 'General case' 1 N--CA 1.543 4.215 0 O-C-N 120.207 -1.558 . . . . 0.0 111.088 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.71 -35.04 78.43 Favored 'General case' 1 N--CA 1.552 4.665 0 O-C-N 121.071 -1.018 . . . . 0.0 108.987 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.73 -38.5 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.469 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -55.02 -35.64 64.63 Favored 'General case' 0 N--CA 1.529 3.5 0 CA-C-O 121.258 0.552 . . . . 0.0 109.8 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -54.09 -47.44 71.73 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 122.367 1.08 . . . . 0.0 109.802 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.65 -32.05 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -77.52 -18.35 57.11 Favored 'General case' 0 N--CA 1.531 3.616 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.03 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -87.33 -14.97 39.29 Favored 'General case' 1 N--CA 1.552 4.633 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.85 -24.11 32.63 Favored Glycine 1 N--CA 1.521 4.313 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -121.53 152.95 38.63 Favored 'General case' 1 N--CA 1.542 4.135 0 C-N-CA 125.158 1.383 . . . . 0.0 110.408 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 92.4 p -82.7 148.7 58.59 Favored Pre-proline 0 N--CA 1.534 3.734 0 C-N-CA 126.344 1.857 . . . . 0.0 111.292 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 N--CA 1.527 3.466 0 CA-C-N 121.411 1.54 . . . . 0.0 111.632 -174.669 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.687 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -72.14 -28.83 63.5 Favored 'General case' 0 N--CA 1.53 3.547 0 O-C-N 121.896 -0.503 . . . . 0.0 110.814 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -70.66 -34.12 71.68 Favored 'General case' 0 N--CA 1.526 3.341 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.077 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 23.3 pt -72.03 -26.3 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.464 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -51.44 69.53 Favored 'General case' 1 N--CA 1.541 4.084 0 C-N-CA 123.73 0.812 . . . . 0.0 112.023 -177.147 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.5 tt -73.14 -31.84 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.792 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.168 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -54.17 -29.25 44.94 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.879 0.872 . . . . 0.0 110.346 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 6.5 mm -68.68 -38.75 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.822 0 C-N-CA 123.78 0.832 . . . . 0.0 109.593 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.93 -41.75 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.257 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.46 -44.6 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.34 -30.4 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.06 -37.6 93.02 Favored Glycine 1 N--CA 1.52 4.263 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 68.1 m -68.47 -37.89 80.56 Favored 'General case' 0 N--CA 1.523 3.177 0 C-N-CA 123.581 0.752 . . . . 0.0 111.02 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.74 -45.57 93.77 Favored 'General case' 0 N--CA 1.536 3.842 0 C-N-CA 123.07 0.548 . . . . 0.0 111.576 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 1.5 tp -60.96 -49.39 84.91 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.362 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.18 -22.59 63.13 Favored Glycine 1 N--CA 1.528 4.817 0 O-C-N 120.402 -1.436 . . . . 0.0 112.566 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.55 -41.4 79.85 Favored 'General case' 0 N--CA 1.533 3.69 0 CA-C-O 121.769 0.795 . . . . 0.0 108.993 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . 0.451 ' HE ' ' CD1' ' B' ' 693' ' ' ILE . 25.4 mmt180 -53.72 -24.2 14.07 Favored 'General case' 0 N--CA 1.534 3.769 0 C-N-CA 124.765 1.226 . . . . 0.0 113.409 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 75.0 mt -53.24 -35.81 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 C-N-CA 123.484 0.714 . . . . 0.0 110.549 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 5.5 m -54.27 -26.27 15.07 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.377 0 C-N-CA 123.981 0.913 . . . . 0.0 111.687 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -53.97 -31.12 49.66 Favored 'General case' 0 N--CA 1.531 3.587 0 C-N-CA 123.278 0.631 . . . . 0.0 112.144 -173.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -71.4 -45.05 63.73 Favored 'General case' 0 N--CA 1.529 3.479 0 CA-C-O 121.99 0.9 . . . . 0.0 108.833 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.64 -34.76 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.089 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.71 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.13 -34.24 71.81 Favored 'General case' 0 N--CA 1.52 3.063 0 C-N-CA 124.674 1.19 . . . . 0.0 110.027 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 54.7 m -58.97 -46.58 87.71 Favored 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.72 -36.49 84.46 Favored 'General case' 1 N--CA 1.543 4.204 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.77 -40.97 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.669 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -66.28 -23.29 66.37 Favored 'General case' 0 N--CA 1.515 2.804 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.833 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -49.35 -47.18 47.61 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 123.43 0.692 . . . . 0.0 110.153 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.94 -48.17 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.966 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.148 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -76.7 -4.81 45.2 Favored 'General case' 0 N--CA 1.534 3.752 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.881 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -114.5 -12.82 12.26 Favored 'General case' 0 N--CA 1.52 3.036 0 C-N-CA 124.769 1.228 . . . . 0.0 108.849 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -49.86 -31.89 17.62 Favored Glycine 0 N--CA 1.51 3.618 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -78.28 153.75 31.53 Favored 'General case' 0 N--CA 1.523 3.183 0 CA-C-O 121.694 0.759 . . . . 0.0 109.084 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 99.5 p -80.11 149.83 70.42 Favored Pre-proline 0 N--CA 1.53 3.546 0 C-N-CA 126.72 2.008 . . . . 0.0 112.283 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -56.18 131.08 43.69 Favored 'Trans proline' 0 C--N 1.403 3.418 0 CA-C-N 120.761 1.308 . . . . 0.0 110.341 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 57.6 tp . . . . . 0 N--CA 1.527 3.398 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.615 -179.671 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.509 2.509 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -61.88 -50.37 72.51 Favored 'General case' 0 N--CA 1.53 3.569 0 CA-C-O 121.407 0.623 . . . . 0.0 112.345 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -63.16 -35.5 80.5 Favored 'General case' 0 N--CA 1.522 3.137 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.401 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 95.6 mt -74.85 -28.08 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 C-N-CA 125.246 1.418 . . . . 0.0 110.995 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -50.97 58.28 Favored 'General case' 1 N--CA 1.559 4.984 0 CA-C-N 119.873 1.215 . . . . 0.0 110.282 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 14.3 tt -64.52 -32.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 124.199 0.999 . . . . 0.0 109.088 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -53.85 -33.04 55.13 Favored 'General case' 0 N--CA 1.518 2.936 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.906 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.24 -42.51 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.861 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.706 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.02 -34.9 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.31 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 60.8 mt -64.62 -44.64 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.95 -30.76 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 C-N-CA 123.7 0.8 . . . . 0.0 109.047 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.21 -31.88 82.25 Favored Glycine 1 N--CA 1.52 4.26 0 C-N-CA 123.427 0.537 . . . . 0.0 112.005 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.1 m -69.04 -37.26 78.47 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.476 0.71 . . . . 0.0 111.279 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.05 -44.59 91.83 Favored 'General case' 1 N--CA 1.539 4.024 0 C-N-CA 123.298 0.639 . . . . 0.0 112.574 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 693' ' ' ILE 0.268 0.1 OUTLIER -62.46 -48.76 86.77 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.742 0 CA-C-N 118.314 0.506 . . . . 0.0 111.714 -175.929 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.6 -23.78 61.13 Favored Glycine 1 N--CA 1.527 4.754 0 O-C-N 121.778 -0.576 . . . . 0.0 113.068 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.24 -42.12 72.63 Favored 'General case' 0 N--CA 1.539 3.995 0 C-N-CA 124.617 1.167 . . . . 0.0 110.705 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -52.55 -25.62 10.96 Favored 'General case' 0 N--CA 1.537 3.918 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 8.7 tp -54.5 -37.8 39.44 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.401 0 CA-C-N 119.897 1.226 . . . . 0.0 112.677 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.76 -30.47 22.66 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 C-N-CA 123.441 0.696 . . . . 0.0 111.733 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -54.46 -26.45 31.19 Favored 'General case' 0 N--CA 1.534 3.726 0 C-N-CA 122.934 0.493 . . . . 0.0 109.706 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.9 68.4 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 122.664 0.386 . . . . 0.0 110.096 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.0 -31.09 49.01 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.002 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 6.2 tp -53.31 -33.96 55.5 Favored 'General case' 0 N--CA 1.534 3.751 0 C-N-CA 123.158 0.583 . . . . 0.0 110.113 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 83.8 p -58.05 -46.03 86.05 Favored 'General case' 0 N--CA 1.531 3.579 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 39.5 tp -66.96 -35.19 79.42 Favored 'General case' 1 N--CA 1.54 4.034 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 58.8 t -69.06 -42.23 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.637 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -67.24 -23.45 65.71 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.466 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -50.76 -48.29 59.32 Favored 'General case' 0 N--CA 1.512 2.633 0 CA-C-O 121.671 0.748 . . . . 0.0 109.427 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.88 -41.04 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.583 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -76.08 -20.67 57.5 Favored 'General case' 0 N--CA 1.536 3.854 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.806 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . 0.483 HE21 ' NE2' ' B' ' 710' ' ' GLN . 33.1 tt0 -99.1 -11.91 21.0 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 125.355 1.462 . . . . 0.0 109.434 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.94 -31.12 24.18 Favored Glycine 1 N--CA 1.519 4.213 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 177.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -107.92 142.67 37.67 Favored 'General case' 0 N--CA 1.534 3.768 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 68.8 m -82.42 146.83 54.89 Favored Pre-proline 0 N--CA 1.528 3.468 0 C-N-CA 125.296 1.438 . . . . 0.0 111.201 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--N 1.402 3.382 0 CA-C-N 121.326 1.509 . . . . 0.0 109.342 -177.726 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 N--CA 1.526 3.355 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -71.46 -29.55 64.98 Favored 'General case' 0 N--CA 1.528 3.443 0 O-C-N 121.831 -0.543 . . . . 0.0 111.033 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -70.52 -36.53 73.8 Favored 'General case' 0 N--CA 1.517 2.923 0 CA-C-O 118.639 -0.695 . . . . 0.0 111.255 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . 0.555 HD12 ' N ' ' B' ' 683' ' ' ARG . 2.2 pp -71.6 -23.79 22.87 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.293 0 CA-C-N 119.544 1.065 . . . . 0.0 110.121 179.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . 0.555 ' N ' HD12 ' B' ' 682' ' ' ILE . 0.2 OUTLIER -61.03 -53.08 61.56 Favored 'General case' 0 N--CA 1.532 3.655 0 CA-C-O 121.511 0.672 . . . . 0.0 112.309 -176.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 18.7 tt -74.76 -31.78 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.078 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -52.25 -45.79 65.5 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.376 1.07 . . . . 0.0 111.869 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.52 -36.79 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.422 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 12.0 mm -60.36 -41.58 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.44 -44.18 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.55 -31.59 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.836 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.61 -44.6 97.31 Favored Glycine 1 N--CA 1.521 4.342 0 C-N-CA 124.071 0.843 . . . . 0.0 112.316 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.4 m -68.18 -37.48 81.0 Favored 'General case' 0 N--CA 1.527 3.382 0 CA-C-O 122.121 0.962 . . . . 0.0 110.022 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 2.2 tp -58.59 -45.31 89.36 Favored 'General case' 0 N--CA 1.518 2.962 0 CA-C-N 113.339 -1.755 . . . . 0.0 113.379 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.491 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.1 OUTLIER -70.52 -38.75 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.857 0 C-N-CA 122.714 0.406 . . . . 0.0 111.751 -177.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.53 -28.1 67.04 Favored Glycine 1 N--CA 1.53 4.944 0 O-C-N 121.014 -1.054 . . . . 0.0 112.16 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 4.9 tt -66.46 -40.31 89.33 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 125.02 1.328 . . . . 0.0 110.213 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . 0.478 ' HE ' HD11 ' A' ' 693' ' ' ILE . 36.1 mmt180 -51.02 -24.68 3.95 Favored 'General case' 0 N--CA 1.528 3.473 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.8 tt -53.5 -35.96 26.6 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 CA-C-N 119.329 0.968 . . . . 0.0 111.947 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 13.4 p -53.39 -30.01 17.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 C-N-CA 124.278 1.031 . . . . 0.0 111.617 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -57.34 -28.14 62.87 Favored 'General case' 0 N--CA 1.536 3.855 0 O-C-N 121.53 -0.731 . . . . 0.0 110.697 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.13 -41.76 73.5 Favored 'General case' 0 N--CA 1.529 3.508 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.59 -32.02 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.716 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 15.6 tp -54.12 -31.02 51.05 Favored 'General case' 1 N--CA 1.542 4.128 0 C-N-CA 123.516 0.726 . . . . 0.0 109.114 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 62.7 m -56.63 -45.3 81.62 Favored 'General case' 0 N--CA 1.535 3.814 0 O-C-N 121.194 -0.941 . . . . 0.0 111.762 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.14 -34.78 78.85 Favored 'General case' 1 N--CA 1.547 4.4 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.86 -39.21 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -61.28 -22.44 64.86 Favored 'General case' 0 N--CA 1.523 3.189 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -52.34 -44.75 65.33 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-O 121.96 0.886 . . . . 0.0 109.462 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 98.7 t -58.16 -37.1 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.715 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -77.64 -5.68 51.2 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.434 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . 0.483 ' NE2' HE21 ' A' ' 710' ' ' GLN . 10.5 tp-100 -89.22 -17.33 29.28 Favored 'General case' 1 N--CA 1.561 5.086 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -81.64 -24.95 55.04 Favored Glycine 1 N--CA 1.521 4.312 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -80.23 152.81 28.91 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 125.898 1.679 . . . . 0.0 108.298 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 97.8 p -102.12 146.79 32.92 Favored Pre-proline 1 N--CA 1.551 4.6 0 C-N-CA 125.222 1.409 . . . . 0.0 114.155 -176.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo . . . . . 0 C--N 1.406 3.553 0 CA-C-N 120.405 1.18 . . . . 0.0 109.939 -178.543 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 N--CA 1.53 3.555 0 CA-C-O 121.703 0.763 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -71.27 -28.6 64.26 Favored 'General case' 0 N--CA 1.524 3.233 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.537 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -72.5 -36.53 68.42 Favored 'General case' 0 N--CA 1.526 3.371 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.957 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 23.8 pt -72.91 -29.11 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 CA-C-N 118.054 0.388 . . . . 0.0 110.082 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -52.59 -54.64 30.27 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-O 121.617 0.722 . . . . 0.0 111.648 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.6 tt -69.43 -30.98 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.818 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.05 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.6 -43.33 99.07 Favored 'General case' 0 N--CA 1.528 3.446 0 CA-C-O 122.88 1.324 . . . . 0.0 109.28 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.33 -44.4 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.744 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.46 -45.62 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 CA-C-O 118.826 -0.607 . . . . 0.0 110.295 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 19.4 tt -62.55 -39.15 83.45 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.625 0 CA-C-N 119.808 1.186 . . . . 0.0 108.64 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 19.7 t -65.88 -29.91 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.763 0 C-N-CA 123.934 0.894 . . . . 0.0 108.753 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -68.75 -24.94 75.42 Favored Glycine 1 N--CA 1.526 4.694 0 CA-C-N 119.017 0.826 . . . . 0.0 113.474 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 70.5 m -67.61 -50.44 58.14 Favored 'General case' 0 N--CA 1.532 3.673 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . 0.478 HD12 ' H ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -52.66 -32.62 43.19 Favored 'General case' 0 N--CA 1.519 2.986 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . 0.5 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.2 OUTLIER -59.99 -37.7 73.53 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 CA-C-N 119.436 1.016 . . . . 0.0 113.172 -176.004 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -67.99 -38.86 89.1 Favored Glycine 1 N--CA 1.523 4.479 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . 0.592 HD22 ' O ' ' C' ' 695' ' ' LEU . 0.0 OUTLIER -63.9 -37.08 86.09 Favored 'General case' 0 N--CA 1.534 3.745 0 C-N-CA 124.995 1.318 . . . . 0.0 111.946 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -50.9 -27.12 6.84 Favored 'General case' 1 N--CA 1.549 4.489 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 29.2 pt -54.07 -38.42 37.97 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.335 0 CA-C-N 120.155 1.343 . . . . 0.0 114.278 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.4 p -55.75 -35.5 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -55.89 -26.97 49.76 Favored 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.311 0.644 . . . . 0.0 110.457 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.95 69.51 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 121.939 -0.475 . . . . 0.0 110.467 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.62 -30.84 48.64 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.155 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 9.1 tp -53.4 -34.64 58.53 Favored 'General case' 0 N--CA 1.531 3.604 0 CA-C-O 118.841 -0.6 . . . . 0.0 110.786 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 62.9 m -58.7 -46.95 86.16 Favored 'General case' 0 N--CA 1.533 3.709 0 CA-C-N 119.284 0.947 . . . . 0.0 112.971 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.85 -35.3 80.28 Favored 'General case' 1 N--CA 1.549 4.523 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.879 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.94 -38.38 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' C' ' 710' ' ' GLN . 63.2 t30 -58.22 -30.1 66.22 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.642 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -47.36 -42.1 20.96 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.04 0.838 . . . . 0.0 112.168 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.65 -44.79 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -77.4 -6.61 54.01 Favored 'General case' 1 N--CA 1.539 4.004 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.75 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.4 tt0 -114.65 -11.28 12.37 Favored 'General case' 0 N--CA 1.517 2.905 0 C-N-CA 125.474 1.509 . . . . 0.0 108.745 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -53.09 -24.49 21.15 Favored Glycine 1 N--CA 1.519 4.17 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -88.15 155.95 19.51 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.942 0.897 . . . . 0.0 108.718 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 95.5 p -77.58 149.38 78.04 Favored Pre-proline 0 N--CA 1.535 3.793 0 C-N-CA 125.973 1.709 . . . . 0.0 112.551 -173.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -55.72 129.83 37.16 Favored 'Trans proline' 0 C--N 1.409 3.747 0 CA-C-N 120.374 1.169 . . . . 0.0 110.906 -173.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.523 3.221 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.519 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 N--CA 1.505 2.275 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -55.13 -37.24 66.67 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -73.24 -38.26 66.07 Favored 'General case' 0 N--CA 1.532 3.645 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.46 -25.74 19.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.069 0 C-N-CA 125.624 1.57 . . . . 0.0 111.574 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -67.26 -53.7 27.58 Favored 'General case' 1 N--CA 1.544 4.248 0 C-N-CA 124.539 1.136 . . . . 0.0 112.006 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 15.2 tt -68.23 -32.89 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.195 0 CA-C-N 114.051 -1.431 . . . . 0.0 109.151 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -52.47 -34.83 50.86 Favored 'General case' 0 N--CA 1.516 2.849 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.982 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 13.0 mm -63.44 -37.62 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 CA-C-O 121.762 0.792 . . . . 0.0 109.201 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -37.24 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.183 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 62.0 mt -65.48 -43.82 94.35 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.5 t -61.99 -28.94 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.15 -31.62 78.1 Favored Glycine 0 N--CA 1.513 3.787 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.693 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 49.9 m -69.34 -37.19 77.56 Favored 'General case' 0 N--CA 1.53 3.542 0 C-N-CA 123.201 0.6 . . . . 0.0 111.077 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.6 mp -58.08 -45.05 87.8 Favored 'General case' 0 N--CA 1.538 3.944 0 C-N-CA 123.487 0.715 . . . . 0.0 112.071 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.875 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.271 0.8 OUTLIER -60.28 -48.52 87.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.135 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.771 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.5 -26.3 69.53 Favored Glycine 1 N--CA 1.531 4.997 0 CA-C-N 120.164 1.347 . . . . 0.0 112.296 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.0 tt -64.77 -42.83 94.82 Favored 'General case' 0 N--CA 1.537 3.905 0 C-N-CA 124.059 0.944 . . . . 0.0 109.985 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -54.34 -26.11 27.89 Favored 'General case' 0 N--CA 1.538 3.958 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 70.2 mt -55.11 -39.06 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 C-N-CA 123.562 0.745 . . . . 0.0 112.257 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.57 -29.1 33.27 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.522 0 C-N-CA 123.49 0.716 . . . . 0.0 112.584 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -52.06 -26.03 10.01 Favored 'General case' 0 N--CA 1.535 3.779 0 C-N-CA 123.264 0.626 . . . . 0.0 110.949 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.55 -32.42 62.97 Favored 'General case' 0 N--CA 1.532 3.642 0 O-C-N 121.936 -0.477 . . . . 0.0 109.803 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.9 m -68.65 -30.82 48.52 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.123 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.83 -34.71 55.28 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 123.42 0.688 . . . . 0.0 110.391 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 89.0 p -58.89 -46.24 88.33 Favored 'General case' 0 N--CA 1.529 3.476 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 30.2 tp -67.02 -34.79 78.49 Favored 'General case' 1 N--CA 1.543 4.21 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.16 -39.29 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -69.71 -29.08 66.4 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.246 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -50.78 -40.41 55.06 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.537 0.684 . . . . 0.0 110.376 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.22 -38.43 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.899 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.737 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -74.99 -25.72 59.04 Favored 'General case' 0 N--CA 1.538 3.937 0 CA-C-O 121.057 0.456 . . . . 0.0 109.788 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -89.36 -7.77 54.57 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.51 -20.71 7.79 Favored Glycine 1 N--CA 1.524 4.506 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -120.69 152.05 38.74 Favored 'General case' 0 N--CA 1.526 3.329 0 C-N-CA 125.265 1.426 . . . . 0.0 109.293 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 94.5 p -82.34 150.45 63.91 Favored Pre-proline 0 N--CA 1.531 3.595 0 C-N-CA 125.884 1.674 . . . . 0.0 110.244 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo . . . . . 0 C--N 1.401 3.332 0 CA-C-N 122.259 1.842 . . . . 0.0 112.503 -175.782 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.2 tt . . . . . 0 N--CA 1.524 3.262 0 CA-C-O 120.813 0.34 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -71.11 -31.06 67.31 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -69.69 -38.53 77.03 Favored 'General case' 0 N--CA 1.526 3.362 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.544 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 20.3 pt -71.56 -31.94 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.301 0 CA-C-N 117.986 0.357 . . . . 0.0 110.282 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -52.82 -54.39 34.9 Favored 'General case' 1 N--CA 1.539 4.018 0 CA-C-O 121.776 0.798 . . . . 0.0 111.007 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -31.46 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.307 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -59.55 -43.41 93.54 Favored 'General case' 1 N--CA 1.539 4.012 0 CA-C-O 121.691 0.758 . . . . 0.0 109.658 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.66 -36.33 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 C-N-CA 124.215 1.006 . . . . 0.0 108.617 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 27.8 mm -65.17 -42.72 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 47.9 mm -60.28 -41.17 86.08 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.281 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.49 -31.22 48.26 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.108 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.98 -33.19 86.57 Favored Glycine 1 N--CA 1.518 4.163 0 C-N-CA 123.924 0.773 . . . . 0.0 112.693 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.2 m -68.15 -37.26 80.86 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.52 0.728 . . . . 0.0 111.577 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.69 -43.07 80.14 Favored 'General case' 0 N--CA 1.536 3.843 0 C-N-CA 123.39 0.676 . . . . 0.0 112.559 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.798 HD11 ' HE ' ' C' ' 696' ' ' ARG 0.276 0.8 OUTLIER -60.25 -48.73 86.99 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.502 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.242 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.45 -23.29 70.17 Favored Glycine 1 N--CA 1.531 5.023 0 CA-C-N 120.423 1.465 . . . . 0.0 112.518 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.29 -43.17 92.02 Favored 'General case' 1 N--CA 1.541 4.093 0 C-N-CA 123.359 0.664 . . . . 0.0 109.655 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . 0.875 ' HE ' HD11 ' A' ' 693' ' ' ILE . 23.5 mmt180 -52.99 -24.02 8.56 Favored 'General case' 0 N--CA 1.536 3.86 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 78.1 mt -51.72 -35.71 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 C-N-CA 123.327 0.651 . . . . 0.0 110.425 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.23 -26.08 17.88 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.235 0 C-N-CA 124.444 1.097 . . . . 0.0 111.397 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -53.66 -28.76 35.07 Favored 'General case' 1 N--CA 1.547 4.404 0 O-C-N 121.313 -0.867 . . . . 0.0 110.387 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.66 -44.11 67.78 Favored 'General case' 0 N--CA 1.525 3.282 0 CA-C-O 122.028 0.918 . . . . 0.0 108.627 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 79.0 t -68.84 -33.6 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.04 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -35.5 66.03 Favored 'General case' 0 N--CA 1.532 3.642 0 C-N-CA 123.65 0.78 . . . . 0.0 110.405 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 48.8 m -59.77 -48.01 83.4 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.54 -34.85 77.91 Favored 'General case' 1 N--CA 1.54 4.052 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.219 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.23 -44.93 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . 0.453 HD22 ' C ' ' B' ' 706' ' ' ASN . 0.1 OUTLIER -74.41 -20.52 60.02 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.568 -178.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . 0.441 ' N ' HD22 ' B' ' 706' ' ' ASN . 16.5 tpt180 -47.39 -35.01 7.7 Favored 'General case' 0 N--CA 1.519 3.001 0 CA-C-N 118.566 0.621 . . . . 0.0 109.921 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.37 -39.13 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.815 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' B' ' 706' ' ' ASN . 71.9 mtm180 -76.49 -30.83 57.41 Favored 'General case' 0 N--CA 1.524 3.252 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.76 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -89.23 2.33 54.41 Favored 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.6 -28.1 50.6 Favored Glycine 1 N--CA 1.517 4.086 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -108.62 127.79 54.27 Favored 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 97.9 p -82.24 147.67 57.66 Favored Pre-proline 0 N--CA 1.528 3.462 0 C-N-CA 125.278 1.431 . . . . 0.0 110.758 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 C--N 1.401 3.334 0 CA-C-N 121.473 1.562 . . . . 0.0 110.363 -176.629 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' C' ' 683' ' ' ARG . 7.8 mp . . . . . 0 N--CA 1.504 2.269 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -56.4 -38.73 71.93 Favored 'General case' 0 N--CA 1.53 3.535 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -173.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -72.93 -37.83 67.03 Favored 'General case' 0 N--CA 1.534 3.757 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 86.7 mt -73.37 -25.68 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.355 0 C-N-CA 125.365 1.466 . . . . 0.0 111.246 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' C' ' 679' ' ' LEU . 0.9 OUTLIER -67.03 -51.3 56.48 Favored 'General case' 0 N--CA 1.536 3.872 0 C-N-CA 124.449 1.099 . . . . 0.0 110.71 -177.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.3 tt -71.2 -30.31 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.928 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -52.52 -27.48 16.62 Favored 'General case' 0 N--CA 1.526 3.343 0 CA-C-O 121.512 0.673 . . . . 0.0 109.959 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 22.8 mm -68.94 -48.2 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 C-N-CA 124.635 1.174 . . . . 0.0 108.937 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 10.9 mm -57.74 -41.99 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.389 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.365 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.34 -49.19 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.702 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.97 -30.87 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.886 0 C-N-CA 123.666 0.786 . . . . 0.0 109.921 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.8 -32.54 84.56 Favored Glycine 1 N--CA 1.52 4.242 0 C-N-CA 123.367 0.508 . . . . 0.0 112.777 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 68.7 m -67.65 -35.99 79.93 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 124.056 0.942 . . . . 0.0 112.135 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.11 -41.74 68.65 Favored 'General case' 0 N--CA 1.539 3.976 0 C-N-CA 123.433 0.693 . . . . 0.0 112.606 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . 0.432 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -60.27 -41.4 86.88 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.255 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.166 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -68.46 -31.59 74.16 Favored Glycine 1 N--CA 1.524 4.553 0 O-C-N 121.093 -1.004 . . . . 0.0 111.456 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.04 -42.07 99.67 Favored 'General case' 0 N--CA 1.534 3.769 0 C-N-CA 124.594 1.158 . . . . 0.0 112.156 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . 0.798 ' HE ' HD11 ' B' ' 693' ' ' ILE . 25.6 mmt180 -53.3 -27.36 22.57 Favored 'General case' 1 N--CA 1.542 4.146 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -176.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 10.5 tp -55.71 -39.34 54.92 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.371 0 CA-C-N 119.664 1.12 . . . . 0.0 113.848 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.82 -31.7 41.04 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.338 0 C-N-CA 123.276 0.63 . . . . 0.0 112.235 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -54.41 -25.42 24.65 Favored 'General case' 0 N--CA 1.531 3.575 0 C-N-CA 123.121 0.568 . . . . 0.0 109.95 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.46 -34.98 65.0 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 122.086 -0.384 . . . . 0.0 110.159 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.3 m -68.83 -30.73 47.99 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.045 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 11.0 tp -52.89 -36.14 58.96 Favored 'General case' 0 N--CA 1.533 3.712 0 C-N-CA 123.154 0.581 . . . . 0.0 110.474 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 89.0 p -58.87 -47.0 86.47 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 39.8 tp -67.4 -34.88 78.17 Favored 'General case' 1 N--CA 1.543 4.191 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.86 -38.95 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.546 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' C' ' 710' ' ' GLN . 64.3 t30 -66.26 -25.69 67.0 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.856 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -48.22 -33.23 8.25 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 123.643 0.777 . . . . 0.0 111.133 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.66 -47.66 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -77.93 -9.92 59.33 Favored 'General case' 1 N--CA 1.542 4.172 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.623 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' C' ' 706' ' ' ASN . 50.9 tt0 -112.56 -7.64 13.87 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 125.884 1.674 . . . . 0.0 107.869 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.5 -25.04 33.41 Favored Glycine 0 N--CA 1.511 3.665 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -99.87 152.35 20.25 Favored 'General case' 0 N--CA 1.525 3.276 0 C-N-CA 123.911 0.885 . . . . 0.0 108.782 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 53.9 m -81.71 149.26 63.67 Favored Pre-proline 0 N--CA 1.529 3.502 0 CA-C-O 116.626 -1.654 . . . . 0.0 110.601 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -54.33 130.19 38.56 Favored 'Trans proline' 0 C--N 1.401 3.308 0 CA-C-N 122.233 1.833 . . . . 0.0 112.651 -175.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 51.8 mt . . . . . 0 N--CA 1.522 3.141 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.138 179.424 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.517 2.879 0 CA-C-O 119.804 -0.141 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -61.87 -50.05 73.78 Favored 'General case' 0 N--CA 1.529 3.48 0 CA-C-O 121.474 0.655 . . . . 0.0 111.208 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -64.15 -37.47 87.57 Favored 'General case' 0 N--CA 1.518 2.944 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.072 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -25.53 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.359 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -51.38 52.39 Favored 'General case' 1 N--CA 1.562 5.162 0 CA-C-N 119.973 1.26 . . . . 0.0 110.28 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.9 tt -67.73 -30.45 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.222 0 C-N-CA 123.696 0.798 . . . . 0.0 110.292 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -52.33 -30.01 26.41 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.124 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 21.9 mm -69.18 -46.94 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.453 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 7.9 mm -55.09 -39.54 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 C-N-CA 123.522 0.729 . . . . 0.0 109.503 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 59.6 mt -59.82 -47.13 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.978 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.58 -30.61 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 123.563 0.745 . . . . 0.0 109.736 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.98 -30.88 76.62 Favored Glycine 1 N--CA 1.518 4.116 0 C-N-CA 123.49 0.566 . . . . 0.0 112.654 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 63.3 m -67.56 -36.26 80.6 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 123.664 0.786 . . . . 0.0 111.842 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.3 mp -54.44 -42.15 70.24 Favored 'General case' 0 N--CA 1.539 3.99 0 C-N-CA 123.878 0.871 . . . . 0.0 112.993 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.522 HD11 ' HE ' ' B' ' 696' ' ' ARG . 0.4 OUTLIER -64.29 -49.8 79.41 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.08 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.494 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.59 -22.43 65.93 Favored Glycine 1 N--CA 1.528 4.827 0 CA-C-N 119.811 1.187 . . . . 0.0 112.553 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.28 -43.7 93.97 Favored 'General case' 0 N--CA 1.535 3.812 0 C-N-CA 123.835 0.854 . . . . 0.0 109.645 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . 0.718 ' HE ' HD11 ' C' ' 693' ' ' ILE . 17.6 mmt180 -54.67 -28.66 48.98 Favored 'General case' 0 N--CA 1.537 3.898 0 C-N-CA 124.262 1.025 . . . . 0.0 113.563 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 64.1 mt -55.45 -37.69 46.02 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 C-N-CA 123.609 0.764 . . . . 0.0 109.89 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -55.18 -26.78 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 C-N-CA 124.888 1.275 . . . . 0.0 110.969 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -51.73 -27.91 13.4 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.532 0.733 . . . . 0.0 112.087 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.15 96.2 Favored 'General case' 0 N--CA 1.524 3.245 0 O-C-N 121.595 -0.691 . . . . 0.0 109.58 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.99 -33.62 56.16 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.236 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 9.9 tp -55.0 -36.09 65.08 Favored 'General case' 0 N--CA 1.535 3.804 0 C-N-CA 123.2 0.6 . . . . 0.0 110.037 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.4 p -59.16 -47.5 85.07 Favored 'General case' 0 N--CA 1.525 3.3 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 41.3 tp -64.49 -35.78 82.07 Favored 'General case' 1 N--CA 1.546 4.354 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 90.1 t -69.61 -40.27 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.625 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 710' ' ' GLN . 55.1 t30 -64.89 -25.78 68.04 Favored 'General case' 0 N--CA 1.516 2.852 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.777 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -48.57 -44.4 36.63 Favored 'General case' 0 N--CA 1.518 2.961 0 C-N-CA 124.552 1.141 . . . . 0.0 110.402 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.87 -44.16 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -77.81 -12.7 60.0 Favored 'General case' 0 N--CA 1.538 3.926 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.621 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 706' ' ' ASN . 12.1 tt0 -112.93 -12.54 13.25 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 125.615 1.566 . . . . 0.0 109.181 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.91 -29.81 20.78 Favored Glycine 0 N--CA 1.515 3.903 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -93.11 149.68 21.05 Favored 'General case' 0 N--CA 1.522 3.135 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 70.3 m -81.93 148.12 59.98 Favored Pre-proline 0 N--CA 1.532 3.638 0 C-N-CA 125.686 1.594 . . . . 0.0 110.133 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.401 3.297 0 CA-C-N 121.794 1.676 . . . . 0.0 110.6 -175.759 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 2.2 tm? . . . . . 0 N--CA 1.511 2.622 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -68.17 -43.16 78.82 Favored 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 122.449 0.3 . . . . 0.0 110.848 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -69.15 -35.33 76.22 Favored 'General case' 0 N--CA 1.53 3.545 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.56 -24.81 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 C-N-CA 124.504 1.122 . . . . 0.0 110.605 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -64.13 -53.82 43.54 Favored 'General case' 1 N--CA 1.546 4.341 0 CA-C-N 119.362 0.983 . . . . 0.0 111.496 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.2 tt -68.07 -30.33 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.146 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -51.27 -32.82 25.96 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 123.515 0.726 . . . . 0.0 112.153 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . 0.452 ' N ' HD12 ' B' ' 686' ' ' ILE . 1.5 mp -69.23 -45.62 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.267 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 34.2 mt -56.1 -41.15 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 C-N-CA 123.271 0.628 . . . . 0.0 109.938 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 42.2 mm -62.32 -48.91 86.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.109 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.96 -29.8 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 C-N-CA 124.339 1.055 . . . . 0.0 109.967 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.73 -37.03 94.09 Favored Glycine 1 N--CA 1.524 4.553 0 C-N-CA 123.278 0.466 . . . . 0.0 112.45 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.5 m -67.36 -36.14 80.77 Favored 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 124.445 1.098 . . . . 0.0 111.873 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.1 mp -53.29 -33.91 55.15 Favored 'General case' 0 N--CA 1.533 3.711 0 CA-C-O 118.541 -0.742 . . . . 0.0 112.26 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.14 -41.33 81.36 Favored 'Isoleucine or valine' 1 N--CA 1.557 4.888 0 CA-C-N 120.246 1.384 . . . . 0.0 111.236 -177.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -55.82 -46.41 83.32 Favored Glycine 1 N--CA 1.526 4.695 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER -73.28 -32.31 64.58 Favored 'General case' 1 N--CA 1.554 4.771 0 CA-C-N 117.625 0.713 . . . . 0.0 110.82 179.298 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . 0.522 ' HE ' HD11 ' A' ' 693' ' ' ILE . 14.1 tpp180 -50.18 -26.61 4.77 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 125.625 1.57 . . . . 0.0 113.699 -176.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . 0.494 HD13 ' O ' ' B' ' 697' ' ' ILE . 0.0 OUTLIER -54.44 -36.04 33.17 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.14 0 C-N-CA 124.212 1.005 . . . . 0.0 111.051 -178.874 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.1 p -51.91 -26.49 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 124.735 1.214 . . . . 0.0 112.037 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -51.97 -25.89 9.32 Favored 'General case' 1 N--CA 1.54 4.046 0 C-N-CA 123.321 0.648 . . . . 0.0 110.18 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.89 -42.05 79.17 Favored 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 122.992 0.517 . . . . 0.0 111.313 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.67 -32.72 56.19 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 118.405 0.548 . . . . 0.0 110.383 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -32.2 52.53 Favored 'General case' 1 N--CA 1.545 4.309 0 C-N-CA 124.159 0.984 . . . . 0.0 109.529 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 51.6 m -57.26 -44.51 84.0 Favored 'General case' 1 N--CA 1.543 4.185 0 O-C-N 120.53 -1.356 . . . . 0.0 111.936 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 45.2 tp -65.25 -34.43 78.33 Favored 'General case' 1 N--CA 1.549 4.48 0 O-C-N 121.362 -0.836 . . . . 0.0 108.88 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 26.3 t -66.76 -39.93 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -61.12 -32.9 72.59 Favored 'General case' 0 N--CA 1.522 3.157 0 CA-C-O 118.497 -0.763 . . . . 0.0 110.412 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -49.8 -47.9 51.03 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 121.277 0.561 . . . . 0.0 110.003 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.87 -40.65 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.726 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.463 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.74 -29.82 59.01 Favored 'General case' 0 N--CA 1.523 3.219 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.719 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . 0.444 HE21 ' CA ' ' B' ' 710' ' ' GLN . 0.0 OUTLIER -89.69 -6.5 56.04 Favored 'General case' 0 N--CA 1.519 3.01 0 C-N-CA 124.515 1.126 . . . . 0.0 109.265 -178.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -59.7 -31.98 72.82 Favored Glycine 0 N--CA 1.513 3.788 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -89.61 154.31 20.07 Favored 'General case' 0 N--CA 1.529 3.502 0 C-N-CA 124.049 0.939 . . . . 0.0 109.346 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 3.3 t -80.82 150.05 68.51 Favored Pre-proline 0 N--CA 1.534 3.758 0 C-N-CA 126.735 2.014 . . . . 0.0 111.1 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.528 3.532 0 CA-C-N 120.744 1.301 . . . . 0.0 110.468 -174.743 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.529 3.503 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -70.82 -29.7 65.93 Favored 'General case' 0 N--CA 1.528 3.447 0 CA-C-O 120.592 0.234 . . . . 0.0 110.56 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -71.72 -37.92 70.55 Favored 'General case' 0 N--CA 1.518 2.926 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.218 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . 0.502 HD12 ' N ' ' C' ' 683' ' ' ARG . 1.9 pp -72.31 -23.23 21.23 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.225 0 CA-C-N 119.365 0.984 . . . . 0.0 110.505 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . 0.502 ' N ' HD12 ' C' ' 682' ' ' ILE . 0.0 OUTLIER -66.32 -51.58 55.89 Favored 'General case' 0 N--CA 1.535 3.797 0 C-N-CA 124.026 0.931 . . . . 0.0 112.289 -176.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -72.29 -31.77 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.867 0 C-N-CA 123.605 0.762 . . . . 0.0 110.249 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -48.75 -23.71 1.15 Allowed 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 125.546 1.538 . . . . 0.0 112.764 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.11 -37.02 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.731 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.77 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 37.7 pt -61.86 -41.54 91.16 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.679 0 CA-C-N 120.783 1.629 . . . . 0.0 110.006 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 50.2 mt -63.63 -50.14 79.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.35 -38.64 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 C-N-CA 124.202 1.001 . . . . 0.0 110.59 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.79 -49.25 50.38 Favored Glycine 1 N--CA 1.525 4.567 0 C-N-CA 125.339 1.447 . . . . 0.0 111.712 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 73.1 m -58.79 -34.97 72.07 Favored 'General case' 0 N--CA 1.52 3.072 0 CA-C-O 121.841 0.829 . . . . 0.0 108.998 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.64 -44.55 85.69 Favored 'General case' 0 N--CA 1.524 3.251 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.452 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . 0.718 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.266 0.1 OUTLIER -65.22 -47.97 85.33 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.741 0 CA-C-N 119.113 0.87 . . . . 0.0 111.595 -177.221 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.22 -21.3 46.63 Favored Glycine 1 N--CA 1.531 4.999 0 CA-C-N 118.993 0.815 . . . . 0.0 112.656 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.79 -43.08 63.23 Favored 'General case' 0 N--CA 1.537 3.891 0 C-N-CA 124.028 0.931 . . . . 0.0 109.037 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -53.5 -25.51 16.85 Favored 'General case' 0 N--CA 1.532 3.663 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 40.1 mm -53.06 -37.65 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.939 0 C-N-CA 124.33 1.052 . . . . 0.0 112.724 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.03 -30.59 23.9 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.275 0 C-N-CA 123.61 0.764 . . . . 0.0 111.737 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -63.35 -27.64 69.45 Favored 'General case' 0 N--CA 1.538 3.966 0 O-C-N 121.433 -0.792 . . . . 0.0 110.857 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.1 -39.75 75.35 Favored 'General case' 0 N--CA 1.535 3.815 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.58 -32.01 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.078 0 C-N-CA 125.095 1.358 . . . . 0.0 109.041 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 16.0 tp -55.15 -33.04 62.6 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.401 0.68 . . . . 0.0 109.537 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 67.9 m -56.81 -46.33 81.68 Favored 'General case' 0 N--CA 1.532 3.626 0 CA-C-N 118.831 0.741 . . . . 0.0 112.629 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.4 tp -65.13 -35.3 80.67 Favored 'General case' 1 N--CA 1.549 4.509 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.99 -38.93 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -64.68 -25.52 67.98 Favored 'General case' 0 N--CA 1.52 3.055 0 C-N-CA 123.793 0.837 . . . . 0.0 110.298 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . 0.428 HH11 ' NE2' ' A' ' 710' ' ' GLN . 8.7 tpp180 -48.87 -44.12 39.58 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.74 0.781 . . . . 0.0 111.048 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.01 -39.71 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.343 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -76.54 -21.45 55.67 Favored 'General case' 0 N--CA 1.53 3.562 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.707 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -88.94 -11.15 45.26 Favored 'General case' 0 N--CA 1.513 2.714 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.96 -19.11 21.12 Favored Glycine 1 N--CA 1.517 4.079 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -107.24 153.17 23.09 Favored 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 124.858 1.263 . . . . 0.0 109.11 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 83.5 p -81.6 152.21 69.43 Favored Pre-proline 0 N--CA 1.528 3.459 0 C-N-CA 126.369 1.868 . . . . 0.0 111.545 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -53.04 131.83 44.71 Favored 'Trans proline' 0 C--N 1.401 3.331 0 CA-C-N 121.625 1.616 . . . . 0.0 112.066 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 46.3 tp . . . . . 0 N--CA 1.524 3.274 0 C-N-CA 125.848 1.659 . . . . 0.0 110.795 -179.375 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.502 2.161 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -60.18 -49.72 76.51 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -65.99 -33.51 75.98 Favored 'General case' 0 N--CA 1.535 3.815 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.76 -27.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 C-N-CA 125.212 1.405 . . . . 0.0 109.853 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -63.86 -52.04 61.85 Favored 'General case' 1 N--CA 1.545 4.299 0 O-C-N 121.495 -0.753 . . . . 0.0 111.471 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.9 tt -67.42 -31.97 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 C-N-CA 123.908 0.883 . . . . 0.0 109.287 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -58.94 -41.8 88.23 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.876 0.87 . . . . 0.0 109.036 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.27 -36.04 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 C-N-CA 124.962 1.305 . . . . 0.0 108.681 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 56.5 mt -66.7 -37.41 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.75 -43.35 91.41 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.529 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.71 -29.51 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.925 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.75 -32.09 81.86 Favored Glycine 1 N--CA 1.516 4.016 0 C-N-CA 123.614 0.626 . . . . 0.0 112.309 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 68.2 m -68.31 -36.19 78.93 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 123.659 0.784 . . . . 0.0 111.764 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 8.9 mp -54.03 -39.62 66.32 Favored 'General case' 0 N--CA 1.537 3.886 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.53 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.261 0.1 OUTLIER -62.48 -49.72 82.74 Favored 'Isoleucine or valine' 1 N--CA 1.556 4.864 0 CA-C-N 119.429 1.013 . . . . 0.0 112.664 -176.12 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.15 -30.84 71.45 Favored Glycine 1 N--CA 1.527 4.719 0 CA-C-N 119.187 0.903 . . . . 0.0 112.866 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.18 -42.23 99.34 Favored 'General case' 0 N--CA 1.536 3.855 0 C-N-CA 124.568 1.147 . . . . 0.0 111.576 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . 0.783 ' HE ' HD11 ' C' ' 693' ' ' ILE . 26.5 mmt180 -52.67 -26.02 12.58 Favored 'General case' 0 N--CA 1.537 3.916 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 16.5 tt -53.46 -38.3 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.9 p -55.25 -30.77 25.37 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 C-N-CA 123.414 0.685 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -61.45 -28.22 69.12 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.097 0.559 . . . . 0.0 110.797 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.43 -41.92 72.25 Favored 'General case' 0 N--CA 1.53 3.553 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 88.5 t -68.59 -32.85 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 125.007 1.323 . . . . 0.0 108.953 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 13.5 tp -55.33 -30.26 59.91 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 124.089 0.956 . . . . 0.0 109.371 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 78.3 p -56.04 -45.63 79.14 Favored 'General case' 0 N--CA 1.533 3.723 0 O-C-N 121.485 -0.76 . . . . 0.0 111.572 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.23 -34.81 78.46 Favored 'General case' 1 N--CA 1.545 4.319 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.38 -39.35 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -63.12 -21.05 65.93 Favored 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.407 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -49.35 -46.8 47.49 Favored 'General case' 0 N--CA 1.513 2.711 0 CA-C-O 121.748 0.785 . . . . 0.0 109.168 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.68 -41.88 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -77.25 -5.51 49.61 Favored 'General case' 0 N--CA 1.522 3.143 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.209 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.64 -17.2 23.52 Favored 'General case' 1 N--CA 1.558 4.937 0 CA-C-N 118.671 0.669 . . . . 0.0 109.947 -179.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -84.09 -28.24 34.72 Favored Glycine 1 N--CA 1.522 4.419 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -75.49 135.23 40.66 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 112.901 -1.65 . . . . 0.0 108.317 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 96.0 p -82.67 146.67 53.59 Favored Pre-proline 0 N--CA 1.534 3.725 0 CA-C-O 117.574 -1.203 . . . . 0.0 110.665 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.398 3.184 0 CA-C-N 121.42 1.543 . . . . 0.0 109.616 -176.554 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.163 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -57.84 -49.61 76.09 Favored 'General case' 0 N--CA 1.532 3.67 0 CA-C-O 121.599 0.714 . . . . 0.0 111.24 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -65.19 -33.63 76.45 Favored 'General case' 0 N--CA 1.52 3.073 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.554 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 29.2 mm -74.09 -28.45 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.152 0 C-N-CA 124.596 1.158 . . . . 0.0 110.425 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -66.13 -55.41 16.54 Favored 'General case' 1 N--CA 1.547 4.385 0 CA-C-O 122.379 1.085 . . . . 0.0 110.615 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . 0.55 ' O ' HD13 ' B' ' 684' ' ' ILE . 0.0 OUTLIER -64.75 -30.55 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.879 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.46 -178.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.41 -44.36 65.36 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 123.647 0.779 . . . . 0.0 111.511 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 27.2 mt -62.81 -37.9 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 C-N-CA 124.869 1.268 . . . . 0.0 110.311 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 39.1 mm -57.61 -41.62 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 50.4 mm -62.98 -44.99 99.99 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.538 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 176.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.43 -31.07 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 C-N-CA 123.351 0.661 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.54 -42.84 95.45 Favored Glycine 1 N--CA 1.524 4.539 0 C-N-CA 123.539 0.59 . . . . 0.0 112.593 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 66.7 m -67.31 -36.25 81.11 Favored 'General case' 0 N--CA 1.528 3.46 0 CA-C-O 122.342 1.068 . . . . 0.0 110.212 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 2.6 tp -54.04 -35.05 61.56 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 113.191 -1.822 . . . . 0.0 112.909 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -42.32 59.47 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.624 0 CA-C-N 118.641 0.655 . . . . 0.0 110.663 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -53.58 -44.75 68.31 Favored Glycine 1 N--CA 1.523 4.472 0 N-CA-C 116.025 1.17 . . . . 0.0 116.025 -175.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . 0.321 0.0 OUTLIER -67.23 -30.85 70.87 Favored 'General case' 1 N--CA 1.557 4.893 0 CA-C-N 118.267 1.034 . . . . 0.0 112.247 -179.162 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . 0.53 ' HE ' HD11 ' A' ' 693' ' ' ILE . 34.1 mmt180 -48.22 -25.02 1.34 Allowed 'General case' 0 N--CA 1.538 3.936 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 25.9 pt -54.27 -36.69 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.964 0 CA-C-N 118.864 0.757 . . . . 0.0 112.543 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.96 -32.57 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -55.62 -25.77 40.58 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.386 0.674 . . . . 0.0 109.67 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.18 72.6 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 122.711 0.404 . . . . 0.0 110.643 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.78 -31.38 50.52 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.3 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 11.8 tp -54.32 -33.9 59.86 Favored 'General case' 0 N--CA 1.531 3.581 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.157 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 27.0 m -57.69 -46.38 84.41 Favored 'General case' 0 N--CA 1.531 3.577 0 CA-C-N 119.246 0.93 . . . . 0.0 113.4 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 37.5 tp -65.27 -35.9 82.44 Favored 'General case' 1 N--CA 1.552 4.667 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.4 -38.58 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.354 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -62.32 -26.62 68.53 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.054 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -49.11 -47.43 45.3 Favored 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.694 0.759 . . . . 0.0 109.687 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.22 -37.97 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.853 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -75.38 -24.51 57.26 Favored 'General case' 0 N--CA 1.53 3.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.025 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -89.35 -13.38 37.99 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.1 -25.72 32.82 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -96.86 154.22 17.43 Favored 'General case' 0 N--CA 1.533 3.7 0 C-N-CA 124.559 1.144 . . . . 0.0 108.517 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 82.5 p -80.64 152.03 72.04 Favored Pre-proline 0 N--CA 1.536 3.84 0 C-N-CA 126.201 1.8 . . . . 0.0 112.973 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo . . . . . 0 C--N 1.407 3.635 0 CA-C-N 121.159 1.45 . . . . 0.0 112.022 -173.517 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.327 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -60.16 -49.4 77.8 Favored 'General case' 0 N--CA 1.533 3.692 0 C-N-CA 122.994 0.518 . . . . 0.0 110.627 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -64.18 -33.71 76.41 Favored 'General case' 0 N--CA 1.525 3.301 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 27.9 mm -73.79 -31.5 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 C-N-CA 124.451 1.101 . . . . 0.0 111.13 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -49.52 69.64 Favored 'General case' 1 N--CA 1.554 4.773 0 CA-C-O 121.617 0.722 . . . . 0.0 111.52 -176.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -29.02 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 C-N-CA 125.319 1.448 . . . . 0.0 110.27 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -51.2 -30.37 16.91 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.408 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . 0.414 ' N ' HD12 ' C' ' 686' ' ' ILE . 1.5 mp -68.45 -40.69 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.981 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 45.4 mt -60.5 -34.81 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.563 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.54 -47.6 92.22 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.451 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.4 -29.12 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.231 0 C-N-CA 124.253 1.021 . . . . 0.0 109.74 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.84 92.69 Favored Glycine 1 N--CA 1.522 4.369 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 60.6 m -68.98 -37.17 78.6 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.126 0.97 . . . . 0.0 111.137 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.6 mp -55.71 -35.42 66.09 Favored 'General case' 1 N--CA 1.54 4.042 0 C-N-CA 123.573 0.749 . . . . 0.0 112.09 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . 0.783 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.269 0.4 OUTLIER -72.11 -47.22 55.35 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.704 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.52 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -53.96 -44.91 72.33 Favored Glycine 1 N--CA 1.525 4.588 0 N-CA-C 116.393 1.317 . . . . 0.0 116.393 -175.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -65.81 -31.04 71.77 Favored 'General case' 1 N--CA 1.552 4.645 0 CA-C-N 118.408 1.104 . . . . 0.0 112.697 -178.85 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -48.95 -25.26 1.84 Allowed 'General case' 1 N--CA 1.544 4.258 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 18.2 tt -53.1 -35.3 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 C-N-CA 123.256 0.622 . . . . 0.0 111.388 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -53.18 -30.65 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 C-N-CA 124.198 0.999 . . . . 0.0 111.506 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -58.89 -28.43 66.16 Favored 'General case' 0 N--CA 1.537 3.907 0 O-C-N 121.655 -0.653 . . . . 0.0 110.474 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.34 -42.38 71.98 Favored 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.49 -32.39 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.796 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 21.1 tp -54.94 -33.43 62.28 Favored 'General case' 0 N--CA 1.536 3.871 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 87.0 p -57.33 -45.37 84.36 Favored 'General case' 0 N--CA 1.529 3.485 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -37.39 85.48 Favored 'General case' 1 N--CA 1.544 4.228 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.14 -37.94 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.8 p30 -60.12 -31.91 70.5 Favored 'General case' 0 N--CA 1.518 2.953 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.143 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -48.22 -47.27 35.73 Favored 'General case' 0 N--CA 1.516 2.852 0 C-N-CA 123.517 0.727 . . . . 0.0 111.258 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 49.3 t -64.13 -47.71 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -78.76 -10.15 59.68 Favored 'General case' 0 N--CA 1.536 3.868 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' C' ' 706' ' ' ASN . 38.7 tt0 -113.7 -10.87 13.02 Favored 'General case' 0 N--CA 1.533 3.679 0 C-N-CA 124.965 1.306 . . . . 0.0 109.175 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.21 -35.33 54.83 Favored Glycine 0 N--CA 1.509 3.523 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -79.53 152.78 29.97 Favored 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 96.0 p -81.17 150.03 67.29 Favored Pre-proline 0 N--CA 1.531 3.588 0 CA-C-O 116.739 -1.601 . . . . 0.0 111.09 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.14 131.05 42.71 Favored 'Trans proline' 0 C--N 1.401 3.302 0 CA-C-N 121.9 1.714 . . . . 0.0 112.255 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 N--CA 1.53 3.566 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.246 179.616 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.369 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -62.96 -51.35 67.2 Favored 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -67.41 -31.39 71.57 Favored 'General case' 1 N--CA 1.539 4.005 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 47.6 mm -74.88 -26.68 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.489 0 C-N-CA 124.911 1.284 . . . . 0.0 110.269 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -66.35 -54.0 29.61 Favored 'General case' 1 N--CA 1.55 4.559 0 CA-C-O 121.775 0.797 . . . . 0.0 111.13 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.44 -30.82 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.353 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -56.82 -31.35 64.64 Favored 'General case' 0 N--CA 1.515 2.813 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.789 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.6 mm -68.58 -39.25 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 54.3 mt -65.42 -36.32 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.194 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 72.1 mt -67.45 -42.95 87.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.026 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.92 -30.15 47.94 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.338 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.7 97.52 Favored Glycine 1 N--CA 1.524 4.565 0 C-N-CA 124.002 0.811 . . . . 0.0 112.175 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 71.0 m -68.78 -37.83 79.6 Favored 'General case' 0 N--CA 1.522 3.16 0 CA-C-O 122.084 0.945 . . . . 0.0 109.883 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 1.9 tp -59.44 -44.78 92.86 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.02 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.535 ' O ' HD13 ' A' ' 693' ' ' ILE . 0.0 OUTLIER -72.13 -32.46 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.757 0 O-C-N 121.896 -0.502 . . . . 0.0 112.092 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.18 -44.59 96.3 Favored Glycine 1 N--CA 1.52 4.246 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . 0.334 0.0 OUTLIER -68.09 -31.97 71.96 Favored 'General case' 1 N--CA 1.549 4.506 0 CA-C-N 118.279 1.039 . . . . 0.0 112.452 -178.715 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -48.6 -24.7 1.42 Allowed 'General case' 0 N--CA 1.539 3.982 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 17.4 tt -52.39 -35.07 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 123.186 0.594 . . . . 0.0 111.845 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.8 p -52.95 -30.3 15.86 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 C-N-CA 123.789 0.836 . . . . 0.0 111.309 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -61.29 -29.37 69.83 Favored 'General case' 0 N--CA 1.536 3.827 0 O-C-N 121.433 -0.792 . . . . 0.0 110.328 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.55 -37.94 74.09 Favored 'General case' 0 N--CA 1.535 3.783 0 CA-C-O 121.629 0.728 . . . . 0.0 109.059 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.47 -30.24 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.255 0 C-N-CA 124.75 1.22 . . . . 0.0 108.56 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.1 -30.58 49.06 Favored 'General case' 0 N--CA 1.534 3.74 0 C-N-CA 123.428 0.691 . . . . 0.0 109.236 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 72.6 p -56.52 -45.83 80.9 Favored 'General case' 0 N--CA 1.533 3.711 0 O-C-N 121.473 -0.767 . . . . 0.0 111.601 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 34.6 tp -62.63 -35.49 79.77 Favored 'General case' 1 N--CA 1.552 4.653 0 O-C-N 121.34 -0.85 . . . . 0.0 108.935 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.1 -38.59 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.623 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . 0.645 HD22 ' HE ' ' A' ' 709' ' ' ARG . 7.3 t-20 -60.53 -22.83 64.05 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 123.784 0.833 . . . . 0.0 109.798 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -53.5 -42.55 67.46 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.602 0.715 . . . . 0.0 109.646 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.42 -37.46 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.144 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . 0.645 ' HE ' HD22 ' A' ' 706' ' ' ASN . 54.9 mtm180 -77.67 -4.44 46.12 Favored 'General case' 0 N--CA 1.516 2.856 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.999 175.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -91.35 -17.52 25.74 Favored 'General case' 1 N--CA 1.562 5.17 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -78.6 -18.51 75.48 Favored Glycine 1 N--CA 1.523 4.498 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -98.98 144.74 27.8 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 126.654 1.982 . . . . 0.0 106.235 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 78.4 p -104.53 143.94 27.71 Favored Pre-proline 1 N--CA 1.55 4.53 0 CA-C-O 117.929 -1.034 . . . . 0.0 113.474 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo . . . . . 0 C--N 1.409 3.754 0 CA-C-N 120.988 1.389 . . . . 0.0 110.938 178.222 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -55.45 -29.44 58.66 Favored 'General case' 1 N--CA 1.541 4.08 0 CA-C-N 120.156 1.344 . . . . 0.0 111.176 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -72.66 -34.65 67.39 Favored 'General case' 0 N--CA 1.532 3.649 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.54 -25.16 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.375 0 C-N-CA 124.386 1.074 . . . . 0.0 108.78 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -65.75 -45.9 80.87 Favored 'General case' 1 N--CA 1.549 4.487 0 O-C-N 121.54 -0.725 . . . . 0.0 111.566 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 13.7 tt -66.05 -30.54 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.34 -27.3 67.02 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.842 0.857 . . . . 0.0 110.122 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.09 -43.25 81.89 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.204 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 62.6 mt -72.43 -38.41 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.091 0 C-N-CA 124.718 1.207 . . . . 0.0 111.81 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 3.3 tp -58.38 -37.53 64.25 Favored 'Isoleucine or valine' 1 N--CA 1.556 4.844 0 CA-C-N 119.161 0.891 . . . . 0.0 110.215 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.98 -27.54 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 C-N-CA 124.298 1.039 . . . . 0.0 109.98 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -80.16 -27.58 52.14 Favored Glycine 1 N--CA 1.518 4.161 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 49.9 m -69.19 -52.42 28.1 Favored 'General case' 0 N--CA 1.534 3.764 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -34.69 75.39 Favored 'General case' 0 N--CA 1.538 3.974 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.452 HD11 ' HE ' ' C' ' 696' ' ' ARG . 1.2 tp -58.87 -44.86 91.59 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.263 0 CA-C-N 119.54 1.064 . . . . 0.0 111.495 -177.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.15 -31.25 80.12 Favored Glycine 1 N--CA 1.521 4.325 0 O-C-N 120.643 -1.285 . . . . 0.0 111.224 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.92 -43.18 96.7 Favored 'General case' 0 N--CA 1.535 3.824 0 C-N-CA 124.243 1.017 . . . . 0.0 111.506 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -53.03 -26.96 17.44 Favored 'General case' 1 N--CA 1.54 4.05 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.9 tt -54.82 -39.28 47.37 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.387 0 CA-C-N 120.116 1.325 . . . . 0.0 113.973 -174.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.58 -30.53 36.97 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.225 0 C-N-CA 123.332 0.653 . . . . 0.0 111.683 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -53.96 -26.48 25.86 Favored 'General case' 0 N--CA 1.533 3.709 0 C-N-CA 123.145 0.578 . . . . 0.0 109.532 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.89 -36.95 68.22 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 122.787 0.435 . . . . 0.0 110.199 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.43 -29.63 44.78 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.025 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 6.4 tp -52.37 -35.91 52.56 Favored 'General case' 0 N--CA 1.531 3.611 0 CA-C-O 118.866 -0.588 . . . . 0.0 110.721 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 68.9 m -59.28 -46.52 88.32 Favored 'General case' 0 N--CA 1.533 3.714 0 CA-C-N 118.949 0.795 . . . . 0.0 112.864 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 51.0 tp -66.23 -36.02 81.93 Favored 'General case' 1 N--CA 1.547 4.383 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.28 -38.29 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -59.54 -31.78 69.73 Favored 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.11 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -48.45 -45.29 36.35 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 124.934 1.294 . . . . 0.0 111.368 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 59.0 t -62.83 -49.95 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.25 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -79.57 -3.92 49.14 Favored 'General case' 1 N--CA 1.551 4.595 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.551 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -109.98 -13.3 14.44 Favored 'General case' 0 N--CA 1.528 3.427 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.38 -28.48 20.39 Favored Glycine 0 N--CA 1.515 3.925 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -86.23 155.14 20.83 Favored 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 123.796 0.838 . . . . 0.0 108.992 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 90.0 p -79.0 150.19 74.57 Favored Pre-proline 0 N--CA 1.534 3.74 0 C-N-CA 126.479 1.911 . . . . 0.0 112.598 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo . . . . . 0 C--N 1.408 3.679 0 CA-C-N 120.626 1.259 . . . . 0.0 111.031 -174.503 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -58.02 -50.25 74.08 Favored 'General case' 0 N--CA 1.536 3.854 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -174.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -63.21 -33.58 75.8 Favored 'General case' 0 N--CA 1.529 3.486 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.49 -29.12 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 C-N-CA 125.724 1.609 . . . . 0.0 110.514 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -51.85 52.94 Favored 'General case' 1 N--CA 1.55 4.536 0 C-N-CA 123.682 0.793 . . . . 0.0 111.479 -176.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.4 tt -63.08 -39.75 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.427 0 C-N-CA 124.099 0.96 . . . . 0.0 109.465 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -53.09 -42.61 66.07 Favored 'General case' 0 N--CA 1.517 2.88 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.82 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.88 -36.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 20.4 mt -63.5 -44.11 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.65 -43.66 95.31 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.299 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.08 -37.77 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 C-N-CA 123.853 0.861 . . . . 0.0 110.134 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -57.19 -32.96 63.97 Favored Glycine 1 N--CA 1.522 4.425 0 C-N-CA 123.727 0.68 . . . . 0.0 113.756 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 63.1 m -63.39 -34.62 78.13 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 124.355 1.062 . . . . 0.0 112.57 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 4.0 mp -52.85 -34.79 55.91 Favored 'General case' 0 N--CA 1.532 3.668 0 C-N-CA 123.618 0.767 . . . . 0.0 112.659 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . 0.44 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.2 OUTLIER -58.58 -43.81 88.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.445 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.643 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -69.2 -29.93 71.92 Favored Glycine 1 N--CA 1.522 4.399 0 O-C-N 121.232 -0.917 . . . . 0.0 110.917 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.85 -42.83 99.53 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 123.83 0.852 . . . . 0.0 110.506 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . 0.452 ' HE ' HD11 ' B' ' 693' ' ' ILE . 26.2 mmt180 -56.41 -26.83 54.64 Favored 'General case' 1 N--CA 1.543 4.194 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 69.9 mt -54.85 -39.55 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 C-N-CA 122.976 0.51 . . . . 0.0 112.319 -176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.79 -32.05 54.44 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.488 0 CA-C-N 119.235 0.925 . . . . 0.0 112.241 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -53.99 -26.99 28.79 Favored 'General case' 0 N--CA 1.536 3.857 0 O-C-N 121.836 -0.54 . . . . 0.0 110.501 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.72 -32.83 65.91 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 122.039 -0.413 . . . . 0.0 110.341 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.1 m -68.81 -29.84 44.93 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.095 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.5 tp -51.77 -36.3 46.91 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-O 118.709 -0.662 . . . . 0.0 110.914 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 24.5 t -59.06 -46.24 88.77 Favored 'General case' 0 N--CA 1.534 3.747 0 CA-C-N 119.148 0.885 . . . . 0.0 112.914 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 37.9 tp -65.72 -34.53 78.39 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.31 -39.84 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' C' ' 710' ' ' GLN . 33.2 t-20 -65.81 -23.98 66.81 Favored 'General case' 0 N--CA 1.524 3.24 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.764 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -47.89 -42.83 27.88 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 123.992 0.917 . . . . 0.0 111.271 -178.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 43.5 t -65.44 -47.02 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -78.1 -11.84 59.94 Favored 'General case' 0 N--CA 1.539 3.986 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.314 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' C' ' 706' ' ' ASN . 49.5 tt0 -109.91 -9.94 14.76 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 125.093 1.357 . . . . 0.0 108.654 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.78 -27.13 49.04 Favored Glycine 0 N--CA 1.514 3.899 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -99.32 152.71 19.63 Favored 'General case' 0 N--CA 1.529 3.509 0 C-N-CA 123.935 0.894 . . . . 0.0 109.327 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 88.0 p -82.28 148.96 60.86 Favored Pre-proline 0 N--CA 1.528 3.473 0 C-N-CA 125.947 1.699 . . . . 0.0 109.714 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -54.66 132.19 50.11 Favored 'Trans proline' 0 C--N 1.398 3.164 0 CA-C-N 121.612 1.611 . . . . 0.0 112.854 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.515 2.81 0 CA-C-N 112.308 -2.224 . . . . 0.0 105.917 179.169 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 N--CA 1.505 2.296 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -59.47 -49.43 77.81 Favored 'General case' 0 N--CA 1.533 3.693 0 CA-C-O 121.207 0.527 . . . . 0.0 111.348 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -66.93 -29.23 69.04 Favored 'General case' 0 N--CA 1.523 3.221 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 30.7 mm -74.96 -32.2 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.243 0 C-N-CA 124.562 1.145 . . . . 0.0 110.614 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -48.51 69.39 Favored 'General case' 1 N--CA 1.549 4.521 0 O-C-N 121.935 -0.478 . . . . 0.0 111.738 -176.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.1 tt -68.34 -31.18 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 C-N-CA 123.916 0.886 . . . . 0.0 109.826 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -48.51 -24.63 1.36 Allowed 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 124.624 1.17 . . . . 0.0 111.448 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.38 -40.14 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 117.268 -1.349 . . . . 0.0 111.094 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 40.0 pt -53.33 -36.31 26.21 Favored 'Isoleucine or valine' 1 N--CA 1.567 5.388 0 CA-C-N 121.531 1.969 . . . . 0.0 109.93 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.93 -49.14 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 23.9 t -68.17 -29.27 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 125.256 1.423 . . . . 0.0 111.295 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -82.31 -32.19 29.06 Favored Glycine 1 N--CA 1.525 4.571 0 C-N-CA 124.589 1.09 . . . . 0.0 112.317 -175.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 74.3 m -69.05 -51.37 39.63 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 123.839 0.856 . . . . 0.0 113.109 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.49 -31.77 73.02 Favored 'General case' 1 N--CA 1.541 4.096 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.806 HD11 ' HE ' ' B' ' 696' ' ' ARG . 1.3 tp -59.34 -42.65 88.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.431 0 CA-C-N 120.77 1.623 . . . . 0.0 111.295 -176.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.62 -27.53 72.36 Favored Glycine 1 N--CA 1.525 4.609 0 O-C-N 121.02 -1.05 . . . . 0.0 110.968 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.7 -36.68 83.74 Favored 'General case' 1 N--CA 1.544 4.261 0 C-N-CA 123.861 0.864 . . . . 0.0 109.075 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -54.78 -29.25 53.72 Favored 'General case' 1 N--CA 1.542 4.161 0 O-C-N 121.45 -0.781 . . . . 0.0 112.025 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 46.9 mm -57.51 -38.6 64.4 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.047 0 C-N-CA 123.479 0.712 . . . . 0.0 109.839 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 92.1 t -58.17 -37.78 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 125.077 1.351 . . . . 0.0 111.265 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -55.13 -24.85 28.14 Favored 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 123.317 0.647 . . . . 0.0 110.002 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.2 64.31 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 122.163 -0.336 . . . . 0.0 110.14 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.97 -31.32 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.996 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.07 -36.7 63.4 Favored 'General case' 0 N--CA 1.534 3.765 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.651 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 61.5 m -58.75 -47.07 85.94 Favored 'General case' 0 N--CA 1.536 3.862 0 CA-C-N 119.252 0.933 . . . . 0.0 112.868 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 35.8 tp -65.76 -35.04 79.58 Favored 'General case' 1 N--CA 1.54 4.072 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 87.2 t -68.65 -38.65 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 710' ' ' GLN . 17.6 t30 -58.34 -23.13 55.82 Favored 'General case' 0 N--CA 1.516 2.869 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.349 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -47.04 -40.01 13.95 Favored 'General case' 0 N--CA 1.527 3.395 0 C-N-CA 123.667 0.787 . . . . 0.0 111.125 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.96 -45.56 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -76.86 -11.04 59.76 Favored 'General case' 0 N--CA 1.533 3.682 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.698 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 706' ' ' ASN . 35.6 tt0 -113.55 -14.18 12.7 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 125.702 1.601 . . . . 0.0 109.466 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -74.33 -14.89 80.45 Favored Glycine 1 N--CA 1.534 5.213 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 174.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -75.76 146.52 39.97 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 128.207 2.603 . . . . 0.0 107.177 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 67.5 m -81.85 146.99 57.28 Favored Pre-proline 1 N--CA 1.54 4.051 0 C-N-CA 124.402 1.081 . . . . 0.0 112.247 -176.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--N 1.401 3.3 0 CA-C-N 120.998 1.392 . . . . 0.0 109.476 -176.54 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -55.95 -50.62 70.28 Favored 'General case' 0 N--CA 1.535 3.816 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.07 -34.54 78.26 Favored 'General case' 0 N--CA 1.529 3.514 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.5 -29.03 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.222 0 C-N-CA 125.141 1.377 . . . . 0.0 110.403 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -46.93 74.37 Favored 'General case' 1 N--CA 1.556 4.857 0 O-C-N 121.208 -0.933 . . . . 0.0 110.282 -176.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -71.22 -30.74 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 C-N-CA 124.238 1.015 . . . . 0.0 109.765 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -56.56 -45.67 81.14 Favored 'General case' 0 N--CA 1.519 2.983 0 CA-C-O 122.35 1.072 . . . . 0.0 109.351 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.22 -37.82 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.085 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 52.5 mt -65.51 -40.71 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.71 -44.17 96.64 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.335 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.82 -30.24 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 C-N-CA 123.444 0.698 . . . . 0.0 109.825 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.3 92.49 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.139 0.4 . . . . 0.0 112.969 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 66.8 m -59.48 -35.27 73.78 Favored 'General case' 0 N--CA 1.532 3.649 0 C-N-CA 124.323 1.049 . . . . 0.0 112.437 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.4 mp -53.47 -36.36 61.55 Favored 'General case' 0 N--CA 1.534 3.763 0 C-N-CA 123.747 0.819 . . . . 0.0 112.653 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.412 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.3 OUTLIER -60.81 -46.54 96.01 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.306 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.313 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.47 -29.95 76.4 Favored Glycine 1 N--CA 1.525 4.597 0 O-C-N 121.445 -0.784 . . . . 0.0 111.747 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.97 -42.39 94.04 Favored 'General case' 0 N--CA 1.532 3.671 0 C-N-CA 124.44 1.096 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . 0.806 ' HE ' HD11 ' A' ' 693' ' ' ILE . 20.9 mmt180 -52.68 -24.95 9.54 Favored 'General case' 0 N--CA 1.535 3.801 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 19.6 tt -53.05 -37.07 25.75 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.377 0 CA-C-N 120.28 1.4 . . . . 0.0 112.592 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 14.6 p -54.48 -29.8 20.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.348 0 C-N-CA 124.074 0.95 . . . . 0.0 111.33 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -57.08 -27.67 61.93 Favored 'General case' 0 N--CA 1.538 3.968 0 O-C-N 121.259 -0.901 . . . . 0.0 110.666 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -67.88 -42.71 80.82 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 83.9 t -68.99 -32.33 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.868 0 CA-C-N 113.835 -1.529 . . . . 0.0 109.124 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 20.2 tp -55.23 -34.23 63.78 Favored 'General case' 1 N--CA 1.54 4.032 0 C-N-CA 123.059 0.543 . . . . 0.0 109.602 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 57.0 m -57.81 -46.7 84.29 Favored 'General case' 0 N--CA 1.531 3.61 0 CA-C-N 118.79 0.723 . . . . 0.0 112.674 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.18 -36.08 83.08 Favored 'General case' 1 N--CA 1.551 4.601 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.53 -39.04 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' B' ' 710' ' ' GLN . 6.0 t-20 -66.02 -23.57 66.59 Favored 'General case' 0 N--CA 1.516 2.848 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.889 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -48.88 -45.38 41.07 Favored 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 123.993 0.917 . . . . 0.0 109.39 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 50.3 t -62.4 -48.27 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.794 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.86 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -77.92 -9.98 59.35 Favored 'General case' 0 N--CA 1.539 3.979 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.016 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . 0.5 HE22 HE22 ' A' ' 710' ' ' GLN . 26.3 tt0 -112.35 -11.55 13.67 Favored 'General case' 0 N--CA 1.527 3.394 0 C-N-CA 125.109 1.364 . . . . 0.0 109.285 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.96 -35.4 58.93 Favored Glycine 0 N--CA 1.513 3.788 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -83.85 154.46 23.46 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 114.747 -0.726 . . . . 0.0 109.157 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 67.7 m -80.18 149.65 69.85 Favored Pre-proline 0 N--CA 1.529 3.484 0 C-N-CA 126.624 1.969 . . . . 0.0 111.138 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--N 1.4 3.285 0 CA-C-N 120.981 1.386 . . . . 0.0 110.943 -174.313 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 N--CA 1.506 2.332 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -61.09 -48.86 79.72 Favored 'General case' 0 N--CA 1.535 3.813 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -35.11 79.79 Favored 'General case' 1 N--CA 1.54 4.065 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 36.2 mm -73.32 -27.23 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.908 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.667 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -66.38 -54.09 28.42 Favored 'General case' 1 N--CA 1.549 4.514 0 CA-C-O 121.86 0.838 . . . . 0.0 112.311 -176.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.17 -29.58 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.216 0 C-N-CA 125.122 1.369 . . . . 0.0 110.148 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -51.98 -33.23 37.09 Favored 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 124.327 1.051 . . . . 0.0 110.432 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . 0.417 ' N ' HD12 ' C' ' 686' ' ' ILE . 1.5 mp -68.57 -47.64 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 40.2 mt -57.19 -43.82 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 C-N-CA 123.528 0.731 . . . . 0.0 110.421 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.09 -48.55 87.96 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.406 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 23.2 t -57.9 -30.73 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 C-N-CA 124.41 1.084 . . . . 0.0 109.698 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.98 -40.82 95.45 Favored Glycine 1 N--CA 1.524 4.552 0 C-N-CA 123.532 0.587 . . . . 0.0 112.887 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 71.2 m -67.66 -36.64 81.11 Favored 'General case' 0 N--CA 1.528 3.44 0 CA-C-O 122.193 0.997 . . . . 0.0 110.037 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.8 tp -55.29 -45.02 76.24 Favored 'General case' 0 N--CA 1.517 2.923 0 CA-C-N 113.438 -1.71 . . . . 0.0 114.235 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . 0.545 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.0 OUTLIER -69.45 -35.82 68.66 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.212 0 CA-C-N 118.272 0.487 . . . . 0.0 112.276 -176.414 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.48 -26.18 70.61 Favored Glycine 1 N--CA 1.523 4.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.71 -43.25 76.4 Favored 'General case' 0 N--CA 1.535 3.819 0 C-N-CA 124.683 1.193 . . . . 0.0 110.181 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -53.24 -25.65 15.0 Favored 'General case' 0 N--CA 1.533 3.693 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 17.0 tt -54.41 -38.63 41.5 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.261 0 CA-C-N 119.513 1.051 . . . . 0.0 113.342 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . 0.461 ' O ' HG22 ' C' ' 701' ' ' VAL . 10.0 p -55.31 -31.09 26.24 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 C-N-CA 123.539 0.736 . . . . 0.0 111.814 -178.459 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -54.44 -25.91 27.78 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 122.92 0.488 . . . . 0.0 109.875 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.19 -32.99 62.64 Favored 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . 0.461 HG22 ' O ' ' C' ' 698' ' ' VAL . 3.3 m -69.06 -30.82 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.919 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 5.9 tp -52.08 -34.18 42.59 Favored 'General case' 0 N--CA 1.532 3.67 0 C-N-CA 123.549 0.74 . . . . 0.0 110.68 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 6.4 t -58.99 -46.45 88.12 Favored 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 44.6 tp -67.05 -35.56 80.14 Favored 'General case' 1 N--CA 1.54 4.072 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.1 -39.22 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -59.81 -21.16 60.49 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.062 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -47.21 -47.97 24.17 Favored 'General case' 0 N--CA 1.525 3.28 0 CA-C-O 122.13 0.967 . . . . 0.0 110.204 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.74 -43.05 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.762 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -76.76 -9.7 58.86 Favored 'General case' 0 N--CA 1.526 3.335 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.054 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -89.62 -14.16 35.55 Favored 'General case' 1 N--CA 1.546 4.339 0 C-N-CA 123.25 0.62 . . . . 0.0 110.075 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -69.33 -7.9 58.24 Favored Glycine 1 N--CA 1.527 4.716 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -75.35 156.11 35.83 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 125.891 1.676 . . . . 0.0 109.43 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 92.6 p -114.23 146.5 35.91 Favored Pre-proline 0 N--CA 1.527 3.378 0 C-N-CA 125.714 1.606 . . . . 0.0 107.181 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -59.33 131.23 39.71 Favored 'Trans proline' 0 N--CA 1.527 3.492 0 CA-C-N 121.954 1.734 . . . . 0.0 109.961 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.532 3.627 0 C-N-CA 124.902 1.281 . . . . 0.0 110.035 -179.742 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.513 2.707 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -59.29 -48.09 82.92 Favored 'General case' 0 N--CA 1.537 3.895 0 CA-C-N 118.61 0.641 . . . . 0.0 111.735 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -70.01 -36.52 75.17 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.92 -24.42 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.832 0 C-N-CA 123.781 0.833 . . . . 0.0 109.705 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -64.92 -53.67 42.73 Favored 'General case' 1 N--CA 1.545 4.275 0 CA-C-N 118.826 0.739 . . . . 0.0 111.547 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.28 -30.43 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.994 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -51.08 -36.81 42.11 Favored 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.155 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 15.4 mt -68.9 -37.47 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 C-N-CA 124.333 1.053 . . . . 0.0 109.726 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 10.8 mm -57.81 -37.68 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.952 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.2 -42.55 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.41 -30.88 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 C-N-CA 123.584 0.754 . . . . 0.0 109.506 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.73 -41.97 98.77 Favored Glycine 1 N--CA 1.525 4.62 0 C-N-CA 123.673 0.654 . . . . 0.0 111.589 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.4 m -69.02 -37.89 78.88 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-O 122.272 1.034 . . . . 0.0 110.229 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.01 -44.6 97.18 Favored 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 113.287 -1.779 . . . . 0.0 113.458 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.517 ' O ' HD13 ' A' ' 693' ' ' ILE . 0.1 OUTLIER -70.13 -35.58 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -76.69 -12.4 84.49 Favored Glycine 1 N--CA 1.535 5.24 0 O-C-N 121.012 -1.055 . . . . 0.0 110.991 178.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.92 -38.92 83.52 Favored 'General case' 0 N--CA 1.539 3.98 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . 0.657 ' HE ' HD11 ' C' ' 693' ' ' ILE . 32.4 mmt180 -52.31 -25.23 9.02 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 125.05 1.34 . . . . 0.0 113.692 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 31.2 mm -53.28 -38.84 32.65 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.362 0 CA-C-N 118.611 0.641 . . . . 0.0 111.343 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.67 -28.63 23.68 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.305 0 C-N-CA 123.813 0.845 . . . . 0.0 112.428 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -52.46 -26.38 12.66 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 123.22 0.608 . . . . 0.0 110.901 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.87 -34.72 65.74 Favored 'General case' 0 N--CA 1.53 3.547 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.0 m -69.48 -31.79 50.54 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.107 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 10.2 tp -54.74 -36.06 64.4 Favored 'General case' 0 N--CA 1.538 3.947 0 C-N-CA 122.928 0.491 . . . . 0.0 110.252 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.0 p -59.38 -46.18 89.37 Favored 'General case' 0 N--CA 1.528 3.463 0 CA-C-N 118.383 0.538 . . . . 0.0 112.348 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 44.8 tp -65.42 -34.62 78.72 Favored 'General case' 1 N--CA 1.543 4.203 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.19 -38.89 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.597 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -62.49 -29.33 70.47 Favored 'General case' 0 N--CA 1.515 2.778 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.312 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -50.45 -48.54 56.44 Favored 'General case' 0 N--CA 1.519 3.002 0 C-N-CA 123.328 0.651 . . . . 0.0 111.954 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.34 -39.11 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -75.75 -23.38 56.0 Favored 'General case' 0 N--CA 1.527 3.421 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.369 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -92.23 -7.63 47.65 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.36 1.464 . . . . 0.0 107.429 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.83 -21.62 7.62 Favored Glycine 1 N--CA 1.524 4.532 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -119.48 135.2 54.87 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 125.336 1.454 . . . . 0.0 107.253 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 96.1 p -82.27 146.6 54.88 Favored Pre-proline 0 N--CA 1.528 3.426 0 CA-C-O 117.483 -1.246 . . . . 0.0 110.366 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 C--N 1.398 3.165 0 CA-C-N 121.414 1.541 . . . . 0.0 110.709 -177.22 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . 0.493 HD12 ' N ' ' B' ' 680' ' ' TRP . 1.3 pp . . . . . 0 N--CA 1.511 2.624 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . 0.493 ' N ' HD12 ' B' ' 679' ' ' LEU . 16.6 t-105 -57.77 -26.24 61.6 Favored 'General case' 1 N--CA 1.551 4.606 0 CA-C-N 121.032 1.742 . . . . 0.0 110.262 -179.188 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -71.8 -40.25 69.32 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.952 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . 0.467 HD12 ' N ' ' B' ' 683' ' ' ARG . 1.3 pp -72.52 -25.22 22.54 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.234 0 CA-C-N 119.582 1.083 . . . . 0.0 110.192 178.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . 0.467 ' N ' HD12 ' B' ' 682' ' ' ILE . 3.3 tmt_? -59.35 -53.55 56.87 Favored 'General case' 0 N--CA 1.538 3.953 0 CA-C-N 118.168 0.44 . . . . 0.0 111.794 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 14.6 tt -70.52 -34.36 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.164 0 C-N-CA 124.003 0.921 . . . . 0.0 110.628 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -53.74 -46.75 70.99 Favored 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 124.48 1.112 . . . . 0.0 111.367 -175.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 43.9 mt -64.46 -39.89 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.894 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 59.8 mt -64.54 -40.11 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 97.8 mt -59.67 -45.34 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.58 -38.36 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.444 0 C-N-CA 123.565 0.746 . . . . 0.0 109.723 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -53.39 -19.84 9.47 Favored Glycine 1 N--CA 1.53 4.931 0 O-C-N 121.417 -0.802 . . . . 0.0 114.136 -177.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.6 m -68.95 -51.78 36.03 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.34 -31.71 61.93 Favored 'General case' 0 N--CA 1.533 3.679 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.667 HD11 ' HE ' ' C' ' 696' ' ' ARG . 0.1 OUTLIER -57.82 -41.77 80.54 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.221 0 CA-C-N 120.37 1.441 . . . . 0.0 111.981 -175.182 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -68.81 -33.54 75.69 Favored Glycine 1 N--CA 1.525 4.574 0 O-C-N 121.08 -1.012 . . . . 0.0 110.642 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.02 -42.32 94.08 Favored 'General case' 1 N--CA 1.548 4.456 0 C-N-CA 124.116 0.967 . . . . 0.0 112.728 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -49.98 -26.19 4.02 Favored 'General case' 1 N--CA 1.542 4.139 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . 0.45 HD13 ' O ' ' B' ' 697' ' ' ILE . 0.1 OUTLIER -53.82 -38.15 35.05 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.374 0 CA-C-N 118.696 0.68 . . . . 0.0 111.51 -176.809 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.39 -28.2 18.27 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.182 0 C-N-CA 124.059 0.944 . . . . 0.0 112.412 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -52.93 -26.82 16.22 Favored 'General case' 1 N--CA 1.541 4.082 0 C-N-CA 123.398 0.679 . . . . 0.0 109.744 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.49 76.37 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 122.707 0.403 . . . . 0.0 110.468 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.1 m -69.08 -32.0 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.13 -35.68 59.97 Favored 'General case' 0 N--CA 1.534 3.738 0 C-N-CA 123.044 0.538 . . . . 0.0 111.379 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 8.4 t -60.8 -47.39 86.55 Favored 'General case' 0 N--CA 1.535 3.799 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.098 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 44.0 tp -65.13 -34.91 79.52 Favored 'General case' 1 N--CA 1.544 4.248 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.9 -40.71 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.69 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 710' ' ' GLN . 4.6 m120 -72.04 -24.77 61.59 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.905 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -49.57 -35.81 21.78 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 118.826 0.739 . . . . 0.0 110.284 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.52 -48.15 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -77.37 -10.77 59.65 Favored 'General case' 1 N--CA 1.543 4.177 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.509 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 706' ' ' ASN . 33.1 tt0 -112.84 -5.31 13.88 Favored 'General case' 0 N--CA 1.518 2.93 0 C-N-CA 125.523 1.529 . . . . 0.0 108.071 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.77 -29.3 33.18 Favored Glycine 0 N--CA 1.512 3.759 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -98.02 137.58 36.61 Favored 'General case' 0 N--CA 1.528 3.444 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 89.1 p -81.39 146.8 58.5 Favored Pre-proline 0 N--CA 1.528 3.444 0 C-N-CA 125.246 1.418 . . . . 0.0 111.443 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--N 1.399 3.196 0 CA-C-N 121.112 1.433 . . . . 0.0 110.262 -177.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 683' ' ' ARG . 46.8 mt . . . . . 0 N--CA 1.51 2.562 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -43.06 86.21 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -72.8 -37.48 67.52 Favored 'General case' 0 N--CA 1.538 3.927 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 49.0 mm -74.53 -25.86 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 C-N-CA 125.322 1.449 . . . . 0.0 110.917 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' C' ' 679' ' ' LEU . 64.2 ttt180 -66.13 -56.15 12.87 Favored 'General case' 1 N--CA 1.542 4.173 0 CA-C-O 121.658 0.742 . . . . 0.0 110.912 -177.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.9 -36.08 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.785 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.56 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -56.11 -45.9 79.31 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.046 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.74 -42.38 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 124.246 1.018 . . . . 0.0 109.096 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.22 -36.09 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.525 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.25 -42.12 95.27 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 74.7 t -62.67 -31.15 51.14 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.158 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.93 -29.49 74.71 Favored Glycine 1 N--CA 1.517 4.053 0 C-N-CA 123.473 0.558 . . . . 0.0 112.439 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.2 m -67.98 -36.52 80.16 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.42 0.688 . . . . 0.0 111.561 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.83 -44.29 73.76 Favored 'General case' 0 N--CA 1.537 3.883 0 C-N-CA 123.455 0.702 . . . . 0.0 112.503 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . 0.657 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.267 0.1 OUTLIER -60.21 -49.26 84.82 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.622 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.825 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.45 -27.39 60.79 Favored Glycine 1 N--CA 1.528 4.813 0 CA-C-N 119.489 1.04 . . . . 0.0 112.625 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -67.35 -42.12 84.02 Favored 'General case' 0 N--CA 1.538 3.935 0 C-N-CA 124.684 1.194 . . . . 0.0 111.118 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . 0.667 ' HE ' HD11 ' B' ' 693' ' ' ILE . 29.5 mmt180 -52.28 -24.98 8.32 Favored 'General case' 0 N--CA 1.539 3.996 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 30.0 pt -53.75 -38.02 34.07 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.495 0 CA-C-N 120.591 1.541 . . . . 0.0 113.094 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.76 -30.1 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.638 0 C-N-CA 122.517 0.327 . . . . 0.0 111.85 -176.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.68 -26.17 31.8 Favored 'General case' 0 N--CA 1.533 3.721 0 C-N-CA 123.622 0.769 . . . . 0.0 109.436 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.61 -39.83 74.28 Favored 'General case' 0 N--CA 1.523 3.179 0 O-C-N 121.754 -0.591 . . . . 0.0 109.862 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.1 m -69.53 -32.58 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.999 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.61 -34.56 58.88 Favored 'General case' 0 N--CA 1.537 3.876 0 C-N-CA 123.5 0.72 . . . . 0.0 111.056 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 69.5 m -59.96 -46.21 90.15 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-N 118.392 0.542 . . . . 0.0 111.998 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.72 -36.1 83.2 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 94.5 t -68.02 -40.29 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' C' ' 710' ' ' GLN . 2.8 m120 -65.7 -23.56 66.79 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-O 118.711 -0.662 . . . . 0.0 109.771 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -49.27 -44.07 43.56 Favored 'General case' 0 N--CA 1.519 2.977 0 C-N-CA 123.691 0.797 . . . . 0.0 110.045 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.1 t -62.29 -48.99 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.992 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 33.7 mtp85 -78.75 -10.2 59.69 Favored 'General case' 0 N--CA 1.532 3.664 0 CA-C-N 115.084 -0.962 . . . . 0.0 113.206 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.2 tt0 -112.24 -10.62 13.82 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 124.863 1.265 . . . . 0.0 108.666 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.86 -33.73 43.77 Favored Glycine 0 N--CA 1.509 3.548 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -86.04 152.86 22.56 Favored 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 94.1 p -80.99 149.66 67.19 Favored Pre-proline 0 N--CA 1.534 3.742 0 C-N-CA 125.845 1.658 . . . . 0.0 110.063 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.45 129.96 37.52 Favored 'Trans proline' 0 C--N 1.4 3.261 0 CA-C-N 122.204 1.823 . . . . 0.0 112.992 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . 0.518 ' CD1' ' H ' ' C' ' 715' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.527 3.391 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.379 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -57.54 -44.35 85.11 Favored 'General case' 0 N--CA 1.532 3.663 0 C-N-CA 123.769 0.828 . . . . 0.0 110.79 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -70.7 -34.65 72.18 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.706 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 25.4 mm -74.15 -26.61 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.445 0 C-N-CA 125.383 1.473 . . . . 0.0 110.879 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -66.25 -53.37 37.73 Favored 'General case' 0 N--CA 1.539 3.987 0 CA-C-O 122.271 1.034 . . . . 0.0 111.24 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.4 tt -69.5 -30.0 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.2 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -52.7 -39.42 61.99 Favored 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.35 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.47 -43.64 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.311 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 54.5 mt -56.29 -34.62 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 58.9 mt -67.02 -46.72 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.15 -30.65 39.95 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.476 0 C-N-CA 123.362 0.665 . . . . 0.0 109.295 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.07 -40.61 98.3 Favored Glycine 0 N--CA 1.516 3.97 0 C-N-CA 123.482 0.563 . . . . 0.0 112.87 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 67.0 m -58.52 -35.41 72.23 Favored 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 124.342 1.057 . . . . 0.0 112.469 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 6.6 mp -53.75 -33.58 56.22 Favored 'General case' 0 N--CA 1.532 3.666 0 C-N-CA 123.61 0.764 . . . . 0.0 111.381 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -43.97 89.95 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.274 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -174.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -67.29 -32.34 79.51 Favored Glycine 1 N--CA 1.531 4.967 0 O-C-N 121.064 -1.022 . . . . 0.0 111.215 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.24 -37.75 84.19 Favored 'General case' 1 N--CA 1.546 4.351 0 C-N-CA 124.626 1.171 . . . . 0.0 110.414 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . 0.41 ' HE ' ' CD1' ' C' ' 693' ' ' ILE . 24.7 mmt180 -61.02 -29.6 69.81 Favored 'General case' 1 N--CA 1.546 4.344 0 O-C-N 121.309 -0.869 . . . . 0.0 112.45 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 39.8 mm -56.74 -37.93 55.61 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.041 0 CA-C-O 121.934 0.873 . . . . 0.0 109.803 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 39.2 t -56.54 -30.07 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.318 0 C-N-CA 125.727 1.611 . . . . 0.0 110.629 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -59.91 -30.06 68.79 Favored 'General case' 0 N--CA 1.538 3.929 0 C-N-CA 123.493 0.717 . . . . 0.0 111.469 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.98 -43.38 68.16 Favored 'General case' 0 N--CA 1.523 3.209 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.95 -33.44 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.008 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.958 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.58 -35.2 70.07 Favored 'General case' 0 N--CA 1.531 3.59 0 C-N-CA 123.494 0.717 . . . . 0.0 109.801 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.0 p -58.89 -46.62 87.43 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.92 -34.75 78.67 Favored 'General case' 1 N--CA 1.545 4.285 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.069 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.08 -39.11 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 710' ' ' GLN . 23.7 t-20 -62.19 -29.44 70.38 Favored 'General case' 0 N--CA 1.517 2.921 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.936 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -48.02 -33.72 8.38 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 123.959 0.904 . . . . 0.0 111.251 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.42 -46.75 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -77.7 -11.27 59.86 Favored 'General case' 1 N--CA 1.541 4.083 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.143 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 706' ' ' ASN . 17.7 tt0 -114.53 -11.96 12.35 Favored 'General case' 0 N--CA 1.522 3.135 0 C-N-CA 126.054 1.742 . . . . 0.0 108.545 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.73 -30.1 27.44 Favored Glycine 0 N--CA 1.51 3.598 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -85.84 152.65 22.83 Favored 'General case' 0 N--CA 1.522 3.154 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 41.7 t -81.05 149.54 66.73 Favored Pre-proline 0 N--CA 1.527 3.423 0 C-N-CA 126.055 1.742 . . . . 0.0 111.625 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo . . . . . 0 C--N 1.406 3.578 0 CA-C-N 122.215 1.827 . . . . 0.0 111.847 -176.879 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 N--CA 1.519 3.011 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -69.69 -30.4 68.05 Favored 'General case' 0 N--CA 1.527 3.42 0 O-C-N 122.183 -0.323 . . . . 0.0 111.035 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -73.05 -38.79 66.36 Favored 'General case' 0 N--CA 1.524 3.249 0 CA-C-O 118.986 -0.53 . . . . 0.0 110.275 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . 0.489 HD12 ' N ' ' B' ' 683' ' ' ARG . 1.8 pp -73.48 -25.42 21.06 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.01 0 CA-C-N 119.204 0.911 . . . . 0.0 109.497 177.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . 0.489 ' N ' HD12 ' B' ' 682' ' ' ILE . 0.0 OUTLIER -58.43 -51.81 68.27 Favored 'General case' 1 N--CA 1.539 4.007 0 C-N-CA 123.241 0.616 . . . . 0.0 111.768 -177.495 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.7 tt -74.19 -33.68 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.866 0.866 . . . . 0.0 110.979 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -53.96 -47.14 71.65 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 113.938 -1.483 . . . . 0.0 113.099 -173.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 16.8 mt -59.76 -36.84 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 124.074 0.95 . . . . 0.0 111.172 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . 0.474 ' N ' HD12 ' B' ' 687' ' ' ILE . 1.4 mp -59.87 -37.25 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.61 -41.77 91.4 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.178 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.74 -31.62 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.931 0 C-N-CA 123.271 0.628 . . . . 0.0 109.506 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.59 -42.8 98.7 Favored Glycine 1 N--CA 1.524 4.521 0 C-N-CA 123.866 0.746 . . . . 0.0 112.474 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.3 m -67.67 -36.87 81.52 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-O 122.078 0.942 . . . . 0.0 110.218 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.23 -44.81 79.95 Favored 'General case' 0 N--CA 1.518 2.972 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.034 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -49.05 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.951 0 C-N-CA 123.334 0.654 . . . . 0.0 112.638 -176.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.9 -21.76 59.2 Favored Glycine 1 N--CA 1.524 4.53 0 CA-C-N 119.699 1.136 . . . . 0.0 112.978 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.09 -43.77 70.42 Favored 'General case' 1 N--CA 1.54 4.069 0 C-N-CA 123.621 0.769 . . . . 0.0 109.93 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -53.98 -26.02 23.8 Favored 'General case' 0 N--CA 1.536 3.852 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 38.4 mm -55.29 -38.77 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 123.904 0.882 . . . . 0.0 112.885 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.99 -31.41 45.52 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.527 0 CA-C-N 119.096 0.862 . . . . 0.0 111.95 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -54.21 -25.65 24.06 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.182 0.593 . . . . 0.0 109.94 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.45 -31.96 62.37 Favored 'General case' 0 N--CA 1.531 3.583 0 O-C-N 121.723 -0.611 . . . . 0.0 110.068 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.0 -30.04 45.35 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 9.6 tp -52.82 -35.25 56.85 Favored 'General case' 0 N--CA 1.532 3.631 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.486 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 52.1 m -58.11 -46.29 85.8 Favored 'General case' 0 N--CA 1.536 3.827 0 CA-C-N 119.233 0.924 . . . . 0.0 112.377 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 45.3 tp -64.54 -35.88 82.39 Favored 'General case' 1 N--CA 1.543 4.214 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.45 -38.42 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.554 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -58.16 -25.33 61.37 Favored 'General case' 0 N--CA 1.52 3.064 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.205 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -46.76 -47.66 20.72 Favored 'General case' 0 N--CA 1.515 2.819 0 C-N-CA 124.528 1.131 . . . . 0.0 112.569 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.56 -49.7 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.779 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -81.04 -6.91 59.36 Favored 'General case' 1 N--CA 1.545 4.29 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -110.75 -8.46 14.55 Favored 'General case' 1 N--CA 1.539 4.006 0 C-N-CA 124.569 1.148 . . . . 0.0 108.836 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -56.29 -27.08 52.16 Favored Glycine 0 N--CA 1.511 3.659 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -98.0 148.59 23.34 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.937 0.895 . . . . 0.0 108.981 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 49.5 m -82.15 149.83 63.27 Favored Pre-proline 0 N--CA 1.528 3.451 0 C-N-CA 125.808 1.643 . . . . 0.0 110.763 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo . . . . . 0 C--N 1.403 3.415 0 CA-C-N 122.138 1.799 . . . . 0.0 112.099 -176.621 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 68.6 mt . . . . . 0 N--CA 1.51 2.565 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -43.47 83.13 Favored 'General case' 0 N--CA 1.538 3.945 0 CA-C-N 119.361 0.982 . . . . 0.0 112.464 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -73.44 -36.55 65.94 Favored 'General case' 0 N--CA 1.529 3.521 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.31 -38.36 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 123.965 0.906 . . . . 0.0 110.804 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -67.96 -51.04 52.06 Favored 'General case' 0 N--CA 1.536 3.873 0 C-N-CA 124.28 1.032 . . . . 0.0 111.366 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 18.5 tt -60.84 -30.71 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 CA-C-O 122.154 0.978 . . . . 0.0 110.686 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -50.58 -27.78 7.42 Favored 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.841 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.69 -47.99 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 124.547 1.139 . . . . 0.0 109.292 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 21.4 mm -54.22 -46.0 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 C-N-CA 124.123 0.969 . . . . 0.0 111.78 -174.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 16.9 tt -68.04 -40.18 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.984 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.25 -30.36 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.767 0.827 . . . . 0.0 109.304 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -72.15 -20.71 79.22 Favored Glycine 1 N--CA 1.522 4.387 0 CA-C-N 118.914 0.779 . . . . 0.0 112.692 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.8 m -68.17 -50.33 55.15 Favored 'General case' 0 N--CA 1.529 3.485 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . 0.479 HD12 ' H ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -53.73 -32.69 53.01 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -175.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . 0.479 ' H ' HD12 ' C' ' 692' ' ' LEU . 0.3 OUTLIER -61.99 -33.77 59.84 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.004 0 CA-C-N 119.618 1.099 . . . . 0.0 111.364 -177.52 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -72.71 -33.28 60.61 Favored Glycine 1 N--CA 1.52 4.254 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.37 -41.93 94.75 Favored 'General case' 0 N--CA 1.535 3.796 0 C-N-CA 124.874 1.27 . . . . 0.0 111.023 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -52.08 -24.32 6.65 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 10.7 tp -52.1 -38.29 23.83 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.35 0 CA-C-N 119.434 1.016 . . . . 0.0 112.357 -176.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.3 p -56.59 -30.65 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.999 0 C-N-CA 123.543 0.737 . . . . 0.0 111.836 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -54.28 -26.95 31.97 Favored 'General case' 0 N--CA 1.536 3.86 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.84 65.58 Favored 'General case' 0 N--CA 1.521 3.116 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.54 -30.42 45.21 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.142 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 9.8 tp -53.44 -35.61 60.66 Favored 'General case' 0 N--CA 1.535 3.808 0 CA-C-O 119.067 -0.492 . . . . 0.0 110.461 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 64.8 m -59.28 -45.99 89.76 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-N 118.941 0.792 . . . . 0.0 112.789 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 40.2 tp -66.51 -34.84 78.82 Favored 'General case' 1 N--CA 1.548 4.448 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.7 -38.87 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' C' ' 710' ' ' GLN . 9.4 t-20 -58.24 -34.22 70.2 Favored 'General case' 0 C--O 1.183 -2.418 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.28 -177.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -46.63 -45.5 19.13 Favored 'General case' 0 N--CA 1.511 2.602 0 C-N-CA 124.464 1.106 . . . . 0.0 112.319 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.8 -45.81 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -77.99 -4.62 47.95 Favored 'General case' 0 N--CA 1.526 3.339 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.687 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' C' ' 706' ' ' ASN . 1.8 tt0 -111.29 -15.53 13.59 Favored 'General case' 1 N--CA 1.546 4.345 0 C-N-CA 124.307 1.043 . . . . 0.0 108.465 -178.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -77.01 -11.72 85.32 Favored Glycine 1 N--CA 1.533 5.117 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 174.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -76.03 153.67 36.28 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 128.321 2.648 . . . . 0.0 107.646 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 58.9 m -80.69 145.8 59.03 Favored Pre-proline 1 N--CA 1.545 4.317 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -69.83 131.51 21.29 Favored 'Trans proline' 0 C--N 1.4 3.272 0 CA-C-N 120.36 1.164 . . . . 0.0 110.459 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 N--CA 1.525 3.315 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.585 177.534 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.5 2.031 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -67.39 -49.35 64.24 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -66.5 -30.95 71.4 Favored 'General case' 0 N--CA 1.532 3.66 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 682' ' ' ILE . . . . . 0.45 ' O ' HD13 ' A' ' 686' ' ' ILE . 51.0 mm -74.65 -30.31 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.86 0 C-N-CA 125.53 1.532 . . . . 0.0 110.19 177.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -51.47 57.0 Favored 'General case' 1 N--CA 1.548 4.463 0 C-N-CA 123.463 0.705 . . . . 0.0 111.964 -178.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.5 tt -65.8 -35.66 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.753 0 CA-C-O 122.091 0.948 . . . . 0.0 109.611 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -60.18 -40.91 91.62 Favored 'General case' 0 N--CA 1.512 2.669 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.825 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 686' ' ' ILE . . . . . 0.45 HD13 ' O ' ' A' ' 682' ' ' ILE . 1.2 mp -55.18 -49.19 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.793 0.837 . . . . 0.0 109.232 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 53.8 mt -56.81 -40.47 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 78.8 mt -68.26 -41.12 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.967 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.18 -30.63 49.24 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.601 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.21 -34.64 90.51 Favored Glycine 1 N--CA 1.522 4.405 0 C-N-CA 123.637 0.637 . . . . 0.0 111.991 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 62.9 m -68.39 -37.27 80.23 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.615 0.766 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.8 -44.44 86.31 Favored 'General case' 0 N--CA 1.536 3.864 0 C-N-CA 123.499 0.72 . . . . 0.0 112.627 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 693' ' ' ILE . . . . . 0.43 ' O ' HD13 ' A' ' 693' ' ' ILE 0.259 0.3 OUTLIER -61.3 -43.83 97.3 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.215 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -173.248 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.03 -34.15 89.19 Favored Glycine 1 N--CA 1.534 5.206 0 CA-C-N 120.017 1.28 . . . . 0.0 111.822 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.0 -39.78 86.92 Favored 'General case' 1 N--CA 1.541 4.114 0 C-N-CA 124.715 1.206 . . . . 0.0 110.326 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 696' ' ' ARG . . . . . 0.651 ' HE ' HD11 ' C' ' 693' ' ' ILE . 23.0 mmt180 -59.97 -28.25 67.52 Favored 'General case' 1 N--CA 1.544 4.275 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.3 -36.66 41.14 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.313 0 CA-C-O 122.09 0.948 . . . . 0.0 109.618 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 68.7 t -54.58 -28.0 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.092 0 C-N-CA 126.69 1.996 . . . . 0.0 111.216 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -53.15 -25.8 14.67 Favored 'General case' 0 N--CA 1.534 3.753 0 C-N-CA 123.559 0.744 . . . . 0.0 110.748 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.49 -39.89 74.01 Favored 'General case' 0 N--CA 1.525 3.297 0 O-C-N 121.766 -0.584 . . . . 0.0 109.668 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.8 -36.03 67.88 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.16 -35.45 64.77 Favored 'General case' 1 N--CA 1.54 4.073 0 C-N-CA 123.526 0.731 . . . . 0.0 110.806 -179.532 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 9.6 t -60.62 -46.89 88.57 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 44.8 tp -67.58 -36.82 81.65 Favored 'General case' 0 N--CA 1.536 3.865 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.88 -46.36 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 C-N-CA 123.295 0.638 . . . . 0.0 110.027 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 706' ' ' ASN . . . . . 0.434 HD22 ' C ' ' A' ' 706' ' ' ASN . 0.2 OUTLIER -72.47 -20.09 61.45 Favored 'General case' 0 N--CA 1.513 2.68 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.142 -178.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -48.07 -44.36 31.33 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 123.682 0.793 . . . . 0.0 109.798 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.37 -43.49 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.75 -19.85 57.16 Favored 'General case' 0 N--CA 1.528 3.465 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.5 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 710' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 706' ' ' ASN . 2.6 tt0 -89.88 -14.83 33.45 Favored 'General case' 0 N--CA 1.538 3.937 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -59.15 -12.41 16.29 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -74.19 154.56 39.01 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 124.424 1.089 . . . . 0.0 108.37 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 73.0 m -94.53 147.41 33.19 Favored Pre-proline 0 N--CA 1.528 3.472 0 C-N-CA 125.123 1.369 . . . . 0.0 107.866 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 N--CA 1.527 3.496 0 CA-C-N 121.574 1.598 . . . . 0.0 109.739 -174.962 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 N--CA 1.525 3.323 0 CA-C-O 120.462 0.172 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -71.1 -30.13 66.14 Favored 'General case' 0 N--CA 1.529 3.519 0 O-C-N 122.126 -0.359 . . . . 0.0 110.607 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -68.95 -37.95 79.16 Favored 'General case' 0 N--CA 1.519 3.015 0 CA-C-O 118.902 -0.57 . . . . 0.0 111.056 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 682' ' ' ILE . . . . . 0.473 HD12 ' N ' ' B' ' 683' ' ' ARG . 2.1 pp -72.2 -23.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.809 0 CA-C-N 118.943 0.792 . . . . 0.0 110.767 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 683' ' ' ARG . . . . . 0.473 ' N ' HD12 ' B' ' 682' ' ' ILE . 1.3 ttp180 -60.34 -54.28 47.58 Favored 'General case' 1 N--CA 1.546 4.369 0 CA-C-N 119.205 0.911 . . . . 0.0 112.736 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -70.7 -31.32 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.97 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.072 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -52.56 -30.05 28.74 Favored 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 124.0 0.92 . . . . 0.0 112.873 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 686' ' ' ILE . . . . . 0.475 ' N ' HD12 ' B' ' 686' ' ' ILE . 1.4 mp -68.69 -36.51 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.755 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.08 -42.45 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.321 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.84 -50.29 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.985 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.36 -29.04 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.304 0 C-N-CA 124.519 1.127 . . . . 0.0 108.879 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.13 -17.92 68.52 Favored Glycine 1 N--CA 1.524 4.516 0 C-N-CA 123.674 0.654 . . . . 0.0 113.172 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 75.1 m -68.92 -52.21 31.74 Favored 'General case' 0 N--CA 1.527 3.421 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.17 -32.78 73.44 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.469 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.2 OUTLIER -60.64 -38.65 79.1 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.38 0 CA-C-N 120.384 1.447 . . . . 0.0 112.148 -176.425 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.88 -34.62 89.12 Favored Glycine 1 N--CA 1.526 4.7 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.21 -42.44 95.14 Favored 'General case' 0 N--CA 1.538 3.933 0 C-N-CA 124.572 1.149 . . . . 0.0 111.261 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -51.85 -24.23 5.88 Favored 'General case' 0 N--CA 1.536 3.863 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 20.0 tt -52.18 -36.71 21.13 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 CA-C-N 120.959 1.709 . . . . 0.0 111.844 -176.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 13.5 p -54.84 -28.12 19.59 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.028 0 C-N-CA 123.821 0.848 . . . . 0.0 111.17 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -55.75 -28.04 53.83 Favored 'General case' 1 N--CA 1.546 4.347 0 O-C-N 121.451 -0.781 . . . . 0.0 109.828 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.54 -44.09 68.21 Favored 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 65.5 t -68.85 -32.16 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.271 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 2.9 tp -54.2 -35.52 62.46 Favored 'General case' 0 N--CA 1.536 3.858 0 C-N-CA 123.391 0.676 . . . . 0.0 110.275 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 20.7 t -60.07 -46.68 88.75 Favored 'General case' 0 N--CA 1.529 3.525 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 36.2 tp -67.4 -34.6 77.6 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.43 -43.57 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 706' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' B' ' 709' ' ' ARG . 11.5 p30 -72.4 -22.71 61.08 Favored 'General case' 0 N--CA 1.517 2.913 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.062 -178.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -48.43 -36.96 15.92 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.296 0.57 . . . . 0.0 110.306 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.42 -41.52 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 176.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 709' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' B' ' 706' ' ' ASN . 86.5 mtt180 -75.92 -17.08 59.9 Favored 'General case' 0 N--CA 1.525 3.288 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.667 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -87.96 -12.33 44.87 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.76 -19.08 6.26 Favored Glycine 1 N--CA 1.521 4.344 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -114.24 130.04 56.63 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 124.99 1.316 . . . . 0.0 107.737 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 96.4 p -82.82 147.41 54.84 Favored Pre-proline 0 N--CA 1.526 3.366 0 C-N-CA 125.182 1.393 . . . . 0.0 110.53 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--N 1.4 3.268 0 CA-C-N 121.653 1.626 . . . . 0.0 110.671 -177.365 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.527 3.41 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -68.85 -37.13 78.91 Favored 'General case' 0 N--CA 1.524 3.271 0 CA-C-O 121.597 0.713 . . . . 0.0 110.961 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -66.35 -40.37 89.76 Favored 'General case' 0 N--CA 1.518 2.935 0 CA-C-N 114.151 -1.386 . . . . 0.0 111.415 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 18.2 pt -73.01 -29.38 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -52.09 66.96 Favored 'General case' 1 N--CA 1.55 4.562 0 C-N-CA 123.106 0.563 . . . . 0.0 110.421 -176.434 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.94 -36.33 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -52.17 -27.66 15.26 Favored 'General case' 0 N--CA 1.526 3.366 0 C-N-CA 124.214 1.005 . . . . 0.0 110.816 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 9.0 mm -67.61 -48.01 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.235 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 23.8 mt -64.33 -36.06 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.749 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.891 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 44.3 mm -59.86 -42.59 89.67 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.202 0 CA-C-N 118.151 0.432 . . . . 0.0 110.192 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.62 -31.69 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 C-N-CA 123.838 0.855 . . . . 0.0 110.328 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.66 -36.3 93.08 Favored Glycine 1 N--CA 1.522 4.428 0 C-N-CA 123.259 0.457 . . . . 0.0 112.194 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 64.2 m -68.12 -37.35 81.01 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.876 0.87 . . . . 0.0 111.805 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.13 -45.01 92.05 Favored 'General case' 0 N--CA 1.536 3.866 0 C-N-CA 123.589 0.755 . . . . 0.0 112.675 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 693' ' ' ILE . . . . . 0.651 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.286 0.1 OUTLIER -63.38 -48.84 85.39 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.466 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.95 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild core ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -55.2 -31.99 56.8 Favored Glycine 1 N--CA 1.531 5.016 0 CA-C-N 119.214 0.915 . . . . 0.0 113.279 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.23 -38.8 88.78 Favored 'General case' 0 N--CA 1.539 3.984 0 C-N-CA 124.728 1.211 . . . . 0.0 110.357 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -60.09 -28.48 67.87 Favored 'General case' 1 N--CA 1.543 4.203 0 O-C-N 121.575 -0.703 . . . . 0.0 111.878 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.71 -36.97 44.75 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.155 0 CA-C-O 121.916 0.865 . . . . 0.0 109.512 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.59 -27.13 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.292 0 C-N-CA 126.395 1.878 . . . . 0.0 110.695 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -54.09 -27.11 30.74 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.139 0.576 . . . . 0.0 111.797 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.84 86.86 Favored 'General case' 0 N--CA 1.527 3.405 0 O-C-N 122.038 -0.414 . . . . 0.0 110.367 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 14.0 m -70.51 -31.75 47.53 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.025 0 CA-C-N 118.09 0.404 . . . . 0.0 110.085 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.66 -33.7 61.11 Favored 'General case' 0 N--CA 1.53 3.563 0 C-N-CA 123.521 0.729 . . . . 0.0 110.629 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 64.3 m -58.6 -46.95 85.9 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 21.7 tp -65.56 -34.88 79.28 Favored 'General case' 1 N--CA 1.549 4.505 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.81 -38.88 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -65.46 -23.89 67.03 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 123.251 0.62 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 11.5 tpt85 -49.73 -37.24 28.55 Favored 'General case' 0 N--CA 1.516 2.849 0 CA-C-O 121.753 0.787 . . . . 0.0 110.76 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.75 -37.33 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.015 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.83 -28.7 58.37 Favored 'General case' 1 N--CA 1.54 4.031 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -89.71 -3.05 58.39 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 124.615 1.166 . . . . 0.0 109.133 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.92 -24.34 33.96 Favored Glycine 1 N--CA 1.526 4.67 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 176.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -121.2 143.97 48.84 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 113.042 -1.579 . . . . 0.0 107.769 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 90.1 p -82.57 146.66 53.94 Favored Pre-proline 0 N--CA 1.53 3.527 0 CA-C-O 117.305 -1.331 . . . . 0.0 110.239 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.5 131.34 42.08 Favored 'Trans proline' 0 C--N 1.399 3.193 0 CA-C-N 121.614 1.612 . . . . 0.0 111.169 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 61.6 mt . . . . . 0 N--CA 1.521 3.107 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.19 179.685 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 32.9 m120 . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 13.1 p90 -64.65 -21.14 66.65 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.841 0.856 . . . . 0.0 111.106 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.91 -30.29 5.72 Favored 'General case' 0 N--CA 1.511 2.62 0 C-N-CA 125.607 1.563 . . . . 0.0 111.574 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -68.16 -48.25 65.82 Favored 'General case' 0 N--CA 1.528 3.468 0 CA-C-O 121.711 0.767 . . . . 0.0 110.741 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -61.54 -33.45 73.87 Favored 'General case' 0 N--CA 1.527 3.382 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.101 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.4 mm -76.23 -34.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.456 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -53.41 26.3 Favored 'General case' 1 N--CA 1.546 4.372 0 O-C-N 121.721 -0.612 . . . . 0.0 111.988 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.9 tt -55.52 -35.3 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 CA-C-O 122.479 1.133 . . . . 0.0 110.234 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -58.83 -33.68 70.68 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 112.933 -1.939 . . . . 0.0 110.478 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.0 mm -68.64 -37.93 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.072 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 24.1 mt -58.25 -39.23 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.25 -44.42 99.1 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.015 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 67.0 t -64.36 -30.35 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.943 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.83 -33.73 88.01 Favored Glycine 0 N--CA 1.514 3.883 0 C-N-CA 123.87 0.748 . . . . 0.0 112.124 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.9 m -68.16 -37.04 80.59 Favored 'General case' 0 N--CA 1.526 3.331 0 C-N-CA 123.362 0.665 . . . . 0.0 111.009 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.3 mp -58.97 -43.23 91.34 Favored 'General case' 0 N--CA 1.537 3.921 0 C-N-CA 123.212 0.605 . . . . 0.0 111.787 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.7 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.268 0.8 OUTLIER -63.66 -48.88 84.67 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -175.718 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.43 -25.61 65.26 Favored Glycine 1 N--CA 1.526 4.694 0 O-C-N 120.704 -1.248 . . . . 0.0 112.981 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.33 -38.74 88.37 Favored 'General case' 0 N--CA 1.536 3.86 0 C-N-CA 124.116 0.967 . . . . 0.0 110.604 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . 0.413 ' HE ' ' CD1' ' C' ' 693' ' ' ILE . 13.9 mmt180 -52.03 -23.74 5.66 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 18.6 tt -51.96 -36.42 19.77 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.178 0 CA-C-N 119.444 1.02 . . . . 0.0 111.333 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 11.2 p -54.64 -27.42 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 C-N-CA 124.235 1.014 . . . . 0.0 111.107 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -55.07 -28.79 55.02 Favored 'General case' 1 N--CA 1.545 4.319 0 O-C-N 121.692 -0.63 . . . . 0.0 109.879 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.19 -45.03 67.49 Favored 'General case' 0 N--CA 1.522 3.14 0 CA-C-O 122.031 0.92 . . . . 0.0 108.966 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.7 -34.31 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.816 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.233 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.6 tp -55.64 -34.81 65.27 Favored 'General case' 0 N--CA 1.529 3.498 0 C-N-CA 123.965 0.906 . . . . 0.0 111.021 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 51.0 m -59.1 -45.02 91.94 Favored 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 35.7 tp -67.66 -34.8 77.65 Favored 'General case' 0 N--CA 1.538 3.95 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 66.1 t -67.86 -39.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.828 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 710' ' ' GLN . 16.1 m120 -59.21 -23.63 62.44 Favored 'General case' 0 N--CA 1.512 2.658 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.891 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 22.8 tpt85 -48.07 -41.02 24.93 Favored 'General case' 0 N--CA 1.524 3.269 0 CA-C-O 121.372 0.606 . . . . 0.0 110.84 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 52.9 t -72.6 -41.97 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-N 114.689 -1.141 . . . . 0.0 107.944 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -76.72 -11.35 59.83 Favored 'General case' 1 N--CA 1.545 4.298 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.417 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 706' ' ' ASN . 1.4 tm0? -111.87 -10.4 14.0 Favored 'General case' 0 N--CA 1.516 2.851 0 C-N-CA 125.549 1.54 . . . . 0.0 107.634 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.13 -22.83 7.04 Favored Glycine 1 N--CA 1.518 4.135 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -98.39 153.46 18.55 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 124.076 0.95 . . . . 0.0 109.472 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 66.1 m -80.51 152.17 72.55 Favored Pre-proline 0 N--CA 1.526 3.345 0 C-N-CA 126.859 2.064 . . . . 0.0 111.216 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.33 130.6 39.21 Favored 'Trans proline' 0 C--N 1.401 3.302 0 CA-C-N 121.527 1.581 . . . . 0.0 111.74 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 58.7 mt 60.37 42.58 14.56 Favored 'General case' 0 N--CA 1.52 3.047 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.694 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 61.5 p . . . . . 0 N--CA 1.524 3.266 0 C-N-CA 124.446 1.098 . . . . 0.0 112.1 179.609 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -71.2 174.68 6.07 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 124.119 0.968 . . . . 0.0 110.035 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -48.66 -29.24 4.16 Favored 'General case' 0 N--CA 1.518 2.929 0 C-N-CA 125.691 1.597 . . . . 0.0 112.299 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -63.36 -49.52 73.55 Favored 'General case' 0 N--CA 1.532 3.643 0 CA-C-N 118.367 0.531 . . . . 0.0 111.32 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -64.0 -31.53 72.75 Favored 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.88 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.02 -32.22 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.864 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.26 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -51.57 48.87 Favored 'General case' 1 N--CA 1.554 4.745 0 CA-C-N 118.713 0.688 . . . . 0.0 112.057 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.8 tt -62.1 -31.66 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-O 122.029 0.918 . . . . 0.0 110.779 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -51.94 -35.29 45.34 Favored 'General case' 0 N--CA 1.513 2.685 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.762 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.22 -41.56 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.082 0 C-N-CA 124.607 1.163 . . . . 0.0 108.788 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 47.3 mt -60.38 -37.37 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 64.0 mt -64.62 -44.79 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.43 -30.32 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 C-N-CA 123.827 0.851 . . . . 0.0 108.727 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.26 -30.58 78.1 Favored Glycine 1 N--CA 1.517 4.054 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 32.4 m -68.79 -37.59 79.4 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 123.431 0.692 . . . . 0.0 111.413 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.32 -41.4 75.94 Favored 'General case' 0 N--CA 1.535 3.781 0 C-N-CA 123.443 0.697 . . . . 0.0 111.932 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.748 HD11 ' HE ' ' C' ' 696' ' ' ARG 0.292 0.3 OUTLIER -60.7 -46.1 96.47 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.386 0 CA-C-N 118.956 0.798 . . . . 0.0 112.206 -176.485 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.83 -27.68 64.67 Favored Glycine 1 N--CA 1.528 4.833 0 CA-C-N 119.159 0.89 . . . . 0.0 112.307 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.4 tt -67.93 -37.38 81.58 Favored 'General case' 1 N--CA 1.548 4.431 0 C-N-CA 125.126 1.37 . . . . 0.0 109.31 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . 0.7 ' HE ' HD11 ' A' ' 693' ' ' ILE . 25.0 mmt180 -62.89 -27.37 69.31 Favored 'General case' 1 N--CA 1.54 4.073 0 C-N-CA 123.806 0.842 . . . . 0.0 112.336 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.51 -38.78 50.73 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.593 0 CA-C-O 122.477 1.132 . . . . 0.0 109.473 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 64.3 t -57.21 -29.6 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.032 0 C-N-CA 126.962 2.105 . . . . 0.0 111.293 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -53.75 -26.92 25.7 Favored 'General case' 0 N--CA 1.534 3.774 0 C-N-CA 122.976 0.51 . . . . 0.0 111.16 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.42 -35.14 67.48 Favored 'General case' 0 N--CA 1.528 3.449 0 O-C-N 121.956 -0.465 . . . . 0.0 109.849 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.7 -32.7 53.32 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.343 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 7.9 tp -54.97 -33.67 62.62 Favored 'General case' 0 N--CA 1.539 3.999 0 C-N-CA 124.087 0.955 . . . . 0.0 110.421 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 84.9 p -59.01 -45.73 89.94 Favored 'General case' 0 N--CA 1.528 3.471 0 O-C-N 122.344 -0.223 . . . . 0.0 111.21 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . 0.404 HD13 HE21 ' C' ' 710' ' ' GLN . 23.3 tp -63.09 -36.56 84.0 Favored 'General case' 1 N--CA 1.548 4.427 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.74 -42.09 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.427 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -75.48 -21.41 58.09 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 123.126 0.57 . . . . 0.0 110.101 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.18 -42.63 60.98 Favored 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.52 -42.35 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.903 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -75.31 -7.54 54.23 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.225 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.99 -14.76 17.73 Favored 'General case' 1 N--CA 1.546 4.33 0 C-N-CA 124.201 1.0 . . . . 0.0 108.825 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -84.33 -18.15 63.08 Favored Glycine 1 N--CA 1.522 4.378 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -87.93 152.35 22.13 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 126.72 2.008 . . . . 0.0 108.285 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 67.0 m -93.23 148.63 36.0 Favored Pre-proline 1 N--CA 1.547 4.381 0 C-N-CA 125.914 1.686 . . . . 0.0 113.764 -176.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -60.46 132.75 45.07 Favored 'Trans proline' 0 C--N 1.404 3.46 0 CA-C-N 120.788 1.317 . . . . 0.0 109.76 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 28.6 mt -46.56 165.8 0.02 OUTLIER 'General case' 0 N--CA 1.535 3.787 0 C-N-CA 125.259 1.424 . . . . 0.0 111.84 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.522 3.174 0 CA-C-O 117.774 -1.108 . . . . 0.0 112.369 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 6.0 p30 . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 31.8 p90 56.55 -56.14 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.42 0 C-N-CA 126.373 1.869 . . . . 0.0 114.016 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 7.1 tt -51.6 -44.41 62.84 Favored 'General case' 0 N--CA 1.516 2.86 0 C-N-CA 125.25 1.42 . . . . 0.0 112.293 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -61.6 -49.75 75.36 Favored 'General case' 0 N--CA 1.529 3.522 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -66.01 -33.73 76.48 Favored 'General case' 0 N--CA 1.531 3.591 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 95.5 mt -74.34 -25.33 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.807 0 C-N-CA 124.789 1.236 . . . . 0.0 110.445 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -50.69 62.52 Favored 'General case' 1 N--CA 1.555 4.82 0 CA-C-N 119.682 1.128 . . . . 0.0 110.133 -178.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.2 tt -66.25 -31.06 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.41 0 C-N-CA 123.71 0.804 . . . . 0.0 109.115 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -54.86 -28.38 49.66 Favored 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.015 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 21.4 mm -68.5 -44.13 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 C-N-CA 123.689 0.796 . . . . 0.0 109.548 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.71 -41.0 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.59 -47.35 93.36 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.253 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.91 -30.11 47.83 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.161 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.05 82.47 Favored Glycine 1 N--CA 1.516 4.029 0 C-N-CA 123.625 0.631 . . . . 0.0 112.408 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 62.4 m -67.9 -37.07 81.27 Favored 'General case' 0 N--CA 1.533 3.681 0 C-N-CA 123.463 0.705 . . . . 0.0 111.698 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.91 -40.81 77.01 Favored 'General case' 0 N--CA 1.533 3.689 0 C-N-CA 123.339 0.656 . . . . 0.0 111.868 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . 0.421 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -60.62 -39.89 82.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -174.181 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -71.41 -25.56 75.11 Favored Glycine 1 N--CA 1.531 5.002 0 O-C-N 121.074 -1.016 . . . . 0.0 111.107 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.85 -43.38 98.96 Favored 'General case' 0 N--CA 1.535 3.806 0 C-N-CA 123.99 0.916 . . . . 0.0 109.392 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . 0.748 ' HE ' HD11 ' B' ' 693' ' ' ILE . 10.1 mmt180 -54.2 -25.49 23.07 Favored 'General case' 0 N--CA 1.539 3.986 0 C-N-CA 125.045 1.338 . . . . 0.0 114.565 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 72.2 mt -53.84 -37.54 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.863 0 CA-C-N 118.541 0.609 . . . . 0.0 109.841 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.05 -26.18 32.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.238 0 C-N-CA 124.965 1.306 . . . . 0.0 111.971 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -53.59 -27.54 27.16 Favored 'General case' 1 N--CA 1.549 4.523 0 O-C-N 120.972 -1.08 . . . . 0.0 110.219 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -61.41 -46.07 91.67 Favored 'General case' 0 N--CA 1.525 3.325 0 O-C-N 121.967 -0.458 . . . . 0.0 110.881 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.1 -31.33 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.63 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.68 -34.16 57.79 Favored 'General case' 0 N--CA 1.536 3.86 0 C-N-CA 123.12 0.568 . . . . 0.0 110.742 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 86.9 p -59.67 -46.35 89.3 Favored 'General case' 0 N--CA 1.532 3.642 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 45.7 tp -65.8 -35.68 81.39 Favored 'General case' 1 N--CA 1.542 4.147 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.31 -43.45 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.38 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -68.4 -25.43 65.04 Favored 'General case' 0 N--CA 1.515 2.8 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.25 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.09 -43.92 61.15 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 119.087 0.858 . . . . 0.0 109.233 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.25 -47.39 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.1 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -74.73 -15.72 60.77 Favored 'General case' 0 N--CA 1.535 3.792 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.895 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . 0.404 HE21 HD13 ' B' ' 704' ' ' LEU . 4.7 mm100 -114.12 -3.86 13.2 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -48.83 -27.81 6.71 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 124.399 0.999 . . . . 0.0 111.796 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -75.44 155.18 36.56 Favored 'General case' 0 N--CA 1.526 3.336 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 31.1 t -77.76 146.96 73.6 Favored Pre-proline 0 N--CA 1.536 3.865 0 C-N-CA 125.001 1.32 . . . . 0.0 112.584 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -58.51 129.95 35.02 Favored 'Trans proline' 0 C--N 1.408 3.699 0 CA-C-N 120.643 1.265 . . . . 0.0 110.234 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 60.3 tp -88.39 -43.37 11.54 Favored 'General case' 0 N--CA 1.525 3.304 0 CA-C-N 114.273 -1.33 . . . . 0.0 108.0 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.522 3.127 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.779 179.744 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 41.9 t30 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -158.43 -173.7 4.43 Favored 'General case' 0 N--CA 1.523 3.187 0 C-N-CA 124.453 1.101 . . . . 0.0 108.535 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 683' ' ' ARG . 18.6 mt -50.34 -41.42 51.34 Favored 'General case' 0 N--CA 1.504 2.272 0 C-N-CA 125.487 1.515 . . . . 0.0 112.639 -178.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -55.97 -45.38 78.92 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -73.18 -38.71 66.06 Favored 'General case' 0 N--CA 1.533 3.706 0 CA-C-O 121.555 0.693 . . . . 0.0 109.485 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 50.6 mm -74.89 -26.0 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 125.072 1.349 . . . . 0.0 111.276 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 679' ' ' LEU . 56.5 ttt180 -67.06 -55.7 13.21 Favored 'General case' 1 N--CA 1.542 4.146 0 C-N-CA 123.976 0.91 . . . . 0.0 110.56 -177.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.3 tt -64.4 -32.54 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.537 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -52.57 -44.02 65.62 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.946 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 66.5 mt -68.54 -37.22 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.445 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 42.9 mt -65.89 -34.69 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.697 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 48.3 mm -63.72 -42.46 96.05 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.383 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 88.0 t -64.98 -29.88 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.882 0 C-N-CA 123.664 0.786 . . . . 0.0 108.959 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -61.19 -36.84 93.01 Favored Glycine 1 N--CA 1.522 4.413 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 53.4 m -68.91 -37.34 78.89 Favored 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 124.027 0.931 . . . . 0.0 111.451 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.8 mp -58.04 -38.97 77.24 Favored 'General case' 1 N--CA 1.546 4.332 0 C-N-CA 124.175 0.99 . . . . 0.0 112.346 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.806 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.268 1.3 tp -69.23 -45.76 78.78 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.027 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.205 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -73.7 -12.21 80.66 Favored Glycine 1 N--CA 1.525 4.578 0 O-C-N 120.744 -1.222 . . . . 0.0 112.046 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . 0.426 ' O ' HD23 ' A' ' 695' ' ' LEU . 6.1 tt -70.48 -41.28 72.92 Favored 'General case' 0 N--CA 1.535 3.8 0 C-N-CA 124.127 0.971 . . . . 0.0 109.745 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . 0.841 ' HE ' HD11 ' C' ' 693' ' ' ILE . 22.8 mmt180 -52.51 -28.41 20.39 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.952 0.901 . . . . 0.0 113.054 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 42.0 mm -56.39 -43.81 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.332 0 C-N-CA 124.041 0.936 . . . . 0.0 112.486 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 3.3 p -66.66 -51.91 51.32 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.623 0 CA-C-N 118.702 0.683 . . . . 0.0 112.618 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' A' ' 702' ' ' LEU 0.522 0.9 OUTLIER -54.8 -18.93 5.39 Favored 'General case' 0 C--O 1.165 -3.392 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.255 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -51.93 -29.51 20.52 Favored 'General case' 1 N--CA 1.539 4.012 0 O-C-N 120.93 -1.106 . . . . 0.0 109.009 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 12.7 m -62.75 -29.27 46.63 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.491 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 699' ' ' PHE . 7.1 tt -50.5 -34.64 25.88 Favored 'General case' 1 N--CA 1.541 4.113 0 C-N-CA 125.311 1.445 . . . . 0.0 110.955 -178.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 68.0 m -59.34 -45.32 91.7 Favored 'General case' 0 N--CA 1.534 3.772 0 CA-C-N 118.467 0.576 . . . . 0.0 110.78 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.06 -35.21 80.0 Favored 'General case' 1 N--CA 1.54 4.025 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 50.1 t -68.06 -39.78 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.788 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 710' ' ' GLN . 3.1 m120 -64.82 -24.6 67.6 Favored 'General case' 0 N--CA 1.512 2.674 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.61 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . 0.468 HH12 ' NH2' ' B' ' 707' ' ' ARG . 21.6 tpt180 -47.71 -30.86 4.16 Favored 'General case' 0 N--CA 1.529 3.486 0 C-N-CA 123.3 0.64 . . . . 0.0 111.446 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 58.1 t -75.03 -47.89 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.59 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.97 -12.19 59.96 Favored 'General case' 1 N--CA 1.549 4.496 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.707 179.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 706' ' ' ASN . 51.9 tt0 -112.81 -4.15 14.05 Favored 'General case' 0 N--CA 1.518 2.963 0 C-N-CA 125.591 1.556 . . . . 0.0 108.065 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.68 -27.84 50.35 Favored Glycine 0 N--CA 1.509 3.548 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -96.8 153.12 18.07 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 123.677 0.791 . . . . 0.0 109.138 177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 50.8 m -80.89 149.32 66.86 Favored Pre-proline 0 N--CA 1.526 3.37 0 C-N-CA 125.965 1.706 . . . . 0.0 111.315 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.19 130.96 43.51 Favored 'Trans proline' 0 C--N 1.403 3.43 0 CA-C-N 122.019 1.757 . . . . 0.0 111.059 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 715' ' ' LEU . 1.7 mm? -61.51 -117.87 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 124.996 1.318 . . . . 0.0 110.125 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 N--CA 1.524 3.249 0 CA-C-O 118.398 -0.81 . . . . 0.0 110.816 -179.804 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -168.68 133.0 1.54 Allowed 'General case' 0 N--CA 1.52 3.072 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.3 -30.83 12.82 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.467 1.507 . . . . 0.0 112.477 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -61.61 -49.24 77.37 Favored 'General case' 0 N--CA 1.534 3.768 0 CA-C-N 118.394 0.543 . . . . 0.0 112.316 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.14 -37.82 86.65 Favored 'General case' 0 N--CA 1.525 3.325 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.43 -29.39 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.916 0 C-N-CA 125.397 1.479 . . . . 0.0 110.921 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -50.98 60.67 Favored 'General case' 1 N--CA 1.547 4.389 0 C-N-CA 123.601 0.76 . . . . 0.0 111.719 -177.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.68 -30.84 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 124.068 0.947 . . . . 0.0 109.808 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -56.18 -34.49 66.27 Favored 'General case' 0 N--CA 1.523 3.211 0 C-N-CA 124.58 1.152 . . . . 0.0 110.441 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 24.3 mm -60.43 -37.52 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.677 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.581 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.31 -40.02 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.114 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.93 -48.52 87.46 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.28 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.86 -31.37 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.761 0 C-N-CA 123.839 0.855 . . . . 0.0 109.688 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.37 -32.31 83.76 Favored Glycine 1 N--CA 1.516 4.021 0 C-N-CA 123.607 0.622 . . . . 0.0 112.439 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 62.5 m -67.98 -36.9 80.82 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 123.507 0.723 . . . . 0.0 111.971 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 9.0 mp -54.68 -41.75 70.56 Favored 'General case' 0 N--CA 1.537 3.885 0 C-N-CA 123.431 0.692 . . . . 0.0 112.737 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.422 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.2 OUTLIER -60.37 -43.94 94.9 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.297 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -174.975 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -66.43 -28.49 73.75 Favored Glycine 1 N--CA 1.525 4.617 0 O-C-N 121.177 -0.952 . . . . 0.0 111.746 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -62.1 -42.13 98.91 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 124.529 1.131 . . . . 0.0 110.682 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . 0.806 ' HE ' HD11 ' A' ' 693' ' ' ILE . 25.1 mmt180 -52.33 -25.62 10.09 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.33 -37.61 37.48 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.501 0 CA-C-N 120.538 1.517 . . . . 0.0 112.26 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.3 p -54.36 -27.66 17.49 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.128 0 C-N-CA 124.523 1.129 . . . . 0.0 112.063 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -52.08 -25.66 9.23 Favored 'General case' 0 N--CA 1.537 3.89 0 C-N-CA 123.357 0.663 . . . . 0.0 110.104 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.38 -38.45 68.88 Favored 'General case' 0 N--CA 1.52 3.031 0 C-N-CA 122.72 0.408 . . . . 0.0 110.17 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -69.42 -30.39 45.42 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 8.8 tp -52.53 -35.32 53.14 Favored 'General case' 0 N--CA 1.537 3.881 0 C-N-CA 122.974 0.51 . . . . 0.0 110.71 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 1.6 t -58.74 -46.16 88.05 Favored 'General case' 1 N--CA 1.54 4.045 0 CA-C-N 118.824 0.738 . . . . 0.0 112.081 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 34.5 tp -66.38 -34.77 78.71 Favored 'General case' 1 N--CA 1.542 4.174 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.87 -38.51 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -63.58 -24.04 67.64 Favored 'General case' 0 N--CA 1.522 3.168 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.01 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . 0.468 ' NH2' HH12 ' A' ' 707' ' ' ARG . 17.2 tpt180 -49.56 -47.75 48.95 Favored 'General case' 0 N--CA 1.522 3.149 0 CA-C-O 121.8 0.809 . . . . 0.0 110.438 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 51.3 t -63.14 -37.46 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.712 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.456 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -75.31 -28.06 59.55 Favored 'General case' 0 N--CA 1.531 3.624 0 CA-C-O 121.18 0.514 . . . . 0.0 109.896 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -89.91 -4.87 57.3 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.963 1.305 . . . . 0.0 108.466 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.75 -23.42 29.49 Favored Glycine 1 N--CA 1.523 4.434 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -120.27 141.25 50.16 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 125.33 1.452 . . . . 0.0 107.59 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 68.5 m -82.97 146.61 52.38 Favored Pre-proline 0 N--CA 1.529 3.502 0 CA-C-O 117.285 -1.34 . . . . 0.0 110.157 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -65.21 130.81 26.5 Favored 'Trans proline' 0 C--N 1.395 3.004 0 CA-C-N 121.701 1.643 . . . . 0.0 109.192 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -60.18 -21.8 62.15 Favored 'General case' 0 N--CA 1.527 3.388 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.122 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.522 3.167 0 C-N-CA 124.297 1.039 . . . . 0.0 112.177 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -169.06 -40.44 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.591 0.756 . . . . 0.0 109.195 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.58 -43.21 62.37 Favored 'General case' 0 N--CA 1.521 3.113 0 C-N-CA 124.887 1.275 . . . . 0.0 111.663 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -65.64 -48.75 71.1 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.813 0.445 . . . . 0.0 111.891 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -64.64 -34.46 78.33 Favored 'General case' 0 N--CA 1.529 3.495 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 93.9 mt -74.86 -24.89 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.946 0 C-N-CA 124.944 1.298 . . . . 0.0 110.662 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -66.18 -53.14 41.06 Favored 'General case' 1 N--CA 1.547 4.423 0 CA-C-N 118.999 0.818 . . . . 0.0 110.529 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.3 tt -66.34 -30.77 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.228 0 C-N-CA 123.873 0.869 . . . . 0.0 109.422 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -53.32 -31.28 43.41 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.926 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 16.5 mm -67.99 -46.93 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.015 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.4 -34.39 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.752 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 79.0 mt -68.33 -44.82 83.42 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.327 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.98 -30.67 45.99 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.44 -42.04 96.09 Favored Glycine 1 N--CA 1.523 4.47 0 C-N-CA 123.88 0.753 . . . . 0.0 112.658 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 70.2 m -67.36 -36.83 82.19 Favored 'General case' 0 N--CA 1.529 3.477 0 CA-C-O 122.232 1.015 . . . . 0.0 109.94 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.67 -41.11 80.89 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 113.306 -1.77 . . . . 0.0 113.037 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . 0.841 HD11 ' HE ' ' A' ' 696' ' ' ARG . 0.6 OUTLIER -68.85 -47.66 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -176.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.22 -25.87 60.68 Favored Glycine 1 N--CA 1.53 4.941 0 CA-C-N 119.62 1.1 . . . . 0.0 112.441 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.07 -42.59 99.7 Favored 'General case' 0 N--CA 1.534 3.773 0 C-N-CA 124.348 1.059 . . . . 0.0 109.237 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -53.94 -26.59 26.25 Favored 'General case' 0 N--CA 1.532 3.674 0 C-N-CA 124.927 1.291 . . . . 0.0 113.88 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 76.1 mt -54.64 -38.3 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.837 0 C-N-CA 123.413 0.685 . . . . 0.0 111.699 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.52 -28.91 23.5 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.263 0 C-N-CA 123.643 0.777 . . . . 0.0 112.55 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -52.66 -27.49 17.51 Favored 'General case' 0 N--CA 1.536 3.854 0 C-N-CA 122.978 0.511 . . . . 0.0 110.826 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.63 -33.52 66.37 Favored 'General case' 0 N--CA 1.531 3.597 0 O-C-N 121.877 -0.514 . . . . 0.0 110.259 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.8 -30.95 48.79 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.222 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 7.1 tp -52.83 -33.03 47.51 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.75 0.82 . . . . 0.0 110.441 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 83.4 p -58.08 -46.07 86.08 Favored 'General case' 0 N--CA 1.53 3.531 0 O-C-N 121.766 -0.584 . . . . 0.0 111.572 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.25 -36.09 82.52 Favored 'General case' 1 N--CA 1.544 4.246 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.9 t -68.54 -41.48 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -68.07 -22.91 64.91 Favored 'General case' 0 N--CA 1.514 2.751 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.219 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -49.85 -47.31 51.74 Favored 'General case' 0 N--CA 1.511 2.62 0 CA-C-O 121.932 0.872 . . . . 0.0 109.124 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.4 -40.06 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.728 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.416 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.93 -22.9 55.52 Favored 'General case' 0 N--CA 1.534 3.775 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -89.15 -13.52 38.21 Favored 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -53.85 -27.33 36.17 Favored Glycine 1 N--CA 1.517 4.076 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -95.34 154.67 17.08 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 124.36 1.064 . . . . 0.0 108.849 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 99.4 p -80.3 149.57 69.32 Favored Pre-proline 0 N--CA 1.529 3.508 0 C-N-CA 126.388 1.875 . . . . 0.0 111.363 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -56.45 131.29 44.85 Favored 'Trans proline' 0 C--N 1.402 3.392 0 CA-C-N 120.918 1.364 . . . . 0.0 110.289 -174.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 34.6 mt 65.28 176.81 0.2 Allowed 'General case' 0 N--CA 1.522 3.132 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.442 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.522 3.166 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.182 -179.591 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -156.65 -76.94 0.09 Allowed 'General case' 0 N--CA 1.521 3.078 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp -52.06 -27.88 15.39 Favored 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 124.212 1.005 . . . . 0.0 112.639 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -66.77 -51.42 56.0 Favored 'General case' 0 N--CA 1.532 3.64 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.95 -32.84 74.75 Favored 'General case' 0 N--CA 1.526 3.373 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 91.4 mt -74.62 -29.84 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.544 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -59.33 -52.78 64.18 Favored 'General case' 1 N--CA 1.555 4.789 0 CA-C-O 122.264 1.03 . . . . 0.0 110.942 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.8 tt -70.37 -32.28 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.715 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.079 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -50.13 -25.03 3.13 Favored 'General case' 0 N--CA 1.53 3.528 0 C-N-CA 123.85 0.86 . . . . 0.0 112.549 -174.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.91 -35.17 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 17.3 pt -64.01 -39.15 84.42 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.416 0 CA-C-N 120.016 1.28 . . . . 0.0 109.62 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.1 -48.73 85.8 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.254 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 50.4 t -67.39 -41.38 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 124.513 1.125 . . . . 0.0 110.03 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.52 -40.61 90.92 Favored Glycine 1 N--CA 1.522 4.402 0 C-N-CA 125.241 1.4 . . . . 0.0 112.798 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 74.2 m -67.28 -35.26 79.13 Favored 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 124.29 1.036 . . . . 0.0 108.415 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.21 -47.07 86.7 Favored 'General case' 0 N--CA 1.523 3.208 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.768 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.516 HD11 ' HE ' ' B' ' 696' ' ' ARG . 0.0 OUTLIER -70.82 -27.93 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.868 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.39 -29.36 70.12 Favored Glycine 1 N--CA 1.528 4.833 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.7 tt -67.01 -40.12 87.21 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 125.581 1.552 . . . . 0.0 110.36 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . 0.475 ' HE ' HD11 ' C' ' 693' ' ' ILE . 38.4 mmt180 -52.27 -25.42 9.34 Favored 'General case' 0 N--CA 1.531 3.611 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 15.8 tt -54.13 -38.99 40.3 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.172 0 CA-C-N 119.302 0.955 . . . . 0.0 113.096 -175.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 10.3 p -57.33 -30.44 35.55 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.164 0 C-N-CA 123.412 0.685 . . . . 0.0 111.672 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -53.97 -25.25 19.85 Favored 'General case' 0 N--CA 1.537 3.886 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.05 -34.45 63.57 Favored 'General case' 0 N--CA 1.523 3.199 0 O-C-N 122.035 -0.415 . . . . 0.0 109.933 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.47 -32.02 51.43 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.209 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.2 -33.03 51.0 Favored 'General case' 0 N--CA 1.535 3.82 0 C-N-CA 123.811 0.844 . . . . 0.0 110.77 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 68.5 m -58.03 -45.64 86.62 Favored 'General case' 0 N--CA 1.531 3.612 0 O-C-N 121.652 -0.655 . . . . 0.0 110.919 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.04 -34.49 78.56 Favored 'General case' 1 N--CA 1.543 4.19 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 48.0 t -67.63 -39.66 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.949 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -67.77 -25.95 65.87 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.372 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -50.05 -41.65 48.16 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.543 0.687 . . . . 0.0 111.173 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 68.1 t -61.68 -38.97 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -76.14 -20.62 57.43 Favored 'General case' 0 N--CA 1.524 3.257 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.503 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -88.66 -12.45 42.41 Favored 'General case' 0 N--CA 1.518 2.956 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -60.2 -13.82 30.01 Favored Glycine 1 N--CA 1.517 4.076 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 177.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -108.56 154.57 21.76 Favored 'General case' 0 N--CA 1.532 3.665 0 C-N-CA 125.06 1.344 . . . . 0.0 109.77 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 48.4 t -80.47 150.13 69.79 Favored Pre-proline 0 N--CA 1.53 3.571 0 C-N-CA 126.107 1.763 . . . . 0.0 110.877 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.72 130.35 38.52 Favored 'Trans proline' 0 C--N 1.402 3.359 0 CA-C-N 122.247 1.838 . . . . 0.0 113.221 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 45.0 tp -87.73 106.97 18.41 Favored 'General case' 0 N--CA 1.523 3.191 0 CA-C-N 113.221 -1.808 . . . . 0.0 108.094 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.524 3.24 0 CA-C-O 118.106 -0.949 . . . . 0.0 111.916 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -166.15 175.16 8.61 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 124.228 1.011 . . . . 0.0 108.411 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' B' ' 683' ' ' ARG . 63.7 mt -52.36 -46.41 66.15 Favored 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 123.533 0.733 . . . . 0.0 112.656 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -59.45 -43.44 93.16 Favored 'General case' 0 N--CA 1.532 3.661 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -72.34 -37.32 68.88 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 93.0 mt -74.82 -25.16 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 C-N-CA 125.029 1.332 . . . . 0.0 111.862 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' B' ' 679' ' ' LEU . 17.4 ttp180 -66.13 -52.24 50.39 Favored 'General case' 1 N--CA 1.549 4.481 0 C-N-CA 124.381 1.072 . . . . 0.0 110.577 -177.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.46 -32.77 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 CA-C-N 113.692 -1.595 . . . . 0.0 108.815 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -54.1 -30.79 49.91 Favored 'General case' 0 N--CA 1.52 3.028 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.276 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 17.9 mm -68.87 -41.85 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.626 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 40.3 mt -71.39 -34.86 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.016 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 50.8 mm -58.7 -40.19 78.7 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.668 0 CA-C-N 119.449 1.022 . . . . 0.0 109.738 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.41 -31.95 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.534 0 C-N-CA 123.704 0.802 . . . . 0.0 110.501 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.32 -32.34 79.37 Favored Glycine 1 N--CA 1.517 4.037 0 C-N-CA 123.404 0.526 . . . . 0.0 112.683 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 58.9 m -67.5 -36.96 82.09 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.719 0.808 . . . . 0.0 111.63 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 9.4 mp -56.55 -45.79 81.05 Favored 'General case' 0 N--CA 1.537 3.907 0 C-N-CA 123.44 0.696 . . . . 0.0 112.681 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.738 HD11 ' HE ' ' C' ' 696' ' ' ARG . 1.0 OUTLIER -62.71 -49.04 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -175.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -61.9 -25.21 65.62 Favored Glycine 1 N--CA 1.525 4.601 0 CA-C-N 119.628 1.103 . . . . 0.0 113.12 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 4.4 tt -66.74 -41.86 87.18 Favored 'General case' 0 N--CA 1.535 3.797 0 C-N-CA 124.567 1.147 . . . . 0.0 110.639 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . 0.516 ' HE ' HD11 ' A' ' 693' ' ' ILE . 26.7 mmt180 -52.13 -25.26 8.48 Favored 'General case' 0 N--CA 1.536 3.833 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.8 tt -54.14 -36.88 33.64 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 CA-C-N 119.878 1.217 . . . . 0.0 112.066 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.14 -27.97 17.21 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.012 0 C-N-CA 124.332 1.053 . . . . 0.0 111.779 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -52.15 -25.82 9.89 Favored 'General case' 0 N--CA 1.538 3.965 0 C-N-CA 123.402 0.681 . . . . 0.0 109.756 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.73 -38.43 69.77 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 122.767 0.427 . . . . 0.0 110.017 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.24 -32.01 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.956 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.42 -36.45 61.53 Favored 'General case' 0 N--CA 1.537 3.897 0 C-N-CA 122.908 0.483 . . . . 0.0 110.809 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 26.5 m -62.11 -47.21 85.63 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 46.7 tp -67.83 -35.92 79.45 Favored 'General case' 1 N--CA 1.545 4.32 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.14 -43.25 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.365 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -71.29 -20.99 62.14 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.876 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -47.73 -46.7 30.03 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 40.1 t -59.35 -41.59 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.389 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -76.69 -22.11 54.43 Favored 'General case' 0 N--CA 1.533 3.678 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.866 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -8.3 36.22 Favored 'General case' 0 N--CA 1.517 2.916 0 C-N-CA 124.925 1.29 . . . . 0.0 108.44 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.12 -32.49 35.71 Favored Glycine 1 N--CA 1.516 4.015 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -100.81 130.99 46.91 Favored 'General case' 0 N--CA 1.529 3.507 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 88.1 p -81.94 146.8 56.52 Favored Pre-proline 0 N--CA 1.527 3.422 0 C-N-CA 124.947 1.299 . . . . 0.0 110.627 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -67.0 130.01 21.99 Favored 'Trans proline' 0 C--N 1.399 3.195 0 CA-C-N 121.334 1.512 . . . . 0.0 109.445 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 56.3 mt -81.83 177.2 9.01 Favored 'General case' 0 N--CA 1.52 3.064 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.401 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.521 3.124 0 CA-C-O 117.854 -1.069 . . . . 0.0 108.894 179.727 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 . . . . . 0 N--CA 1.497 1.875 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -170.83 -30.0 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 123.994 0.918 . . . . 0.0 109.191 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.27 -43.95 79.28 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 124.809 1.243 . . . . 0.0 111.352 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -69.78 -40.07 76.25 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.217 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -65.68 -37.37 86.3 Favored 'General case' 0 N--CA 1.52 3.046 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.036 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 26.9 pt -73.09 -25.7 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 CA-C-N 118.347 0.521 . . . . 0.0 110.627 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -50.07 70.86 Favored 'General case' 1 N--CA 1.546 4.361 0 C-N-CA 122.806 0.443 . . . . 0.0 110.826 -176.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.48 -31.95 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.564 0 C-N-CA 124.002 0.921 . . . . 0.0 109.7 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -53.9 -41.14 67.28 Favored 'General case' 0 N--CA 1.518 2.969 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.37 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.71 -39.12 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.92 -45.06 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.664 0 C-N-CA 123.458 0.703 . . . . 0.0 110.56 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 76.0 mt -59.9 -49.04 85.44 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.42 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.62 -29.65 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.125 0 C-N-CA 125.286 1.434 . . . . 0.0 109.688 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.27 -31.69 81.69 Favored Glycine 1 N--CA 1.519 4.21 0 C-N-CA 123.717 0.675 . . . . 0.0 112.388 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.3 m -68.28 -36.39 79.31 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.962 0.905 . . . . 0.0 111.849 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.27 -35.7 62.83 Favored 'General case' 0 N--CA 1.534 3.755 0 CA-C-O 118.295 -0.859 . . . . 0.0 113.265 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . 0.497 ' O ' HD12 ' C' ' 693' ' ' ILE 0.255 0.1 OUTLIER -60.53 -49.98 82.22 Favored 'Isoleucine or valine' 1 N--CA 1.561 5.121 0 CA-C-N 120.272 1.397 . . . . 0.0 112.455 -176.164 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.17 -29.22 68.02 Favored Glycine 1 N--CA 1.532 5.054 0 CA-C-N 119.452 1.024 . . . . 0.0 111.69 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.59 -42.41 98.28 Favored 'General case' 0 N--CA 1.538 3.939 0 C-N-CA 123.653 0.781 . . . . 0.0 109.836 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . 0.738 ' HE ' HD11 ' B' ' 693' ' ' ILE . 24.4 mmt180 -53.82 -25.2 18.28 Favored 'General case' 1 N--CA 1.542 4.164 0 C-N-CA 124.673 1.189 . . . . 0.0 113.82 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 70.6 mt -54.94 -39.78 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 O-C-N 121.625 -0.672 . . . . 0.0 110.454 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 2.9 p -67.36 -30.97 50.85 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.405 0 C-N-CA 123.859 0.864 . . . . 0.0 110.875 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.56 -30.15 65.01 Favored 'General case' 1 N--CA 1.542 4.143 0 O-C-N 121.055 -1.028 . . . . 0.0 111.689 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.98 -37.59 72.73 Favored 'General case' 1 N--CA 1.54 4.025 0 CA-C-O 121.8 0.809 . . . . 0.0 109.104 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.36 -28.05 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.277 0 C-N-CA 125.066 1.346 . . . . 0.0 108.678 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.1 tp -52.25 -32.66 38.11 Favored 'General case' 0 N--CA 1.532 3.643 0 C-N-CA 123.53 0.732 . . . . 0.0 110.108 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 89.1 p -56.56 -46.13 80.87 Favored 'General case' 0 N--CA 1.53 3.553 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 46.5 tp -66.04 -35.11 79.65 Favored 'General case' 1 N--CA 1.547 4.384 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.03 -40.02 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.0 OUTLIER -71.92 -23.73 61.52 Favored 'General case' 0 N--CA 1.517 2.902 0 CA-C-O 118.245 -0.883 . . . . 0.0 109.225 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -48.47 -32.04 7.24 Favored 'General case' 0 N--CA 1.526 3.357 0 CA-C-N 118.832 0.742 . . . . 0.0 110.499 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.74 -49.07 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -77.84 -10.26 59.47 Favored 'General case' 1 N--CA 1.54 4.06 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.701 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.6 tt0 -114.14 -9.28 12.93 Favored 'General case' 0 N--CA 1.522 3.145 0 C-N-CA 125.365 1.466 . . . . 0.0 108.759 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -57.58 -30.04 61.74 Favored Glycine 0 N--CA 1.512 3.712 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -80.76 155.13 26.84 Favored 'General case' 0 N--CA 1.524 3.269 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 97.0 p -79.49 149.15 71.39 Favored Pre-proline 0 N--CA 1.528 3.469 0 C-N-CA 126.281 1.832 . . . . 0.0 111.757 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -56.87 131.86 48.11 Favored 'Trans proline' 0 C--N 1.401 3.316 0 CA-C-N 120.669 1.274 . . . . 0.0 111.001 -174.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 65.56 -67.87 0.13 Allowed 'General case' 0 N--CA 1.527 3.376 0 C-N-CA 125.616 1.566 . . . . 0.0 110.72 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 83.2 p . . . . . 0 N--CA 1.526 3.328 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.494 -179.036 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 54.87 102.74 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.19 0 C-N-CA 124.294 1.038 . . . . 0.0 112.152 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 680' ' ' TRP . 0.3 OUTLIER -52.37 -22.44 4.62 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 125.262 1.425 . . . . 0.0 112.493 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . 0.406 ' N ' HD12 ' A' ' 679' ' ' LEU . 95.1 m95 -57.3 -51.1 70.72 Favored 'General case' 0 N--CA 1.533 3.689 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -64.88 -31.28 72.44 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.53 -33.59 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.966 0 C-N-CA 123.879 0.872 . . . . 0.0 108.664 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -51.79 42.42 Favored 'General case' 1 N--CA 1.554 4.748 0 CA-C-N 118.48 0.582 . . . . 0.0 112.11 -177.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.39 -38.23 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 CA-C-O 122.496 1.141 . . . . 0.0 110.184 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -52.39 -29.29 23.36 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 113.111 -1.858 . . . . 0.0 111.113 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 28.5 mm -68.46 -37.23 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 C-N-CA 124.244 1.018 . . . . 0.0 109.602 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 37.5 mt -64.9 -38.27 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.268 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.53 -41.72 93.66 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.27 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.76 -30.51 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.92 0 C-N-CA 123.965 0.906 . . . . 0.0 109.185 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.16 -34.29 89.26 Favored Glycine 1 N--CA 1.518 4.159 0 C-N-CA 123.382 0.515 . . . . 0.0 111.985 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.5 m -68.67 -37.51 79.66 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.562 0.745 . . . . 0.0 111.172 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 7.9 mp -57.54 -42.54 83.15 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 123.751 0.82 . . . . 0.0 112.328 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.77 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.274 0.5 OUTLIER -62.44 -48.91 86.09 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.308 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.231 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.44 -30.29 67.91 Favored Glycine 1 N--CA 1.53 4.954 0 CA-C-N 119.814 1.188 . . . . 0.0 112.899 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.94 -41.47 99.51 Favored 'General case' 1 N--CA 1.539 4.013 0 C-N-CA 124.411 1.084 . . . . 0.0 111.234 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -51.71 -24.28 5.55 Favored 'General case' 0 N--CA 1.538 3.933 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 18.5 tt -52.7 -36.03 22.22 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.26 0 CA-C-N 120.143 1.338 . . . . 0.0 111.684 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 12.6 p -54.09 -28.19 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.951 0 C-N-CA 124.304 1.042 . . . . 0.0 111.43 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -55.9 -29.08 59.44 Favored 'General case' 1 N--CA 1.544 4.256 0 O-C-N 121.489 -0.757 . . . . 0.0 109.764 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.7 -43.08 69.72 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 63.0 t -68.87 -33.34 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.112 0 C-N-CA 124.713 1.205 . . . . 0.0 109.105 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.13 -32.62 62.22 Favored 'General case' 0 N--CA 1.535 3.817 0 C-N-CA 124.175 0.99 . . . . 0.0 109.901 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.5 p -59.04 -45.14 91.48 Favored 'General case' 0 N--CA 1.528 3.426 0 O-C-N 121.353 -0.842 . . . . 0.0 111.253 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.21 -33.35 74.39 Favored 'General case' 1 N--CA 1.542 4.152 0 O-C-N 121.431 -0.793 . . . . 0.0 108.959 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.18 -39.22 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.873 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . 0.438 ' ND2' HH11 ' A' ' 709' ' ' ARG . 9.3 m120 -62.71 -22.8 66.78 Favored 'General case' 0 N--CA 1.519 3.007 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.693 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -50.38 -41.34 51.72 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-O 121.915 0.864 . . . . 0.0 110.012 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 64.1 t -62.96 -36.68 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . 0.438 HH11 ' ND2' ' A' ' 706' ' ' ASN . 50.6 mtm180 -75.7 -3.86 37.1 Favored 'General case' 0 N--CA 1.523 3.195 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.46 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -103.26 -14.9 16.15 Favored 'General case' 1 N--CA 1.552 4.662 0 C-N-CA 123.685 0.794 . . . . 0.0 108.921 177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -81.94 -6.65 88.77 Favored Glycine 1 N--CA 1.528 4.82 0 N-CA-C 106.736 -2.546 . . . . 0.0 106.736 173.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -105.47 154.29 20.54 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 128.036 2.534 . . . . 0.0 106.611 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 32.1 t -98.13 147.3 32.89 Favored Pre-proline 1 N--CA 1.556 4.831 0 C-N-CA 125.422 1.489 . . . . 0.0 112.997 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -68.76 129.82 19.4 Favored 'Trans proline' 0 C--N 1.408 3.668 0 CA-C-N 121.212 1.468 . . . . 0.0 109.048 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 41.3 mt 50.05 70.63 0.48 Allowed 'General case' 0 N--CA 1.522 3.137 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.799 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.522 3.168 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.281 -179.658 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -169.16 176.61 5.18 Favored 'General case' 0 N--CA 1.522 3.137 0 C-N-CA 124.162 0.985 . . . . 0.0 109.367 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -27.67 14.09 Favored 'General case' 0 N--CA 1.516 2.853 0 C-N-CA 124.352 1.061 . . . . 0.0 113.732 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -70.98 -49.79 41.42 Favored 'General case' 0 N--CA 1.535 3.791 0 CA-C-O 121.155 0.503 . . . . 0.0 111.576 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -61.05 -31.42 71.07 Favored 'General case' 0 N--CA 1.533 3.688 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.98 -25.55 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.786 0 C-N-CA 125.913 1.685 . . . . 0.0 111.021 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . 0.404 HH11 HD12 ' B' ' 687' ' ' ILE . 0.6 OUTLIER -66.07 -52.29 50.24 Favored 'General case' 1 N--CA 1.547 4.386 0 CA-C-O 121.574 0.702 . . . . 0.0 111.409 -177.964 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.8 tt -68.0 -32.34 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.171 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.594 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -54.27 -30.49 50.75 Favored 'General case' 0 N--CA 1.522 3.15 0 C-N-CA 123.827 0.851 . . . . 0.0 111.213 -177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 16.1 mm -66.21 -37.69 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.937 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . 0.404 HD12 HH11 ' B' ' 683' ' ' ARG . 38.5 mt -62.3 -38.37 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.1 -46.53 93.41 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.361 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.4 t -62.04 -30.04 47.79 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.26 -31.73 81.82 Favored Glycine 1 N--CA 1.519 4.223 0 C-N-CA 123.562 0.601 . . . . 0.0 112.455 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 61.4 m -68.58 -36.92 79.41 Favored 'General case' 0 N--CA 1.527 3.388 0 C-N-CA 123.658 0.783 . . . . 0.0 111.367 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.56 -43.19 79.73 Favored 'General case' 0 N--CA 1.536 3.868 0 C-N-CA 123.713 0.805 . . . . 0.0 112.52 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.801 HD11 ' HE ' ' C' ' 696' ' ' ARG 0.281 0.6 OUTLIER -60.42 -48.97 86.16 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.621 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.091 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.77 -26.95 71.43 Favored Glycine 1 N--CA 1.533 5.121 0 CA-C-N 120.734 1.606 . . . . 0.0 112.373 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 5.3 tt -62.95 -43.05 99.86 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.806 0.843 . . . . 0.0 110.955 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . 0.77 ' HE ' HD11 ' A' ' 693' ' ' ILE . 26.0 mmt180 -53.14 -27.12 19.38 Favored 'General case' 1 N--CA 1.539 4.003 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 70.9 mt -54.74 -37.95 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.51 0 C-N-CA 123.954 0.902 . . . . 0.0 111.794 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.11 -31.61 42.11 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.301 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -54.23 -25.76 24.88 Favored 'General case' 0 N--CA 1.539 3.988 0 CA-C-N 118.793 0.724 . . . . 0.0 111.207 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.1 -37.78 69.85 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 121.65 -0.656 . . . . 0.0 110.248 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.22 -32.59 54.38 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 13.4 tp -54.87 -35.32 63.93 Favored 'General case' 0 N--CA 1.533 3.689 0 C-N-CA 123.154 0.581 . . . . 0.0 110.498 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 80.8 p -59.01 -48.41 81.67 Favored 'General case' 0 N--CA 1.521 3.119 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.22 -35.09 79.16 Favored 'General case' 1 N--CA 1.549 4.517 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.647 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.53 -38.78 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.378 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' B' ' 710' ' ' GLN . 2.2 p30 -62.24 -25.81 68.03 Favored 'General case' 0 N--CA 1.521 3.084 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.625 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 18.6 tpt85 -46.82 -32.56 3.78 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.617 0.767 . . . . 0.0 111.362 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 63.3 t -75.53 -48.8 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -78.36 -11.03 59.92 Favored 'General case' 1 N--CA 1.543 4.182 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.839 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' B' ' 706' ' ' ASN . 28.2 tt0 -113.63 -10.64 13.09 Favored 'General case' 0 N--CA 1.519 3.018 0 C-N-CA 125.929 1.692 . . . . 0.0 108.556 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.74 -24.43 32.92 Favored Glycine 0 N--CA 1.51 3.608 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -95.48 152.82 18.08 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 123.461 0.705 . . . . 0.0 109.226 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 48.7 m -81.31 150.76 68.26 Favored Pre-proline 0 N--CA 1.533 3.686 0 C-N-CA 126.264 1.826 . . . . 0.0 111.267 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.87 130.38 38.87 Favored 'Trans proline' 0 C--N 1.402 3.382 0 CA-C-N 121.984 1.744 . . . . 0.0 112.33 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . 0.754 ' H ' HD13 ' B' ' 715' ' ' LEU . 0.0 OUTLIER -58.64 170.15 0.83 Allowed 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.656 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 N--CA 1.519 2.999 0 C-N-CA 124.09 0.956 . . . . 0.0 111.955 -179.458 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 12.0 m120 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 25.3 t-105 -166.31 -71.3 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.034 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -24.05 64.47 Favored 'General case' 0 N--CA 1.521 3.117 0 C-N-CA 124.574 1.15 . . . . 0.0 110.814 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -70.15 -45.38 66.9 Favored 'General case' 0 N--CA 1.513 2.72 0 C-N-CA 124.809 1.244 . . . . 0.0 111.204 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -61.74 -38.78 89.22 Favored 'General case' 0 N--CA 1.518 2.939 0 CA-C-N 113.978 -1.464 . . . . 0.0 111.659 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 26.5 pt -72.45 -36.6 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 C-N-CA 122.671 0.388 . . . . 0.0 111.01 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -52.86 -51.23 61.78 Favored 'General case' 0 N--CA 1.539 3.98 0 CA-C-O 121.7 0.762 . . . . 0.0 111.625 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.23 -34.48 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.828 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -55.54 -43.74 76.07 Favored 'General case' 0 N--CA 1.537 3.891 0 C-N-CA 123.618 0.767 . . . . 0.0 109.523 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.51 -37.76 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.814 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 41.5 mt -71.08 -41.99 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 49.1 mm -59.68 -48.79 86.15 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.472 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 70.8 t -60.73 -30.22 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.671 0 C-N-CA 124.136 0.975 . . . . 0.0 109.737 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.27 91.87 Favored Glycine 1 N--CA 1.519 4.182 0 C-N-CA 123.307 0.479 . . . . 0.0 112.488 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 66.7 m -67.5 -37.07 82.28 Favored 'General case' 0 N--CA 1.528 3.472 0 C-N-CA 123.768 0.827 . . . . 0.0 112.041 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.73 -39.9 68.73 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 123.434 0.694 . . . . 0.0 112.312 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -40.85 86.28 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.07 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -174.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -71.71 -27.38 71.04 Favored Glycine 1 N--CA 1.527 4.721 0 O-C-N 121.173 -0.954 . . . . 0.0 110.973 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.48 -42.59 99.01 Favored 'General case' 0 N--CA 1.531 3.581 0 C-N-CA 124.176 0.99 . . . . 0.0 109.651 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . 0.801 ' HE ' HD11 ' B' ' 693' ' ' ILE . 25.5 mmt180 -53.96 -26.46 25.83 Favored 'General case' 0 N--CA 1.537 3.896 0 C-N-CA 124.471 1.109 . . . . 0.0 113.846 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 73.9 mt -54.62 -38.59 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 C-N-CA 123.578 0.751 . . . . 0.0 111.342 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 5.8 p -56.01 -27.33 22.82 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.324 0 C-N-CA 124.074 0.95 . . . . 0.0 112.281 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -51.73 -27.33 11.62 Favored 'General case' 0 N--CA 1.538 3.964 0 C-N-CA 123.311 0.645 . . . . 0.0 111.179 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.3 -34.11 66.19 Favored 'General case' 0 N--CA 1.532 3.649 0 O-C-N 121.857 -0.527 . . . . 0.0 109.952 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.1 m -69.36 -31.82 50.99 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.093 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 6.9 tp -53.5 -35.67 60.89 Favored 'General case' 0 N--CA 1.538 3.959 0 C-N-CA 123.293 0.637 . . . . 0.0 110.373 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 88.8 p -61.32 -47.8 84.28 Favored 'General case' 0 N--CA 1.516 2.867 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 45.9 tp -67.71 -35.52 78.95 Favored 'General case' 1 N--CA 1.546 4.331 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 74.7 t -69.04 -46.09 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -76.03 -23.36 55.15 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 123.515 0.51 . . . . 0.0 110.799 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -46.15 62.58 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.03 -43.23 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.891 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.682 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -75.96 -5.85 48.19 Favored 'General case' 0 N--CA 1.538 3.933 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.404 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -113.02 -12.67 13.19 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 125.619 1.568 . . . . 0.0 107.934 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.16 -33.8 31.08 Favored Glycine 0 N--CA 1.513 3.807 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -82.66 153.83 25.2 Favored 'General case' 0 N--CA 1.526 3.327 0 CA-C-N 114.201 -1.0 . . . . 0.0 108.626 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 59.8 m -80.2 149.23 69.08 Favored Pre-proline 0 N--CA 1.531 3.612 0 C-N-CA 126.201 1.8 . . . . 0.0 111.274 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -56.21 130.03 38.01 Favored 'Trans proline' 0 C--N 1.402 3.36 0 CA-C-N 121.175 1.455 . . . . 0.0 110.792 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -68.57 -19.77 64.49 Favored 'General case' 0 N--CA 1.524 3.273 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.56 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.52 3.061 0 C-N-CA 123.831 0.852 . . . . 0.0 109.099 -179.684 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 71.6 t-105 -166.9 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 28.2 tp -51.81 -43.39 63.08 Favored 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 124.328 1.051 . . . . 0.0 111.719 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -64.69 -36.24 83.65 Favored 'General case' 0 N--CA 1.528 3.436 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -72.54 -36.64 68.32 Favored 'General case' 0 N--CA 1.533 3.68 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.33 -24.46 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 C-N-CA 124.725 1.21 . . . . 0.0 109.882 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -67.14 -53.44 30.62 Favored 'General case' 1 N--CA 1.554 4.75 0 CA-C-N 119.488 1.04 . . . . 0.0 112.334 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.11 -32.01 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 C-N-CA 124.234 1.014 . . . . 0.0 109.727 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -56.82 -32.28 65.57 Favored 'General case' 0 N--CA 1.508 2.474 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.234 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 24.2 mm -68.33 -46.02 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 C-N-CA 124.172 0.989 . . . . 0.0 109.344 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.64 -35.95 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.178 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.301 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.67 -48.13 90.13 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.215 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.36 -31.36 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.409 0 C-N-CA 123.533 0.733 . . . . 0.0 109.83 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.27 -50.44 65.0 Favored Glycine 1 N--CA 1.52 4.261 0 C-N-CA 124.082 0.849 . . . . 0.0 112.494 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.2 m -58.66 -35.37 72.45 Favored 'General case' 0 N--CA 1.533 3.719 0 C-N-CA 124.475 1.11 . . . . 0.0 111.015 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 2.1 tp -53.81 -34.82 60.38 Favored 'General case' 0 N--CA 1.512 2.636 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.127 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.408 ' O ' HD13 ' A' ' 693' ' ' ILE . 0.3 OUTLIER -60.45 -38.96 79.66 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -177.088 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -72.87 -29.89 64.42 Favored Glycine 1 N--CA 1.519 4.232 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.2 tt -59.75 -42.47 93.29 Favored 'General case' 1 N--CA 1.541 4.076 0 C-N-CA 124.496 1.118 . . . . 0.0 110.944 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -51.31 -24.7 4.86 Favored 'General case' 0 N--CA 1.527 3.398 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 10.1 tp -53.05 -37.61 27.2 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.671 0 CA-C-N 119.837 1.199 . . . . 0.0 112.689 -176.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.18 -28.11 17.5 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.444 0 C-N-CA 124.222 1.009 . . . . 0.0 110.981 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -56.04 -27.65 54.13 Favored 'General case' 0 N--CA 1.536 3.833 0 O-C-N 121.506 -0.747 . . . . 0.0 110.008 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -66.98 -44.55 80.15 Favored 'General case' 0 N--CA 1.526 3.336 0 CA-C-O 122.18 0.99 . . . . 0.0 108.645 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 84.2 t -68.77 -33.72 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.173 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.36 -33.93 63.84 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 123.506 0.723 . . . . 0.0 110.161 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 86.0 p -58.08 -46.27 85.75 Favored 'General case' 0 N--CA 1.53 3.537 0 O-C-N 121.788 -0.57 . . . . 0.0 111.985 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.54 -35.85 82.32 Favored 'General case' 1 N--CA 1.542 4.175 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.78 -39.9 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . 0.633 HD22 ' HE ' ' A' ' 709' ' ' ARG . 3.9 m120 -66.19 -24.29 66.6 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.314 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -49.55 -46.67 49.01 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 124.027 0.931 . . . . 0.0 110.48 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.65 -50.85 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.915 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.482 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . 0.633 ' HE ' HD22 ' A' ' 706' ' ' ASN . 34.1 ptt180 -80.66 -3.45 50.63 Favored 'General case' 1 N--CA 1.55 4.536 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 178.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -111.57 -13.25 13.84 Favored 'General case' 0 N--CA 1.539 3.999 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.74 -31.19 53.54 Favored Glycine 0 N--CA 1.514 3.866 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -80.24 155.09 27.5 Favored 'General case' 0 N--CA 1.521 3.079 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 67.8 m -79.4 149.68 72.5 Favored Pre-proline 0 N--CA 1.532 3.629 0 C-N-CA 126.307 1.843 . . . . 0.0 112.111 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -55.57 130.83 42.6 Favored 'Trans proline' 0 C--N 1.402 3.391 0 CA-C-N 120.614 1.255 . . . . 0.0 110.817 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 54.5 tp 57.95 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 125.805 1.642 . . . . 0.0 111.043 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.522 3.137 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.378 179.735 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 7.4 p90 59.07 -30.44 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 126.379 1.872 . . . . 0.0 114.863 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.35 -45.02 95.07 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 123.688 0.795 . . . . 0.0 110.882 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -69.93 -36.16 75.12 Favored 'General case' 0 N--CA 1.522 3.136 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.451 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -40.73 76.76 Favored 'General case' 0 N--CA 1.531 3.586 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.893 -176.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . 0.534 HD12 ' N ' ' B' ' 683' ' ' ARG . 2.0 pp -72.19 -25.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 CA-C-N 118.701 0.682 . . . . 0.0 110.905 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . 0.534 ' N ' HD12 ' B' ' 682' ' ' ILE . 0.0 OUTLIER -67.05 -52.7 38.98 Favored 'General case' 1 N--CA 1.539 4.008 0 C-N-CA 123.988 0.915 . . . . 0.0 112.34 -177.739 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.4 tt -70.93 -30.16 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 123.833 0.853 . . . . 0.0 110.752 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -36.36 24.77 Favored 'General case' 0 N--CA 1.524 3.227 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.239 -173.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . 0.462 ' N ' HD12 ' B' ' 686' ' ' ILE . 1.5 mp -69.48 -37.55 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.311 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 34.4 mt -58.87 -35.04 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 35.8 mm -66.65 -46.7 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.28 -31.14 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 C-N-CA 123.85 0.86 . . . . 0.0 108.843 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.2 94.05 Favored Glycine 1 N--CA 1.523 4.436 0 C-N-CA 123.808 0.718 . . . . 0.0 111.817 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 71.1 m -69.09 -41.04 78.03 Favored 'General case' 0 N--CA 1.518 2.957 0 C-N-CA 123.563 0.745 . . . . 0.0 110.765 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.42 -45.91 88.8 Favored 'General case' 0 N--CA 1.535 3.806 0 C-N-CA 123.484 0.714 . . . . 0.0 112.614 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.683 HD11 ' HE ' ' C' ' 696' ' ' ARG . 0.0 OUTLIER -64.5 -34.98 73.13 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.137 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.719 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.1 -28.84 71.1 Favored Glycine 1 N--CA 1.527 4.721 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.3 tt -65.06 -43.52 91.97 Favored 'General case' 0 N--CA 1.531 3.614 0 C-N-CA 124.375 1.07 . . . . 0.0 109.808 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -54.96 -26.33 35.74 Favored 'General case' 0 N--CA 1.537 3.895 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 64.3 mt -55.18 -39.2 50.03 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 C-N-CA 123.236 0.614 . . . . 0.0 112.147 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -55.63 -28.64 23.56 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.51 0 C-N-CA 123.672 0.789 . . . . 0.0 112.468 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -51.77 -26.16 9.07 Favored 'General case' 0 N--CA 1.531 3.613 0 C-N-CA 123.2 0.6 . . . . 0.0 111.304 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.33 -32.33 62.42 Favored 'General case' 0 N--CA 1.53 3.569 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.8 m -69.26 -31.18 48.75 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.212 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 4.4 tp -53.46 -32.51 50.34 Favored 'General case' 0 N--CA 1.538 3.943 0 C-N-CA 123.671 0.789 . . . . 0.0 110.556 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 67.9 p -57.41 -45.33 84.69 Favored 'General case' 0 N--CA 1.532 3.642 0 O-C-N 121.759 -0.588 . . . . 0.0 111.019 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.11 -35.11 79.69 Favored 'General case' 1 N--CA 1.539 4.023 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.77 -40.0 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -63.47 -21.8 66.52 Favored 'General case' 0 N--CA 1.519 3.025 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.631 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -47.42 -47.55 26.63 Favored 'General case' 0 N--CA 1.519 3.022 0 C-N-CA 123.335 0.654 . . . . 0.0 109.495 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 52.7 t -58.95 -42.85 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.18 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -77.21 -15.51 59.46 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.681 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.5 -14.44 23.68 Favored 'General case' 1 N--CA 1.553 4.676 0 C-N-CA 124.123 0.969 . . . . 0.0 109.865 -177.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -87.72 -26.43 29.65 Favored Glycine 1 N--CA 1.523 4.438 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -75.59 146.95 39.99 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 126.01 1.724 . . . . 0.0 108.567 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 50.9 m -88.43 149.55 44.78 Favored Pre-proline 0 N--CA 1.537 3.922 0 C-N-CA 125.637 1.575 . . . . 0.0 113.266 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.27 132.31 51.48 Favored 'Trans proline' 0 C--N 1.402 3.359 0 CA-C-N 121.513 1.576 . . . . 0.0 111.983 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.93 -57.09 0.34 Allowed 'General case' 0 N--CA 1.537 3.914 0 C-N-CA 125.104 1.361 . . . . 0.0 107.565 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 60.4 p . . . . . 0 N--CA 1.526 3.369 0 C-N-CA 124.532 1.133 . . . . 0.0 113.054 179.067 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -165.16 176.51 8.41 Favored 'General case' 0 N--CA 1.526 3.341 0 C-N-CA 123.797 0.839 . . . . 0.0 108.988 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.45 -42.69 61.75 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 125.319 1.447 . . . . 0.0 111.907 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -68.13 -39.26 82.75 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.42 0.688 . . . . 0.0 111.429 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -68.82 -38.61 80.0 Favored 'General case' 0 N--CA 1.521 3.082 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.082 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 11.5 pt -73.24 -38.96 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.673 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -45.32 62.23 Favored 'General case' 0 N--CA 1.534 3.739 0 C-N-CA 123.237 0.615 . . . . 0.0 111.276 -176.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.7 tt -74.38 -34.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.939 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -60.31 -38.59 84.15 Favored 'General case' 0 N--CA 1.536 3.837 0 C-N-CA 124.018 0.927 . . . . 0.0 109.593 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.3 -37.05 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.081 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.377 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 8.2 mm -67.15 -43.44 88.54 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 41.4 mm -59.15 -49.14 84.43 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.359 0 CA-C-O 120.581 0.229 . . . . 0.0 110.529 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.23 -31.33 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -68.66 -36.5 83.05 Favored Glycine 0 N--CA 1.51 3.605 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.462 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 65.3 m -68.15 -36.77 80.2 Favored 'General case' 0 N--CA 1.529 3.497 0 CA-C-O 121.935 0.874 . . . . 0.0 110.006 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.17 -45.88 75.75 Favored 'General case' 0 N--CA 1.521 3.114 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.683 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . 0.54 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.1 OUTLIER -70.15 -35.98 65.91 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.056 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -176.676 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -75.12 -16.42 80.6 Favored Glycine 1 N--CA 1.522 4.417 0 O-C-N 121.648 -0.658 . . . . 0.0 111.72 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.25 -41.72 85.15 Favored 'General case' 0 N--CA 1.538 3.956 0 C-N-CA 124.489 1.116 . . . . 0.0 108.491 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . 0.683 ' HE ' HD11 ' B' ' 693' ' ' ILE . 32.0 mmt180 -52.12 -23.61 5.67 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 125.286 1.435 . . . . 0.0 114.362 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 11.0 tp -54.33 -38.51 40.38 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.431 0 CA-C-N 119.052 0.842 . . . . 0.0 112.777 -177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.89 -29.45 21.66 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.177 0 C-N-CA 124.356 1.063 . . . . 0.0 112.353 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -53.04 -25.05 11.17 Favored 'General case' 0 N--CA 1.533 3.694 0 C-N-CA 123.375 0.67 . . . . 0.0 110.086 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.15 70.53 Favored 'General case' 0 N--CA 1.523 3.195 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.35 -32.08 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.64 -34.77 59.7 Favored 'General case' 0 N--CA 1.537 3.88 0 C-N-CA 122.923 0.489 . . . . 0.0 110.314 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 58.9 m -59.28 -47.03 86.92 Favored 'General case' 0 N--CA 1.53 3.528 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 36.7 tp -66.62 -34.73 78.54 Favored 'General case' 1 N--CA 1.549 4.486 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.76 -38.39 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.371 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.95 -23.31 63.46 Favored 'General case' 0 N--CA 1.521 3.088 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.186 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -48.03 -46.06 32.68 Favored 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 121.873 0.844 . . . . 0.0 110.554 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.09 -43.45 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -77.12 -9.57 58.83 Favored 'General case' 0 N--CA 1.531 3.595 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.439 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -89.63 -15.48 32.62 Favored 'General case' 1 N--CA 1.547 4.376 0 C-N-CA 123.53 0.732 . . . . 0.0 109.782 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -71.6 -6.55 62.84 Favored Glycine 1 N--CA 1.524 4.547 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 175.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -75.97 155.14 35.31 Favored 'General case' 0 N--CA 1.512 2.632 0 C-N-CA 125.451 1.5 . . . . 0.0 109.027 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 95.9 p -100.48 146.96 32.91 Favored Pre-proline 0 N--CA 1.53 3.55 0 C-N-CA 125.357 1.463 . . . . 0.0 108.725 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -63.75 130.27 27.36 Favored 'Trans proline' 0 N--CA 1.521 3.105 0 CA-C-N 121.493 1.569 . . . . 0.0 109.061 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 55.9 79.46 0.17 Allowed 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 125.312 1.445 . . . . 0.0 109.926 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 N--CA 1.523 3.185 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.091 -179.631 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -165.3 -77.66 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.054 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -23.68 4.28 Favored 'General case' 0 N--CA 1.515 2.821 0 C-N-CA 124.133 0.973 . . . . 0.0 112.857 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -68.72 -50.43 50.81 Favored 'General case' 0 N--CA 1.529 3.513 0 CA-C-O 121.406 0.622 . . . . 0.0 111.989 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -61.5 -34.66 75.88 Favored 'General case' 0 N--CA 1.528 3.457 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.4 -24.95 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 C-N-CA 125.357 1.463 . . . . 0.0 110.074 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -66.79 -54.75 19.42 Favored 'General case' 1 N--CA 1.559 5.012 0 CA-C-N 119.592 1.087 . . . . 0.0 110.523 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.38 -30.78 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.945 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -55.26 -31.67 61.73 Favored 'General case' 0 N--CA 1.513 2.679 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.764 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 20.4 mm -64.11 -46.04 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.073 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 48.3 mt -56.93 -36.32 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.47 -45.3 85.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.059 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.13 -30.21 49.13 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.243 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.42 -32.79 85.37 Favored Glycine 1 N--CA 1.518 4.123 0 C-N-CA 123.596 0.617 . . . . 0.0 112.059 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 69.0 m -68.17 -36.95 80.44 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.558 0.743 . . . . 0.0 111.329 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.13 -44.16 83.09 Favored 'General case' 0 N--CA 1.538 3.962 0 C-N-CA 123.518 0.727 . . . . 0.0 112.363 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.533 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.257 0.5 OUTLIER -61.4 -49.69 83.45 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.293 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -175.587 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.34 -24.47 67.51 Favored Glycine 1 N--CA 1.527 4.741 0 CA-C-N 119.877 1.217 . . . . 0.0 112.721 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.5 tt -65.03 -43.27 92.94 Favored 'General case' 0 N--CA 1.535 3.816 0 C-N-CA 123.68 0.792 . . . . 0.0 109.715 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -53.39 -27.29 23.26 Favored 'General case' 1 N--CA 1.54 4.048 0 C-N-CA 124.199 1.0 . . . . 0.0 113.228 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.08 -38.21 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 C-N-CA 123.463 0.705 . . . . 0.0 110.36 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 2.0 p -55.71 -26.29 19.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.129 0 C-N-CA 124.566 1.146 . . . . 0.0 111.725 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -51.89 -26.02 9.28 Favored 'General case' 0 N--CA 1.539 3.995 0 C-N-CA 123.25 0.62 . . . . 0.0 110.777 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.69 -44.48 81.53 Favored 'General case' 0 N--CA 1.528 3.45 0 O-C-N 121.868 -0.52 . . . . 0.0 110.503 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 3.0 m -70.3 -33.49 54.46 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.433 0 CA-C-N 118.8 0.727 . . . . 0.0 109.969 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 4.7 tp -54.97 -33.21 62.2 Favored 'General case' 0 N--CA 1.537 3.885 0 C-N-CA 123.626 0.77 . . . . 0.0 109.857 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 96.0 p -59.36 -48.14 82.75 Favored 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 36.3 tp -63.94 -34.05 77.09 Favored 'General case' 1 N--CA 1.548 4.46 0 O-C-N 121.205 -0.935 . . . . 0.0 108.599 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.72 -38.34 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -61.47 -28.24 69.14 Favored 'General case' 0 N--CA 1.536 3.83 0 C-N-CA 122.92 0.488 . . . . 0.0 110.32 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -49.21 -47.52 46.08 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 121.714 0.769 . . . . 0.0 109.143 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.48 -36.3 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.722 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.666 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.1 -27.79 60.02 Favored 'General case' 0 N--CA 1.532 3.672 0 CA-C-O 120.925 0.393 . . . . 0.0 110.047 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -90.14 -13.47 35.63 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 124.623 1.169 . . . . 0.0 109.184 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.8 -25.64 9.69 Favored Glycine 1 N--CA 1.521 4.349 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -115.9 151.37 35.46 Favored 'General case' 0 N--CA 1.533 3.715 0 C-N-CA 124.573 1.149 . . . . 0.0 108.801 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 69.4 m -82.79 147.26 54.57 Favored Pre-proline 0 N--CA 1.528 3.442 0 C-N-CA 125.408 1.483 . . . . 0.0 109.694 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -61.53 130.85 33.25 Favored 'Trans proline' 0 C--N 1.396 3.067 0 CA-C-N 121.805 1.68 . . . . 0.0 110.03 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.8 pp -66.99 148.24 52.2 Favored 'General case' 0 N--CA 1.523 3.213 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.981 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 N--CA 1.522 3.169 0 CA-C-O 117.89 -1.053 . . . . 0.0 111.898 -179.638 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -165.35 -47.31 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 123.642 0.777 . . . . 0.0 109.062 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.8 tt -54.62 -40.3 68.8 Favored 'General case' 0 N--CA 1.514 2.759 0 C-N-CA 124.701 1.2 . . . . 0.0 111.862 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -68.32 -48.21 65.51 Favored 'General case' 0 N--CA 1.528 3.432 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -62.32 -31.96 72.65 Favored 'General case' 0 N--CA 1.536 3.872 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.05 -25.24 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.029 0 C-N-CA 125.628 1.571 . . . . 0.0 111.007 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -52.32 59.23 Favored 'General case' 1 N--CA 1.55 4.537 0 CA-C-N 118.677 0.672 . . . . 0.0 110.475 -178.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 18.5 tt -71.21 -30.29 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.798 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.664 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -51.06 -36.56 40.52 Favored 'General case' 0 N--CA 1.525 3.296 0 CA-C-O 121.64 0.733 . . . . 0.0 111.819 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.67 -36.73 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 C-N-CA 125.196 1.399 . . . . 0.0 109.677 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 18.1 mm -61.56 -41.08 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.8 -44.5 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.881 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.85 -30.7 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.799 0 C-N-CA 123.566 0.746 . . . . 0.0 109.087 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.66 -32.48 83.24 Favored Glycine 1 N--CA 1.52 4.271 0 C-N-CA 123.399 0.523 . . . . 0.0 112.114 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.6 m -68.18 -37.13 80.64 Favored 'General case' 0 N--CA 1.524 3.236 0 C-N-CA 123.597 0.759 . . . . 0.0 111.175 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.4 mp -57.35 -44.19 84.11 Favored 'General case' 0 N--CA 1.539 3.996 0 C-N-CA 123.674 0.79 . . . . 0.0 112.391 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.451 ' CD1' ' HE ' ' C' ' 696' ' ' ARG 0.291 0.1 OUTLIER -67.22 -48.25 78.98 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.48 0 C-N-CA 123.036 0.534 . . . . 0.0 110.478 -176.292 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -54.89 -34.77 57.68 Favored Glycine 1 N--CA 1.53 4.945 0 O-C-N 121.379 -0.826 . . . . 0.0 112.416 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 9.5 tt -72.45 -40.41 67.06 Favored 'General case' 0 N--CA 1.534 3.768 0 C-N-CA 125.159 1.383 . . . . 0.0 109.859 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . 0.533 ' HE ' HD11 ' A' ' 693' ' ' ILE . 11.7 tpp180 -51.64 -24.5 5.64 Favored 'General case' 0 N--CA 1.531 3.597 0 C-N-CA 126.317 1.847 . . . . 0.0 113.823 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.21 -35.63 30.35 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.099 0 C-N-CA 123.789 0.836 . . . . 0.0 112.273 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -52.97 -27.49 12.97 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 C-N-CA 124.503 1.121 . . . . 0.0 111.903 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -52.38 -25.52 10.05 Favored 'General case' 0 N--CA 1.539 3.981 0 C-N-CA 123.635 0.774 . . . . 0.0 109.909 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -57.5 -37.52 73.09 Favored 'General case' 0 N--CA 1.524 3.261 0 O-C-N 121.53 -0.731 . . . . 0.0 109.882 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.47 -33.17 55.99 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.349 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.16 -32.93 50.29 Favored 'General case' 1 N--CA 1.546 4.326 0 C-N-CA 124.303 1.041 . . . . 0.0 109.603 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 69.3 m -59.41 -45.35 91.76 Favored 'General case' 1 N--CA 1.543 4.215 0 O-C-N 120.207 -1.558 . . . . 0.0 111.088 177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 40.8 tp -62.71 -35.04 78.43 Favored 'General case' 1 N--CA 1.552 4.665 0 O-C-N 121.071 -1.018 . . . . 0.0 108.987 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 44.1 t -63.73 -38.5 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.469 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -55.02 -35.64 64.63 Favored 'General case' 0 N--CA 1.529 3.5 0 CA-C-O 121.258 0.552 . . . . 0.0 109.8 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -54.09 -47.44 71.73 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 122.367 1.08 . . . . 0.0 109.802 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.65 -32.05 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.668 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -77.52 -18.35 57.11 Favored 'General case' 0 N--CA 1.531 3.616 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.03 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -87.33 -14.97 39.29 Favored 'General case' 1 N--CA 1.552 4.633 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.85 -24.11 32.63 Favored Glycine 1 N--CA 1.521 4.313 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -121.53 152.95 38.63 Favored 'General case' 1 N--CA 1.542 4.135 0 C-N-CA 125.158 1.383 . . . . 0.0 110.408 176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 92.4 p -82.7 148.7 58.59 Favored Pre-proline 0 N--CA 1.534 3.734 0 C-N-CA 126.344 1.857 . . . . 0.0 111.292 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -57.15 131.18 43.59 Favored 'Trans proline' 0 N--CA 1.527 3.466 0 CA-C-N 121.411 1.54 . . . . 0.0 111.632 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.59 -7.21 49.05 Favored 'General case' 0 N--CA 1.535 3.806 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.327 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.523 3.191 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.863 -179.59 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 58.59 113.1 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.287 0 C-N-CA 124.251 1.02 . . . . 0.0 111.872 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.31 -23.27 5.53 Favored 'General case' 0 N--CA 1.513 2.687 0 C-N-CA 125.158 1.383 . . . . 0.0 112.514 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 37.2 m95 -72.14 -28.83 63.5 Favored 'General case' 0 N--CA 1.53 3.547 0 O-C-N 121.896 -0.503 . . . . 0.0 110.814 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -70.66 -34.12 71.68 Favored 'General case' 0 N--CA 1.526 3.341 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.077 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 23.3 pt -72.03 -26.3 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.464 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -51.44 69.53 Favored 'General case' 1 N--CA 1.541 4.084 0 C-N-CA 123.73 0.812 . . . . 0.0 112.023 -177.147 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.5 tt -73.14 -31.84 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.792 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.168 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -54.17 -29.25 44.94 Favored 'General case' 0 N--CA 1.527 3.379 0 C-N-CA 123.879 0.872 . . . . 0.0 110.346 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 6.5 mm -68.68 -38.75 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.822 0 C-N-CA 123.78 0.832 . . . . 0.0 109.593 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.93 -41.75 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.257 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.46 -44.6 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.82 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 78.1 t -66.34 -30.4 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -60.06 -37.6 93.02 Favored Glycine 1 N--CA 1.52 4.263 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 68.1 m -68.47 -37.89 80.56 Favored 'General case' 0 N--CA 1.523 3.177 0 C-N-CA 123.581 0.752 . . . . 0.0 111.02 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.74 -45.57 93.77 Favored 'General case' 0 N--CA 1.536 3.842 0 C-N-CA 123.07 0.548 . . . . 0.0 111.576 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . . . . . . . . . 1.5 tp -60.96 -49.39 84.91 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.362 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -62.18 -22.59 63.13 Favored Glycine 1 N--CA 1.528 4.817 0 O-C-N 120.402 -1.436 . . . . 0.0 112.566 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 3.1 tt -68.55 -41.4 79.85 Favored 'General case' 0 N--CA 1.533 3.69 0 CA-C-O 121.769 0.795 . . . . 0.0 108.993 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . 0.451 ' HE ' ' CD1' ' B' ' 693' ' ' ILE . 25.4 mmt180 -53.72 -24.2 14.07 Favored 'General case' 0 N--CA 1.534 3.769 0 C-N-CA 124.765 1.226 . . . . 0.0 113.409 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 75.0 mt -53.24 -35.81 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 C-N-CA 123.484 0.714 . . . . 0.0 110.549 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 5.5 m -54.27 -26.27 15.07 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.377 0 C-N-CA 123.981 0.913 . . . . 0.0 111.687 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -53.97 -31.12 49.66 Favored 'General case' 0 N--CA 1.531 3.587 0 C-N-CA 123.278 0.631 . . . . 0.0 112.144 -173.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -71.4 -45.05 63.73 Favored 'General case' 0 N--CA 1.529 3.479 0 CA-C-O 121.99 0.9 . . . . 0.0 108.833 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.64 -34.76 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.089 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.71 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.13 -34.24 71.81 Favored 'General case' 0 N--CA 1.52 3.063 0 C-N-CA 124.674 1.19 . . . . 0.0 110.027 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 54.7 m -58.97 -46.58 87.71 Favored 'General case' 0 N--CA 1.517 2.892 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.72 -36.49 84.46 Favored 'General case' 1 N--CA 1.543 4.204 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.77 -40.97 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.669 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -66.28 -23.29 66.37 Favored 'General case' 0 N--CA 1.515 2.804 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.833 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -49.35 -47.18 47.61 Favored 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 123.43 0.692 . . . . 0.0 110.153 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.94 -48.17 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.966 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.148 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -76.7 -4.81 45.2 Favored 'General case' 0 N--CA 1.534 3.752 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.881 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -114.5 -12.82 12.26 Favored 'General case' 0 N--CA 1.52 3.036 0 C-N-CA 124.769 1.228 . . . . 0.0 108.849 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -49.86 -31.89 17.62 Favored Glycine 0 N--CA 1.51 3.618 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -78.28 153.75 31.53 Favored 'General case' 0 N--CA 1.523 3.183 0 CA-C-O 121.694 0.759 . . . . 0.0 109.084 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 99.5 p -80.11 149.83 70.42 Favored Pre-proline 0 N--CA 1.53 3.546 0 C-N-CA 126.72 2.008 . . . . 0.0 112.283 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -56.18 131.08 43.69 Favored 'Trans proline' 0 C--N 1.403 3.418 0 CA-C-N 120.761 1.308 . . . . 0.0 110.341 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 57.6 tp -56.94 90.89 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.398 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.615 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.52 3.065 0 CA-C-O 118.083 -0.961 . . . . 0.0 111.541 -179.882 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.589 ' HE1' HH22 ' C' ' 683' ' ' ARG . 58.3 t-105 57.58 -87.21 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 124.077 0.951 . . . . 0.0 110.867 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 5.4 tt -52.43 -35.52 52.26 Favored 'General case' 0 N--CA 1.509 2.509 0 C-N-CA 125.046 1.338 . . . . 0.0 111.859 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -61.88 -50.37 72.51 Favored 'General case' 0 N--CA 1.53 3.569 0 CA-C-O 121.407 0.623 . . . . 0.0 112.345 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -63.16 -35.5 80.5 Favored 'General case' 0 N--CA 1.522 3.137 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.401 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 95.6 mt -74.85 -28.08 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 C-N-CA 125.246 1.418 . . . . 0.0 110.995 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -50.97 58.28 Favored 'General case' 1 N--CA 1.559 4.984 0 CA-C-N 119.873 1.215 . . . . 0.0 110.282 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 14.3 tt -64.52 -32.15 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 124.199 0.999 . . . . 0.0 109.088 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -53.85 -33.04 55.13 Favored 'General case' 0 N--CA 1.518 2.936 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.906 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.24 -42.51 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.861 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.706 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.02 -34.9 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.31 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 60.8 mt -64.62 -44.64 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.95 -30.76 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 C-N-CA 123.7 0.8 . . . . 0.0 109.047 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.21 -31.88 82.25 Favored Glycine 1 N--CA 1.52 4.26 0 C-N-CA 123.427 0.537 . . . . 0.0 112.005 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.1 m -69.04 -37.26 78.47 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.476 0.71 . . . . 0.0 111.279 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.05 -44.59 91.83 Favored 'General case' 1 N--CA 1.539 4.024 0 C-N-CA 123.298 0.639 . . . . 0.0 112.574 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 693' ' ' ILE 0.268 0.1 OUTLIER -62.46 -48.76 86.77 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.742 0 CA-C-N 118.314 0.506 . . . . 0.0 111.714 -175.929 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.6 -23.78 61.13 Favored Glycine 1 N--CA 1.527 4.754 0 O-C-N 121.778 -0.576 . . . . 0.0 113.068 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.24 -42.12 72.63 Favored 'General case' 0 N--CA 1.539 3.995 0 C-N-CA 124.617 1.167 . . . . 0.0 110.705 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -52.55 -25.62 10.96 Favored 'General case' 0 N--CA 1.537 3.918 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 8.7 tp -54.5 -37.8 39.44 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.401 0 CA-C-N 119.897 1.226 . . . . 0.0 112.677 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.76 -30.47 22.66 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 C-N-CA 123.441 0.696 . . . . 0.0 111.733 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -54.46 -26.45 31.19 Favored 'General case' 0 N--CA 1.534 3.726 0 C-N-CA 122.934 0.493 . . . . 0.0 109.706 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.9 68.4 Favored 'General case' 0 N--CA 1.524 3.238 0 C-N-CA 122.664 0.386 . . . . 0.0 110.096 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.0 -31.09 49.01 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.002 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 6.2 tp -53.31 -33.96 55.5 Favored 'General case' 0 N--CA 1.534 3.751 0 C-N-CA 123.158 0.583 . . . . 0.0 110.113 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 83.8 p -58.05 -46.03 86.05 Favored 'General case' 0 N--CA 1.531 3.579 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 39.5 tp -66.96 -35.19 79.42 Favored 'General case' 1 N--CA 1.54 4.034 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 58.8 t -69.06 -42.23 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.637 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -67.24 -23.45 65.71 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.466 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -50.76 -48.29 59.32 Favored 'General case' 0 N--CA 1.512 2.633 0 CA-C-O 121.671 0.748 . . . . 0.0 109.427 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.88 -41.04 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.747 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.583 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -76.08 -20.67 57.5 Favored 'General case' 0 N--CA 1.536 3.854 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.806 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . 0.483 HE21 ' NE2' ' B' ' 710' ' ' GLN . 33.1 tt0 -99.1 -11.91 21.0 Favored 'General case' 0 N--CA 1.521 3.088 0 C-N-CA 125.355 1.462 . . . . 0.0 109.434 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.94 -31.12 24.18 Favored Glycine 1 N--CA 1.519 4.213 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 177.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -107.92 142.67 37.67 Favored 'General case' 0 N--CA 1.534 3.768 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 68.8 m -82.42 146.83 54.89 Favored Pre-proline 0 N--CA 1.528 3.468 0 C-N-CA 125.296 1.438 . . . . 0.0 111.201 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.1 131.1 33.12 Favored 'Trans proline' 0 C--N 1.402 3.382 0 CA-C-N 121.326 1.509 . . . . 0.0 109.342 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.82 153.88 13.07 Favored 'General case' 0 N--CA 1.524 3.225 0 C-N-CA 125.249 1.42 . . . . 0.0 110.293 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.521 3.091 0 C-N-CA 123.977 0.911 . . . . 0.0 111.258 -179.8 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -166.17 -74.18 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.123 0 C-N-CA 123.616 0.767 . . . . 0.0 109.042 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.36 -46.71 89.1 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 123.77 0.828 . . . . 0.0 110.706 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -71.46 -29.55 64.98 Favored 'General case' 0 N--CA 1.528 3.443 0 O-C-N 121.831 -0.543 . . . . 0.0 111.033 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -70.52 -36.53 73.8 Favored 'General case' 0 N--CA 1.517 2.923 0 CA-C-O 118.639 -0.695 . . . . 0.0 111.255 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . 0.555 HD12 ' N ' ' B' ' 683' ' ' ARG . 2.2 pp -71.6 -23.79 22.87 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.293 0 CA-C-N 119.544 1.065 . . . . 0.0 110.121 179.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . 0.555 ' N ' HD12 ' B' ' 682' ' ' ILE . 0.2 OUTLIER -61.03 -53.08 61.56 Favored 'General case' 0 N--CA 1.532 3.655 0 CA-C-O 121.511 0.672 . . . . 0.0 112.309 -176.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 18.7 tt -74.76 -31.78 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.078 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -52.25 -45.79 65.5 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.376 1.07 . . . . 0.0 111.869 -173.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.52 -36.79 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.422 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 12.0 mm -60.36 -41.58 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.44 -44.18 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.766 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.55 -31.59 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.836 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.61 -44.6 97.31 Favored Glycine 1 N--CA 1.521 4.342 0 C-N-CA 124.071 0.843 . . . . 0.0 112.316 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.4 m -68.18 -37.48 81.0 Favored 'General case' 0 N--CA 1.527 3.382 0 CA-C-O 122.121 0.962 . . . . 0.0 110.022 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 2.2 tp -58.59 -45.31 89.36 Favored 'General case' 0 N--CA 1.518 2.962 0 CA-C-N 113.339 -1.755 . . . . 0.0 113.379 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.491 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.1 OUTLIER -70.52 -38.75 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.857 0 C-N-CA 122.714 0.406 . . . . 0.0 111.751 -177.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.53 -28.1 67.04 Favored Glycine 1 N--CA 1.53 4.944 0 O-C-N 121.014 -1.054 . . . . 0.0 112.16 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 4.9 tt -66.46 -40.31 89.33 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 125.02 1.328 . . . . 0.0 110.213 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . 0.478 ' HE ' HD11 ' A' ' 693' ' ' ILE . 36.1 mmt180 -51.02 -24.68 3.95 Favored 'General case' 0 N--CA 1.528 3.473 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.8 tt -53.5 -35.96 26.6 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 CA-C-N 119.329 0.968 . . . . 0.0 111.947 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 13.4 p -53.39 -30.01 17.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 C-N-CA 124.278 1.031 . . . . 0.0 111.617 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -57.34 -28.14 62.87 Favored 'General case' 0 N--CA 1.536 3.855 0 O-C-N 121.53 -0.731 . . . . 0.0 110.697 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.13 -41.76 73.5 Favored 'General case' 0 N--CA 1.529 3.508 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 61.4 t -68.59 -32.02 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.716 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 15.6 tp -54.12 -31.02 51.05 Favored 'General case' 1 N--CA 1.542 4.128 0 C-N-CA 123.516 0.726 . . . . 0.0 109.114 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 62.7 m -56.63 -45.3 81.62 Favored 'General case' 0 N--CA 1.535 3.814 0 O-C-N 121.194 -0.941 . . . . 0.0 111.762 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.14 -34.78 78.85 Favored 'General case' 1 N--CA 1.547 4.4 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.86 -39.21 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -61.28 -22.44 64.86 Favored 'General case' 0 N--CA 1.523 3.189 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -52.34 -44.75 65.33 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-O 121.96 0.886 . . . . 0.0 109.462 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 98.7 t -58.16 -37.1 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.715 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -77.64 -5.68 51.2 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.434 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . 0.483 ' NE2' HE21 ' A' ' 710' ' ' GLN . 10.5 tp-100 -89.22 -17.33 29.28 Favored 'General case' 1 N--CA 1.561 5.086 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -81.64 -24.95 55.04 Favored Glycine 1 N--CA 1.521 4.312 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -80.23 152.81 28.91 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 125.898 1.679 . . . . 0.0 108.298 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 97.8 p -102.12 146.79 32.92 Favored Pre-proline 1 N--CA 1.551 4.6 0 C-N-CA 125.222 1.409 . . . . 0.0 114.155 -176.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.23 131.95 18.66 Favored 'Trans proline' 0 C--N 1.406 3.553 0 CA-C-N 120.405 1.18 . . . . 0.0 109.939 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 80.1 mt -95.65 -178.67 4.47 Favored 'General case' 0 N--CA 1.531 3.607 0 C-N-CA 125.252 1.421 . . . . 0.0 108.652 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.523 3.198 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.106 179.654 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 11.3 t30 . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 32.1 p90 -61.15 -41.31 96.52 Favored 'General case' 0 N--CA 1.526 3.358 0 C-N-CA 123.996 0.918 . . . . 0.0 111.372 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.38 -45.63 90.22 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 124.484 1.114 . . . . 0.0 109.912 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -71.27 -28.6 64.26 Favored 'General case' 0 N--CA 1.524 3.233 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.537 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -72.5 -36.53 68.42 Favored 'General case' 0 N--CA 1.526 3.371 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.957 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 23.8 pt -72.91 -29.11 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 CA-C-N 118.054 0.388 . . . . 0.0 110.082 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . 0.589 HH22 ' HE1' ' A' ' 678' ' ' TRP . 72.9 ttt180 -52.59 -54.64 30.27 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-O 121.617 0.722 . . . . 0.0 111.648 -177.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 16.6 tt -69.43 -30.98 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.818 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.05 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.6 -43.33 99.07 Favored 'General case' 0 N--CA 1.528 3.446 0 CA-C-O 122.88 1.324 . . . . 0.0 109.28 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.33 -44.4 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.744 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.46 -45.62 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 CA-C-O 118.826 -0.607 . . . . 0.0 110.295 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 19.4 tt -62.55 -39.15 83.45 Favored 'Isoleucine or valine' 1 N--CA 1.552 4.625 0 CA-C-N 119.808 1.186 . . . . 0.0 108.64 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 19.7 t -65.88 -29.91 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.763 0 C-N-CA 123.934 0.894 . . . . 0.0 108.753 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -68.75 -24.94 75.42 Favored Glycine 1 N--CA 1.526 4.694 0 CA-C-N 119.017 0.826 . . . . 0.0 113.474 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 70.5 m -67.61 -50.44 58.14 Favored 'General case' 0 N--CA 1.532 3.673 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . 0.478 HD12 ' H ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -52.66 -32.62 43.19 Favored 'General case' 0 N--CA 1.519 2.986 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . 0.5 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.2 OUTLIER -59.99 -37.7 73.53 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 CA-C-N 119.436 1.016 . . . . 0.0 113.172 -176.004 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -67.99 -38.86 89.1 Favored Glycine 1 N--CA 1.523 4.479 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . 0.592 HD22 ' O ' ' C' ' 695' ' ' LEU . 0.0 OUTLIER -63.9 -37.08 86.09 Favored 'General case' 0 N--CA 1.534 3.745 0 C-N-CA 124.995 1.318 . . . . 0.0 111.946 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -50.9 -27.12 6.84 Favored 'General case' 1 N--CA 1.549 4.489 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 29.2 pt -54.07 -38.42 37.97 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.335 0 CA-C-N 120.155 1.343 . . . . 0.0 114.278 -174.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.4 p -55.75 -35.5 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.826 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -55.89 -26.97 49.76 Favored 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 123.311 0.644 . . . . 0.0 110.457 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.95 69.51 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 121.939 -0.475 . . . . 0.0 110.467 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.62 -30.84 48.64 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.155 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 9.1 tp -53.4 -34.64 58.53 Favored 'General case' 0 N--CA 1.531 3.604 0 CA-C-O 118.841 -0.6 . . . . 0.0 110.786 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 62.9 m -58.7 -46.95 86.16 Favored 'General case' 0 N--CA 1.533 3.709 0 CA-C-N 119.284 0.947 . . . . 0.0 112.971 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.85 -35.3 80.28 Favored 'General case' 1 N--CA 1.549 4.523 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.879 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.94 -38.38 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' C' ' 710' ' ' GLN . 63.2 t30 -58.22 -30.1 66.22 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.642 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -47.36 -42.1 20.96 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.04 0.838 . . . . 0.0 112.168 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.65 -44.79 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.68 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -77.4 -6.61 54.01 Favored 'General case' 1 N--CA 1.539 4.004 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.75 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.4 tt0 -114.65 -11.28 12.37 Favored 'General case' 0 N--CA 1.517 2.905 0 C-N-CA 125.474 1.509 . . . . 0.0 108.745 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -53.09 -24.49 21.15 Favored Glycine 1 N--CA 1.519 4.17 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -88.15 155.95 19.51 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.942 0.897 . . . . 0.0 108.718 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 95.5 p -77.58 149.38 78.04 Favored Pre-proline 0 N--CA 1.535 3.793 0 C-N-CA 125.973 1.709 . . . . 0.0 112.551 -173.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -55.72 129.83 37.16 Favored 'Trans proline' 0 C--N 1.409 3.747 0 CA-C-N 120.374 1.169 . . . . 0.0 110.906 -173.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 51.92 -101.39 0.11 Allowed 'General case' 0 N--CA 1.523 3.221 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.519 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.523 3.183 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.827 179.672 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -66.41 150.47 48.86 Favored 'General case' 0 N--CA 1.522 3.167 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.426 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 6.8 mp -52.61 -43.1 65.14 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 125.267 1.427 . . . . 0.0 111.948 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -55.13 -37.24 66.67 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -73.24 -38.26 66.07 Favored 'General case' 0 N--CA 1.532 3.645 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.46 -25.74 19.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.069 0 C-N-CA 125.624 1.57 . . . . 0.0 111.574 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -67.26 -53.7 27.58 Favored 'General case' 1 N--CA 1.544 4.248 0 C-N-CA 124.539 1.136 . . . . 0.0 112.006 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 15.2 tt -68.23 -32.89 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.195 0 CA-C-N 114.051 -1.431 . . . . 0.0 109.151 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -52.47 -34.83 50.86 Favored 'General case' 0 N--CA 1.516 2.849 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.982 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 13.0 mm -63.44 -37.62 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.718 0 CA-C-O 121.762 0.792 . . . . 0.0 109.201 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -37.24 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.183 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 62.0 mt -65.48 -43.82 94.35 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 76.5 t -61.99 -28.94 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.15 -31.62 78.1 Favored Glycine 0 N--CA 1.513 3.787 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.693 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 49.9 m -69.34 -37.19 77.56 Favored 'General case' 0 N--CA 1.53 3.542 0 C-N-CA 123.201 0.6 . . . . 0.0 111.077 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.6 mp -58.08 -45.05 87.8 Favored 'General case' 0 N--CA 1.538 3.944 0 C-N-CA 123.487 0.715 . . . . 0.0 112.071 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.875 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.271 0.8 OUTLIER -60.28 -48.52 87.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.135 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.771 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.5 -26.3 69.53 Favored Glycine 1 N--CA 1.531 4.997 0 CA-C-N 120.164 1.347 . . . . 0.0 112.296 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.0 tt -64.77 -42.83 94.82 Favored 'General case' 0 N--CA 1.537 3.905 0 C-N-CA 124.059 0.944 . . . . 0.0 109.985 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -54.34 -26.11 27.89 Favored 'General case' 0 N--CA 1.538 3.958 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 70.2 mt -55.11 -39.06 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 C-N-CA 123.562 0.745 . . . . 0.0 112.257 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.57 -29.1 33.27 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.522 0 C-N-CA 123.49 0.716 . . . . 0.0 112.584 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -52.06 -26.03 10.01 Favored 'General case' 0 N--CA 1.535 3.779 0 C-N-CA 123.264 0.626 . . . . 0.0 110.949 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.55 -32.42 62.97 Favored 'General case' 0 N--CA 1.532 3.642 0 O-C-N 121.936 -0.477 . . . . 0.0 109.803 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.9 m -68.65 -30.82 48.52 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.123 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.83 -34.71 55.28 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 123.42 0.688 . . . . 0.0 110.391 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 89.0 p -58.89 -46.24 88.33 Favored 'General case' 0 N--CA 1.529 3.476 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 30.2 tp -67.02 -34.79 78.49 Favored 'General case' 1 N--CA 1.543 4.21 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.16 -39.29 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -69.71 -29.08 66.4 Favored 'General case' 0 N--CA 1.516 2.836 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.246 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -50.78 -40.41 55.06 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.537 0.684 . . . . 0.0 110.376 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.22 -38.43 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.899 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.737 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -74.99 -25.72 59.04 Favored 'General case' 0 N--CA 1.538 3.937 0 CA-C-O 121.057 0.456 . . . . 0.0 109.788 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -89.36 -7.77 54.57 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.51 -20.71 7.79 Favored Glycine 1 N--CA 1.524 4.506 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -120.69 152.05 38.74 Favored 'General case' 0 N--CA 1.526 3.329 0 C-N-CA 125.265 1.426 . . . . 0.0 109.293 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 94.5 p -82.34 150.45 63.91 Favored Pre-proline 0 N--CA 1.531 3.595 0 C-N-CA 125.884 1.674 . . . . 0.0 110.244 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -53.92 130.01 37.12 Favored 'Trans proline' 0 C--N 1.401 3.332 0 CA-C-N 122.259 1.842 . . . . 0.0 112.503 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 62.0 mt -97.87 42.44 1.09 Allowed 'General case' 0 N--CA 1.522 3.174 0 CA-C-N 113.589 -1.641 . . . . 0.0 108.717 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 N--CA 1.523 3.221 0 C-N-CA 124.23 1.012 . . . . 0.0 111.948 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -102.13 178.03 4.72 Favored 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 124.643 1.177 . . . . 0.0 109.84 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 6.2 tt -54.38 -45.68 72.88 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 125.512 1.525 . . . . 0.0 111.828 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -71.11 -31.06 67.31 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -69.69 -38.53 77.03 Favored 'General case' 0 N--CA 1.526 3.362 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.544 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 20.3 pt -71.56 -31.94 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.301 0 CA-C-N 117.986 0.357 . . . . 0.0 110.282 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -52.82 -54.39 34.9 Favored 'General case' 1 N--CA 1.539 4.018 0 CA-C-O 121.776 0.798 . . . . 0.0 111.007 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -31.46 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.307 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -59.55 -43.41 93.54 Favored 'General case' 1 N--CA 1.539 4.012 0 CA-C-O 121.691 0.758 . . . . 0.0 109.658 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.66 -36.33 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.797 0 C-N-CA 124.215 1.006 . . . . 0.0 108.617 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 27.8 mm -65.17 -42.72 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 47.9 mm -60.28 -41.17 86.08 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.281 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.49 -31.22 48.26 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.108 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.98 -33.19 86.57 Favored Glycine 1 N--CA 1.518 4.163 0 C-N-CA 123.924 0.773 . . . . 0.0 112.693 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.2 m -68.15 -37.26 80.86 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.52 0.728 . . . . 0.0 111.577 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.69 -43.07 80.14 Favored 'General case' 0 N--CA 1.536 3.843 0 C-N-CA 123.39 0.676 . . . . 0.0 112.559 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.798 HD11 ' HE ' ' C' ' 696' ' ' ARG 0.276 0.8 OUTLIER -60.25 -48.73 86.99 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.502 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.242 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.45 -23.29 70.17 Favored Glycine 1 N--CA 1.531 5.023 0 CA-C-N 120.423 1.465 . . . . 0.0 112.518 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.29 -43.17 92.02 Favored 'General case' 1 N--CA 1.541 4.093 0 C-N-CA 123.359 0.664 . . . . 0.0 109.655 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . 0.875 ' HE ' HD11 ' A' ' 693' ' ' ILE . 23.5 mmt180 -52.99 -24.02 8.56 Favored 'General case' 0 N--CA 1.536 3.86 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 78.1 mt -51.72 -35.71 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 C-N-CA 123.327 0.651 . . . . 0.0 110.425 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.23 -26.08 17.88 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.235 0 C-N-CA 124.444 1.097 . . . . 0.0 111.397 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -53.66 -28.76 35.07 Favored 'General case' 1 N--CA 1.547 4.404 0 O-C-N 121.313 -0.867 . . . . 0.0 110.387 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.66 -44.11 67.78 Favored 'General case' 0 N--CA 1.525 3.282 0 CA-C-O 122.028 0.918 . . . . 0.0 108.627 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 79.0 t -68.84 -33.6 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.836 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.04 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.65 -35.5 66.03 Favored 'General case' 0 N--CA 1.532 3.642 0 C-N-CA 123.65 0.78 . . . . 0.0 110.405 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 48.8 m -59.77 -48.01 83.4 Favored 'General case' 0 N--CA 1.523 3.177 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.54 -34.85 77.91 Favored 'General case' 1 N--CA 1.54 4.052 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.219 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.23 -44.93 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . 0.453 HD22 ' C ' ' B' ' 706' ' ' ASN . 0.1 OUTLIER -74.41 -20.52 60.02 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.568 -178.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . 0.441 ' N ' HD22 ' B' ' 706' ' ' ASN . 16.5 tpt180 -47.39 -35.01 7.7 Favored 'General case' 0 N--CA 1.519 3.001 0 CA-C-N 118.566 0.621 . . . . 0.0 109.921 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.37 -39.13 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.815 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' B' ' 706' ' ' ASN . 71.9 mtm180 -76.49 -30.83 57.41 Favored 'General case' 0 N--CA 1.524 3.252 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.76 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -89.23 2.33 54.41 Favored 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.6 -28.1 50.6 Favored Glycine 1 N--CA 1.517 4.086 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -108.62 127.79 54.27 Favored 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 97.9 p -82.24 147.67 57.66 Favored Pre-proline 0 N--CA 1.528 3.462 0 C-N-CA 125.278 1.431 . . . . 0.0 110.758 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -58.73 131.13 40.41 Favored 'Trans proline' 0 C--N 1.401 3.334 0 CA-C-N 121.473 1.562 . . . . 0.0 110.363 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 49.7 tp 60.81 143.74 0.01 OUTLIER 'General case' 0 N--CA 1.525 3.301 0 C-N-CA 126.097 1.759 . . . . 0.0 111.042 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.52 3.068 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.548 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -66.46 177.69 1.45 Allowed 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 124.029 0.931 . . . . 0.0 111.636 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' C' ' 683' ' ' ARG . 7.8 mp -53.53 -43.37 68.31 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 125.619 1.568 . . . . 0.0 112.149 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -56.4 -38.73 71.93 Favored 'General case' 0 N--CA 1.53 3.535 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -173.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -72.93 -37.83 67.03 Favored 'General case' 0 N--CA 1.534 3.757 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 86.7 mt -73.37 -25.68 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.355 0 C-N-CA 125.365 1.466 . . . . 0.0 111.246 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' C' ' 679' ' ' LEU . 0.9 OUTLIER -67.03 -51.3 56.48 Favored 'General case' 0 N--CA 1.536 3.872 0 C-N-CA 124.449 1.099 . . . . 0.0 110.71 -177.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.3 tt -71.2 -30.31 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.928 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -52.52 -27.48 16.62 Favored 'General case' 0 N--CA 1.526 3.343 0 CA-C-O 121.512 0.673 . . . . 0.0 109.959 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 22.8 mm -68.94 -48.2 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 C-N-CA 124.635 1.174 . . . . 0.0 108.937 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 10.9 mm -57.74 -41.99 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.389 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.365 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.34 -49.19 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.702 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.97 -30.87 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.886 0 C-N-CA 123.666 0.786 . . . . 0.0 109.921 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.8 -32.54 84.56 Favored Glycine 1 N--CA 1.52 4.242 0 C-N-CA 123.367 0.508 . . . . 0.0 112.777 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 68.7 m -67.65 -35.99 79.93 Favored 'General case' 0 N--CA 1.527 3.398 0 C-N-CA 124.056 0.942 . . . . 0.0 112.135 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.11 -41.74 68.65 Favored 'General case' 0 N--CA 1.539 3.976 0 C-N-CA 123.433 0.693 . . . . 0.0 112.606 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . 0.432 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -60.27 -41.4 86.88 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.255 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -174.166 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -68.46 -31.59 74.16 Favored Glycine 1 N--CA 1.524 4.553 0 O-C-N 121.093 -1.004 . . . . 0.0 111.456 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.04 -42.07 99.67 Favored 'General case' 0 N--CA 1.534 3.769 0 C-N-CA 124.594 1.158 . . . . 0.0 112.156 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . 0.798 ' HE ' HD11 ' B' ' 693' ' ' ILE . 25.6 mmt180 -53.3 -27.36 22.57 Favored 'General case' 1 N--CA 1.542 4.146 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -176.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 10.5 tp -55.71 -39.34 54.92 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.371 0 CA-C-N 119.664 1.12 . . . . 0.0 113.848 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.82 -31.7 41.04 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.338 0 C-N-CA 123.276 0.63 . . . . 0.0 112.235 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -54.41 -25.42 24.65 Favored 'General case' 0 N--CA 1.531 3.575 0 C-N-CA 123.121 0.568 . . . . 0.0 109.95 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.46 -34.98 65.0 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 122.086 -0.384 . . . . 0.0 110.159 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.3 m -68.83 -30.73 47.99 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.045 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 11.0 tp -52.89 -36.14 58.96 Favored 'General case' 0 N--CA 1.533 3.712 0 C-N-CA 123.154 0.581 . . . . 0.0 110.474 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 89.0 p -58.87 -47.0 86.47 Favored 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 39.8 tp -67.4 -34.88 78.17 Favored 'General case' 1 N--CA 1.543 4.191 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 84.0 t -68.86 -38.95 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.546 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' C' ' 710' ' ' GLN . 64.3 t30 -66.26 -25.69 67.0 Favored 'General case' 0 N--CA 1.515 2.784 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.856 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -48.22 -33.23 8.25 Favored 'General case' 0 N--CA 1.521 3.078 0 C-N-CA 123.643 0.777 . . . . 0.0 111.133 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.66 -47.66 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -77.93 -9.92 59.33 Favored 'General case' 1 N--CA 1.542 4.172 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.623 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' C' ' 706' ' ' ASN . 50.9 tt0 -112.56 -7.64 13.87 Favored 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 125.884 1.674 . . . . 0.0 107.869 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.5 -25.04 33.41 Favored Glycine 0 N--CA 1.511 3.665 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -99.87 152.35 20.25 Favored 'General case' 0 N--CA 1.525 3.276 0 C-N-CA 123.911 0.885 . . . . 0.0 108.782 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 53.9 m -81.71 149.26 63.67 Favored Pre-proline 0 N--CA 1.529 3.502 0 CA-C-O 116.626 -1.654 . . . . 0.0 110.601 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -54.33 130.19 38.56 Favored 'Trans proline' 0 C--N 1.401 3.308 0 CA-C-N 122.233 1.833 . . . . 0.0 112.651 -175.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.56 153.51 40.21 Favored 'General case' 0 N--CA 1.522 3.141 0 CA-C-N 113.666 -1.606 . . . . 0.0 109.138 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 95.9 p . . . . . 0 N--CA 1.523 3.177 0 C-N-CA 123.634 0.774 . . . . 0.0 109.803 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -61.27 -32.4 72.22 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 124.004 0.922 . . . . 0.0 110.971 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -50.91 -43.37 59.92 Favored 'General case' 0 N--CA 1.517 2.879 0 C-N-CA 124.519 1.128 . . . . 0.0 111.185 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -61.87 -50.05 73.78 Favored 'General case' 0 N--CA 1.529 3.48 0 CA-C-O 121.474 0.655 . . . . 0.0 111.208 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -64.15 -37.47 87.57 Favored 'General case' 0 N--CA 1.518 2.944 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.072 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -25.53 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.359 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -51.38 52.39 Favored 'General case' 1 N--CA 1.562 5.162 0 CA-C-N 119.973 1.26 . . . . 0.0 110.28 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.9 tt -67.73 -30.45 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.222 0 C-N-CA 123.696 0.798 . . . . 0.0 110.292 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -52.33 -30.01 26.41 Favored 'General case' 0 N--CA 1.515 2.814 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.124 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 21.9 mm -69.18 -46.94 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.453 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 7.9 mm -55.09 -39.54 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 C-N-CA 123.522 0.729 . . . . 0.0 109.503 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 59.6 mt -59.82 -47.13 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.978 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.58 -30.61 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 C-N-CA 123.563 0.745 . . . . 0.0 109.736 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.98 -30.88 76.62 Favored Glycine 1 N--CA 1.518 4.116 0 C-N-CA 123.49 0.566 . . . . 0.0 112.654 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 63.3 m -67.56 -36.26 80.6 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 123.664 0.786 . . . . 0.0 111.842 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 10.3 mp -54.44 -42.15 70.24 Favored 'General case' 0 N--CA 1.539 3.99 0 C-N-CA 123.878 0.871 . . . . 0.0 112.993 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.522 HD11 ' HE ' ' B' ' 696' ' ' ARG . 0.4 OUTLIER -64.29 -49.8 79.41 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.08 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.494 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.59 -22.43 65.93 Favored Glycine 1 N--CA 1.528 4.827 0 CA-C-N 119.811 1.187 . . . . 0.0 112.553 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.28 -43.7 93.97 Favored 'General case' 0 N--CA 1.535 3.812 0 C-N-CA 123.835 0.854 . . . . 0.0 109.645 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . 0.718 ' HE ' HD11 ' C' ' 693' ' ' ILE . 17.6 mmt180 -54.67 -28.66 48.98 Favored 'General case' 0 N--CA 1.537 3.898 0 C-N-CA 124.262 1.025 . . . . 0.0 113.563 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 64.1 mt -55.45 -37.69 46.02 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 C-N-CA 123.609 0.764 . . . . 0.0 109.89 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -55.18 -26.78 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.938 0 C-N-CA 124.888 1.275 . . . . 0.0 110.969 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -51.73 -27.91 13.4 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.532 0.733 . . . . 0.0 112.087 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.15 96.2 Favored 'General case' 0 N--CA 1.524 3.245 0 O-C-N 121.595 -0.691 . . . . 0.0 109.58 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.99 -33.62 56.16 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.236 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 9.9 tp -55.0 -36.09 65.08 Favored 'General case' 0 N--CA 1.535 3.804 0 C-N-CA 123.2 0.6 . . . . 0.0 110.037 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.4 p -59.16 -47.5 85.07 Favored 'General case' 0 N--CA 1.525 3.3 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 41.3 tp -64.49 -35.78 82.07 Favored 'General case' 1 N--CA 1.546 4.354 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 90.1 t -69.61 -40.27 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.625 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 710' ' ' GLN . 55.1 t30 -64.89 -25.78 68.04 Favored 'General case' 0 N--CA 1.516 2.852 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.777 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -48.57 -44.4 36.63 Favored 'General case' 0 N--CA 1.518 2.961 0 C-N-CA 124.552 1.141 . . . . 0.0 110.402 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.87 -44.16 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -77.81 -12.7 60.0 Favored 'General case' 0 N--CA 1.538 3.926 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.621 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 706' ' ' ASN . 12.1 tt0 -112.93 -12.54 13.25 Favored 'General case' 0 N--CA 1.525 3.304 0 C-N-CA 125.615 1.566 . . . . 0.0 109.181 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -50.91 -29.81 20.78 Favored Glycine 0 N--CA 1.515 3.903 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -93.11 149.68 21.05 Favored 'General case' 0 N--CA 1.522 3.135 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 70.3 m -81.93 148.12 59.98 Favored Pre-proline 0 N--CA 1.532 3.638 0 C-N-CA 125.686 1.594 . . . . 0.0 110.133 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -56.72 131.22 44.3 Favored 'Trans proline' 0 C--N 1.401 3.297 0 CA-C-N 121.794 1.676 . . . . 0.0 110.6 -175.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 52.6 tp 63.1 149.25 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 126.05 1.74 . . . . 0.0 110.33 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.523 3.202 0 C-N-CA 123.771 0.829 . . . . 0.0 110.078 -179.756 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 20.0 m120 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -166.41 135.82 3.1 Favored 'General case' 0 N--CA 1.531 3.589 0 C-N-CA 123.357 0.663 . . . . 0.0 109.545 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -50.49 -43.72 55.72 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 125.96 1.704 . . . . 0.0 111.456 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -68.17 -43.16 78.82 Favored 'General case' 0 N--CA 1.532 3.632 0 C-N-CA 122.449 0.3 . . . . 0.0 110.848 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -69.15 -35.33 76.22 Favored 'General case' 0 N--CA 1.53 3.545 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.56 -24.81 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 C-N-CA 124.504 1.122 . . . . 0.0 110.605 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -64.13 -53.82 43.54 Favored 'General case' 1 N--CA 1.546 4.341 0 CA-C-N 119.362 0.983 . . . . 0.0 111.496 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 16.2 tt -68.07 -30.33 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.146 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -51.27 -32.82 25.96 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 123.515 0.726 . . . . 0.0 112.153 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . 0.452 ' N ' HD12 ' B' ' 686' ' ' ILE . 1.5 mp -69.23 -45.62 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.267 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 34.2 mt -56.1 -41.15 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 C-N-CA 123.271 0.628 . . . . 0.0 109.938 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 42.2 mm -62.32 -48.91 86.12 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.109 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.96 -29.8 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 C-N-CA 124.339 1.055 . . . . 0.0 109.967 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.73 -37.03 94.09 Favored Glycine 1 N--CA 1.524 4.553 0 C-N-CA 123.278 0.466 . . . . 0.0 112.45 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 67.5 m -67.36 -36.14 80.77 Favored 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 124.445 1.098 . . . . 0.0 111.873 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 10.1 mp -53.29 -33.91 55.15 Favored 'General case' 0 N--CA 1.533 3.711 0 CA-C-O 118.541 -0.742 . . . . 0.0 112.26 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.14 -41.33 81.36 Favored 'Isoleucine or valine' 1 N--CA 1.557 4.888 0 CA-C-N 120.246 1.384 . . . . 0.0 111.236 -177.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -55.82 -46.41 83.32 Favored Glycine 1 N--CA 1.526 4.695 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER -73.28 -32.31 64.58 Favored 'General case' 1 N--CA 1.554 4.771 0 CA-C-N 117.625 0.713 . . . . 0.0 110.82 179.298 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . 0.522 ' HE ' HD11 ' A' ' 693' ' ' ILE . 14.1 tpp180 -50.18 -26.61 4.77 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 125.625 1.57 . . . . 0.0 113.699 -176.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . 0.494 HD13 ' O ' ' B' ' 697' ' ' ILE . 0.0 OUTLIER -54.44 -36.04 33.17 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.14 0 C-N-CA 124.212 1.005 . . . . 0.0 111.051 -178.874 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.1 p -51.91 -26.49 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.935 0 C-N-CA 124.735 1.214 . . . . 0.0 112.037 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -51.97 -25.89 9.32 Favored 'General case' 1 N--CA 1.54 4.046 0 C-N-CA 123.321 0.648 . . . . 0.0 110.18 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.89 -42.05 79.17 Favored 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 122.992 0.517 . . . . 0.0 111.313 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.67 -32.72 56.19 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 118.405 0.548 . . . . 0.0 110.383 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -32.2 52.53 Favored 'General case' 1 N--CA 1.545 4.309 0 C-N-CA 124.159 0.984 . . . . 0.0 109.529 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 51.6 m -57.26 -44.51 84.0 Favored 'General case' 1 N--CA 1.543 4.185 0 O-C-N 120.53 -1.356 . . . . 0.0 111.936 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 45.2 tp -65.25 -34.43 78.33 Favored 'General case' 1 N--CA 1.549 4.48 0 O-C-N 121.362 -0.836 . . . . 0.0 108.88 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 26.3 t -66.76 -39.93 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.877 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -61.12 -32.9 72.59 Favored 'General case' 0 N--CA 1.522 3.157 0 CA-C-O 118.497 -0.763 . . . . 0.0 110.412 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -49.8 -47.9 51.03 Favored 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 121.277 0.561 . . . . 0.0 110.003 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.87 -40.65 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.726 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.463 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.74 -29.82 59.01 Favored 'General case' 0 N--CA 1.523 3.219 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.719 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . 0.444 HE21 ' CA ' ' B' ' 710' ' ' GLN . 0.0 OUTLIER -89.69 -6.5 56.04 Favored 'General case' 0 N--CA 1.519 3.01 0 C-N-CA 124.515 1.126 . . . . 0.0 109.265 -178.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -59.7 -31.98 72.82 Favored Glycine 0 N--CA 1.513 3.788 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -89.61 154.31 20.07 Favored 'General case' 0 N--CA 1.529 3.502 0 C-N-CA 124.049 0.939 . . . . 0.0 109.346 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 3.3 t -80.82 150.05 68.51 Favored Pre-proline 0 N--CA 1.534 3.758 0 C-N-CA 126.735 2.014 . . . . 0.0 111.1 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -55.6 130.18 39.1 Favored 'Trans proline' 0 N--CA 1.528 3.532 0 CA-C-N 120.744 1.301 . . . . 0.0 110.468 -174.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 59.63 123.8 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.326 0 C-N-CA 126.077 1.751 . . . . 0.0 110.004 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.522 3.136 0 C-N-CA 123.847 0.859 . . . . 0.0 109.89 179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 27.7 m120 . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -66.33 164.24 16.46 Favored 'General case' 0 N--CA 1.526 3.373 0 C-N-CA 124.135 0.974 . . . . 0.0 109.845 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.7 -29.31 17.84 Favored 'General case' 0 N--CA 1.529 3.503 0 C-N-CA 124.089 0.955 . . . . 0.0 112.671 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -70.82 -29.7 65.93 Favored 'General case' 0 N--CA 1.528 3.447 0 CA-C-O 120.592 0.234 . . . . 0.0 110.56 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -71.72 -37.92 70.55 Favored 'General case' 0 N--CA 1.518 2.926 0 CA-C-O 118.748 -0.644 . . . . 0.0 111.218 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . 0.502 HD12 ' N ' ' C' ' 683' ' ' ARG . 1.9 pp -72.31 -23.23 21.23 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.225 0 CA-C-N 119.365 0.984 . . . . 0.0 110.505 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . 0.502 ' N ' HD12 ' C' ' 682' ' ' ILE . 0.0 OUTLIER -66.32 -51.58 55.89 Favored 'General case' 0 N--CA 1.535 3.797 0 C-N-CA 124.026 0.931 . . . . 0.0 112.289 -176.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -72.29 -31.77 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.867 0 C-N-CA 123.605 0.762 . . . . 0.0 110.249 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -48.75 -23.71 1.15 Allowed 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 125.546 1.538 . . . . 0.0 112.764 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -56.11 -37.02 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.731 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.77 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 37.7 pt -61.86 -41.54 91.16 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.679 0 CA-C-N 120.783 1.629 . . . . 0.0 110.006 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 50.2 mt -63.63 -50.14 79.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.143 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.35 -38.64 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 C-N-CA 124.202 1.001 . . . . 0.0 110.59 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.79 -49.25 50.38 Favored Glycine 1 N--CA 1.525 4.567 0 C-N-CA 125.339 1.447 . . . . 0.0 111.712 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 73.1 m -58.79 -34.97 72.07 Favored 'General case' 0 N--CA 1.52 3.072 0 CA-C-O 121.841 0.829 . . . . 0.0 108.998 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.64 -44.55 85.69 Favored 'General case' 0 N--CA 1.524 3.251 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.452 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . 0.718 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.266 0.1 OUTLIER -65.22 -47.97 85.33 Favored 'Isoleucine or valine' 1 N--CA 1.554 4.741 0 CA-C-N 119.113 0.87 . . . . 0.0 111.595 -177.221 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.22 -21.3 46.63 Favored Glycine 1 N--CA 1.531 4.999 0 CA-C-N 118.993 0.815 . . . . 0.0 112.656 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.79 -43.08 63.23 Favored 'General case' 0 N--CA 1.537 3.891 0 C-N-CA 124.028 0.931 . . . . 0.0 109.037 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -53.5 -25.51 16.85 Favored 'General case' 0 N--CA 1.532 3.663 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 40.1 mm -53.06 -37.65 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.939 0 C-N-CA 124.33 1.052 . . . . 0.0 112.724 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.03 -30.59 23.9 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.275 0 C-N-CA 123.61 0.764 . . . . 0.0 111.737 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -63.35 -27.64 69.45 Favored 'General case' 0 N--CA 1.538 3.966 0 O-C-N 121.433 -0.792 . . . . 0.0 110.857 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.1 -39.75 75.35 Favored 'General case' 0 N--CA 1.535 3.815 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.58 -32.01 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.078 0 C-N-CA 125.095 1.358 . . . . 0.0 109.041 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 16.0 tp -55.15 -33.04 62.6 Favored 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 123.401 0.68 . . . . 0.0 109.537 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 67.9 m -56.81 -46.33 81.68 Favored 'General case' 0 N--CA 1.532 3.626 0 CA-C-N 118.831 0.741 . . . . 0.0 112.629 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 42.4 tp -65.13 -35.3 80.67 Favored 'General case' 1 N--CA 1.549 4.509 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.99 -38.93 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -64.68 -25.52 67.98 Favored 'General case' 0 N--CA 1.52 3.055 0 C-N-CA 123.793 0.837 . . . . 0.0 110.298 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . 0.428 HH11 ' NE2' ' A' ' 710' ' ' GLN . 8.7 tpp180 -48.87 -44.12 39.58 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.74 0.781 . . . . 0.0 111.048 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.01 -39.71 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.343 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -76.54 -21.45 55.67 Favored 'General case' 0 N--CA 1.53 3.562 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.707 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -88.94 -11.15 45.26 Favored 'General case' 0 N--CA 1.513 2.714 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.96 -19.11 21.12 Favored Glycine 1 N--CA 1.517 4.079 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -107.24 153.17 23.09 Favored 'General case' 0 N--CA 1.528 3.442 0 C-N-CA 124.858 1.263 . . . . 0.0 109.11 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 83.5 p -81.6 152.21 69.43 Favored Pre-proline 0 N--CA 1.528 3.459 0 C-N-CA 126.369 1.868 . . . . 0.0 111.545 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -53.04 131.83 44.71 Favored 'Trans proline' 0 C--N 1.401 3.331 0 CA-C-N 121.625 1.616 . . . . 0.0 112.066 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 46.3 tp 62.73 148.94 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 125.848 1.659 . . . . 0.0 110.795 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.52 3.067 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.464 -179.924 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -70.87 172.85 8.18 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.776 0.83 . . . . 0.0 109.975 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.6 pp -52.15 -24.62 7.33 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 125.318 1.447 . . . . 0.0 112.834 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -60.18 -49.72 76.51 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -65.99 -33.51 75.98 Favored 'General case' 0 N--CA 1.535 3.815 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.76 -27.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 C-N-CA 125.212 1.405 . . . . 0.0 109.853 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -63.86 -52.04 61.85 Favored 'General case' 1 N--CA 1.545 4.299 0 O-C-N 121.495 -0.753 . . . . 0.0 111.471 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.9 tt -67.42 -31.97 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 C-N-CA 123.908 0.883 . . . . 0.0 109.287 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -58.94 -41.8 88.23 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.876 0.87 . . . . 0.0 109.036 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.27 -36.04 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 C-N-CA 124.962 1.305 . . . . 0.0 108.681 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 56.5 mt -66.7 -37.41 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.75 -43.35 91.41 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.529 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.71 -29.51 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.925 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.75 -32.09 81.86 Favored Glycine 1 N--CA 1.516 4.016 0 C-N-CA 123.614 0.626 . . . . 0.0 112.309 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 68.2 m -68.31 -36.19 78.93 Favored 'General case' 0 N--CA 1.532 3.657 0 C-N-CA 123.659 0.784 . . . . 0.0 111.764 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 8.9 mp -54.03 -39.62 66.32 Favored 'General case' 0 N--CA 1.537 3.886 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.53 HD11 ' HE ' ' B' ' 696' ' ' ARG 0.261 0.1 OUTLIER -62.48 -49.72 82.74 Favored 'Isoleucine or valine' 1 N--CA 1.556 4.864 0 CA-C-N 119.429 1.013 . . . . 0.0 112.664 -176.12 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.15 -30.84 71.45 Favored Glycine 1 N--CA 1.527 4.719 0 CA-C-N 119.187 0.903 . . . . 0.0 112.866 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.18 -42.23 99.34 Favored 'General case' 0 N--CA 1.536 3.855 0 C-N-CA 124.568 1.147 . . . . 0.0 111.576 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . 0.783 ' HE ' HD11 ' C' ' 693' ' ' ILE . 26.5 mmt180 -52.67 -26.02 12.58 Favored 'General case' 0 N--CA 1.537 3.916 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 16.5 tt -53.46 -38.3 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.9 p -55.25 -30.77 25.37 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 C-N-CA 123.414 0.685 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -61.45 -28.22 69.12 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.097 0.559 . . . . 0.0 110.797 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.43 -41.92 72.25 Favored 'General case' 0 N--CA 1.53 3.553 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 88.5 t -68.59 -32.85 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 125.007 1.323 . . . . 0.0 108.953 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 13.5 tp -55.33 -30.26 59.91 Favored 'General case' 0 N--CA 1.53 3.543 0 C-N-CA 124.089 0.956 . . . . 0.0 109.371 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 78.3 p -56.04 -45.63 79.14 Favored 'General case' 0 N--CA 1.533 3.723 0 O-C-N 121.485 -0.76 . . . . 0.0 111.572 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.23 -34.81 78.46 Favored 'General case' 1 N--CA 1.545 4.319 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 17.2 t -68.38 -39.35 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -63.12 -21.05 65.93 Favored 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.407 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -49.35 -46.8 47.49 Favored 'General case' 0 N--CA 1.513 2.711 0 CA-C-O 121.748 0.785 . . . . 0.0 109.168 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.68 -41.88 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -77.25 -5.51 49.61 Favored 'General case' 0 N--CA 1.522 3.143 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.209 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.64 -17.2 23.52 Favored 'General case' 1 N--CA 1.558 4.937 0 CA-C-N 118.671 0.669 . . . . 0.0 109.947 -179.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -84.09 -28.24 34.72 Favored Glycine 1 N--CA 1.522 4.419 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -75.49 135.23 40.66 Favored 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 112.901 -1.65 . . . . 0.0 108.317 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 96.0 p -82.67 146.67 53.59 Favored Pre-proline 0 N--CA 1.534 3.725 0 CA-C-O 117.574 -1.203 . . . . 0.0 110.665 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -62.86 130.68 30.16 Favored 'Trans proline' 0 C--N 1.398 3.184 0 CA-C-N 121.42 1.543 . . . . 0.0 109.616 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -68.1 81.83 0.22 Allowed 'General case' 0 N--CA 1.53 3.525 0 C-N-CA 124.893 1.277 . . . . 0.0 108.947 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.52 3.029 0 C-N-CA 124.072 0.949 . . . . 0.0 111.939 -179.659 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -69.63 120.84 16.01 Favored 'General case' 0 N--CA 1.521 3.076 0 C-N-CA 123.907 0.883 . . . . 0.0 111.009 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -21.3 3.01 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 125.572 1.549 . . . . 0.0 112.847 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -57.84 -49.61 76.09 Favored 'General case' 0 N--CA 1.532 3.67 0 CA-C-O 121.599 0.714 . . . . 0.0 111.24 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -65.19 -33.63 76.45 Favored 'General case' 0 N--CA 1.52 3.073 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.554 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 29.2 mm -74.09 -28.45 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.152 0 C-N-CA 124.596 1.158 . . . . 0.0 110.425 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -66.13 -55.41 16.54 Favored 'General case' 1 N--CA 1.547 4.385 0 CA-C-O 122.379 1.085 . . . . 0.0 110.615 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . 0.55 ' O ' HD13 ' B' ' 684' ' ' ILE . 0.0 OUTLIER -64.75 -30.55 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.879 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.46 -178.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.41 -44.36 65.36 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 123.647 0.779 . . . . 0.0 111.511 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 27.2 mt -62.81 -37.9 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 C-N-CA 124.869 1.268 . . . . 0.0 110.311 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 39.1 mm -57.61 -41.62 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 50.4 mm -62.98 -44.99 99.99 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.538 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 176.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.43 -31.07 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 C-N-CA 123.351 0.661 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.54 -42.84 95.45 Favored Glycine 1 N--CA 1.524 4.539 0 C-N-CA 123.539 0.59 . . . . 0.0 112.593 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 66.7 m -67.31 -36.25 81.11 Favored 'General case' 0 N--CA 1.528 3.46 0 CA-C-O 122.342 1.068 . . . . 0.0 110.212 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 2.6 tp -54.04 -35.05 61.56 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-N 113.191 -1.822 . . . . 0.0 112.909 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -42.32 59.47 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.624 0 CA-C-N 118.641 0.655 . . . . 0.0 110.663 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -53.58 -44.75 68.31 Favored Glycine 1 N--CA 1.523 4.472 0 N-CA-C 116.025 1.17 . . . . 0.0 116.025 -175.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . 0.321 0.0 OUTLIER -67.23 -30.85 70.87 Favored 'General case' 1 N--CA 1.557 4.893 0 CA-C-N 118.267 1.034 . . . . 0.0 112.247 -179.162 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . 0.53 ' HE ' HD11 ' A' ' 693' ' ' ILE . 34.1 mmt180 -48.22 -25.02 1.34 Allowed 'General case' 0 N--CA 1.538 3.936 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 25.9 pt -54.27 -36.69 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.964 0 CA-C-N 118.864 0.757 . . . . 0.0 112.543 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.96 -32.57 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -55.62 -25.77 40.58 Favored 'General case' 0 N--CA 1.534 3.755 0 C-N-CA 123.386 0.674 . . . . 0.0 109.67 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.18 72.6 Favored 'General case' 0 N--CA 1.524 3.262 0 C-N-CA 122.711 0.404 . . . . 0.0 110.643 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.4 m -68.78 -31.38 50.52 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.3 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 11.8 tp -54.32 -33.9 59.86 Favored 'General case' 0 N--CA 1.531 3.581 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.157 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 27.0 m -57.69 -46.38 84.41 Favored 'General case' 0 N--CA 1.531 3.577 0 CA-C-N 119.246 0.93 . . . . 0.0 113.4 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 37.5 tp -65.27 -35.9 82.44 Favored 'General case' 1 N--CA 1.552 4.667 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.4 -38.58 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.354 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -62.32 -26.62 68.53 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.054 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -49.11 -47.43 45.3 Favored 'General case' 0 N--CA 1.508 2.443 0 CA-C-O 121.694 0.759 . . . . 0.0 109.687 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.22 -37.97 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.853 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -75.38 -24.51 57.26 Favored 'General case' 0 N--CA 1.53 3.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.025 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -89.35 -13.38 37.99 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.1 -25.72 32.82 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -96.86 154.22 17.43 Favored 'General case' 0 N--CA 1.533 3.7 0 C-N-CA 124.559 1.144 . . . . 0.0 108.517 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 82.5 p -80.64 152.03 72.04 Favored Pre-proline 0 N--CA 1.536 3.84 0 C-N-CA 126.201 1.8 . . . . 0.0 112.973 -175.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.5 130.32 39.48 Favored 'Trans proline' 0 C--N 1.407 3.635 0 CA-C-N 121.159 1.45 . . . . 0.0 112.022 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 66.4 mt -86.42 175.88 8.16 Favored 'General case' 0 N--CA 1.524 3.24 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.447 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.523 3.194 0 C-N-CA 124.123 0.969 . . . . 0.0 109.527 -179.791 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -82.96 -152.46 0.11 Allowed 'General case' 0 N--CA 1.528 3.443 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -21.77 1.66 Allowed 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 125.19 1.396 . . . . 0.0 112.843 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -60.16 -49.4 77.8 Favored 'General case' 0 N--CA 1.533 3.692 0 C-N-CA 122.994 0.518 . . . . 0.0 110.627 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -64.18 -33.71 76.41 Favored 'General case' 0 N--CA 1.525 3.301 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 27.9 mm -73.79 -31.5 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 C-N-CA 124.451 1.101 . . . . 0.0 111.13 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -49.52 69.64 Favored 'General case' 1 N--CA 1.554 4.773 0 CA-C-O 121.617 0.722 . . . . 0.0 111.52 -176.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -29.02 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 C-N-CA 125.319 1.448 . . . . 0.0 110.27 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -51.2 -30.37 16.91 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.408 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . 0.414 ' N ' HD12 ' C' ' 686' ' ' ILE . 1.5 mp -68.45 -40.69 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.981 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 45.4 mt -60.5 -34.81 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.563 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.54 -47.6 92.22 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.451 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.4 -29.12 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.231 0 C-N-CA 124.253 1.021 . . . . 0.0 109.74 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.84 92.69 Favored Glycine 1 N--CA 1.522 4.369 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 60.6 m -68.98 -37.17 78.6 Favored 'General case' 0 N--CA 1.521 3.115 0 C-N-CA 124.126 0.97 . . . . 0.0 111.137 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.6 mp -55.71 -35.42 66.09 Favored 'General case' 1 N--CA 1.54 4.042 0 C-N-CA 123.573 0.749 . . . . 0.0 112.09 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . 0.783 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.269 0.4 OUTLIER -72.11 -47.22 55.35 Favored 'Isoleucine or valine' 1 N--CA 1.553 4.704 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.52 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -53.96 -44.91 72.33 Favored Glycine 1 N--CA 1.525 4.588 0 N-CA-C 116.393 1.317 . . . . 0.0 116.393 -175.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -65.81 -31.04 71.77 Favored 'General case' 1 N--CA 1.552 4.645 0 CA-C-N 118.408 1.104 . . . . 0.0 112.697 -178.85 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -48.95 -25.26 1.84 Allowed 'General case' 1 N--CA 1.544 4.258 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 18.2 tt -53.1 -35.3 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 C-N-CA 123.256 0.622 . . . . 0.0 111.388 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -53.18 -30.65 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.936 0 C-N-CA 124.198 0.999 . . . . 0.0 111.506 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -58.89 -28.43 66.16 Favored 'General case' 0 N--CA 1.537 3.907 0 O-C-N 121.655 -0.653 . . . . 0.0 110.474 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.34 -42.38 71.98 Favored 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.49 -32.39 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 CA-C-N 114.186 -1.37 . . . . 0.0 108.796 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 21.1 tp -54.94 -33.43 62.28 Favored 'General case' 0 N--CA 1.536 3.871 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 87.0 p -57.33 -45.37 84.36 Favored 'General case' 0 N--CA 1.529 3.485 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -37.39 85.48 Favored 'General case' 1 N--CA 1.544 4.228 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 45.5 t -66.14 -37.94 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.431 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' C' ' 710' ' ' GLN . 1.8 p30 -60.12 -31.91 70.5 Favored 'General case' 0 N--CA 1.518 2.953 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.143 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -48.22 -47.27 35.73 Favored 'General case' 0 N--CA 1.516 2.852 0 C-N-CA 123.517 0.727 . . . . 0.0 111.258 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 49.3 t -64.13 -47.71 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -78.76 -10.15 59.68 Favored 'General case' 0 N--CA 1.536 3.868 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' C' ' 706' ' ' ASN . 38.7 tt0 -113.7 -10.87 13.02 Favored 'General case' 0 N--CA 1.533 3.679 0 C-N-CA 124.965 1.306 . . . . 0.0 109.175 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.21 -35.33 54.83 Favored Glycine 0 N--CA 1.509 3.523 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -79.53 152.78 29.97 Favored 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 96.0 p -81.17 150.03 67.29 Favored Pre-proline 0 N--CA 1.531 3.588 0 CA-C-O 116.739 -1.601 . . . . 0.0 111.09 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.14 131.05 42.71 Favored 'Trans proline' 0 C--N 1.401 3.302 0 CA-C-N 121.9 1.714 . . . . 0.0 112.255 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.97 94.64 0.05 Allowed 'General case' 0 N--CA 1.53 3.566 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.246 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.521 3.123 0 CA-C-O 117.853 -1.07 . . . . 0.0 112.444 -179.403 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -170.01 -78.02 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.099 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -23.52 5.3 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 125.328 1.451 . . . . 0.0 114.179 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -62.96 -51.35 67.2 Favored 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -67.41 -31.39 71.57 Favored 'General case' 1 N--CA 1.539 4.005 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 47.6 mm -74.88 -26.68 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.489 0 C-N-CA 124.911 1.284 . . . . 0.0 110.269 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -66.35 -54.0 29.61 Favored 'General case' 1 N--CA 1.55 4.559 0 CA-C-O 121.775 0.797 . . . . 0.0 111.13 -177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.1 tt -63.44 -30.82 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.353 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -56.82 -31.35 64.64 Favored 'General case' 0 N--CA 1.515 2.813 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.789 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 16.6 mm -68.58 -39.25 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 54.3 mt -65.42 -36.32 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.194 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 72.1 mt -67.45 -42.95 87.72 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.026 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.92 -30.15 47.94 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.338 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.7 97.52 Favored Glycine 1 N--CA 1.524 4.565 0 C-N-CA 124.002 0.811 . . . . 0.0 112.175 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 71.0 m -68.78 -37.83 79.6 Favored 'General case' 0 N--CA 1.522 3.16 0 CA-C-O 122.084 0.945 . . . . 0.0 109.883 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 1.9 tp -59.44 -44.78 92.86 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.02 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.535 ' O ' HD13 ' A' ' 693' ' ' ILE . 0.0 OUTLIER -72.13 -32.46 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.757 0 O-C-N 121.896 -0.502 . . . . 0.0 112.092 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -59.18 -44.59 96.3 Favored Glycine 1 N--CA 1.52 4.246 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . 0.334 0.0 OUTLIER -68.09 -31.97 71.96 Favored 'General case' 1 N--CA 1.549 4.506 0 CA-C-N 118.279 1.039 . . . . 0.0 112.452 -178.715 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -48.6 -24.7 1.42 Allowed 'General case' 0 N--CA 1.539 3.982 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 17.4 tt -52.39 -35.07 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 123.186 0.594 . . . . 0.0 111.845 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 14.8 p -52.95 -30.3 15.86 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 C-N-CA 123.789 0.836 . . . . 0.0 111.309 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -61.29 -29.37 69.83 Favored 'General case' 0 N--CA 1.536 3.827 0 O-C-N 121.433 -0.792 . . . . 0.0 110.328 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.55 -37.94 74.09 Favored 'General case' 0 N--CA 1.535 3.783 0 CA-C-O 121.629 0.728 . . . . 0.0 109.059 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.47 -30.24 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.255 0 C-N-CA 124.75 1.22 . . . . 0.0 108.56 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.1 -30.58 49.06 Favored 'General case' 0 N--CA 1.534 3.74 0 C-N-CA 123.428 0.691 . . . . 0.0 109.236 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 72.6 p -56.52 -45.83 80.9 Favored 'General case' 0 N--CA 1.533 3.711 0 O-C-N 121.473 -0.767 . . . . 0.0 111.601 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 34.6 tp -62.63 -35.49 79.77 Favored 'General case' 1 N--CA 1.552 4.653 0 O-C-N 121.34 -0.85 . . . . 0.0 108.935 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.1 -38.59 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.623 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . 0.645 HD22 ' HE ' ' A' ' 709' ' ' ARG . 7.3 t-20 -60.53 -22.83 64.05 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 123.784 0.833 . . . . 0.0 109.798 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -53.5 -42.55 67.46 Favored 'General case' 0 N--CA 1.512 2.628 0 CA-C-O 121.602 0.715 . . . . 0.0 109.646 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.42 -37.46 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.144 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . 0.645 ' HE ' HD22 ' A' ' 706' ' ' ASN . 54.9 mtm180 -77.67 -4.44 46.12 Favored 'General case' 0 N--CA 1.516 2.856 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.999 175.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -91.35 -17.52 25.74 Favored 'General case' 1 N--CA 1.562 5.17 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -78.6 -18.51 75.48 Favored Glycine 1 N--CA 1.523 4.498 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -98.98 144.74 27.8 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 126.654 1.982 . . . . 0.0 106.235 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 78.4 p -104.53 143.94 27.71 Favored Pre-proline 1 N--CA 1.55 4.53 0 CA-C-O 117.929 -1.034 . . . . 0.0 113.474 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -64.06 131.42 30.58 Favored 'Trans proline' 0 C--N 1.409 3.754 0 CA-C-N 120.988 1.389 . . . . 0.0 110.938 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.97 172.31 7.07 Favored 'General case' 0 N--CA 1.535 3.779 0 C-N-CA 125.52 1.528 . . . . 0.0 108.838 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.52 3.069 0 CA-C-O 117.48 -1.247 . . . . 0.0 108.699 179.662 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 9.2 t90 60.56 56.41 3.08 Favored 'General case' 0 N--CA 1.519 2.992 0 C-N-CA 124.567 1.147 . . . . 0.0 111.399 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 1.4 pp -52.42 -17.99 1.45 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -55.45 -29.44 58.66 Favored 'General case' 1 N--CA 1.541 4.08 0 CA-C-N 120.156 1.344 . . . . 0.0 111.176 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -72.66 -34.65 67.39 Favored 'General case' 0 N--CA 1.532 3.649 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.54 -25.16 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.375 0 C-N-CA 124.386 1.074 . . . . 0.0 108.78 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -65.75 -45.9 80.87 Favored 'General case' 1 N--CA 1.549 4.487 0 O-C-N 121.54 -0.725 . . . . 0.0 111.566 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 13.7 tt -66.05 -30.54 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.34 -27.3 67.02 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.842 0.857 . . . . 0.0 110.122 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.09 -43.25 81.89 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.204 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 62.6 mt -72.43 -38.41 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.091 0 C-N-CA 124.718 1.207 . . . . 0.0 111.81 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 3.3 tp -58.38 -37.53 64.25 Favored 'Isoleucine or valine' 1 N--CA 1.556 4.844 0 CA-C-N 119.161 0.891 . . . . 0.0 110.215 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.98 -27.54 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 C-N-CA 124.298 1.039 . . . . 0.0 109.98 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -80.16 -27.58 52.14 Favored Glycine 1 N--CA 1.518 4.161 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 49.9 m -69.19 -52.42 28.1 Favored 'General case' 0 N--CA 1.534 3.764 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -34.69 75.39 Favored 'General case' 0 N--CA 1.538 3.974 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.452 HD11 ' HE ' ' C' ' 696' ' ' ARG . 1.2 tp -58.87 -44.86 91.59 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.263 0 CA-C-N 119.54 1.064 . . . . 0.0 111.495 -177.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.15 -31.25 80.12 Favored Glycine 1 N--CA 1.521 4.325 0 O-C-N 120.643 -1.285 . . . . 0.0 111.224 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.92 -43.18 96.7 Favored 'General case' 0 N--CA 1.535 3.824 0 C-N-CA 124.243 1.017 . . . . 0.0 111.506 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -53.03 -26.96 17.44 Favored 'General case' 1 N--CA 1.54 4.05 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 18.9 tt -54.82 -39.28 47.37 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.387 0 CA-C-N 120.116 1.325 . . . . 0.0 113.973 -174.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.58 -30.53 36.97 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.225 0 C-N-CA 123.332 0.653 . . . . 0.0 111.683 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -53.96 -26.48 25.86 Favored 'General case' 0 N--CA 1.533 3.709 0 C-N-CA 123.145 0.578 . . . . 0.0 109.532 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.89 -36.95 68.22 Favored 'General case' 0 N--CA 1.523 3.224 0 C-N-CA 122.787 0.435 . . . . 0.0 110.199 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.43 -29.63 44.78 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.025 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 6.4 tp -52.37 -35.91 52.56 Favored 'General case' 0 N--CA 1.531 3.611 0 CA-C-O 118.866 -0.588 . . . . 0.0 110.721 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 68.9 m -59.28 -46.52 88.32 Favored 'General case' 0 N--CA 1.533 3.714 0 CA-C-N 118.949 0.795 . . . . 0.0 112.864 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 51.0 tp -66.23 -36.02 81.93 Favored 'General case' 1 N--CA 1.547 4.383 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.28 -38.29 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -59.54 -31.78 69.73 Favored 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.11 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -48.45 -45.29 36.35 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 124.934 1.294 . . . . 0.0 111.368 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 59.0 t -62.83 -49.95 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.25 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -79.57 -3.92 49.14 Favored 'General case' 1 N--CA 1.551 4.595 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.551 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -109.98 -13.3 14.44 Favored 'General case' 0 N--CA 1.528 3.427 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.38 -28.48 20.39 Favored Glycine 0 N--CA 1.515 3.925 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -86.23 155.14 20.83 Favored 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 123.796 0.838 . . . . 0.0 108.992 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 90.0 p -79.0 150.19 74.57 Favored Pre-proline 0 N--CA 1.534 3.74 0 C-N-CA 126.479 1.911 . . . . 0.0 112.598 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -54.06 131.71 46.15 Favored 'Trans proline' 0 C--N 1.408 3.679 0 CA-C-N 120.626 1.259 . . . . 0.0 111.031 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 4.8 tt -144.19 -57.02 0.37 Allowed 'General case' 0 N--CA 1.527 3.417 0 CA-C-N 113.169 -1.832 . . . . 0.0 106.586 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.521 3.113 0 C-N-CA 124.908 1.283 . . . . 0.0 113.758 178.54 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 39.4 t30 . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -58.24 -57.23 13.81 Favored 'General case' 0 N--CA 1.529 3.479 0 CA-C-O 122.096 0.951 . . . . 0.0 110.172 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 pp -60.9 -28.49 68.94 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.629 1.572 . . . . 0.0 112.696 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -58.02 -50.25 74.08 Favored 'General case' 0 N--CA 1.536 3.854 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -174.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -63.21 -33.58 75.8 Favored 'General case' 0 N--CA 1.529 3.486 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.49 -29.12 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 C-N-CA 125.724 1.609 . . . . 0.0 110.514 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -51.85 52.94 Favored 'General case' 1 N--CA 1.55 4.536 0 C-N-CA 123.682 0.793 . . . . 0.0 111.479 -176.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 14.4 tt -63.08 -39.75 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.427 0 C-N-CA 124.099 0.96 . . . . 0.0 109.465 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -53.09 -42.61 66.07 Favored 'General case' 0 N--CA 1.517 2.88 0 CA-C-N 114.398 -1.274 . . . . 0.0 111.82 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.88 -36.26 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.415 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 20.4 mt -63.5 -44.11 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.65 -43.66 95.31 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.299 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 94.8 t -66.08 -37.77 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 C-N-CA 123.853 0.861 . . . . 0.0 110.134 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -57.19 -32.96 63.97 Favored Glycine 1 N--CA 1.522 4.425 0 C-N-CA 123.727 0.68 . . . . 0.0 113.756 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 63.1 m -63.39 -34.62 78.13 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 124.355 1.062 . . . . 0.0 112.57 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 4.0 mp -52.85 -34.79 55.91 Favored 'General case' 0 N--CA 1.532 3.668 0 C-N-CA 123.618 0.767 . . . . 0.0 112.659 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . 0.44 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.2 OUTLIER -58.58 -43.81 88.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.445 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.643 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -69.2 -29.93 71.92 Favored Glycine 1 N--CA 1.522 4.399 0 O-C-N 121.232 -0.917 . . . . 0.0 110.917 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.85 -42.83 99.53 Favored 'General case' 0 N--CA 1.532 3.664 0 C-N-CA 123.83 0.852 . . . . 0.0 110.506 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . 0.452 ' HE ' HD11 ' B' ' 693' ' ' ILE . 26.2 mmt180 -56.41 -26.83 54.64 Favored 'General case' 1 N--CA 1.543 4.194 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 69.9 mt -54.85 -39.55 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 C-N-CA 122.976 0.51 . . . . 0.0 112.319 -176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.79 -32.05 54.44 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.488 0 CA-C-N 119.235 0.925 . . . . 0.0 112.241 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -53.99 -26.99 28.79 Favored 'General case' 0 N--CA 1.536 3.857 0 O-C-N 121.836 -0.54 . . . . 0.0 110.501 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.72 -32.83 65.91 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 122.039 -0.413 . . . . 0.0 110.341 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 2.1 m -68.81 -29.84 44.93 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.095 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 12.5 tp -51.77 -36.3 46.91 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-O 118.709 -0.662 . . . . 0.0 110.914 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 24.5 t -59.06 -46.24 88.77 Favored 'General case' 0 N--CA 1.534 3.747 0 CA-C-N 119.148 0.885 . . . . 0.0 112.914 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 37.9 tp -65.72 -34.53 78.39 Favored 'General case' 0 N--CA 1.534 3.773 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.31 -39.84 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.591 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' C' ' 710' ' ' GLN . 33.2 t-20 -65.81 -23.98 66.81 Favored 'General case' 0 N--CA 1.524 3.24 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.764 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -47.89 -42.83 27.88 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 123.992 0.917 . . . . 0.0 111.271 -178.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 43.5 t -65.44 -47.02 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -78.1 -11.84 59.94 Favored 'General case' 0 N--CA 1.539 3.986 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.314 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' C' ' 706' ' ' ASN . 49.5 tt0 -109.91 -9.94 14.76 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 125.093 1.357 . . . . 0.0 108.654 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -55.78 -27.13 49.04 Favored Glycine 0 N--CA 1.514 3.899 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -99.32 152.71 19.63 Favored 'General case' 0 N--CA 1.529 3.509 0 C-N-CA 123.935 0.894 . . . . 0.0 109.327 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 88.0 p -82.28 148.96 60.86 Favored Pre-proline 0 N--CA 1.528 3.473 0 C-N-CA 125.947 1.699 . . . . 0.0 109.714 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -54.66 132.19 50.11 Favored 'Trans proline' 0 C--N 1.398 3.164 0 CA-C-N 121.612 1.611 . . . . 0.0 112.854 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -158.63 -49.93 0.06 Allowed 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 112.308 -2.224 . . . . 0.0 105.917 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 86.2 p . . . . . 0 N--CA 1.522 3.168 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.56 178.665 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.87 -13.74 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 124.002 0.921 . . . . 0.0 110.664 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp -50.12 -22.93 1.86 Allowed 'General case' 0 N--CA 1.505 2.296 0 C-N-CA 125.306 1.443 . . . . 0.0 113.482 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -59.47 -49.43 77.81 Favored 'General case' 0 N--CA 1.533 3.693 0 CA-C-O 121.207 0.527 . . . . 0.0 111.348 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -66.93 -29.23 69.04 Favored 'General case' 0 N--CA 1.523 3.221 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 30.7 mm -74.96 -32.2 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.243 0 C-N-CA 124.562 1.145 . . . . 0.0 110.614 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -48.51 69.39 Favored 'General case' 1 N--CA 1.549 4.521 0 O-C-N 121.935 -0.478 . . . . 0.0 111.738 -176.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.1 tt -68.34 -31.18 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.782 0 C-N-CA 123.916 0.886 . . . . 0.0 109.826 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -48.51 -24.63 1.36 Allowed 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 124.624 1.17 . . . . 0.0 111.448 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.38 -40.14 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 117.268 -1.349 . . . . 0.0 111.094 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 40.0 pt -53.33 -36.31 26.21 Favored 'Isoleucine or valine' 1 N--CA 1.567 5.388 0 CA-C-N 121.531 1.969 . . . . 0.0 109.93 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.93 -49.14 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 23.9 t -68.17 -29.27 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 125.256 1.423 . . . . 0.0 111.295 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -82.31 -32.19 29.06 Favored Glycine 1 N--CA 1.525 4.571 0 C-N-CA 124.589 1.09 . . . . 0.0 112.317 -175.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 74.3 m -69.05 -51.37 39.63 Favored 'General case' 0 N--CA 1.516 2.84 0 C-N-CA 123.839 0.856 . . . . 0.0 113.109 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.49 -31.77 73.02 Favored 'General case' 1 N--CA 1.541 4.096 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.806 HD11 ' HE ' ' B' ' 696' ' ' ARG . 1.3 tp -59.34 -42.65 88.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.431 0 CA-C-N 120.77 1.623 . . . . 0.0 111.295 -176.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -70.62 -27.53 72.36 Favored Glycine 1 N--CA 1.525 4.609 0 O-C-N 121.02 -1.05 . . . . 0.0 110.968 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.7 -36.68 83.74 Favored 'General case' 1 N--CA 1.544 4.261 0 C-N-CA 123.861 0.864 . . . . 0.0 109.075 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -54.78 -29.25 53.72 Favored 'General case' 1 N--CA 1.542 4.161 0 O-C-N 121.45 -0.781 . . . . 0.0 112.025 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 46.9 mm -57.51 -38.6 64.4 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.047 0 C-N-CA 123.479 0.712 . . . . 0.0 109.839 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 92.1 t -58.17 -37.78 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 C-N-CA 125.077 1.351 . . . . 0.0 111.265 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -55.13 -24.85 28.14 Favored 'General case' 0 N--CA 1.53 3.572 0 C-N-CA 123.317 0.647 . . . . 0.0 110.002 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.2 64.31 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 122.163 -0.336 . . . . 0.0 110.14 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.97 -31.32 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.996 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.07 -36.7 63.4 Favored 'General case' 0 N--CA 1.534 3.765 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.651 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 61.5 m -58.75 -47.07 85.94 Favored 'General case' 0 N--CA 1.536 3.862 0 CA-C-N 119.252 0.933 . . . . 0.0 112.868 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 35.8 tp -65.76 -35.04 79.58 Favored 'General case' 1 N--CA 1.54 4.072 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 87.2 t -68.65 -38.65 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 710' ' ' GLN . 17.6 t30 -58.34 -23.13 55.82 Favored 'General case' 0 N--CA 1.516 2.869 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.349 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -47.04 -40.01 13.95 Favored 'General case' 0 N--CA 1.527 3.395 0 C-N-CA 123.667 0.787 . . . . 0.0 111.125 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.96 -45.56 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -76.86 -11.04 59.76 Favored 'General case' 0 N--CA 1.533 3.682 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.698 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 706' ' ' ASN . 35.6 tt0 -113.55 -14.18 12.7 Favored 'General case' 0 N--CA 1.528 3.473 0 C-N-CA 125.702 1.601 . . . . 0.0 109.466 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -74.33 -14.89 80.45 Favored Glycine 1 N--CA 1.534 5.213 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 174.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -75.76 146.52 39.97 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 128.207 2.603 . . . . 0.0 107.177 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 67.5 m -81.85 146.99 57.28 Favored Pre-proline 1 N--CA 1.54 4.051 0 C-N-CA 124.402 1.081 . . . . 0.0 112.247 -176.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.94 130.19 31.82 Favored 'Trans proline' 0 C--N 1.401 3.3 0 CA-C-N 120.998 1.392 . . . . 0.0 109.476 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.31 169.22 18.47 Favored 'General case' 0 N--CA 1.527 3.4 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.575 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 97.8 p . . . . . 0 N--CA 1.522 3.168 0 C-N-CA 123.747 0.819 . . . . 0.0 110.423 -179.756 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 54.92 105.52 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 124.296 1.039 . . . . 0.0 111.899 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.81 -20.59 2.28 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.505 1.522 . . . . 0.0 113.432 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -55.95 -50.62 70.28 Favored 'General case' 0 N--CA 1.535 3.816 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.07 -34.54 78.26 Favored 'General case' 0 N--CA 1.529 3.514 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.5 -29.03 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.222 0 C-N-CA 125.141 1.377 . . . . 0.0 110.403 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -46.93 74.37 Favored 'General case' 1 N--CA 1.556 4.857 0 O-C-N 121.208 -0.933 . . . . 0.0 110.282 -176.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -71.22 -30.74 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 C-N-CA 124.238 1.015 . . . . 0.0 109.765 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -56.56 -45.67 81.14 Favored 'General case' 0 N--CA 1.519 2.983 0 CA-C-O 122.35 1.072 . . . . 0.0 109.351 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.22 -37.82 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.085 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 52.5 mt -65.51 -40.71 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.71 -44.17 96.64 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.335 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.82 -30.24 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 C-N-CA 123.444 0.698 . . . . 0.0 109.825 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.3 92.49 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.139 0.4 . . . . 0.0 112.969 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 66.8 m -59.48 -35.27 73.78 Favored 'General case' 0 N--CA 1.532 3.649 0 C-N-CA 124.323 1.049 . . . . 0.0 112.437 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 8.4 mp -53.47 -36.36 61.55 Favored 'General case' 0 N--CA 1.534 3.763 0 C-N-CA 123.747 0.819 . . . . 0.0 112.653 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.412 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.3 OUTLIER -60.81 -46.54 96.01 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.306 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.313 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.47 -29.95 76.4 Favored Glycine 1 N--CA 1.525 4.597 0 O-C-N 121.445 -0.784 . . . . 0.0 111.747 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.97 -42.39 94.04 Favored 'General case' 0 N--CA 1.532 3.671 0 C-N-CA 124.44 1.096 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . 0.806 ' HE ' HD11 ' A' ' 693' ' ' ILE . 20.9 mmt180 -52.68 -24.95 9.54 Favored 'General case' 0 N--CA 1.535 3.801 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 19.6 tt -53.05 -37.07 25.75 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.377 0 CA-C-N 120.28 1.4 . . . . 0.0 112.592 -176.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 14.6 p -54.48 -29.8 20.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.348 0 C-N-CA 124.074 0.95 . . . . 0.0 111.33 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -57.08 -27.67 61.93 Favored 'General case' 0 N--CA 1.538 3.968 0 O-C-N 121.259 -0.901 . . . . 0.0 110.666 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -67.88 -42.71 80.82 Favored 'General case' 0 N--CA 1.528 3.446 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 83.9 t -68.99 -32.33 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.868 0 CA-C-N 113.835 -1.529 . . . . 0.0 109.124 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 20.2 tp -55.23 -34.23 63.78 Favored 'General case' 1 N--CA 1.54 4.032 0 C-N-CA 123.059 0.543 . . . . 0.0 109.602 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 57.0 m -57.81 -46.7 84.29 Favored 'General case' 0 N--CA 1.531 3.61 0 CA-C-N 118.79 0.723 . . . . 0.0 112.674 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.18 -36.08 83.08 Favored 'General case' 1 N--CA 1.551 4.601 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.53 -39.04 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' B' ' 710' ' ' GLN . 6.0 t-20 -66.02 -23.57 66.59 Favored 'General case' 0 N--CA 1.516 2.848 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.889 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -48.88 -45.38 41.07 Favored 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 123.993 0.917 . . . . 0.0 109.39 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 50.3 t -62.4 -48.27 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.794 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.86 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -77.92 -9.98 59.35 Favored 'General case' 0 N--CA 1.539 3.979 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.016 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . 0.5 HE22 HE22 ' A' ' 710' ' ' GLN . 26.3 tt0 -112.35 -11.55 13.67 Favored 'General case' 0 N--CA 1.527 3.394 0 C-N-CA 125.109 1.364 . . . . 0.0 109.285 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.96 -35.4 58.93 Favored Glycine 0 N--CA 1.513 3.788 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -83.85 154.46 23.46 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 114.747 -0.726 . . . . 0.0 109.157 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 67.7 m -80.18 149.65 69.85 Favored Pre-proline 0 N--CA 1.529 3.484 0 C-N-CA 126.624 1.969 . . . . 0.0 111.138 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -56.02 131.54 46.57 Favored 'Trans proline' 0 C--N 1.4 3.285 0 CA-C-N 120.981 1.386 . . . . 0.0 110.943 -174.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.34 176.35 9.06 Favored 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 114.084 -1.417 . . . . 0.0 109.699 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.522 3.169 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.039 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -3.72 1.44 Allowed 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 124.048 0.939 . . . . 0.0 112.728 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 4.5 pp -51.91 -22.77 4.12 Favored 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 124.883 1.273 . . . . 0.0 113.263 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -61.09 -48.86 79.72 Favored 'General case' 0 N--CA 1.535 3.813 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.75 -35.11 79.79 Favored 'General case' 1 N--CA 1.54 4.065 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 36.2 mm -73.32 -27.23 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.908 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.667 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -66.38 -54.09 28.42 Favored 'General case' 1 N--CA 1.549 4.514 0 CA-C-O 121.86 0.838 . . . . 0.0 112.311 -176.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 17.2 tt -64.17 -29.58 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.216 0 C-N-CA 125.122 1.369 . . . . 0.0 110.148 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -51.98 -33.23 37.09 Favored 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 124.327 1.051 . . . . 0.0 110.432 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . 0.417 ' N ' HD12 ' C' ' 686' ' ' ILE . 1.5 mp -68.57 -47.64 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.278 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 40.2 mt -57.19 -43.82 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 C-N-CA 123.528 0.731 . . . . 0.0 110.421 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.09 -48.55 87.96 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.406 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 23.2 t -57.9 -30.73 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.536 0 C-N-CA 124.41 1.084 . . . . 0.0 109.698 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -65.98 -40.82 95.45 Favored Glycine 1 N--CA 1.524 4.552 0 C-N-CA 123.532 0.587 . . . . 0.0 112.887 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 71.2 m -67.66 -36.64 81.11 Favored 'General case' 0 N--CA 1.528 3.44 0 CA-C-O 122.193 0.997 . . . . 0.0 110.037 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 1.8 tp -55.29 -45.02 76.24 Favored 'General case' 0 N--CA 1.517 2.923 0 CA-C-N 113.438 -1.71 . . . . 0.0 114.235 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . 0.545 HD13 ' O ' ' C' ' 693' ' ' ILE . 0.0 OUTLIER -69.45 -35.82 68.66 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.212 0 CA-C-N 118.272 0.487 . . . . 0.0 112.276 -176.414 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -64.48 -26.18 70.61 Favored Glycine 1 N--CA 1.523 4.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.71 -43.25 76.4 Favored 'General case' 0 N--CA 1.535 3.819 0 C-N-CA 124.683 1.193 . . . . 0.0 110.181 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -53.24 -25.65 15.0 Favored 'General case' 0 N--CA 1.533 3.693 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 17.0 tt -54.41 -38.63 41.5 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.261 0 CA-C-N 119.513 1.051 . . . . 0.0 113.342 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . 0.461 ' O ' HG22 ' C' ' 701' ' ' VAL . 10.0 p -55.31 -31.09 26.24 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.162 0 C-N-CA 123.539 0.736 . . . . 0.0 111.814 -178.459 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -54.44 -25.91 27.78 Favored 'General case' 0 N--CA 1.531 3.61 0 C-N-CA 122.92 0.488 . . . . 0.0 109.875 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.19 -32.99 62.64 Favored 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . 0.461 HG22 ' O ' ' C' ' 698' ' ' VAL . 3.3 m -69.06 -30.82 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.919 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 5.9 tp -52.08 -34.18 42.59 Favored 'General case' 0 N--CA 1.532 3.67 0 C-N-CA 123.549 0.74 . . . . 0.0 110.68 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 6.4 t -58.99 -46.45 88.12 Favored 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 44.6 tp -67.05 -35.56 80.14 Favored 'General case' 1 N--CA 1.54 4.072 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.1 -39.22 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.785 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -59.81 -21.16 60.49 Favored 'General case' 0 N--CA 1.51 2.543 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.062 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -47.21 -47.97 24.17 Favored 'General case' 0 N--CA 1.525 3.28 0 CA-C-O 122.13 0.967 . . . . 0.0 110.204 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.74 -43.05 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.762 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -76.76 -9.7 58.86 Favored 'General case' 0 N--CA 1.526 3.335 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.054 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -89.62 -14.16 35.55 Favored 'General case' 1 N--CA 1.546 4.339 0 C-N-CA 123.25 0.62 . . . . 0.0 110.075 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -69.33 -7.9 58.24 Favored Glycine 1 N--CA 1.527 4.716 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -75.35 156.11 35.83 Favored 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 125.891 1.676 . . . . 0.0 109.43 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 92.6 p -114.23 146.5 35.91 Favored Pre-proline 0 N--CA 1.527 3.378 0 C-N-CA 125.714 1.606 . . . . 0.0 107.181 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -59.33 131.23 39.71 Favored 'Trans proline' 0 N--CA 1.527 3.492 0 CA-C-N 121.954 1.734 . . . . 0.0 109.961 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -146.23 -171.67 3.77 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 124.902 1.281 . . . . 0.0 110.035 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.519 3.01 0 C-N-CA 123.974 0.909 . . . . 0.0 109.086 179.873 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -165.58 130.52 2.43 Favored 'General case' 0 N--CA 1.522 3.165 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -50.22 -44.27 53.22 Favored 'General case' 0 N--CA 1.513 2.707 0 C-N-CA 125.225 1.41 . . . . 0.0 112.071 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -59.29 -48.09 82.92 Favored 'General case' 0 N--CA 1.537 3.895 0 CA-C-N 118.61 0.641 . . . . 0.0 111.735 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -70.01 -36.52 75.17 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.92 -24.42 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.832 0 C-N-CA 123.781 0.833 . . . . 0.0 109.705 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -64.92 -53.67 42.73 Favored 'General case' 1 N--CA 1.545 4.275 0 CA-C-N 118.826 0.739 . . . . 0.0 111.547 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.28 -30.43 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.994 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -51.08 -36.81 42.11 Favored 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.155 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 15.4 mt -68.9 -37.47 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 C-N-CA 124.333 1.053 . . . . 0.0 109.726 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 10.8 mm -57.81 -37.68 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.952 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.2 -42.55 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.41 -30.88 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 C-N-CA 123.584 0.754 . . . . 0.0 109.506 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.73 -41.97 98.77 Favored Glycine 1 N--CA 1.525 4.62 0 C-N-CA 123.673 0.654 . . . . 0.0 111.589 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 66.4 m -69.02 -37.89 78.88 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-O 122.272 1.034 . . . . 0.0 110.229 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.01 -44.6 97.18 Favored 'General case' 0 N--CA 1.515 2.81 0 CA-C-N 113.287 -1.779 . . . . 0.0 113.458 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.517 ' O ' HD13 ' A' ' 693' ' ' ILE . 0.1 OUTLIER -70.13 -35.58 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -76.69 -12.4 84.49 Favored Glycine 1 N--CA 1.535 5.24 0 O-C-N 121.012 -1.055 . . . . 0.0 110.991 178.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.92 -38.92 83.52 Favored 'General case' 0 N--CA 1.539 3.98 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . 0.657 ' HE ' HD11 ' C' ' 693' ' ' ILE . 32.4 mmt180 -52.31 -25.23 9.02 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 125.05 1.34 . . . . 0.0 113.692 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 31.2 mm -53.28 -38.84 32.65 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.362 0 CA-C-N 118.611 0.641 . . . . 0.0 111.343 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 7.5 p -55.67 -28.63 23.68 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.305 0 C-N-CA 123.813 0.845 . . . . 0.0 112.428 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -52.46 -26.38 12.66 Favored 'General case' 0 N--CA 1.537 3.879 0 C-N-CA 123.22 0.608 . . . . 0.0 110.901 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.87 -34.72 65.74 Favored 'General case' 0 N--CA 1.53 3.547 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 2.0 m -69.48 -31.79 50.54 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.107 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 10.2 tp -54.74 -36.06 64.4 Favored 'General case' 0 N--CA 1.538 3.947 0 C-N-CA 122.928 0.491 . . . . 0.0 110.252 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 97.0 p -59.38 -46.18 89.37 Favored 'General case' 0 N--CA 1.528 3.463 0 CA-C-N 118.383 0.538 . . . . 0.0 112.348 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 44.8 tp -65.42 -34.62 78.72 Favored 'General case' 1 N--CA 1.543 4.203 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.19 -38.89 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.597 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -62.49 -29.33 70.47 Favored 'General case' 0 N--CA 1.515 2.778 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.312 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -50.45 -48.54 56.44 Favored 'General case' 0 N--CA 1.519 3.002 0 C-N-CA 123.328 0.651 . . . . 0.0 111.954 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.34 -39.11 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -75.75 -23.38 56.0 Favored 'General case' 0 N--CA 1.527 3.421 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.369 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -92.23 -7.63 47.65 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.36 1.464 . . . . 0.0 107.429 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.83 -21.62 7.62 Favored Glycine 1 N--CA 1.524 4.532 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -119.48 135.2 54.87 Favored 'General case' 0 N--CA 1.526 3.334 0 C-N-CA 125.336 1.454 . . . . 0.0 107.253 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 96.1 p -82.27 146.6 54.88 Favored Pre-proline 0 N--CA 1.528 3.426 0 CA-C-O 117.483 -1.246 . . . . 0.0 110.366 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -59.98 130.88 36.52 Favored 'Trans proline' 0 C--N 1.398 3.165 0 CA-C-N 121.414 1.541 . . . . 0.0 110.709 -177.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.3 tm? 62.19 76.88 0.35 Allowed 'General case' 0 N--CA 1.525 3.309 0 C-N-CA 125.622 1.569 . . . . 0.0 110.133 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.522 3.151 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.167 -179.851 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 34.7 m120 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -58.32 149.22 25.09 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 123.991 0.916 . . . . 0.0 111.209 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . 0.493 HD12 ' N ' ' B' ' 680' ' ' TRP . 1.3 pp -57.87 -23.06 51.34 Favored 'General case' 0 N--CA 1.511 2.624 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . 0.493 ' N ' HD12 ' B' ' 679' ' ' LEU . 16.6 t-105 -57.77 -26.24 61.6 Favored 'General case' 1 N--CA 1.551 4.606 0 CA-C-N 121.032 1.742 . . . . 0.0 110.262 -179.188 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -71.8 -40.25 69.32 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.952 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . 0.467 HD12 ' N ' ' B' ' 683' ' ' ARG . 1.3 pp -72.52 -25.22 22.54 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.234 0 CA-C-N 119.582 1.083 . . . . 0.0 110.192 178.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . 0.467 ' N ' HD12 ' B' ' 682' ' ' ILE . 3.3 tmt_? -59.35 -53.55 56.87 Favored 'General case' 0 N--CA 1.538 3.953 0 CA-C-N 118.168 0.44 . . . . 0.0 111.794 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 14.6 tt -70.52 -34.36 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.164 0 C-N-CA 124.003 0.921 . . . . 0.0 110.628 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -53.74 -46.75 70.99 Favored 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 124.48 1.112 . . . . 0.0 111.367 -175.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 43.9 mt -64.46 -39.89 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.894 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 59.8 mt -64.54 -40.11 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 97.8 mt -59.67 -45.34 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.58 -38.36 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.444 0 C-N-CA 123.565 0.746 . . . . 0.0 109.723 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -53.39 -19.84 9.47 Favored Glycine 1 N--CA 1.53 4.931 0 O-C-N 121.417 -0.802 . . . . 0.0 114.136 -177.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.6 m -68.95 -51.78 36.03 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.34 -31.71 61.93 Favored 'General case' 0 N--CA 1.533 3.679 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.667 HD11 ' HE ' ' C' ' 696' ' ' ARG . 0.1 OUTLIER -57.82 -41.77 80.54 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.221 0 CA-C-N 120.37 1.441 . . . . 0.0 111.981 -175.182 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -68.81 -33.54 75.69 Favored Glycine 1 N--CA 1.525 4.574 0 O-C-N 121.08 -1.012 . . . . 0.0 110.642 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.02 -42.32 94.08 Favored 'General case' 1 N--CA 1.548 4.456 0 C-N-CA 124.116 0.967 . . . . 0.0 112.728 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -49.98 -26.19 4.02 Favored 'General case' 1 N--CA 1.542 4.139 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . 0.45 HD13 ' O ' ' B' ' 697' ' ' ILE . 0.1 OUTLIER -53.82 -38.15 35.05 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.374 0 CA-C-N 118.696 0.68 . . . . 0.0 111.51 -176.809 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.39 -28.2 18.27 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.182 0 C-N-CA 124.059 0.944 . . . . 0.0 112.412 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -52.93 -26.82 16.22 Favored 'General case' 1 N--CA 1.541 4.082 0 C-N-CA 123.398 0.679 . . . . 0.0 109.744 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.49 76.37 Favored 'General case' 0 N--CA 1.521 3.116 0 C-N-CA 122.707 0.403 . . . . 0.0 110.468 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 1.1 m -69.08 -32.0 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.13 -35.68 59.97 Favored 'General case' 0 N--CA 1.534 3.738 0 C-N-CA 123.044 0.538 . . . . 0.0 111.379 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 8.4 t -60.8 -47.39 86.55 Favored 'General case' 0 N--CA 1.535 3.799 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.098 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 44.0 tp -65.13 -34.91 79.52 Favored 'General case' 1 N--CA 1.544 4.248 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.9 -40.71 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.69 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' B' ' 710' ' ' GLN . 4.6 m120 -72.04 -24.77 61.59 Favored 'General case' 0 N--CA 1.507 2.424 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.905 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -49.57 -35.81 21.78 Favored 'General case' 0 N--CA 1.529 3.476 0 CA-C-N 118.826 0.739 . . . . 0.0 110.284 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.52 -48.15 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -77.37 -10.77 59.65 Favored 'General case' 1 N--CA 1.543 4.177 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.509 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 706' ' ' ASN . 33.1 tt0 -112.84 -5.31 13.88 Favored 'General case' 0 N--CA 1.518 2.93 0 C-N-CA 125.523 1.529 . . . . 0.0 108.071 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.77 -29.3 33.18 Favored Glycine 0 N--CA 1.512 3.759 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -98.02 137.58 36.61 Favored 'General case' 0 N--CA 1.528 3.444 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 89.1 p -81.39 146.8 58.5 Favored Pre-proline 0 N--CA 1.528 3.444 0 C-N-CA 125.246 1.418 . . . . 0.0 111.443 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -69.06 130.53 20.37 Favored 'Trans proline' 0 C--N 1.399 3.196 0 CA-C-N 121.112 1.433 . . . . 0.0 110.262 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 9.8 mp -86.73 -77.09 0.33 Allowed 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 125.41 1.484 . . . . 0.0 107.313 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.522 3.135 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.516 179.749 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -166.74 -106.2 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 123.899 0.88 . . . . 0.0 109.335 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 683' ' ' ARG . 46.8 mt -50.25 -44.32 53.51 Favored 'General case' 0 N--CA 1.51 2.562 0 C-N-CA 124.751 1.221 . . . . 0.0 112.482 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -43.06 86.21 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -177.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -72.8 -37.48 67.52 Favored 'General case' 0 N--CA 1.538 3.927 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 49.0 mm -74.53 -25.86 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 C-N-CA 125.322 1.449 . . . . 0.0 110.917 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' C' ' 679' ' ' LEU . 64.2 ttt180 -66.13 -56.15 12.87 Favored 'General case' 1 N--CA 1.542 4.173 0 CA-C-O 121.658 0.742 . . . . 0.0 110.912 -177.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.9 -36.08 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.785 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.56 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -56.11 -45.9 79.31 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.046 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.74 -42.38 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.96 0 C-N-CA 124.246 1.018 . . . . 0.0 109.096 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.22 -36.09 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.525 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.25 -42.12 95.27 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.331 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 74.7 t -62.67 -31.15 51.14 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.158 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -66.93 -29.49 74.71 Favored Glycine 1 N--CA 1.517 4.053 0 C-N-CA 123.473 0.558 . . . . 0.0 112.439 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.2 m -67.98 -36.52 80.16 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.42 0.688 . . . . 0.0 111.561 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 9.3 mp -54.83 -44.29 73.76 Favored 'General case' 0 N--CA 1.537 3.883 0 C-N-CA 123.455 0.702 . . . . 0.0 112.503 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . 0.657 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.267 0.1 OUTLIER -60.21 -49.26 84.82 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.622 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.825 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -58.45 -27.39 60.79 Favored Glycine 1 N--CA 1.528 4.813 0 CA-C-N 119.489 1.04 . . . . 0.0 112.625 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -67.35 -42.12 84.02 Favored 'General case' 0 N--CA 1.538 3.935 0 C-N-CA 124.684 1.194 . . . . 0.0 111.118 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . 0.667 ' HE ' HD11 ' B' ' 693' ' ' ILE . 29.5 mmt180 -52.28 -24.98 8.32 Favored 'General case' 0 N--CA 1.539 3.996 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 30.0 pt -53.75 -38.02 34.07 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.495 0 CA-C-N 120.591 1.541 . . . . 0.0 113.094 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.76 -30.1 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.638 0 C-N-CA 122.517 0.327 . . . . 0.0 111.85 -176.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.68 -26.17 31.8 Favored 'General case' 0 N--CA 1.533 3.721 0 C-N-CA 123.622 0.769 . . . . 0.0 109.436 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.61 -39.83 74.28 Favored 'General case' 0 N--CA 1.523 3.179 0 O-C-N 121.754 -0.591 . . . . 0.0 109.862 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.1 m -69.53 -32.58 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.999 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.61 -34.56 58.88 Favored 'General case' 0 N--CA 1.537 3.876 0 C-N-CA 123.5 0.72 . . . . 0.0 111.056 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 69.5 m -59.96 -46.21 90.15 Favored 'General case' 0 N--CA 1.53 3.536 0 CA-C-N 118.392 0.542 . . . . 0.0 111.998 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.72 -36.1 83.2 Favored 'General case' 1 N--CA 1.542 4.141 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 94.5 t -68.02 -40.29 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.652 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' C' ' 710' ' ' GLN . 2.8 m120 -65.7 -23.56 66.79 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-O 118.711 -0.662 . . . . 0.0 109.771 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -49.27 -44.07 43.56 Favored 'General case' 0 N--CA 1.519 2.977 0 C-N-CA 123.691 0.797 . . . . 0.0 110.045 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 48.1 t -62.29 -48.99 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.992 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 33.7 mtp85 -78.75 -10.2 59.69 Favored 'General case' 0 N--CA 1.532 3.664 0 CA-C-N 115.084 -0.962 . . . . 0.0 113.206 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' C' ' 706' ' ' ASN . 48.2 tt0 -112.24 -10.62 13.82 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 124.863 1.265 . . . . 0.0 108.666 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.86 -33.73 43.77 Favored Glycine 0 N--CA 1.509 3.548 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -86.04 152.86 22.56 Favored 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 94.1 p -80.99 149.66 67.19 Favored Pre-proline 0 N--CA 1.534 3.742 0 C-N-CA 125.845 1.658 . . . . 0.0 110.063 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.45 129.96 37.52 Favored 'Trans proline' 0 C--N 1.4 3.261 0 CA-C-N 122.204 1.823 . . . . 0.0 112.992 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . 0.518 ' CD1' ' H ' ' C' ' 715' ' ' LEU . 0.0 OUTLIER -87.46 -177.38 5.9 Favored 'General case' 0 N--CA 1.527 3.391 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.379 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.522 3.174 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.65 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -122.58 -104.97 0.37 Allowed 'General case' 0 N--CA 1.53 3.575 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -21.43 3.04 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 124.825 1.25 . . . . 0.0 112.167 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -57.54 -44.35 85.11 Favored 'General case' 0 N--CA 1.532 3.663 0 C-N-CA 123.769 0.828 . . . . 0.0 110.79 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -70.7 -34.65 72.18 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.706 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . . . . . . . . . 25.4 mm -74.15 -26.61 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.445 0 C-N-CA 125.383 1.473 . . . . 0.0 110.879 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -66.25 -53.37 37.73 Favored 'General case' 0 N--CA 1.539 3.987 0 CA-C-O 122.271 1.034 . . . . 0.0 111.24 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 17.4 tt -69.5 -30.0 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.748 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.2 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -52.7 -39.42 61.99 Favored 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.35 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.47 -43.64 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.311 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 54.5 mt -56.29 -34.62 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.432 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 58.9 mt -67.02 -46.72 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.923 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 98.6 t -58.15 -30.65 39.95 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.476 0 C-N-CA 123.362 0.665 . . . . 0.0 109.295 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.07 -40.61 98.3 Favored Glycine 0 N--CA 1.516 3.97 0 C-N-CA 123.482 0.563 . . . . 0.0 112.87 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 67.0 m -58.52 -35.41 72.23 Favored 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 124.342 1.057 . . . . 0.0 112.469 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 6.6 mp -53.75 -33.58 56.22 Favored 'General case' 0 N--CA 1.532 3.666 0 C-N-CA 123.61 0.764 . . . . 0.0 111.381 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -43.97 89.95 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.274 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -174.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -67.29 -32.34 79.51 Favored Glycine 1 N--CA 1.531 4.967 0 O-C-N 121.064 -1.022 . . . . 0.0 111.215 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.24 -37.75 84.19 Favored 'General case' 1 N--CA 1.546 4.351 0 C-N-CA 124.626 1.171 . . . . 0.0 110.414 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . 0.41 ' HE ' ' CD1' ' C' ' 693' ' ' ILE . 24.7 mmt180 -61.02 -29.6 69.81 Favored 'General case' 1 N--CA 1.546 4.344 0 O-C-N 121.309 -0.869 . . . . 0.0 112.45 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 39.8 mm -56.74 -37.93 55.61 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.041 0 CA-C-O 121.934 0.873 . . . . 0.0 109.803 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 39.2 t -56.54 -30.07 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.318 0 C-N-CA 125.727 1.611 . . . . 0.0 110.629 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -59.91 -30.06 68.79 Favored 'General case' 0 N--CA 1.538 3.929 0 C-N-CA 123.493 0.717 . . . . 0.0 111.469 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.98 -43.38 68.16 Favored 'General case' 0 N--CA 1.523 3.209 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.95 -33.44 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.008 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.958 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.58 -35.2 70.07 Favored 'General case' 0 N--CA 1.531 3.59 0 C-N-CA 123.494 0.717 . . . . 0.0 109.801 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 92.0 p -58.89 -46.62 87.43 Favored 'General case' 0 N--CA 1.53 3.534 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.92 -34.75 78.67 Favored 'General case' 1 N--CA 1.545 4.285 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.069 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.08 -39.11 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.694 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 710' ' ' GLN . 23.7 t-20 -62.19 -29.44 70.38 Favored 'General case' 0 N--CA 1.517 2.921 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.936 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -48.02 -33.72 8.38 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 123.959 0.904 . . . . 0.0 111.251 -178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 57.8 t -76.42 -46.75 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.624 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -77.7 -11.27 59.86 Favored 'General case' 1 N--CA 1.541 4.083 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.143 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 706' ' ' ASN . 17.7 tt0 -114.53 -11.96 12.35 Favored 'General case' 0 N--CA 1.522 3.135 0 C-N-CA 126.054 1.742 . . . . 0.0 108.545 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -51.73 -30.1 27.44 Favored Glycine 0 N--CA 1.51 3.598 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -85.84 152.65 22.83 Favored 'General case' 0 N--CA 1.522 3.154 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 41.7 t -81.05 149.54 66.73 Favored Pre-proline 0 N--CA 1.527 3.423 0 C-N-CA 126.055 1.742 . . . . 0.0 111.625 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -54.02 130.38 39.1 Favored 'Trans proline' 0 C--N 1.406 3.578 0 CA-C-N 122.215 1.827 . . . . 0.0 111.847 -176.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 59.55 110.55 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.503 0 C-N-CA 125.203 1.401 . . . . 0.0 109.829 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.522 3.17 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.148 -179.714 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -65.06 -33.24 75.57 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 124.121 0.968 . . . . 0.0 111.211 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.5 pp -60.54 -31.0 70.11 Favored 'General case' 0 N--CA 1.519 3.011 0 C-N-CA 124.025 0.93 . . . . 0.0 111.962 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -69.69 -30.4 68.05 Favored 'General case' 0 N--CA 1.527 3.42 0 O-C-N 122.183 -0.323 . . . . 0.0 111.035 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -73.05 -38.79 66.36 Favored 'General case' 0 N--CA 1.524 3.249 0 CA-C-O 118.986 -0.53 . . . . 0.0 110.275 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . 0.489 HD12 ' N ' ' B' ' 683' ' ' ARG . 1.8 pp -73.48 -25.42 21.06 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.01 0 CA-C-N 119.204 0.911 . . . . 0.0 109.497 177.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . 0.489 ' N ' HD12 ' B' ' 682' ' ' ILE . 0.0 OUTLIER -58.43 -51.81 68.27 Favored 'General case' 1 N--CA 1.539 4.007 0 C-N-CA 123.241 0.616 . . . . 0.0 111.768 -177.495 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.7 tt -74.19 -33.68 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.506 0 C-N-CA 123.866 0.866 . . . . 0.0 110.979 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -53.96 -47.14 71.65 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 113.938 -1.483 . . . . 0.0 113.099 -173.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . . . . . . . . . 16.8 mt -59.76 -36.84 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.673 0 C-N-CA 124.074 0.95 . . . . 0.0 111.172 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . 0.474 ' N ' HD12 ' B' ' 687' ' ' ILE . 1.4 mp -59.87 -37.25 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.61 -41.77 91.4 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.178 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.74 -31.62 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.931 0 C-N-CA 123.271 0.628 . . . . 0.0 109.506 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.59 -42.8 98.7 Favored Glycine 1 N--CA 1.524 4.521 0 C-N-CA 123.866 0.746 . . . . 0.0 112.474 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 69.3 m -67.67 -36.87 81.52 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-O 122.078 0.942 . . . . 0.0 110.218 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.23 -44.81 79.95 Favored 'General case' 0 N--CA 1.518 2.972 0 CA-C-N 113.59 -1.641 . . . . 0.0 113.034 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -49.05 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.951 0 C-N-CA 123.334 0.654 . . . . 0.0 112.638 -176.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -60.9 -21.76 59.2 Favored Glycine 1 N--CA 1.524 4.53 0 CA-C-N 119.699 1.136 . . . . 0.0 112.978 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.09 -43.77 70.42 Favored 'General case' 1 N--CA 1.54 4.069 0 C-N-CA 123.621 0.769 . . . . 0.0 109.93 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -53.98 -26.02 23.8 Favored 'General case' 0 N--CA 1.536 3.852 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 38.4 mm -55.29 -38.77 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 123.904 0.882 . . . . 0.0 112.885 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.99 -31.41 45.52 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.527 0 CA-C-N 119.096 0.862 . . . . 0.0 111.95 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -54.21 -25.65 24.06 Favored 'General case' 0 N--CA 1.532 3.658 0 C-N-CA 123.182 0.593 . . . . 0.0 109.94 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.45 -31.96 62.37 Favored 'General case' 0 N--CA 1.531 3.583 0 O-C-N 121.723 -0.611 . . . . 0.0 110.068 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.0 -30.04 45.35 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 9.6 tp -52.82 -35.25 56.85 Favored 'General case' 0 N--CA 1.532 3.631 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.486 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 52.1 m -58.11 -46.29 85.8 Favored 'General case' 0 N--CA 1.536 3.827 0 CA-C-N 119.233 0.924 . . . . 0.0 112.377 -177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 45.3 tp -64.54 -35.88 82.39 Favored 'General case' 1 N--CA 1.543 4.214 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.45 -38.42 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.554 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -58.16 -25.33 61.37 Favored 'General case' 0 N--CA 1.52 3.064 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.205 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -46.76 -47.66 20.72 Favored 'General case' 0 N--CA 1.515 2.819 0 C-N-CA 124.528 1.131 . . . . 0.0 112.569 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.56 -49.7 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.779 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -81.04 -6.91 59.36 Favored 'General case' 1 N--CA 1.545 4.29 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -110.75 -8.46 14.55 Favored 'General case' 1 N--CA 1.539 4.006 0 C-N-CA 124.569 1.148 . . . . 0.0 108.836 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -56.29 -27.08 52.16 Favored Glycine 0 N--CA 1.511 3.659 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -98.0 148.59 23.34 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 123.937 0.895 . . . . 0.0 108.981 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 49.5 m -82.15 149.83 63.27 Favored Pre-proline 0 N--CA 1.528 3.451 0 C-N-CA 125.808 1.643 . . . . 0.0 110.763 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.86 130.99 41.97 Favored 'Trans proline' 0 C--N 1.403 3.415 0 CA-C-N 122.138 1.799 . . . . 0.0 112.099 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -53.8 157.64 2.28 Favored 'General case' 0 N--CA 1.523 3.224 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.423 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.524 3.248 0 C-N-CA 124.539 1.136 . . . . 0.0 112.148 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 67.93 -59.86 0.42 Allowed 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 125.072 1.349 . . . . 0.0 110.799 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 68.6 mt -49.53 -41.45 41.23 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 124.822 1.249 . . . . 0.0 112.626 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -43.47 83.13 Favored 'General case' 0 N--CA 1.538 3.945 0 CA-C-N 119.361 0.982 . . . . 0.0 112.464 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -73.44 -36.55 65.94 Favored 'General case' 0 N--CA 1.529 3.521 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.31 -38.36 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 C-N-CA 123.965 0.906 . . . . 0.0 110.804 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -67.96 -51.04 52.06 Favored 'General case' 0 N--CA 1.536 3.873 0 C-N-CA 124.28 1.032 . . . . 0.0 111.366 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 18.5 tt -60.84 -30.71 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.824 0 CA-C-O 122.154 0.978 . . . . 0.0 110.686 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -50.58 -27.78 7.42 Favored 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.841 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.69 -47.99 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 124.547 1.139 . . . . 0.0 109.292 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 21.4 mm -54.22 -46.0 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 C-N-CA 124.123 0.969 . . . . 0.0 111.78 -174.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 16.9 tt -68.04 -40.18 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.984 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 57.5 t -67.25 -30.36 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.767 0.827 . . . . 0.0 109.304 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -72.15 -20.71 79.22 Favored Glycine 1 N--CA 1.522 4.387 0 CA-C-N 118.914 0.779 . . . . 0.0 112.692 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 67.8 m -68.17 -50.33 55.15 Favored 'General case' 0 N--CA 1.529 3.485 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . 0.479 HD12 ' H ' ' C' ' 693' ' ' ILE . 0.3 OUTLIER -53.73 -32.69 53.01 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -175.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . 0.479 ' H ' HD12 ' C' ' 692' ' ' LEU . 0.3 OUTLIER -61.99 -33.77 59.84 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.004 0 CA-C-N 119.618 1.099 . . . . 0.0 111.364 -177.52 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -72.71 -33.28 60.61 Favored Glycine 1 N--CA 1.52 4.254 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.37 -41.93 94.75 Favored 'General case' 0 N--CA 1.535 3.796 0 C-N-CA 124.874 1.27 . . . . 0.0 111.023 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -52.08 -24.32 6.65 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 10.7 tp -52.1 -38.29 23.83 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.35 0 CA-C-N 119.434 1.016 . . . . 0.0 112.357 -176.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 10.3 p -56.59 -30.65 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.999 0 C-N-CA 123.543 0.737 . . . . 0.0 111.836 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -54.28 -26.95 31.97 Favored 'General case' 0 N--CA 1.536 3.86 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.84 65.58 Favored 'General case' 0 N--CA 1.521 3.116 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.54 -30.42 45.21 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.142 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 9.8 tp -53.44 -35.61 60.66 Favored 'General case' 0 N--CA 1.535 3.808 0 CA-C-O 119.067 -0.492 . . . . 0.0 110.461 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 64.8 m -59.28 -45.99 89.76 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-N 118.941 0.792 . . . . 0.0 112.789 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 40.2 tp -66.51 -34.84 78.82 Favored 'General case' 1 N--CA 1.548 4.448 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.7 -38.87 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' C' ' 710' ' ' GLN . 9.4 t-20 -58.24 -34.22 70.2 Favored 'General case' 0 C--O 1.183 -2.418 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.28 -177.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -46.63 -45.5 19.13 Favored 'General case' 0 N--CA 1.511 2.602 0 C-N-CA 124.464 1.106 . . . . 0.0 112.319 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.8 -45.81 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.103 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -77.99 -4.62 47.95 Favored 'General case' 0 N--CA 1.526 3.339 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.687 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' C' ' 706' ' ' ASN . 1.8 tt0 -111.29 -15.53 13.59 Favored 'General case' 1 N--CA 1.546 4.345 0 C-N-CA 124.307 1.043 . . . . 0.0 108.465 -178.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -77.01 -11.72 85.32 Favored Glycine 1 N--CA 1.533 5.117 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 174.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -76.03 153.67 36.28 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 128.321 2.648 . . . . 0.0 107.646 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 58.9 m -80.69 145.8 59.03 Favored Pre-proline 1 N--CA 1.545 4.317 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -69.83 131.51 21.29 Favored 'Trans proline' 0 C--N 1.4 3.272 0 CA-C-N 120.36 1.164 . . . . 0.0 110.459 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 90.3 mt -76.37 163.65 26.78 Favored 'General case' 0 N--CA 1.525 3.315 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.585 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.524 3.25 0 C-N-CA 124.395 1.078 . . . . 0.0 112.429 179.742 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 677' ' ' ASN . . . . . . . . . . . . . 29.0 m120 . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 60.22 128.3 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.045 0 C-N-CA 124.844 1.257 . . . . 0.0 112.11 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 2.0 pp -51.44 -24.37 4.92 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 126.069 1.748 . . . . 0.0 113.052 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 680' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -67.39 -49.35 64.24 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 681' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -66.5 -30.95 71.4 Favored 'General case' 0 N--CA 1.532 3.66 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 682' ' ' ILE . . . . . 0.45 ' O ' HD13 ' A' ' 686' ' ' ILE . 51.0 mm -74.65 -30.31 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.86 0 C-N-CA 125.53 1.532 . . . . 0.0 110.19 177.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -51.47 57.0 Favored 'General case' 1 N--CA 1.548 4.463 0 C-N-CA 123.463 0.705 . . . . 0.0 111.964 -178.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 684' ' ' ILE . . . . . . . . . . . . . 16.5 tt -65.8 -35.66 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.753 0 CA-C-O 122.091 0.948 . . . . 0.0 109.611 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -60.18 -40.91 91.62 Favored 'General case' 0 N--CA 1.512 2.669 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.825 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' ILE . . . . . 0.45 HD13 ' O ' ' A' ' 682' ' ' ILE . 1.2 mp -55.18 -49.19 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.793 0.837 . . . . 0.0 109.232 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' ILE . . . . . . . . . . . . . 53.8 mt -56.81 -40.47 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.042 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 78.8 mt -68.26 -41.12 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.967 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.18 -30.63 49.24 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.601 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -63.21 -34.64 90.51 Favored Glycine 1 N--CA 1.522 4.405 0 C-N-CA 123.637 0.637 . . . . 0.0 111.991 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 62.9 m -68.39 -37.27 80.23 Favored 'General case' 0 N--CA 1.527 3.407 0 C-N-CA 123.615 0.766 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.8 -44.44 86.31 Favored 'General case' 0 N--CA 1.536 3.864 0 C-N-CA 123.499 0.72 . . . . 0.0 112.627 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' ILE . . . . . 0.43 ' O ' HD13 ' A' ' 693' ' ' ILE 0.259 0.3 OUTLIER -61.3 -43.83 97.3 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.215 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -173.248 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -63.03 -34.15 89.19 Favored Glycine 1 N--CA 1.534 5.206 0 CA-C-N 120.017 1.28 . . . . 0.0 111.822 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.0 -39.78 86.92 Favored 'General case' 1 N--CA 1.541 4.114 0 C-N-CA 124.715 1.206 . . . . 0.0 110.326 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . 0.651 ' HE ' HD11 ' C' ' 693' ' ' ILE . 23.0 mmt180 -59.97 -28.25 67.52 Favored 'General case' 1 N--CA 1.544 4.275 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.3 -36.66 41.14 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.313 0 CA-C-O 122.09 0.948 . . . . 0.0 109.618 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' VAL . . . . . . . . . . . . . 68.7 t -54.58 -28.0 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.092 0 C-N-CA 126.69 1.996 . . . . 0.0 111.216 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -53.15 -25.8 14.67 Favored 'General case' 0 N--CA 1.534 3.753 0 C-N-CA 123.559 0.744 . . . . 0.0 110.748 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' ALA . . . . . . . . . . . . . . . -56.49 -39.89 74.01 Favored 'General case' 0 N--CA 1.525 3.297 0 O-C-N 121.766 -0.584 . . . . 0.0 109.668 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' VAL . . . . . . . . . . . . . 1.7 m -69.8 -36.03 67.88 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.16 -35.45 64.77 Favored 'General case' 1 N--CA 1.54 4.073 0 C-N-CA 123.526 0.731 . . . . 0.0 110.806 -179.532 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' SER . . . . . . . . . . . . . 9.6 t -60.62 -46.89 88.57 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 44.8 tp -67.58 -36.82 81.65 Favored 'General case' 0 N--CA 1.536 3.865 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.88 -46.36 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.282 0 C-N-CA 123.295 0.638 . . . . 0.0 110.027 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' ASN . . . . . 0.434 HD22 ' C ' ' A' ' 706' ' ' ASN . 0.2 OUTLIER -72.47 -20.09 61.45 Favored 'General case' 0 N--CA 1.513 2.68 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.142 -178.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -48.07 -44.36 31.33 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 123.682 0.793 . . . . 0.0 109.798 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.37 -43.49 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.75 -19.85 57.16 Favored 'General case' 0 N--CA 1.528 3.465 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.5 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 706' ' ' ASN . 2.6 tt0 -89.88 -14.83 33.45 Favored 'General case' 0 N--CA 1.538 3.937 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' GLY . . . . . . . . . . . . . . . -59.15 -12.41 16.29 Favored Glycine 1 N--CA 1.519 4.192 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 176.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -74.19 154.56 39.01 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 124.424 1.089 . . . . 0.0 108.37 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 73.0 m -94.53 147.41 33.19 Favored Pre-proline 0 N--CA 1.528 3.472 0 C-N-CA 125.123 1.369 . . . . 0.0 107.866 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.07 129.99 30.81 Favored 'Trans proline' 0 N--CA 1.527 3.496 0 CA-C-N 121.574 1.598 . . . . 0.0 109.739 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' LEU . . . . . 0.434 ' H ' ' CD2' ' A' ' 715' ' ' LEU . 1.5 pt? -74.79 -10.83 59.89 Favored 'General case' 0 N--CA 1.525 3.318 0 CA-C-N 114.319 -1.309 . . . . 0.0 110.899 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' SER . . . . . . . . . . . . . 37.6 t . . . . . 0 N--CA 1.52 3.036 0 C-N-CA 124.122 0.969 . . . . 0.0 111.783 -179.719 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 677' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 678' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -64.15 -13.67 49.8 Favored 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 123.893 0.877 . . . . 0.0 111.41 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 679' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.69 -45.97 92.15 Favored 'General case' 0 N--CA 1.525 3.323 0 C-N-CA 123.554 0.742 . . . . 0.0 110.624 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 680' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -71.1 -30.13 66.14 Favored 'General case' 0 N--CA 1.529 3.519 0 O-C-N 122.126 -0.359 . . . . 0.0 110.607 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 681' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -68.95 -37.95 79.16 Favored 'General case' 0 N--CA 1.519 3.015 0 CA-C-O 118.902 -0.57 . . . . 0.0 111.056 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 682' ' ' ILE . . . . . 0.473 HD12 ' N ' ' B' ' 683' ' ' ARG . 2.1 pp -72.2 -23.33 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.809 0 CA-C-N 118.943 0.792 . . . . 0.0 110.767 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 683' ' ' ARG . . . . . 0.473 ' N ' HD12 ' B' ' 682' ' ' ILE . 1.3 ttp180 -60.34 -54.28 47.58 Favored 'General case' 1 N--CA 1.546 4.369 0 CA-C-N 119.205 0.911 . . . . 0.0 112.736 -177.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 684' ' ' ILE . . . . . . . . . . . . . 15.1 tt -70.7 -31.32 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.97 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.072 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 685' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -52.56 -30.05 28.74 Favored 'General case' 0 N--CA 1.524 3.23 0 C-N-CA 124.0 0.92 . . . . 0.0 112.873 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 686' ' ' ILE . . . . . 0.475 ' N ' HD12 ' B' ' 686' ' ' ILE . 1.4 mp -68.69 -36.51 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.755 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 687' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.08 -42.45 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.321 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 688' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.84 -50.29 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.985 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 689' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.36 -29.04 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.304 0 C-N-CA 124.519 1.127 . . . . 0.0 108.879 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 690' ' ' GLY . . . . . . . . . . . . . . . -67.13 -17.92 68.52 Favored Glycine 1 N--CA 1.524 4.516 0 C-N-CA 123.674 0.654 . . . . 0.0 113.172 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 691' ' ' SER . . . . . . . . . . . . . 75.1 m -68.92 -52.21 31.74 Favored 'General case' 0 N--CA 1.527 3.421 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 692' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.17 -32.78 73.44 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.469 HD13 ' O ' ' B' ' 693' ' ' ILE . 0.2 OUTLIER -60.64 -38.65 79.1 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.38 0 CA-C-N 120.384 1.447 . . . . 0.0 112.148 -176.425 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 694' ' ' GLY . . . . . . . . . . . . . . . -65.88 -34.62 89.12 Favored Glycine 1 N--CA 1.526 4.7 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 695' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.21 -42.44 95.14 Favored 'General case' 0 N--CA 1.538 3.933 0 C-N-CA 124.572 1.149 . . . . 0.0 111.261 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 696' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -51.85 -24.23 5.88 Favored 'General case' 0 N--CA 1.536 3.863 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 697' ' ' ILE . . . . . . . . . . . . . 20.0 tt -52.18 -36.71 21.13 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.332 0 CA-C-N 120.959 1.709 . . . . 0.0 111.844 -176.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 698' ' ' VAL . . . . . . . . . . . . . 13.5 p -54.84 -28.12 19.59 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.028 0 C-N-CA 123.821 0.848 . . . . 0.0 111.17 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 699' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -55.75 -28.04 53.83 Favored 'General case' 1 N--CA 1.546 4.347 0 O-C-N 121.451 -0.781 . . . . 0.0 109.828 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 700' ' ' ALA . . . . . . . . . . . . . . . -70.54 -44.09 68.21 Favored 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 701' ' ' VAL . . . . . . . . . . . . . 65.5 t -68.85 -32.16 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.271 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 2.9 tp -54.2 -35.52 62.46 Favored 'General case' 0 N--CA 1.536 3.858 0 C-N-CA 123.391 0.676 . . . . 0.0 110.275 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 703' ' ' SER . . . . . . . . . . . . . 20.7 t -60.07 -46.68 88.75 Favored 'General case' 0 N--CA 1.529 3.525 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 704' ' ' LEU . . . . . . . . . . . . . 36.2 tp -67.4 -34.6 77.6 Favored 'General case' 0 N--CA 1.536 3.874 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 705' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.43 -43.57 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 706' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' B' ' 709' ' ' ARG . 11.5 p30 -72.4 -22.71 61.08 Favored 'General case' 0 N--CA 1.517 2.913 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.062 -178.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 707' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -48.43 -36.96 15.92 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.296 0.57 . . . . 0.0 110.306 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 708' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.42 -41.52 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 176.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 709' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' B' ' 706' ' ' ASN . 86.5 mtt180 -75.92 -17.08 59.9 Favored 'General case' 0 N--CA 1.525 3.288 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.667 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 710' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -87.96 -12.33 44.87 Favored 'General case' 0 N--CA 1.516 2.834 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 711' ' ' GLY . . . . . . . . . . . . . . . -52.76 -19.08 6.26 Favored Glycine 1 N--CA 1.521 4.344 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 712' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -114.24 130.04 56.63 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 124.99 1.316 . . . . 0.0 107.737 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 713' ' ' SER . . . . . . . . . . . . . 96.4 p -82.82 147.41 54.84 Favored Pre-proline 0 N--CA 1.526 3.366 0 C-N-CA 125.182 1.393 . . . . 0.0 110.53 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 714' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -57.65 131.63 45.38 Favored 'Trans proline' 0 C--N 1.4 3.268 0 CA-C-N 121.653 1.626 . . . . 0.0 110.671 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 715' ' ' LEU . . . . . . . . . . . . . 52.5 tp -52.3 -21.9 3.96 Favored 'General case' 0 N--CA 1.528 3.435 0 CA-C-N 113.67 -1.605 . . . . 0.0 111.777 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 716' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.52 3.05 0 CA-C-O 117.588 -1.196 . . . . 0.0 109.425 179.836 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 677' ' ' ASN . . . . . . . . . . . . . 5.1 p30 . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 678' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -66.85 144.48 56.25 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 123.848 0.859 . . . . 0.0 109.656 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 679' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.11 -44.63 64.53 Favored 'General case' 0 N--CA 1.527 3.41 0 C-N-CA 125.288 1.435 . . . . 0.0 112.69 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 680' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -68.85 -37.13 78.91 Favored 'General case' 0 N--CA 1.524 3.271 0 CA-C-O 121.597 0.713 . . . . 0.0 110.961 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 681' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -66.35 -40.37 89.76 Favored 'General case' 0 N--CA 1.518 2.935 0 CA-C-N 114.151 -1.386 . . . . 0.0 111.415 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 682' ' ' ILE . . . . . . . . . . . . . 18.2 pt -73.01 -29.38 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 683' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -52.09 66.96 Favored 'General case' 1 N--CA 1.55 4.562 0 C-N-CA 123.106 0.563 . . . . 0.0 110.421 -176.434 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 684' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.94 -36.33 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 685' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -52.17 -27.66 15.26 Favored 'General case' 0 N--CA 1.526 3.366 0 C-N-CA 124.214 1.005 . . . . 0.0 110.816 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 686' ' ' ILE . . . . . . . . . . . . . 9.0 mm -67.61 -48.01 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.235 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 687' ' ' ILE . . . . . . . . . . . . . 23.8 mt -64.33 -36.06 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.749 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.891 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 688' ' ' ILE . . . . . . . . . . . . . 44.3 mm -59.86 -42.59 89.67 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.202 0 CA-C-N 118.151 0.432 . . . . 0.0 110.192 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 689' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.62 -31.69 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 C-N-CA 123.838 0.855 . . . . 0.0 110.328 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 690' ' ' GLY . . . . . . . . . . . . . . . -62.66 -36.3 93.08 Favored Glycine 1 N--CA 1.522 4.428 0 C-N-CA 123.259 0.457 . . . . 0.0 112.194 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 691' ' ' SER . . . . . . . . . . . . . 64.2 m -68.12 -37.35 81.01 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 123.876 0.87 . . . . 0.0 111.805 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 692' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.13 -45.01 92.05 Favored 'General case' 0 N--CA 1.536 3.866 0 C-N-CA 123.589 0.755 . . . . 0.0 112.675 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 693' ' ' ILE . . . . . 0.651 HD11 ' HE ' ' A' ' 696' ' ' ARG 0.286 0.1 OUTLIER -63.38 -48.84 85.39 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.466 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.95 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' C' C ' 694' ' ' GLY . . . . . . . . . . . . . . . -55.2 -31.99 56.8 Favored Glycine 1 N--CA 1.531 5.016 0 CA-C-N 119.214 0.915 . . . . 0.0 113.279 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 695' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.23 -38.8 88.78 Favored 'General case' 0 N--CA 1.539 3.984 0 C-N-CA 124.728 1.211 . . . . 0.0 110.357 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 696' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -60.09 -28.48 67.87 Favored 'General case' 1 N--CA 1.543 4.203 0 O-C-N 121.575 -0.703 . . . . 0.0 111.878 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 697' ' ' ILE . . . . . . . . . . . . . 60.9 mt -55.71 -36.97 44.75 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.155 0 CA-C-O 121.916 0.865 . . . . 0.0 109.512 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 698' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.59 -27.13 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.292 0 C-N-CA 126.395 1.878 . . . . 0.0 110.695 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 699' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -54.09 -27.11 30.74 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 123.139 0.576 . . . . 0.0 111.797 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 700' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.84 86.86 Favored 'General case' 0 N--CA 1.527 3.405 0 O-C-N 122.038 -0.414 . . . . 0.0 110.367 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 701' ' ' VAL . . . . . . . . . . . . . 14.0 m -70.51 -31.75 47.53 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.025 0 CA-C-N 118.09 0.404 . . . . 0.0 110.085 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.66 -33.7 61.11 Favored 'General case' 0 N--CA 1.53 3.563 0 C-N-CA 123.521 0.729 . . . . 0.0 110.629 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 703' ' ' SER . . . . . . . . . . . . . 64.3 m -58.6 -46.95 85.9 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 704' ' ' LEU . . . . . . . . . . . . . 21.7 tp -65.56 -34.88 79.28 Favored 'General case' 1 N--CA 1.549 4.505 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 705' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.81 -38.88 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 706' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -65.46 -23.89 67.03 Favored 'General case' 0 N--CA 1.524 3.247 0 C-N-CA 123.251 0.62 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 707' ' ' ARG . . . . . . . . . . . . . 11.5 tpt85 -49.73 -37.24 28.55 Favored 'General case' 0 N--CA 1.516 2.849 0 CA-C-O 121.753 0.787 . . . . 0.0 110.76 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 708' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.75 -37.33 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.015 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 709' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.83 -28.7 58.37 Favored 'General case' 1 N--CA 1.54 4.031 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 710' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -89.71 -3.05 58.39 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 124.615 1.166 . . . . 0.0 109.133 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 711' ' ' GLY . . . . . . . . . . . . . . . -54.92 -24.34 33.96 Favored Glycine 1 N--CA 1.526 4.67 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 176.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 712' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -121.2 143.97 48.84 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 113.042 -1.579 . . . . 0.0 107.769 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 713' ' ' SER . . . . . . . . . . . . . 90.1 p -82.57 146.66 53.94 Favored Pre-proline 0 N--CA 1.53 3.527 0 CA-C-O 117.305 -1.331 . . . . 0.0 110.239 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 714' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.5 131.34 42.08 Favored 'Trans proline' 0 C--N 1.399 3.193 0 CA-C-N 121.614 1.612 . . . . 0.0 111.169 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 715' ' ' LEU . . . . . . . . . . . . . 61.6 mt -65.81 -167.14 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.19 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 716' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 N--CA 1.523 3.195 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.355 -179.988 . . . . . . . . 0 0 . 1 stop_ save_